data_2mb1_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2mb1 _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 511' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.232 0.158 0 CA-C-O 121.108 0.48 . . . . 0.0 111.428 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 512' ' ' ASN . . . . . . . . . . . . . 7.5 m-20 -131.35 82.46 62.28 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.434 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 513' ' ' PRO . . . . . 0.405 ' HA ' ' O ' ' A' ' 552' ' ' ASP . 85.3 Cg_endo -79.07 20.71 0.79 Allowed 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.895 2.396 . . . . 0.0 113.097 -179.642 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 34.8 t30 -96.67 -31.25 12.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.96 0.41 . . . . 0.0 110.786 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 515' ' ' LEU . . . . . . . . . . . . . 18.9 mt -83.52 73.85 10.16 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.886 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 516' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -72.47 -15.28 61.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.59 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 517' ' ' TYR . . . . . . . . . . . . . 48.2 m-85 -79.16 -66.03 0.92 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.819 0.342 . . . . 0.0 111.433 -179.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 518' ' ' TRP . . . . . 0.494 ' O ' ' N ' ' A' ' 520' ' ' THR . 21.2 m-90 -70.32 -14.38 62.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.884 -179.492 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 519' ' ' THR . . . . . 0.541 ' OG1' ' N ' ' A' ' 520' ' ' THR . 1.7 p 56.98 -78.8 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 116.727 -0.215 . . . . 0.0 110.719 -179.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 520' ' ' THR . . . . . 0.541 ' N ' ' OG1' ' A' ' 519' ' ' THR . 1.1 m 176.83 -62.68 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.149 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 521' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -72.73 -12.27 60.95 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 177.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 522' ' ' ASP . . . . . 0.427 ' O ' HG22 ' A' ' 527' ' ' ILE . 1.9 m-20 -93.89 -11.03 31.95 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.699 178.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -45.48 -27.92 0.81 Allowed 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.44 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 524' ' ' GLY . . . . . 0.433 ' HA2' ' CG1' ' A' ' 527' ' ' ILE . . . 147.62 41.38 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.489 -0.863 . . . . 0.0 112.477 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -100.44 -60.11 1.58 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.743 0.306 . . . . 0.0 111.737 -179.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -132.48 37.57 3.5 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-O 121.488 0.661 . . . . 0.0 110.103 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 527' ' ' ILE . . . . . 0.468 ' HA ' ' CB ' ' A' ' 544' ' ' ALA . 1.8 pp -95.94 -0.96 10.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 114.811 -1.086 . . . . 0.0 112.793 -178.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 528' ' ' GLY . . . . . . . . . . . . . . . -57.63 -12.56 9.94 Favored Glycine 0 CA--C 1.521 0.414 0 C-N-CA 120.875 -0.679 . . . . 0.0 113.976 -179.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 529' ' ' LEU . . . . . . . . . . . . . 1.2 pp -98.75 -39.37 8.68 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 117.757 0.779 . . . . 0.0 112.167 -179.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 530' ' ' ALA . . . . . 0.536 ' HB2' ' HB3' ' A' ' 543' ' ' TYR . . . -103.93 1.8 31.72 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 -178.461 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 531' ' ' TRP . . . . . 0.452 ' HB2' ' O ' ' A' ' 527' ' ' ILE . 54.9 t90 -72.04 30.3 0.05 Allowed 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -178.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 532' ' ' ILE . . . . . 0.473 ' H ' ' C ' ' A' ' 530' ' ' ALA . 1.3 pp -159.65 70.87 3.27 Favored Pre-proline 0 C--N 1.332 -0.181 0 CA-C-O 120.723 0.297 . . . . 0.0 110.894 179.176 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 533' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -51.26 103.51 0.07 OUTLIER 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.659 2.239 . . . . 0.0 111.742 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 534' ' ' TYR . . . . . 0.427 ' CD1' HD13 ' A' ' 532' ' ' ILE . 0.4 OUTLIER -96.17 -55.06 3.08 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -179.006 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 -118.52 -35.23 3.8 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 -179.1 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . -87.44 -175.06 48.68 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.891 -179.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -56.59 -159.34 0.01 OUTLIER 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.884 2.39 . . . . 0.0 111.692 179.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 538' ' ' ALA . . . . . 0.456 ' C ' ' H ' ' A' ' 540' ' ' GLU . . . -43.99 -49.83 8.48 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.067 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 539' ' ' ALA . . . . . 0.433 ' O ' ' HB3' ' A' ' 530' ' ' ALA . . . 71.66 -46.7 0.65 Allowed 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.205 0.526 . . . . 0.0 111.548 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 540' ' ' GLU . . . . . 0.456 ' H ' ' C ' ' A' ' 538' ' ' ALA . 2.5 mt-10 -36.95 -29.09 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.057 -0.974 . . . . 0.0 112.304 -179.352 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 541' ' ' GLY . . . . . 0.406 ' N ' ' O ' ' A' ' 539' ' ' ALA . . . -127.79 -48.66 0.17 Allowed Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.028 179.21 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 542' ' ' ILE . . . . . 0.423 ' CD1' ' HA ' ' A' ' 539' ' ' ALA . 2.6 pp -68.09 -25.14 31.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -179.355 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 543' ' ' TYR . . . . . 0.536 ' HB3' ' HB2' ' A' ' 530' ' ' ALA . 6.1 t80 -115.3 -8.0 12.32 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.857 0.361 . . . . 0.0 111.145 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 544' ' ' ALA . . . . . 0.49 ' CB ' ' HB3' ' A' ' 530' ' ' ALA . . . -99.31 -33.22 10.81 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.06 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 545' ' ' GLU . . . . . 0.47 ' HG3' ' H ' ' A' ' 548' ' ' MET . 14.3 tp10 -118.67 -32.67 4.49 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.209 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 40.71 42.1 2.66 Favored Glycine 0 CA--C 1.521 0.417 0 CA-C-N 115.917 -0.583 . . . . 0.0 113.747 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 547' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -173.16 -61.14 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 117.4 0.6 . . . . 0.0 112.14 179.608 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 548' ' ' MET . . . . . 0.484 ' O ' ' HG3' ' A' ' 551' ' ' GLN . 4.3 mtt -95.31 11.71 31.64 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.709 0.29 . . . . 0.0 111.481 -179.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 549' ' ' HIS . . . . . 0.46 ' O ' ' CG2' ' A' ' 519' ' ' THR . 14.7 p-80 -65.47 -11.08 39.81 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.861 0.363 . . . . 0.0 110.791 179.423 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 550' ' ' ASN . . . . . 0.505 ' O ' ' N ' ' A' ' 552' ' ' ASP . 15.0 m-20 -95.87 -41.08 8.99 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -179.092 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 551' ' ' GLN . . . . . 0.484 ' HG3' ' O ' ' A' ' 548' ' ' MET . 0.0 OUTLIER -62.36 73.31 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.171 0.51 . . . . 0.0 110.469 -179.882 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 552' ' ' ASP . . . . . 0.505 ' N ' ' O ' ' A' ' 550' ' ' ASN . 1.9 p30 -90.25 22.2 3.44 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.601 -179.581 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . 124.04 -30.52 4.78 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.891 -0.671 . . . . 0.0 111.668 -179.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 554' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -55.73 -53.65 54.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.559 0.695 . . . . 0.0 110.138 178.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 555' ' ' ILE . . . . . 0.408 ' CG2' ' O ' ' A' ' 555' ' ' ILE . 4.0 mm -79.52 58.96 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.696 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 556' ' ' CYS . . . . . . . . . . . . . 6.3 t . . . . . 0 C--N 1.326 -0.436 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.469 -179.796 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 511' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.983 0.42 . . . . 0.0 111.485 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 512' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -131.72 77.23 73.09 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.403 179.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 513' ' ' PRO . . . . . 0.417 ' HA ' ' O ' ' A' ' 552' ' ' ASP . 87.7 Cg_endo -79.75 22.52 0.72 Allowed 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.932 2.421 . . . . 0.0 113.177 -179.533 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 25.8 t30 -96.67 -28.97 14.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.691 0.281 . . . . 0.0 110.804 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 515' ' ' LEU . . . . . . . . . . . . . 46.4 mt -90.59 72.87 6.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.926 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 516' ' ' HIS . . . . . 0.421 ' HA ' ' CB ' ' A' ' 552' ' ' ASP . 1.4 t60 -76.7 -7.34 55.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.655 -179.742 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 517' ' ' TYR . . . . . . . . . . . . . 42.9 m-85 -85.26 -49.5 8.14 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.674 0.274 . . . . 0.0 111.524 -179.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 518' ' ' TRP . . . . . 0.495 ' O ' ' N ' ' A' ' 520' ' ' THR . 3.0 m-90 -88.56 -11.55 45.3 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 111.886 0.328 . . . . 0.0 111.886 -179.331 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 519' ' ' THR . . . . . 0.566 ' OG1' ' N ' ' A' ' 520' ' ' THR . 1.3 p 56.22 -79.08 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.81 -0.177 . . . . 0.0 110.989 179.799 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 520' ' ' THR . . . . . 0.566 ' N ' ' OG1' ' A' ' 519' ' ' THR . 1.2 m 179.46 -62.74 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 179.435 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 521' ' ' GLN . . . . . . . . . . . . . 6.8 mt-30 -74.16 -12.07 60.48 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 177.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 522' ' ' ASP . . . . . 0.449 ' O ' HG23 ' A' ' 527' ' ' ILE . 20.8 m-20 -93.95 -10.57 33.28 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.854 179.296 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 523' ' ' GLU . . . . . 0.446 ' HA ' ' CD1' ' A' ' 518' ' ' TRP . 14.1 pt-20 -45.24 -26.65 0.52 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.515 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . 147.6 41.35 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.289 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -101.23 -60.46 1.52 Allowed 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 111.941 0.349 . . . . 0.0 111.941 -179.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -131.44 36.84 3.74 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-O 121.541 0.686 . . . . 0.0 110.129 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 527' ' ' ILE . . . . . 0.474 ' HA ' ' CB ' ' A' ' 544' ' ' ALA . 2.1 pp -95.77 -0.38 10.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 114.762 -1.108 . . . . 0.0 112.709 -178.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 528' ' ' GLY . . . . . . . . . . . . . . . -60.41 -10.47 16.85 Favored Glycine 0 CA--C 1.521 0.423 0 C-N-CA 120.82 -0.705 . . . . 0.0 113.948 -179.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 529' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -98.47 -33.69 10.92 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 117.569 0.684 . . . . 0.0 111.502 -179.585 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 530' ' ' ALA . . . . . 0.513 ' C ' ' H ' ' A' ' 532' ' ' ILE . . . -103.75 1.63 31.96 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -178.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 531' ' ' TRP . . . . . 0.437 ' O ' ' CG2' ' A' ' 532' ' ' ILE . 0.2 OUTLIER -71.15 30.2 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -179.056 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 532' ' ' ILE . . . . . 0.513 ' H ' ' C ' ' A' ' 530' ' ' ALA . 1.1 pt -161.02 75.38 2.57 Favored Pre-proline 0 N--CA 1.456 -0.162 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.471 179.301 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 533' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -36.89 85.98 0.01 OUTLIER 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 123.5 2.8 . . . . 0.0 113.399 -179.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 534' ' ' TYR . . . . . 0.455 ' N ' ' O ' ' A' ' 532' ' ' ILE . 0.6 OUTLIER -96.7 -49.51 5.07 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.269 -179.991 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -57.53 -34.85 69.56 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.548 -179.329 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 143.47 -64.57 0.48 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.566 -0.826 . . . . 0.0 112.531 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -58.72 -165.48 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.622 2.215 . . . . 0.0 111.711 179.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 538' ' ' ALA . . . . . . . . . . . . . . . -62.13 -51.1 69.24 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.292 179.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 539' ' ' ALA . . . . . 0.464 ' HA ' ' CD1' ' A' ' 542' ' ' ILE . . . 68.45 -53.72 0.54 Allowed 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.599 179.725 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 540' ' ' GLU . . . . . 0.419 ' O ' ' HB1' ' A' ' 544' ' ' ALA . 0.6 OUTLIER -37.28 -27.98 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.022 -0.99 . . . . 0.0 112.09 -179.416 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 541' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 539' ' ' ALA . . . -124.57 -47.31 0.23 Allowed Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.14 179.155 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 542' ' ' ILE . . . . . 0.464 ' CD1' ' HA ' ' A' ' 539' ' ' ALA . 2.6 pp -72.65 -22.92 20.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 -179.634 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 543' ' ' TYR . . . . . 0.455 ' HB3' ' HB3' ' A' ' 530' ' ' ALA . 89.8 t80 -111.02 -8.05 14.48 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.067 0.461 . . . . 0.0 110.68 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 544' ' ' ALA . . . . . 0.474 ' CB ' ' HA ' ' A' ' 527' ' ' ILE . . . -103.04 -32.86 9.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.02 179.43 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 545' ' ' GLU . . . . . 0.421 ' HG3' ' H ' ' A' ' 548' ' ' MET . 29.3 tp10 -118.49 -32.74 4.52 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.207 -179.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 38.17 37.61 0.48 Allowed Glycine 0 CA--C 1.519 0.326 0 CA-C-N 115.723 -0.672 . . . . 0.0 113.985 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 547' ' ' LEU . . . . . 0.439 ' HG ' ' N ' ' A' ' 548' ' ' MET . 0.0 OUTLIER -170.58 -61.99 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 117.694 0.747 . . . . 0.0 112.506 179.484 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 548' ' ' MET . . . . . 0.439 ' N ' ' HG ' ' A' ' 547' ' ' LEU . 0.0 OUTLIER -96.45 11.31 35.38 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.731 0.301 . . . . 0.0 111.124 179.682 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 549' ' ' HIS . . . . . 0.489 ' O ' ' CG2' ' A' ' 519' ' ' THR . 6.0 p-80 -63.43 -10.99 19.76 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.919 179.6 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 550' ' ' ASN . . . . . 0.402 ' O ' ' N ' ' A' ' 552' ' ' ASP . 44.9 m-20 -95.73 -34.25 12.0 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -179.021 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 551' ' ' GLN . . . . . 0.412 ' HG2' ' HG3' ' A' ' 548' ' ' MET . 2.5 pt20 -66.87 71.86 0.09 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.016 0.436 . . . . 0.0 110.55 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 552' ' ' ASP . . . . . 0.445 ' HA ' ' O ' ' A' ' 519' ' ' THR . 2.6 p30 -93.62 21.95 5.89 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.37 -179.626 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . 123.9 -31.91 4.38 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.885 -0.674 . . . . 0.0 111.752 -179.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 554' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.42 -57.85 11.17 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.493 0.663 . . . . 0.0 110.194 179.017 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 555' ' ' ILE . . . . . 0.401 ' O ' ' CG2' ' A' ' 555' ' ' ILE . 2.8 mm -72.36 63.77 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 CA-C-N 114.892 -1.049 . . . . 0.0 110.724 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 556' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.475 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.328 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 511' ' ' CYS . . . . . . . . . . . . . 1.5 t . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.947 0.403 . . . . 0.0 111.315 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 512' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -109.76 78.2 1.18 Allowed Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.468 179.727 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 513' ' ' PRO . . . . . 0.414 ' HA ' ' O ' ' A' ' 552' ' ' ASP . 73.6 Cg_endo -75.89 18.42 0.63 Allowed 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.92 2.414 . . . . 0.0 113.106 -179.494 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -96.7 -34.26 11.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.782 0.325 . . . . 0.0 110.773 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 515' ' ' LEU . . . . . . . . . . . . . 52.6 mt -78.9 75.13 5.41 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.943 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 516' ' ' HIS . . . . . . . . . . . . . 1.3 p-80 -79.87 -7.23 58.61 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.677 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 517' ' ' TYR . . . . . 0.422 ' HB2' ' CE3' ' A' ' 518' ' ' TRP . 44.5 m-85 -77.79 -59.9 2.59 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.783 0.325 . . . . 0.0 111.309 -179.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 518' ' ' TRP . . . . . 0.55 ' O ' ' N ' ' A' ' 520' ' ' THR . 13.9 m-90 -91.17 4.68 51.62 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.793 -179.618 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 519' ' ' THR . . . . . 0.534 ' OG1' ' N ' ' A' ' 520' ' ' THR . 1.3 p 54.42 -76.6 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 116.851 -0.159 . . . . 0.0 110.986 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 520' ' ' THR . . . . . 0.55 ' N ' ' O ' ' A' ' 518' ' ' TRP . 1.2 m 176.98 -62.47 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.231 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 179.436 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 521' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.81 -12.37 61.57 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.418 178.103 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 522' ' ' ASP . . . . . 0.43 ' HA ' ' CG2' ' A' ' 527' ' ' ILE . 1.1 m-20 -93.93 -11.2 31.49 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.939 179.294 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -45.52 -27.56 0.76 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.474 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 524' ' ' GLY . . . . . 0.426 ' HA2' ' CG1' ' A' ' 527' ' ' ILE . . . 144.99 42.45 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.508 -0.854 . . . . 0.0 112.229 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -101.32 -60.31 1.55 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.713 0.292 . . . . 0.0 111.706 -179.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -131.8 38.43 3.55 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-O 121.521 0.677 . . . . 0.0 110.036 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 527' ' ' ILE . . . . . 0.483 ' HA ' ' CB ' ' A' ' 544' ' ' ALA . 2.1 pp -95.8 -0.5 10.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 114.719 -1.128 . . . . 0.0 112.775 -178.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 528' ' ' GLY . . . . . . . . . . . . . . . -57.71 -14.31 14.94 Favored Glycine 0 CA--C 1.521 0.452 0 C-N-CA 120.762 -0.733 . . . . 0.0 114.005 -179.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 529' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -98.74 -33.66 10.83 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 117.666 0.733 . . . . 0.0 111.909 -179.334 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 530' ' ' ALA . . . . . 0.52 ' C ' ' H ' ' A' ' 532' ' ' ILE . . . -103.85 1.96 32.11 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -178.604 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 531' ' ' TRP . . . . . 0.471 ' HA ' ' HG2' ' A' ' 540' ' ' GLU . 57.3 t-105 -68.43 30.09 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.546 0.573 . . . . 0.0 112.546 -178.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 532' ' ' ILE . . . . . 0.52 ' H ' ' C ' ' A' ' 530' ' ' ALA . 1.1 pt -160.2 71.9 3.04 Favored Pre-proline 0 C--N 1.331 -0.207 0 CA-C-O 120.827 0.346 . . . . 0.0 110.742 179.037 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 533' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_endo -47.11 88.43 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 123.148 2.565 . . . . 0.0 112.821 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 534' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -96.43 -43.6 7.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.283 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -57.75 -34.78 69.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.552 -179.341 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 149.13 -64.77 0.4 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.529 -0.843 . . . . 0.0 112.579 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_endo -57.3 -164.09 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.576 2.184 . . . . 0.0 111.8 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 538' ' ' ALA . . . . . . . . . . . . . . . -72.03 -47.2 53.45 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.619 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 539' ' ' ALA . . . . . 0.458 ' HA ' ' CD1' ' A' ' 542' ' ' ILE . . . 70.7 -53.73 0.66 Allowed 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.33 0.586 . . . . 0.0 111.227 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 540' ' ' GLU . . . . . 0.471 ' HG2' ' HA ' ' A' ' 531' ' ' TRP . 15.6 mt-10 -37.26 -28.17 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.543 0 CA-C-N 114.828 -1.078 . . . . 0.0 112.37 -179.442 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 541' ' ' GLY . . . . . 0.445 ' HA3' ' CD2' ' A' ' 549' ' ' HIS . . . -126.24 -40.17 0.38 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.388 179.51 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 542' ' ' ILE . . . . . 0.458 ' CD1' ' HA ' ' A' ' 539' ' ' ALA . 2.6 pp -79.88 -23.16 11.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 112.122 0.415 . . . . 0.0 112.122 -179.406 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 543' ' ' TYR . . . . . 0.445 ' HB3' ' HB3' ' A' ' 530' ' ' ALA . 89.0 t80 -111.48 -7.79 14.31 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.042 0.449 . . . . 0.0 110.613 179.63 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 544' ' ' ALA . . . . . 0.483 ' CB ' ' HA ' ' A' ' 527' ' ' ILE . . . -103.06 -36.91 7.98 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.381 179.181 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 545' ' ' GLU . . . . . 0.424 ' CG ' ' H ' ' A' ' 548' ' ' MET . 20.2 tp10 -118.91 -32.57 4.45 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.099 -0.955 . . . . 0.0 111.1 179.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 37.09 47.58 1.38 Allowed Glycine 0 C--N 1.331 0.285 0 CA-C-N 115.992 -0.549 . . . . 0.0 113.387 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 547' ' ' LEU . . . . . 0.664 ' HG ' ' N ' ' A' ' 548' ' ' MET . 0.0 OUTLIER -174.87 -57.55 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 117.276 0.538 . . . . 0.0 111.834 179.949 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 548' ' ' MET . . . . . 0.664 ' N ' ' HG ' ' A' ' 547' ' ' LEU . 0.0 OUTLIER -96.0 11.49 33.85 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.644 0.259 . . . . 0.0 111.344 -179.999 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 549' ' ' HIS . . . . . 0.451 ' O ' ' CG2' ' A' ' 519' ' ' THR . 12.8 t-80 -62.59 -11.82 19.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.817 0.341 . . . . 0.0 110.629 179.431 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 550' ' ' ASN . . . . . 0.477 ' O ' ' N ' ' A' ' 552' ' ' ASP . 32.7 m-20 -96.22 -39.74 9.52 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.629 -179.531 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 551' ' ' GLN . . . . . 0.415 ' HG3' ' O ' ' A' ' 548' ' ' MET . 1.5 pt20 -61.81 73.93 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.228 0.537 . . . . 0.0 110.843 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 552' ' ' ASP . . . . . 0.492 ' HA ' ' O ' ' A' ' 519' ' ' THR . 1.6 p30 -83.78 22.24 1.15 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.541 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . 124.25 -26.75 5.73 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 121.01 -0.614 . . . . 0.0 111.62 -179.131 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 554' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -59.23 -53.32 59.65 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.438 0.637 . . . . 0.0 110.117 178.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 555' ' ' ILE . . . . . . . . . . . . . 8.1 mm -84.59 54.02 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 CA-C-N 114.945 -1.025 . . . . 0.0 111.111 -179.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 556' ' ' CYS . . . . . . . . . . . . . 8.0 p . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.392 179.953 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 511' ' ' CYS . . . . . . . . . . . . . 2.5 m . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.938 0.399 . . . . 0.0 111.611 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 512' ' ' ASN . . . . . 0.416 ' O ' ' O ' ' A' ' 552' ' ' ASP . 0.5 OUTLIER -118.05 81.73 16.63 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.351 179.653 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 513' ' ' PRO . . . . . 0.475 ' HA ' ' O ' ' A' ' 552' ' ' ASP . 64.4 Cg_endo -75.21 18.78 0.54 Allowed 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 123.0 2.467 . . . . 0.0 113.235 -179.773 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 24.2 t30 -96.71 -34.17 11.46 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.873 0.368 . . . . 0.0 110.859 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 515' ' ' LEU . . . . . . . . . . . . . 2.7 mt -84.68 74.07 10.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.006 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 516' ' ' HIS . . . . . 0.43 ' HA ' ' CB ' ' A' ' 552' ' ' ASP . 14.2 t60 -71.47 -8.4 53.65 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.91 -179.726 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 517' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -82.26 -62.5 1.61 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.712 0.291 . . . . 0.0 111.629 -179.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 518' ' ' TRP . . . . . 0.506 ' O ' ' N ' ' A' ' 520' ' ' THR . 14.4 m-90 -71.39 -17.86 62.39 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.661 -179.467 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 519' ' ' THR . . . . . 0.508 ' OG1' ' N ' ' A' ' 520' ' ' THR . 1.8 p 54.04 -80.29 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 116.621 -0.263 . . . . 0.0 110.919 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 520' ' ' THR . . . . . 0.508 ' N ' ' OG1' ' A' ' 519' ' ' THR . 1.2 m 177.71 -62.85 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 179.065 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 521' ' ' GLN . . . . . 0.407 ' HB2' ' HB3' ' A' ' 548' ' ' MET . 0.7 OUTLIER -72.64 -11.69 60.74 Favored 'General case' 0 CA--C 1.513 -0.45 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 177.989 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 522' ' ' ASP . . . . . 0.44 ' HA ' ' CG2' ' A' ' 527' ' ' ILE . 2.4 m-20 -87.47 -11.04 50.17 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.745 179.146 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -45.2 -26.6 0.51 Allowed 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.902 -179.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 524' ' ' GLY . . . . . 0.459 ' HA2' ' CG1' ' A' ' 527' ' ' ILE . . . 148.51 40.52 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.458 -0.877 . . . . 0.0 112.386 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -98.21 -59.65 1.71 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.806 0.336 . . . . 0.0 111.892 -179.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -133.59 32.44 3.6 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.577 0.703 . . . . 0.0 110.018 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 527' ' ' ILE . . . . . 0.543 HG21 ' HB2' ' A' ' 544' ' ' ALA . 2.3 pp -95.86 -0.56 10.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 114.593 -1.185 . . . . 0.0 112.644 -178.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 528' ' ' GLY . . . . . . . . . . . . . . . -58.88 -4.57 2.3 Favored Glycine 0 CA--C 1.522 0.52 0 N-CA-C 114.696 0.638 . . . . 0.0 114.696 -178.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 529' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -98.2 -42.24 7.52 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 118.031 0.915 . . . . 0.0 111.672 -179.59 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 530' ' ' ALA . . . . . 0.428 ' HB2' ' CB ' ' A' ' 544' ' ' ALA . . . -103.85 1.99 32.14 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.354 0.502 . . . . 0.0 112.354 -179.239 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 531' ' ' TRP . . . . . 0.499 ' HB2' ' O ' ' A' ' 527' ' ' ILE . 22.5 t-105 -54.83 -9.27 0.33 Allowed 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 112.893 0.701 . . . . 0.0 112.893 -178.134 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 532' ' ' ILE . . . . . 0.401 ' O ' ' CD1' ' A' ' 532' ' ' ILE . 1.6 pp -135.34 76.23 56.89 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-O 121.039 0.447 . . . . 0.0 111.05 179.313 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 533' ' ' PRO . . . . . 0.405 ' HG3' ' H ' ' A' ' 540' ' ' GLU . 32.4 Cg_exo -63.29 89.51 0.13 Allowed 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 123.058 2.506 . . . . 0.0 112.591 -179.586 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 534' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -60.52 -54.35 46.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.993 0.425 . . . . 0.0 110.151 179.415 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -118.18 22.99 11.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.702 179.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . -122.34 153.1 16.84 Favored Glycine 0 C--N 1.333 0.377 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.736 -179.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -71.28 -89.47 0.0 OUTLIER 'Trans proline' 0 CA--C 1.534 0.503 0 C-N-CA 122.714 2.276 . . . . 0.0 112.834 -179.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 538' ' ' ALA . . . . . . . . . . . . . . . -99.29 17.11 20.89 Favored 'General case' 0 C--N 1.333 -0.114 0 N-CA-C 111.534 0.198 . . . . 0.0 111.534 -179.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 539' ' ' ALA . . . . . 0.41 ' HA ' ' CD1' ' A' ' 542' ' ' ILE . . . -34.12 -43.8 0.16 Allowed 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 -179.395 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 540' ' ' GLU . . . . . 0.429 ' CB ' ' HA ' ' A' ' 531' ' ' TRP . 0.0 OUTLIER -60.1 -6.84 1.53 Allowed 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -178.579 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 541' ' ' GLY . . . . . 0.4 ' HA2' ' OD1' ' A' ' 522' ' ' ASP . . . -125.62 -40.6 0.38 Allowed Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 121.026 -0.607 . . . . 0.0 111.919 178.811 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 542' ' ' ILE . . . . . 0.472 ' HA ' ' CB ' ' A' ' 549' ' ' HIS . 2.1 pp -97.26 -19.36 6.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -179.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 543' ' ' TYR . . . . . . . . . . . . . 29.4 t80 -108.85 -16.3 14.19 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.048 0.452 . . . . 0.0 110.65 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 544' ' ' ALA . . . . . 0.543 ' HB2' HG21 ' A' ' 527' ' ' ILE . . . -91.2 -16.81 27.08 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.604 179.73 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 545' ' ' GLU . . . . . 0.409 ' HG2' ' N ' ' A' ' 549' ' ' HIS . 5.4 tp10 -118.44 -32.82 4.51 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.343 -179.758 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 35.84 41.35 0.42 Allowed Glycine 0 CA--C 1.521 0.412 0 CA-C-N 115.841 -0.618 . . . . 0.0 114.133 179.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 547' ' ' LEU . . . . . 0.412 ' HG ' ' N ' ' A' ' 548' ' ' MET . 0.0 OUTLIER -172.45 -62.11 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 117.615 0.708 . . . . 0.0 112.084 179.401 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 548' ' ' MET . . . . . 0.412 ' N ' ' HG ' ' A' ' 547' ' ' LEU . 0.0 OUTLIER -96.32 11.6 34.11 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.06 0.457 . . . . 0.0 110.378 179.02 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 549' ' ' HIS . . . . . 0.472 ' CB ' ' HA ' ' A' ' 542' ' ' ILE . 0.3 OUTLIER -59.53 -11.3 4.43 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.323 179.744 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 550' ' ' ASN . . . . . 0.49 ' O ' ' N ' ' A' ' 552' ' ' ASP . 45.5 t30 -94.54 -34.22 12.75 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -178.461 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 551' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -64.25 70.95 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.131 0.491 . . . . 0.0 110.4 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 552' ' ' ASP . . . . . 0.49 ' N ' ' O ' ' A' ' 550' ' ' ASN . 2.9 p30 -101.69 21.91 13.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.513 -179.319 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . 123.69 -31.73 4.48 Favored Glycine 0 N--CA 1.449 -0.461 0 N-CA-C 111.47 -0.652 . . . . 0.0 111.47 -179.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 554' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -62.58 -49.1 76.58 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.493 0.663 . . . . 0.0 109.648 178.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 555' ' ' ILE . . . . . . . . . . . . . 6.0 mm -88.63 60.62 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 CA-C-N 114.789 -1.096 . . . . 0.0 110.659 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 556' ' ' CYS . . . . . . . . . . . . . 20.1 m . . . . . 0 C--N 1.326 -0.443 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.38 -179.781 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 511' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.11 0 CA-C-O 121.152 0.501 . . . . 0.0 111.222 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 512' ' ' ASN . . . . . . . . . . . . . 34.3 m-20 -156.15 79.6 4.03 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.056 179.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 513' ' ' PRO . . . . . 0.415 ' HB3' ' HG ' ' A' ' 554' ' ' LEU . 26.0 Cg_exo -61.5 -15.83 43.74 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 123.056 2.504 . . . . 0.0 112.479 -179.567 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 22.6 t30 -57.47 -43.52 84.09 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.29 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 515' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -81.18 73.82 8.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.822 0.344 . . . . 0.0 111.065 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 516' ' ' HIS . . . . . 0.491 ' CE1' ' CE1' ' A' ' 517' ' ' TYR . 19.1 p80 -89.25 -7.25 55.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.622 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 517' ' ' TYR . . . . . 0.491 ' CE1' ' CE1' ' A' ' 516' ' ' HIS . 43.1 m-85 -74.93 -30.85 61.36 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 111.702 0.26 . . . . 0.0 111.702 -179.525 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 518' ' ' TRP . . . . . 0.582 ' O ' ' N ' ' A' ' 520' ' ' THR . 8.5 m-90 -117.92 -0.03 11.79 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 -179.504 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 519' ' ' THR . . . . . 0.558 ' OG1' ' N ' ' A' ' 520' ' ' THR . 1.2 p 49.38 -78.37 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 120.485 0.183 . . . . 0.0 111.405 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 520' ' ' THR . . . . . 0.582 ' N ' ' O ' ' A' ' 518' ' ' TRP . 1.3 m -179.15 -62.45 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 179.519 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 521' ' ' GLN . . . . . . . . . . . . . 8.2 mt-30 -72.78 -11.87 60.78 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.32 177.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 522' ' ' ASP . . . . . 0.437 ' O ' HG23 ' A' ' 527' ' ' ILE . 68.8 m-20 -91.63 -10.71 39.41 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.81 179.128 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -45.26 -26.71 0.54 Allowed 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.48 -179.72 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . 146.53 41.47 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.356 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -100.66 -60.95 1.43 Allowed 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 111.785 0.291 . . . . 0.0 111.785 -179.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -131.96 38.17 3.55 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-O 121.549 0.69 . . . . 0.0 110.132 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 527' ' ' ILE . . . . . 0.476 ' HA ' ' CB ' ' A' ' 544' ' ' ALA . 2.1 pp -95.79 -2.51 10.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 114.746 -1.116 . . . . 0.0 112.844 -178.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 528' ' ' GLY . . . . . . . . . . . . . . . -56.47 -16.59 16.1 Favored Glycine 0 CA--C 1.52 0.403 0 C-N-CA 120.791 -0.719 . . . . 0.0 114.028 -179.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 529' ' ' LEU . . . . . 0.409 ' CD1' ' O ' ' A' ' 543' ' ' TYR . 0.7 OUTLIER -99.21 -32.82 11.02 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 117.809 0.805 . . . . 0.0 112.292 -179.394 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 530' ' ' ALA . . . . . 0.462 ' C ' ' H ' ' A' ' 532' ' ' ILE . . . -103.82 1.52 31.66 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -179.022 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 531' ' ' TRP . . . . . 0.439 ' HB2' ' O ' ' A' ' 527' ' ' ILE . 55.5 t90 -73.48 30.33 0.07 Allowed 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -179.299 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 532' ' ' ILE . . . . . 0.462 ' H ' ' C ' ' A' ' 530' ' ' ALA . 1.1 pt -158.26 77.41 3.44 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-O 120.739 0.304 . . . . 0.0 110.888 179.425 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 533' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_exo -41.74 88.14 0.01 OUTLIER 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 123.045 2.497 . . . . 0.0 112.956 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 534' ' ' TYR . . . . . 0.437 ' N ' ' O ' ' A' ' 532' ' ' ILE . 12.5 t80 -96.51 -51.98 4.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.483 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -57.73 -34.84 69.93 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.635 -179.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 144.89 -64.18 0.46 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.506 -0.854 . . . . 0.0 112.597 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -55.29 -168.88 0.02 OUTLIER 'Trans proline' 0 CA--C 1.515 -0.457 0 C-N-CA 122.606 2.204 . . . . 0.0 111.906 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 538' ' ' ALA . . . . . 0.416 ' C ' ' H ' ' A' ' 540' ' ' GLU . . . -63.93 -53.47 49.9 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.199 179.605 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 539' ' ' ALA . . . . . 0.463 ' HA ' HD11 ' A' ' 542' ' ' ILE . . . 67.81 -49.93 0.52 Allowed 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.995 179.5 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 540' ' ' GLU . . . . . 0.455 ' O ' ' HB3' ' A' ' 544' ' ' ALA . 0.2 OUTLIER -37.6 -27.0 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.927 -1.033 . . . . 0.0 112.414 -179.275 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 541' ' ' GLY . . . . . 0.411 ' N ' ' O ' ' A' ' 539' ' ' ALA . . . -125.94 -43.6 0.27 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.755 -0.736 . . . . 0.0 111.889 179.129 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 542' ' ' ILE . . . . . 0.463 HD11 ' HA ' ' A' ' 539' ' ' ALA . 1.0 OUTLIER -69.93 -25.91 29.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 112.363 0.505 . . . . 0.0 112.363 -179.713 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 543' ' ' TYR . . . . . 0.456 ' HB2' ' HA ' ' A' ' 539' ' ' ALA . 0.1 OUTLIER -111.69 -9.27 14.14 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.903 0.382 . . . . 0.0 110.784 179.988 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 544' ' ' ALA . . . . . 0.476 ' CB ' ' HA ' ' A' ' 527' ' ' ILE . . . -100.52 -33.67 10.24 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.84 179.689 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 545' ' ' GLU . . . . . 0.455 ' HG3' ' H ' ' A' ' 548' ' ' MET . 37.6 tp10 -118.86 -32.77 4.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.316 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 39.3 39.82 1.16 Allowed Glycine 0 CA--C 1.519 0.304 0 CA-C-N 115.732 -0.667 . . . . 0.0 113.976 179.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 547' ' ' LEU . . . . . 0.417 ' HG ' ' N ' ' A' ' 548' ' ' MET . 0.0 OUTLIER -173.24 -61.76 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 117.702 0.751 . . . . 0.0 112.303 179.43 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 548' ' ' MET . . . . . 0.455 ' H ' ' HG3' ' A' ' 545' ' ' GLU . 0.0 OUTLIER -96.32 11.51 34.4 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.7 0.286 . . . . 0.0 111.084 179.559 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 549' ' ' HIS . . . . . 0.479 ' O ' ' CG2' ' A' ' 519' ' ' THR . 9.8 p80 -61.12 -11.56 9.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.85 0.357 . . . . 0.0 111.013 179.462 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 550' ' ' ASN . . . . . . . . . . . . . 48.5 m-20 -96.09 -30.79 13.35 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -179.083 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 551' ' ' GLN . . . . . 0.403 ' HG2' ' HG3' ' A' ' 548' ' ' MET . 2.7 pt20 -68.08 70.95 0.16 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.038 0.447 . . . . 0.0 110.696 -179.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 552' ' ' ASP . . . . . 0.417 ' HB2' ' HA ' ' A' ' 516' ' ' HIS . 1.9 p30 -94.95 21.82 7.21 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.244 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . 123.83 -27.91 5.56 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.856 -0.688 . . . . 0.0 111.629 -179.259 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 554' ' ' LEU . . . . . 0.415 ' HG ' ' HB3' ' A' ' 513' ' ' PRO . 0.4 OUTLIER -61.93 -55.32 30.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.567 0.698 . . . . 0.0 110.034 179.067 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 555' ' ' ILE . . . . . . . . . . . . . 1.8 mm -71.66 66.94 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 114.78 -1.1 . . . . 0.0 110.421 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 556' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.323 -0.571 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.742 -179.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 511' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.53 0.192 0 CA-C-O 120.912 0.387 . . . . 0.0 111.44 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 512' ' ' ASN . . . . . . . . . . . . . 35.1 m-20 -120.53 79.99 30.16 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.652 179.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 513' ' ' PRO . . . . . 0.403 ' HA ' ' O ' ' A' ' 552' ' ' ASP . 42.7 Cg_endo -68.18 -10.23 28.28 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.651 2.234 . . . . 0.0 112.56 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 39.7 t30 -74.62 -29.98 61.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.08 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 515' ' ' LEU . . . . . . . . . . . . . 65.5 mt -84.94 74.6 10.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.886 0.374 . . . . 0.0 110.93 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 516' ' ' HIS . . . . . 0.429 ' HA ' ' HB3' ' A' ' 552' ' ' ASP . 1.9 p-80 -89.09 -7.13 56.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.582 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 517' ' ' TYR . . . . . . . . . . . . . 31.2 m-85 -70.65 -50.79 33.05 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.69 0.281 . . . . 0.0 111.638 -179.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 518' ' ' TRP . . . . . 0.494 ' O ' ' N ' ' A' ' 520' ' ' THR . 24.1 m-90 -112.56 10.04 19.52 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 111.914 0.338 . . . . 0.0 111.914 -179.644 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 519' ' ' THR . . . . . 0.509 HG21 ' HA ' ' A' ' 549' ' ' HIS . 1.1 p 60.88 -70.13 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 116.65 -0.25 . . . . 0.0 110.915 179.627 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 520' ' ' THR . . . . . 0.494 ' N ' ' O ' ' A' ' 518' ' ' TRP . 1.0 OUTLIER 174.95 -62.82 0.01 OUTLIER 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.152 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 521' ' ' GLN . . . . . 0.486 ' HB3' ' OE1' ' A' ' 545' ' ' GLU . 0.7 OUTLIER -73.36 -11.95 60.66 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 178.188 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 522' ' ' ASP . . . . . 0.402 ' HB3' ' O ' ' A' ' 518' ' ' TRP . 0.6 OUTLIER -91.93 -10.97 37.57 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.912 179.1 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -45.07 -27.5 0.58 Allowed 'General case' 0 CA--C 1.528 0.107 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.304 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . 151.41 41.24 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.852 -0.69 . . . . 0.0 112.144 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -122.2 -20.33 6.24 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -143.79 30.25 1.34 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.254 0.55 . . . . 0.0 110.903 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 527' ' ' ILE . . . . . 0.529 ' O ' ' HB2' ' A' ' 531' ' ' TRP . 2.3 pp -95.64 -24.72 4.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.934 -179.562 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 528' ' ' GLY . . . . . . . . . . . . . . . -49.47 -13.23 0.43 Allowed Glycine 0 CA--C 1.523 0.575 0 C-N-CA 121.154 -0.545 . . . . 0.0 114.369 -179.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 529' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -98.03 -47.83 5.36 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 117.864 0.832 . . . . 0.0 111.863 -179.168 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 530' ' ' ALA . . . . . 0.521 ' C ' ' H ' ' A' ' 532' ' ' ILE . . . -103.69 1.93 32.49 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 -178.437 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 531' ' ' TRP . . . . . 0.529 ' HB2' ' O ' ' A' ' 527' ' ' ILE . 58.8 t90 -68.85 30.53 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -179.074 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 532' ' ' ILE . . . . . 0.521 ' H ' ' C ' ' A' ' 530' ' ' ALA . 1.3 pp -156.76 69.48 4.63 Favored Pre-proline 0 CA--C 1.53 0.182 0 CA-C-O 120.8 0.334 . . . . 0.0 110.91 179.357 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 533' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -52.8 105.15 0.11 Allowed 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.673 2.249 . . . . 0.0 111.875 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 534' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -96.08 -55.31 3.01 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 111.984 0.364 . . . . 0.0 111.984 -179.258 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -118.77 -35.02 3.79 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -179.338 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . -85.08 -175.24 50.57 Favored Glycine 0 CA--C 1.518 0.233 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.979 -179.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_endo -56.81 -159.09 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.884 2.389 . . . . 0.0 111.874 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 538' ' ' ALA . . . . . . . . . . . . . . . -43.87 -48.76 8.42 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.55 -0.296 . . . . 0.0 111.349 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 539' ' ' ALA . . . . . 0.518 ' HA ' ' CD1' ' A' ' 542' ' ' ILE . . . 72.13 -49.3 0.69 Allowed 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.256 0.551 . . . . 0.0 111.482 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 540' ' ' GLU . . . . . 0.416 ' HG2' ' CD1' ' A' ' 531' ' ' TRP . 3.1 mt-10 -36.84 -31.45 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.863 -1.062 . . . . 0.0 112.494 -179.192 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 541' ' ' GLY . . . . . 0.408 ' O ' ' HB3' ' A' ' 549' ' ' HIS . . . -130.89 -18.95 1.32 Allowed Glycine 0 CA--C 1.52 0.369 0 C-N-CA 120.198 -1.001 . . . . 0.0 113.617 -179.738 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 542' ' ' ILE . . . . . 0.518 ' CD1' ' HA ' ' A' ' 539' ' ' ALA . 2.6 pp -96.25 -22.45 5.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 117.148 0.474 . . . . 0.0 112.251 -179.514 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 543' ' ' TYR . . . . . 0.5 ' HB2' ' HA ' ' A' ' 539' ' ' ALA . 0.2 OUTLIER -115.32 -12.08 11.83 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.966 0.412 . . . . 0.0 110.847 179.444 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 544' ' ' ALA . . . . . 0.436 ' CB ' ' HB1' ' A' ' 530' ' ' ALA . . . -92.02 -26.32 18.41 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.216 179.532 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 545' ' ' GLU . . . . . 0.499 ' HG3' ' H ' ' A' ' 548' ' ' MET . 19.7 tp10 -113.09 -33.41 6.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.773 -179.162 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 35.02 34.12 0.04 OUTLIER Glycine 0 CA--C 1.519 0.307 0 CA-C-N 115.776 -0.647 . . . . 0.0 114.259 179.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 547' ' ' LEU . . . . . 0.427 ' HG ' ' N ' ' A' ' 548' ' ' MET . 0.0 OUTLIER -176.41 -61.41 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 118.008 0.904 . . . . 0.0 112.695 -179.993 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 548' ' ' MET . . . . . 0.551 ' O ' ' HG3' ' A' ' 551' ' ' GLN . 0.4 OUTLIER -89.62 11.7 18.97 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.754 0.312 . . . . 0.0 110.935 179.733 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 549' ' ' HIS . . . . . 0.509 ' HA ' HG21 ' A' ' 519' ' ' THR . 0.2 OUTLIER -64.88 -12.08 44.87 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.972 0.415 . . . . 0.0 110.62 179.588 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 550' ' ' ASN . . . . . 0.419 ' O ' ' N ' ' A' ' 552' ' ' ASP . 4.2 m120 -96.92 -35.48 10.87 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -179.022 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 551' ' ' GLN . . . . . 0.551 ' HG3' ' O ' ' A' ' 548' ' ' MET . 0.0 OUTLIER -66.37 72.59 0.08 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.044 0.449 . . . . 0.0 110.639 -179.515 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 552' ' ' ASP . . . . . 0.485 ' HA ' ' HA ' ' A' ' 519' ' ' THR . 3.0 m-20 -87.27 21.63 2.36 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.149 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . 114.26 -29.1 7.86 Favored Glycine 0 N--CA 1.451 -0.339 0 N-CA-C 111.315 -0.714 . . . . 0.0 111.315 -179.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 554' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -63.16 -57.49 10.37 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.635 0.731 . . . . 0.0 110.054 179.182 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 555' ' ' ILE . . . . . . . . . . . . . 2.8 mm -71.54 65.0 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 CA-C-N 114.695 -1.139 . . . . 0.0 110.815 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 556' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.325 -0.5 0 CA-C-N 115.56 -0.746 . . . . 0.0 111.232 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 511' ' ' CYS . . . . . . . . . . . . . 6.7 m . . . . . 0 CA--C 1.527 0.08 0 CA-C-O 120.92 0.39 . . . . 0.0 111.53 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 512' ' ' ASN . . . . . . . . . . . . . 24.3 t30 -113.36 81.73 5.37 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.451 179.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 513' ' ' PRO . . . . . 0.443 ' HA ' ' O ' ' A' ' 552' ' ' ASP . 73.0 Cg_endo -76.01 18.95 0.61 Allowed 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.989 2.459 . . . . 0.0 113.293 -179.584 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -96.72 -28.96 14.06 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.705 0.288 . . . . 0.0 111.024 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 515' ' ' LEU . . . . . . . . . . . . . 70.0 mt -84.22 74.54 10.29 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.899 0.38 . . . . 0.0 110.946 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 516' ' ' HIS . . . . . 0.421 ' HA ' ' CB ' ' A' ' 552' ' ' ASP . 68.0 m-70 -70.14 -23.75 63.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.507 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 517' ' ' TYR . . . . . . . . . . . . . 50.3 m-85 -73.62 -64.18 1.05 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.711 0.291 . . . . 0.0 111.637 -179.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 518' ' ' TRP . . . . . 0.476 ' O ' ' N ' ' A' ' 520' ' ' THR . 27.3 m-90 -69.82 -17.65 63.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.844 -179.422 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 519' ' ' THR . . . . . 0.545 ' OG1' ' N ' ' A' ' 520' ' ' THR . 2.1 p 57.83 -79.78 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 120.518 0.199 . . . . 0.0 110.519 -179.707 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 520' ' ' THR . . . . . 0.545 ' N ' ' OG1' ' A' ' 519' ' ' THR . 1.2 m 177.67 -62.61 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 179.195 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 521' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -71.68 -13.87 61.87 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 177.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 522' ' ' ASP . . . . . 0.434 ' O ' HG21 ' A' ' 527' ' ' ILE . 2.8 m-20 -94.04 -11.11 31.43 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.88 179.044 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -45.51 -27.48 0.75 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.456 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 524' ' ' GLY . . . . . 0.414 ' HA2' ' CG1' ' A' ' 527' ' ' ILE . . . 146.21 42.11 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.55 -0.833 . . . . 0.0 112.313 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -101.51 -60.16 1.58 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.736 0.303 . . . . 0.0 111.775 -179.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -132.15 38.65 3.48 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-O 121.503 0.668 . . . . 0.0 110.049 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 527' ' ' ILE . . . . . 0.465 ' HA ' ' CB ' ' A' ' 544' ' ' ALA . 2.1 pp -95.83 -0.25 10.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 114.663 -1.153 . . . . 0.0 112.71 -178.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 528' ' ' GLY . . . . . . . . . . . . . . . -53.26 -14.8 3.36 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 114.535 0.574 . . . . 0.0 114.535 -178.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 529' ' ' LEU . . . . . 0.53 ' CD1' ' N ' ' A' ' 529' ' ' LEU . 0.0 OUTLIER -98.66 -33.98 10.74 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 118.055 0.927 . . . . 0.0 111.609 -179.57 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 530' ' ' ALA . . . . . 0.439 ' HB2' ' HB3' ' A' ' 543' ' ' TYR . . . -103.71 1.17 31.47 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -179.308 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 531' ' ' TRP . . . . . 0.426 ' HA ' ' HG2' ' A' ' 540' ' ' GLU . 9.9 t90 -56.28 -12.33 1.56 Allowed 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -179.14 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 532' ' ' ILE . . . . . 0.414 ' O ' ' CD1' ' A' ' 532' ' ' ILE . 1.7 pp -133.14 73.95 73.91 Favored Pre-proline 0 N--CA 1.452 -0.373 0 CA-C-O 121.06 0.457 . . . . 0.0 111.327 179.703 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 533' ' ' PRO . . . . . 0.425 ' HB3' ' O ' ' A' ' 538' ' ' ALA . 1.7 Cg_endo -45.73 92.29 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 123.037 2.492 . . . . 0.0 112.671 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 534' ' ' TYR . . . . . . . . . . . . . 47.4 p90 -96.31 -25.4 15.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.116 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -69.75 -34.78 74.28 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.399 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 147.87 -64.09 0.42 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.822 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -59.36 -164.72 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.605 2.203 . . . . 0.0 112.033 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 538' ' ' ALA . . . . . 0.425 ' O ' ' HB3' ' A' ' 533' ' ' PRO . . . -69.3 -47.45 64.48 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.726 179.743 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 539' ' ' ALA . . . . . 0.44 ' HA ' ' CD1' ' A' ' 542' ' ' ILE . . . 69.17 -53.94 0.58 Allowed 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.306 0.574 . . . . 0.0 111.45 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 540' ' ' GLU . . . . . 0.426 ' HG2' ' HA ' ' A' ' 531' ' ' TRP . 10.6 mt-10 -37.57 -27.59 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.895 -1.048 . . . . 0.0 112.121 -179.541 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 541' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 539' ' ' ALA . . . -124.76 -46.85 0.24 Allowed Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.136 179.069 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 542' ' ' ILE . . . . . 0.44 ' CD1' ' HA ' ' A' ' 539' ' ' ALA . 2.6 pp -73.47 -24.59 20.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 -179.367 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 543' ' ' TYR . . . . . 0.439 ' HB3' ' HB2' ' A' ' 530' ' ' ALA . 6.5 t80 -114.11 -7.72 13.04 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.878 0.37 . . . . 0.0 110.963 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 544' ' ' ALA . . . . . 0.465 ' CB ' ' HA ' ' A' ' 527' ' ' ILE . . . -103.14 -33.89 9.06 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 121.22 0.534 . . . . 0.0 109.948 179.362 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 545' ' ' GLU . . . . . 0.461 ' HG3' ' H ' ' A' ' 548' ' ' MET . 23.1 tp10 -118.56 -32.66 4.52 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.272 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 37.68 43.42 1.18 Allowed Glycine 0 CA--C 1.52 0.376 0 CA-C-N 115.931 -0.577 . . . . 0.0 113.771 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 547' ' ' LEU . . . . . 0.547 ' HG ' ' N ' ' A' ' 548' ' ' MET . 0.0 OUTLIER -172.94 -61.23 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 117.362 0.581 . . . . 0.0 111.874 179.628 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 548' ' ' MET . . . . . 0.547 ' N ' ' HG ' ' A' ' 547' ' ' LEU . 0.0 OUTLIER -96.03 11.59 33.54 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.672 0.272 . . . . 0.0 111.209 179.68 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 549' ' ' HIS . . . . . 0.457 ' O ' ' CG2' ' A' ' 519' ' ' THR . 10.0 p80 -61.49 -11.35 10.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.695 0.283 . . . . 0.0 110.904 179.372 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 550' ' ' ASN . . . . . 0.442 ' O ' ' N ' ' A' ' 552' ' ' ASP . 8.3 m120 -95.98 -34.23 11.86 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -179.204 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 551' ' ' GLN . . . . . 0.4 ' HG2' ' CG ' ' A' ' 548' ' ' MET . 0.0 OUTLIER -65.39 72.79 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.133 0.492 . . . . 0.0 110.325 179.895 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 552' ' ' ASP . . . . . 0.499 ' HA ' ' HA ' ' A' ' 519' ' ' THR . 1.6 p30 -90.6 22.33 3.54 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.602 -0.727 . . . . 0.0 111.724 -179.447 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . 124.27 -27.52 5.54 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.863 -0.684 . . . . 0.0 111.739 -179.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 554' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -61.67 -57.13 13.17 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.49 0.662 . . . . 0.0 109.937 178.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 555' ' ' ILE . . . . . . . . . . . . . 4.2 mm -76.93 70.42 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 CA-C-N 114.821 -1.081 . . . . 0.0 110.862 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 556' ' ' CYS . . . . . . . . . . . . . 34.7 m . . . . . 0 C--N 1.323 -0.557 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.748 -179.781 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 511' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.528 0.107 0 CA-C-O 120.961 0.41 . . . . 0.0 111.426 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 512' ' ' ASN . . . . . . . . . . . . . 18.5 m-20 -131.25 77.68 73.87 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.663 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 513' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -68.0 -12.28 34.75 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.608 2.206 . . . . 0.0 112.41 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -65.32 -29.03 69.74 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.887 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 515' ' ' LEU . . . . . . . . . . . . . 74.4 mt -95.54 71.18 3.11 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.881 179.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 516' ' ' HIS . . . . . 0.453 ' HA ' ' CB ' ' A' ' 552' ' ' ASP . 15.4 p80 -74.53 -7.34 52.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.676 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 517' ' ' TYR . . . . . . . . . . . . . 65.0 m-85 -79.9 -59.4 2.74 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.781 0.324 . . . . 0.0 111.592 -179.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 518' ' ' TRP . . . . . 0.42 ' HA ' ' CE3' ' A' ' 518' ' ' TRP . 0.1 OUTLIER -74.17 -21.61 59.77 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.925 -179.036 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 519' ' ' THR . . . . . 0.53 ' OG1' ' N ' ' A' ' 520' ' ' THR . 2.3 p 63.38 -77.27 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 110.321 -0.252 . . . . 0.0 110.321 -179.505 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 520' ' ' THR . . . . . 0.53 ' N ' ' OG1' ' A' ' 519' ' ' THR . 1.0 OUTLIER 171.25 -62.4 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 179.227 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 521' ' ' GLN . . . . . 0.407 ' HG2' ' OE2' ' A' ' 545' ' ' GLU . 0.0 OUTLIER -72.72 -11.08 60.48 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.364 178.048 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -91.15 -21.19 21.29 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.631 178.758 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 523' ' ' GLU . . . . . 0.443 ' HG3' ' HA ' ' A' ' 520' ' ' THR . 8.9 mm-40 -45.84 -29.75 1.46 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.435 178.417 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 524' ' ' GLY . . . . . 0.416 ' HA2' ' CG1' ' A' ' 527' ' ' ILE . . . 144.51 39.16 0.06 OUTLIER Glycine 0 N--CA 1.443 -0.838 0 CA-C-N 114.816 -1.083 . . . . 0.0 110.405 -179.28 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -97.89 -59.49 1.75 Allowed 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 -178.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -130.81 40.37 3.49 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-O 121.549 0.69 . . . . 0.0 110.087 179.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 527' ' ' ILE . . . . . 0.459 ' O ' ' HB2' ' A' ' 531' ' ' TRP . 1.9 pp -95.67 -12.91 8.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 114.903 -1.044 . . . . 0.0 112.483 -179.03 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 528' ' ' GLY . . . . . . . . . . . . . . . -48.45 -19.81 1.35 Allowed Glycine 0 CA--C 1.522 0.477 0 N-CA-C 114.624 0.61 . . . . 0.0 114.624 -179.131 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 529' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -98.57 -39.98 8.45 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 117.873 0.837 . . . . 0.0 112.415 -179.01 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 530' ' ' ALA . . . . . 0.542 ' C ' ' H ' ' A' ' 532' ' ' ILE . . . -103.88 2.06 32.14 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 -178.467 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 531' ' ' TRP . . . . . 0.48 ' HA ' ' HG2' ' A' ' 540' ' ' GLU . 73.3 t-105 -67.45 30.22 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -178.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 532' ' ' ILE . . . . . 0.542 ' H ' ' C ' ' A' ' 530' ' ' ALA . 1.3 pp -160.31 71.51 2.99 Favored Pre-proline 0 N--CA 1.454 -0.259 0 CA-C-O 120.837 0.351 . . . . 0.0 110.555 178.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 533' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -48.82 86.86 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 123.22 2.613 . . . . 0.0 112.829 -179.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 534' ' ' TYR . . . . . 0.4 ' N ' ' O ' ' A' ' 532' ' ' ILE . 0.2 OUTLIER -96.51 -38.3 10.06 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.049 179.804 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -62.58 -34.87 77.86 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.456 -179.412 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 151.09 -66.88 0.34 Allowed Glycine 0 CA--C 1.519 0.315 0 C-N-CA 120.47 -0.871 . . . . 0.0 112.62 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -57.2 -164.63 0.02 OUTLIER 'Trans proline' 0 CA--C 1.518 -0.307 0 C-N-CA 122.611 2.207 . . . . 0.0 111.735 179.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 538' ' ' ALA . . . . . . . . . . . . . . . -74.4 -48.33 28.43 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.432 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 539' ' ' ALA . . . . . 0.467 ' HA ' ' CD1' ' A' ' 542' ' ' ILE . . . 70.62 -51.83 0.67 Allowed 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.391 0.615 . . . . 0.0 111.277 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 540' ' ' GLU . . . . . 0.48 ' HG2' ' HA ' ' A' ' 531' ' ' TRP . 7.2 mt-10 -36.89 -30.68 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.809 -1.087 . . . . 0.0 112.538 -179.169 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 541' ' ' GLY . . . . . 0.451 ' HA3' ' CD2' ' A' ' 549' ' ' HIS . . . -126.95 -30.15 0.83 Allowed Glycine 0 CA--C 1.518 0.254 0 C-N-CA 120.412 -0.899 . . . . 0.0 112.999 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 542' ' ' ILE . . . . . 0.467 ' CD1' ' HA ' ' A' ' 539' ' ' ALA . 2.6 pp -88.82 -22.03 6.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 -179.532 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 543' ' ' TYR . . . . . 0.477 ' HB3' ' HB1' ' A' ' 530' ' ' ALA . 10.1 t80 -115.26 -8.43 12.32 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.892 0.377 . . . . 0.0 110.78 179.706 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 544' ' ' ALA . . . . . 0.429 ' CB ' ' CB ' ' A' ' 530' ' ' ALA . . . -103.01 -38.38 7.36 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-O 121.428 0.632 . . . . 0.0 109.572 179.217 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 545' ' ' GLU . . . . . 0.582 ' HG3' ' H ' ' A' ' 548' ' ' MET . 4.7 tp10 -118.95 -32.81 4.36 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.035 -0.984 . . . . 0.0 111.375 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 37.96 46.01 1.7 Allowed Glycine 0 CA--C 1.519 0.298 0 CA-C-N 115.895 -0.593 . . . . 0.0 113.975 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 547' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER 179.03 -60.95 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 117.552 0.676 . . . . 0.0 112.049 179.682 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 548' ' ' MET . . . . . 0.582 ' H ' ' HG3' ' A' ' 545' ' ' GLU . 0.4 OUTLIER -87.83 11.74 14.8 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 111.765 0.283 . . . . 0.0 111.765 -179.769 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 549' ' ' HIS . . . . . 0.451 ' CD2' ' HA3' ' A' ' 541' ' ' GLY . 10.1 t-80 -66.69 -11.63 55.01 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.918 0.39 . . . . 0.0 110.233 179.245 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 550' ' ' ASN . . . . . 0.659 ' O ' ' N ' ' A' ' 552' ' ' ASP . 42.1 m-20 -96.24 -56.1 2.74 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.552 -179.751 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 551' ' ' GLN . . . . . 0.545 ' HG3' ' O ' ' A' ' 548' ' ' MET . 1.4 pp0? -44.24 76.41 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.583 -179.616 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 552' ' ' ASP . . . . . 0.659 ' N ' ' O ' ' A' ' 550' ' ' ASN . 2.3 p30 -94.45 22.24 6.33 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.247 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . 124.12 -28.39 5.37 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.865 -0.683 . . . . 0.0 111.708 -179.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 554' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -58.32 -59.81 4.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.341 0.591 . . . . 0.0 110.162 179.033 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 555' ' ' ILE . . . . . . . . . . . . . 5.6 mm -78.4 62.73 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.647 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 556' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.325 -0.467 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.712 -179.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 511' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.528 0.133 0 CA-C-O 121.216 0.532 . . . . 0.0 111.575 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 512' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -136.58 82.18 33.87 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.252 179.642 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 513' ' ' PRO . . . . . 0.482 ' HA ' ' O ' ' A' ' 552' ' ' ASP . 58.2 Cg_endo -72.68 9.22 1.33 Allowed 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.839 2.359 . . . . 0.0 113.314 -179.375 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -95.87 -24.81 16.26 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.684 0.278 . . . . 0.0 110.997 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 515' ' ' LEU . . . . . . . . . . . . . 84.6 mt -87.1 74.59 9.6 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.831 0.348 . . . . 0.0 111.062 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 516' ' ' HIS . . . . . 0.429 ' HA ' ' CB ' ' A' ' 552' ' ' ASP . 25.0 p80 -81.14 -7.28 59.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.713 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 517' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -71.49 -46.72 59.06 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.679 0.276 . . . . 0.0 111.541 -179.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 518' ' ' TRP . . . . . 0.522 ' O ' ' N ' ' A' ' 520' ' ' THR . 12.3 m-90 -101.8 -3.87 27.31 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -179.314 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 519' ' ' THR . . . . . 0.555 ' HA ' ' HA ' ' A' ' 552' ' ' ASP . 4.1 p 56.41 -78.07 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 120.551 0.215 . . . . 0.0 110.757 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 520' ' ' THR . . . . . 0.522 ' N ' ' O ' ' A' ' 518' ' ' TRP . 1.1 m 176.04 -62.43 0.01 OUTLIER 'General case' 0 CA--C 1.521 -0.171 0 N-CA-C 109.171 -0.678 . . . . 0.0 109.171 179.375 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 521' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -71.64 -12.56 61.4 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 177.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 522' ' ' ASP . . . . . 0.431 ' O ' HG22 ' A' ' 527' ' ' ILE . 1.2 m-20 -93.86 -11.21 31.62 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.667 178.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -45.69 -27.88 0.89 Allowed 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.253 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 524' ' ' GLY . . . . . 0.406 ' HA2' ' CG1' ' A' ' 527' ' ' ILE . . . 145.41 43.02 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.243 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -102.56 -58.97 1.78 Allowed 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 -179.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -131.61 39.89 3.45 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-O 121.565 0.698 . . . . 0.0 109.986 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 527' ' ' ILE . . . . . 0.489 ' HA ' ' CB ' ' A' ' 544' ' ' ALA . 1.9 pp -95.61 -0.54 10.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 114.764 -1.107 . . . . 0.0 112.693 -178.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 528' ' ' GLY . . . . . . . . . . . . . . . -60.23 -14.34 32.65 Favored Glycine 0 CA--C 1.52 0.387 0 C-N-CA 120.865 -0.683 . . . . 0.0 113.901 -179.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 529' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -98.55 -33.84 10.83 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 117.477 0.638 . . . . 0.0 111.68 -179.408 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 530' ' ' ALA . . . . . 0.448 ' HB2' ' N ' ' A' ' 544' ' ' ALA . . . -103.81 1.53 31.69 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -179.057 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 531' ' ' TRP . . . . . 0.425 ' HB2' ' O ' ' A' ' 527' ' ' ILE . 73.2 t-105 -56.08 -12.6 1.55 Allowed 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 -179.378 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 532' ' ' ILE . . . . . 0.413 HD11 ' CD1' ' A' ' 534' ' ' TYR . 1.5 pp -129.44 75.21 80.26 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 120.978 0.418 . . . . 0.0 110.984 179.699 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 533' ' ' PRO . . . . . 0.407 ' HB3' ' O ' ' A' ' 538' ' ' ALA . 5.6 Cg_endo -48.91 89.88 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 123.099 2.533 . . . . 0.0 112.85 -179.672 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 534' ' ' TYR . . . . . 0.413 ' CD1' HD11 ' A' ' 532' ' ' ILE . 1.3 m-85 -96.3 -13.33 23.41 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.068 179.524 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -76.85 -34.87 57.81 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.282 -179.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 536' ' ' GLY . . . . . 0.417 ' N ' ' CD ' ' A' ' 537' ' ' PRO . . . 141.42 -49.54 0.76 Allowed Glycine 0 CA--C 1.52 0.347 0 C-N-CA 120.518 -0.848 . . . . 0.0 112.915 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 537' ' ' PRO . . . . . 0.417 ' CD ' ' N ' ' A' ' 536' ' ' GLY . 5.6 Cg_exo -76.56 -168.0 0.52 Allowed 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 122.714 2.276 . . . . 0.0 111.931 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 538' ' ' ALA . . . . . 0.407 ' O ' ' HB3' ' A' ' 533' ' ' PRO . . . -56.28 -47.63 78.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.461 179.505 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 539' ' ' ALA . . . . . 0.568 ' HA ' ' CD1' ' A' ' 542' ' ' ILE . . . 68.14 -59.47 0.43 Allowed 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 121.362 0.601 . . . . 0.0 111.976 179.339 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 540' ' ' GLU . . . . . 0.409 ' OE2' ' CE3' ' A' ' 531' ' ' TRP . 2.7 mt-10 -37.49 -28.77 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 114.871 -1.059 . . . . 0.0 112.293 -179.108 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 541' ' ' GLY . . . . . 0.404 ' O ' ' HB2' ' A' ' 549' ' ' HIS . . . -121.9 -26.71 1.85 Allowed Glycine 0 CA--C 1.521 0.41 0 C-N-CA 120.479 -0.867 . . . . 0.0 113.27 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 542' ' ' ILE . . . . . 0.568 ' CD1' ' HA ' ' A' ' 539' ' ' ALA . 2.6 pp -95.84 -20.59 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -179.345 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 543' ' ' TYR . . . . . 0.546 ' HB2' ' HA ' ' A' ' 539' ' ' ALA . 0.3 OUTLIER -107.84 -10.73 15.5 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.112 0.482 . . . . 0.0 110.113 178.901 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 544' ' ' ALA . . . . . 0.489 ' CB ' ' HA ' ' A' ' 527' ' ' ILE . . . -103.16 -38.45 7.28 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.78 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 545' ' ' GLU . . . . . 0.525 ' HG3' ' H ' ' A' ' 548' ' ' MET . 5.9 tp10 -118.91 -32.96 4.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.151 -0.932 . . . . 0.0 111.487 -179.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 37.72 49.37 1.89 Allowed Glycine 0 CA--C 1.52 0.403 0 CA-C-N 115.988 -0.551 . . . . 0.0 113.822 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 547' ' ' LEU . . . . . 0.414 ' HG ' ' N ' ' A' ' 548' ' ' MET . 0.0 OUTLIER 178.99 -60.83 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 117.528 0.664 . . . . 0.0 111.976 179.633 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 548' ' ' MET . . . . . 0.525 ' H ' ' HG3' ' A' ' 545' ' ' GLU . 0.0 OUTLIER -86.38 11.76 11.65 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.671 0.272 . . . . 0.0 111.566 -179.802 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 549' ' ' HIS . . . . . 0.509 ' O ' ' CG2' ' A' ' 519' ' ' THR . 56.6 t60 -67.96 -10.97 57.77 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.899 0.381 . . . . 0.0 110.412 179.249 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 550' ' ' ASN . . . . . 0.432 ' O ' ' N ' ' A' ' 552' ' ' ASP . 38.9 t30 -92.89 -25.91 17.86 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.126 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 551' ' ' GLN . . . . . 0.522 ' HG2' ' O ' ' A' ' 548' ' ' MET . 2.3 mm-40 -66.91 70.32 0.08 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.249 0.547 . . . . 0.0 110.123 179.719 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 552' ' ' ASP . . . . . 0.555 ' HA ' ' HA ' ' A' ' 519' ' ' THR . 1.7 p30 -89.37 21.6 3.26 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.679 -179.46 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . 123.41 -32.82 4.19 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.885 -0.674 . . . . 0.0 111.592 -179.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 554' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -52.14 -58.06 7.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.498 0.665 . . . . 0.0 110.348 179.226 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 555' ' ' ILE . . . . . . . . . . . . . 3.7 mm -72.62 60.86 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 CA-C-N 114.808 -1.087 . . . . 0.0 110.942 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 556' ' ' CYS . . . . . . . . . . . . . 5.3 t . . . . . 0 C--N 1.326 -0.449 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.373 -179.955 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 511' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.462 0.142 0 CA-C-O 121.032 0.444 . . . . 0.0 111.776 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 512' ' ' ASN . . . . . 0.4 ' O ' ' O ' ' A' ' 552' ' ' ASP . 0.9 OUTLIER -158.55 77.93 3.25 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.393 179.865 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 513' ' ' PRO . . . . . 0.511 ' HA ' ' O ' ' A' ' 552' ' ' ASP . 73.8 Cg_endo -76.67 19.14 0.66 Allowed 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 123.039 2.493 . . . . 0.0 113.462 -179.494 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 23.6 t30 -96.79 -34.56 11.26 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.642 0.258 . . . . 0.0 111.137 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 515' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -90.71 72.49 6.71 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.897 0.38 . . . . 0.0 111.085 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 516' ' ' HIS . . . . . 0.477 ' HA ' ' HB2' ' A' ' 552' ' ' ASP . 7.7 p80 -80.13 -7.25 58.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.751 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 517' ' ' TYR . . . . . . . . . . . . . 37.9 m-85 -69.55 -29.69 67.32 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 111.67 0.248 . . . . 0.0 111.67 -179.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 518' ' ' TRP . . . . . 0.482 ' O ' ' N ' ' A' ' 520' ' ' THR . 4.7 m-90 -118.03 -8.28 10.74 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -179.246 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 519' ' ' THR . . . . . 0.521 ' OG1' ' N ' ' A' ' 520' ' ' THR . 1.3 p 59.82 -76.53 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 120.475 0.179 . . . . 0.0 110.537 -179.725 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 520' ' ' THR . . . . . 0.521 ' N ' ' OG1' ' A' ' 519' ' ' THR . 1.0 OUTLIER 172.24 -62.7 0.01 OUTLIER 'General case' 0 C--O 1.232 0.147 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 179.146 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 521' ' ' GLN . . . . . . . . . . . . . 5.8 mt-30 -73.42 -12.01 60.66 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 177.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 522' ' ' ASP . . . . . 0.432 ' O ' HG23 ' A' ' 527' ' ' ILE . 9.6 m-20 -93.47 -11.12 32.81 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.684 178.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -45.51 -27.09 0.67 Allowed 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.539 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 524' ' ' GLY . . . . . 0.44 ' HA2' ' CG1' ' A' ' 527' ' ' ILE . . . 148.6 41.13 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.577 -0.82 . . . . 0.0 112.225 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -99.62 -59.95 1.62 Allowed 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 111.879 0.325 . . . . 0.0 111.879 -179.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -132.0 35.97 3.7 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.505 0.669 . . . . 0.0 110.135 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 527' ' ' ILE . . . . . 0.495 ' HA ' ' CB ' ' A' ' 544' ' ' ALA . 2.2 pp -95.85 -0.42 10.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 114.741 -1.118 . . . . 0.0 112.836 -178.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 528' ' ' GLY . . . . . . . . . . . . . . . -60.23 -8.82 9.55 Favored Glycine 0 CA--C 1.522 0.495 0 C-N-CA 120.907 -0.663 . . . . 0.0 114.146 -179.243 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 529' ' ' LEU . . . . . . . . . . . . . 2.0 pp -98.54 -35.0 10.37 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 117.819 0.809 . . . . 0.0 111.624 -179.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 530' ' ' ALA . . . . . 0.495 ' C ' ' H ' ' A' ' 532' ' ' ILE . . . -103.64 1.63 32.23 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -179.273 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 531' ' ' TRP . . . . . 0.423 ' HB3' ' O ' ' A' ' 527' ' ' ILE . 0.2 OUTLIER -70.4 30.71 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -178.853 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 532' ' ' ILE . . . . . 0.495 ' H ' ' C ' ' A' ' 530' ' ' ALA . 1.3 pt -156.68 78.92 3.89 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 120.665 0.269 . . . . 0.0 110.735 179.183 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 533' ' ' PRO . . . . . . . . . . . . . 99.9 Cg_exo -39.46 86.16 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 123.327 2.685 . . . . 0.0 113.212 -179.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 534' ' ' TYR . . . . . 0.463 ' N ' ' O ' ' A' ' 532' ' ' ILE . 1.7 t80 -96.61 -50.99 4.49 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.282 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -57.78 -34.95 70.12 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.459 -179.41 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 145.79 -63.98 0.45 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.563 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -59.94 -166.99 0.04 OUTLIER 'Trans proline' 0 CA--C 1.516 -0.393 0 C-N-CA 122.605 2.203 . . . . 0.0 111.833 179.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 538' ' ' ALA . . . . . 0.436 ' C ' ' H ' ' A' ' 540' ' ' GLU . . . -61.65 -52.82 62.75 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.114 179.606 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 539' ' ' ALA . . . . . 0.455 ' HA ' HD13 ' A' ' 542' ' ' ILE . . . 68.13 -47.01 0.53 Allowed 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.99 179.414 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 540' ' ' GLU . . . . . 0.436 ' H ' ' C ' ' A' ' 538' ' ' ALA . 0.8 OUTLIER -37.39 -28.15 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.126 -0.943 . . . . 0.0 112.366 -179.139 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 541' ' ' GLY . . . . . 0.453 ' HA3' ' CD2' ' A' ' 549' ' ' HIS . . . -127.63 -42.06 0.27 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.012 179.308 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 542' ' ' ILE . . . . . 0.455 HD13 ' HA ' ' A' ' 539' ' ' ALA . 0.8 OUTLIER -69.63 -26.31 30.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 -179.79 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 543' ' ' TYR . . . . . 0.435 ' CD1' HD12 ' A' ' 542' ' ' ILE . 1.8 m-85 -110.68 -10.19 14.49 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.054 0.454 . . . . 0.0 110.697 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 544' ' ' ALA . . . . . 0.495 ' CB ' ' HA ' ' A' ' 527' ' ' ILE . . . -97.9 -30.54 12.69 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.035 179.751 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 545' ' ' GLU . . . . . 0.475 ' HG3' ' H ' ' A' ' 548' ' ' MET . 6.3 tp10 -118.87 -32.81 4.39 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.475 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 35.56 40.13 0.28 Allowed Glycine 0 CA--C 1.52 0.399 0 CA-C-N 116.025 -0.534 . . . . 0.0 113.808 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 547' ' ' LEU . . . . . 0.441 ' HG ' ' N ' ' A' ' 548' ' ' MET . 0.0 OUTLIER -173.65 -61.41 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 117.498 0.649 . . . . 0.0 112.1 179.748 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 548' ' ' MET . . . . . 0.628 ' O ' ' HG3' ' A' ' 551' ' ' GLN . 0.0 OUTLIER -94.36 11.92 28.83 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.758 0.314 . . . . 0.0 111.133 179.674 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 549' ' ' HIS . . . . . 0.463 ' O ' ' CG2' ' A' ' 519' ' ' THR . 12.1 t-80 -64.41 -10.75 26.94 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 120.846 -0.342 . . . . 0.0 110.82 179.582 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 550' ' ' ASN . . . . . 0.501 ' O ' ' N ' ' A' ' 552' ' ' ASP . 41.9 m-20 -94.82 -34.8 12.34 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.875 0.695 . . . . 0.0 112.875 -178.557 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 551' ' ' GLN . . . . . 0.628 ' HG3' ' O ' ' A' ' 548' ' ' MET . 1.1 pp0? -62.34 68.12 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.112 0.482 . . . . 0.0 111.238 -179.451 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 552' ' ' ASP . . . . . 0.511 ' O ' ' HA ' ' A' ' 513' ' ' PRO . 1.7 p30 -94.83 20.93 8.09 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.284 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . 123.63 -31.04 4.72 Favored Glycine 0 N--CA 1.45 -0.399 0 N-CA-C 111.321 -0.711 . . . . 0.0 111.321 -179.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 554' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -55.9 -52.5 63.87 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.475 0.655 . . . . 0.0 110.037 179.066 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 555' ' ' ILE . . . . . 0.41 ' O ' ' CG2' ' A' ' 555' ' ' ILE . 5.2 mm -82.9 56.32 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 CA-C-N 114.884 -1.053 . . . . 0.0 110.53 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 556' ' ' CYS . . . . . . . . . . . . . 17.6 t . . . . . 0 C--N 1.327 -0.381 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.432 -179.768 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 511' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.462 0.128 0 CA-C-O 120.974 0.416 . . . . 0.0 111.73 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 512' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -140.13 73.75 31.58 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.39 179.324 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 513' ' ' PRO . . . . . 0.465 ' HA ' ' O ' ' A' ' 552' ' ' ASP . 31.3 Cg_exo -60.96 -14.73 34.5 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.899 2.399 . . . . 0.0 112.625 -179.612 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -69.42 -43.36 73.53 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.474 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 515' ' ' LEU . . . . . . . . . . . . . 53.1 mt -66.53 76.33 0.1 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.88 0.371 . . . . 0.0 111.076 -179.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 516' ' ' HIS . . . . . 0.55 ' HA ' ' HB3' ' A' ' 552' ' ' ASP . 0.2 OUTLIER -84.55 -7.16 59.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.722 -179.857 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 517' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -79.11 -61.82 1.89 Allowed 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -179.199 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 518' ' ' TRP . . . . . 0.488 ' O ' ' N ' ' A' ' 520' ' ' THR . 4.1 m-90 -87.13 -3.91 59.1 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -178.696 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 519' ' ' THR . . . . . 0.506 ' OG1' ' N ' ' A' ' 520' ' ' THR . 3.0 p 59.66 -76.49 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.391 0.139 . . . . 0.0 110.704 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 520' ' ' THR . . . . . 0.506 ' N ' ' OG1' ' A' ' 519' ' ' THR . 1.0 OUTLIER 173.04 -62.59 0.01 OUTLIER 'General case' 0 CA--C 1.521 -0.17 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 179.367 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 521' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -73.32 -12.75 60.95 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.426 178.189 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 522' ' ' ASP . . . . . 0.419 ' HB2' ' O ' ' A' ' 518' ' ' TRP . 2.5 m-20 -93.91 -11.09 31.78 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.832 179.025 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -45.57 -28.01 0.87 Allowed 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.514 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 524' ' ' GLY . . . . . 0.449 ' HA2' ' CG1' ' A' ' 527' ' ' ILE . . . 147.34 42.18 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.471 -0.871 . . . . 0.0 112.354 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -101.39 -58.6 1.85 Allowed 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -179.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -132.03 35.08 3.76 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-O 121.566 0.698 . . . . 0.0 110.161 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 527' ' ' ILE . . . . . 0.453 ' HA ' ' CB ' ' A' ' 544' ' ' ALA . 2.2 pp -95.65 -0.45 10.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 114.797 -1.092 . . . . 0.0 112.606 -178.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 528' ' ' GLY . . . . . . . . . . . . . . . -59.17 -7.65 5.43 Favored Glycine 0 CA--C 1.522 0.511 0 C-N-CA 121.018 -0.61 . . . . 0.0 114.256 -179.244 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 529' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -97.77 -35.9 10.39 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 117.772 0.786 . . . . 0.0 111.36 -179.584 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 530' ' ' ALA . . . . . 0.529 ' C ' ' H ' ' A' ' 532' ' ' ILE . . . -103.76 1.97 32.34 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -179.392 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 531' ' ' TRP . . . . . 0.438 ' HA ' ' HG2' ' A' ' 540' ' ' GLU . 9.9 t90 -67.41 30.24 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 -178.8 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 532' ' ' ILE . . . . . 0.529 ' H ' ' C ' ' A' ' 530' ' ' ALA . 1.1 pt -159.31 72.77 3.42 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-O 120.843 0.354 . . . . 0.0 110.403 179.012 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 533' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_endo -49.74 86.38 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 123.129 2.552 . . . . 0.0 112.692 -179.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 534' ' ' TYR . . . . . 0.411 ' N ' ' O ' ' A' ' 532' ' ' ILE . 20.8 t80 -96.55 -29.76 13.69 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.156 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -71.14 -34.86 71.4 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.542 -179.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 152.51 -66.13 0.34 Allowed Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.579 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -58.06 -162.67 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.612 2.208 . . . . 0.0 111.608 179.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 538' ' ' ALA . . . . . . . . . . . . . . . -76.5 -46.21 27.66 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.645 179.673 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 539' ' ' ALA . . . . . 0.472 ' HA ' ' HB2' ' A' ' 543' ' ' TYR . . . 70.56 -51.15 0.67 Allowed 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.264 0.554 . . . . 0.0 111.46 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 540' ' ' GLU . . . . . 0.438 ' HG2' ' HA ' ' A' ' 531' ' ' TRP . 7.1 mt-10 -37.38 -28.71 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.85 -1.068 . . . . 0.0 112.347 -179.371 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 541' ' ' GLY . . . . . 0.405 ' O ' ' HB3' ' A' ' 545' ' ' GLU . . . -128.19 -38.07 0.4 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.746 179.59 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 542' ' ' ILE . . . . . 0.457 ' CD1' ' HA ' ' A' ' 539' ' ' ALA . 2.5 pp -78.86 -25.57 13.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -179.19 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 543' ' ' TYR . . . . . 0.472 ' HB2' ' HA ' ' A' ' 539' ' ' ALA . 0.4 OUTLIER -114.58 -6.86 12.8 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.896 0.379 . . . . 0.0 110.73 179.568 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 544' ' ' ALA . . . . . 0.457 ' CB ' ' HB2' ' A' ' 530' ' ' ALA . . . -99.9 -29.99 12.27 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.953 179.206 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 545' ' ' GLU . . . . . 0.513 ' HG3' ' H ' ' A' ' 548' ' ' MET . 6.2 tp10 -118.61 -32.92 4.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.474 -179.737 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 35.2 43.14 0.45 Allowed Glycine 0 CA--C 1.519 0.339 0 CA-C-N 115.923 -0.58 . . . . 0.0 114.295 179.443 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 547' ' ' LEU . . . . . 0.485 ' HG ' ' N ' ' A' ' 548' ' ' MET . 0.0 OUTLIER -178.7 -61.27 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 117.753 0.776 . . . . 0.0 112.006 179.683 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 548' ' ' MET . . . . . 0.556 ' O ' ' HG2' ' A' ' 551' ' ' GLN . 0.0 OUTLIER -89.96 12.12 18.48 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.854 0.359 . . . . 0.0 111.031 179.669 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 549' ' ' HIS . . . . . 0.494 ' O ' ' CG2' ' A' ' 519' ' ' THR . 75.7 t60 -64.81 -11.21 34.52 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.832 0.349 . . . . 0.0 110.75 179.558 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 550' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -94.24 -17.62 22.49 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.43 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 551' ' ' GLN . . . . . 0.556 ' HG2' ' O ' ' A' ' 548' ' ' MET . 0.9 OUTLIER -70.46 65.82 0.3 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.162 0.506 . . . . 0.0 110.364 179.667 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 552' ' ' ASP . . . . . 0.55 ' HB3' ' HA ' ' A' ' 516' ' ' HIS . 4.3 m-20 -91.37 21.75 4.31 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.35 -179.717 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . 117.33 -35.28 4.19 Favored Glycine 0 N--CA 1.45 -0.413 0 N-CA-C 111.332 -0.707 . . . . 0.0 111.332 -179.336 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 554' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -56.23 -59.23 5.24 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.524 0.678 . . . . 0.0 109.844 178.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 555' ' ' ILE . . . . . . . . . . . . . 3.9 mm -73.46 62.33 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 CA-C-N 114.705 -1.134 . . . . 0.0 110.657 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 556' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.327 -0.406 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.647 -179.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 511' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.119 0 CA-C-O 121.272 0.558 . . . . 0.0 110.986 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 512' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -140.21 83.34 15.76 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.07 179.383 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 513' ' ' PRO . . . . . 0.456 ' HA ' ' O ' ' A' ' 552' ' ' ASP . 74.2 Cg_endo -76.9 21.94 0.57 Allowed 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.932 2.422 . . . . 0.0 113.246 -179.278 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 20.0 t30 -96.83 -46.21 6.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.691 0.281 . . . . 0.0 110.687 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 515' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -72.18 75.57 0.97 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.925 0.393 . . . . 0.0 110.799 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 516' ' ' HIS . . . . . 0.448 ' HA ' ' HB3' ' A' ' 552' ' ' ASP . 0.1 OUTLIER -73.67 -7.41 51.92 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.786 -179.785 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 517' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -88.72 -48.48 7.49 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.716 0.293 . . . . 0.0 111.711 -179.469 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 518' ' ' TRP . . . . . 0.484 ' O ' ' N ' ' A' ' 520' ' ' THR . 3.7 m-90 -84.07 -8.4 59.12 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 -179.32 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 519' ' ' THR . . . . . 0.549 ' OG1' ' N ' ' A' ' 520' ' ' THR . 2.7 p 59.34 -78.56 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 120.581 0.229 . . . . 0.0 110.469 -179.763 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 520' ' ' THR . . . . . 0.549 ' N ' ' OG1' ' A' ' 519' ' ' THR . 1.2 m 172.73 -62.78 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 179.083 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 521' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 -74.98 -12.03 60.24 Favored 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 177.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 522' ' ' ASP . . . . . 0.414 ' O ' HG21 ' A' ' 527' ' ' ILE . 1.9 m-20 -93.99 -10.95 31.94 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.541 178.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -45.33 -27.51 0.68 Allowed 'General case' 0 C--O 1.232 0.158 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.552 -179.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 524' ' ' GLY . . . . . 0.429 ' HA2' ' CG1' ' A' ' 527' ' ' ILE . . . 146.35 42.29 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.566 -0.826 . . . . 0.0 112.306 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -101.32 -59.27 1.73 Allowed 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 111.917 0.34 . . . . 0.0 111.917 -179.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -132.25 35.97 3.65 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-O 121.512 0.673 . . . . 0.0 110.146 179.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 527' ' ' ILE . . . . . 0.455 ' HA ' ' CB ' ' A' ' 544' ' ' ALA . 2.2 pp -95.7 -0.64 10.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 114.769 -1.105 . . . . 0.0 112.701 -178.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 528' ' ' GLY . . . . . . . . . . . . . . . -62.08 -8.11 15.84 Favored Glycine 0 CA--C 1.521 0.414 0 C-N-CA 120.939 -0.648 . . . . 0.0 114.035 -179.229 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 529' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -98.32 -35.62 10.26 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 117.587 0.693 . . . . 0.0 111.556 -179.574 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 530' ' ' ALA . . . . . 0.424 ' HB1' ' CB ' ' A' ' 544' ' ' ALA . . . -103.66 -1.08 28.67 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -179.118 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 531' ' ' TRP . . . . . 0.448 ' HB2' ' O ' ' A' ' 527' ' ' ILE . 14.5 t-105 -56.09 -12.3 1.44 Allowed 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 112.039 0.385 . . . . 0.0 112.039 -179.187 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 532' ' ' ILE . . . . . 0.408 ' O ' ' CD1' ' A' ' 532' ' ' ILE . 1.6 pp -130.13 75.65 79.05 Favored Pre-proline 0 N--CA 1.451 -0.421 0 CA-C-O 121.005 0.431 . . . . 0.0 111.132 179.727 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 533' ' ' PRO . . . . . 0.401 ' HB3' ' O ' ' A' ' 538' ' ' ALA . 3.9 Cg_endo -46.95 92.25 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 123.169 2.579 . . . . 0.0 112.672 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 534' ' ' TYR . . . . . . . . . . . . . 46.9 p90 -96.18 -22.82 17.05 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.127 179.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -73.98 -34.86 64.39 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.303 -179.685 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 150.25 -64.28 0.39 Allowed Glycine 0 CA--C 1.519 0.332 0 C-N-CA 120.491 -0.862 . . . . 0.0 112.833 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -59.92 -164.17 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.651 2.234 . . . . 0.0 112.097 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 538' ' ' ALA . . . . . 0.401 ' O ' ' HB3' ' A' ' 533' ' ' PRO . . . -70.41 -46.53 63.79 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.678 179.753 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 539' ' ' ALA . . . . . 0.57 ' HA ' ' HB2' ' A' ' 543' ' ' TYR . . . 70.68 -52.35 0.67 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.212 0.53 . . . . 0.0 111.709 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 540' ' ' GLU . . . . . 0.435 ' HG2' ' HA ' ' A' ' 531' ' ' TRP . 13.0 mt-10 -37.21 -28.07 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.831 -1.077 . . . . 0.0 112.427 -179.231 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 541' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' A' ' 539' ' ' ALA . . . -126.79 -41.65 0.3 Allowed Glycine 0 CA--C 1.52 0.347 0 C-N-CA 120.505 -0.855 . . . . 0.0 112.338 179.206 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 542' ' ' ILE . . . . . 0.475 ' CD1' ' HA ' ' A' ' 539' ' ' ALA . 2.5 pp -75.8 -25.55 17.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -179.377 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 543' ' ' TYR . . . . . 0.57 ' HB2' ' HA ' ' A' ' 539' ' ' ALA . 0.2 OUTLIER -115.65 -5.66 12.16 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.862 0.363 . . . . 0.0 110.948 179.839 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 544' ' ' ALA . . . . . 0.455 ' CB ' ' HA ' ' A' ' 527' ' ' ILE . . . -102.78 -32.66 9.71 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.783 179.216 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 545' ' ' GLU . . . . . 0.48 ' HG3' ' H ' ' A' ' 548' ' ' MET . 50.3 tp10 -118.53 -32.85 4.48 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.301 179.834 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 35.55 39.35 0.23 Allowed Glycine 0 CA--C 1.519 0.337 0 CA-C-N 115.583 -0.735 . . . . 0.0 114.176 179.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 547' ' ' LEU . . . . . 0.446 ' HG ' ' N ' ' A' ' 548' ' ' MET . 0.0 OUTLIER -173.9 -61.8 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 117.756 0.778 . . . . 0.0 112.621 179.517 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 548' ' ' MET . . . . . 0.48 ' H ' ' HG3' ' A' ' 545' ' ' GLU . 0.0 OUTLIER -96.22 11.48 34.32 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.68 0.276 . . . . 0.0 111.339 179.96 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 549' ' ' HIS . . . . . 0.466 ' O ' ' CG2' ' A' ' 519' ' ' THR . 2.4 p-80 -62.29 -11.32 14.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.824 0.345 . . . . 0.0 110.804 179.221 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 550' ' ' ASN . . . . . 0.441 ' O ' ' N ' ' A' ' 552' ' ' ASP . 26.2 t-20 -95.1 -32.06 13.27 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -179.212 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 551' ' ' GLN . . . . . 0.447 ' HG2' ' CG ' ' A' ' 548' ' ' MET . 1.6 pt20 -64.99 74.44 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.421 0.629 . . . . 0.0 110.576 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 552' ' ' ASP . . . . . 0.544 ' HA ' ' HA ' ' A' ' 519' ' ' THR . 15.6 m-20 -78.61 19.12 0.51 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.583 -0.735 . . . . 0.0 112.023 -179.544 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . 123.61 -31.05 4.72 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.785 -0.721 . . . . 0.0 111.817 -179.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 554' ' ' LEU . . . . . . . . . . . . . 1.5 mp -53.02 -56.56 15.17 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.485 0.66 . . . . 0.0 110.592 179.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 555' ' ' ILE . . . . . . . . . . . . . 2.3 mm -69.57 66.27 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 114.785 -1.098 . . . . 0.0 110.614 -179.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 556' ' ' CYS . . . . . . . . . . . . . 7.9 t . . . . . 0 C--N 1.323 -0.575 0 CA-C-N 115.461 -0.79 . . . . 0.0 111.649 -179.635 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 511' ' ' CYS . . . . . 0.402 ' HA ' ' HB3' ' A' ' 556' ' ' CYS . 28.9 t . . . . . 0 C--O 1.231 0.129 0 CA-C-O 121.025 0.441 . . . . 0.0 111.688 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 512' ' ' ASN . . . . . 0.424 ' C ' ' HA3' ' A' ' 553' ' ' GLY . 87.4 m-20 -111.07 81.22 2.63 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.871 179.113 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 513' ' ' PRO . . . . . 0.516 ' HA ' ' O ' ' A' ' 552' ' ' ASP . 55.5 Cg_endo -71.79 11.9 0.62 Allowed 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 122.839 2.36 . . . . 0.0 113.276 -179.275 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 -96.62 -15.99 21.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.663 0.268 . . . . 0.0 110.969 179.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 515' ' ' LEU . . . . . . . . . . . . . 1.4 mp -94.46 73.94 3.82 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.894 0.378 . . . . 0.0 110.943 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 516' ' ' HIS . . . . . 0.439 ' HA ' ' HB3' ' A' ' 552' ' ' ASP . 0.2 OUTLIER -80.59 -7.09 59.14 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.872 -179.774 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 517' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -72.17 -66.08 0.69 Allowed 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -179.088 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 518' ' ' TRP . . . . . 0.48 ' O ' ' N ' ' A' ' 520' ' ' THR . 12.0 m-90 -93.32 0.51 56.97 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.489 0.552 . . . . 0.0 112.489 -178.737 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 519' ' ' THR . . . . . 0.512 HG23 ' HA ' ' A' ' 549' ' ' HIS . 2.8 p 60.56 -75.19 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 110.627 -0.138 . . . . 0.0 110.627 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 520' ' ' THR . . . . . 0.48 ' N ' ' O ' ' A' ' 518' ' ' TRP . 1.0 OUTLIER 172.27 -62.95 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.241 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 179.155 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 521' ' ' GLN . . . . . 0.405 ' NE2' HG22 ' A' ' 520' ' ' THR . 0.7 OUTLIER -68.33 -15.43 63.56 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 178.245 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 522' ' ' ASP . . . . . 0.413 ' HB2' ' O ' ' A' ' 518' ' ' TRP . 2.8 m-20 -94.19 -11.93 29.34 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 115.668 -0.697 . . . . 0.0 111.273 179.563 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -51.98 -31.73 30.55 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-O 121.069 0.462 . . . . 0.0 110.846 179.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . 162.89 40.29 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.471 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.02 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -133.02 -32.17 1.23 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.632 0.253 . . . . 0.0 111.592 -179.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -137.84 56.52 1.75 Allowed 'General case' 0 CA--C 1.515 -0.373 0 CA-C-O 121.393 0.615 . . . . 0.0 110.306 179.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 527' ' ' ILE . . . . . 0.439 ' CD1' ' N ' ' A' ' 528' ' ' GLY . 1.4 pp -95.31 -18.55 6.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.721 -179.511 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 528' ' ' GLY . . . . . 0.439 ' N ' ' CD1' ' A' ' 527' ' ' ILE . . . 26.79 -144.92 0.01 OUTLIER Glycine 0 C--N 1.336 0.559 0 N-CA-C 114.716 0.647 . . . . 0.0 114.716 179.171 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 529' ' ' LEU . . . . . 0.415 HD11 ' N ' ' A' ' 530' ' ' ALA . 0.2 OUTLIER -63.55 -17.59 62.96 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.426 -0.387 . . . . 0.0 111.715 -179.624 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 530' ' ' ALA . . . . . 0.487 ' C ' ' H ' ' A' ' 532' ' ' ILE . . . -81.58 1.99 31.23 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -179.361 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 531' ' ' TRP . . . . . 0.448 ' HA ' ' HG2' ' A' ' 540' ' ' GLU . 0.1 OUTLIER -72.18 27.38 0.05 Allowed 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -179.15 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 532' ' ' ILE . . . . . 0.487 ' H ' ' C ' ' A' ' 530' ' ' ALA . 1.1 pp -159.03 72.16 3.54 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-O 120.793 0.33 . . . . 0.0 110.541 179.074 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 533' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_endo -49.62 88.34 0.02 OUTLIER 'Trans proline' 0 C--N 1.343 0.243 0 C-N-CA 123.08 2.52 . . . . 0.0 112.625 -179.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 534' ' ' TYR . . . . . . . . . . . . . 65.3 t80 -96.46 -28.37 14.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.273 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -72.59 -35.03 67.81 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.503 -179.452 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 151.99 -65.03 0.36 Allowed Glycine 0 N--CA 1.453 -0.208 0 C-N-CA 120.496 -0.859 . . . . 0.0 112.547 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_endo -57.38 -163.27 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.636 2.224 . . . . 0.0 111.718 179.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 538' ' ' ALA . . . . . . . . . . . . . . . -76.81 -46.62 24.24 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.512 179.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 539' ' ' ALA . . . . . 0.549 ' HA ' ' CD1' ' A' ' 542' ' ' ILE . . . 70.79 -52.4 0.67 Allowed 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 121.336 0.589 . . . . 0.0 111.545 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 540' ' ' GLU . . . . . 0.448 ' HG2' ' HA ' ' A' ' 531' ' ' TRP . 10.2 mt-10 -36.8 -30.85 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.797 -1.092 . . . . 0.0 112.43 -179.143 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 541' ' ' GLY . . . . . . . . . . . . . . . -126.79 -22.29 1.63 Allowed Glycine 0 CA--C 1.518 0.274 0 C-N-CA 120.35 -0.928 . . . . 0.0 113.355 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 542' ' ' ILE . . . . . 0.549 ' CD1' ' HA ' ' A' ' 539' ' ' ALA . 2.6 pp -96.4 -18.85 6.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 -179.133 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 543' ' ' TYR . . . . . 0.473 ' HB2' ' HA ' ' A' ' 539' ' ' ALA . 0.4 OUTLIER -114.21 -11.81 12.57 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.808 179.58 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 544' ' ' ALA . . . . . 0.45 ' CB ' ' CB ' ' A' ' 530' ' ' ALA . . . -103.36 -36.23 8.1 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 121.336 0.589 . . . . 0.0 110.635 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 545' ' ' GLU . . . . . 0.616 ' HG2' ' HB2' ' A' ' 548' ' ' MET . 2.9 tp10 -118.51 -32.7 4.52 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.218 -0.901 . . . . 0.0 111.452 -179.243 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 37.99 51.22 2.11 Favored Glycine 0 C--N 1.332 0.308 0 C-N-CA 121.259 -0.496 . . . . 0.0 112.664 -179.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 547' ' ' LEU . . . . . 0.53 ' HG ' ' N ' ' A' ' 548' ' ' MET . 0.3 OUTLIER -172.78 -46.19 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 120.9 -0.32 . . . . 0.0 111.618 -179.292 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 548' ' ' MET . . . . . 0.616 ' HB2' ' HG2' ' A' ' 545' ' ' GLU . 0.0 OUTLIER -96.58 11.61 34.61 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.811 0.338 . . . . 0.0 111.0 179.285 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 549' ' ' HIS . . . . . 0.512 ' HA ' HG23 ' A' ' 519' ' ' THR . 11.4 p-80 -69.05 -11.21 60.58 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.008 0.432 . . . . 0.0 110.405 179.528 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 550' ' ' ASN . . . . . . . . . . . . . 35.2 t30 -95.93 -17.63 20.9 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.817 -179.391 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 551' ' ' GLN . . . . . 0.488 ' HG2' ' O ' ' A' ' 548' ' ' MET . 7.8 mm-40 -69.23 62.76 0.14 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.964 0.411 . . . . 0.0 110.569 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 552' ' ' ASP . . . . . 0.516 ' O ' ' HA ' ' A' ' 513' ' ' PRO . 2.8 m-20 -94.12 21.74 6.54 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.18 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 553' ' ' GLY . . . . . 0.424 ' HA3' ' C ' ' A' ' 512' ' ' ASN . . . 115.26 -33.98 5.03 Favored Glycine 0 N--CA 1.448 -0.564 0 N-CA-C 111.212 -0.755 . . . . 0.0 111.212 -179.242 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 554' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -53.37 -50.82 64.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.592 0.711 . . . . 0.0 110.177 178.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 555' ' ' ILE . . . . . 0.432 ' O ' ' CG2' ' A' ' 555' ' ' ILE . 4.1 mm -81.1 54.76 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 114.73 -1.123 . . . . 0.0 110.91 -179.743 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 556' ' ' CYS . . . . . 0.402 ' HB3' ' HA ' ' A' ' 511' ' ' CYS . 29.1 p . . . . . 0 C--N 1.326 -0.444 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.03 179.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 511' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.53 0.189 0 CA-C-O 121.079 0.466 . . . . 0.0 111.597 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 512' ' ' ASN . . . . . 0.471 ' O ' ' O ' ' A' ' 552' ' ' ASP . 24.7 p30 -127.0 83.37 66.16 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.177 179.466 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 513' ' ' PRO . . . . . 0.422 ' HA ' ' O ' ' A' ' 552' ' ' ASP . 74.2 Cg_endo -76.17 22.1 0.51 Allowed 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 123.023 2.482 . . . . 0.0 113.27 -179.59 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -96.68 -26.02 15.34 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.811 0.339 . . . . 0.0 110.609 179.553 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 515' ' ' LEU . . . . . . . . . . . . . 31.7 mt -95.55 71.91 3.14 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.885 179.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 516' ' ' HIS . . . . . 0.457 ' HA ' ' CB ' ' A' ' 552' ' ' ASP . 6.2 p-80 -73.61 -7.35 51.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.721 -179.821 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 517' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -72.54 -59.74 2.57 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 111.903 0.334 . . . . 0.0 111.903 -179.435 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 518' ' ' TRP . . . . . 0.462 ' O ' ' N ' ' A' ' 520' ' ' THR . 0.7 OUTLIER -80.07 -22.39 42.31 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.06 0.392 . . . . 0.0 112.06 -178.837 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 519' ' ' THR . . . . . 0.539 ' OG1' ' N ' ' A' ' 520' ' ' THR . 3.4 p 57.42 -81.29 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.459 0.171 . . . . 0.0 110.741 -179.728 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 520' ' ' THR . . . . . 0.539 ' N ' ' OG1' ' A' ' 519' ' ' THR . 1.1 m 176.19 -62.58 0.01 OUTLIER 'General case' 0 CA--C 1.52 -0.174 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 179.517 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 521' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -72.07 -11.97 61.0 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.346 177.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 522' ' ' ASP . . . . . 0.425 ' O ' HG21 ' A' ' 527' ' ' ILE . 62.0 m-20 -93.49 -11.09 32.81 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.803 179.093 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 523' ' ' GLU . . . . . 0.456 ' HA ' ' CD1' ' A' ' 518' ' ' TRP . 0.1 OUTLIER -45.59 -27.92 0.86 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.698 -179.738 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 524' ' ' GLY . . . . . 0.447 ' HA2' ' CG1' ' A' ' 527' ' ' ILE . . . 150.52 40.04 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.343 -0.932 . . . . 0.0 112.439 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -97.91 -60.5 1.55 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.72 0.295 . . . . 0.0 111.589 -179.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -133.86 36.98 3.27 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-O 121.645 0.736 . . . . 0.0 110.33 179.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 527' ' ' ILE . . . . . 0.493 ' HA ' ' CB ' ' A' ' 544' ' ' ALA . 1.6 pp -96.13 -0.72 10.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 114.676 -1.147 . . . . 0.0 112.956 -178.795 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 528' ' ' GLY . . . . . . . . . . . . . . . -55.19 -14.75 6.4 Favored Glycine 0 CA--C 1.521 0.455 0 C-N-CA 120.845 -0.693 . . . . 0.0 114.0 -179.342 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 529' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -98.73 -38.38 9.11 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 117.756 0.778 . . . . 0.0 112.303 -179.266 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 530' ' ' ALA . . . . . 0.499 ' C ' ' H ' ' A' ' 532' ' ' ILE . . . -103.68 1.71 32.25 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 -178.492 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 531' ' ' TRP . . . . . 0.466 ' HB3' ' O ' ' A' ' 527' ' ' ILE . 0.2 OUTLIER -71.31 30.46 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 112.405 0.521 . . . . 0.0 112.405 -178.896 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 532' ' ' ILE . . . . . 0.499 ' H ' ' C ' ' A' ' 530' ' ' ALA . 1.1 pt -159.04 73.24 3.52 Favored Pre-proline 0 N--CA 1.454 -0.256 0 CA-C-O 120.734 0.302 . . . . 0.0 110.403 179.031 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 533' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -50.74 84.95 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 123.071 2.514 . . . . 0.0 112.683 -179.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 534' ' ' TYR . . . . . 0.42 ' N ' ' O ' ' A' ' 532' ' ' ILE . 0.2 OUTLIER -96.48 -31.58 12.73 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.975 179.788 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -68.06 -34.94 77.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.333 -179.512 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 148.85 -63.9 0.41 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.651 -179.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -59.22 -165.98 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.639 2.226 . . . . 0.0 111.984 179.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 538' ' ' ALA . . . . . . . . . . . . . . . -71.54 -49.79 37.44 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.508 179.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 539' ' ' ALA . . . . . 0.509 ' HA ' ' CD1' ' A' ' 542' ' ' ILE . . . 69.14 -53.05 0.59 Allowed 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 121.206 0.527 . . . . 0.0 111.688 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 540' ' ' GLU . . . . . 0.433 ' HG2' ' HA ' ' A' ' 531' ' ' TRP . 0.8 OUTLIER -37.3 -30.2 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.942 -1.026 . . . . 0.0 112.234 -179.286 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 541' ' ' GLY . . . . . . . . . . . . . . . -126.05 -30.27 0.88 Allowed Glycine 0 N--CA 1.453 -0.223 0 C-N-CA 120.479 -0.867 . . . . 0.0 113.216 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 542' ' ' ILE . . . . . 0.509 ' CD1' ' HA ' ' A' ' 539' ' ' ALA . 2.6 pp -87.89 -21.84 6.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 112.0 0.37 . . . . 0.0 112.0 -179.371 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 543' ' ' TYR . . . . . 0.468 ' CD2' ' CD1' ' A' ' 542' ' ' ILE . 6.1 m-85 -113.54 -10.19 13.19 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 120.812 0.339 . . . . 0.0 110.637 179.259 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 544' ' ' ALA . . . . . 0.493 ' CB ' ' HA ' ' A' ' 527' ' ' ILE . . . -103.35 -37.58 7.58 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 121.213 0.53 . . . . 0.0 110.198 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 545' ' ' GLU . . . . . 0.515 ' HG3' ' H ' ' A' ' 548' ' ' MET . 5.5 tp10 -118.73 -32.69 4.46 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.489 -179.088 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 37.72 45.39 1.48 Allowed Glycine 0 CA--C 1.52 0.398 0 CA-C-N 115.999 -0.546 . . . . 0.0 114.038 179.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 547' ' ' LEU . . . . . 0.46 ' HG ' ' N ' ' A' ' 548' ' ' MET . 0.0 OUTLIER -178.59 -61.26 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 117.594 0.697 . . . . 0.0 112.03 179.479 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 548' ' ' MET . . . . . 0.555 ' O ' ' HG2' ' A' ' 551' ' ' GLN . 0.0 OUTLIER -90.63 12.06 20.11 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.715 0.293 . . . . 0.0 111.345 179.923 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 549' ' ' HIS . . . . . 0.5 ' O ' ' CG2' ' A' ' 519' ' ' THR . 12.7 t60 -65.51 -11.11 40.49 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.744 -0.383 . . . . 0.0 110.462 179.482 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 550' ' ' ASN . . . . . . . . . . . . . 22.8 m-80 -93.7 -12.59 28.93 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.965 -0.294 . . . . 0.0 111.456 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 551' ' ' GLN . . . . . 0.555 ' HG2' ' O ' ' A' ' 548' ' ' MET . 2.9 mm100 -73.47 59.2 0.6 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.913 0.387 . . . . 0.0 110.35 179.536 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 552' ' ' ASP . . . . . 0.471 ' O ' ' O ' ' A' ' 512' ' ' ASN . 2.8 p30 -98.78 22.04 10.62 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.188 -179.591 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . 123.74 -31.86 4.43 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.819 -0.705 . . . . 0.0 111.487 -179.238 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 554' ' ' LEU . . . . . . . . . . . . . 1.4 mt -55.01 -56.12 23.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.382 0.61 . . . . 0.0 110.183 179.121 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 555' ' ' ILE . . . . . . . . . . . . . 5.5 mm -79.23 60.01 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.997 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 556' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.327 -0.385 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.376 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 511' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.53 0.175 0 CA-C-O 121.066 0.46 . . . . 0.0 111.508 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 512' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -122.11 83.89 45.26 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.417 179.542 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 513' ' ' PRO . . . . . 0.422 ' HB3' ' HG ' ' A' ' 554' ' ' LEU . 73.5 Cg_endo -75.36 -0.82 10.53 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.844 2.363 . . . . 0.0 113.124 -179.466 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 20.2 t30 -62.93 -40.24 97.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.736 0.303 . . . . 0.0 110.907 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 515' ' ' LEU . . . . . 0.45 ' HB3' ' CZ3' ' A' ' 518' ' ' TRP . 0.9 OUTLIER -95.71 58.99 2.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.017 0.437 . . . . 0.0 111.06 -179.812 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 516' ' ' HIS . . . . . . . . . . . . . 42.4 t-80 -73.01 -6.54 46.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.874 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 517' ' ' TYR . . . . . . . . . . . . . 48.8 m-85 -61.07 -27.88 68.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.718 0.294 . . . . 0.0 111.174 -179.388 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 518' ' ' TRP . . . . . 0.522 ' O ' ' N ' ' A' ' 520' ' ' THR . 1.5 p90 -117.92 -14.97 10.02 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.87 -179.612 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 519' ' ' THR . . . . . 0.538 ' CG2' ' O ' ' A' ' 549' ' ' HIS . 14.9 p 55.2 -79.43 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.55 0.214 . . . . 0.0 111.084 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 520' ' ' THR . . . . . 0.522 ' N ' ' O ' ' A' ' 518' ' ' TRP . 1.1 m 177.41 -62.59 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 179.479 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 521' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -74.65 -12.06 60.34 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.32 177.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 522' ' ' ASP . . . . . 0.418 ' O ' HG23 ' A' ' 527' ' ' ILE . 13.4 m-20 -92.56 -10.7 36.62 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.675 179.037 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -45.19 -26.37 0.48 Allowed 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.581 -179.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 524' ' ' GLY . . . . . 0.411 ' HA2' ' CG1' ' A' ' 527' ' ' ILE . . . 146.06 40.92 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.441 -0.885 . . . . 0.0 112.604 179.797 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -100.36 -60.2 1.57 Allowed 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 -179.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -132.51 37.63 3.49 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.541 0.686 . . . . 0.0 110.068 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 527' ' ' ILE . . . . . 0.452 ' HA ' ' CB ' ' A' ' 544' ' ' ALA . 2.3 pp -95.97 -0.25 10.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 114.708 -1.133 . . . . 0.0 112.912 -178.802 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 528' ' ' GLY . . . . . . . . . . . . . . . -56.87 -9.38 3.73 Favored Glycine 0 CA--C 1.523 0.576 0 C-N-CA 121.01 -0.614 . . . . 0.0 114.47 -179.151 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 529' ' ' LEU . . . . . 0.436 ' HG ' ' N ' ' A' ' 530' ' ' ALA . 1.2 pt? -98.56 -37.46 9.54 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 118.002 0.901 . . . . 0.0 112.021 -179.407 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 530' ' ' ALA . . . . . 0.5 ' C ' ' H ' ' A' ' 532' ' ' ILE . . . -103.82 1.94 32.16 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 -178.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 531' ' ' TRP . . . . . 0.444 ' HB2' ' O ' ' A' ' 527' ' ' ILE . 10.2 t90 -68.03 30.31 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 -178.639 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 532' ' ' ILE . . . . . 0.5 ' H ' ' C ' ' A' ' 530' ' ' ALA . 1.3 pp -158.89 70.84 3.6 Favored Pre-proline 0 C--N 1.332 -0.177 0 CA-C-O 120.707 0.289 . . . . 0.0 111.462 179.309 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 533' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -54.83 102.07 0.08 OUTLIER 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.335 2.024 . . . . 0.0 111.508 179.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 534' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -96.15 -54.88 3.14 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -178.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -118.32 -34.91 3.93 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 111.87 0.322 . . . . 0.0 111.87 -179.247 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . -86.37 -176.29 49.69 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.539 -0.839 . . . . 0.0 112.783 -179.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 537' ' ' PRO . . . . . 0.403 ' HG2' ' CD1' ' A' ' 542' ' ' ILE . 14.0 Cg_endo -56.52 -158.83 0.01 OUTLIER 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.87 2.38 . . . . 0.0 111.818 179.69 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 538' ' ' ALA . . . . . 0.428 ' C ' ' H ' ' A' ' 540' ' ' GLU . . . -45.06 -49.06 11.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.141 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 539' ' ' ALA . . . . . 0.439 ' HA ' ' HB2' ' A' ' 543' ' ' TYR . . . 71.54 -48.79 0.68 Allowed 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.306 0.574 . . . . 0.0 111.459 179.77 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 540' ' ' GLU . . . . . 0.428 ' H ' ' C ' ' A' ' 538' ' ' ALA . 4.3 mt-10 -36.94 -29.33 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 114.901 -1.045 . . . . 0.0 112.354 -179.326 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 541' ' ' GLY . . . . . . . . . . . . . . . -127.98 -42.73 0.25 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.369 179.434 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 542' ' ' ILE . . . . . 0.432 ' CD1' ' HA ' ' A' ' 539' ' ' ALA . 2.6 pp -74.35 -24.88 19.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -179.317 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 543' ' ' TYR . . . . . 0.443 ' HB3' ' HB1' ' A' ' 530' ' ' ALA . 2.8 t80 -114.4 -7.97 12.86 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.847 0.356 . . . . 0.0 110.814 179.725 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 544' ' ' ALA . . . . . 0.455 ' CB ' ' HB2' ' A' ' 530' ' ' ALA . . . -98.29 -32.36 11.58 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 179.038 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 545' ' ' GLU . . . . . 0.522 ' HG3' ' H ' ' A' ' 548' ' ' MET . 4.4 tp10 -118.67 -32.6 4.51 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.178 -179.84 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 40.22 42.83 2.53 Favored Glycine 0 CA--C 1.52 0.372 0 CA-C-N 115.941 -0.572 . . . . 0.0 113.956 179.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 547' ' ' LEU . . . . . 0.424 ' HG ' ' N ' ' A' ' 548' ' ' MET . 0.0 OUTLIER -175.54 -61.15 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 117.511 0.656 . . . . 0.0 111.972 179.504 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 548' ' ' MET . . . . . 0.522 ' H ' ' HG3' ' A' ' 545' ' ' GLU . 0.1 OUTLIER -89.76 11.5 19.85 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.649 0.262 . . . . 0.0 111.311 -179.983 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 549' ' ' HIS . . . . . 0.538 ' O ' ' CG2' ' A' ' 519' ' ' THR . 7.2 p80 -65.61 -11.24 42.67 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.139 0.495 . . . . 0.0 110.662 179.328 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 550' ' ' ASN . . . . . 0.445 ' ND2' ' CE1' ' A' ' 549' ' ' HIS . 1.1 m-80 -96.22 -7.57 35.3 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.413 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 551' ' ' GLN . . . . . 0.52 ' HG3' ' HG2' ' A' ' 548' ' ' MET . 8.2 mm-40 -71.81 53.41 0.24 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.706 0.289 . . . . 0.0 111.63 -179.33 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 552' ' ' ASP . . . . . 0.468 ' HB2' ' HA ' ' A' ' 519' ' ' THR . 6.3 t70 -114.15 21.68 14.53 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.738 0.304 . . . . 0.0 110.766 179.392 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . 116.96 -31.07 6.03 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.744 -0.741 . . . . 0.0 111.324 -178.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 554' ' ' LEU . . . . . 0.422 ' HG ' ' HB3' ' A' ' 513' ' ' PRO . 11.8 mt -57.61 -53.44 58.16 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-O 121.505 0.669 . . . . 0.0 109.631 178.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 555' ' ' ILE . . . . . . . . . . . . . 9.6 mm -89.05 54.93 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 CA-C-N 114.978 -1.01 . . . . 0.0 109.99 179.44 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 556' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.867 -179.459 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 511' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.132 0 CA-C-O 121.061 0.458 . . . . 0.0 111.486 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 512' ' ' ASN . . . . . 0.403 ' O ' ' O ' ' A' ' 552' ' ' ASP . 9.6 m-20 -110.7 83.59 3.57 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.503 179.557 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 513' ' ' PRO . . . . . 0.416 ' HA ' ' O ' ' A' ' 552' ' ' ASP . 90.1 Cg_endo -79.27 22.91 0.66 Allowed 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.953 2.436 . . . . 0.0 113.185 -179.639 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -96.65 -27.66 14.69 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.778 0.323 . . . . 0.0 110.798 179.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 515' ' ' LEU . . . . . . . . . . . . . 1.6 mt -93.06 72.48 4.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.803 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 516' ' ' HIS . . . . . 0.432 ' HA ' ' CB ' ' A' ' 552' ' ' ASP . 2.4 t60 -72.11 -7.53 49.51 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.827 -179.772 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 517' ' ' TYR . . . . . . . . . . . . . 41.6 m-85 -83.96 -66.11 0.93 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.853 0.359 . . . . 0.0 111.448 -179.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 518' ' ' TRP . . . . . 0.435 ' O ' ' N ' ' A' ' 520' ' ' THR . 0.1 OUTLIER -69.33 -19.01 63.87 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.625 -179.459 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 519' ' ' THR . . . . . 0.532 ' OG1' ' N ' ' A' ' 520' ' ' THR . 1.5 p 61.45 -78.26 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.65 -0.25 . . . . 0.0 110.39 -179.69 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 520' ' ' THR . . . . . 0.532 ' N ' ' OG1' ' A' ' 519' ' ' THR . 1.0 OUTLIER 173.12 -62.93 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 179.07 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 521' ' ' GLN . . . . . 0.468 ' HB3' ' OE2' ' A' ' 545' ' ' GLU . 6.0 tt0 -74.52 -15.65 60.86 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 177.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 522' ' ' ASP . . . . . 0.483 ' O ' HG21 ' A' ' 527' ' ' ILE . 13.5 t70 -94.07 -10.45 33.35 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.786 178.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 523' ' ' GLU . . . . . 0.433 ' HA ' ' CD1' ' A' ' 518' ' ' TRP . 0.0 OUTLIER -44.95 -26.88 0.47 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.539 -179.524 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 524' ' ' GLY . . . . . 0.418 ' HA2' ' CG1' ' A' ' 527' ' ' ILE . . . 153.14 40.56 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.288 179.838 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -97.67 -56.3 2.55 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.165 0.431 . . . . 0.0 112.165 -179.342 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -133.2 41.22 3.13 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-O 121.496 0.665 . . . . 0.0 110.185 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 527' ' ' ILE . . . . . 0.483 HG21 ' O ' ' A' ' 522' ' ' ASP . 1.8 pp -95.82 -0.62 10.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 114.783 -1.099 . . . . 0.0 112.918 -178.853 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 528' ' ' GLY . . . . . . . . . . . . . . . -60.3 -13.21 28.0 Favored Glycine 0 CA--C 1.521 0.447 0 C-N-CA 120.852 -0.689 . . . . 0.0 114.131 -179.013 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 529' ' ' LEU . . . . . 0.472 ' CD1' ' N ' ' A' ' 529' ' ' LEU . 0.0 OUTLIER -99.13 -30.44 12.29 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 117.614 0.707 . . . . 0.0 111.817 -179.645 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 530' ' ' ALA . . . . . 0.496 ' C ' ' H ' ' A' ' 532' ' ' ILE . . . -103.61 1.69 32.38 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -179.136 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 531' ' ' TRP . . . . . 0.528 ' HA ' ' HG2' ' A' ' 540' ' ' GLU . 0.2 OUTLIER -71.33 30.34 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -178.92 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 532' ' ' ILE . . . . . 0.496 ' H ' ' C ' ' A' ' 530' ' ' ALA . 1.1 pt -158.58 72.98 3.78 Favored Pre-proline 0 N--CA 1.453 -0.311 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.472 179.14 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 533' ' ' PRO . . . . . 0.41 ' HB3' ' O ' ' A' ' 537' ' ' PRO . 1.2 Cg_endo -44.25 85.25 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 123.46 2.773 . . . . 0.0 113.014 -179.625 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 534' ' ' TYR . . . . . 0.446 ' N ' ' O ' ' A' ' 532' ' ' ILE . 7.7 t80 -96.65 -39.47 9.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.329 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 20.6 t80 -57.68 -34.98 69.97 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.549 -179.191 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 146.55 -52.41 0.56 Allowed Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.467 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 537' ' ' PRO . . . . . 0.41 ' O ' ' HB3' ' A' ' 533' ' ' PRO . 2.0 Cg_endo -78.06 -174.53 2.28 Favored 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 122.725 2.283 . . . . 0.0 111.173 179.392 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 538' ' ' ALA . . . . . . . . . . . . . . . -57.11 -51.23 70.14 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.951 -0.3 . . . . 0.0 110.624 179.554 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 539' ' ' ALA . . . . . 0.434 ' O ' ' N ' ' A' ' 541' ' ' GLY . . . 71.07 -50.76 0.69 Allowed 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 121.265 0.555 . . . . 0.0 111.402 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 540' ' ' GLU . . . . . 0.528 ' HG2' ' HA ' ' A' ' 531' ' ' TRP . 5.3 mt-10 -37.74 -24.34 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 114.896 -1.047 . . . . 0.0 112.759 -179.445 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 541' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 539' ' ' ALA . . . -111.15 -58.36 0.48 Allowed Glycine 0 CA--C 1.52 0.384 0 C-N-CA 120.488 -0.863 . . . . 0.0 113.227 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 542' ' ' ILE . . . . . 0.432 ' HA ' ' CD2' ' A' ' 549' ' ' HIS . 0.2 OUTLIER -76.94 -22.82 14.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 113.477 0.917 . . . . 0.0 113.477 -178.366 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 543' ' ' TYR . . . . . 0.426 ' HB2' ' CA ' ' A' ' 539' ' ' ALA . 10.5 m-85 -101.56 -11.19 19.44 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.27 0.557 . . . . 0.0 110.345 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 544' ' ' ALA . . . . . 0.476 ' CB ' ' HB2' ' A' ' 530' ' ' ALA . . . -100.03 -28.86 12.85 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 115.228 -0.897 . . . . 0.0 110.034 179.689 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 545' ' ' GLU . . . . . 0.488 ' HG3' ' H ' ' A' ' 548' ' ' MET . 3.9 tp10 -118.68 -32.78 4.45 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.384 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 36.39 39.73 0.36 Allowed Glycine 0 CA--C 1.519 0.308 0 CA-C-N 115.759 -0.655 . . . . 0.0 114.371 179.454 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 547' ' ' LEU . . . . . 0.427 ' HG ' ' N ' ' A' ' 548' ' ' MET . 0.0 OUTLIER -176.71 -61.73 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 117.734 0.767 . . . . 0.0 112.247 179.449 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 548' ' ' MET . . . . . 0.488 ' H ' ' HG3' ' A' ' 545' ' ' GLU . 0.0 OUTLIER -95.38 11.38 32.94 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.728 0.299 . . . . 0.0 111.053 179.634 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 549' ' ' HIS . . . . . 0.474 ' O ' ' CG2' ' A' ' 519' ' ' THR . 16.5 p80 -62.72 -10.82 14.0 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.024 179.549 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 550' ' ' ASN . . . . . 0.444 ' O ' ' N ' ' A' ' 552' ' ' ASP . 1.8 m120 -95.56 -33.82 12.26 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -178.633 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 551' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -65.9 71.51 0.06 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.182 0.515 . . . . 0.0 110.466 -179.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 552' ' ' ASP . . . . . 0.475 ' HA ' ' O ' ' A' ' 519' ' ' THR . 2.4 p30 -94.71 22.12 6.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.397 -179.48 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . 123.97 -32.65 4.13 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.799 -0.715 . . . . 0.0 111.677 -179.393 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 554' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -58.75 -59.18 5.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.488 0.661 . . . . 0.0 109.96 178.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 555' ' ' ILE . . . . . . . . . . . . . 3.2 mm -72.27 65.69 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 CA-C-N 114.867 -1.06 . . . . 0.0 110.618 179.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 556' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.324 -0.5 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.565 -179.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 511' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.232 0.156 0 CA-C-O 120.993 0.425 . . . . 0.0 111.569 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 512' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -124.04 80.4 57.68 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.48 179.724 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 513' ' ' PRO . . . . . 0.433 ' HA ' ' O ' ' A' ' 552' ' ' ASP . 94.2 Cg_endo -80.98 24.85 0.66 Allowed 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 123.021 2.481 . . . . 0.0 113.179 -179.679 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 17.8 t-20 -96.73 -30.31 13.28 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.707 0.289 . . . . 0.0 110.797 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 515' ' ' LEU . . . . . . . . . . . . . 32.9 mt -89.17 72.97 8.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.847 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 516' ' ' HIS . . . . . 0.413 ' HA ' ' CB ' ' A' ' 552' ' ' ASP . 62.2 t-80 -76.69 -15.69 59.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.541 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 517' ' ' TYR . . . . . . . . . . . . . 57.4 m-85 -80.1 -36.72 35.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.736 0.303 . . . . 0.0 111.373 -179.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 518' ' ' TRP . . . . . 0.462 ' O ' ' N ' ' A' ' 520' ' ' THR . 3.9 m-90 -94.92 -21.27 18.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.501 -179.532 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 519' ' ' THR . . . . . 0.55 ' OG1' ' N ' ' A' ' 520' ' ' THR . 1.2 p 58.41 -78.64 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.843 -179.797 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 520' ' ' THR . . . . . 0.55 ' N ' ' OG1' ' A' ' 519' ' ' THR . 1.1 m 178.18 -62.97 0.01 OUTLIER 'General case' 0 CA--C 1.521 -0.171 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 179.234 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 521' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -74.42 -14.3 60.83 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 177.825 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 522' ' ' ASP . . . . . 0.414 ' O ' HG22 ' A' ' 527' ' ' ILE . 22.1 m-20 -94.13 -11.12 31.16 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.961 179.086 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -45.3 -28.29 0.8 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.235 -179.816 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . 148.61 42.03 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.43 179.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -104.37 -54.8 2.47 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 111.833 0.309 . . . . 0.0 111.833 -179.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -131.74 48.44 2.42 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-O 121.536 0.684 . . . . 0.0 110.014 179.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 527' ' ' ILE . . . . . 0.457 ' O ' ' HB2' ' A' ' 531' ' ' TRP . 1.5 pp -95.45 -6.33 10.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 114.916 -1.038 . . . . 0.0 112.517 -178.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 528' ' ' GLY . . . . . . . . . . . . . . . -54.86 -13.04 4.12 Favored Glycine 0 CA--C 1.521 0.445 0 C-N-CA 120.971 -0.633 . . . . 0.0 113.817 -179.472 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 529' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -97.01 -41.01 8.59 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 117.392 0.596 . . . . 0.0 111.431 -179.296 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 530' ' ' ALA . . . . . 0.496 ' C ' ' H ' ' A' ' 532' ' ' ILE . . . -103.76 2.05 32.46 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.789 0.662 . . . . 0.0 112.789 -178.807 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 531' ' ' TRP . . . . . 0.457 ' HB2' ' O ' ' A' ' 527' ' ' ILE . 62.1 t90 -70.89 25.99 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -179.088 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 532' ' ' ILE . . . . . 0.496 ' H ' ' C ' ' A' ' 530' ' ' ALA . 1.3 pp -159.25 70.98 3.45 Favored Pre-proline 0 C--N 1.332 -0.191 0 CA-C-O 120.843 0.354 . . . . 0.0 110.885 179.105 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 533' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -51.36 110.63 0.44 Allowed 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.735 2.29 . . . . 0.0 111.907 179.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 534' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -96.33 -55.01 3.08 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -179.143 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -118.47 -35.23 3.81 Favored 'General case' 0 N--CA 1.463 0.179 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -179.121 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . -83.26 -175.11 50.83 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.535 -0.841 . . . . 0.0 112.89 -179.369 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -58.12 -156.9 0.01 OUTLIER 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.657 2.238 . . . . 0.0 111.266 179.554 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 538' ' ' ALA . . . . . . . . . . . . . . . -43.58 -44.01 5.95 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.7 0.286 . . . . 0.0 111.141 179.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 539' ' ' ALA . . . . . 0.431 ' O ' ' N ' ' A' ' 541' ' ' GLY . . . 71.1 -49.54 0.68 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 121.108 0.48 . . . . 0.0 111.665 179.781 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 540' ' ' GLU . . . . . 0.45 ' CG ' ' HA ' ' A' ' 531' ' ' TRP . 3.7 mt-10 -37.66 -25.75 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.142 -0.935 . . . . 0.0 112.656 -179.506 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 541' ' ' GLY . . . . . 0.431 ' N ' ' O ' ' A' ' 539' ' ' ALA . . . -112.73 -55.42 0.45 Allowed Glycine 0 CA--C 1.523 0.549 0 C-N-CA 120.384 -0.912 . . . . 0.0 113.819 -179.559 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 542' ' ' ILE . . . . . 0.437 HD11 HG22 ' A' ' 542' ' ' ILE . 0.2 OUTLIER -79.18 -22.94 12.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 113.691 0.997 . . . . 0.0 113.691 -178.133 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 543' ' ' TYR . . . . . 0.414 ' HB2' ' CA ' ' A' ' 539' ' ' ALA . 9.7 m-85 -99.02 -16.97 18.51 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.248 0.547 . . . . 0.0 110.028 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 544' ' ' ALA . . . . . 0.433 ' CA ' ' HB3' ' A' ' 530' ' ' ALA . . . -91.52 -24.44 19.63 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.201 179.856 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 545' ' ' GLU . . . . . 0.464 ' HG3' ' H ' ' A' ' 548' ' ' MET . 3.7 tp10 -118.78 -32.65 4.46 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.405 -179.805 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 39.41 42.36 1.82 Allowed Glycine 0 CA--C 1.52 0.378 0 CA-C-N 115.883 -0.599 . . . . 0.0 114.366 179.436 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 547' ' ' LEU . . . . . 0.457 ' HG ' ' N ' ' A' ' 548' ' ' MET . 0.0 OUTLIER -178.51 -61.97 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 117.713 0.756 . . . . 0.0 112.094 179.122 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 548' ' ' MET . . . . . 0.464 ' H ' ' HG3' ' A' ' 545' ' ' GLU . 0.0 OUTLIER -96.08 11.43 34.21 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.751 0.31 . . . . 0.0 110.975 179.504 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 549' ' ' HIS . . . . . 0.474 ' O ' ' CG2' ' A' ' 519' ' ' THR . 5.1 p-80 -61.19 -11.08 7.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.079 179.631 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 550' ' ' ASN . . . . . 0.43 ' O ' ' N ' ' A' ' 552' ' ' ASP . 28.9 t-20 -95.12 -34.64 12.2 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 -178.788 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 551' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -66.49 72.08 0.08 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.139 0.495 . . . . 0.0 110.419 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 552' ' ' ASP . . . . . 0.441 ' HA ' ' O ' ' A' ' 519' ' ' THR . 4.5 p30 -93.87 22.33 5.76 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.514 -179.448 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . 124.2 -28.03 5.44 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.838 -0.696 . . . . 0.0 111.645 -179.27 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 554' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -59.67 -53.32 59.36 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.551 0.691 . . . . 0.0 109.787 178.824 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 555' ' ' ILE . . . . . 0.409 ' O ' ' CG2' ' A' ' 555' ' ' ILE . 3.2 mm -78.95 62.02 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 114.755 -1.111 . . . . 0.0 110.374 179.808 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 556' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.325 -0.473 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.444 -179.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 511' ' ' CYS . . . . . . . . . . . . . 9.6 m . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.935 0.398 . . . . 0.0 111.573 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 512' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -115.76 79.11 7.48 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.512 179.82 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 513' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -83.48 25.23 0.7 Allowed 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.839 2.359 . . . . 0.0 113.042 -179.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -96.66 -29.69 13.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.814 0.34 . . . . 0.0 111.107 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 515' ' ' LEU . . . . . . . . . . . . . 1.5 mt -88.13 73.08 9.05 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.025 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 516' ' ' HIS . . . . . 0.421 ' HA ' ' CB ' ' A' ' 552' ' ' ASP . 1.7 t60 -79.53 -7.21 58.32 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.601 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 517' ' ' TYR . . . . . . . . . . . . . 40.2 m-85 -80.19 -54.27 5.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.655 0.264 . . . . 0.0 111.686 -179.318 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 518' ' ' TRP . . . . . 0.526 ' O ' ' N ' ' A' ' 520' ' ' THR . 4.1 m-90 -92.37 -3.33 55.49 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 -179.02 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 519' ' ' THR . . . . . 0.573 ' OG1' ' N ' ' A' ' 520' ' ' THR . 1.3 p 55.83 -78.13 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 120.591 0.234 . . . . 0.0 110.978 179.746 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 520' ' ' THR . . . . . 0.573 ' N ' ' OG1' ' A' ' 519' ' ' THR . 1.1 m 177.01 -62.58 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.515 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 521' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.84 -12.07 60.57 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 177.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 522' ' ' ASP . . . . . 0.427 ' HB2' ' O ' ' A' ' 518' ' ' TRP . 3.2 m-20 -93.62 -10.72 33.65 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.781 179.047 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 523' ' ' GLU . . . . . 0.408 ' HA ' ' CD1' ' A' ' 518' ' ' TRP . 0.3 OUTLIER -45.39 -27.62 0.73 Allowed 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.501 -179.936 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 524' ' ' GLY . . . . . 0.426 ' HA2' ' CG1' ' A' ' 527' ' ' ILE . . . 146.05 42.34 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.579 -0.819 . . . . 0.0 112.299 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -101.52 -59.65 1.66 Allowed 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 111.941 0.349 . . . . 0.0 111.941 -179.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -131.82 36.58 3.69 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-O 121.503 0.668 . . . . 0.0 110.066 179.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 527' ' ' ILE . . . . . 0.496 ' HA ' ' CB ' ' A' ' 544' ' ' ALA . 2.1 pp -95.7 -0.43 10.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 114.787 -1.097 . . . . 0.0 112.735 -178.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 528' ' ' GLY . . . . . . . . . . . . . . . -56.83 -13.77 8.84 Favored Glycine 0 CA--C 1.52 0.349 0 C-N-CA 120.892 -0.67 . . . . 0.0 114.024 -179.406 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 529' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -98.55 -32.81 11.26 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 117.639 0.719 . . . . 0.0 111.724 -179.379 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 530' ' ' ALA . . . . . 0.553 ' C ' ' H ' ' A' ' 532' ' ' ILE . . . -103.69 1.84 32.36 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -178.901 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 531' ' ' TRP . . . . . 0.442 ' HA ' ' HG2' ' A' ' 540' ' ' GLU . 4.5 t90 -68.26 26.68 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -179.02 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 532' ' ' ILE . . . . . 0.553 ' H ' ' C ' ' A' ' 530' ' ' ALA . 1.3 pp -160.56 71.04 2.88 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 120.846 0.355 . . . . 0.0 110.386 179.014 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 533' ' ' PRO . . . . . 0.402 ' HB3' ' O ' ' A' ' 538' ' ' ALA . 1.2 Cg_endo -44.71 85.22 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 123.451 2.768 . . . . 0.0 113.118 -179.449 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 534' ' ' TYR . . . . . 0.449 ' N ' ' O ' ' A' ' 532' ' ' ILE . 5.8 t80 -96.78 -34.26 11.38 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.148 179.606 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -60.92 -34.93 75.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.567 -179.369 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 536' ' ' GLY . . . . . 0.41 ' N ' ' CD ' ' A' ' 537' ' ' PRO . . . 145.12 -50.4 0.64 Allowed Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.522 -0.847 . . . . 0.0 112.603 -179.817 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 537' ' ' PRO . . . . . 0.41 ' CD ' ' N ' ' A' ' 536' ' ' GLY . 6.1 Cg_exo -74.64 -164.08 0.21 Allowed 'Trans proline' 0 N--CA 1.461 -0.43 0 C-N-CA 122.601 2.201 . . . . 0.0 111.474 179.594 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 538' ' ' ALA . . . . . 0.402 ' O ' ' HB3' ' A' ' 533' ' ' PRO . . . -68.4 -46.78 69.05 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.83 0.347 . . . . 0.0 110.258 179.328 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 539' ' ' ALA . . . . . 0.445 ' HA ' ' CD1' ' A' ' 542' ' ' ILE . . . 70.15 -54.04 0.63 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 121.363 0.601 . . . . 0.0 111.443 179.841 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 540' ' ' GLU . . . . . 0.442 ' HG2' ' HA ' ' A' ' 531' ' ' TRP . 12.8 mt-10 -37.52 -27.23 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 114.781 -1.099 . . . . 0.0 112.248 -179.31 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 541' ' ' GLY . . . . . 0.423 ' N ' ' O ' ' A' ' 539' ' ' ALA . . . -125.26 -46.35 0.23 Allowed Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.051 179.006 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 542' ' ' ILE . . . . . 0.445 ' CD1' ' HA ' ' A' ' 539' ' ' ALA . 2.6 pp -73.93 -23.88 19.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -179.503 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 543' ' ' TYR . . . . . 0.522 ' HB3' ' HB1' ' A' ' 530' ' ' ALA . 23.5 t80 -112.54 -8.45 13.84 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.944 0.402 . . . . 0.0 110.843 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 544' ' ' ALA . . . . . 0.496 ' CB ' ' HA ' ' A' ' 527' ' ' ILE . . . -103.18 -35.21 8.56 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.939 179.316 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 545' ' ' GLU . . . . . 0.476 ' HG3' ' H ' ' A' ' 548' ' ' MET . 28.1 tp10 -118.59 -32.61 4.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.331 -0.85 . . . . 0.0 111.05 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 38.9 40.51 1.09 Allowed Glycine 0 CA--C 1.52 0.355 0 CA-C-N 115.856 -0.611 . . . . 0.0 113.896 179.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 547' ' ' LEU . . . . . 0.532 ' HG ' ' N ' ' A' ' 548' ' ' MET . 0.0 OUTLIER -172.0 -61.47 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 117.537 0.669 . . . . 0.0 112.204 179.568 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 548' ' ' MET . . . . . 0.554 ' O ' ' HG3' ' A' ' 551' ' ' GLN . 0.0 OUTLIER -96.17 11.78 33.15 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.773 0.321 . . . . 0.0 111.688 179.95 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 549' ' ' HIS . . . . . 0.502 ' O ' ' CG2' ' A' ' 519' ' ' THR . 28.5 p80 -64.73 -11.0 31.52 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.88 0.372 . . . . 0.0 110.77 179.255 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 550' ' ' ASN . . . . . 0.46 ' O ' ' N ' ' A' ' 552' ' ' ASP . 5.9 m120 -96.18 -37.98 10.34 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -178.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 551' ' ' GLN . . . . . 0.554 ' HG3' ' O ' ' A' ' 548' ' ' MET . 0.0 OUTLIER -64.62 72.51 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.073 0.463 . . . . 0.0 110.712 -179.621 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 552' ' ' ASP . . . . . 0.46 ' N ' ' O ' ' A' ' 550' ' ' ASN . 2.3 p30 -92.51 21.9 5.03 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.203 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . 123.94 -27.81 5.55 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.952 -0.642 . . . . 0.0 111.766 -179.307 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 554' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -60.56 -60.67 3.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.404 0.621 . . . . 0.0 110.066 179.007 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 555' ' ' ILE . . . . . . . . . . . . . 3.6 mm -72.71 70.87 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 CA-C-N 114.999 -1.0 . . . . 0.0 110.494 179.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 556' ' ' CYS . . . . . . . . . . . . . 58.7 m . . . . . 0 C--N 1.323 -0.546 0 CA-C-N 115.333 -0.849 . . . . 0.0 112.039 -179.446 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 511' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.455 -0.209 0 CA-C-O 121.068 0.461 . . . . 0.0 111.522 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 512' ' ' ASN . . . . . . . . . . . . . 18.7 p30 -115.52 77.44 5.95 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.077 179.326 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 513' ' ' PRO . . . . . 0.512 ' HA ' ' O ' ' A' ' 552' ' ' ASP . 28.5 Cg_endo -64.5 -10.62 24.95 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.805 2.337 . . . . 0.0 112.345 -179.789 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -81.11 -22.29 39.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.213 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 515' ' ' LEU . . . . . . . . . . . . . 61.5 mt -88.85 74.62 8.23 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.928 0.394 . . . . 0.0 111.094 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 516' ' ' HIS . . . . . 0.458 ' HA ' ' HB3' ' A' ' 552' ' ' ASP . 98.9 m-70 -80.08 -7.27 58.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.693 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 517' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 -78.54 -37.94 41.66 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 111.648 0.24 . . . . 0.0 111.648 -179.354 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 518' ' ' TRP . . . . . 0.595 ' O ' ' N ' ' A' ' 520' ' ' THR . 14.8 m-90 -111.06 5.11 19.97 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 111.99 0.367 . . . . 0.0 111.99 -179.376 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 519' ' ' THR . . . . . 0.524 ' HA ' ' HA ' ' A' ' 552' ' ' ASP . 2.4 p 50.08 -78.32 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 120.421 0.153 . . . . 0.0 110.999 -179.862 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 520' ' ' THR . . . . . 0.595 ' N ' ' O ' ' A' ' 518' ' ' TRP . 1.2 m 179.45 -62.57 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 179.248 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 521' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -72.38 -12.02 60.94 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.301 178.004 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 522' ' ' ASP . . . . . 0.439 ' HA ' ' CG2' ' A' ' 527' ' ' ILE . 64.9 m-20 -91.71 -10.82 38.77 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.962 179.21 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -45.28 -26.78 0.55 Allowed 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.464 -179.762 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . 145.59 41.99 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.547 -0.835 . . . . 0.0 112.309 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -101.99 -60.57 1.51 Allowed 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 111.784 0.29 . . . . 0.0 111.784 -179.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -131.35 37.8 3.67 Favored 'General case' 0 CA--C 1.512 -0.506 0 CA-C-O 121.52 0.676 . . . . 0.0 110.066 179.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 527' ' ' ILE . . . . . 0.471 ' HA ' ' CB ' ' A' ' 544' ' ' ALA . 2.1 pp -95.78 -0.49 10.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-N 114.847 -1.07 . . . . 0.0 112.724 -178.889 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 528' ' ' GLY . . . . . . . . . . . . . . . -58.94 -13.34 18.78 Favored Glycine 0 CA--C 1.521 0.443 0 C-N-CA 120.877 -0.678 . . . . 0.0 113.896 -179.336 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 529' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -98.63 -33.11 11.09 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 117.56 0.68 . . . . 0.0 111.759 -179.425 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 530' ' ' ALA . . . . . 0.483 ' HB3' ' HB3' ' A' ' 543' ' ' TYR . . . -103.62 -0.97 28.92 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 -178.84 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 531' ' ' TRP . . . . . 0.434 ' HA ' ' HG2' ' A' ' 540' ' ' GLU . 8.9 t90 -56.62 -11.12 1.19 Allowed 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 112.057 0.392 . . . . 0.0 112.057 -179.189 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 532' ' ' ILE . . . . . 0.406 ' O ' ' CD1' ' A' ' 532' ' ' ILE . 1.6 pp -133.45 73.79 72.64 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.037 0.446 . . . . 0.0 111.218 179.632 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 533' ' ' PRO . . . . . 0.401 ' HB3' ' O ' ' A' ' 538' ' ' ALA . 1.0 OUTLIER -44.18 92.95 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 123.165 2.577 . . . . 0.0 112.798 -179.988 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 534' ' ' TYR . . . . . . . . . . . . . 45.0 t80 -96.4 -25.51 15.68 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.079 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -70.57 -34.9 72.72 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.355 -179.559 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 147.32 -64.63 0.42 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.549 -0.834 . . . . 0.0 112.889 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -59.14 -165.01 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.641 2.227 . . . . 0.0 112.011 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 538' ' ' ALA . . . . . 0.401 ' O ' ' HB3' ' A' ' 533' ' ' PRO . . . -66.59 -48.27 70.09 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.558 179.759 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 539' ' ' ALA . . . . . 0.44 ' HA ' ' CD1' ' A' ' 542' ' ' ILE . . . 69.54 -53.56 0.6 Allowed 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.302 0.573 . . . . 0.0 111.546 179.867 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 540' ' ' GLU . . . . . 0.434 ' HG2' ' HA ' ' A' ' 531' ' ' TRP . 14.4 mt-10 -37.32 -27.39 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.889 -1.051 . . . . 0.0 112.266 -179.377 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 541' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 539' ' ' ALA . . . -125.63 -46.71 0.22 Allowed Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.034 179.007 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 542' ' ' ILE . . . . . 0.44 ' CD1' ' HA ' ' A' ' 539' ' ' ALA . 2.6 pp -73.28 -23.89 20.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -179.515 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 543' ' ' TYR . . . . . 0.483 ' HB3' ' HB3' ' A' ' 530' ' ' ALA . 21.4 t80 -112.85 -7.62 13.75 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.991 0.424 . . . . 0.0 110.936 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 544' ' ' ALA . . . . . 0.471 ' CB ' ' HA ' ' A' ' 527' ' ' ILE . . . -103.04 -33.41 9.27 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.866 179.328 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 545' ' ' GLU . . . . . 0.48 ' HG3' ' H ' ' A' ' 548' ' ' MET . 3.9 tp10 -118.59 -32.58 4.54 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.43 -0.805 . . . . 0.0 111.0 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 38.01 46.86 1.85 Allowed Glycine 0 CA--C 1.519 0.294 0 CA-C-N 115.804 -0.635 . . . . 0.0 114.148 179.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 547' ' ' LEU . . . . . 0.442 ' HG ' ' N ' ' A' ' 548' ' ' MET . 0.0 OUTLIER -179.07 -61.5 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 117.6 0.7 . . . . 0.0 111.801 179.268 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 548' ' ' MET . . . . . 0.48 ' H ' ' HG3' ' A' ' 545' ' ' GLU . 0.0 OUTLIER -95.08 11.59 31.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.694 0.283 . . . . 0.0 111.088 179.503 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 549' ' ' HIS . . . . . 0.461 ' O ' ' CG2' ' A' ' 519' ' ' THR . 16.4 p80 -60.64 -11.52 7.53 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.07 179.586 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 550' ' ' ASN . . . . . 0.544 ' O ' ' N ' ' A' ' 552' ' ' ASP . 8.6 m-20 -94.8 -40.19 9.88 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 -179.332 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 551' ' ' GLN . . . . . 0.402 ' HG3' ' O ' ' A' ' 551' ' ' GLN . 2.4 pt20 -60.34 73.06 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.189 0.519 . . . . 0.0 110.303 179.829 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 552' ' ' ASP . . . . . 0.544 ' N ' ' O ' ' A' ' 550' ' ' ASN . 11.8 m-20 -84.62 21.73 1.45 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.933 -179.278 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 553' ' ' GLY . . . . . 0.406 ' HA3' ' N ' ' A' ' 513' ' ' PRO . . . 116.7 12.84 8.35 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.105 -179.653 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 554' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -104.41 -51.59 3.07 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.42 0.629 . . . . 0.0 109.93 179.75 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 555' ' ' ILE . . . . . 0.402 ' O ' ' CG2' ' A' ' 555' ' ' ILE . 2.2 mm -78.27 -1.69 4.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 114.923 -1.035 . . . . 0.0 111.231 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 556' ' ' CYS . . . . . . . . . . . . . 25.9 p . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.973 178.817 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 511' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.462 0.17 0 CA-C-O 120.878 0.371 . . . . 0.0 111.611 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 512' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -107.72 83.94 1.81 Allowed Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.755 179.736 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 513' ' ' PRO . . . . . 0.403 ' HA ' ' O ' ' A' ' 552' ' ' ASP . 57.2 Cg_endo -71.27 -6.08 18.41 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.76 2.306 . . . . 0.0 112.86 -179.859 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -71.71 -28.29 63.6 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.189 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 515' ' ' LEU . . . . . . . . . . . . . 83.4 mt -92.06 72.24 5.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.855 0.36 . . . . 0.0 111.08 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 516' ' ' HIS . . . . . 0.511 ' CE1' ' CZ ' ' A' ' 517' ' ' TYR . 10.7 p80 -86.15 -7.18 58.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.669 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 517' ' ' TYR . . . . . 0.511 ' CZ ' ' CE1' ' A' ' 516' ' ' HIS . 46.2 m-85 -84.03 -19.43 34.45 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.711 -0.222 . . . . 0.0 111.576 -179.809 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 518' ' ' TRP . . . . . 0.5 ' O ' ' N ' ' A' ' 520' ' ' THR . 4.4 m-90 -118.08 -13.32 9.97 Favored 'General case' 0 C--N 1.332 -0.164 0 N-CA-C 112.227 0.454 . . . . 0.0 112.227 -179.134 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 519' ' ' THR . . . . . 0.563 ' OG1' ' N ' ' A' ' 520' ' ' THR . 1.2 p 57.5 -78.13 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 110.643 -0.132 . . . . 0.0 110.643 -179.691 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 520' ' ' THR . . . . . 0.563 ' N ' ' OG1' ' A' ' 519' ' ' THR . 1.2 m 178.53 -62.75 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.227 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 521' ' ' GLN . . . . . . . . . . . . . 10.7 mt-30 -75.54 -11.74 60.09 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.268 178.206 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 522' ' ' ASP . . . . . 0.45 ' HB2' ' O ' ' A' ' 518' ' ' TRP . 45.2 m-20 -94.48 -12.39 27.8 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.013 178.588 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -50.0 -25.22 3.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.701 178.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . 139.48 37.9 0.11 Allowed Glycine 0 N--CA 1.445 -0.708 0 N-CA-C 110.3 -1.12 . . . . 0.0 110.3 -179.075 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -107.94 -42.96 4.55 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.273 -0.464 . . . . 0.0 111.61 -178.543 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -136.8 42.74 2.45 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-O 121.441 0.638 . . . . 0.0 110.157 179.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 527' ' ' ILE . . . . . 0.44 ' O ' ' HB2' ' A' ' 531' ' ' TRP . 1.8 pp -95.53 -8.38 9.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 114.994 -1.003 . . . . 0.0 112.39 -179.056 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 528' ' ' GLY . . . . . . . . . . . . . . . -55.95 -16.32 12.51 Favored Glycine 0 CA--C 1.52 0.402 0 C-N-CA 120.938 -0.649 . . . . 0.0 114.009 -179.222 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 529' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -98.49 -35.3 10.3 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 117.581 0.69 . . . . 0.0 111.767 -179.314 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 530' ' ' ALA . . . . . 0.43 ' HB1' ' CA ' ' A' ' 544' ' ' ALA . . . -103.6 1.06 31.61 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.694 0.627 . . . . 0.0 112.694 -178.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 531' ' ' TRP . . . . . 0.44 ' HB2' ' O ' ' A' ' 527' ' ' ILE . 22.4 t90 -56.08 -12.81 1.63 Allowed 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 111.878 0.325 . . . . 0.0 111.878 -179.439 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 532' ' ' ILE . . . . . 0.421 ' O ' ' CD1' ' A' ' 532' ' ' ILE . 1.6 pp -129.8 74.74 80.43 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 120.908 0.385 . . . . 0.0 111.06 179.665 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 533' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -51.89 94.91 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.891 2.394 . . . . 0.0 112.688 -179.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 534' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -96.26 -17.13 20.97 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.09 179.558 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -75.89 -35.01 60.0 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.369 -179.595 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 143.88 -64.15 0.48 Allowed Glycine 0 CA--C 1.519 0.297 0 C-N-CA 120.484 -0.865 . . . . 0.0 112.788 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -58.95 -165.79 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.689 2.259 . . . . 0.0 112.177 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 538' ' ' ALA . . . . . . . . . . . . . . . -63.02 -49.76 73.37 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.474 179.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 539' ' ' ALA . . . . . 0.511 ' HA ' ' CD1' ' A' ' 542' ' ' ILE . . . 68.01 -57.63 0.46 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 121.389 0.614 . . . . 0.0 111.804 179.578 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -37.48 -29.94 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.942 -1.026 . . . . 0.0 112.338 -179.173 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 541' ' ' GLY . . . . . . . . . . . . . . . -122.89 -26.23 1.76 Allowed Glycine 0 CA--C 1.52 0.379 0 C-N-CA 120.281 -0.961 . . . . 0.0 113.503 -179.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 542' ' ' ILE . . . . . 0.511 ' CD1' ' HA ' ' A' ' 539' ' ' ALA . 2.6 pp -96.48 -21.47 5.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 112.392 0.515 . . . . 0.0 112.392 -179.247 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 543' ' ' TYR . . . . . 0.44 ' HB2' ' HA ' ' A' ' 539' ' ' ALA . 3.6 t80 -107.86 -13.75 14.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.084 0.468 . . . . 0.0 110.263 179.536 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 544' ' ' ALA . . . . . 0.43 ' CA ' ' HB1' ' A' ' 530' ' ' ALA . . . -92.16 -21.58 20.32 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.309 179.453 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 545' ' ' GLU . . . . . 0.491 ' OE2' ' HB2' ' A' ' 548' ' ' MET . 4.2 tp10 -118.36 -33.35 4.38 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.363 -179.666 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 35.21 40.71 0.26 Allowed Glycine 0 CA--C 1.519 0.297 0 CA-C-N 115.808 -0.633 . . . . 0.0 114.472 179.278 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 547' ' ' LEU . . . . . 0.429 ' HG ' ' N ' ' A' ' 548' ' ' MET . 0.0 OUTLIER -179.79 -61.43 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 118.004 0.902 . . . . 0.0 112.46 179.567 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 548' ' ' MET . . . . . 0.491 ' HB2' ' OE2' ' A' ' 545' ' ' GLU . 0.0 OUTLIER -94.6 11.65 30.31 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.818 0.342 . . . . 0.0 111.085 179.794 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 549' ' ' HIS . . . . . 0.491 ' O ' ' CG2' ' A' ' 519' ' ' THR . 6.7 p-80 -62.6 -11.12 14.88 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.079 179.568 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 550' ' ' ASN . . . . . 0.429 ' O ' ' N ' ' A' ' 552' ' ' ASP . 47.3 m-20 -96.04 -33.06 12.26 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -178.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 551' ' ' GLN . . . . . 0.413 ' HG2' ' CG ' ' A' ' 548' ' ' MET . 1.7 pt20 -66.36 71.53 0.07 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.109 0.48 . . . . 0.0 110.654 -179.79 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 552' ' ' ASP . . . . . 0.431 ' CB ' ' HA ' ' A' ' 516' ' ' HIS . 3.3 p30 -95.38 21.96 7.47 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.396 -179.661 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . 123.89 -31.05 4.66 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.902 -0.666 . . . . 0.0 111.683 -179.279 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 554' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -61.48 -58.76 6.88 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.42 0.628 . . . . 0.0 109.87 178.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 555' ' ' ILE . . . . . . . . . . . . . 3.2 mm -73.28 63.29 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.694 179.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 556' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.326 -0.447 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.432 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 507' ' ' ALA . . . . . 0.426 ' HB3' ' CG ' ' A' ' 559' ' ' ARG . . . . . . . . 0 N--CA 1.487 1.406 0 CA-C-O 120.922 0.391 . . . . 0.0 111.105 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 508' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -128.58 77.38 77.46 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.949 179.634 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 509' ' ' PRO . . . . . 0.447 ' HG3' ' HA ' ' A' ' 559' ' ' ARG . 17.4 Cg_exo -66.74 -65.37 0.04 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.245 0 C-N-CA 122.658 2.239 . . . . 0.0 111.755 179.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 510' ' ' LYS . . . . . 0.475 ' HG2' ' N ' ' A' ' 511' ' ' CYS . 0.0 OUTLIER 177.25 -34.76 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.406 179.641 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 511' ' ' CYS . . . . . 0.475 ' N ' ' HG2' ' A' ' 510' ' ' LYS . 0.6 OUTLIER 43.97 64.57 1.24 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.103 -0.953 . . . . 0.0 111.428 179.491 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 512' ' ' ASN . . . . . . . . . . . . . 7.5 m-20 -131.35 82.46 62.28 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.434 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 513' ' ' PRO . . . . . 0.405 ' HA ' ' O ' ' A' ' 552' ' ' ASP . 85.3 Cg_endo -79.07 20.71 0.79 Allowed 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.895 2.396 . . . . 0.0 113.097 -179.642 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 34.8 t30 -96.67 -31.25 12.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.96 0.41 . . . . 0.0 110.786 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 515' ' ' LEU . . . . . . . . . . . . . 18.9 mt -83.52 73.85 10.16 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.886 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 516' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -72.47 -15.28 61.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.59 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 517' ' ' TYR . . . . . . . . . . . . . 48.2 m-85 -79.16 -66.03 0.92 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.819 0.342 . . . . 0.0 111.433 -179.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 518' ' ' TRP . . . . . 0.494 ' O ' ' N ' ' A' ' 520' ' ' THR . 21.2 m-90 -70.32 -14.38 62.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.884 -179.492 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 519' ' ' THR . . . . . 0.541 ' OG1' ' N ' ' A' ' 520' ' ' THR . 1.7 p 56.98 -78.8 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 116.727 -0.215 . . . . 0.0 110.719 -179.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 520' ' ' THR . . . . . 0.541 ' N ' ' OG1' ' A' ' 519' ' ' THR . 1.1 m 176.83 -62.68 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.149 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 521' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -72.73 -12.27 60.95 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 177.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 522' ' ' ASP . . . . . 0.427 ' O ' HG22 ' A' ' 527' ' ' ILE . 1.9 m-20 -93.89 -11.03 31.95 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.699 178.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -45.48 -27.92 0.81 Allowed 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.44 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 524' ' ' GLY . . . . . 0.433 ' HA2' ' CG1' ' A' ' 527' ' ' ILE . . . 147.62 41.38 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.489 -0.863 . . . . 0.0 112.477 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -100.44 -60.11 1.58 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.743 0.306 . . . . 0.0 111.737 -179.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -132.48 37.57 3.5 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-O 121.488 0.661 . . . . 0.0 110.103 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 527' ' ' ILE . . . . . 0.468 ' HA ' ' CB ' ' A' ' 544' ' ' ALA . 1.8 pp -95.94 -0.96 10.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 114.811 -1.086 . . . . 0.0 112.793 -178.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 528' ' ' GLY . . . . . . . . . . . . . . . -57.63 -12.56 9.94 Favored Glycine 0 CA--C 1.521 0.414 0 C-N-CA 120.875 -0.679 . . . . 0.0 113.976 -179.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 529' ' ' LEU . . . . . . . . . . . . . 1.2 pp -98.75 -39.37 8.68 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 117.757 0.779 . . . . 0.0 112.167 -179.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 530' ' ' ALA . . . . . 0.536 ' HB2' ' HB3' ' A' ' 543' ' ' TYR . . . -103.93 1.8 31.72 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 -178.461 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 531' ' ' TRP . . . . . 0.452 ' HB2' ' O ' ' A' ' 527' ' ' ILE . 54.9 t90 -72.04 30.3 0.05 Allowed 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -178.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 532' ' ' ILE . . . . . 0.473 ' H ' ' C ' ' A' ' 530' ' ' ALA . 1.3 pp -159.65 70.87 3.27 Favored Pre-proline 0 C--N 1.332 -0.181 0 CA-C-O 120.723 0.297 . . . . 0.0 110.894 179.176 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 533' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -51.26 103.51 0.07 OUTLIER 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.659 2.239 . . . . 0.0 111.742 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 534' ' ' TYR . . . . . 0.427 ' CD1' HD13 ' A' ' 532' ' ' ILE . 0.4 OUTLIER -96.17 -55.06 3.08 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -179.006 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 -118.52 -35.23 3.8 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 -179.1 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . -87.44 -175.06 48.68 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.891 -179.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -56.59 -159.34 0.01 OUTLIER 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.884 2.39 . . . . 0.0 111.692 179.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 538' ' ' ALA . . . . . 0.456 ' C ' ' H ' ' A' ' 540' ' ' GLU . . . -43.99 -49.83 8.48 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.067 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 539' ' ' ALA . . . . . 0.433 ' O ' ' HB3' ' A' ' 530' ' ' ALA . . . 71.66 -46.7 0.65 Allowed 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.205 0.526 . . . . 0.0 111.548 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 540' ' ' GLU . . . . . 0.456 ' H ' ' C ' ' A' ' 538' ' ' ALA . 2.5 mt-10 -36.95 -29.09 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.057 -0.974 . . . . 0.0 112.304 -179.352 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 541' ' ' GLY . . . . . 0.406 ' N ' ' O ' ' A' ' 539' ' ' ALA . . . -127.79 -48.66 0.17 Allowed Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.028 179.21 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 542' ' ' ILE . . . . . 0.423 ' CD1' ' HA ' ' A' ' 539' ' ' ALA . 2.6 pp -68.09 -25.14 31.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -179.355 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 543' ' ' TYR . . . . . 0.536 ' HB3' ' HB2' ' A' ' 530' ' ' ALA . 6.1 t80 -115.3 -8.0 12.32 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.857 0.361 . . . . 0.0 111.145 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 544' ' ' ALA . . . . . 0.49 ' CB ' ' HB3' ' A' ' 530' ' ' ALA . . . -99.31 -33.22 10.81 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.06 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 545' ' ' GLU . . . . . 0.47 ' HG3' ' H ' ' A' ' 548' ' ' MET . 14.3 tp10 -118.67 -32.67 4.49 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.209 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 40.71 42.1 2.66 Favored Glycine 0 CA--C 1.521 0.417 0 CA-C-N 115.917 -0.583 . . . . 0.0 113.747 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 547' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -173.16 -61.14 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 117.4 0.6 . . . . 0.0 112.14 179.608 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 548' ' ' MET . . . . . 0.484 ' O ' ' HG3' ' A' ' 551' ' ' GLN . 4.3 mtt -95.31 11.71 31.64 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.709 0.29 . . . . 0.0 111.481 -179.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 549' ' ' HIS . . . . . 0.46 ' O ' ' CG2' ' A' ' 519' ' ' THR . 14.7 p-80 -65.47 -11.08 39.81 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.861 0.363 . . . . 0.0 110.791 179.423 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 550' ' ' ASN . . . . . 0.505 ' O ' ' N ' ' A' ' 552' ' ' ASP . 15.0 m-20 -95.87 -41.08 8.99 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -179.092 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 551' ' ' GLN . . . . . 0.484 ' HG3' ' O ' ' A' ' 548' ' ' MET . 0.0 OUTLIER -62.36 73.31 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.171 0.51 . . . . 0.0 110.469 -179.882 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 552' ' ' ASP . . . . . 0.505 ' N ' ' O ' ' A' ' 550' ' ' ASN . 1.9 p30 -90.25 22.2 3.44 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.601 -179.581 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . 124.04 -30.52 4.78 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.891 -0.671 . . . . 0.0 111.668 -179.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 554' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -55.73 -53.65 54.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.559 0.695 . . . . 0.0 110.138 178.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 555' ' ' ILE . . . . . 0.408 ' CG2' ' O ' ' A' ' 555' ' ' ILE . 4.0 mm -79.52 58.96 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.696 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 556' ' ' CYS . . . . . . . . . . . . . 6.3 t -73.98 -7.49 52.59 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.469 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -67.36 -7.67 47.03 Favored Glycine 0 CA--C 1.52 0.375 0 C-N-CA 120.811 -0.709 . . . . 0.0 113.489 -179.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 558' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -53.55 -59.38 4.67 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 117.276 0.538 . . . . 0.0 111.249 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 559' ' ' ARG . . . . . 0.447 ' HA ' ' HG3' ' A' ' 509' ' ' PRO . 2.2 mpt_? 56.55 164.81 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.225 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 560' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.205 -0.903 . . . . 0.0 110.958 -179.976 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.384 0 CA-C-O 120.838 0.351 . . . . 0.0 111.116 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 508' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.37 77.63 76.81 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.916 179.63 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 509' ' ' PRO . . . . . 0.467 ' O ' ' CE ' ' A' ' 510' ' ' LYS . 73.9 Cg_endo -75.14 -8.82 20.24 Favored 'Trans proline' 0 C--N 1.343 0.241 0 C-N-CA 122.636 2.224 . . . . 0.0 112.63 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 510' ' ' LYS . . . . . 0.467 ' CE ' ' O ' ' A' ' 509' ' ' PRO . 0.0 OUTLIER 82.44 -31.22 0.09 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 121.029 0.442 . . . . 0.0 111.615 -179.912 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 511' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 45.32 90.15 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.485 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 512' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -131.72 77.23 73.09 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.403 179.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 513' ' ' PRO . . . . . 0.417 ' HA ' ' O ' ' A' ' 552' ' ' ASP . 87.7 Cg_endo -79.75 22.52 0.72 Allowed 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.932 2.421 . . . . 0.0 113.177 -179.533 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 25.8 t30 -96.67 -28.97 14.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.691 0.281 . . . . 0.0 110.804 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 515' ' ' LEU . . . . . . . . . . . . . 46.4 mt -90.59 72.87 6.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.926 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 516' ' ' HIS . . . . . 0.421 ' HA ' ' CB ' ' A' ' 552' ' ' ASP . 1.4 t60 -76.7 -7.34 55.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.655 -179.742 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 517' ' ' TYR . . . . . . . . . . . . . 42.9 m-85 -85.26 -49.5 8.14 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.674 0.274 . . . . 0.0 111.524 -179.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 518' ' ' TRP . . . . . 0.495 ' O ' ' N ' ' A' ' 520' ' ' THR . 3.0 m-90 -88.56 -11.55 45.3 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 111.886 0.328 . . . . 0.0 111.886 -179.331 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 519' ' ' THR . . . . . 0.566 ' OG1' ' N ' ' A' ' 520' ' ' THR . 1.3 p 56.22 -79.08 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.81 -0.177 . . . . 0.0 110.989 179.799 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 520' ' ' THR . . . . . 0.566 ' N ' ' OG1' ' A' ' 519' ' ' THR . 1.2 m 179.46 -62.74 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 179.435 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 521' ' ' GLN . . . . . . . . . . . . . 6.8 mt-30 -74.16 -12.07 60.48 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 177.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 522' ' ' ASP . . . . . 0.449 ' O ' HG23 ' A' ' 527' ' ' ILE . 20.8 m-20 -93.95 -10.57 33.28 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.854 179.296 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 523' ' ' GLU . . . . . 0.446 ' HA ' ' CD1' ' A' ' 518' ' ' TRP . 14.1 pt-20 -45.24 -26.65 0.52 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.515 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . 147.6 41.35 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.289 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -101.23 -60.46 1.52 Allowed 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 111.941 0.349 . . . . 0.0 111.941 -179.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -131.44 36.84 3.74 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-O 121.541 0.686 . . . . 0.0 110.129 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 527' ' ' ILE . . . . . 0.474 ' HA ' ' CB ' ' A' ' 544' ' ' ALA . 2.1 pp -95.77 -0.38 10.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 114.762 -1.108 . . . . 0.0 112.709 -178.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 528' ' ' GLY . . . . . . . . . . . . . . . -60.41 -10.47 16.85 Favored Glycine 0 CA--C 1.521 0.423 0 C-N-CA 120.82 -0.705 . . . . 0.0 113.948 -179.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 529' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -98.47 -33.69 10.92 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 117.569 0.684 . . . . 0.0 111.502 -179.585 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 530' ' ' ALA . . . . . 0.513 ' C ' ' H ' ' A' ' 532' ' ' ILE . . . -103.75 1.63 31.96 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -178.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 531' ' ' TRP . . . . . 0.437 ' O ' ' CG2' ' A' ' 532' ' ' ILE . 0.2 OUTLIER -71.15 30.2 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -179.056 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 532' ' ' ILE . . . . . 0.513 ' H ' ' C ' ' A' ' 530' ' ' ALA . 1.1 pt -161.02 75.38 2.57 Favored Pre-proline 0 N--CA 1.456 -0.162 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.471 179.301 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 533' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -36.89 85.98 0.01 OUTLIER 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 123.5 2.8 . . . . 0.0 113.399 -179.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 534' ' ' TYR . . . . . 0.455 ' N ' ' O ' ' A' ' 532' ' ' ILE . 0.6 OUTLIER -96.7 -49.51 5.07 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.269 -179.991 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -57.53 -34.85 69.56 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.548 -179.329 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 143.47 -64.57 0.48 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.566 -0.826 . . . . 0.0 112.531 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -58.72 -165.48 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.622 2.215 . . . . 0.0 111.711 179.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 538' ' ' ALA . . . . . . . . . . . . . . . -62.13 -51.1 69.24 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.292 179.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 539' ' ' ALA . . . . . 0.464 ' HA ' ' CD1' ' A' ' 542' ' ' ILE . . . 68.45 -53.72 0.54 Allowed 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.599 179.725 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 540' ' ' GLU . . . . . 0.419 ' O ' ' HB1' ' A' ' 544' ' ' ALA . 0.6 OUTLIER -37.28 -27.98 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.022 -0.99 . . . . 0.0 112.09 -179.416 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 541' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 539' ' ' ALA . . . -124.57 -47.31 0.23 Allowed Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.14 179.155 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 542' ' ' ILE . . . . . 0.464 ' CD1' ' HA ' ' A' ' 539' ' ' ALA . 2.6 pp -72.65 -22.92 20.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 -179.634 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 543' ' ' TYR . . . . . 0.455 ' HB3' ' HB3' ' A' ' 530' ' ' ALA . 89.8 t80 -111.02 -8.05 14.48 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.067 0.461 . . . . 0.0 110.68 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 544' ' ' ALA . . . . . 0.474 ' CB ' ' HA ' ' A' ' 527' ' ' ILE . . . -103.04 -32.86 9.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.02 179.43 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 545' ' ' GLU . . . . . 0.421 ' HG3' ' H ' ' A' ' 548' ' ' MET . 29.3 tp10 -118.49 -32.74 4.52 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.207 -179.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 38.17 37.61 0.48 Allowed Glycine 0 CA--C 1.519 0.326 0 CA-C-N 115.723 -0.672 . . . . 0.0 113.985 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 547' ' ' LEU . . . . . 0.439 ' HG ' ' N ' ' A' ' 548' ' ' MET . 0.0 OUTLIER -170.58 -61.99 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 117.694 0.747 . . . . 0.0 112.506 179.484 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 548' ' ' MET . . . . . 0.439 ' N ' ' HG ' ' A' ' 547' ' ' LEU . 0.0 OUTLIER -96.45 11.31 35.38 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.731 0.301 . . . . 0.0 111.124 179.682 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 549' ' ' HIS . . . . . 0.489 ' O ' ' CG2' ' A' ' 519' ' ' THR . 6.0 p-80 -63.43 -10.99 19.76 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.919 179.6 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 550' ' ' ASN . . . . . 0.402 ' O ' ' N ' ' A' ' 552' ' ' ASP . 44.9 m-20 -95.73 -34.25 12.0 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -179.021 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 551' ' ' GLN . . . . . 0.412 ' HG2' ' HG3' ' A' ' 548' ' ' MET . 2.5 pt20 -66.87 71.86 0.09 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.016 0.436 . . . . 0.0 110.55 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 552' ' ' ASP . . . . . 0.445 ' HA ' ' O ' ' A' ' 519' ' ' THR . 2.6 p30 -93.62 21.95 5.89 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.37 -179.626 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . 123.9 -31.91 4.38 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.885 -0.674 . . . . 0.0 111.752 -179.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 554' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.42 -57.85 11.17 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.493 0.663 . . . . 0.0 110.194 179.017 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 555' ' ' ILE . . . . . 0.401 ' O ' ' CG2' ' A' ' 555' ' ' ILE . 2.8 mm -72.36 63.77 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 CA-C-N 114.892 -1.049 . . . . 0.0 110.724 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 556' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -70.21 -12.31 61.5 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.328 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -53.96 -21.28 16.44 Favored Glycine 0 CA--C 1.519 0.313 0 C-N-CA 120.885 -0.674 . . . . 0.0 113.118 -179.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 558' ' ' LEU . . . . . 0.411 ' CD1' ' N ' ' A' ' 559' ' ' ARG . 3.0 pp -49.7 -45.98 49.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.791 0.329 . . . . 0.0 111.447 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 559' ' ' ARG . . . . . 0.411 ' N ' ' CD1' ' A' ' 558' ' ' LEU . 6.4 mpt_? 50.34 -177.73 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.261 -179.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 560' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.192 -0.908 . . . . 0.0 111.094 179.928 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.382 0 CA-C-O 120.914 0.388 . . . . 0.0 111.142 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 508' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -128.7 95.01 33.37 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.091 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 509' ' ' PRO . . . . . 0.546 ' O ' ' CE ' ' A' ' 510' ' ' LYS . 73.0 Cg_endo -76.45 -17.66 16.3 Favored 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 122.532 2.155 . . . . 0.0 112.406 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 510' ' ' LYS . . . . . 0.546 ' CE ' ' O ' ' A' ' 509' ' ' PRO . 0.0 OUTLIER 88.5 -15.02 0.36 Allowed 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 122.974 0.51 . . . . 0.0 111.322 -179.761 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 511' ' ' CYS . . . . . . . . . . . . . 1.5 t 47.0 81.65 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.315 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 512' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -109.76 78.2 1.18 Allowed Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.468 179.727 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 513' ' ' PRO . . . . . 0.414 ' HA ' ' O ' ' A' ' 552' ' ' ASP . 73.6 Cg_endo -75.89 18.42 0.63 Allowed 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.92 2.414 . . . . 0.0 113.106 -179.494 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -96.7 -34.26 11.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.782 0.325 . . . . 0.0 110.773 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 515' ' ' LEU . . . . . . . . . . . . . 52.6 mt -78.9 75.13 5.41 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.943 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 516' ' ' HIS . . . . . . . . . . . . . 1.3 p-80 -79.87 -7.23 58.61 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.677 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 517' ' ' TYR . . . . . 0.422 ' HB2' ' CE3' ' A' ' 518' ' ' TRP . 44.5 m-85 -77.79 -59.9 2.59 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.783 0.325 . . . . 0.0 111.309 -179.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 518' ' ' TRP . . . . . 0.55 ' O ' ' N ' ' A' ' 520' ' ' THR . 13.9 m-90 -91.17 4.68 51.62 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.793 -179.618 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 519' ' ' THR . . . . . 0.534 ' OG1' ' N ' ' A' ' 520' ' ' THR . 1.3 p 54.42 -76.6 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 116.851 -0.159 . . . . 0.0 110.986 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 520' ' ' THR . . . . . 0.55 ' N ' ' O ' ' A' ' 518' ' ' TRP . 1.2 m 176.98 -62.47 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.231 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 179.436 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 521' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.81 -12.37 61.57 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.418 178.103 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 522' ' ' ASP . . . . . 0.43 ' HA ' ' CG2' ' A' ' 527' ' ' ILE . 1.1 m-20 -93.93 -11.2 31.49 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.939 179.294 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -45.52 -27.56 0.76 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.474 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 524' ' ' GLY . . . . . 0.426 ' HA2' ' CG1' ' A' ' 527' ' ' ILE . . . 144.99 42.45 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.508 -0.854 . . . . 0.0 112.229 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -101.32 -60.31 1.55 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.713 0.292 . . . . 0.0 111.706 -179.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -131.8 38.43 3.55 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-O 121.521 0.677 . . . . 0.0 110.036 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 527' ' ' ILE . . . . . 0.483 ' HA ' ' CB ' ' A' ' 544' ' ' ALA . 2.1 pp -95.8 -0.5 10.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 114.719 -1.128 . . . . 0.0 112.775 -178.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 528' ' ' GLY . . . . . . . . . . . . . . . -57.71 -14.31 14.94 Favored Glycine 0 CA--C 1.521 0.452 0 C-N-CA 120.762 -0.733 . . . . 0.0 114.005 -179.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 529' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -98.74 -33.66 10.83 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 117.666 0.733 . . . . 0.0 111.909 -179.334 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 530' ' ' ALA . . . . . 0.52 ' C ' ' H ' ' A' ' 532' ' ' ILE . . . -103.85 1.96 32.11 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -178.604 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 531' ' ' TRP . . . . . 0.471 ' HA ' ' HG2' ' A' ' 540' ' ' GLU . 57.3 t-105 -68.43 30.09 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.546 0.573 . . . . 0.0 112.546 -178.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 532' ' ' ILE . . . . . 0.52 ' H ' ' C ' ' A' ' 530' ' ' ALA . 1.1 pt -160.2 71.9 3.04 Favored Pre-proline 0 C--N 1.331 -0.207 0 CA-C-O 120.827 0.346 . . . . 0.0 110.742 179.037 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 533' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_endo -47.11 88.43 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 123.148 2.565 . . . . 0.0 112.821 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 534' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -96.43 -43.6 7.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.283 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -57.75 -34.78 69.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.552 -179.341 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 149.13 -64.77 0.4 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.529 -0.843 . . . . 0.0 112.579 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_endo -57.3 -164.09 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.576 2.184 . . . . 0.0 111.8 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 538' ' ' ALA . . . . . . . . . . . . . . . -72.03 -47.2 53.45 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.619 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 539' ' ' ALA . . . . . 0.458 ' HA ' ' CD1' ' A' ' 542' ' ' ILE . . . 70.7 -53.73 0.66 Allowed 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.33 0.586 . . . . 0.0 111.227 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 540' ' ' GLU . . . . . 0.471 ' HG2' ' HA ' ' A' ' 531' ' ' TRP . 15.6 mt-10 -37.26 -28.17 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.543 0 CA-C-N 114.828 -1.078 . . . . 0.0 112.37 -179.442 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 541' ' ' GLY . . . . . 0.445 ' HA3' ' CD2' ' A' ' 549' ' ' HIS . . . -126.24 -40.17 0.38 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.388 179.51 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 542' ' ' ILE . . . . . 0.458 ' CD1' ' HA ' ' A' ' 539' ' ' ALA . 2.6 pp -79.88 -23.16 11.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 112.122 0.415 . . . . 0.0 112.122 -179.406 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 543' ' ' TYR . . . . . 0.445 ' HB3' ' HB3' ' A' ' 530' ' ' ALA . 89.0 t80 -111.48 -7.79 14.31 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.042 0.449 . . . . 0.0 110.613 179.63 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 544' ' ' ALA . . . . . 0.483 ' CB ' ' HA ' ' A' ' 527' ' ' ILE . . . -103.06 -36.91 7.98 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.381 179.181 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 545' ' ' GLU . . . . . 0.424 ' CG ' ' H ' ' A' ' 548' ' ' MET . 20.2 tp10 -118.91 -32.57 4.45 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.099 -0.955 . . . . 0.0 111.1 179.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 37.09 47.58 1.38 Allowed Glycine 0 C--N 1.331 0.285 0 CA-C-N 115.992 -0.549 . . . . 0.0 113.387 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 547' ' ' LEU . . . . . 0.664 ' HG ' ' N ' ' A' ' 548' ' ' MET . 0.0 OUTLIER -174.87 -57.55 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 117.276 0.538 . . . . 0.0 111.834 179.949 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 548' ' ' MET . . . . . 0.664 ' N ' ' HG ' ' A' ' 547' ' ' LEU . 0.0 OUTLIER -96.0 11.49 33.85 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.644 0.259 . . . . 0.0 111.344 -179.999 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 549' ' ' HIS . . . . . 0.451 ' O ' ' CG2' ' A' ' 519' ' ' THR . 12.8 t-80 -62.59 -11.82 19.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.817 0.341 . . . . 0.0 110.629 179.431 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 550' ' ' ASN . . . . . 0.477 ' O ' ' N ' ' A' ' 552' ' ' ASP . 32.7 m-20 -96.22 -39.74 9.52 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.629 -179.531 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 551' ' ' GLN . . . . . 0.415 ' HG3' ' O ' ' A' ' 548' ' ' MET . 1.5 pt20 -61.81 73.93 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.228 0.537 . . . . 0.0 110.843 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 552' ' ' ASP . . . . . 0.492 ' HA ' ' O ' ' A' ' 519' ' ' THR . 1.6 p30 -83.78 22.24 1.15 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.541 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . 124.25 -26.75 5.73 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 121.01 -0.614 . . . . 0.0 111.62 -179.131 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 554' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -59.23 -53.32 59.65 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.438 0.637 . . . . 0.0 110.117 178.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 555' ' ' ILE . . . . . . . . . . . . . 8.1 mm -84.59 54.02 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 CA-C-N 114.945 -1.025 . . . . 0.0 111.111 -179.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 556' ' ' CYS . . . . . . . . . . . . . 8.0 p -75.02 -7.32 53.35 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.392 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -56.73 -12.95 7.26 Favored Glycine 0 CA--C 1.521 0.414 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.963 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 558' ' ' LEU . . . . . . . . . . . . . 1.5 pp -46.5 -52.12 13.93 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.89 0.376 . . . . 0.0 111.701 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 559' ' ' ARG . . . . . 0.416 ' NH1' ' CD ' ' A' ' 509' ' ' PRO . 3.0 mpt_? 51.95 -173.63 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.874 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 560' ' ' GLN . . . . . . . . . . . . . 14.4 mm-40 . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.255 -0.879 . . . . 0.0 110.85 179.924 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.269 0 CA-C-O 120.875 0.369 . . . . 0.0 111.036 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 508' ' ' GLN . . . . . . . . . . . . . 4.8 mp0 -128.26 82.58 68.23 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.955 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 509' ' ' PRO . . . . . 0.484 ' O ' ' CE ' ' A' ' 510' ' ' LYS . 88.9 Cg_endo -85.0 -11.57 7.55 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 122.696 2.264 . . . . 0.0 112.542 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 510' ' ' LYS . . . . . 0.484 ' CE ' ' O ' ' A' ' 509' ' ' PRO . 0.0 OUTLIER 81.33 -26.48 0.15 Allowed 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 121.08 0.467 . . . . 0.0 111.015 -179.252 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 511' ' ' CYS . . . . . 0.405 ' H ' ' C ' ' A' ' 509' ' ' PRO . 2.5 m 44.18 69.25 0.43 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.611 179.543 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 512' ' ' ASN . . . . . 0.416 ' O ' ' O ' ' A' ' 552' ' ' ASP . 0.5 OUTLIER -118.05 81.73 16.63 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.351 179.653 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 513' ' ' PRO . . . . . 0.475 ' HA ' ' O ' ' A' ' 552' ' ' ASP . 64.4 Cg_endo -75.21 18.78 0.54 Allowed 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 123.0 2.467 . . . . 0.0 113.235 -179.773 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 24.2 t30 -96.71 -34.17 11.46 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.873 0.368 . . . . 0.0 110.859 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 515' ' ' LEU . . . . . . . . . . . . . 2.7 mt -84.68 74.07 10.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.006 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 516' ' ' HIS . . . . . 0.43 ' HA ' ' CB ' ' A' ' 552' ' ' ASP . 14.2 t60 -71.47 -8.4 53.65 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.91 -179.726 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 517' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -82.26 -62.5 1.61 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.712 0.291 . . . . 0.0 111.629 -179.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 518' ' ' TRP . . . . . 0.506 ' O ' ' N ' ' A' ' 520' ' ' THR . 14.4 m-90 -71.39 -17.86 62.39 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.661 -179.467 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 519' ' ' THR . . . . . 0.508 ' OG1' ' N ' ' A' ' 520' ' ' THR . 1.8 p 54.04 -80.29 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 116.621 -0.263 . . . . 0.0 110.919 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 520' ' ' THR . . . . . 0.508 ' N ' ' OG1' ' A' ' 519' ' ' THR . 1.2 m 177.71 -62.85 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 179.065 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 521' ' ' GLN . . . . . 0.407 ' HB2' ' HB3' ' A' ' 548' ' ' MET . 0.7 OUTLIER -72.64 -11.69 60.74 Favored 'General case' 0 CA--C 1.513 -0.45 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 177.989 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 522' ' ' ASP . . . . . 0.44 ' HA ' ' CG2' ' A' ' 527' ' ' ILE . 2.4 m-20 -87.47 -11.04 50.17 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.745 179.146 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -45.2 -26.6 0.51 Allowed 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.902 -179.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 524' ' ' GLY . . . . . 0.459 ' HA2' ' CG1' ' A' ' 527' ' ' ILE . . . 148.51 40.52 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.458 -0.877 . . . . 0.0 112.386 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -98.21 -59.65 1.71 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.806 0.336 . . . . 0.0 111.892 -179.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -133.59 32.44 3.6 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.577 0.703 . . . . 0.0 110.018 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 527' ' ' ILE . . . . . 0.543 HG21 ' HB2' ' A' ' 544' ' ' ALA . 2.3 pp -95.86 -0.56 10.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 114.593 -1.185 . . . . 0.0 112.644 -178.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 528' ' ' GLY . . . . . . . . . . . . . . . -58.88 -4.57 2.3 Favored Glycine 0 CA--C 1.522 0.52 0 N-CA-C 114.696 0.638 . . . . 0.0 114.696 -178.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 529' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -98.2 -42.24 7.52 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 118.031 0.915 . . . . 0.0 111.672 -179.59 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 530' ' ' ALA . . . . . 0.428 ' HB2' ' CB ' ' A' ' 544' ' ' ALA . . . -103.85 1.99 32.14 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.354 0.502 . . . . 0.0 112.354 -179.239 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 531' ' ' TRP . . . . . 0.499 ' HB2' ' O ' ' A' ' 527' ' ' ILE . 22.5 t-105 -54.83 -9.27 0.33 Allowed 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 112.893 0.701 . . . . 0.0 112.893 -178.134 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 532' ' ' ILE . . . . . 0.401 ' O ' ' CD1' ' A' ' 532' ' ' ILE . 1.6 pp -135.34 76.23 56.89 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-O 121.039 0.447 . . . . 0.0 111.05 179.313 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 533' ' ' PRO . . . . . 0.405 ' HG3' ' H ' ' A' ' 540' ' ' GLU . 32.4 Cg_exo -63.29 89.51 0.13 Allowed 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 123.058 2.506 . . . . 0.0 112.591 -179.586 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 534' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -60.52 -54.35 46.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.993 0.425 . . . . 0.0 110.151 179.415 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -118.18 22.99 11.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.702 179.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . -122.34 153.1 16.84 Favored Glycine 0 C--N 1.333 0.377 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.736 -179.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -71.28 -89.47 0.0 OUTLIER 'Trans proline' 0 CA--C 1.534 0.503 0 C-N-CA 122.714 2.276 . . . . 0.0 112.834 -179.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 538' ' ' ALA . . . . . . . . . . . . . . . -99.29 17.11 20.89 Favored 'General case' 0 C--N 1.333 -0.114 0 N-CA-C 111.534 0.198 . . . . 0.0 111.534 -179.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 539' ' ' ALA . . . . . 0.41 ' HA ' ' CD1' ' A' ' 542' ' ' ILE . . . -34.12 -43.8 0.16 Allowed 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 -179.395 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 540' ' ' GLU . . . . . 0.429 ' CB ' ' HA ' ' A' ' 531' ' ' TRP . 0.0 OUTLIER -60.1 -6.84 1.53 Allowed 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -178.579 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 541' ' ' GLY . . . . . 0.4 ' HA2' ' OD1' ' A' ' 522' ' ' ASP . . . -125.62 -40.6 0.38 Allowed Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 121.026 -0.607 . . . . 0.0 111.919 178.811 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 542' ' ' ILE . . . . . 0.472 ' HA ' ' CB ' ' A' ' 549' ' ' HIS . 2.1 pp -97.26 -19.36 6.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -179.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 543' ' ' TYR . . . . . . . . . . . . . 29.4 t80 -108.85 -16.3 14.19 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.048 0.452 . . . . 0.0 110.65 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 544' ' ' ALA . . . . . 0.543 ' HB2' HG21 ' A' ' 527' ' ' ILE . . . -91.2 -16.81 27.08 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.604 179.73 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 545' ' ' GLU . . . . . 0.409 ' HG2' ' N ' ' A' ' 549' ' ' HIS . 5.4 tp10 -118.44 -32.82 4.51 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.343 -179.758 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 35.84 41.35 0.42 Allowed Glycine 0 CA--C 1.521 0.412 0 CA-C-N 115.841 -0.618 . . . . 0.0 114.133 179.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 547' ' ' LEU . . . . . 0.412 ' HG ' ' N ' ' A' ' 548' ' ' MET . 0.0 OUTLIER -172.45 -62.11 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 117.615 0.708 . . . . 0.0 112.084 179.401 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 548' ' ' MET . . . . . 0.412 ' N ' ' HG ' ' A' ' 547' ' ' LEU . 0.0 OUTLIER -96.32 11.6 34.11 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.06 0.457 . . . . 0.0 110.378 179.02 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 549' ' ' HIS . . . . . 0.472 ' CB ' ' HA ' ' A' ' 542' ' ' ILE . 0.3 OUTLIER -59.53 -11.3 4.43 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.323 179.744 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 550' ' ' ASN . . . . . 0.49 ' O ' ' N ' ' A' ' 552' ' ' ASP . 45.5 t30 -94.54 -34.22 12.75 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -178.461 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 551' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -64.25 70.95 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.131 0.491 . . . . 0.0 110.4 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 552' ' ' ASP . . . . . 0.49 ' N ' ' O ' ' A' ' 550' ' ' ASN . 2.9 p30 -101.69 21.91 13.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.513 -179.319 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . 123.69 -31.73 4.48 Favored Glycine 0 N--CA 1.449 -0.461 0 N-CA-C 111.47 -0.652 . . . . 0.0 111.47 -179.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 554' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -62.58 -49.1 76.58 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.493 0.663 . . . . 0.0 109.648 178.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 555' ' ' ILE . . . . . . . . . . . . . 6.0 mm -88.63 60.62 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 CA-C-N 114.789 -1.096 . . . . 0.0 110.659 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 556' ' ' CYS . . . . . . . . . . . . . 20.1 m -55.37 -20.46 11.97 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.38 -179.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -48.15 -24.55 3.49 Favored Glycine 0 C--N 1.333 0.401 0 C-N-CA 120.934 -0.651 . . . . 0.0 113.01 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 558' ' ' LEU . . . . . 0.412 ' CD1' ' N ' ' A' ' 559' ' ' ARG . 3.9 pp -52.61 -44.94 66.33 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.913 0.387 . . . . 0.0 111.346 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 559' ' ' ARG . . . . . 0.424 ' HD2' ' N ' ' A' ' 559' ' ' ARG . 0.9 OUTLIER 59.53 169.22 0.07 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.783 -179.909 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 560' ' ' GLN . . . . . . . . . . . . . 4.2 mp0 . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.207 -0.901 . . . . 0.0 110.844 -179.989 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.325 0 CA-C-O 120.82 0.343 . . . . 0.0 111.175 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 508' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -128.38 77.5 77.0 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.561 179.211 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 509' ' ' PRO . . . . . 0.56 ' C ' ' HG3' ' A' ' 510' ' ' LYS . 70.9 Cg_endo -86.7 62.93 4.56 Favored 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 122.89 2.393 . . . . 0.0 112.85 -179.44 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 510' ' ' LYS . . . . . 0.56 ' HG3' ' C ' ' A' ' 509' ' ' PRO . 0.0 OUTLIER 32.48 -90.49 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 120.966 0.413 . . . . 0.0 111.947 179.365 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 511' ' ' CYS . . . . . 0.464 ' N ' ' O ' ' A' ' 509' ' ' PRO . 0.0 OUTLIER 74.98 75.96 0.1 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.222 179.405 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 512' ' ' ASN . . . . . . . . . . . . . 34.3 m-20 -156.15 79.6 4.03 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.056 179.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 513' ' ' PRO . . . . . 0.415 ' HB3' ' HG ' ' A' ' 554' ' ' LEU . 26.0 Cg_exo -61.5 -15.83 43.74 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 123.056 2.504 . . . . 0.0 112.479 -179.567 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 22.6 t30 -57.47 -43.52 84.09 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.29 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 515' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -81.18 73.82 8.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.822 0.344 . . . . 0.0 111.065 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 516' ' ' HIS . . . . . 0.491 ' CE1' ' CE1' ' A' ' 517' ' ' TYR . 19.1 p80 -89.25 -7.25 55.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.622 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 517' ' ' TYR . . . . . 0.491 ' CE1' ' CE1' ' A' ' 516' ' ' HIS . 43.1 m-85 -74.93 -30.85 61.36 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 111.702 0.26 . . . . 0.0 111.702 -179.525 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 518' ' ' TRP . . . . . 0.582 ' O ' ' N ' ' A' ' 520' ' ' THR . 8.5 m-90 -117.92 -0.03 11.79 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 -179.504 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 519' ' ' THR . . . . . 0.558 ' OG1' ' N ' ' A' ' 520' ' ' THR . 1.2 p 49.38 -78.37 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 120.485 0.183 . . . . 0.0 111.405 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 520' ' ' THR . . . . . 0.582 ' N ' ' O ' ' A' ' 518' ' ' TRP . 1.3 m -179.15 -62.45 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 179.519 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 521' ' ' GLN . . . . . . . . . . . . . 8.2 mt-30 -72.78 -11.87 60.78 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.32 177.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 522' ' ' ASP . . . . . 0.437 ' O ' HG23 ' A' ' 527' ' ' ILE . 68.8 m-20 -91.63 -10.71 39.41 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.81 179.128 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -45.26 -26.71 0.54 Allowed 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.48 -179.72 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . 146.53 41.47 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.356 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -100.66 -60.95 1.43 Allowed 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 111.785 0.291 . . . . 0.0 111.785 -179.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -131.96 38.17 3.55 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-O 121.549 0.69 . . . . 0.0 110.132 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 527' ' ' ILE . . . . . 0.476 ' HA ' ' CB ' ' A' ' 544' ' ' ALA . 2.1 pp -95.79 -2.51 10.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 114.746 -1.116 . . . . 0.0 112.844 -178.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 528' ' ' GLY . . . . . . . . . . . . . . . -56.47 -16.59 16.1 Favored Glycine 0 CA--C 1.52 0.403 0 C-N-CA 120.791 -0.719 . . . . 0.0 114.028 -179.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 529' ' ' LEU . . . . . 0.409 ' CD1' ' O ' ' A' ' 543' ' ' TYR . 0.7 OUTLIER -99.21 -32.82 11.02 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 117.809 0.805 . . . . 0.0 112.292 -179.394 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 530' ' ' ALA . . . . . 0.462 ' C ' ' H ' ' A' ' 532' ' ' ILE . . . -103.82 1.52 31.66 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -179.022 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 531' ' ' TRP . . . . . 0.439 ' HB2' ' O ' ' A' ' 527' ' ' ILE . 55.5 t90 -73.48 30.33 0.07 Allowed 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -179.299 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 532' ' ' ILE . . . . . 0.462 ' H ' ' C ' ' A' ' 530' ' ' ALA . 1.1 pt -158.26 77.41 3.44 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-O 120.739 0.304 . . . . 0.0 110.888 179.425 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 533' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_exo -41.74 88.14 0.01 OUTLIER 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 123.045 2.497 . . . . 0.0 112.956 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 534' ' ' TYR . . . . . 0.437 ' N ' ' O ' ' A' ' 532' ' ' ILE . 12.5 t80 -96.51 -51.98 4.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.483 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -57.73 -34.84 69.93 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.635 -179.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 144.89 -64.18 0.46 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.506 -0.854 . . . . 0.0 112.597 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -55.29 -168.88 0.02 OUTLIER 'Trans proline' 0 CA--C 1.515 -0.457 0 C-N-CA 122.606 2.204 . . . . 0.0 111.906 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 538' ' ' ALA . . . . . 0.416 ' C ' ' H ' ' A' ' 540' ' ' GLU . . . -63.93 -53.47 49.9 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.199 179.605 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 539' ' ' ALA . . . . . 0.463 ' HA ' HD11 ' A' ' 542' ' ' ILE . . . 67.81 -49.93 0.52 Allowed 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.995 179.5 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 540' ' ' GLU . . . . . 0.455 ' O ' ' HB3' ' A' ' 544' ' ' ALA . 0.2 OUTLIER -37.6 -27.0 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.927 -1.033 . . . . 0.0 112.414 -179.275 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 541' ' ' GLY . . . . . 0.411 ' N ' ' O ' ' A' ' 539' ' ' ALA . . . -125.94 -43.6 0.27 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.755 -0.736 . . . . 0.0 111.889 179.129 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 542' ' ' ILE . . . . . 0.463 HD11 ' HA ' ' A' ' 539' ' ' ALA . 1.0 OUTLIER -69.93 -25.91 29.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 112.363 0.505 . . . . 0.0 112.363 -179.713 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 543' ' ' TYR . . . . . 0.456 ' HB2' ' HA ' ' A' ' 539' ' ' ALA . 0.1 OUTLIER -111.69 -9.27 14.14 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.903 0.382 . . . . 0.0 110.784 179.988 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 544' ' ' ALA . . . . . 0.476 ' CB ' ' HA ' ' A' ' 527' ' ' ILE . . . -100.52 -33.67 10.24 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.84 179.689 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 545' ' ' GLU . . . . . 0.455 ' HG3' ' H ' ' A' ' 548' ' ' MET . 37.6 tp10 -118.86 -32.77 4.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.316 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 39.3 39.82 1.16 Allowed Glycine 0 CA--C 1.519 0.304 0 CA-C-N 115.732 -0.667 . . . . 0.0 113.976 179.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 547' ' ' LEU . . . . . 0.417 ' HG ' ' N ' ' A' ' 548' ' ' MET . 0.0 OUTLIER -173.24 -61.76 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 117.702 0.751 . . . . 0.0 112.303 179.43 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 548' ' ' MET . . . . . 0.455 ' H ' ' HG3' ' A' ' 545' ' ' GLU . 0.0 OUTLIER -96.32 11.51 34.4 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.7 0.286 . . . . 0.0 111.084 179.559 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 549' ' ' HIS . . . . . 0.479 ' O ' ' CG2' ' A' ' 519' ' ' THR . 9.8 p80 -61.12 -11.56 9.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.85 0.357 . . . . 0.0 111.013 179.462 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 550' ' ' ASN . . . . . . . . . . . . . 48.5 m-20 -96.09 -30.79 13.35 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -179.083 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 551' ' ' GLN . . . . . 0.403 ' HG2' ' HG3' ' A' ' 548' ' ' MET . 2.7 pt20 -68.08 70.95 0.16 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.038 0.447 . . . . 0.0 110.696 -179.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 552' ' ' ASP . . . . . 0.417 ' HB2' ' HA ' ' A' ' 516' ' ' HIS . 1.9 p30 -94.95 21.82 7.21 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.244 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . 123.83 -27.91 5.56 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.856 -0.688 . . . . 0.0 111.629 -179.259 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 554' ' ' LEU . . . . . 0.415 ' HG ' ' HB3' ' A' ' 513' ' ' PRO . 0.4 OUTLIER -61.93 -55.32 30.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.567 0.698 . . . . 0.0 110.034 179.067 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 555' ' ' ILE . . . . . . . . . . . . . 1.8 mm -71.66 66.94 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 114.78 -1.1 . . . . 0.0 110.421 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 556' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -72.79 -7.29 49.96 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.742 -179.588 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 557' ' ' GLY . . . . . 0.418 ' C ' ' HD3' ' A' ' 559' ' ' ARG . . . -62.31 -2.58 4.28 Favored Glycine 0 CA--C 1.524 0.602 0 C-N-CA 121.02 -0.609 . . . . 0.0 113.897 -179.425 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 558' ' ' LEU . . . . . . . . . . . . . 3.9 pp -72.33 -9.79 58.95 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -179.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 559' ' ' ARG . . . . . 0.418 ' HD3' ' C ' ' A' ' 557' ' ' GLY . 0.0 OUTLIER -44.97 167.0 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 120.891 0.377 . . . . 0.0 111.49 -179.525 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 560' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 . . . . . 0 C--O 1.25 1.088 0 CA-C-O 118.236 -0.888 . . . . 0.0 110.907 -179.974 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 507' ' ' ALA . . . . . 0.468 ' CB ' ' HB3' ' A' ' 559' ' ' ARG . . . . . . . . 0 N--CA 1.486 1.36 0 CA-C-O 120.898 0.38 . . . . 0.0 111.215 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 508' ' ' GLN . . . . . . . . . . . . . 3.0 mm100 -128.94 77.27 78.13 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.893 179.028 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 509' ' ' PRO . . . . . 0.474 ' O ' ' HB3' ' A' ' 510' ' ' LYS . 11.7 Cg_exo -70.49 -65.11 0.04 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 122.714 2.276 . . . . 0.0 111.695 179.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 510' ' ' LYS . . . . . 0.475 ' HG2' ' N ' ' A' ' 511' ' ' CYS . 0.0 OUTLIER 173.52 -32.48 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.005 179.69 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 511' ' ' CYS . . . . . 0.475 ' N ' ' HG2' ' A' ' 510' ' ' LYS . 0.0 OUTLIER 43.43 67.14 0.69 Allowed 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.44 179.883 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 512' ' ' ASN . . . . . . . . . . . . . 35.1 m-20 -120.53 79.99 30.16 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.652 179.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 513' ' ' PRO . . . . . 0.403 ' HA ' ' O ' ' A' ' 552' ' ' ASP . 42.7 Cg_endo -68.18 -10.23 28.28 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.651 2.234 . . . . 0.0 112.56 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 39.7 t30 -74.62 -29.98 61.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.08 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 515' ' ' LEU . . . . . . . . . . . . . 65.5 mt -84.94 74.6 10.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.886 0.374 . . . . 0.0 110.93 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 516' ' ' HIS . . . . . 0.429 ' HA ' ' HB3' ' A' ' 552' ' ' ASP . 1.9 p-80 -89.09 -7.13 56.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.582 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 517' ' ' TYR . . . . . . . . . . . . . 31.2 m-85 -70.65 -50.79 33.05 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.69 0.281 . . . . 0.0 111.638 -179.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 518' ' ' TRP . . . . . 0.494 ' O ' ' N ' ' A' ' 520' ' ' THR . 24.1 m-90 -112.56 10.04 19.52 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 111.914 0.338 . . . . 0.0 111.914 -179.644 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 519' ' ' THR . . . . . 0.509 HG21 ' HA ' ' A' ' 549' ' ' HIS . 1.1 p 60.88 -70.13 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 116.65 -0.25 . . . . 0.0 110.915 179.627 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 520' ' ' THR . . . . . 0.494 ' N ' ' O ' ' A' ' 518' ' ' TRP . 1.0 OUTLIER 174.95 -62.82 0.01 OUTLIER 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.152 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 521' ' ' GLN . . . . . 0.486 ' HB3' ' OE1' ' A' ' 545' ' ' GLU . 0.7 OUTLIER -73.36 -11.95 60.66 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 178.188 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 522' ' ' ASP . . . . . 0.402 ' HB3' ' O ' ' A' ' 518' ' ' TRP . 0.6 OUTLIER -91.93 -10.97 37.57 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.912 179.1 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -45.07 -27.5 0.58 Allowed 'General case' 0 CA--C 1.528 0.107 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.304 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . 151.41 41.24 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.852 -0.69 . . . . 0.0 112.144 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -122.2 -20.33 6.24 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -143.79 30.25 1.34 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.254 0.55 . . . . 0.0 110.903 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 527' ' ' ILE . . . . . 0.529 ' O ' ' HB2' ' A' ' 531' ' ' TRP . 2.3 pp -95.64 -24.72 4.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.934 -179.562 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 528' ' ' GLY . . . . . . . . . . . . . . . -49.47 -13.23 0.43 Allowed Glycine 0 CA--C 1.523 0.575 0 C-N-CA 121.154 -0.545 . . . . 0.0 114.369 -179.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 529' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -98.03 -47.83 5.36 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 117.864 0.832 . . . . 0.0 111.863 -179.168 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 530' ' ' ALA . . . . . 0.521 ' C ' ' H ' ' A' ' 532' ' ' ILE . . . -103.69 1.93 32.49 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 -178.437 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 531' ' ' TRP . . . . . 0.529 ' HB2' ' O ' ' A' ' 527' ' ' ILE . 58.8 t90 -68.85 30.53 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -179.074 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 532' ' ' ILE . . . . . 0.521 ' H ' ' C ' ' A' ' 530' ' ' ALA . 1.3 pp -156.76 69.48 4.63 Favored Pre-proline 0 CA--C 1.53 0.182 0 CA-C-O 120.8 0.334 . . . . 0.0 110.91 179.357 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 533' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -52.8 105.15 0.11 Allowed 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.673 2.249 . . . . 0.0 111.875 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 534' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -96.08 -55.31 3.01 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 111.984 0.364 . . . . 0.0 111.984 -179.258 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -118.77 -35.02 3.79 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -179.338 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . -85.08 -175.24 50.57 Favored Glycine 0 CA--C 1.518 0.233 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.979 -179.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_endo -56.81 -159.09 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.884 2.389 . . . . 0.0 111.874 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 538' ' ' ALA . . . . . . . . . . . . . . . -43.87 -48.76 8.42 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.55 -0.296 . . . . 0.0 111.349 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 539' ' ' ALA . . . . . 0.518 ' HA ' ' CD1' ' A' ' 542' ' ' ILE . . . 72.13 -49.3 0.69 Allowed 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.256 0.551 . . . . 0.0 111.482 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 540' ' ' GLU . . . . . 0.416 ' HG2' ' CD1' ' A' ' 531' ' ' TRP . 3.1 mt-10 -36.84 -31.45 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.863 -1.062 . . . . 0.0 112.494 -179.192 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 541' ' ' GLY . . . . . 0.408 ' O ' ' HB3' ' A' ' 549' ' ' HIS . . . -130.89 -18.95 1.32 Allowed Glycine 0 CA--C 1.52 0.369 0 C-N-CA 120.198 -1.001 . . . . 0.0 113.617 -179.738 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 542' ' ' ILE . . . . . 0.518 ' CD1' ' HA ' ' A' ' 539' ' ' ALA . 2.6 pp -96.25 -22.45 5.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 117.148 0.474 . . . . 0.0 112.251 -179.514 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 543' ' ' TYR . . . . . 0.5 ' HB2' ' HA ' ' A' ' 539' ' ' ALA . 0.2 OUTLIER -115.32 -12.08 11.83 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.966 0.412 . . . . 0.0 110.847 179.444 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 544' ' ' ALA . . . . . 0.436 ' CB ' ' HB1' ' A' ' 530' ' ' ALA . . . -92.02 -26.32 18.41 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.216 179.532 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 545' ' ' GLU . . . . . 0.499 ' HG3' ' H ' ' A' ' 548' ' ' MET . 19.7 tp10 -113.09 -33.41 6.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.773 -179.162 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 35.02 34.12 0.04 OUTLIER Glycine 0 CA--C 1.519 0.307 0 CA-C-N 115.776 -0.647 . . . . 0.0 114.259 179.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 547' ' ' LEU . . . . . 0.427 ' HG ' ' N ' ' A' ' 548' ' ' MET . 0.0 OUTLIER -176.41 -61.41 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 118.008 0.904 . . . . 0.0 112.695 -179.993 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 548' ' ' MET . . . . . 0.551 ' O ' ' HG3' ' A' ' 551' ' ' GLN . 0.4 OUTLIER -89.62 11.7 18.97 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.754 0.312 . . . . 0.0 110.935 179.733 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 549' ' ' HIS . . . . . 0.509 ' HA ' HG21 ' A' ' 519' ' ' THR . 0.2 OUTLIER -64.88 -12.08 44.87 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.972 0.415 . . . . 0.0 110.62 179.588 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 550' ' ' ASN . . . . . 0.419 ' O ' ' N ' ' A' ' 552' ' ' ASP . 4.2 m120 -96.92 -35.48 10.87 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -179.022 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 551' ' ' GLN . . . . . 0.551 ' HG3' ' O ' ' A' ' 548' ' ' MET . 0.0 OUTLIER -66.37 72.59 0.08 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.044 0.449 . . . . 0.0 110.639 -179.515 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 552' ' ' ASP . . . . . 0.485 ' HA ' ' HA ' ' A' ' 519' ' ' THR . 3.0 m-20 -87.27 21.63 2.36 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.149 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . 114.26 -29.1 7.86 Favored Glycine 0 N--CA 1.451 -0.339 0 N-CA-C 111.315 -0.714 . . . . 0.0 111.315 -179.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 554' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -63.16 -57.49 10.37 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.635 0.731 . . . . 0.0 110.054 179.182 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 555' ' ' ILE . . . . . . . . . . . . . 2.8 mm -71.54 65.0 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 CA-C-N 114.695 -1.139 . . . . 0.0 110.815 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 556' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -73.47 -7.42 51.68 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.56 -0.746 . . . . 0.0 111.232 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 557' ' ' GLY . . . . . 0.402 ' C ' ' HD3' ' A' ' 559' ' ' ARG . . . -63.31 -2.4 5.41 Favored Glycine 0 CA--C 1.522 0.505 0 C-N-CA 121.096 -0.573 . . . . 0.0 113.351 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 558' ' ' LEU . . . . . 0.401 ' O ' ' NE2' ' A' ' 560' ' ' GLN . 2.4 pp -63.34 -46.73 85.24 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 117.048 0.424 . . . . 0.0 111.842 -179.643 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 559' ' ' ARG . . . . . 0.468 ' HB3' ' CB ' ' A' ' 507' ' ' ALA . 0.0 OUTLIER 47.34 -171.85 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 120.909 0.385 . . . . 0.0 111.082 -179.582 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 560' ' ' GLN . . . . . 0.401 ' NE2' ' O ' ' A' ' 558' ' ' LEU . 2.9 mp0 . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.21 -0.9 . . . . 0.0 111.044 179.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.39 0 CA-C-O 120.823 0.344 . . . . 0.0 111.007 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 508' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -128.31 85.19 61.09 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.837 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 509' ' ' PRO . . . . . 0.533 ' O ' ' CE ' ' A' ' 510' ' ' LYS . 0.9 OUTLIER -84.51 -16.61 5.65 Favored 'Trans proline' 0 N--CA 1.458 -0.568 0 C-N-CA 123.177 2.585 . . . . 0.0 112.214 -179.816 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 510' ' ' LYS . . . . . 0.533 ' CE ' ' O ' ' A' ' 509' ' ' PRO . 0.0 OUTLIER 83.19 -16.25 0.59 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.113 -179.342 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 511' ' ' CYS . . . . . . . . . . . . . 6.7 m 45.44 66.44 0.91 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.53 179.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 512' ' ' ASN . . . . . . . . . . . . . 24.3 t30 -113.36 81.73 5.37 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.451 179.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 513' ' ' PRO . . . . . 0.443 ' HA ' ' O ' ' A' ' 552' ' ' ASP . 73.0 Cg_endo -76.01 18.95 0.61 Allowed 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.989 2.459 . . . . 0.0 113.293 -179.584 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -96.72 -28.96 14.06 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.705 0.288 . . . . 0.0 111.024 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 515' ' ' LEU . . . . . . . . . . . . . 70.0 mt -84.22 74.54 10.29 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.899 0.38 . . . . 0.0 110.946 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 516' ' ' HIS . . . . . 0.421 ' HA ' ' CB ' ' A' ' 552' ' ' ASP . 68.0 m-70 -70.14 -23.75 63.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.507 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 517' ' ' TYR . . . . . . . . . . . . . 50.3 m-85 -73.62 -64.18 1.05 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.711 0.291 . . . . 0.0 111.637 -179.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 518' ' ' TRP . . . . . 0.476 ' O ' ' N ' ' A' ' 520' ' ' THR . 27.3 m-90 -69.82 -17.65 63.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.844 -179.422 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 519' ' ' THR . . . . . 0.545 ' OG1' ' N ' ' A' ' 520' ' ' THR . 2.1 p 57.83 -79.78 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 120.518 0.199 . . . . 0.0 110.519 -179.707 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 520' ' ' THR . . . . . 0.545 ' N ' ' OG1' ' A' ' 519' ' ' THR . 1.2 m 177.67 -62.61 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 179.195 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 521' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -71.68 -13.87 61.87 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 177.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 522' ' ' ASP . . . . . 0.434 ' O ' HG21 ' A' ' 527' ' ' ILE . 2.8 m-20 -94.04 -11.11 31.43 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.88 179.044 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -45.51 -27.48 0.75 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.456 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 524' ' ' GLY . . . . . 0.414 ' HA2' ' CG1' ' A' ' 527' ' ' ILE . . . 146.21 42.11 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.55 -0.833 . . . . 0.0 112.313 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -101.51 -60.16 1.58 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.736 0.303 . . . . 0.0 111.775 -179.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -132.15 38.65 3.48 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-O 121.503 0.668 . . . . 0.0 110.049 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 527' ' ' ILE . . . . . 0.465 ' HA ' ' CB ' ' A' ' 544' ' ' ALA . 2.1 pp -95.83 -0.25 10.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 114.663 -1.153 . . . . 0.0 112.71 -178.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 528' ' ' GLY . . . . . . . . . . . . . . . -53.26 -14.8 3.36 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 114.535 0.574 . . . . 0.0 114.535 -178.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 529' ' ' LEU . . . . . 0.53 ' CD1' ' N ' ' A' ' 529' ' ' LEU . 0.0 OUTLIER -98.66 -33.98 10.74 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 118.055 0.927 . . . . 0.0 111.609 -179.57 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 530' ' ' ALA . . . . . 0.439 ' HB2' ' HB3' ' A' ' 543' ' ' TYR . . . -103.71 1.17 31.47 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -179.308 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 531' ' ' TRP . . . . . 0.426 ' HA ' ' HG2' ' A' ' 540' ' ' GLU . 9.9 t90 -56.28 -12.33 1.56 Allowed 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -179.14 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 532' ' ' ILE . . . . . 0.414 ' O ' ' CD1' ' A' ' 532' ' ' ILE . 1.7 pp -133.14 73.95 73.91 Favored Pre-proline 0 N--CA 1.452 -0.373 0 CA-C-O 121.06 0.457 . . . . 0.0 111.327 179.703 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 533' ' ' PRO . . . . . 0.425 ' HB3' ' O ' ' A' ' 538' ' ' ALA . 1.7 Cg_endo -45.73 92.29 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 123.037 2.492 . . . . 0.0 112.671 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 534' ' ' TYR . . . . . . . . . . . . . 47.4 p90 -96.31 -25.4 15.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.116 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -69.75 -34.78 74.28 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.399 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 147.87 -64.09 0.42 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.822 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -59.36 -164.72 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.605 2.203 . . . . 0.0 112.033 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 538' ' ' ALA . . . . . 0.425 ' O ' ' HB3' ' A' ' 533' ' ' PRO . . . -69.3 -47.45 64.48 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.726 179.743 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 539' ' ' ALA . . . . . 0.44 ' HA ' ' CD1' ' A' ' 542' ' ' ILE . . . 69.17 -53.94 0.58 Allowed 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.306 0.574 . . . . 0.0 111.45 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 540' ' ' GLU . . . . . 0.426 ' HG2' ' HA ' ' A' ' 531' ' ' TRP . 10.6 mt-10 -37.57 -27.59 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.895 -1.048 . . . . 0.0 112.121 -179.541 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 541' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 539' ' ' ALA . . . -124.76 -46.85 0.24 Allowed Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.136 179.069 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 542' ' ' ILE . . . . . 0.44 ' CD1' ' HA ' ' A' ' 539' ' ' ALA . 2.6 pp -73.47 -24.59 20.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 -179.367 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 543' ' ' TYR . . . . . 0.439 ' HB3' ' HB2' ' A' ' 530' ' ' ALA . 6.5 t80 -114.11 -7.72 13.04 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.878 0.37 . . . . 0.0 110.963 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 544' ' ' ALA . . . . . 0.465 ' CB ' ' HA ' ' A' ' 527' ' ' ILE . . . -103.14 -33.89 9.06 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 121.22 0.534 . . . . 0.0 109.948 179.362 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 545' ' ' GLU . . . . . 0.461 ' HG3' ' H ' ' A' ' 548' ' ' MET . 23.1 tp10 -118.56 -32.66 4.52 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.272 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 37.68 43.42 1.18 Allowed Glycine 0 CA--C 1.52 0.376 0 CA-C-N 115.931 -0.577 . . . . 0.0 113.771 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 547' ' ' LEU . . . . . 0.547 ' HG ' ' N ' ' A' ' 548' ' ' MET . 0.0 OUTLIER -172.94 -61.23 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 117.362 0.581 . . . . 0.0 111.874 179.628 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 548' ' ' MET . . . . . 0.547 ' N ' ' HG ' ' A' ' 547' ' ' LEU . 0.0 OUTLIER -96.03 11.59 33.54 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.672 0.272 . . . . 0.0 111.209 179.68 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 549' ' ' HIS . . . . . 0.457 ' O ' ' CG2' ' A' ' 519' ' ' THR . 10.0 p80 -61.49 -11.35 10.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.695 0.283 . . . . 0.0 110.904 179.372 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 550' ' ' ASN . . . . . 0.442 ' O ' ' N ' ' A' ' 552' ' ' ASP . 8.3 m120 -95.98 -34.23 11.86 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -179.204 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 551' ' ' GLN . . . . . 0.4 ' HG2' ' CG ' ' A' ' 548' ' ' MET . 0.0 OUTLIER -65.39 72.79 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.133 0.492 . . . . 0.0 110.325 179.895 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 552' ' ' ASP . . . . . 0.499 ' HA ' ' HA ' ' A' ' 519' ' ' THR . 1.6 p30 -90.6 22.33 3.54 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.602 -0.727 . . . . 0.0 111.724 -179.447 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . 124.27 -27.52 5.54 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.863 -0.684 . . . . 0.0 111.739 -179.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 554' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -61.67 -57.13 13.17 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.49 0.662 . . . . 0.0 109.937 178.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 555' ' ' ILE . . . . . . . . . . . . . 4.2 mm -76.93 70.42 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 CA-C-N 114.821 -1.081 . . . . 0.0 110.862 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 556' ' ' CYS . . . . . . . . . . . . . 34.7 m -68.41 -7.68 33.81 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.748 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -65.77 -2.42 11.85 Favored Glycine 0 CA--C 1.521 0.461 0 C-N-CA 120.984 -0.627 . . . . 0.0 113.639 -179.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 558' ' ' LEU . . . . . . . . . . . . . 4.1 pp -61.33 -15.61 37.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 117.079 0.439 . . . . 0.0 111.847 -179.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 559' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.72 -177.18 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.94 0.4 . . . . 0.0 111.51 -179.474 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 560' ' ' GLN . . . . . . . . . . . . . 16.9 mt-30 . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.214 -0.898 . . . . 0.0 110.92 179.834 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 507' ' ' ALA . . . . . 0.403 ' HB1' ' HB3' ' A' ' 559' ' ' ARG . . . . . . . . 0 N--CA 1.486 1.347 0 CA-C-O 120.881 0.372 . . . . 0.0 111.06 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 508' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.36 78.0 76.26 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.012 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 509' ' ' PRO . . . . . 0.507 ' O ' ' CE ' ' A' ' 510' ' ' LYS . 95.3 Cg_endo -80.62 -15.01 11.18 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.538 2.159 . . . . 0.0 112.527 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 510' ' ' LYS . . . . . 0.507 ' CE ' ' O ' ' A' ' 509' ' ' PRO . 0.0 OUTLIER 82.09 -22.26 0.26 Allowed 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.561 -179.885 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 511' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 45.3 81.35 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.426 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 512' ' ' ASN . . . . . . . . . . . . . 18.5 m-20 -131.25 77.68 73.87 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.663 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 513' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -68.0 -12.28 34.75 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.608 2.206 . . . . 0.0 112.41 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -65.32 -29.03 69.74 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.887 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 515' ' ' LEU . . . . . . . . . . . . . 74.4 mt -95.54 71.18 3.11 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.881 179.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 516' ' ' HIS . . . . . 0.453 ' HA ' ' CB ' ' A' ' 552' ' ' ASP . 15.4 p80 -74.53 -7.34 52.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.676 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 517' ' ' TYR . . . . . . . . . . . . . 65.0 m-85 -79.9 -59.4 2.74 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.781 0.324 . . . . 0.0 111.592 -179.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 518' ' ' TRP . . . . . 0.42 ' HA ' ' CE3' ' A' ' 518' ' ' TRP . 0.1 OUTLIER -74.17 -21.61 59.77 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.925 -179.036 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 519' ' ' THR . . . . . 0.53 ' OG1' ' N ' ' A' ' 520' ' ' THR . 2.3 p 63.38 -77.27 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 110.321 -0.252 . . . . 0.0 110.321 -179.505 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 520' ' ' THR . . . . . 0.53 ' N ' ' OG1' ' A' ' 519' ' ' THR . 1.0 OUTLIER 171.25 -62.4 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 179.227 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 521' ' ' GLN . . . . . 0.407 ' HG2' ' OE2' ' A' ' 545' ' ' GLU . 0.0 OUTLIER -72.72 -11.08 60.48 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.364 178.048 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -91.15 -21.19 21.29 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.631 178.758 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 523' ' ' GLU . . . . . 0.443 ' HG3' ' HA ' ' A' ' 520' ' ' THR . 8.9 mm-40 -45.84 -29.75 1.46 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.435 178.417 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 524' ' ' GLY . . . . . 0.416 ' HA2' ' CG1' ' A' ' 527' ' ' ILE . . . 144.51 39.16 0.06 OUTLIER Glycine 0 N--CA 1.443 -0.838 0 CA-C-N 114.816 -1.083 . . . . 0.0 110.405 -179.28 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -97.89 -59.49 1.75 Allowed 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 -178.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -130.81 40.37 3.49 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-O 121.549 0.69 . . . . 0.0 110.087 179.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 527' ' ' ILE . . . . . 0.459 ' O ' ' HB2' ' A' ' 531' ' ' TRP . 1.9 pp -95.67 -12.91 8.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 114.903 -1.044 . . . . 0.0 112.483 -179.03 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 528' ' ' GLY . . . . . . . . . . . . . . . -48.45 -19.81 1.35 Allowed Glycine 0 CA--C 1.522 0.477 0 N-CA-C 114.624 0.61 . . . . 0.0 114.624 -179.131 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 529' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -98.57 -39.98 8.45 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 117.873 0.837 . . . . 0.0 112.415 -179.01 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 530' ' ' ALA . . . . . 0.542 ' C ' ' H ' ' A' ' 532' ' ' ILE . . . -103.88 2.06 32.14 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 -178.467 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 531' ' ' TRP . . . . . 0.48 ' HA ' ' HG2' ' A' ' 540' ' ' GLU . 73.3 t-105 -67.45 30.22 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -178.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 532' ' ' ILE . . . . . 0.542 ' H ' ' C ' ' A' ' 530' ' ' ALA . 1.3 pp -160.31 71.51 2.99 Favored Pre-proline 0 N--CA 1.454 -0.259 0 CA-C-O 120.837 0.351 . . . . 0.0 110.555 178.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 533' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -48.82 86.86 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 123.22 2.613 . . . . 0.0 112.829 -179.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 534' ' ' TYR . . . . . 0.4 ' N ' ' O ' ' A' ' 532' ' ' ILE . 0.2 OUTLIER -96.51 -38.3 10.06 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.049 179.804 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -62.58 -34.87 77.86 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.456 -179.412 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 151.09 -66.88 0.34 Allowed Glycine 0 CA--C 1.519 0.315 0 C-N-CA 120.47 -0.871 . . . . 0.0 112.62 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -57.2 -164.63 0.02 OUTLIER 'Trans proline' 0 CA--C 1.518 -0.307 0 C-N-CA 122.611 2.207 . . . . 0.0 111.735 179.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 538' ' ' ALA . . . . . . . . . . . . . . . -74.4 -48.33 28.43 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.432 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 539' ' ' ALA . . . . . 0.467 ' HA ' ' CD1' ' A' ' 542' ' ' ILE . . . 70.62 -51.83 0.67 Allowed 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.391 0.615 . . . . 0.0 111.277 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 540' ' ' GLU . . . . . 0.48 ' HG2' ' HA ' ' A' ' 531' ' ' TRP . 7.2 mt-10 -36.89 -30.68 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.809 -1.087 . . . . 0.0 112.538 -179.169 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 541' ' ' GLY . . . . . 0.451 ' HA3' ' CD2' ' A' ' 549' ' ' HIS . . . -126.95 -30.15 0.83 Allowed Glycine 0 CA--C 1.518 0.254 0 C-N-CA 120.412 -0.899 . . . . 0.0 112.999 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 542' ' ' ILE . . . . . 0.467 ' CD1' ' HA ' ' A' ' 539' ' ' ALA . 2.6 pp -88.82 -22.03 6.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 -179.532 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 543' ' ' TYR . . . . . 0.477 ' HB3' ' HB1' ' A' ' 530' ' ' ALA . 10.1 t80 -115.26 -8.43 12.32 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.892 0.377 . . . . 0.0 110.78 179.706 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 544' ' ' ALA . . . . . 0.429 ' CB ' ' CB ' ' A' ' 530' ' ' ALA . . . -103.01 -38.38 7.36 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-O 121.428 0.632 . . . . 0.0 109.572 179.217 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 545' ' ' GLU . . . . . 0.582 ' HG3' ' H ' ' A' ' 548' ' ' MET . 4.7 tp10 -118.95 -32.81 4.36 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.035 -0.984 . . . . 0.0 111.375 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 37.96 46.01 1.7 Allowed Glycine 0 CA--C 1.519 0.298 0 CA-C-N 115.895 -0.593 . . . . 0.0 113.975 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 547' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER 179.03 -60.95 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 117.552 0.676 . . . . 0.0 112.049 179.682 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 548' ' ' MET . . . . . 0.582 ' H ' ' HG3' ' A' ' 545' ' ' GLU . 0.4 OUTLIER -87.83 11.74 14.8 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 111.765 0.283 . . . . 0.0 111.765 -179.769 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 549' ' ' HIS . . . . . 0.451 ' CD2' ' HA3' ' A' ' 541' ' ' GLY . 10.1 t-80 -66.69 -11.63 55.01 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.918 0.39 . . . . 0.0 110.233 179.245 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 550' ' ' ASN . . . . . 0.659 ' O ' ' N ' ' A' ' 552' ' ' ASP . 42.1 m-20 -96.24 -56.1 2.74 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.552 -179.751 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 551' ' ' GLN . . . . . 0.545 ' HG3' ' O ' ' A' ' 548' ' ' MET . 1.4 pp0? -44.24 76.41 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.583 -179.616 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 552' ' ' ASP . . . . . 0.659 ' N ' ' O ' ' A' ' 550' ' ' ASN . 2.3 p30 -94.45 22.24 6.33 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.247 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . 124.12 -28.39 5.37 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.865 -0.683 . . . . 0.0 111.708 -179.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 554' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -58.32 -59.81 4.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.341 0.591 . . . . 0.0 110.162 179.033 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 555' ' ' ILE . . . . . . . . . . . . . 5.6 mm -78.4 62.73 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.647 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 556' ' ' CYS . . . . . 0.423 ' O ' ' HD3' ' A' ' 559' ' ' ARG . 0.2 OUTLIER -68.38 -7.51 32.08 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.712 -179.634 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -66.65 -2.38 15.78 Favored Glycine 0 CA--C 1.522 0.517 0 C-N-CA 120.997 -0.621 . . . . 0.0 113.578 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 558' ' ' LEU . . . . . . . . . . . . . 2.4 pp -62.78 -48.32 79.66 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 117.072 0.436 . . . . 0.0 111.855 -179.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 559' ' ' ARG . . . . . 0.423 ' HD3' ' O ' ' A' ' 556' ' ' CYS . 0.0 OUTLIER 45.45 -166.54 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.841 -179.227 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 560' ' ' GLN . . . . . . . . . . . . . 3.4 mp0 . . . . . 0 C--O 1.247 0.972 0 CA-C-O 118.26 -0.876 . . . . 0.0 111.133 179.778 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 507' ' ' ALA . . . . . 0.416 ' CB ' ' HB3' ' A' ' 559' ' ' ARG . . . . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 120.931 0.396 . . . . 0.0 111.205 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 508' ' ' GLN . . . . . . . . . . . . . 8.0 mp0 -128.65 77.12 77.95 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.813 179.342 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 509' ' ' PRO . . . . . 0.405 ' HG3' ' HA ' ' A' ' 559' ' ' ARG . 21.1 Cg_exo -65.78 -65.21 0.05 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.235 0 C-N-CA 122.645 2.23 . . . . 0.0 111.837 179.766 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 510' ' ' LYS . . . . . 0.45 ' HG2' ' N ' ' A' ' 511' ' ' CYS . 0.0 OUTLIER 179.79 -35.87 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.507 179.723 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 511' ' ' CYS . . . . . 0.45 ' N ' ' HG2' ' A' ' 510' ' ' LYS . 0.5 OUTLIER 43.79 63.32 1.62 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.072 -0.967 . . . . 0.0 111.575 179.53 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 512' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -136.58 82.18 33.87 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.252 179.642 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 513' ' ' PRO . . . . . 0.482 ' HA ' ' O ' ' A' ' 552' ' ' ASP . 58.2 Cg_endo -72.68 9.22 1.33 Allowed 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.839 2.359 . . . . 0.0 113.314 -179.375 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -95.87 -24.81 16.26 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.684 0.278 . . . . 0.0 110.997 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 515' ' ' LEU . . . . . . . . . . . . . 84.6 mt -87.1 74.59 9.6 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.831 0.348 . . . . 0.0 111.062 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 516' ' ' HIS . . . . . 0.429 ' HA ' ' CB ' ' A' ' 552' ' ' ASP . 25.0 p80 -81.14 -7.28 59.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.713 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 517' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -71.49 -46.72 59.06 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.679 0.276 . . . . 0.0 111.541 -179.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 518' ' ' TRP . . . . . 0.522 ' O ' ' N ' ' A' ' 520' ' ' THR . 12.3 m-90 -101.8 -3.87 27.31 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -179.314 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 519' ' ' THR . . . . . 0.555 ' HA ' ' HA ' ' A' ' 552' ' ' ASP . 4.1 p 56.41 -78.07 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 120.551 0.215 . . . . 0.0 110.757 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 520' ' ' THR . . . . . 0.522 ' N ' ' O ' ' A' ' 518' ' ' TRP . 1.1 m 176.04 -62.43 0.01 OUTLIER 'General case' 0 CA--C 1.521 -0.171 0 N-CA-C 109.171 -0.678 . . . . 0.0 109.171 179.375 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 521' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -71.64 -12.56 61.4 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 177.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 522' ' ' ASP . . . . . 0.431 ' O ' HG22 ' A' ' 527' ' ' ILE . 1.2 m-20 -93.86 -11.21 31.62 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.667 178.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -45.69 -27.88 0.89 Allowed 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.253 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 524' ' ' GLY . . . . . 0.406 ' HA2' ' CG1' ' A' ' 527' ' ' ILE . . . 145.41 43.02 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.243 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -102.56 -58.97 1.78 Allowed 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 -179.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -131.61 39.89 3.45 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-O 121.565 0.698 . . . . 0.0 109.986 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 527' ' ' ILE . . . . . 0.489 ' HA ' ' CB ' ' A' ' 544' ' ' ALA . 1.9 pp -95.61 -0.54 10.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 114.764 -1.107 . . . . 0.0 112.693 -178.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 528' ' ' GLY . . . . . . . . . . . . . . . -60.23 -14.34 32.65 Favored Glycine 0 CA--C 1.52 0.387 0 C-N-CA 120.865 -0.683 . . . . 0.0 113.901 -179.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 529' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -98.55 -33.84 10.83 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 117.477 0.638 . . . . 0.0 111.68 -179.408 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 530' ' ' ALA . . . . . 0.448 ' HB2' ' N ' ' A' ' 544' ' ' ALA . . . -103.81 1.53 31.69 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -179.057 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 531' ' ' TRP . . . . . 0.425 ' HB2' ' O ' ' A' ' 527' ' ' ILE . 73.2 t-105 -56.08 -12.6 1.55 Allowed 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 -179.378 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 532' ' ' ILE . . . . . 0.413 HD11 ' CD1' ' A' ' 534' ' ' TYR . 1.5 pp -129.44 75.21 80.26 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 120.978 0.418 . . . . 0.0 110.984 179.699 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 533' ' ' PRO . . . . . 0.407 ' HB3' ' O ' ' A' ' 538' ' ' ALA . 5.6 Cg_endo -48.91 89.88 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 123.099 2.533 . . . . 0.0 112.85 -179.672 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 534' ' ' TYR . . . . . 0.413 ' CD1' HD11 ' A' ' 532' ' ' ILE . 1.3 m-85 -96.3 -13.33 23.41 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.068 179.524 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -76.85 -34.87 57.81 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.282 -179.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 536' ' ' GLY . . . . . 0.417 ' N ' ' CD ' ' A' ' 537' ' ' PRO . . . 141.42 -49.54 0.76 Allowed Glycine 0 CA--C 1.52 0.347 0 C-N-CA 120.518 -0.848 . . . . 0.0 112.915 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 537' ' ' PRO . . . . . 0.417 ' CD ' ' N ' ' A' ' 536' ' ' GLY . 5.6 Cg_exo -76.56 -168.0 0.52 Allowed 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 122.714 2.276 . . . . 0.0 111.931 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 538' ' ' ALA . . . . . 0.407 ' O ' ' HB3' ' A' ' 533' ' ' PRO . . . -56.28 -47.63 78.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.461 179.505 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 539' ' ' ALA . . . . . 0.568 ' HA ' ' CD1' ' A' ' 542' ' ' ILE . . . 68.14 -59.47 0.43 Allowed 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 121.362 0.601 . . . . 0.0 111.976 179.339 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 540' ' ' GLU . . . . . 0.409 ' OE2' ' CE3' ' A' ' 531' ' ' TRP . 2.7 mt-10 -37.49 -28.77 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 114.871 -1.059 . . . . 0.0 112.293 -179.108 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 541' ' ' GLY . . . . . 0.404 ' O ' ' HB2' ' A' ' 549' ' ' HIS . . . -121.9 -26.71 1.85 Allowed Glycine 0 CA--C 1.521 0.41 0 C-N-CA 120.479 -0.867 . . . . 0.0 113.27 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 542' ' ' ILE . . . . . 0.568 ' CD1' ' HA ' ' A' ' 539' ' ' ALA . 2.6 pp -95.84 -20.59 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -179.345 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 543' ' ' TYR . . . . . 0.546 ' HB2' ' HA ' ' A' ' 539' ' ' ALA . 0.3 OUTLIER -107.84 -10.73 15.5 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.112 0.482 . . . . 0.0 110.113 178.901 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 544' ' ' ALA . . . . . 0.489 ' CB ' ' HA ' ' A' ' 527' ' ' ILE . . . -103.16 -38.45 7.28 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.78 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 545' ' ' GLU . . . . . 0.525 ' HG3' ' H ' ' A' ' 548' ' ' MET . 5.9 tp10 -118.91 -32.96 4.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.151 -0.932 . . . . 0.0 111.487 -179.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 37.72 49.37 1.89 Allowed Glycine 0 CA--C 1.52 0.403 0 CA-C-N 115.988 -0.551 . . . . 0.0 113.822 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 547' ' ' LEU . . . . . 0.414 ' HG ' ' N ' ' A' ' 548' ' ' MET . 0.0 OUTLIER 178.99 -60.83 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 117.528 0.664 . . . . 0.0 111.976 179.633 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 548' ' ' MET . . . . . 0.525 ' H ' ' HG3' ' A' ' 545' ' ' GLU . 0.0 OUTLIER -86.38 11.76 11.65 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.671 0.272 . . . . 0.0 111.566 -179.802 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 549' ' ' HIS . . . . . 0.509 ' O ' ' CG2' ' A' ' 519' ' ' THR . 56.6 t60 -67.96 -10.97 57.77 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.899 0.381 . . . . 0.0 110.412 179.249 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 550' ' ' ASN . . . . . 0.432 ' O ' ' N ' ' A' ' 552' ' ' ASP . 38.9 t30 -92.89 -25.91 17.86 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.126 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 551' ' ' GLN . . . . . 0.522 ' HG2' ' O ' ' A' ' 548' ' ' MET . 2.3 mm-40 -66.91 70.32 0.08 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.249 0.547 . . . . 0.0 110.123 179.719 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 552' ' ' ASP . . . . . 0.555 ' HA ' ' HA ' ' A' ' 519' ' ' THR . 1.7 p30 -89.37 21.6 3.26 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.679 -179.46 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . 123.41 -32.82 4.19 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.885 -0.674 . . . . 0.0 111.592 -179.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 554' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -52.14 -58.06 7.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.498 0.665 . . . . 0.0 110.348 179.226 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 555' ' ' ILE . . . . . . . . . . . . . 3.7 mm -72.62 60.86 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 CA-C-N 114.808 -1.087 . . . . 0.0 110.942 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 556' ' ' CYS . . . . . . . . . . . . . 5.3 t -76.53 -7.78 55.86 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.373 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -74.0 -5.17 69.61 Favored Glycine 0 C--N 1.332 0.308 0 C-N-CA 120.641 -0.79 . . . . 0.0 113.013 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 558' ' ' LEU . . . . . . . . . . . . . 2.3 pp -58.72 -47.13 85.65 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.879 0.371 . . . . 0.0 111.133 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 559' ' ' ARG . . . . . 0.477 ' CB ' ' NE2' ' A' ' 560' ' ' GLN . 2.8 mmt85 63.87 171.25 0.17 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.232 179.832 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 560' ' ' GLN . . . . . 0.477 ' NE2' ' CB ' ' A' ' 559' ' ' ARG . 4.7 mp0 . . . . . 0 C--O 1.25 1.116 0 CA-C-O 118.247 -0.882 . . . . 0.0 111.325 179.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 507' ' ' ALA . . . . . 0.423 ' HB2' ' CA ' ' A' ' 559' ' ' ARG . . . . . . . . 0 N--CA 1.485 1.295 0 CA-C-O 121.083 0.468 . . . . 0.0 111.196 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 508' ' ' GLN . . . . . . . . . . . . . 7.3 mt-30 -129.02 77.39 77.99 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.507 179.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 509' ' ' PRO . . . . . 0.45 ' HB3' HD13 ' A' ' 558' ' ' LEU . 13.2 Cg_exo -69.79 -64.49 0.04 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.298 0 C-N-CA 122.734 2.289 . . . . 0.0 112.016 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 510' ' ' LYS . . . . . 0.439 ' HG3' ' N ' ' A' ' 511' ' ' CYS . 0.0 OUTLIER 178.65 -35.35 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.861 -179.914 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 511' ' ' CYS . . . . . 0.439 ' N ' ' HG3' ' A' ' 510' ' ' LYS . 0.1 OUTLIER 39.71 87.47 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.223 -0.899 . . . . 0.0 111.776 179.537 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 512' ' ' ASN . . . . . 0.4 ' O ' ' O ' ' A' ' 552' ' ' ASP . 0.9 OUTLIER -158.55 77.93 3.25 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.393 179.865 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 513' ' ' PRO . . . . . 0.511 ' HA ' ' O ' ' A' ' 552' ' ' ASP . 73.8 Cg_endo -76.67 19.14 0.66 Allowed 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 123.039 2.493 . . . . 0.0 113.462 -179.494 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 23.6 t30 -96.79 -34.56 11.26 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.642 0.258 . . . . 0.0 111.137 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 515' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -90.71 72.49 6.71 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.897 0.38 . . . . 0.0 111.085 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 516' ' ' HIS . . . . . 0.477 ' HA ' ' HB2' ' A' ' 552' ' ' ASP . 7.7 p80 -80.13 -7.25 58.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.751 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 517' ' ' TYR . . . . . . . . . . . . . 37.9 m-85 -69.55 -29.69 67.32 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 111.67 0.248 . . . . 0.0 111.67 -179.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 518' ' ' TRP . . . . . 0.482 ' O ' ' N ' ' A' ' 520' ' ' THR . 4.7 m-90 -118.03 -8.28 10.74 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -179.246 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 519' ' ' THR . . . . . 0.521 ' OG1' ' N ' ' A' ' 520' ' ' THR . 1.3 p 59.82 -76.53 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 120.475 0.179 . . . . 0.0 110.537 -179.725 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 520' ' ' THR . . . . . 0.521 ' N ' ' OG1' ' A' ' 519' ' ' THR . 1.0 OUTLIER 172.24 -62.7 0.01 OUTLIER 'General case' 0 C--O 1.232 0.147 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 179.146 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 521' ' ' GLN . . . . . . . . . . . . . 5.8 mt-30 -73.42 -12.01 60.66 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 177.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 522' ' ' ASP . . . . . 0.432 ' O ' HG23 ' A' ' 527' ' ' ILE . 9.6 m-20 -93.47 -11.12 32.81 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.684 178.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -45.51 -27.09 0.67 Allowed 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.539 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 524' ' ' GLY . . . . . 0.44 ' HA2' ' CG1' ' A' ' 527' ' ' ILE . . . 148.6 41.13 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.577 -0.82 . . . . 0.0 112.225 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -99.62 -59.95 1.62 Allowed 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 111.879 0.325 . . . . 0.0 111.879 -179.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -132.0 35.97 3.7 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.505 0.669 . . . . 0.0 110.135 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 527' ' ' ILE . . . . . 0.495 ' HA ' ' CB ' ' A' ' 544' ' ' ALA . 2.2 pp -95.85 -0.42 10.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 114.741 -1.118 . . . . 0.0 112.836 -178.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 528' ' ' GLY . . . . . . . . . . . . . . . -60.23 -8.82 9.55 Favored Glycine 0 CA--C 1.522 0.495 0 C-N-CA 120.907 -0.663 . . . . 0.0 114.146 -179.243 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 529' ' ' LEU . . . . . . . . . . . . . 2.0 pp -98.54 -35.0 10.37 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 117.819 0.809 . . . . 0.0 111.624 -179.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 530' ' ' ALA . . . . . 0.495 ' C ' ' H ' ' A' ' 532' ' ' ILE . . . -103.64 1.63 32.23 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -179.273 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 531' ' ' TRP . . . . . 0.423 ' HB3' ' O ' ' A' ' 527' ' ' ILE . 0.2 OUTLIER -70.4 30.71 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -178.853 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 532' ' ' ILE . . . . . 0.495 ' H ' ' C ' ' A' ' 530' ' ' ALA . 1.3 pt -156.68 78.92 3.89 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 120.665 0.269 . . . . 0.0 110.735 179.183 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 533' ' ' PRO . . . . . . . . . . . . . 99.9 Cg_exo -39.46 86.16 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 123.327 2.685 . . . . 0.0 113.212 -179.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 534' ' ' TYR . . . . . 0.463 ' N ' ' O ' ' A' ' 532' ' ' ILE . 1.7 t80 -96.61 -50.99 4.49 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.282 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -57.78 -34.95 70.12 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.459 -179.41 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 145.79 -63.98 0.45 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.563 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -59.94 -166.99 0.04 OUTLIER 'Trans proline' 0 CA--C 1.516 -0.393 0 C-N-CA 122.605 2.203 . . . . 0.0 111.833 179.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 538' ' ' ALA . . . . . 0.436 ' C ' ' H ' ' A' ' 540' ' ' GLU . . . -61.65 -52.82 62.75 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.114 179.606 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 539' ' ' ALA . . . . . 0.455 ' HA ' HD13 ' A' ' 542' ' ' ILE . . . 68.13 -47.01 0.53 Allowed 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.99 179.414 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 540' ' ' GLU . . . . . 0.436 ' H ' ' C ' ' A' ' 538' ' ' ALA . 0.8 OUTLIER -37.39 -28.15 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.126 -0.943 . . . . 0.0 112.366 -179.139 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 541' ' ' GLY . . . . . 0.453 ' HA3' ' CD2' ' A' ' 549' ' ' HIS . . . -127.63 -42.06 0.27 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.012 179.308 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 542' ' ' ILE . . . . . 0.455 HD13 ' HA ' ' A' ' 539' ' ' ALA . 0.8 OUTLIER -69.63 -26.31 30.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 -179.79 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 543' ' ' TYR . . . . . 0.435 ' CD1' HD12 ' A' ' 542' ' ' ILE . 1.8 m-85 -110.68 -10.19 14.49 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.054 0.454 . . . . 0.0 110.697 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 544' ' ' ALA . . . . . 0.495 ' CB ' ' HA ' ' A' ' 527' ' ' ILE . . . -97.9 -30.54 12.69 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.035 179.751 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 545' ' ' GLU . . . . . 0.475 ' HG3' ' H ' ' A' ' 548' ' ' MET . 6.3 tp10 -118.87 -32.81 4.39 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.475 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 35.56 40.13 0.28 Allowed Glycine 0 CA--C 1.52 0.399 0 CA-C-N 116.025 -0.534 . . . . 0.0 113.808 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 547' ' ' LEU . . . . . 0.441 ' HG ' ' N ' ' A' ' 548' ' ' MET . 0.0 OUTLIER -173.65 -61.41 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 117.498 0.649 . . . . 0.0 112.1 179.748 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 548' ' ' MET . . . . . 0.628 ' O ' ' HG3' ' A' ' 551' ' ' GLN . 0.0 OUTLIER -94.36 11.92 28.83 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.758 0.314 . . . . 0.0 111.133 179.674 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 549' ' ' HIS . . . . . 0.463 ' O ' ' CG2' ' A' ' 519' ' ' THR . 12.1 t-80 -64.41 -10.75 26.94 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 120.846 -0.342 . . . . 0.0 110.82 179.582 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 550' ' ' ASN . . . . . 0.501 ' O ' ' N ' ' A' ' 552' ' ' ASP . 41.9 m-20 -94.82 -34.8 12.34 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.875 0.695 . . . . 0.0 112.875 -178.557 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 551' ' ' GLN . . . . . 0.628 ' HG3' ' O ' ' A' ' 548' ' ' MET . 1.1 pp0? -62.34 68.12 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.112 0.482 . . . . 0.0 111.238 -179.451 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 552' ' ' ASP . . . . . 0.511 ' O ' ' HA ' ' A' ' 513' ' ' PRO . 1.7 p30 -94.83 20.93 8.09 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.284 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . 123.63 -31.04 4.72 Favored Glycine 0 N--CA 1.45 -0.399 0 N-CA-C 111.321 -0.711 . . . . 0.0 111.321 -179.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 554' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -55.9 -52.5 63.87 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.475 0.655 . . . . 0.0 110.037 179.066 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 555' ' ' ILE . . . . . 0.41 ' O ' ' CG2' ' A' ' 555' ' ' ILE . 5.2 mm -82.9 56.32 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 CA-C-N 114.884 -1.053 . . . . 0.0 110.53 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 556' ' ' CYS . . . . . 0.536 ' O ' ' HD2' ' A' ' 559' ' ' ARG . 17.6 t -77.93 -7.24 56.5 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.432 -179.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 557' ' ' GLY . . . . . 0.45 ' C ' ' H ' ' A' ' 559' ' ' ARG . . . -67.16 -2.36 18.37 Favored Glycine 0 CA--C 1.522 0.494 0 C-N-CA 121.208 -0.52 . . . . 0.0 113.814 -179.458 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 558' ' ' LEU . . . . . 0.45 HD13 ' HB3' ' A' ' 509' ' ' PRO . 3.8 pp -71.93 27.71 0.05 OUTLIER 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -179.664 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 559' ' ' ARG . . . . . 0.536 ' HD2' ' O ' ' A' ' 556' ' ' CYS . 1.8 mpt_? -61.15 -164.16 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.594 0.235 . . . . 0.0 110.482 179.718 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 560' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.227 -0.892 . . . . 0.0 111.052 -179.994 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 507' ' ' ALA . . . . . 0.4 ' CB ' ' CG ' ' A' ' 559' ' ' ARG . . . . . . . . 0 N--CA 1.486 1.354 0 CA-C-O 120.791 0.329 . . . . 0.0 111.129 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 508' ' ' GLN . . . . . . . . . . . . . 4.0 tm0? -128.45 77.7 76.81 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.962 179.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 509' ' ' PRO . . . . . 0.458 ' O ' ' CG ' ' A' ' 510' ' ' LYS . 90.2 Cg_endo -78.77 -19.99 10.78 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.548 2.165 . . . . 0.0 112.509 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 510' ' ' LYS . . . . . 0.458 ' CG ' ' O ' ' A' ' 509' ' ' PRO . 0.0 OUTLIER 91.5 -29.11 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 123.182 0.593 . . . . 0.0 111.077 -179.797 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 511' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 52.03 103.81 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.73 179.166 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 512' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -140.13 73.75 31.58 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.39 179.324 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 513' ' ' PRO . . . . . 0.465 ' HA ' ' O ' ' A' ' 552' ' ' ASP . 31.3 Cg_exo -60.96 -14.73 34.5 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.899 2.399 . . . . 0.0 112.625 -179.612 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -69.42 -43.36 73.53 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.474 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 515' ' ' LEU . . . . . . . . . . . . . 53.1 mt -66.53 76.33 0.1 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.88 0.371 . . . . 0.0 111.076 -179.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 516' ' ' HIS . . . . . 0.55 ' HA ' ' HB3' ' A' ' 552' ' ' ASP . 0.2 OUTLIER -84.55 -7.16 59.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.722 -179.857 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 517' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -79.11 -61.82 1.89 Allowed 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -179.199 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 518' ' ' TRP . . . . . 0.488 ' O ' ' N ' ' A' ' 520' ' ' THR . 4.1 m-90 -87.13 -3.91 59.1 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -178.696 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 519' ' ' THR . . . . . 0.506 ' OG1' ' N ' ' A' ' 520' ' ' THR . 3.0 p 59.66 -76.49 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.391 0.139 . . . . 0.0 110.704 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 520' ' ' THR . . . . . 0.506 ' N ' ' OG1' ' A' ' 519' ' ' THR . 1.0 OUTLIER 173.04 -62.59 0.01 OUTLIER 'General case' 0 CA--C 1.521 -0.17 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 179.367 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 521' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -73.32 -12.75 60.95 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.426 178.189 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 522' ' ' ASP . . . . . 0.419 ' HB2' ' O ' ' A' ' 518' ' ' TRP . 2.5 m-20 -93.91 -11.09 31.78 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.832 179.025 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -45.57 -28.01 0.87 Allowed 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.514 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 524' ' ' GLY . . . . . 0.449 ' HA2' ' CG1' ' A' ' 527' ' ' ILE . . . 147.34 42.18 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.471 -0.871 . . . . 0.0 112.354 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -101.39 -58.6 1.85 Allowed 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -179.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -132.03 35.08 3.76 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-O 121.566 0.698 . . . . 0.0 110.161 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 527' ' ' ILE . . . . . 0.453 ' HA ' ' CB ' ' A' ' 544' ' ' ALA . 2.2 pp -95.65 -0.45 10.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 114.797 -1.092 . . . . 0.0 112.606 -178.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 528' ' ' GLY . . . . . . . . . . . . . . . -59.17 -7.65 5.43 Favored Glycine 0 CA--C 1.522 0.511 0 C-N-CA 121.018 -0.61 . . . . 0.0 114.256 -179.244 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 529' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -97.77 -35.9 10.39 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 117.772 0.786 . . . . 0.0 111.36 -179.584 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 530' ' ' ALA . . . . . 0.529 ' C ' ' H ' ' A' ' 532' ' ' ILE . . . -103.76 1.97 32.34 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -179.392 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 531' ' ' TRP . . . . . 0.438 ' HA ' ' HG2' ' A' ' 540' ' ' GLU . 9.9 t90 -67.41 30.24 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 -178.8 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 532' ' ' ILE . . . . . 0.529 ' H ' ' C ' ' A' ' 530' ' ' ALA . 1.1 pt -159.31 72.77 3.42 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-O 120.843 0.354 . . . . 0.0 110.403 179.012 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 533' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_endo -49.74 86.38 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 123.129 2.552 . . . . 0.0 112.692 -179.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 534' ' ' TYR . . . . . 0.411 ' N ' ' O ' ' A' ' 532' ' ' ILE . 20.8 t80 -96.55 -29.76 13.69 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.156 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -71.14 -34.86 71.4 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.542 -179.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 152.51 -66.13 0.34 Allowed Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.579 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -58.06 -162.67 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.612 2.208 . . . . 0.0 111.608 179.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 538' ' ' ALA . . . . . . . . . . . . . . . -76.5 -46.21 27.66 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.645 179.673 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 539' ' ' ALA . . . . . 0.472 ' HA ' ' HB2' ' A' ' 543' ' ' TYR . . . 70.56 -51.15 0.67 Allowed 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.264 0.554 . . . . 0.0 111.46 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 540' ' ' GLU . . . . . 0.438 ' HG2' ' HA ' ' A' ' 531' ' ' TRP . 7.1 mt-10 -37.38 -28.71 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.85 -1.068 . . . . 0.0 112.347 -179.371 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 541' ' ' GLY . . . . . 0.405 ' O ' ' HB3' ' A' ' 545' ' ' GLU . . . -128.19 -38.07 0.4 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.746 179.59 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 542' ' ' ILE . . . . . 0.457 ' CD1' ' HA ' ' A' ' 539' ' ' ALA . 2.5 pp -78.86 -25.57 13.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -179.19 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 543' ' ' TYR . . . . . 0.472 ' HB2' ' HA ' ' A' ' 539' ' ' ALA . 0.4 OUTLIER -114.58 -6.86 12.8 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.896 0.379 . . . . 0.0 110.73 179.568 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 544' ' ' ALA . . . . . 0.457 ' CB ' ' HB2' ' A' ' 530' ' ' ALA . . . -99.9 -29.99 12.27 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.953 179.206 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 545' ' ' GLU . . . . . 0.513 ' HG3' ' H ' ' A' ' 548' ' ' MET . 6.2 tp10 -118.61 -32.92 4.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.474 -179.737 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 35.2 43.14 0.45 Allowed Glycine 0 CA--C 1.519 0.339 0 CA-C-N 115.923 -0.58 . . . . 0.0 114.295 179.443 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 547' ' ' LEU . . . . . 0.485 ' HG ' ' N ' ' A' ' 548' ' ' MET . 0.0 OUTLIER -178.7 -61.27 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 117.753 0.776 . . . . 0.0 112.006 179.683 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 548' ' ' MET . . . . . 0.556 ' O ' ' HG2' ' A' ' 551' ' ' GLN . 0.0 OUTLIER -89.96 12.12 18.48 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.854 0.359 . . . . 0.0 111.031 179.669 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 549' ' ' HIS . . . . . 0.494 ' O ' ' CG2' ' A' ' 519' ' ' THR . 75.7 t60 -64.81 -11.21 34.52 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.832 0.349 . . . . 0.0 110.75 179.558 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 550' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -94.24 -17.62 22.49 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.43 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 551' ' ' GLN . . . . . 0.556 ' HG2' ' O ' ' A' ' 548' ' ' MET . 0.9 OUTLIER -70.46 65.82 0.3 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.162 0.506 . . . . 0.0 110.364 179.667 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 552' ' ' ASP . . . . . 0.55 ' HB3' ' HA ' ' A' ' 516' ' ' HIS . 4.3 m-20 -91.37 21.75 4.31 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.35 -179.717 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . 117.33 -35.28 4.19 Favored Glycine 0 N--CA 1.45 -0.413 0 N-CA-C 111.332 -0.707 . . . . 0.0 111.332 -179.336 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 554' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -56.23 -59.23 5.24 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.524 0.678 . . . . 0.0 109.844 178.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 555' ' ' ILE . . . . . . . . . . . . . 3.9 mm -73.46 62.33 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 CA-C-N 114.705 -1.134 . . . . 0.0 110.657 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 556' ' ' CYS . . . . . 0.414 ' O ' ' HD2' ' A' ' 559' ' ' ARG . 0.1 OUTLIER -68.2 -9.74 49.27 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.647 -179.727 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -57.55 -18.1 29.08 Favored Glycine 0 C--N 1.332 0.348 0 C-N-CA 120.623 -0.799 . . . . 0.0 113.005 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 558' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -50.62 -56.56 11.24 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.825 0.345 . . . . 0.0 111.8 -179.743 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 559' ' ' ARG . . . . . 0.414 ' HD2' ' O ' ' A' ' 556' ' ' CYS . 4.2 mpt_? 56.86 -168.47 0.11 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.922 -179.568 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 560' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.094 0 CA-C-O 118.253 -0.88 . . . . 0.0 111.169 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.323 0 CA-C-O 120.79 0.328 . . . . 0.0 111.211 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 508' ' ' GLN . . . . . . . . . . . . . 22.1 mt-30 -128.41 77.4 77.19 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.672 179.324 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 509' ' ' PRO . . . . . 0.449 ' O ' ' N ' ' A' ' 511' ' ' CYS . 98.5 Cg_endo -85.51 63.26 5.72 Favored 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 122.746 2.297 . . . . 0.0 112.75 -179.734 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 510' ' ' LYS . . . . . 0.437 ' HG3' ' C ' ' A' ' 509' ' ' PRO . 0.0 OUTLIER 24.03 -88.36 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 115.947 -0.57 . . . . 0.0 112.366 179.367 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 511' ' ' CYS . . . . . 0.449 ' N ' ' O ' ' A' ' 509' ' ' PRO . 0.0 OUTLIER 75.3 62.11 0.06 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.986 179.61 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 512' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -140.21 83.34 15.76 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.07 179.383 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 513' ' ' PRO . . . . . 0.456 ' HA ' ' O ' ' A' ' 552' ' ' ASP . 74.2 Cg_endo -76.9 21.94 0.57 Allowed 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.932 2.422 . . . . 0.0 113.246 -179.278 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 20.0 t30 -96.83 -46.21 6.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.691 0.281 . . . . 0.0 110.687 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 515' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -72.18 75.57 0.97 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.925 0.393 . . . . 0.0 110.799 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 516' ' ' HIS . . . . . 0.448 ' HA ' ' HB3' ' A' ' 552' ' ' ASP . 0.1 OUTLIER -73.67 -7.41 51.92 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.786 -179.785 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 517' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -88.72 -48.48 7.49 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.716 0.293 . . . . 0.0 111.711 -179.469 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 518' ' ' TRP . . . . . 0.484 ' O ' ' N ' ' A' ' 520' ' ' THR . 3.7 m-90 -84.07 -8.4 59.12 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 -179.32 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 519' ' ' THR . . . . . 0.549 ' OG1' ' N ' ' A' ' 520' ' ' THR . 2.7 p 59.34 -78.56 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 120.581 0.229 . . . . 0.0 110.469 -179.763 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 520' ' ' THR . . . . . 0.549 ' N ' ' OG1' ' A' ' 519' ' ' THR . 1.2 m 172.73 -62.78 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 179.083 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 521' ' ' GLN . . . . . . . . . . . . . 5.3 mt-30 -74.98 -12.03 60.24 Favored 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 177.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 522' ' ' ASP . . . . . 0.414 ' O ' HG21 ' A' ' 527' ' ' ILE . 1.9 m-20 -93.99 -10.95 31.94 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.541 178.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -45.33 -27.51 0.68 Allowed 'General case' 0 C--O 1.232 0.158 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.552 -179.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 524' ' ' GLY . . . . . 0.429 ' HA2' ' CG1' ' A' ' 527' ' ' ILE . . . 146.35 42.29 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.566 -0.826 . . . . 0.0 112.306 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -101.32 -59.27 1.73 Allowed 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 111.917 0.34 . . . . 0.0 111.917 -179.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -132.25 35.97 3.65 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-O 121.512 0.673 . . . . 0.0 110.146 179.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 527' ' ' ILE . . . . . 0.455 ' HA ' ' CB ' ' A' ' 544' ' ' ALA . 2.2 pp -95.7 -0.64 10.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 114.769 -1.105 . . . . 0.0 112.701 -178.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 528' ' ' GLY . . . . . . . . . . . . . . . -62.08 -8.11 15.84 Favored Glycine 0 CA--C 1.521 0.414 0 C-N-CA 120.939 -0.648 . . . . 0.0 114.035 -179.229 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 529' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -98.32 -35.62 10.26 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 117.587 0.693 . . . . 0.0 111.556 -179.574 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 530' ' ' ALA . . . . . 0.424 ' HB1' ' CB ' ' A' ' 544' ' ' ALA . . . -103.66 -1.08 28.67 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -179.118 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 531' ' ' TRP . . . . . 0.448 ' HB2' ' O ' ' A' ' 527' ' ' ILE . 14.5 t-105 -56.09 -12.3 1.44 Allowed 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 112.039 0.385 . . . . 0.0 112.039 -179.187 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 532' ' ' ILE . . . . . 0.408 ' O ' ' CD1' ' A' ' 532' ' ' ILE . 1.6 pp -130.13 75.65 79.05 Favored Pre-proline 0 N--CA 1.451 -0.421 0 CA-C-O 121.005 0.431 . . . . 0.0 111.132 179.727 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 533' ' ' PRO . . . . . 0.401 ' HB3' ' O ' ' A' ' 538' ' ' ALA . 3.9 Cg_endo -46.95 92.25 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 123.169 2.579 . . . . 0.0 112.672 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 534' ' ' TYR . . . . . . . . . . . . . 46.9 p90 -96.18 -22.82 17.05 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.127 179.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -73.98 -34.86 64.39 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.303 -179.685 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 150.25 -64.28 0.39 Allowed Glycine 0 CA--C 1.519 0.332 0 C-N-CA 120.491 -0.862 . . . . 0.0 112.833 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -59.92 -164.17 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.651 2.234 . . . . 0.0 112.097 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 538' ' ' ALA . . . . . 0.401 ' O ' ' HB3' ' A' ' 533' ' ' PRO . . . -70.41 -46.53 63.79 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.678 179.753 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 539' ' ' ALA . . . . . 0.57 ' HA ' ' HB2' ' A' ' 543' ' ' TYR . . . 70.68 -52.35 0.67 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.212 0.53 . . . . 0.0 111.709 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 540' ' ' GLU . . . . . 0.435 ' HG2' ' HA ' ' A' ' 531' ' ' TRP . 13.0 mt-10 -37.21 -28.07 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.831 -1.077 . . . . 0.0 112.427 -179.231 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 541' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' A' ' 539' ' ' ALA . . . -126.79 -41.65 0.3 Allowed Glycine 0 CA--C 1.52 0.347 0 C-N-CA 120.505 -0.855 . . . . 0.0 112.338 179.206 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 542' ' ' ILE . . . . . 0.475 ' CD1' ' HA ' ' A' ' 539' ' ' ALA . 2.5 pp -75.8 -25.55 17.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -179.377 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 543' ' ' TYR . . . . . 0.57 ' HB2' ' HA ' ' A' ' 539' ' ' ALA . 0.2 OUTLIER -115.65 -5.66 12.16 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.862 0.363 . . . . 0.0 110.948 179.839 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 544' ' ' ALA . . . . . 0.455 ' CB ' ' HA ' ' A' ' 527' ' ' ILE . . . -102.78 -32.66 9.71 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.783 179.216 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 545' ' ' GLU . . . . . 0.48 ' HG3' ' H ' ' A' ' 548' ' ' MET . 50.3 tp10 -118.53 -32.85 4.48 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.301 179.834 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 35.55 39.35 0.23 Allowed Glycine 0 CA--C 1.519 0.337 0 CA-C-N 115.583 -0.735 . . . . 0.0 114.176 179.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 547' ' ' LEU . . . . . 0.446 ' HG ' ' N ' ' A' ' 548' ' ' MET . 0.0 OUTLIER -173.9 -61.8 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 117.756 0.778 . . . . 0.0 112.621 179.517 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 548' ' ' MET . . . . . 0.48 ' H ' ' HG3' ' A' ' 545' ' ' GLU . 0.0 OUTLIER -96.22 11.48 34.32 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.68 0.276 . . . . 0.0 111.339 179.96 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 549' ' ' HIS . . . . . 0.466 ' O ' ' CG2' ' A' ' 519' ' ' THR . 2.4 p-80 -62.29 -11.32 14.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.824 0.345 . . . . 0.0 110.804 179.221 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 550' ' ' ASN . . . . . 0.441 ' O ' ' N ' ' A' ' 552' ' ' ASP . 26.2 t-20 -95.1 -32.06 13.27 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -179.212 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 551' ' ' GLN . . . . . 0.447 ' HG2' ' CG ' ' A' ' 548' ' ' MET . 1.6 pt20 -64.99 74.44 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.421 0.629 . . . . 0.0 110.576 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 552' ' ' ASP . . . . . 0.544 ' HA ' ' HA ' ' A' ' 519' ' ' THR . 15.6 m-20 -78.61 19.12 0.51 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.583 -0.735 . . . . 0.0 112.023 -179.544 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . 123.61 -31.05 4.72 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.785 -0.721 . . . . 0.0 111.817 -179.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 554' ' ' LEU . . . . . . . . . . . . . 1.5 mp -53.02 -56.56 15.17 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.485 0.66 . . . . 0.0 110.592 179.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 555' ' ' ILE . . . . . . . . . . . . . 2.3 mm -69.57 66.27 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 114.785 -1.098 . . . . 0.0 110.614 -179.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 556' ' ' CYS . . . . . . . . . . . . . 7.9 t -73.84 -7.3 51.69 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.461 -0.79 . . . . 0.0 111.649 -179.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -62.51 -2.17 4.11 Favored Glycine 0 CA--C 1.524 0.612 0 C-N-CA 121.221 -0.514 . . . . 0.0 113.87 -179.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 558' ' ' LEU . . . . . 0.407 ' CD2' ' CE ' ' A' ' 510' ' ' LYS . 4.1 pp -76.37 27.97 0.12 Allowed 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 -179.158 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 559' ' ' ARG . . . . . 0.417 ' HB3' ' HB3' ' A' ' 509' ' ' PRO . 0.0 OUTLIER -79.79 169.97 17.18 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.83 0.348 . . . . 0.0 110.82 179.682 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 560' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.215 -0.898 . . . . 0.0 110.88 179.973 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 507' ' ' ALA . . . . . 0.467 ' O ' ' HA ' ' A' ' 559' ' ' ARG . . . . . . . . 0 N--CA 1.482 1.173 0 CA-C-O 121.368 0.604 . . . . 0.0 111.408 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 508' ' ' GLN . . . . . . . . . . . . . 3.7 mp0 -128.42 80.13 72.97 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.291 179.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 509' ' ' PRO . . . . . 0.491 ' O ' ' HB3' ' A' ' 510' ' ' LYS . 11.0 Cg_endo -55.42 -66.9 0.08 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.223 0 C-N-CA 122.622 2.215 . . . . 0.0 112.137 -179.802 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 510' ' ' LYS . . . . . 0.491 ' HB3' ' O ' ' A' ' 509' ' ' PRO . 0.0 OUTLIER 171.52 -31.39 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.461 -0.791 . . . . 0.0 110.338 -179.857 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 511' ' ' CYS . . . . . 0.458 ' N ' ' HG2' ' A' ' 510' ' ' LYS . 28.9 t 51.16 68.62 0.76 Allowed 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.688 179.381 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 512' ' ' ASN . . . . . 0.424 ' C ' ' HA3' ' A' ' 553' ' ' GLY . 87.4 m-20 -111.07 81.22 2.63 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.871 179.113 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 513' ' ' PRO . . . . . 0.516 ' HA ' ' O ' ' A' ' 552' ' ' ASP . 55.5 Cg_endo -71.79 11.9 0.62 Allowed 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 122.839 2.36 . . . . 0.0 113.276 -179.275 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 -96.62 -15.99 21.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.663 0.268 . . . . 0.0 110.969 179.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 515' ' ' LEU . . . . . . . . . . . . . 1.4 mp -94.46 73.94 3.82 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.894 0.378 . . . . 0.0 110.943 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 516' ' ' HIS . . . . . 0.439 ' HA ' ' HB3' ' A' ' 552' ' ' ASP . 0.2 OUTLIER -80.59 -7.09 59.14 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.872 -179.774 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 517' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -72.17 -66.08 0.69 Allowed 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -179.088 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 518' ' ' TRP . . . . . 0.48 ' O ' ' N ' ' A' ' 520' ' ' THR . 12.0 m-90 -93.32 0.51 56.97 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.489 0.552 . . . . 0.0 112.489 -178.737 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 519' ' ' THR . . . . . 0.512 HG23 ' HA ' ' A' ' 549' ' ' HIS . 2.8 p 60.56 -75.19 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 110.627 -0.138 . . . . 0.0 110.627 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 520' ' ' THR . . . . . 0.48 ' N ' ' O ' ' A' ' 518' ' ' TRP . 1.0 OUTLIER 172.27 -62.95 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.241 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 179.155 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 521' ' ' GLN . . . . . 0.405 ' NE2' HG22 ' A' ' 520' ' ' THR . 0.7 OUTLIER -68.33 -15.43 63.56 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 178.245 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 522' ' ' ASP . . . . . 0.413 ' HB2' ' O ' ' A' ' 518' ' ' TRP . 2.8 m-20 -94.19 -11.93 29.34 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 115.668 -0.697 . . . . 0.0 111.273 179.563 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -51.98 -31.73 30.55 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-O 121.069 0.462 . . . . 0.0 110.846 179.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . 162.89 40.29 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.471 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.02 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -133.02 -32.17 1.23 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.632 0.253 . . . . 0.0 111.592 -179.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -137.84 56.52 1.75 Allowed 'General case' 0 CA--C 1.515 -0.373 0 CA-C-O 121.393 0.615 . . . . 0.0 110.306 179.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 527' ' ' ILE . . . . . 0.439 ' CD1' ' N ' ' A' ' 528' ' ' GLY . 1.4 pp -95.31 -18.55 6.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.721 -179.511 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 528' ' ' GLY . . . . . 0.439 ' N ' ' CD1' ' A' ' 527' ' ' ILE . . . 26.79 -144.92 0.01 OUTLIER Glycine 0 C--N 1.336 0.559 0 N-CA-C 114.716 0.647 . . . . 0.0 114.716 179.171 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 529' ' ' LEU . . . . . 0.415 HD11 ' N ' ' A' ' 530' ' ' ALA . 0.2 OUTLIER -63.55 -17.59 62.96 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.426 -0.387 . . . . 0.0 111.715 -179.624 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 530' ' ' ALA . . . . . 0.487 ' C ' ' H ' ' A' ' 532' ' ' ILE . . . -81.58 1.99 31.23 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -179.361 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 531' ' ' TRP . . . . . 0.448 ' HA ' ' HG2' ' A' ' 540' ' ' GLU . 0.1 OUTLIER -72.18 27.38 0.05 Allowed 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -179.15 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 532' ' ' ILE . . . . . 0.487 ' H ' ' C ' ' A' ' 530' ' ' ALA . 1.1 pp -159.03 72.16 3.54 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-O 120.793 0.33 . . . . 0.0 110.541 179.074 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 533' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_endo -49.62 88.34 0.02 OUTLIER 'Trans proline' 0 C--N 1.343 0.243 0 C-N-CA 123.08 2.52 . . . . 0.0 112.625 -179.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 534' ' ' TYR . . . . . . . . . . . . . 65.3 t80 -96.46 -28.37 14.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.273 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -72.59 -35.03 67.81 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.503 -179.452 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 151.99 -65.03 0.36 Allowed Glycine 0 N--CA 1.453 -0.208 0 C-N-CA 120.496 -0.859 . . . . 0.0 112.547 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_endo -57.38 -163.27 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.636 2.224 . . . . 0.0 111.718 179.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 538' ' ' ALA . . . . . . . . . . . . . . . -76.81 -46.62 24.24 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.512 179.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 539' ' ' ALA . . . . . 0.549 ' HA ' ' CD1' ' A' ' 542' ' ' ILE . . . 70.79 -52.4 0.67 Allowed 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 121.336 0.589 . . . . 0.0 111.545 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 540' ' ' GLU . . . . . 0.448 ' HG2' ' HA ' ' A' ' 531' ' ' TRP . 10.2 mt-10 -36.8 -30.85 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.797 -1.092 . . . . 0.0 112.43 -179.143 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 541' ' ' GLY . . . . . . . . . . . . . . . -126.79 -22.29 1.63 Allowed Glycine 0 CA--C 1.518 0.274 0 C-N-CA 120.35 -0.928 . . . . 0.0 113.355 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 542' ' ' ILE . . . . . 0.549 ' CD1' ' HA ' ' A' ' 539' ' ' ALA . 2.6 pp -96.4 -18.85 6.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 -179.133 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 543' ' ' TYR . . . . . 0.473 ' HB2' ' HA ' ' A' ' 539' ' ' ALA . 0.4 OUTLIER -114.21 -11.81 12.57 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.808 179.58 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 544' ' ' ALA . . . . . 0.45 ' CB ' ' CB ' ' A' ' 530' ' ' ALA . . . -103.36 -36.23 8.1 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 121.336 0.589 . . . . 0.0 110.635 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 545' ' ' GLU . . . . . 0.616 ' HG2' ' HB2' ' A' ' 548' ' ' MET . 2.9 tp10 -118.51 -32.7 4.52 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.218 -0.901 . . . . 0.0 111.452 -179.243 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 37.99 51.22 2.11 Favored Glycine 0 C--N 1.332 0.308 0 C-N-CA 121.259 -0.496 . . . . 0.0 112.664 -179.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 547' ' ' LEU . . . . . 0.53 ' HG ' ' N ' ' A' ' 548' ' ' MET . 0.3 OUTLIER -172.78 -46.19 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 120.9 -0.32 . . . . 0.0 111.618 -179.292 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 548' ' ' MET . . . . . 0.616 ' HB2' ' HG2' ' A' ' 545' ' ' GLU . 0.0 OUTLIER -96.58 11.61 34.61 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.811 0.338 . . . . 0.0 111.0 179.285 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 549' ' ' HIS . . . . . 0.512 ' HA ' HG23 ' A' ' 519' ' ' THR . 11.4 p-80 -69.05 -11.21 60.58 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.008 0.432 . . . . 0.0 110.405 179.528 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 550' ' ' ASN . . . . . . . . . . . . . 35.2 t30 -95.93 -17.63 20.9 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.817 -179.391 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 551' ' ' GLN . . . . . 0.488 ' HG2' ' O ' ' A' ' 548' ' ' MET . 7.8 mm-40 -69.23 62.76 0.14 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.964 0.411 . . . . 0.0 110.569 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 552' ' ' ASP . . . . . 0.516 ' O ' ' HA ' ' A' ' 513' ' ' PRO . 2.8 m-20 -94.12 21.74 6.54 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.18 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 553' ' ' GLY . . . . . 0.424 ' HA3' ' C ' ' A' ' 512' ' ' ASN . . . 115.26 -33.98 5.03 Favored Glycine 0 N--CA 1.448 -0.564 0 N-CA-C 111.212 -0.755 . . . . 0.0 111.212 -179.242 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 554' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -53.37 -50.82 64.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.592 0.711 . . . . 0.0 110.177 178.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 555' ' ' ILE . . . . . 0.432 ' O ' ' CG2' ' A' ' 555' ' ' ILE . 4.1 mm -81.1 54.76 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 114.73 -1.123 . . . . 0.0 110.91 -179.743 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 556' ' ' CYS . . . . . 0.521 ' O ' ' HD2' ' A' ' 559' ' ' ARG . 29.1 p -97.11 -7.24 33.12 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.03 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 557' ' ' GLY . . . . . 0.456 ' C ' ' H ' ' A' ' 559' ' ' ARG . . . -58.09 -2.16 0.86 Allowed Glycine 0 CA--C 1.522 0.528 0 C-N-CA 121.228 -0.511 . . . . 0.0 114.164 -179.315 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 558' ' ' LEU . . . . . . . . . . . . . 3.6 pp -68.82 27.71 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -179.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 559' ' ' ARG . . . . . 0.521 ' HD2' ' O ' ' A' ' 556' ' ' CYS . 0.0 OUTLIER -76.36 -167.47 0.79 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.82 0.343 . . . . 0.0 110.394 179.431 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 560' ' ' GLN . . . . . . . . . . . . . 7.7 mt-30 . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.318 -0.848 . . . . 0.0 110.936 179.938 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 507' ' ' ALA . . . . . 0.456 ' HB2' ' HB3' ' A' ' 559' ' ' ARG . . . . . . . . 0 N--CA 1.486 1.365 0 CA-C-O 120.854 0.359 . . . . 0.0 111.236 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 508' ' ' GLN . . . . . . . . . . . . . 63.9 mm-40 -128.55 76.76 78.21 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.702 178.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 509' ' ' PRO . . . . . 0.438 ' HG3' ' HA ' ' A' ' 559' ' ' ARG . 13.5 Cg_exo -69.91 -65.39 0.04 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.246 0 C-N-CA 122.816 2.344 . . . . 0.0 111.732 179.662 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 510' ' ' LYS . . . . . 0.474 ' HG2' ' N ' ' A' ' 511' ' ' CYS . 0.0 OUTLIER 177.95 -34.72 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.432 179.785 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 511' ' ' CYS . . . . . 0.474 ' N ' ' HG2' ' A' ' 510' ' ' LYS . 0.5 OUTLIER 43.47 59.2 3.12 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.131 -0.941 . . . . 0.0 111.597 179.535 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 512' ' ' ASN . . . . . 0.471 ' O ' ' O ' ' A' ' 552' ' ' ASP . 24.7 p30 -127.0 83.37 66.16 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.177 179.466 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 513' ' ' PRO . . . . . 0.422 ' HA ' ' O ' ' A' ' 552' ' ' ASP . 74.2 Cg_endo -76.17 22.1 0.51 Allowed 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 123.023 2.482 . . . . 0.0 113.27 -179.59 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -96.68 -26.02 15.34 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.811 0.339 . . . . 0.0 110.609 179.553 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 515' ' ' LEU . . . . . . . . . . . . . 31.7 mt -95.55 71.91 3.14 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.885 179.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 516' ' ' HIS . . . . . 0.457 ' HA ' ' CB ' ' A' ' 552' ' ' ASP . 6.2 p-80 -73.61 -7.35 51.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.721 -179.821 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 517' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -72.54 -59.74 2.57 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 111.903 0.334 . . . . 0.0 111.903 -179.435 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 518' ' ' TRP . . . . . 0.462 ' O ' ' N ' ' A' ' 520' ' ' THR . 0.7 OUTLIER -80.07 -22.39 42.31 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.06 0.392 . . . . 0.0 112.06 -178.837 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 519' ' ' THR . . . . . 0.539 ' OG1' ' N ' ' A' ' 520' ' ' THR . 3.4 p 57.42 -81.29 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.459 0.171 . . . . 0.0 110.741 -179.728 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 520' ' ' THR . . . . . 0.539 ' N ' ' OG1' ' A' ' 519' ' ' THR . 1.1 m 176.19 -62.58 0.01 OUTLIER 'General case' 0 CA--C 1.52 -0.174 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 179.517 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 521' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -72.07 -11.97 61.0 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.346 177.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 522' ' ' ASP . . . . . 0.425 ' O ' HG21 ' A' ' 527' ' ' ILE . 62.0 m-20 -93.49 -11.09 32.81 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.803 179.093 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 523' ' ' GLU . . . . . 0.456 ' HA ' ' CD1' ' A' ' 518' ' ' TRP . 0.1 OUTLIER -45.59 -27.92 0.86 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.698 -179.738 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 524' ' ' GLY . . . . . 0.447 ' HA2' ' CG1' ' A' ' 527' ' ' ILE . . . 150.52 40.04 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.343 -0.932 . . . . 0.0 112.439 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -97.91 -60.5 1.55 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.72 0.295 . . . . 0.0 111.589 -179.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -133.86 36.98 3.27 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-O 121.645 0.736 . . . . 0.0 110.33 179.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 527' ' ' ILE . . . . . 0.493 ' HA ' ' CB ' ' A' ' 544' ' ' ALA . 1.6 pp -96.13 -0.72 10.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 114.676 -1.147 . . . . 0.0 112.956 -178.795 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 528' ' ' GLY . . . . . . . . . . . . . . . -55.19 -14.75 6.4 Favored Glycine 0 CA--C 1.521 0.455 0 C-N-CA 120.845 -0.693 . . . . 0.0 114.0 -179.342 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 529' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -98.73 -38.38 9.11 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 117.756 0.778 . . . . 0.0 112.303 -179.266 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 530' ' ' ALA . . . . . 0.499 ' C ' ' H ' ' A' ' 532' ' ' ILE . . . -103.68 1.71 32.25 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 -178.492 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 531' ' ' TRP . . . . . 0.466 ' HB3' ' O ' ' A' ' 527' ' ' ILE . 0.2 OUTLIER -71.31 30.46 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 112.405 0.521 . . . . 0.0 112.405 -178.896 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 532' ' ' ILE . . . . . 0.499 ' H ' ' C ' ' A' ' 530' ' ' ALA . 1.1 pt -159.04 73.24 3.52 Favored Pre-proline 0 N--CA 1.454 -0.256 0 CA-C-O 120.734 0.302 . . . . 0.0 110.403 179.031 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 533' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -50.74 84.95 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 123.071 2.514 . . . . 0.0 112.683 -179.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 534' ' ' TYR . . . . . 0.42 ' N ' ' O ' ' A' ' 532' ' ' ILE . 0.2 OUTLIER -96.48 -31.58 12.73 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.975 179.788 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -68.06 -34.94 77.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.333 -179.512 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 148.85 -63.9 0.41 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.651 -179.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -59.22 -165.98 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.639 2.226 . . . . 0.0 111.984 179.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 538' ' ' ALA . . . . . . . . . . . . . . . -71.54 -49.79 37.44 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.508 179.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 539' ' ' ALA . . . . . 0.509 ' HA ' ' CD1' ' A' ' 542' ' ' ILE . . . 69.14 -53.05 0.59 Allowed 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 121.206 0.527 . . . . 0.0 111.688 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 540' ' ' GLU . . . . . 0.433 ' HG2' ' HA ' ' A' ' 531' ' ' TRP . 0.8 OUTLIER -37.3 -30.2 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.942 -1.026 . . . . 0.0 112.234 -179.286 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 541' ' ' GLY . . . . . . . . . . . . . . . -126.05 -30.27 0.88 Allowed Glycine 0 N--CA 1.453 -0.223 0 C-N-CA 120.479 -0.867 . . . . 0.0 113.216 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 542' ' ' ILE . . . . . 0.509 ' CD1' ' HA ' ' A' ' 539' ' ' ALA . 2.6 pp -87.89 -21.84 6.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 112.0 0.37 . . . . 0.0 112.0 -179.371 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 543' ' ' TYR . . . . . 0.468 ' CD2' ' CD1' ' A' ' 542' ' ' ILE . 6.1 m-85 -113.54 -10.19 13.19 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 120.812 0.339 . . . . 0.0 110.637 179.259 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 544' ' ' ALA . . . . . 0.493 ' CB ' ' HA ' ' A' ' 527' ' ' ILE . . . -103.35 -37.58 7.58 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 121.213 0.53 . . . . 0.0 110.198 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 545' ' ' GLU . . . . . 0.515 ' HG3' ' H ' ' A' ' 548' ' ' MET . 5.5 tp10 -118.73 -32.69 4.46 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.489 -179.088 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 37.72 45.39 1.48 Allowed Glycine 0 CA--C 1.52 0.398 0 CA-C-N 115.999 -0.546 . . . . 0.0 114.038 179.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 547' ' ' LEU . . . . . 0.46 ' HG ' ' N ' ' A' ' 548' ' ' MET . 0.0 OUTLIER -178.59 -61.26 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 117.594 0.697 . . . . 0.0 112.03 179.479 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 548' ' ' MET . . . . . 0.555 ' O ' ' HG2' ' A' ' 551' ' ' GLN . 0.0 OUTLIER -90.63 12.06 20.11 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.715 0.293 . . . . 0.0 111.345 179.923 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 549' ' ' HIS . . . . . 0.5 ' O ' ' CG2' ' A' ' 519' ' ' THR . 12.7 t60 -65.51 -11.11 40.49 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.744 -0.383 . . . . 0.0 110.462 179.482 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 550' ' ' ASN . . . . . . . . . . . . . 22.8 m-80 -93.7 -12.59 28.93 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.965 -0.294 . . . . 0.0 111.456 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 551' ' ' GLN . . . . . 0.555 ' HG2' ' O ' ' A' ' 548' ' ' MET . 2.9 mm100 -73.47 59.2 0.6 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.913 0.387 . . . . 0.0 110.35 179.536 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 552' ' ' ASP . . . . . 0.471 ' O ' ' O ' ' A' ' 512' ' ' ASN . 2.8 p30 -98.78 22.04 10.62 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.188 -179.591 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . 123.74 -31.86 4.43 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.819 -0.705 . . . . 0.0 111.487 -179.238 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 554' ' ' LEU . . . . . . . . . . . . . 1.4 mt -55.01 -56.12 23.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.382 0.61 . . . . 0.0 110.183 179.121 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 555' ' ' ILE . . . . . . . . . . . . . 5.5 mm -79.23 60.01 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.997 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 556' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -63.98 -13.69 48.21 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.376 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 557' ' ' GLY . . . . . 0.414 ' O ' ' HG2' ' A' ' 559' ' ' ARG . . . -59.47 -15.11 30.68 Favored Glycine 0 C--N 1.331 0.282 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.973 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 558' ' ' LEU . . . . . 0.41 HD13 ' N ' ' A' ' 559' ' ' ARG . 3.0 pp -59.16 -39.31 82.08 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.793 0.297 . . . . 0.0 111.414 -179.802 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 559' ' ' ARG . . . . . 0.456 ' HB3' ' HB2' ' A' ' 507' ' ' ALA . 9.7 mmt180 69.21 -164.16 0.18 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.002 0.43 . . . . 0.0 111.214 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 560' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.25 1.092 0 CA-C-O 118.258 -0.877 . . . . 0.0 110.921 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 507' ' ' ALA . . . . . 0.425 ' CB ' ' HA ' ' A' ' 559' ' ' ARG . . . . . . . . 0 N--CA 1.485 1.295 0 CA-C-O 121.128 0.49 . . . . 0.0 111.296 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 508' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.04 77.46 77.84 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.511 179.423 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 509' ' ' PRO . . . . . 0.539 ' O ' ' HB3' ' A' ' 510' ' ' LYS . 25.1 Cg_exo -63.59 -65.76 0.05 OUTLIER 'Trans proline' 0 N--CA 1.465 -0.179 0 C-N-CA 122.485 2.123 . . . . 0.0 112.022 -179.793 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 510' ' ' LYS . . . . . 0.539 ' HB3' ' O ' ' A' ' 509' ' ' PRO . 0.0 OUTLIER 170.73 -32.33 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.883 179.812 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 511' ' ' CYS . . . . . 0.428 ' N ' ' HG2' ' A' ' 510' ' ' LYS . 0.8 OUTLIER 44.02 47.53 7.27 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.508 179.88 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 512' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -122.11 83.89 45.26 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.417 179.542 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 513' ' ' PRO . . . . . 0.422 ' HB3' ' HG ' ' A' ' 554' ' ' LEU . 73.5 Cg_endo -75.36 -0.82 10.53 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.844 2.363 . . . . 0.0 113.124 -179.466 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 20.2 t30 -62.93 -40.24 97.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.736 0.303 . . . . 0.0 110.907 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 515' ' ' LEU . . . . . 0.45 ' HB3' ' CZ3' ' A' ' 518' ' ' TRP . 0.9 OUTLIER -95.71 58.99 2.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.017 0.437 . . . . 0.0 111.06 -179.812 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 516' ' ' HIS . . . . . . . . . . . . . 42.4 t-80 -73.01 -6.54 46.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.874 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 517' ' ' TYR . . . . . . . . . . . . . 48.8 m-85 -61.07 -27.88 68.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.718 0.294 . . . . 0.0 111.174 -179.388 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 518' ' ' TRP . . . . . 0.522 ' O ' ' N ' ' A' ' 520' ' ' THR . 1.5 p90 -117.92 -14.97 10.02 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.87 -179.612 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 519' ' ' THR . . . . . 0.538 ' CG2' ' O ' ' A' ' 549' ' ' HIS . 14.9 p 55.2 -79.43 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.55 0.214 . . . . 0.0 111.084 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 520' ' ' THR . . . . . 0.522 ' N ' ' O ' ' A' ' 518' ' ' TRP . 1.1 m 177.41 -62.59 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 179.479 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 521' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -74.65 -12.06 60.34 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.32 177.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 522' ' ' ASP . . . . . 0.418 ' O ' HG23 ' A' ' 527' ' ' ILE . 13.4 m-20 -92.56 -10.7 36.62 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.675 179.037 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -45.19 -26.37 0.48 Allowed 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.581 -179.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 524' ' ' GLY . . . . . 0.411 ' HA2' ' CG1' ' A' ' 527' ' ' ILE . . . 146.06 40.92 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.441 -0.885 . . . . 0.0 112.604 179.797 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -100.36 -60.2 1.57 Allowed 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 -179.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -132.51 37.63 3.49 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.541 0.686 . . . . 0.0 110.068 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 527' ' ' ILE . . . . . 0.452 ' HA ' ' CB ' ' A' ' 544' ' ' ALA . 2.3 pp -95.97 -0.25 10.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 114.708 -1.133 . . . . 0.0 112.912 -178.802 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 528' ' ' GLY . . . . . . . . . . . . . . . -56.87 -9.38 3.73 Favored Glycine 0 CA--C 1.523 0.576 0 C-N-CA 121.01 -0.614 . . . . 0.0 114.47 -179.151 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 529' ' ' LEU . . . . . 0.436 ' HG ' ' N ' ' A' ' 530' ' ' ALA . 1.2 pt? -98.56 -37.46 9.54 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 118.002 0.901 . . . . 0.0 112.021 -179.407 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 530' ' ' ALA . . . . . 0.5 ' C ' ' H ' ' A' ' 532' ' ' ILE . . . -103.82 1.94 32.16 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 -178.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 531' ' ' TRP . . . . . 0.444 ' HB2' ' O ' ' A' ' 527' ' ' ILE . 10.2 t90 -68.03 30.31 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 -178.639 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 532' ' ' ILE . . . . . 0.5 ' H ' ' C ' ' A' ' 530' ' ' ALA . 1.3 pp -158.89 70.84 3.6 Favored Pre-proline 0 C--N 1.332 -0.177 0 CA-C-O 120.707 0.289 . . . . 0.0 111.462 179.309 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 533' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -54.83 102.07 0.08 OUTLIER 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.335 2.024 . . . . 0.0 111.508 179.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 534' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -96.15 -54.88 3.14 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -178.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -118.32 -34.91 3.93 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 111.87 0.322 . . . . 0.0 111.87 -179.247 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . -86.37 -176.29 49.69 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.539 -0.839 . . . . 0.0 112.783 -179.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 537' ' ' PRO . . . . . 0.403 ' HG2' ' CD1' ' A' ' 542' ' ' ILE . 14.0 Cg_endo -56.52 -158.83 0.01 OUTLIER 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.87 2.38 . . . . 0.0 111.818 179.69 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 538' ' ' ALA . . . . . 0.428 ' C ' ' H ' ' A' ' 540' ' ' GLU . . . -45.06 -49.06 11.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.141 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 539' ' ' ALA . . . . . 0.439 ' HA ' ' HB2' ' A' ' 543' ' ' TYR . . . 71.54 -48.79 0.68 Allowed 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.306 0.574 . . . . 0.0 111.459 179.77 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 540' ' ' GLU . . . . . 0.428 ' H ' ' C ' ' A' ' 538' ' ' ALA . 4.3 mt-10 -36.94 -29.33 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 114.901 -1.045 . . . . 0.0 112.354 -179.326 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 541' ' ' GLY . . . . . . . . . . . . . . . -127.98 -42.73 0.25 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.369 179.434 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 542' ' ' ILE . . . . . 0.432 ' CD1' ' HA ' ' A' ' 539' ' ' ALA . 2.6 pp -74.35 -24.88 19.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -179.317 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 543' ' ' TYR . . . . . 0.443 ' HB3' ' HB1' ' A' ' 530' ' ' ALA . 2.8 t80 -114.4 -7.97 12.86 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.847 0.356 . . . . 0.0 110.814 179.725 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 544' ' ' ALA . . . . . 0.455 ' CB ' ' HB2' ' A' ' 530' ' ' ALA . . . -98.29 -32.36 11.58 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 179.038 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 545' ' ' GLU . . . . . 0.522 ' HG3' ' H ' ' A' ' 548' ' ' MET . 4.4 tp10 -118.67 -32.6 4.51 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.178 -179.84 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 40.22 42.83 2.53 Favored Glycine 0 CA--C 1.52 0.372 0 CA-C-N 115.941 -0.572 . . . . 0.0 113.956 179.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 547' ' ' LEU . . . . . 0.424 ' HG ' ' N ' ' A' ' 548' ' ' MET . 0.0 OUTLIER -175.54 -61.15 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 117.511 0.656 . . . . 0.0 111.972 179.504 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 548' ' ' MET . . . . . 0.522 ' H ' ' HG3' ' A' ' 545' ' ' GLU . 0.1 OUTLIER -89.76 11.5 19.85 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.649 0.262 . . . . 0.0 111.311 -179.983 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 549' ' ' HIS . . . . . 0.538 ' O ' ' CG2' ' A' ' 519' ' ' THR . 7.2 p80 -65.61 -11.24 42.67 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.139 0.495 . . . . 0.0 110.662 179.328 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 550' ' ' ASN . . . . . 0.445 ' ND2' ' CE1' ' A' ' 549' ' ' HIS . 1.1 m-80 -96.22 -7.57 35.3 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.413 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 551' ' ' GLN . . . . . 0.52 ' HG3' ' HG2' ' A' ' 548' ' ' MET . 8.2 mm-40 -71.81 53.41 0.24 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.706 0.289 . . . . 0.0 111.63 -179.33 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 552' ' ' ASP . . . . . 0.468 ' HB2' ' HA ' ' A' ' 519' ' ' THR . 6.3 t70 -114.15 21.68 14.53 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.738 0.304 . . . . 0.0 110.766 179.392 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . 116.96 -31.07 6.03 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.744 -0.741 . . . . 0.0 111.324 -178.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 554' ' ' LEU . . . . . 0.422 ' HG ' ' HB3' ' A' ' 513' ' ' PRO . 11.8 mt -57.61 -53.44 58.16 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-O 121.505 0.669 . . . . 0.0 109.631 178.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 555' ' ' ILE . . . . . . . . . . . . . 9.6 mm -89.05 54.93 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 CA-C-N 114.978 -1.01 . . . . 0.0 109.99 179.44 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 556' ' ' CYS . . . . . 0.47 ' O ' ' HD3' ' A' ' 559' ' ' ARG . 0.8 OUTLIER -64.7 -9.43 19.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.867 -179.459 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 557' ' ' GLY . . . . . 0.409 ' HA2' ' NH1' ' A' ' 559' ' ' ARG . . . -57.31 -2.52 0.67 Allowed Glycine 0 CA--C 1.523 0.569 0 C-N-CA 121.182 -0.532 . . . . 0.0 114.137 -179.589 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 558' ' ' LEU . . . . . 0.407 HD11 ' HG3' ' A' ' 509' ' ' PRO . 3.8 pp -78.99 27.38 0.23 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 117.113 0.457 . . . . 0.0 112.084 -179.797 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 559' ' ' ARG . . . . . 0.491 ' H ' ' HD3' ' A' ' 559' ' ' ARG . 0.0 OUTLIER -62.21 -160.27 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 110.545 -0.168 . . . . 0.0 110.545 -179.937 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 560' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.179 -0.915 . . . . 0.0 110.927 -179.964 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 507' ' ' ALA . . . . . 0.465 ' CB ' ' HB3' ' A' ' 559' ' ' ARG . . . . . . . . 0 N--CA 1.486 1.336 0 CA-C-O 120.978 0.418 . . . . 0.0 111.345 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 508' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 -128.91 76.96 78.56 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.874 179.007 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 509' ' ' PRO . . . . . 0.43 ' O ' ' HB3' ' A' ' 510' ' ' LYS . 15.3 Cg_exo -68.97 -65.04 0.04 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.21 0 C-N-CA 122.649 2.232 . . . . 0.0 111.803 179.787 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 510' ' ' LYS . . . . . 0.43 ' HB3' ' O ' ' A' ' 509' ' ' PRO . 0.0 OUTLIER 176.16 -31.71 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.778 179.87 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 511' ' ' CYS . . . . . 0.421 ' N ' ' HG2' ' A' ' 510' ' ' LYS . 0.0 OUTLIER 43.72 52.15 6.41 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.486 179.73 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 512' ' ' ASN . . . . . 0.403 ' O ' ' O ' ' A' ' 552' ' ' ASP . 9.6 m-20 -110.7 83.59 3.57 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.503 179.557 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 513' ' ' PRO . . . . . 0.416 ' HA ' ' O ' ' A' ' 552' ' ' ASP . 90.1 Cg_endo -79.27 22.91 0.66 Allowed 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.953 2.436 . . . . 0.0 113.185 -179.639 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -96.65 -27.66 14.69 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.778 0.323 . . . . 0.0 110.798 179.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 515' ' ' LEU . . . . . . . . . . . . . 1.6 mt -93.06 72.48 4.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.803 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 516' ' ' HIS . . . . . 0.432 ' HA ' ' CB ' ' A' ' 552' ' ' ASP . 2.4 t60 -72.11 -7.53 49.51 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.827 -179.772 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 517' ' ' TYR . . . . . . . . . . . . . 41.6 m-85 -83.96 -66.11 0.93 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.853 0.359 . . . . 0.0 111.448 -179.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 518' ' ' TRP . . . . . 0.435 ' O ' ' N ' ' A' ' 520' ' ' THR . 0.1 OUTLIER -69.33 -19.01 63.87 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.625 -179.459 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 519' ' ' THR . . . . . 0.532 ' OG1' ' N ' ' A' ' 520' ' ' THR . 1.5 p 61.45 -78.26 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.65 -0.25 . . . . 0.0 110.39 -179.69 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 520' ' ' THR . . . . . 0.532 ' N ' ' OG1' ' A' ' 519' ' ' THR . 1.0 OUTLIER 173.12 -62.93 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 179.07 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 521' ' ' GLN . . . . . 0.468 ' HB3' ' OE2' ' A' ' 545' ' ' GLU . 6.0 tt0 -74.52 -15.65 60.86 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 177.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 522' ' ' ASP . . . . . 0.483 ' O ' HG21 ' A' ' 527' ' ' ILE . 13.5 t70 -94.07 -10.45 33.35 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.786 178.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 523' ' ' GLU . . . . . 0.433 ' HA ' ' CD1' ' A' ' 518' ' ' TRP . 0.0 OUTLIER -44.95 -26.88 0.47 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.539 -179.524 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 524' ' ' GLY . . . . . 0.418 ' HA2' ' CG1' ' A' ' 527' ' ' ILE . . . 153.14 40.56 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.288 179.838 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -97.67 -56.3 2.55 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.165 0.431 . . . . 0.0 112.165 -179.342 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -133.2 41.22 3.13 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-O 121.496 0.665 . . . . 0.0 110.185 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 527' ' ' ILE . . . . . 0.483 HG21 ' O ' ' A' ' 522' ' ' ASP . 1.8 pp -95.82 -0.62 10.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 114.783 -1.099 . . . . 0.0 112.918 -178.853 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 528' ' ' GLY . . . . . . . . . . . . . . . -60.3 -13.21 28.0 Favored Glycine 0 CA--C 1.521 0.447 0 C-N-CA 120.852 -0.689 . . . . 0.0 114.131 -179.013 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 529' ' ' LEU . . . . . 0.472 ' CD1' ' N ' ' A' ' 529' ' ' LEU . 0.0 OUTLIER -99.13 -30.44 12.29 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 117.614 0.707 . . . . 0.0 111.817 -179.645 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 530' ' ' ALA . . . . . 0.496 ' C ' ' H ' ' A' ' 532' ' ' ILE . . . -103.61 1.69 32.38 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -179.136 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 531' ' ' TRP . . . . . 0.528 ' HA ' ' HG2' ' A' ' 540' ' ' GLU . 0.2 OUTLIER -71.33 30.34 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -178.92 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 532' ' ' ILE . . . . . 0.496 ' H ' ' C ' ' A' ' 530' ' ' ALA . 1.1 pt -158.58 72.98 3.78 Favored Pre-proline 0 N--CA 1.453 -0.311 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.472 179.14 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 533' ' ' PRO . . . . . 0.41 ' HB3' ' O ' ' A' ' 537' ' ' PRO . 1.2 Cg_endo -44.25 85.25 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 123.46 2.773 . . . . 0.0 113.014 -179.625 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 534' ' ' TYR . . . . . 0.446 ' N ' ' O ' ' A' ' 532' ' ' ILE . 7.7 t80 -96.65 -39.47 9.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.329 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 20.6 t80 -57.68 -34.98 69.97 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.549 -179.191 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 146.55 -52.41 0.56 Allowed Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.467 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 537' ' ' PRO . . . . . 0.41 ' O ' ' HB3' ' A' ' 533' ' ' PRO . 2.0 Cg_endo -78.06 -174.53 2.28 Favored 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 122.725 2.283 . . . . 0.0 111.173 179.392 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 538' ' ' ALA . . . . . . . . . . . . . . . -57.11 -51.23 70.14 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.951 -0.3 . . . . 0.0 110.624 179.554 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 539' ' ' ALA . . . . . 0.434 ' O ' ' N ' ' A' ' 541' ' ' GLY . . . 71.07 -50.76 0.69 Allowed 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 121.265 0.555 . . . . 0.0 111.402 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 540' ' ' GLU . . . . . 0.528 ' HG2' ' HA ' ' A' ' 531' ' ' TRP . 5.3 mt-10 -37.74 -24.34 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 114.896 -1.047 . . . . 0.0 112.759 -179.445 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 541' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 539' ' ' ALA . . . -111.15 -58.36 0.48 Allowed Glycine 0 CA--C 1.52 0.384 0 C-N-CA 120.488 -0.863 . . . . 0.0 113.227 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 542' ' ' ILE . . . . . 0.432 ' HA ' ' CD2' ' A' ' 549' ' ' HIS . 0.2 OUTLIER -76.94 -22.82 14.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 113.477 0.917 . . . . 0.0 113.477 -178.366 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 543' ' ' TYR . . . . . 0.426 ' HB2' ' CA ' ' A' ' 539' ' ' ALA . 10.5 m-85 -101.56 -11.19 19.44 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.27 0.557 . . . . 0.0 110.345 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 544' ' ' ALA . . . . . 0.476 ' CB ' ' HB2' ' A' ' 530' ' ' ALA . . . -100.03 -28.86 12.85 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 115.228 -0.897 . . . . 0.0 110.034 179.689 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 545' ' ' GLU . . . . . 0.488 ' HG3' ' H ' ' A' ' 548' ' ' MET . 3.9 tp10 -118.68 -32.78 4.45 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.384 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 36.39 39.73 0.36 Allowed Glycine 0 CA--C 1.519 0.308 0 CA-C-N 115.759 -0.655 . . . . 0.0 114.371 179.454 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 547' ' ' LEU . . . . . 0.427 ' HG ' ' N ' ' A' ' 548' ' ' MET . 0.0 OUTLIER -176.71 -61.73 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 117.734 0.767 . . . . 0.0 112.247 179.449 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 548' ' ' MET . . . . . 0.488 ' H ' ' HG3' ' A' ' 545' ' ' GLU . 0.0 OUTLIER -95.38 11.38 32.94 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.728 0.299 . . . . 0.0 111.053 179.634 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 549' ' ' HIS . . . . . 0.474 ' O ' ' CG2' ' A' ' 519' ' ' THR . 16.5 p80 -62.72 -10.82 14.0 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.024 179.549 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 550' ' ' ASN . . . . . 0.444 ' O ' ' N ' ' A' ' 552' ' ' ASP . 1.8 m120 -95.56 -33.82 12.26 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -178.633 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 551' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -65.9 71.51 0.06 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.182 0.515 . . . . 0.0 110.466 -179.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 552' ' ' ASP . . . . . 0.475 ' HA ' ' O ' ' A' ' 519' ' ' THR . 2.4 p30 -94.71 22.12 6.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.397 -179.48 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . 123.97 -32.65 4.13 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.799 -0.715 . . . . 0.0 111.677 -179.393 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 554' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -58.75 -59.18 5.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.488 0.661 . . . . 0.0 109.96 178.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 555' ' ' ILE . . . . . . . . . . . . . 3.2 mm -72.27 65.69 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 CA-C-N 114.867 -1.06 . . . . 0.0 110.618 179.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 556' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -68.95 -7.47 35.44 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.565 -179.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -65.76 -2.73 12.75 Favored Glycine 0 CA--C 1.52 0.367 0 C-N-CA 120.913 -0.661 . . . . 0.0 113.391 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 558' ' ' LEU . . . . . . . . . . . . . 4.2 pp -64.84 -32.01 73.51 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 117.115 0.458 . . . . 0.0 111.037 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 559' ' ' ARG . . . . . 0.465 ' HB3' ' CB ' ' A' ' 507' ' ' ALA . 1.2 mmm-85 47.96 -172.51 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 120.859 0.362 . . . . 0.0 111.116 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 560' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.254 -0.879 . . . . 0.0 110.95 179.671 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.323 0 CA-C-O 120.883 0.373 . . . . 0.0 111.143 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 508' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -128.28 86.28 58.33 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.689 179.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 509' ' ' PRO . . . . . 0.514 ' O ' ' CE ' ' A' ' 510' ' ' LYS . 4.6 Cg_exo -75.74 -23.72 12.36 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.777 2.318 . . . . 0.0 112.149 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 510' ' ' LYS . . . . . 0.514 ' CE ' ' O ' ' A' ' 509' ' ' PRO . 0.0 OUTLIER 84.03 -22.53 0.22 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.506 -179.831 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 511' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 43.46 76.31 0.08 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.569 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 512' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -124.04 80.4 57.68 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.48 179.724 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 513' ' ' PRO . . . . . 0.433 ' HA ' ' O ' ' A' ' 552' ' ' ASP . 94.2 Cg_endo -80.98 24.85 0.66 Allowed 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 123.021 2.481 . . . . 0.0 113.179 -179.679 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 17.8 t-20 -96.73 -30.31 13.28 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.707 0.289 . . . . 0.0 110.797 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 515' ' ' LEU . . . . . . . . . . . . . 32.9 mt -89.17 72.97 8.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.847 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 516' ' ' HIS . . . . . 0.413 ' HA ' ' CB ' ' A' ' 552' ' ' ASP . 62.2 t-80 -76.69 -15.69 59.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.541 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 517' ' ' TYR . . . . . . . . . . . . . 57.4 m-85 -80.1 -36.72 35.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.736 0.303 . . . . 0.0 111.373 -179.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 518' ' ' TRP . . . . . 0.462 ' O ' ' N ' ' A' ' 520' ' ' THR . 3.9 m-90 -94.92 -21.27 18.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.501 -179.532 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 519' ' ' THR . . . . . 0.55 ' OG1' ' N ' ' A' ' 520' ' ' THR . 1.2 p 58.41 -78.64 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.843 -179.797 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 520' ' ' THR . . . . . 0.55 ' N ' ' OG1' ' A' ' 519' ' ' THR . 1.1 m 178.18 -62.97 0.01 OUTLIER 'General case' 0 CA--C 1.521 -0.171 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 179.234 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 521' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -74.42 -14.3 60.83 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 177.825 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 522' ' ' ASP . . . . . 0.414 ' O ' HG22 ' A' ' 527' ' ' ILE . 22.1 m-20 -94.13 -11.12 31.16 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.961 179.086 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -45.3 -28.29 0.8 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.235 -179.816 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . 148.61 42.03 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.43 179.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -104.37 -54.8 2.47 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 111.833 0.309 . . . . 0.0 111.833 -179.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -131.74 48.44 2.42 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-O 121.536 0.684 . . . . 0.0 110.014 179.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 527' ' ' ILE . . . . . 0.457 ' O ' ' HB2' ' A' ' 531' ' ' TRP . 1.5 pp -95.45 -6.33 10.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 114.916 -1.038 . . . . 0.0 112.517 -178.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 528' ' ' GLY . . . . . . . . . . . . . . . -54.86 -13.04 4.12 Favored Glycine 0 CA--C 1.521 0.445 0 C-N-CA 120.971 -0.633 . . . . 0.0 113.817 -179.472 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 529' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -97.01 -41.01 8.59 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 117.392 0.596 . . . . 0.0 111.431 -179.296 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 530' ' ' ALA . . . . . 0.496 ' C ' ' H ' ' A' ' 532' ' ' ILE . . . -103.76 2.05 32.46 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.789 0.662 . . . . 0.0 112.789 -178.807 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 531' ' ' TRP . . . . . 0.457 ' HB2' ' O ' ' A' ' 527' ' ' ILE . 62.1 t90 -70.89 25.99 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -179.088 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 532' ' ' ILE . . . . . 0.496 ' H ' ' C ' ' A' ' 530' ' ' ALA . 1.3 pp -159.25 70.98 3.45 Favored Pre-proline 0 C--N 1.332 -0.191 0 CA-C-O 120.843 0.354 . . . . 0.0 110.885 179.105 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 533' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -51.36 110.63 0.44 Allowed 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.735 2.29 . . . . 0.0 111.907 179.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 534' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -96.33 -55.01 3.08 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -179.143 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -118.47 -35.23 3.81 Favored 'General case' 0 N--CA 1.463 0.179 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -179.121 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . -83.26 -175.11 50.83 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.535 -0.841 . . . . 0.0 112.89 -179.369 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -58.12 -156.9 0.01 OUTLIER 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.657 2.238 . . . . 0.0 111.266 179.554 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 538' ' ' ALA . . . . . . . . . . . . . . . -43.58 -44.01 5.95 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.7 0.286 . . . . 0.0 111.141 179.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 539' ' ' ALA . . . . . 0.431 ' O ' ' N ' ' A' ' 541' ' ' GLY . . . 71.1 -49.54 0.68 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 121.108 0.48 . . . . 0.0 111.665 179.781 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 540' ' ' GLU . . . . . 0.45 ' CG ' ' HA ' ' A' ' 531' ' ' TRP . 3.7 mt-10 -37.66 -25.75 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.142 -0.935 . . . . 0.0 112.656 -179.506 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 541' ' ' GLY . . . . . 0.431 ' N ' ' O ' ' A' ' 539' ' ' ALA . . . -112.73 -55.42 0.45 Allowed Glycine 0 CA--C 1.523 0.549 0 C-N-CA 120.384 -0.912 . . . . 0.0 113.819 -179.559 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 542' ' ' ILE . . . . . 0.437 HD11 HG22 ' A' ' 542' ' ' ILE . 0.2 OUTLIER -79.18 -22.94 12.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 113.691 0.997 . . . . 0.0 113.691 -178.133 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 543' ' ' TYR . . . . . 0.414 ' HB2' ' CA ' ' A' ' 539' ' ' ALA . 9.7 m-85 -99.02 -16.97 18.51 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.248 0.547 . . . . 0.0 110.028 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 544' ' ' ALA . . . . . 0.433 ' CA ' ' HB3' ' A' ' 530' ' ' ALA . . . -91.52 -24.44 19.63 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.201 179.856 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 545' ' ' GLU . . . . . 0.464 ' HG3' ' H ' ' A' ' 548' ' ' MET . 3.7 tp10 -118.78 -32.65 4.46 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.405 -179.805 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 39.41 42.36 1.82 Allowed Glycine 0 CA--C 1.52 0.378 0 CA-C-N 115.883 -0.599 . . . . 0.0 114.366 179.436 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 547' ' ' LEU . . . . . 0.457 ' HG ' ' N ' ' A' ' 548' ' ' MET . 0.0 OUTLIER -178.51 -61.97 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 117.713 0.756 . . . . 0.0 112.094 179.122 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 548' ' ' MET . . . . . 0.464 ' H ' ' HG3' ' A' ' 545' ' ' GLU . 0.0 OUTLIER -96.08 11.43 34.21 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.751 0.31 . . . . 0.0 110.975 179.504 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 549' ' ' HIS . . . . . 0.474 ' O ' ' CG2' ' A' ' 519' ' ' THR . 5.1 p-80 -61.19 -11.08 7.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.079 179.631 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 550' ' ' ASN . . . . . 0.43 ' O ' ' N ' ' A' ' 552' ' ' ASP . 28.9 t-20 -95.12 -34.64 12.2 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 -178.788 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 551' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -66.49 72.08 0.08 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.139 0.495 . . . . 0.0 110.419 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 552' ' ' ASP . . . . . 0.441 ' HA ' ' O ' ' A' ' 519' ' ' THR . 4.5 p30 -93.87 22.33 5.76 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.514 -179.448 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . 124.2 -28.03 5.44 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.838 -0.696 . . . . 0.0 111.645 -179.27 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 554' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -59.67 -53.32 59.36 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.551 0.691 . . . . 0.0 109.787 178.824 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 555' ' ' ILE . . . . . 0.409 ' O ' ' CG2' ' A' ' 555' ' ' ILE . 3.2 mm -78.95 62.02 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 114.755 -1.111 . . . . 0.0 110.374 179.808 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 556' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -53.44 -22.45 7.85 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.444 -179.787 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 557' ' ' GLY . . . . . 0.407 ' HA2' ' NH1' ' A' ' 559' ' ' ARG . . . -51.91 -22.48 9.22 Favored Glycine 0 C--N 1.332 0.335 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.993 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 558' ' ' LEU . . . . . 0.41 ' CD1' ' N ' ' A' ' 559' ' ' ARG . 3.8 pp -53.73 -43.58 69.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.924 0.393 . . . . 0.0 111.415 -179.822 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 559' ' ' ARG . . . . . 0.41 ' N ' ' CD1' ' A' ' 558' ' ' LEU . 3.3 mpt_? 55.76 -178.14 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.934 -179.65 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 560' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.298 -0.858 . . . . 0.0 110.902 179.998 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.349 0 CA-C-O 120.765 0.317 . . . . 0.0 111.173 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 508' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -128.62 78.2 76.28 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.889 179.594 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 509' ' ' PRO . . . . . 0.47 ' O ' ' CE ' ' A' ' 510' ' ' LYS . 90.5 Cg_endo -90.25 -13.42 2.44 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 122.877 2.385 . . . . 0.0 112.652 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 510' ' ' LYS . . . . . 0.47 ' CE ' ' O ' ' A' ' 509' ' ' PRO . 0.0 OUTLIER 81.22 -28.07 0.13 Allowed 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.076 0.465 . . . . 0.0 111.261 -179.449 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 511' ' ' CYS . . . . . . . . . . . . . 9.6 m 44.21 77.0 0.08 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.573 179.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 512' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -115.76 79.11 7.48 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.512 179.82 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 513' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -83.48 25.23 0.7 Allowed 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.839 2.359 . . . . 0.0 113.042 -179.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -96.66 -29.69 13.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.814 0.34 . . . . 0.0 111.107 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 515' ' ' LEU . . . . . . . . . . . . . 1.5 mt -88.13 73.08 9.05 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.025 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 516' ' ' HIS . . . . . 0.421 ' HA ' ' CB ' ' A' ' 552' ' ' ASP . 1.7 t60 -79.53 -7.21 58.32 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.601 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 517' ' ' TYR . . . . . . . . . . . . . 40.2 m-85 -80.19 -54.27 5.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.655 0.264 . . . . 0.0 111.686 -179.318 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 518' ' ' TRP . . . . . 0.526 ' O ' ' N ' ' A' ' 520' ' ' THR . 4.1 m-90 -92.37 -3.33 55.49 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 -179.02 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 519' ' ' THR . . . . . 0.573 ' OG1' ' N ' ' A' ' 520' ' ' THR . 1.3 p 55.83 -78.13 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 120.591 0.234 . . . . 0.0 110.978 179.746 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 520' ' ' THR . . . . . 0.573 ' N ' ' OG1' ' A' ' 519' ' ' THR . 1.1 m 177.01 -62.58 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.515 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 521' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.84 -12.07 60.57 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 177.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 522' ' ' ASP . . . . . 0.427 ' HB2' ' O ' ' A' ' 518' ' ' TRP . 3.2 m-20 -93.62 -10.72 33.65 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.781 179.047 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 523' ' ' GLU . . . . . 0.408 ' HA ' ' CD1' ' A' ' 518' ' ' TRP . 0.3 OUTLIER -45.39 -27.62 0.73 Allowed 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.501 -179.936 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 524' ' ' GLY . . . . . 0.426 ' HA2' ' CG1' ' A' ' 527' ' ' ILE . . . 146.05 42.34 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.579 -0.819 . . . . 0.0 112.299 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -101.52 -59.65 1.66 Allowed 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 111.941 0.349 . . . . 0.0 111.941 -179.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -131.82 36.58 3.69 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-O 121.503 0.668 . . . . 0.0 110.066 179.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 527' ' ' ILE . . . . . 0.496 ' HA ' ' CB ' ' A' ' 544' ' ' ALA . 2.1 pp -95.7 -0.43 10.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 114.787 -1.097 . . . . 0.0 112.735 -178.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 528' ' ' GLY . . . . . . . . . . . . . . . -56.83 -13.77 8.84 Favored Glycine 0 CA--C 1.52 0.349 0 C-N-CA 120.892 -0.67 . . . . 0.0 114.024 -179.406 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 529' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -98.55 -32.81 11.26 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 117.639 0.719 . . . . 0.0 111.724 -179.379 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 530' ' ' ALA . . . . . 0.553 ' C ' ' H ' ' A' ' 532' ' ' ILE . . . -103.69 1.84 32.36 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -178.901 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 531' ' ' TRP . . . . . 0.442 ' HA ' ' HG2' ' A' ' 540' ' ' GLU . 4.5 t90 -68.26 26.68 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -179.02 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 532' ' ' ILE . . . . . 0.553 ' H ' ' C ' ' A' ' 530' ' ' ALA . 1.3 pp -160.56 71.04 2.88 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 120.846 0.355 . . . . 0.0 110.386 179.014 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 533' ' ' PRO . . . . . 0.402 ' HB3' ' O ' ' A' ' 538' ' ' ALA . 1.2 Cg_endo -44.71 85.22 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 123.451 2.768 . . . . 0.0 113.118 -179.449 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 534' ' ' TYR . . . . . 0.449 ' N ' ' O ' ' A' ' 532' ' ' ILE . 5.8 t80 -96.78 -34.26 11.38 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.148 179.606 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -60.92 -34.93 75.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.567 -179.369 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 536' ' ' GLY . . . . . 0.41 ' N ' ' CD ' ' A' ' 537' ' ' PRO . . . 145.12 -50.4 0.64 Allowed Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.522 -0.847 . . . . 0.0 112.603 -179.817 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 537' ' ' PRO . . . . . 0.41 ' CD ' ' N ' ' A' ' 536' ' ' GLY . 6.1 Cg_exo -74.64 -164.08 0.21 Allowed 'Trans proline' 0 N--CA 1.461 -0.43 0 C-N-CA 122.601 2.201 . . . . 0.0 111.474 179.594 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 538' ' ' ALA . . . . . 0.402 ' O ' ' HB3' ' A' ' 533' ' ' PRO . . . -68.4 -46.78 69.05 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.83 0.347 . . . . 0.0 110.258 179.328 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 539' ' ' ALA . . . . . 0.445 ' HA ' ' CD1' ' A' ' 542' ' ' ILE . . . 70.15 -54.04 0.63 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 121.363 0.601 . . . . 0.0 111.443 179.841 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 540' ' ' GLU . . . . . 0.442 ' HG2' ' HA ' ' A' ' 531' ' ' TRP . 12.8 mt-10 -37.52 -27.23 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 114.781 -1.099 . . . . 0.0 112.248 -179.31 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 541' ' ' GLY . . . . . 0.423 ' N ' ' O ' ' A' ' 539' ' ' ALA . . . -125.26 -46.35 0.23 Allowed Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.051 179.006 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 542' ' ' ILE . . . . . 0.445 ' CD1' ' HA ' ' A' ' 539' ' ' ALA . 2.6 pp -73.93 -23.88 19.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -179.503 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 543' ' ' TYR . . . . . 0.522 ' HB3' ' HB1' ' A' ' 530' ' ' ALA . 23.5 t80 -112.54 -8.45 13.84 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.944 0.402 . . . . 0.0 110.843 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 544' ' ' ALA . . . . . 0.496 ' CB ' ' HA ' ' A' ' 527' ' ' ILE . . . -103.18 -35.21 8.56 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.939 179.316 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 545' ' ' GLU . . . . . 0.476 ' HG3' ' H ' ' A' ' 548' ' ' MET . 28.1 tp10 -118.59 -32.61 4.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.331 -0.85 . . . . 0.0 111.05 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 38.9 40.51 1.09 Allowed Glycine 0 CA--C 1.52 0.355 0 CA-C-N 115.856 -0.611 . . . . 0.0 113.896 179.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 547' ' ' LEU . . . . . 0.532 ' HG ' ' N ' ' A' ' 548' ' ' MET . 0.0 OUTLIER -172.0 -61.47 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 117.537 0.669 . . . . 0.0 112.204 179.568 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 548' ' ' MET . . . . . 0.554 ' O ' ' HG3' ' A' ' 551' ' ' GLN . 0.0 OUTLIER -96.17 11.78 33.15 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.773 0.321 . . . . 0.0 111.688 179.95 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 549' ' ' HIS . . . . . 0.502 ' O ' ' CG2' ' A' ' 519' ' ' THR . 28.5 p80 -64.73 -11.0 31.52 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.88 0.372 . . . . 0.0 110.77 179.255 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 550' ' ' ASN . . . . . 0.46 ' O ' ' N ' ' A' ' 552' ' ' ASP . 5.9 m120 -96.18 -37.98 10.34 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -178.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 551' ' ' GLN . . . . . 0.554 ' HG3' ' O ' ' A' ' 548' ' ' MET . 0.0 OUTLIER -64.62 72.51 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.073 0.463 . . . . 0.0 110.712 -179.621 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 552' ' ' ASP . . . . . 0.46 ' N ' ' O ' ' A' ' 550' ' ' ASN . 2.3 p30 -92.51 21.9 5.03 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.203 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . 123.94 -27.81 5.55 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.952 -0.642 . . . . 0.0 111.766 -179.307 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 554' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -60.56 -60.67 3.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.404 0.621 . . . . 0.0 110.066 179.007 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 555' ' ' ILE . . . . . . . . . . . . . 3.6 mm -72.71 70.87 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 CA-C-N 114.999 -1.0 . . . . 0.0 110.494 179.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 556' ' ' CYS . . . . . 0.532 ' O ' ' HD2' ' A' ' 559' ' ' ARG . 58.7 m -65.09 -8.73 17.8 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.333 -0.849 . . . . 0.0 112.039 -179.446 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 557' ' ' GLY . . . . . 0.485 ' C ' ' H ' ' A' ' 559' ' ' ARG . . . -52.82 -10.34 1.0 Allowed Glycine 0 CA--C 1.522 0.515 0 C-N-CA 121.047 -0.597 . . . . 0.0 113.949 -179.759 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 558' ' ' LEU . . . . . . . . . . . . . 4.1 pp -68.8 27.95 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 -179.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 559' ' ' ARG . . . . . 0.532 ' HD2' ' O ' ' A' ' 556' ' ' CYS . 0.0 OUTLIER -100.83 -173.11 2.31 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.816 0.341 . . . . 0.0 111.111 -179.834 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 560' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.26 -0.876 . . . . 0.0 110.967 179.979 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 507' ' ' ALA . . . . . 0.597 ' O ' ' HA ' ' A' ' 559' ' ' ARG . . . . . . . . 0 N--CA 1.483 1.217 0 CA-C-O 121.445 0.64 . . . . 0.0 111.452 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 508' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.18 77.32 77.0 Favored Pre-proline 0 C--N 1.321 -0.648 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.902 179.142 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 509' ' ' PRO . . . . . 0.523 ' O ' ' HB3' ' A' ' 510' ' ' LYS . 32.3 Cg_exo -62.91 -65.86 0.05 OUTLIER 'Trans proline' 0 C--O 1.231 0.142 0 C-N-CA 122.91 2.407 . . . . 0.0 112.362 -179.558 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 510' ' ' LYS . . . . . 0.523 ' HB3' ' O ' ' A' ' 509' ' ' PRO . 0.0 OUTLIER 168.66 -30.97 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.364 -0.834 . . . . 0.0 109.879 -179.674 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 511' ' ' CYS . . . . . 0.441 ' N ' ' HG2' ' A' ' 510' ' ' LYS . 1.0 OUTLIER 55.86 84.28 0.08 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.006 -0.997 . . . . 0.0 111.522 179.249 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 512' ' ' ASN . . . . . . . . . . . . . 18.7 p30 -115.52 77.44 5.95 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.077 179.326 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 513' ' ' PRO . . . . . 0.512 ' HA ' ' O ' ' A' ' 552' ' ' ASP . 28.5 Cg_endo -64.5 -10.62 24.95 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.805 2.337 . . . . 0.0 112.345 -179.789 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -81.11 -22.29 39.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.213 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 515' ' ' LEU . . . . . . . . . . . . . 61.5 mt -88.85 74.62 8.23 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.928 0.394 . . . . 0.0 111.094 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 516' ' ' HIS . . . . . 0.458 ' HA ' ' HB3' ' A' ' 552' ' ' ASP . 98.9 m-70 -80.08 -7.27 58.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.693 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 517' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 -78.54 -37.94 41.66 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 111.648 0.24 . . . . 0.0 111.648 -179.354 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 518' ' ' TRP . . . . . 0.595 ' O ' ' N ' ' A' ' 520' ' ' THR . 14.8 m-90 -111.06 5.11 19.97 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 111.99 0.367 . . . . 0.0 111.99 -179.376 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 519' ' ' THR . . . . . 0.524 ' HA ' ' HA ' ' A' ' 552' ' ' ASP . 2.4 p 50.08 -78.32 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 120.421 0.153 . . . . 0.0 110.999 -179.862 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 520' ' ' THR . . . . . 0.595 ' N ' ' O ' ' A' ' 518' ' ' TRP . 1.2 m 179.45 -62.57 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 179.248 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 521' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -72.38 -12.02 60.94 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.301 178.004 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 522' ' ' ASP . . . . . 0.439 ' HA ' ' CG2' ' A' ' 527' ' ' ILE . 64.9 m-20 -91.71 -10.82 38.77 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.962 179.21 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -45.28 -26.78 0.55 Allowed 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.464 -179.762 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . 145.59 41.99 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.547 -0.835 . . . . 0.0 112.309 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -101.99 -60.57 1.51 Allowed 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 111.784 0.29 . . . . 0.0 111.784 -179.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -131.35 37.8 3.67 Favored 'General case' 0 CA--C 1.512 -0.506 0 CA-C-O 121.52 0.676 . . . . 0.0 110.066 179.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 527' ' ' ILE . . . . . 0.471 ' HA ' ' CB ' ' A' ' 544' ' ' ALA . 2.1 pp -95.78 -0.49 10.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-N 114.847 -1.07 . . . . 0.0 112.724 -178.889 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 528' ' ' GLY . . . . . . . . . . . . . . . -58.94 -13.34 18.78 Favored Glycine 0 CA--C 1.521 0.443 0 C-N-CA 120.877 -0.678 . . . . 0.0 113.896 -179.336 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 529' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -98.63 -33.11 11.09 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 117.56 0.68 . . . . 0.0 111.759 -179.425 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 530' ' ' ALA . . . . . 0.483 ' HB3' ' HB3' ' A' ' 543' ' ' TYR . . . -103.62 -0.97 28.92 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 -178.84 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 531' ' ' TRP . . . . . 0.434 ' HA ' ' HG2' ' A' ' 540' ' ' GLU . 8.9 t90 -56.62 -11.12 1.19 Allowed 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 112.057 0.392 . . . . 0.0 112.057 -179.189 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 532' ' ' ILE . . . . . 0.406 ' O ' ' CD1' ' A' ' 532' ' ' ILE . 1.6 pp -133.45 73.79 72.64 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.037 0.446 . . . . 0.0 111.218 179.632 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 533' ' ' PRO . . . . . 0.401 ' HB3' ' O ' ' A' ' 538' ' ' ALA . 1.0 OUTLIER -44.18 92.95 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 123.165 2.577 . . . . 0.0 112.798 -179.988 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 534' ' ' TYR . . . . . . . . . . . . . 45.0 t80 -96.4 -25.51 15.68 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.079 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -70.57 -34.9 72.72 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.355 -179.559 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 147.32 -64.63 0.42 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.549 -0.834 . . . . 0.0 112.889 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -59.14 -165.01 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.641 2.227 . . . . 0.0 112.011 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 538' ' ' ALA . . . . . 0.401 ' O ' ' HB3' ' A' ' 533' ' ' PRO . . . -66.59 -48.27 70.09 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.558 179.759 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 539' ' ' ALA . . . . . 0.44 ' HA ' ' CD1' ' A' ' 542' ' ' ILE . . . 69.54 -53.56 0.6 Allowed 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.302 0.573 . . . . 0.0 111.546 179.867 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 540' ' ' GLU . . . . . 0.434 ' HG2' ' HA ' ' A' ' 531' ' ' TRP . 14.4 mt-10 -37.32 -27.39 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.889 -1.051 . . . . 0.0 112.266 -179.377 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 541' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 539' ' ' ALA . . . -125.63 -46.71 0.22 Allowed Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.034 179.007 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 542' ' ' ILE . . . . . 0.44 ' CD1' ' HA ' ' A' ' 539' ' ' ALA . 2.6 pp -73.28 -23.89 20.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -179.515 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 543' ' ' TYR . . . . . 0.483 ' HB3' ' HB3' ' A' ' 530' ' ' ALA . 21.4 t80 -112.85 -7.62 13.75 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.991 0.424 . . . . 0.0 110.936 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 544' ' ' ALA . . . . . 0.471 ' CB ' ' HA ' ' A' ' 527' ' ' ILE . . . -103.04 -33.41 9.27 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.866 179.328 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 545' ' ' GLU . . . . . 0.48 ' HG3' ' H ' ' A' ' 548' ' ' MET . 3.9 tp10 -118.59 -32.58 4.54 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.43 -0.805 . . . . 0.0 111.0 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 38.01 46.86 1.85 Allowed Glycine 0 CA--C 1.519 0.294 0 CA-C-N 115.804 -0.635 . . . . 0.0 114.148 179.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 547' ' ' LEU . . . . . 0.442 ' HG ' ' N ' ' A' ' 548' ' ' MET . 0.0 OUTLIER -179.07 -61.5 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 117.6 0.7 . . . . 0.0 111.801 179.268 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 548' ' ' MET . . . . . 0.48 ' H ' ' HG3' ' A' ' 545' ' ' GLU . 0.0 OUTLIER -95.08 11.59 31.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.694 0.283 . . . . 0.0 111.088 179.503 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 549' ' ' HIS . . . . . 0.461 ' O ' ' CG2' ' A' ' 519' ' ' THR . 16.4 p80 -60.64 -11.52 7.53 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.07 179.586 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 550' ' ' ASN . . . . . 0.544 ' O ' ' N ' ' A' ' 552' ' ' ASP . 8.6 m-20 -94.8 -40.19 9.88 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 -179.332 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 551' ' ' GLN . . . . . 0.402 ' HG3' ' O ' ' A' ' 551' ' ' GLN . 2.4 pt20 -60.34 73.06 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.189 0.519 . . . . 0.0 110.303 179.829 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 552' ' ' ASP . . . . . 0.544 ' N ' ' O ' ' A' ' 550' ' ' ASN . 11.8 m-20 -84.62 21.73 1.45 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.933 -179.278 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 553' ' ' GLY . . . . . 0.406 ' HA3' ' N ' ' A' ' 513' ' ' PRO . . . 116.7 12.84 8.35 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.105 -179.653 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 554' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -104.41 -51.59 3.07 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.42 0.629 . . . . 0.0 109.93 179.75 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 555' ' ' ILE . . . . . 0.402 ' O ' ' CG2' ' A' ' 555' ' ' ILE . 2.2 mm -78.27 -1.69 4.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 114.923 -1.035 . . . . 0.0 111.231 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 556' ' ' CYS . . . . . 0.447 ' O ' ' HD2' ' A' ' 559' ' ' ARG . 25.9 p -68.45 -7.0 28.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.973 178.817 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -56.27 -7.91 2.19 Favored Glycine 0 C--N 1.336 0.557 0 C-N-CA 120.975 -0.631 . . . . 0.0 113.959 -179.364 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 558' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -45.36 -72.64 0.05 Allowed 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 117.31 0.555 . . . . 0.0 111.974 -179.699 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 559' ' ' ARG . . . . . 0.597 ' HA ' ' O ' ' A' ' 507' ' ' ALA . 0.3 OUTLIER 47.49 -173.11 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.052 -179.686 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 560' ' ' GLN . . . . . 0.414 ' HG2' ' O ' ' A' ' 559' ' ' ARG . 3.0 pt20 . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.271 -0.871 . . . . 0.0 112.033 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 507' ' ' ALA . . . . . 0.403 ' HB3' ' N ' ' A' ' 560' ' ' GLN . . . . . . . . 0 N--CA 1.485 1.3 0 CA-C-O 121.15 0.5 . . . . 0.0 111.181 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 508' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.38 77.62 77.12 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.231 179.812 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 509' ' ' PRO . . . . . 0.494 ' O ' ' HB3' ' A' ' 510' ' ' LYS . 11.1 Cg_exo -71.04 -65.44 0.03 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.304 0 C-N-CA 122.563 2.175 . . . . 0.0 111.651 179.631 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 510' ' ' LYS . . . . . 0.494 ' HB3' ' O ' ' A' ' 509' ' ' PRO . 0.0 OUTLIER 173.74 -32.62 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.619 -0.718 . . . . 0.0 110.861 179.706 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 511' ' ' CYS . . . . . 0.439 ' N ' ' HG2' ' A' ' 510' ' ' LYS . 0.1 OUTLIER 42.63 41.11 2.25 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.611 179.78 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 512' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -107.72 83.94 1.81 Allowed Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.755 179.736 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 513' ' ' PRO . . . . . 0.403 ' HA ' ' O ' ' A' ' 552' ' ' ASP . 57.2 Cg_endo -71.27 -6.08 18.41 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.76 2.306 . . . . 0.0 112.86 -179.859 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -71.71 -28.29 63.6 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.189 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 515' ' ' LEU . . . . . . . . . . . . . 83.4 mt -92.06 72.24 5.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.855 0.36 . . . . 0.0 111.08 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 516' ' ' HIS . . . . . 0.511 ' CE1' ' CZ ' ' A' ' 517' ' ' TYR . 10.7 p80 -86.15 -7.18 58.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.669 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 517' ' ' TYR . . . . . 0.511 ' CZ ' ' CE1' ' A' ' 516' ' ' HIS . 46.2 m-85 -84.03 -19.43 34.45 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.711 -0.222 . . . . 0.0 111.576 -179.809 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 518' ' ' TRP . . . . . 0.5 ' O ' ' N ' ' A' ' 520' ' ' THR . 4.4 m-90 -118.08 -13.32 9.97 Favored 'General case' 0 C--N 1.332 -0.164 0 N-CA-C 112.227 0.454 . . . . 0.0 112.227 -179.134 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 519' ' ' THR . . . . . 0.563 ' OG1' ' N ' ' A' ' 520' ' ' THR . 1.2 p 57.5 -78.13 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 110.643 -0.132 . . . . 0.0 110.643 -179.691 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 520' ' ' THR . . . . . 0.563 ' N ' ' OG1' ' A' ' 519' ' ' THR . 1.2 m 178.53 -62.75 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.227 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 521' ' ' GLN . . . . . . . . . . . . . 10.7 mt-30 -75.54 -11.74 60.09 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.268 178.206 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 522' ' ' ASP . . . . . 0.45 ' HB2' ' O ' ' A' ' 518' ' ' TRP . 45.2 m-20 -94.48 -12.39 27.8 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.013 178.588 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -50.0 -25.22 3.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.701 178.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . 139.48 37.9 0.11 Allowed Glycine 0 N--CA 1.445 -0.708 0 N-CA-C 110.3 -1.12 . . . . 0.0 110.3 -179.075 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -107.94 -42.96 4.55 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.273 -0.464 . . . . 0.0 111.61 -178.543 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -136.8 42.74 2.45 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-O 121.441 0.638 . . . . 0.0 110.157 179.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 527' ' ' ILE . . . . . 0.44 ' O ' ' HB2' ' A' ' 531' ' ' TRP . 1.8 pp -95.53 -8.38 9.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 114.994 -1.003 . . . . 0.0 112.39 -179.056 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 528' ' ' GLY . . . . . . . . . . . . . . . -55.95 -16.32 12.51 Favored Glycine 0 CA--C 1.52 0.402 0 C-N-CA 120.938 -0.649 . . . . 0.0 114.009 -179.222 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 529' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -98.49 -35.3 10.3 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 117.581 0.69 . . . . 0.0 111.767 -179.314 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 530' ' ' ALA . . . . . 0.43 ' HB1' ' CA ' ' A' ' 544' ' ' ALA . . . -103.6 1.06 31.61 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.694 0.627 . . . . 0.0 112.694 -178.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 531' ' ' TRP . . . . . 0.44 ' HB2' ' O ' ' A' ' 527' ' ' ILE . 22.4 t90 -56.08 -12.81 1.63 Allowed 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 111.878 0.325 . . . . 0.0 111.878 -179.439 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 532' ' ' ILE . . . . . 0.421 ' O ' ' CD1' ' A' ' 532' ' ' ILE . 1.6 pp -129.8 74.74 80.43 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 120.908 0.385 . . . . 0.0 111.06 179.665 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 533' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -51.89 94.91 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.891 2.394 . . . . 0.0 112.688 -179.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 534' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -96.26 -17.13 20.97 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.09 179.558 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -75.89 -35.01 60.0 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.369 -179.595 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 143.88 -64.15 0.48 Allowed Glycine 0 CA--C 1.519 0.297 0 C-N-CA 120.484 -0.865 . . . . 0.0 112.788 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -58.95 -165.79 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.689 2.259 . . . . 0.0 112.177 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 538' ' ' ALA . . . . . . . . . . . . . . . -63.02 -49.76 73.37 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.474 179.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 539' ' ' ALA . . . . . 0.511 ' HA ' ' CD1' ' A' ' 542' ' ' ILE . . . 68.01 -57.63 0.46 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 121.389 0.614 . . . . 0.0 111.804 179.578 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -37.48 -29.94 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.942 -1.026 . . . . 0.0 112.338 -179.173 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 541' ' ' GLY . . . . . . . . . . . . . . . -122.89 -26.23 1.76 Allowed Glycine 0 CA--C 1.52 0.379 0 C-N-CA 120.281 -0.961 . . . . 0.0 113.503 -179.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 542' ' ' ILE . . . . . 0.511 ' CD1' ' HA ' ' A' ' 539' ' ' ALA . 2.6 pp -96.48 -21.47 5.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 112.392 0.515 . . . . 0.0 112.392 -179.247 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 543' ' ' TYR . . . . . 0.44 ' HB2' ' HA ' ' A' ' 539' ' ' ALA . 3.6 t80 -107.86 -13.75 14.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.084 0.468 . . . . 0.0 110.263 179.536 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 544' ' ' ALA . . . . . 0.43 ' CA ' ' HB1' ' A' ' 530' ' ' ALA . . . -92.16 -21.58 20.32 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.309 179.453 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 545' ' ' GLU . . . . . 0.491 ' OE2' ' HB2' ' A' ' 548' ' ' MET . 4.2 tp10 -118.36 -33.35 4.38 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.363 -179.666 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 35.21 40.71 0.26 Allowed Glycine 0 CA--C 1.519 0.297 0 CA-C-N 115.808 -0.633 . . . . 0.0 114.472 179.278 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 547' ' ' LEU . . . . . 0.429 ' HG ' ' N ' ' A' ' 548' ' ' MET . 0.0 OUTLIER -179.79 -61.43 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 118.004 0.902 . . . . 0.0 112.46 179.567 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 548' ' ' MET . . . . . 0.491 ' HB2' ' OE2' ' A' ' 545' ' ' GLU . 0.0 OUTLIER -94.6 11.65 30.31 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.818 0.342 . . . . 0.0 111.085 179.794 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 549' ' ' HIS . . . . . 0.491 ' O ' ' CG2' ' A' ' 519' ' ' THR . 6.7 p-80 -62.6 -11.12 14.88 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.079 179.568 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 550' ' ' ASN . . . . . 0.429 ' O ' ' N ' ' A' ' 552' ' ' ASP . 47.3 m-20 -96.04 -33.06 12.26 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -178.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 551' ' ' GLN . . . . . 0.413 ' HG2' ' CG ' ' A' ' 548' ' ' MET . 1.7 pt20 -66.36 71.53 0.07 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.109 0.48 . . . . 0.0 110.654 -179.79 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 552' ' ' ASP . . . . . 0.431 ' CB ' ' HA ' ' A' ' 516' ' ' HIS . 3.3 p30 -95.38 21.96 7.47 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.396 -179.661 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . 123.89 -31.05 4.66 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.902 -0.666 . . . . 0.0 111.683 -179.279 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 554' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -61.48 -58.76 6.88 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.42 0.628 . . . . 0.0 109.87 178.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 555' ' ' ILE . . . . . . . . . . . . . 3.2 mm -73.28 63.29 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.694 179.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 556' ' ' CYS . . . . . 0.408 ' O ' ' CD ' ' A' ' 559' ' ' ARG . 0.1 OUTLIER -74.09 -8.0 54.55 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.432 -179.763 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 557' ' ' GLY . . . . . 0.449 ' C ' ' HD3' ' A' ' 559' ' ' ARG . . . -48.7 -23.08 3.12 Favored Glycine 0 C--N 1.333 0.413 0 C-N-CA 120.993 -0.622 . . . . 0.0 113.006 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 558' ' ' LEU . . . . . 0.431 HD12 ' CB ' ' A' ' 509' ' ' PRO . 1.2 pp -55.03 -20.95 10.61 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 559' ' ' ARG . . . . . 0.449 ' HD3' ' C ' ' A' ' 557' ' ' GLY . 0.0 OUTLIER -53.38 -166.82 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 121.152 0.501 . . . . 0.0 111.237 -179.98 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 560' ' ' GLN . . . . . 0.406 ' HG3' ' HG2' ' A' ' 559' ' ' ARG . 5.4 mt-30 . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.229 -0.891 . . . . 0.0 111.181 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 511' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.232 0.158 0 CA-C-O 121.108 0.48 . . . . 0.0 111.428 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 512' ' ' ASN . . . . . . . . . . . . . 7.5 m-20 -131.35 82.46 62.28 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.434 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 513' ' ' PRO . . . . . 0.468 ' HA ' ' O ' ' A' ' 552' ' ' ASP . 85.3 Cg_endo -79.07 20.71 0.79 Allowed 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.895 2.396 . . . . 0.0 113.097 -179.642 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 34.8 t30 -96.67 -31.25 12.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.96 0.41 . . . . 0.0 110.786 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 515' ' ' LEU . . . . . . . . . . . . . 18.9 mt -83.52 73.85 10.16 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.886 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 516' ' ' HIS . . . . . 0.413 ' HA ' ' CB ' ' A' ' 552' ' ' ASP . 1.4 t-80 -72.47 -15.28 61.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.59 -179.78 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 517' ' ' TYR . . . . . . . . . . . . . 48.2 m-85 -79.16 -66.03 0.92 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.819 0.342 . . . . 0.0 111.433 -179.601 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 518' ' ' TRP . . . . . 0.494 ' O ' ' N ' ' A' ' 520' ' ' THR . 21.2 m-90 -70.32 -14.38 62.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.884 -179.492 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 519' ' ' THR . . . . . 0.541 ' OG1' ' N ' ' A' ' 520' ' ' THR . 1.7 p 56.98 -78.8 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 116.727 -0.215 . . . . 0.0 110.719 -179.705 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 520' ' ' THR . . . . . 0.541 ' N ' ' OG1' ' A' ' 519' ' ' THR . 1.1 m 176.83 -62.68 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.149 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 521' ' ' GLN . . . . . 0.419 ' N ' HG22 ' A' ' 520' ' ' THR . 1.6 mp0 -72.73 -12.27 60.95 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 177.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 522' ' ' ASP . . . . . 0.444 ' HA ' ' CG2' ' A' ' 527' ' ' ILE . 1.9 m-20 -93.89 -11.03 31.95 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.699 178.915 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -45.48 -27.92 0.81 Allowed 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.44 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 524' ' ' GLY . . . . . 0.436 ' HA2' ' CG1' ' A' ' 527' ' ' ILE . . . 147.62 41.38 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.489 -0.863 . . . . 0.0 112.477 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -100.44 -60.11 1.58 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.743 0.306 . . . . 0.0 111.737 -179.598 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -132.48 37.57 3.5 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-O 121.488 0.661 . . . . 0.0 110.103 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 527' ' ' ILE . . . . . 0.945 ' HA ' ' HB1' ' A' ' 544' ' ' ALA . 1.8 pp -95.94 -0.96 10.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 114.811 -1.086 . . . . 0.0 112.793 -178.938 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 528' ' ' GLY . . . . . 0.598 ' N ' HD12 ' A' ' 527' ' ' ILE . . . -57.63 -12.56 9.94 Favored Glycine 0 CA--C 1.521 0.414 0 C-N-CA 120.875 -0.679 . . . . 0.0 113.976 -179.344 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 529' ' ' LEU . . . . . 0.504 HD11 ' O ' ' A' ' 543' ' ' TYR . 1.2 pp -98.75 -39.37 8.68 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 117.757 0.779 . . . . 0.0 112.167 -179.241 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 530' ' ' ALA . . . . . 1.019 ' HB3' ' HB2' ' A' ' 544' ' ' ALA . . . -103.93 1.8 31.72 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 -178.461 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 531' ' ' TRP . . . . . 0.481 ' HB2' ' O ' ' A' ' 527' ' ' ILE . 54.9 t90 -72.04 30.3 0.05 Allowed 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -178.911 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 532' ' ' ILE . . . . . 0.62 ' O ' HD12 ' A' ' 532' ' ' ILE . 1.3 pp -159.65 70.87 3.27 Favored Pre-proline 0 C--N 1.332 -0.181 0 CA-C-O 120.723 0.297 . . . . 0.0 110.894 179.176 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 533' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -51.26 103.51 0.07 OUTLIER 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.659 2.239 . . . . 0.0 111.742 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 534' ' ' TYR . . . . . 0.4 ' CD1' HD12 ' A' ' 532' ' ' ILE . 0.4 OUTLIER -96.17 -55.06 3.08 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -179.006 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 -118.52 -35.23 3.8 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 -179.1 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . -87.44 -175.06 48.68 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.891 -179.229 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 537' ' ' PRO . . . . . 0.402 ' HG2' ' CD1' ' A' ' 542' ' ' ILE . 14.1 Cg_endo -56.59 -159.34 0.01 OUTLIER 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.884 2.39 . . . . 0.0 111.692 179.691 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 538' ' ' ALA . . . . . 0.508 ' O ' ' HB3' ' A' ' 539' ' ' ALA . . . -43.99 -49.83 8.48 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.067 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 539' ' ' ALA . . . . . 0.522 ' C ' ' HB1' ' A' ' 530' ' ' ALA . . . 71.66 -46.7 0.65 Allowed 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.205 0.526 . . . . 0.0 111.548 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 540' ' ' GLU . . . . . 0.444 ' HG2' ' HA ' ' A' ' 531' ' ' TRP . 2.5 mt-10 -36.95 -29.09 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.057 -0.974 . . . . 0.0 112.304 -179.352 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 541' ' ' GLY . . . . . 0.406 ' N ' ' O ' ' A' ' 539' ' ' ALA . . . -127.79 -48.66 0.17 Allowed Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.028 179.21 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 542' ' ' ILE . . . . . 0.628 HG22 ' CE1' ' A' ' 549' ' ' HIS . 2.6 pp -68.09 -25.14 31.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -179.355 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 543' ' ' TYR . . . . . 0.534 ' HB2' HD12 ' A' ' 542' ' ' ILE . 6.1 t80 -115.3 -8.0 12.32 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.857 0.361 . . . . 0.0 111.145 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 544' ' ' ALA . . . . . 1.019 ' HB2' ' HB3' ' A' ' 530' ' ' ALA . . . -99.31 -33.22 10.81 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.06 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 545' ' ' GLU . . . . . 0.529 ' HG3' ' H ' ' A' ' 548' ' ' MET . 14.3 tp10 -118.67 -32.67 4.49 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.209 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 40.71 42.1 2.66 Favored Glycine 0 CA--C 1.521 0.417 0 CA-C-N 115.917 -0.583 . . . . 0.0 113.747 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 547' ' ' LEU . . . . . 0.666 HD23 ' H ' ' A' ' 548' ' ' MET . 0.0 OUTLIER -173.16 -61.14 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 117.4 0.6 . . . . 0.0 112.14 179.608 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 548' ' ' MET . . . . . 0.666 ' H ' HD23 ' A' ' 547' ' ' LEU . 4.3 mtt -95.31 11.71 31.64 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.709 0.29 . . . . 0.0 111.481 -179.832 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 549' ' ' HIS . . . . . 0.628 ' CE1' HG22 ' A' ' 542' ' ' ILE . 29.9 p80 -65.47 -11.08 39.81 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.861 0.363 . . . . 0.0 110.791 179.423 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 550' ' ' ASN . . . . . 0.505 ' O ' ' N ' ' A' ' 552' ' ' ASP . 15.0 m-20 -95.87 -41.08 8.99 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -179.092 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 551' ' ' GLN . . . . . 0.51 ' HG3' ' O ' ' A' ' 548' ' ' MET . 0.0 OUTLIER -62.36 73.31 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.171 0.51 . . . . 0.0 110.469 -179.882 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 552' ' ' ASP . . . . . 0.505 ' N ' ' O ' ' A' ' 550' ' ' ASN . 1.9 p30 -90.25 22.2 3.44 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.601 -179.581 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . 124.04 -30.52 4.78 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.891 -0.671 . . . . 0.0 111.668 -179.319 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 554' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -55.73 -53.65 54.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.559 0.695 . . . . 0.0 110.138 178.863 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 555' ' ' ILE . . . . . 0.636 HG22 ' O ' ' A' ' 555' ' ' ILE . 4.0 mm -79.52 58.96 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.696 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 556' ' ' CYS . . . . . . . . . . . . . 6.3 t . . . . . 0 C--N 1.326 -0.436 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.469 -179.796 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 511' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.983 0.42 . . . . 0.0 111.485 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 512' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -131.72 77.23 73.09 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.403 179.659 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 513' ' ' PRO . . . . . 0.462 ' HA ' ' O ' ' A' ' 552' ' ' ASP . 87.7 Cg_endo -79.75 22.52 0.72 Allowed 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.932 2.421 . . . . 0.0 113.177 -179.533 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 25.8 t30 -96.67 -28.97 14.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.691 0.281 . . . . 0.0 110.804 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 515' ' ' LEU . . . . . . . . . . . . . 46.4 mt -90.59 72.87 6.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.926 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 516' ' ' HIS . . . . . 0.434 ' HA ' ' CB ' ' A' ' 552' ' ' ASP . 1.4 t60 -76.7 -7.34 55.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.655 -179.742 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 517' ' ' TYR . . . . . . . . . . . . . 42.9 m-85 -85.26 -49.5 8.14 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.674 0.274 . . . . 0.0 111.524 -179.575 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 518' ' ' TRP . . . . . 0.495 ' O ' ' N ' ' A' ' 520' ' ' THR . 3.0 m-90 -88.56 -11.55 45.3 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 111.886 0.328 . . . . 0.0 111.886 -179.331 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 519' ' ' THR . . . . . 0.572 ' OG1' ' N ' ' A' ' 520' ' ' THR . 1.3 p 56.22 -79.08 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.81 -0.177 . . . . 0.0 110.989 179.799 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 520' ' ' THR . . . . . 0.572 ' N ' ' OG1' ' A' ' 519' ' ' THR . 1.2 m 179.46 -62.74 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 179.435 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 521' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -74.16 -12.07 60.48 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 177.79 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 522' ' ' ASP . . . . . 0.438 ' HB2' ' O ' ' A' ' 518' ' ' TRP . 20.8 m-20 -93.95 -10.57 33.28 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.854 179.296 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 523' ' ' GLU . . . . . 0.466 ' HA ' ' CD1' ' A' ' 518' ' ' TRP . 14.1 pt-20 -45.24 -26.65 0.52 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.515 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . 147.6 41.35 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.289 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -101.23 -60.46 1.52 Allowed 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 111.941 0.349 . . . . 0.0 111.941 -179.466 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -131.44 36.84 3.74 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-O 121.541 0.686 . . . . 0.0 110.129 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 527' ' ' ILE . . . . . 0.935 ' HA ' ' HB1' ' A' ' 544' ' ' ALA . 2.1 pp -95.77 -0.38 10.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 114.762 -1.108 . . . . 0.0 112.709 -178.937 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 528' ' ' GLY . . . . . 0.515 ' N ' HD12 ' A' ' 527' ' ' ILE . . . -60.41 -10.47 16.85 Favored Glycine 0 CA--C 1.521 0.423 0 C-N-CA 120.82 -0.705 . . . . 0.0 113.948 -179.43 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 529' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -98.47 -33.69 10.92 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 117.569 0.684 . . . . 0.0 111.502 -179.585 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 530' ' ' ALA . . . . . 0.93 ' HB3' ' HB2' ' A' ' 544' ' ' ALA . . . -103.75 1.63 31.96 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -178.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 531' ' ' TRP . . . . . 0.547 ' O ' HG23 ' A' ' 532' ' ' ILE . 0.2 OUTLIER -71.15 30.2 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -179.056 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 532' ' ' ILE . . . . . 0.547 HG23 ' O ' ' A' ' 531' ' ' TRP . 1.1 pt -161.02 75.38 2.57 Favored Pre-proline 0 N--CA 1.456 -0.162 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.471 179.301 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 533' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -36.89 85.98 0.01 OUTLIER 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 123.5 2.8 . . . . 0.0 113.399 -179.532 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 534' ' ' TYR . . . . . 0.455 ' N ' ' O ' ' A' ' 532' ' ' ILE . 0.6 OUTLIER -96.7 -49.51 5.07 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.269 -179.991 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -57.53 -34.85 69.56 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.548 -179.329 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 143.47 -64.57 0.48 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.566 -0.826 . . . . 0.0 112.531 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -58.72 -165.48 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.622 2.215 . . . . 0.0 111.711 179.584 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 538' ' ' ALA . . . . . 0.437 ' O ' ' HB3' ' A' ' 539' ' ' ALA . . . -62.13 -51.1 69.24 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.292 179.64 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 539' ' ' ALA . . . . . 0.644 ' C ' ' HB1' ' A' ' 530' ' ' ALA . . . 68.45 -53.72 0.54 Allowed 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.599 179.725 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 540' ' ' GLU . . . . . 0.414 ' O ' ' HB3' ' A' ' 544' ' ' ALA . 0.6 OUTLIER -37.28 -27.98 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.022 -0.99 . . . . 0.0 112.09 -179.416 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 541' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 539' ' ' ALA . . . -124.57 -47.31 0.23 Allowed Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.14 179.155 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 542' ' ' ILE . . . . . 0.514 HG22 ' CE1' ' A' ' 549' ' ' HIS . 2.6 pp -72.65 -22.92 20.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 -179.634 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 543' ' ' TYR . . . . . 0.423 ' C ' ' HB2' ' A' ' 530' ' ' ALA . 89.8 t80 -111.02 -8.05 14.48 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.067 0.461 . . . . 0.0 110.68 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 544' ' ' ALA . . . . . 0.935 ' HB1' ' HA ' ' A' ' 527' ' ' ILE . . . -103.04 -32.86 9.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.02 179.43 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 545' ' ' GLU . . . . . 0.48 ' OE2' HD23 ' A' ' 547' ' ' LEU . 29.3 tp10 -118.49 -32.74 4.52 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.207 -179.76 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 38.17 37.61 0.48 Allowed Glycine 0 CA--C 1.519 0.326 0 CA-C-N 115.723 -0.672 . . . . 0.0 113.985 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 547' ' ' LEU . . . . . 0.6 HD23 ' H ' ' A' ' 548' ' ' MET . 0.0 OUTLIER -170.58 -61.99 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 117.694 0.747 . . . . 0.0 112.506 179.484 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 548' ' ' MET . . . . . 0.6 ' H ' HD23 ' A' ' 547' ' ' LEU . 0.0 OUTLIER -96.45 11.31 35.38 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.731 0.301 . . . . 0.0 111.124 179.682 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 549' ' ' HIS . . . . . 0.514 ' CE1' HG22 ' A' ' 542' ' ' ILE . 6.0 p-80 -63.43 -10.99 19.76 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.919 179.6 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 550' ' ' ASN . . . . . 0.415 ' O ' ' N ' ' A' ' 552' ' ' ASP . 44.9 m-20 -95.73 -34.25 12.0 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -179.021 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 551' ' ' GLN . . . . . 0.418 ' HG2' ' HG3' ' A' ' 548' ' ' MET . 0.7 OUTLIER -66.87 71.86 0.09 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.016 0.436 . . . . 0.0 110.55 -179.888 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 552' ' ' ASP . . . . . 0.462 ' O ' ' HA ' ' A' ' 513' ' ' PRO . 2.6 p30 -93.62 21.95 5.89 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.37 -179.626 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . 123.9 -31.91 4.38 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.885 -0.674 . . . . 0.0 111.752 -179.545 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 554' ' ' LEU . . . . . 0.441 HD11 ' OD2' ' A' ' 552' ' ' ASP . 0.5 OUTLIER -59.42 -57.85 11.17 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.493 0.663 . . . . 0.0 110.194 179.017 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 555' ' ' ILE . . . . . 0.648 HG22 ' O ' ' A' ' 555' ' ' ILE . 2.8 mm -72.36 63.77 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 CA-C-N 114.892 -1.049 . . . . 0.0 110.724 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 556' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.475 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.328 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 511' ' ' CYS . . . . . . . . . . . . . 1.5 t . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.947 0.403 . . . . 0.0 111.315 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 512' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -109.76 78.2 1.18 Allowed Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.468 179.727 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 513' ' ' PRO . . . . . 0.472 ' HA ' ' O ' ' A' ' 552' ' ' ASP . 73.6 Cg_endo -75.89 18.42 0.63 Allowed 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.92 2.414 . . . . 0.0 113.106 -179.494 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -96.7 -34.26 11.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.782 0.325 . . . . 0.0 110.773 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 515' ' ' LEU . . . . . . . . . . . . . 52.6 mt -78.9 75.13 5.41 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.943 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 516' ' ' HIS . . . . . . . . . . . . . 1.3 p-80 -79.87 -7.23 58.61 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.677 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 517' ' ' TYR . . . . . 0.442 ' HB2' ' CE3' ' A' ' 518' ' ' TRP . 44.5 m-85 -77.79 -59.9 2.59 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.783 0.325 . . . . 0.0 111.309 -179.787 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 518' ' ' TRP . . . . . 0.55 ' O ' ' N ' ' A' ' 520' ' ' THR . 13.9 m-90 -91.17 4.68 51.62 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.793 -179.618 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 519' ' ' THR . . . . . 0.534 ' OG1' ' N ' ' A' ' 520' ' ' THR . 1.3 p 54.42 -76.6 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 116.851 -0.159 . . . . 0.0 110.986 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 520' ' ' THR . . . . . 0.55 ' N ' ' O ' ' A' ' 518' ' ' TRP . 1.2 m 176.98 -62.47 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.231 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 179.436 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 521' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -69.81 -12.37 61.57 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.418 178.103 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 522' ' ' ASP . . . . . 0.462 ' HA ' ' CG2' ' A' ' 527' ' ' ILE . 1.1 m-20 -93.93 -11.2 31.49 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.939 179.294 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 523' ' ' GLU . . . . . 0.403 ' HA ' ' HB3' ' A' ' 518' ' ' TRP . 16.8 pt-20 -45.52 -27.56 0.76 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.474 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 524' ' ' GLY . . . . . 0.428 ' HA2' ' CG1' ' A' ' 527' ' ' ILE . . . 144.99 42.45 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.508 -0.854 . . . . 0.0 112.229 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -101.32 -60.31 1.55 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.713 0.292 . . . . 0.0 111.706 -179.603 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -131.8 38.43 3.55 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-O 121.521 0.677 . . . . 0.0 110.036 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 527' ' ' ILE . . . . . 0.893 ' HA ' ' HB1' ' A' ' 544' ' ' ALA . 2.1 pp -95.8 -0.5 10.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 114.719 -1.128 . . . . 0.0 112.775 -178.751 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 528' ' ' GLY . . . . . 0.538 ' N ' HD12 ' A' ' 527' ' ' ILE . . . -57.71 -14.31 14.94 Favored Glycine 0 CA--C 1.521 0.452 0 C-N-CA 120.762 -0.733 . . . . 0.0 114.005 -179.362 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 529' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -98.74 -33.66 10.83 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 117.666 0.733 . . . . 0.0 111.909 -179.334 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 530' ' ' ALA . . . . . 0.945 ' HB3' ' HB2' ' A' ' 544' ' ' ALA . . . -103.85 1.96 32.11 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -178.604 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 531' ' ' TRP . . . . . 0.512 ' O ' HG23 ' A' ' 532' ' ' ILE . 57.3 t-105 -68.43 30.09 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.546 0.573 . . . . 0.0 112.546 -178.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 532' ' ' ILE . . . . . 0.512 HG23 ' O ' ' A' ' 531' ' ' TRP . 1.1 pt -160.2 71.9 3.04 Favored Pre-proline 0 C--N 1.331 -0.207 0 CA-C-O 120.827 0.346 . . . . 0.0 110.742 179.037 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 533' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_endo -47.11 88.43 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 123.148 2.565 . . . . 0.0 112.821 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 534' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -96.43 -43.6 7.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.283 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -57.75 -34.78 69.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.552 -179.341 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 149.13 -64.77 0.4 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.529 -0.843 . . . . 0.0 112.579 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_endo -57.3 -164.09 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.576 2.184 . . . . 0.0 111.8 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 538' ' ' ALA . . . . . 0.498 ' O ' ' HB3' ' A' ' 539' ' ' ALA . . . -72.03 -47.2 53.45 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.619 179.655 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 539' ' ' ALA . . . . . 0.665 ' C ' ' HB1' ' A' ' 530' ' ' ALA . . . 70.7 -53.73 0.66 Allowed 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.33 0.586 . . . . 0.0 111.227 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 540' ' ' GLU . . . . . 0.508 ' HG2' ' HA ' ' A' ' 531' ' ' TRP . 15.6 mt-10 -37.26 -28.17 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.543 0 CA-C-N 114.828 -1.078 . . . . 0.0 112.37 -179.442 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 541' ' ' GLY . . . . . 0.447 ' HA3' ' CD2' ' A' ' 549' ' ' HIS . . . -126.24 -40.17 0.38 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.388 179.51 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 542' ' ' ILE . . . . . 0.676 HG23 ' ND1' ' A' ' 549' ' ' HIS . 2.6 pp -79.88 -23.16 11.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 112.122 0.415 . . . . 0.0 112.122 -179.406 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 543' ' ' TYR . . . . . 0.434 ' C ' ' HB2' ' A' ' 530' ' ' ALA . 89.0 t80 -111.48 -7.79 14.31 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.042 0.449 . . . . 0.0 110.613 179.63 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 544' ' ' ALA . . . . . 0.945 ' HB2' ' HB3' ' A' ' 530' ' ' ALA . . . -103.06 -36.91 7.98 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.381 179.181 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 545' ' ' GLU . . . . . 0.495 ' CG ' ' H ' ' A' ' 548' ' ' MET . 20.2 tp10 -118.91 -32.57 4.45 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.099 -0.955 . . . . 0.0 111.1 179.753 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 37.09 47.58 1.38 Allowed Glycine 0 C--N 1.331 0.285 0 CA-C-N 115.992 -0.549 . . . . 0.0 113.387 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 547' ' ' LEU . . . . . 0.689 ' HG ' ' N ' ' A' ' 548' ' ' MET . 0.0 OUTLIER -174.87 -57.55 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 117.276 0.538 . . . . 0.0 111.834 179.949 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 548' ' ' MET . . . . . 0.689 ' N ' ' HG ' ' A' ' 547' ' ' LEU . 0.0 OUTLIER -96.0 11.49 33.85 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.644 0.259 . . . . 0.0 111.344 -179.999 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 549' ' ' HIS . . . . . 0.676 ' ND1' HG23 ' A' ' 542' ' ' ILE . 12.8 t-80 -62.59 -11.82 19.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.817 0.341 . . . . 0.0 110.629 179.431 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 550' ' ' ASN . . . . . 0.477 ' O ' ' N ' ' A' ' 552' ' ' ASP . 32.7 m-20 -96.22 -39.74 9.52 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.629 -179.531 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 551' ' ' GLN . . . . . 0.437 ' HG3' ' O ' ' A' ' 548' ' ' MET . 0.0 OUTLIER -61.81 73.93 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.228 0.537 . . . . 0.0 110.843 -179.774 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 552' ' ' ASP . . . . . 0.509 ' HA ' ' O ' ' A' ' 519' ' ' THR . 1.6 p30 -83.78 22.24 1.15 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.541 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . 124.25 -26.75 5.73 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 121.01 -0.614 . . . . 0.0 111.62 -179.131 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 554' ' ' LEU . . . . . 0.404 HD11 ' OD1' ' A' ' 552' ' ' ASP . 0.7 OUTLIER -59.23 -53.32 59.65 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.438 0.637 . . . . 0.0 110.117 178.971 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 555' ' ' ILE . . . . . 0.647 HG22 ' O ' ' A' ' 555' ' ' ILE . 8.1 mm -84.59 54.02 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 CA-C-N 114.945 -1.025 . . . . 0.0 111.111 -179.596 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 556' ' ' CYS . . . . . . . . . . . . . 8.0 p . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.392 179.953 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 511' ' ' CYS . . . . . . . . . . . . . 2.5 m . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.938 0.399 . . . . 0.0 111.611 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 512' ' ' ASN . . . . . 0.416 ' O ' ' O ' ' A' ' 552' ' ' ASP . 0.5 OUTLIER -118.05 81.73 16.63 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.351 179.653 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 513' ' ' PRO . . . . . 0.525 ' HA ' ' O ' ' A' ' 552' ' ' ASP . 64.4 Cg_endo -75.21 18.78 0.54 Allowed 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 123.0 2.467 . . . . 0.0 113.235 -179.773 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 24.2 t30 -96.71 -34.17 11.46 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.873 0.368 . . . . 0.0 110.859 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 515' ' ' LEU . . . . . . . . . . . . . 2.7 mt -84.68 74.07 10.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.006 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 516' ' ' HIS . . . . . 0.448 ' HA ' ' CB ' ' A' ' 552' ' ' ASP . 14.2 t60 -71.47 -8.4 53.65 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.91 -179.726 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 517' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -82.26 -62.5 1.61 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.712 0.291 . . . . 0.0 111.629 -179.547 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 518' ' ' TRP . . . . . 0.506 ' O ' ' N ' ' A' ' 520' ' ' THR . 14.4 m-90 -71.39 -17.86 62.39 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.661 -179.467 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 519' ' ' THR . . . . . 0.508 ' OG1' ' N ' ' A' ' 520' ' ' THR . 1.8 p 54.04 -80.29 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 116.621 -0.263 . . . . 0.0 110.919 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 520' ' ' THR . . . . . 0.508 ' N ' ' OG1' ' A' ' 519' ' ' THR . 1.2 m 177.71 -62.85 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 179.065 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 521' ' ' GLN . . . . . 0.435 ' HB2' ' HB3' ' A' ' 548' ' ' MET . 0.7 OUTLIER -72.64 -11.69 60.74 Favored 'General case' 0 CA--C 1.513 -0.45 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 177.989 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 522' ' ' ASP . . . . . 0.475 ' HA ' ' CG2' ' A' ' 527' ' ' ILE . 2.4 m-20 -87.47 -11.04 50.17 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.745 179.146 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -45.2 -26.6 0.51 Allowed 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.902 -179.453 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 524' ' ' GLY . . . . . 0.46 ' HA2' ' CG1' ' A' ' 527' ' ' ILE . . . 148.51 40.52 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.458 -0.877 . . . . 0.0 112.386 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -98.21 -59.65 1.71 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.806 0.336 . . . . 0.0 111.892 -179.476 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -133.59 32.44 3.6 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.577 0.703 . . . . 0.0 110.018 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 527' ' ' ILE . . . . . 0.866 ' HA ' ' HB1' ' A' ' 544' ' ' ALA . 2.3 pp -95.86 -0.56 10.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 114.593 -1.185 . . . . 0.0 112.644 -178.801 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 528' ' ' GLY . . . . . 0.473 ' N ' HD12 ' A' ' 527' ' ' ILE . . . -58.88 -4.57 2.3 Favored Glycine 0 CA--C 1.522 0.52 0 N-CA-C 114.696 0.638 . . . . 0.0 114.696 -178.924 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 529' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -98.2 -42.24 7.52 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 118.031 0.915 . . . . 0.0 111.672 -179.59 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 530' ' ' ALA . . . . . 1.082 ' HB3' ' HB2' ' A' ' 544' ' ' ALA . . . -103.85 1.99 32.14 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.354 0.502 . . . . 0.0 112.354 -179.239 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 531' ' ' TRP . . . . . 0.66 ' CD2' HD13 ' A' ' 527' ' ' ILE . 22.5 t-105 -54.83 -9.27 0.33 Allowed 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 112.893 0.701 . . . . 0.0 112.893 -178.134 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 532' ' ' ILE . . . . . 0.72 ' O ' HD12 ' A' ' 532' ' ' ILE . 1.6 pp -135.34 76.23 56.89 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-O 121.039 0.447 . . . . 0.0 111.05 179.313 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 533' ' ' PRO . . . . . 0.532 ' HG3' ' HB3' ' A' ' 539' ' ' ALA . 32.4 Cg_exo -63.29 89.51 0.13 Allowed 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 123.058 2.506 . . . . 0.0 112.591 -179.586 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 534' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -60.52 -54.35 46.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.993 0.425 . . . . 0.0 110.151 179.415 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -118.18 22.99 11.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.702 179.361 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . -122.34 153.1 16.84 Favored Glycine 0 C--N 1.333 0.377 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.736 -179.756 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -71.28 -89.47 0.0 OUTLIER 'Trans proline' 0 CA--C 1.534 0.503 0 C-N-CA 122.714 2.276 . . . . 0.0 112.834 -179.693 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 538' ' ' ALA . . . . . . . . . . . . . . . -99.29 17.11 20.89 Favored 'General case' 0 C--N 1.333 -0.114 0 N-CA-C 111.534 0.198 . . . . 0.0 111.534 -179.669 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 539' ' ' ALA . . . . . 0.565 ' HA ' HD12 ' A' ' 542' ' ' ILE . . . -34.12 -43.8 0.16 Allowed 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 -179.395 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 540' ' ' GLU . . . . . 0.468 ' CB ' ' HA ' ' A' ' 531' ' ' TRP . 0.0 OUTLIER -60.1 -6.84 1.53 Allowed 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -178.579 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 541' ' ' GLY . . . . . . . . . . . . . . . -125.62 -40.6 0.38 Allowed Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 121.026 -0.607 . . . . 0.0 111.919 178.811 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 542' ' ' ILE . . . . . 0.565 HD12 ' HA ' ' A' ' 539' ' ' ALA . 2.1 pp -97.26 -19.36 6.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -179.833 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 543' ' ' TYR . . . . . 0.445 ' HB3' ' HB1' ' A' ' 539' ' ' ALA . 29.4 t80 -108.85 -16.3 14.19 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.048 0.452 . . . . 0.0 110.65 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 544' ' ' ALA . . . . . 1.082 ' HB2' ' HB3' ' A' ' 530' ' ' ALA . . . -91.2 -16.81 27.08 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.604 179.73 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 545' ' ' GLU . . . . . 0.522 ' OE2' HD23 ' A' ' 547' ' ' LEU . 5.4 tp10 -118.44 -32.82 4.51 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.343 -179.758 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 35.84 41.35 0.42 Allowed Glycine 0 CA--C 1.521 0.412 0 CA-C-N 115.841 -0.618 . . . . 0.0 114.133 179.647 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 547' ' ' LEU . . . . . 0.621 HD23 ' H ' ' A' ' 548' ' ' MET . 0.0 OUTLIER -172.45 -62.11 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 117.615 0.708 . . . . 0.0 112.084 179.401 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 548' ' ' MET . . . . . 0.621 ' H ' HD23 ' A' ' 547' ' ' LEU . 0.0 OUTLIER -96.32 11.6 34.11 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.06 0.457 . . . . 0.0 110.378 179.02 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 549' ' ' HIS . . . . . 0.49 ' CB ' ' HA ' ' A' ' 542' ' ' ILE . 0.3 OUTLIER -59.53 -11.3 4.43 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.323 179.744 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 550' ' ' ASN . . . . . 0.503 ' O ' ' N ' ' A' ' 552' ' ' ASP . 45.5 t30 -94.54 -34.22 12.75 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -178.461 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 551' ' ' GLN . . . . . 0.411 ' HG3' ' O ' ' A' ' 548' ' ' MET . 0.9 OUTLIER -64.25 70.95 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.131 0.491 . . . . 0.0 110.4 -179.907 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 552' ' ' ASP . . . . . 0.525 ' O ' ' HA ' ' A' ' 513' ' ' PRO . 2.9 p30 -101.69 21.91 13.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.513 -179.319 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . 123.69 -31.73 4.48 Favored Glycine 0 N--CA 1.449 -0.461 0 N-CA-C 111.47 -0.652 . . . . 0.0 111.47 -179.25 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 554' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -62.58 -49.1 76.58 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.493 0.663 . . . . 0.0 109.648 178.846 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 555' ' ' ILE . . . . . 0.639 HG22 ' O ' ' A' ' 555' ' ' ILE . 6.0 mm -88.63 60.62 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 CA-C-N 114.789 -1.096 . . . . 0.0 110.659 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 556' ' ' CYS . . . . . . . . . . . . . 20.1 m . . . . . 0 C--N 1.326 -0.443 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.38 -179.781 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 511' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.11 0 CA-C-O 121.152 0.501 . . . . 0.0 111.222 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 512' ' ' ASN . . . . . 0.556 ' HB3' HD23 ' A' ' 515' ' ' LEU . 34.3 m-20 -156.15 79.6 4.03 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.056 179.61 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 513' ' ' PRO . . . . . 0.434 ' HA ' ' O ' ' A' ' 552' ' ' ASP . 26.0 Cg_exo -61.5 -15.83 43.74 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 123.056 2.504 . . . . 0.0 112.479 -179.567 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 22.6 t30 -57.47 -43.52 84.09 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.29 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 515' ' ' LEU . . . . . 0.556 HD23 ' HB3' ' A' ' 512' ' ' ASN . 0.8 OUTLIER -81.18 73.82 8.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.822 0.344 . . . . 0.0 111.065 -179.905 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 516' ' ' HIS . . . . . 0.44 ' HA ' ' HB2' ' A' ' 552' ' ' ASP . 32.3 p-80 -89.25 -7.25 55.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.622 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 517' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -74.93 -30.85 61.36 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 111.702 0.26 . . . . 0.0 111.702 -179.525 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 518' ' ' TRP . . . . . 0.582 ' O ' ' N ' ' A' ' 520' ' ' THR . 8.5 m-90 -117.92 -0.03 11.79 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 -179.504 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 519' ' ' THR . . . . . 0.561 ' OG1' ' N ' ' A' ' 520' ' ' THR . 1.2 p 49.38 -78.37 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 120.485 0.183 . . . . 0.0 111.405 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 520' ' ' THR . . . . . 0.582 ' N ' ' O ' ' A' ' 518' ' ' TRP . 1.3 m -179.15 -62.45 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 179.519 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 521' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -72.78 -11.87 60.78 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.32 177.819 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 522' ' ' ASP . . . . . 0.446 ' HB2' ' O ' ' A' ' 518' ' ' TRP . 68.8 m-20 -91.63 -10.71 39.41 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.81 179.128 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 523' ' ' GLU . . . . . 0.4 ' HA ' ' CD1' ' A' ' 518' ' ' TRP . 0.0 OUTLIER -45.26 -26.71 0.54 Allowed 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.48 -179.72 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . 146.53 41.47 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.356 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -100.66 -60.95 1.43 Allowed 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 111.785 0.291 . . . . 0.0 111.785 -179.629 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -131.96 38.17 3.55 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-O 121.549 0.69 . . . . 0.0 110.132 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 527' ' ' ILE . . . . . 0.894 ' HA ' ' HB1' ' A' ' 544' ' ' ALA . 2.1 pp -95.79 -2.51 10.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 114.746 -1.116 . . . . 0.0 112.844 -178.882 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 528' ' ' GLY . . . . . 0.579 ' N ' HD12 ' A' ' 527' ' ' ILE . . . -56.47 -16.59 16.1 Favored Glycine 0 CA--C 1.52 0.403 0 C-N-CA 120.791 -0.719 . . . . 0.0 114.028 -179.1 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 529' ' ' LEU . . . . . 0.489 ' H ' ' HG ' ' A' ' 529' ' ' LEU . 0.7 OUTLIER -99.21 -32.82 11.02 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 117.809 0.805 . . . . 0.0 112.292 -179.394 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 530' ' ' ALA . . . . . 0.976 ' HB3' ' HB2' ' A' ' 544' ' ' ALA . . . -103.82 1.52 31.66 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -179.022 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 531' ' ' TRP . . . . . 0.467 ' O ' HG23 ' A' ' 532' ' ' ILE . 55.5 t90 -73.48 30.33 0.07 Allowed 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -179.299 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 532' ' ' ILE . . . . . 0.467 HG23 ' O ' ' A' ' 531' ' ' TRP . 1.1 pt -158.26 77.41 3.44 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-O 120.739 0.304 . . . . 0.0 110.888 179.425 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 533' ' ' PRO . . . . . 0.4 ' HG3' ' O ' ' A' ' 538' ' ' ALA . 79.6 Cg_exo -41.74 88.14 0.01 OUTLIER 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 123.045 2.497 . . . . 0.0 112.956 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 534' ' ' TYR . . . . . 0.437 ' N ' ' O ' ' A' ' 532' ' ' ILE . 12.5 t80 -96.51 -51.98 4.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.483 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -57.73 -34.84 69.93 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.635 -179.261 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 144.89 -64.18 0.46 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.506 -0.854 . . . . 0.0 112.597 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -55.29 -168.88 0.02 OUTLIER 'Trans proline' 0 CA--C 1.515 -0.457 0 C-N-CA 122.606 2.204 . . . . 0.0 111.906 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 538' ' ' ALA . . . . . 0.425 ' O ' ' HB3' ' A' ' 539' ' ' ALA . . . -63.93 -53.47 49.9 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.199 179.605 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 539' ' ' ALA . . . . . 0.6 ' O ' ' HB1' ' A' ' 530' ' ' ALA . . . 67.81 -49.93 0.52 Allowed 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.995 179.5 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 540' ' ' GLU . . . . . 0.433 ' O ' ' HB3' ' A' ' 544' ' ' ALA . 0.2 OUTLIER -37.6 -27.0 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.927 -1.033 . . . . 0.0 112.414 -179.275 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 541' ' ' GLY . . . . . 0.411 ' N ' ' O ' ' A' ' 539' ' ' ALA . . . -125.94 -43.6 0.27 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.755 -0.736 . . . . 0.0 111.889 179.129 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 542' ' ' ILE . . . . . 0.444 ' CD1' ' HA ' ' A' ' 539' ' ' ALA . 1.0 OUTLIER -69.93 -25.91 29.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 112.363 0.505 . . . . 0.0 112.363 -179.713 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 543' ' ' TYR . . . . . 0.451 ' C ' ' HB2' ' A' ' 530' ' ' ALA . 0.1 OUTLIER -111.69 -9.27 14.14 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.903 0.382 . . . . 0.0 110.784 179.988 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 544' ' ' ALA . . . . . 0.976 ' HB2' ' HB3' ' A' ' 530' ' ' ALA . . . -100.52 -33.67 10.24 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.84 179.689 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 545' ' ' GLU . . . . . 0.504 ' HG3' ' H ' ' A' ' 548' ' ' MET . 37.6 tp10 -118.86 -32.77 4.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.316 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 39.3 39.82 1.16 Allowed Glycine 0 CA--C 1.519 0.304 0 CA-C-N 115.732 -0.667 . . . . 0.0 113.976 179.815 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 547' ' ' LEU . . . . . 0.616 HD23 ' H ' ' A' ' 548' ' ' MET . 0.0 OUTLIER -173.24 -61.76 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 117.702 0.751 . . . . 0.0 112.303 179.43 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 548' ' ' MET . . . . . 0.616 ' H ' HD23 ' A' ' 547' ' ' LEU . 0.0 OUTLIER -96.32 11.51 34.4 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.7 0.286 . . . . 0.0 111.084 179.559 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 549' ' ' HIS . . . . . 0.496 ' O ' HG21 ' A' ' 519' ' ' THR . 47.8 p-80 -61.12 -11.56 9.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.85 0.357 . . . . 0.0 111.013 179.462 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 550' ' ' ASN . . . . . . . . . . . . . 48.5 m-20 -96.09 -30.79 13.35 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -179.083 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 551' ' ' GLN . . . . . 0.403 ' HG2' ' HG3' ' A' ' 548' ' ' MET . 0.8 OUTLIER -68.08 70.95 0.16 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.038 0.447 . . . . 0.0 110.696 -179.776 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 552' ' ' ASP . . . . . 0.44 ' HB2' ' HA ' ' A' ' 516' ' ' HIS . 1.9 p30 -94.95 21.82 7.21 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.244 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . 123.83 -27.91 5.56 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.856 -0.688 . . . . 0.0 111.629 -179.259 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 554' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -61.93 -55.32 30.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.567 0.698 . . . . 0.0 110.034 179.067 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 555' ' ' ILE . . . . . 0.627 HG22 ' O ' ' A' ' 555' ' ' ILE . 1.8 mm -71.66 66.94 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 114.78 -1.1 . . . . 0.0 110.421 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 556' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.323 -0.571 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.742 -179.588 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 511' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.53 0.192 0 CA-C-O 120.912 0.387 . . . . 0.0 111.44 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 512' ' ' ASN . . . . . . . . . . . . . 35.1 m-20 -120.53 79.99 30.16 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.652 179.761 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 513' ' ' PRO . . . . . 0.461 ' HA ' ' O ' ' A' ' 552' ' ' ASP . 42.7 Cg_endo -68.18 -10.23 28.28 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.651 2.234 . . . . 0.0 112.56 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 39.7 t30 -74.62 -29.98 61.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.08 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 515' ' ' LEU . . . . . . . . . . . . . 65.5 mt -84.94 74.6 10.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.886 0.374 . . . . 0.0 110.93 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 516' ' ' HIS . . . . . 0.436 ' HA ' ' HB3' ' A' ' 552' ' ' ASP . 1.9 p-80 -89.09 -7.13 56.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.582 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 517' ' ' TYR . . . . . . . . . . . . . 31.2 m-85 -70.65 -50.79 33.05 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.69 0.281 . . . . 0.0 111.638 -179.507 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 518' ' ' TRP . . . . . 0.494 ' O ' ' N ' ' A' ' 520' ' ' THR . 24.1 m-90 -112.56 10.04 19.52 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 111.914 0.338 . . . . 0.0 111.914 -179.644 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 519' ' ' THR . . . . . 0.56 HG21 ' O ' ' A' ' 549' ' ' HIS . 1.1 p 60.88 -70.13 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 116.65 -0.25 . . . . 0.0 110.915 179.627 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 520' ' ' THR . . . . . 0.494 ' N ' ' O ' ' A' ' 518' ' ' TRP . 1.0 OUTLIER 174.95 -62.82 0.01 OUTLIER 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.152 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 521' ' ' GLN . . . . . 0.507 ' HB3' ' OE1' ' A' ' 545' ' ' GLU . 2.3 mp0 -73.36 -11.95 60.66 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 178.188 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 522' ' ' ASP . . . . . 0.427 ' HB3' ' O ' ' A' ' 518' ' ' TRP . 0.6 OUTLIER -91.93 -10.97 37.57 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.912 179.1 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -45.07 -27.5 0.58 Allowed 'General case' 0 CA--C 1.528 0.107 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.304 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . 151.41 41.24 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.852 -0.69 . . . . 0.0 112.144 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -122.2 -20.33 6.24 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 526' ' ' ALA . . . . . 0.657 ' O ' ' HB1' ' A' ' 544' ' ' ALA . . . -143.79 30.25 1.34 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.254 0.55 . . . . 0.0 110.903 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 527' ' ' ILE . . . . . 0.827 HD12 ' N ' ' A' ' 528' ' ' GLY . 2.3 pp -95.64 -24.72 4.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.934 -179.562 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 528' ' ' GLY . . . . . 0.827 ' N ' HD12 ' A' ' 527' ' ' ILE . . . -49.47 -13.23 0.43 Allowed Glycine 0 CA--C 1.523 0.575 0 C-N-CA 121.154 -0.545 . . . . 0.0 114.369 -179.605 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 529' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -98.03 -47.83 5.36 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 117.864 0.832 . . . . 0.0 111.863 -179.168 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 530' ' ' ALA . . . . . 1.059 ' HB3' ' HB2' ' A' ' 544' ' ' ALA . . . -103.69 1.93 32.49 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 -178.437 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 531' ' ' TRP . . . . . 0.56 ' HB2' ' O ' ' A' ' 527' ' ' ILE . 58.8 t90 -68.85 30.53 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -179.074 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 532' ' ' ILE . . . . . 0.605 ' O ' HD12 ' A' ' 532' ' ' ILE . 1.3 pp -156.76 69.48 4.63 Favored Pre-proline 0 CA--C 1.53 0.182 0 CA-C-O 120.8 0.334 . . . . 0.0 110.91 179.357 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 533' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -52.8 105.15 0.11 Allowed 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.673 2.249 . . . . 0.0 111.875 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 534' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -96.08 -55.31 3.01 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 111.984 0.364 . . . . 0.0 111.984 -179.258 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -118.77 -35.02 3.79 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -179.338 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . -85.08 -175.24 50.57 Favored Glycine 0 CA--C 1.518 0.233 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.979 -179.224 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_endo -56.81 -159.09 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.884 2.389 . . . . 0.0 111.874 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 538' ' ' ALA . . . . . 0.517 ' O ' ' HB3' ' A' ' 539' ' ' ALA . . . -43.87 -48.76 8.42 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.55 -0.296 . . . . 0.0 111.349 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 539' ' ' ALA . . . . . 0.543 ' HA ' ' CD1' ' A' ' 542' ' ' ILE . . . 72.13 -49.3 0.69 Allowed 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.256 0.551 . . . . 0.0 111.482 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 540' ' ' GLU . . . . . 0.437 ' HG2' ' HA ' ' A' ' 531' ' ' TRP . 3.1 mt-10 -36.84 -31.45 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.863 -1.062 . . . . 0.0 112.494 -179.192 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 541' ' ' GLY . . . . . 0.433 ' O ' ' HB3' ' A' ' 549' ' ' HIS . . . -130.89 -18.95 1.32 Allowed Glycine 0 CA--C 1.52 0.369 0 C-N-CA 120.198 -1.001 . . . . 0.0 113.617 -179.738 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 542' ' ' ILE . . . . . 0.543 ' CD1' ' HA ' ' A' ' 539' ' ' ALA . 2.6 pp -96.25 -22.45 5.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 117.148 0.474 . . . . 0.0 112.251 -179.514 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 543' ' ' TYR . . . . . 0.516 ' HB2' ' HA ' ' A' ' 539' ' ' ALA . 0.2 OUTLIER -115.32 -12.08 11.83 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.966 0.412 . . . . 0.0 110.847 179.444 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 544' ' ' ALA . . . . . 1.059 ' HB2' ' HB3' ' A' ' 530' ' ' ALA . . . -92.02 -26.32 18.41 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.216 179.532 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 545' ' ' GLU . . . . . 0.7 ' OE2' HD23 ' A' ' 547' ' ' LEU . 19.7 tp10 -113.09 -33.41 6.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.773 -179.162 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 35.02 34.12 0.04 OUTLIER Glycine 0 CA--C 1.519 0.307 0 CA-C-N 115.776 -0.647 . . . . 0.0 114.259 179.379 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 547' ' ' LEU . . . . . 0.7 HD23 ' OE2' ' A' ' 545' ' ' GLU . 0.0 OUTLIER -176.41 -61.41 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 118.008 0.904 . . . . 0.0 112.695 -179.993 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 548' ' ' MET . . . . . 0.608 ' H ' HD23 ' A' ' 547' ' ' LEU . 0.4 OUTLIER -89.62 11.7 18.97 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.754 0.312 . . . . 0.0 110.935 179.733 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 549' ' ' HIS . . . . . 0.56 ' O ' HG21 ' A' ' 519' ' ' THR . 0.3 OUTLIER -64.88 -12.08 44.87 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.972 0.415 . . . . 0.0 110.62 179.588 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 550' ' ' ASN . . . . . 0.419 ' O ' ' N ' ' A' ' 552' ' ' ASP . 4.2 m120 -96.92 -35.48 10.87 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -179.022 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 551' ' ' GLN . . . . . 0.578 ' HG3' ' O ' ' A' ' 548' ' ' MET . 0.0 OUTLIER -66.37 72.59 0.08 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.044 0.449 . . . . 0.0 110.639 -179.515 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 552' ' ' ASP . . . . . 0.51 ' HA ' ' HA ' ' A' ' 519' ' ' THR . 3.0 m-20 -87.27 21.63 2.36 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.149 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . 114.26 -29.1 7.86 Favored Glycine 0 N--CA 1.451 -0.339 0 N-CA-C 111.315 -0.714 . . . . 0.0 111.315 -179.207 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 554' ' ' LEU . . . . . 0.404 HD11 ' HB2' ' A' ' 552' ' ' ASP . 0.4 OUTLIER -63.16 -57.49 10.37 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.635 0.731 . . . . 0.0 110.054 179.182 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 555' ' ' ILE . . . . . 0.633 HG22 ' O ' ' A' ' 555' ' ' ILE . 2.8 mm -71.54 65.0 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 CA-C-N 114.695 -1.139 . . . . 0.0 110.815 -179.762 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 556' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.325 -0.5 0 CA-C-N 115.56 -0.746 . . . . 0.0 111.232 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 511' ' ' CYS . . . . . . . . . . . . . 6.7 m . . . . . 0 CA--C 1.527 0.08 0 CA-C-O 120.92 0.39 . . . . 0.0 111.53 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 512' ' ' ASN . . . . . . . . . . . . . 24.3 t30 -113.36 81.73 5.37 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.451 179.536 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 513' ' ' PRO . . . . . 0.515 ' HA ' ' O ' ' A' ' 552' ' ' ASP . 73.0 Cg_endo -76.01 18.95 0.61 Allowed 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.989 2.459 . . . . 0.0 113.293 -179.584 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -96.72 -28.96 14.06 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.705 0.288 . . . . 0.0 111.024 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 515' ' ' LEU . . . . . . . . . . . . . 70.0 mt -84.22 74.54 10.29 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.899 0.38 . . . . 0.0 110.946 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 516' ' ' HIS . . . . . 0.435 ' HA ' ' CB ' ' A' ' 552' ' ' ASP . 68.0 m-70 -70.14 -23.75 63.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.507 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 517' ' ' TYR . . . . . . . . . . . . . 50.3 m-85 -73.62 -64.18 1.05 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.711 0.291 . . . . 0.0 111.637 -179.514 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 518' ' ' TRP . . . . . 0.476 ' O ' ' N ' ' A' ' 520' ' ' THR . 27.3 m-90 -69.82 -17.65 63.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.844 -179.422 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 519' ' ' THR . . . . . 0.548 ' OG1' ' N ' ' A' ' 520' ' ' THR . 2.1 p 57.83 -79.78 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 120.518 0.199 . . . . 0.0 110.519 -179.707 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 520' ' ' THR . . . . . 0.548 ' N ' ' OG1' ' A' ' 519' ' ' THR . 1.2 m 177.67 -62.61 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 179.195 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 521' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -71.68 -13.87 61.87 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 177.879 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 522' ' ' ASP . . . . . 0.458 ' HA ' ' CG2' ' A' ' 527' ' ' ILE . 2.8 m-20 -94.04 -11.11 31.43 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.88 179.044 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -45.51 -27.48 0.75 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.456 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 524' ' ' GLY . . . . . 0.418 ' HA2' ' CG1' ' A' ' 527' ' ' ILE . . . 146.21 42.11 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.55 -0.833 . . . . 0.0 112.313 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -101.51 -60.16 1.58 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.736 0.303 . . . . 0.0 111.775 -179.505 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -132.15 38.65 3.48 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-O 121.503 0.668 . . . . 0.0 110.049 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 527' ' ' ILE . . . . . 0.954 ' HA ' ' HB1' ' A' ' 544' ' ' ALA . 2.1 pp -95.83 -0.25 10.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 114.663 -1.153 . . . . 0.0 112.71 -178.925 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 528' ' ' GLY . . . . . 0.51 ' N ' HD12 ' A' ' 527' ' ' ILE . . . -53.26 -14.8 3.36 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 114.535 0.574 . . . . 0.0 114.535 -178.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 529' ' ' LEU . . . . . 0.788 ' N ' HD13 ' A' ' 529' ' ' LEU . 0.0 OUTLIER -98.66 -33.98 10.74 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 118.055 0.927 . . . . 0.0 111.609 -179.57 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 530' ' ' ALA . . . . . 0.918 ' HB3' ' HB2' ' A' ' 544' ' ' ALA . . . -103.71 1.17 31.47 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -179.308 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 531' ' ' TRP . . . . . 0.47 ' HA ' ' HG2' ' A' ' 540' ' ' GLU . 9.9 t90 -56.28 -12.33 1.56 Allowed 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -179.14 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 532' ' ' ILE . . . . . 0.731 ' O ' HD12 ' A' ' 532' ' ' ILE . 1.7 pp -133.14 73.95 73.91 Favored Pre-proline 0 N--CA 1.452 -0.373 0 CA-C-O 121.06 0.457 . . . . 0.0 111.327 179.703 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 533' ' ' PRO . . . . . 0.435 ' HB3' ' O ' ' A' ' 538' ' ' ALA . 1.7 Cg_endo -45.73 92.29 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 123.037 2.492 . . . . 0.0 112.671 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 534' ' ' TYR . . . . . . . . . . . . . 47.4 p90 -96.31 -25.4 15.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.116 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -69.75 -34.78 74.28 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.399 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 147.87 -64.09 0.42 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.822 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -59.36 -164.72 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.605 2.203 . . . . 0.0 112.033 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 538' ' ' ALA . . . . . 0.46 ' O ' ' HB3' ' A' ' 539' ' ' ALA . . . -69.3 -47.45 64.48 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.726 179.743 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 539' ' ' ALA . . . . . 0.715 ' C ' ' HB1' ' A' ' 530' ' ' ALA . . . 69.17 -53.94 0.58 Allowed 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.306 0.574 . . . . 0.0 111.45 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 540' ' ' GLU . . . . . 0.522 ' O ' ' HB3' ' A' ' 544' ' ' ALA . 10.6 mt-10 -37.57 -27.59 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.895 -1.048 . . . . 0.0 112.121 -179.541 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 541' ' ' GLY . . . . . 0.433 ' O ' ' HB3' ' A' ' 549' ' ' HIS . . . -124.76 -46.85 0.24 Allowed Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.136 179.069 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 542' ' ' ILE . . . . . 0.604 HG22 ' CE1' ' A' ' 549' ' ' HIS . 2.6 pp -73.47 -24.59 20.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 -179.367 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 543' ' ' TYR . . . . . 0.524 ' HB2' HD12 ' A' ' 542' ' ' ILE . 6.5 t80 -114.11 -7.72 13.04 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.878 0.37 . . . . 0.0 110.963 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 544' ' ' ALA . . . . . 0.954 ' HB1' ' HA ' ' A' ' 527' ' ' ILE . . . -103.14 -33.89 9.06 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 121.22 0.534 . . . . 0.0 109.948 179.362 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 545' ' ' GLU . . . . . 0.515 ' HG3' ' H ' ' A' ' 548' ' ' MET . 23.1 tp10 -118.56 -32.66 4.52 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.272 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 37.68 43.42 1.18 Allowed Glycine 0 CA--C 1.52 0.376 0 CA-C-N 115.931 -0.577 . . . . 0.0 113.771 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 547' ' ' LEU . . . . . 0.568 ' HG ' ' N ' ' A' ' 548' ' ' MET . 0.0 OUTLIER -172.94 -61.23 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 117.362 0.581 . . . . 0.0 111.874 179.628 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 548' ' ' MET . . . . . 0.568 ' N ' ' HG ' ' A' ' 547' ' ' LEU . 0.0 OUTLIER -96.03 11.59 33.54 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.672 0.272 . . . . 0.0 111.209 179.68 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 549' ' ' HIS . . . . . 0.604 ' CE1' HG22 ' A' ' 542' ' ' ILE . 10.0 p80 -61.49 -11.35 10.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.695 0.283 . . . . 0.0 110.904 179.372 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 550' ' ' ASN . . . . . 0.442 ' O ' ' N ' ' A' ' 552' ' ' ASP . 8.3 m120 -95.98 -34.23 11.86 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -179.204 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 551' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.39 72.79 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.133 0.492 . . . . 0.0 110.325 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 552' ' ' ASP . . . . . 0.515 ' O ' ' HA ' ' A' ' 513' ' ' PRO . 1.6 p30 -90.6 22.33 3.54 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.602 -0.727 . . . . 0.0 111.724 -179.447 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . 124.27 -27.52 5.54 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.863 -0.684 . . . . 0.0 111.739 -179.387 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 554' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -61.67 -57.13 13.17 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.49 0.662 . . . . 0.0 109.937 178.886 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 555' ' ' ILE . . . . . 0.511 HG22 ' O ' ' A' ' 555' ' ' ILE . 4.2 mm -76.93 70.42 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 CA-C-N 114.821 -1.081 . . . . 0.0 110.862 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 556' ' ' CYS . . . . . . . . . . . . . 34.7 m . . . . . 0 C--N 1.323 -0.557 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.748 -179.781 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 511' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.528 0.107 0 CA-C-O 120.961 0.41 . . . . 0.0 111.426 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 512' ' ' ASN . . . . . . . . . . . . . 18.5 m-20 -131.25 77.68 73.87 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.663 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 513' ' ' PRO . . . . . 0.402 ' HA ' ' O ' ' A' ' 552' ' ' ASP . 41.8 Cg_endo -68.0 -12.28 34.75 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.608 2.206 . . . . 0.0 112.41 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -65.32 -29.03 69.74 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.887 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 515' ' ' LEU . . . . . . . . . . . . . 74.4 mt -95.54 71.18 3.11 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.881 179.81 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 516' ' ' HIS . . . . . 0.465 ' HA ' ' CB ' ' A' ' 552' ' ' ASP . 8.0 p-80 -74.53 -7.34 52.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.676 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 517' ' ' TYR . . . . . . . . . . . . . 65.0 m-85 -79.9 -59.4 2.74 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.781 0.324 . . . . 0.0 111.592 -179.529 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 518' ' ' TRP . . . . . 0.429 ' CD1' ' HA ' ' A' ' 523' ' ' GLU . 0.1 OUTLIER -74.17 -21.61 59.77 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.925 -179.036 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 519' ' ' THR . . . . . 0.564 HG21 ' O ' ' A' ' 549' ' ' HIS . 2.3 p 63.38 -77.27 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 110.321 -0.252 . . . . 0.0 110.321 -179.505 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 520' ' ' THR . . . . . 0.53 ' N ' ' OG1' ' A' ' 519' ' ' THR . 1.0 OUTLIER 171.25 -62.4 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 179.227 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 521' ' ' GLN . . . . . 0.477 ' N ' HG22 ' A' ' 520' ' ' THR . 1.0 OUTLIER -72.72 -11.08 60.48 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.364 178.048 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 522' ' ' ASP . . . . . 0.412 ' HA ' ' CG2' ' A' ' 527' ' ' ILE . 0.8 OUTLIER -91.15 -21.19 21.29 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.631 178.758 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 523' ' ' GLU . . . . . 0.468 ' HG3' ' HA ' ' A' ' 520' ' ' THR . 8.9 mm-40 -45.84 -29.75 1.46 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.435 178.417 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 524' ' ' GLY . . . . . 0.422 ' HA2' ' CG1' ' A' ' 527' ' ' ILE . . . 144.51 39.16 0.06 OUTLIER Glycine 0 N--CA 1.443 -0.838 0 CA-C-N 114.816 -1.083 . . . . 0.0 110.405 -179.28 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -97.89 -59.49 1.75 Allowed 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 -178.31 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 526' ' ' ALA . . . . . 0.524 ' O ' ' HB1' ' A' ' 544' ' ' ALA . . . -130.81 40.37 3.49 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-O 121.549 0.69 . . . . 0.0 110.087 179.774 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 527' ' ' ILE . . . . . 0.8 HD12 ' N ' ' A' ' 528' ' ' GLY . 1.9 pp -95.67 -12.91 8.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 114.903 -1.044 . . . . 0.0 112.483 -179.03 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 528' ' ' GLY . . . . . 0.8 ' N ' HD12 ' A' ' 527' ' ' ILE . . . -48.45 -19.81 1.35 Allowed Glycine 0 CA--C 1.522 0.477 0 N-CA-C 114.624 0.61 . . . . 0.0 114.624 -179.131 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 529' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -98.57 -39.98 8.45 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 117.873 0.837 . . . . 0.0 112.415 -179.01 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 530' ' ' ALA . . . . . 0.973 ' HB3' ' HB2' ' A' ' 544' ' ' ALA . . . -103.88 2.06 32.14 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 -178.467 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 531' ' ' TRP . . . . . 0.519 ' O ' HG23 ' A' ' 532' ' ' ILE . 73.3 t-105 -67.45 30.22 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -178.773 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 532' ' ' ILE . . . . . 0.613 ' O ' HD12 ' A' ' 532' ' ' ILE . 1.3 pp -160.31 71.51 2.99 Favored Pre-proline 0 N--CA 1.454 -0.259 0 CA-C-O 120.837 0.351 . . . . 0.0 110.555 178.982 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 533' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -48.82 86.86 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 123.22 2.613 . . . . 0.0 112.829 -179.696 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 534' ' ' TYR . . . . . 0.4 ' N ' ' O ' ' A' ' 532' ' ' ILE . 0.2 OUTLIER -96.51 -38.3 10.06 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.049 179.804 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -62.58 -34.87 77.86 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.456 -179.412 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 151.09 -66.88 0.34 Allowed Glycine 0 CA--C 1.519 0.315 0 C-N-CA 120.47 -0.871 . . . . 0.0 112.62 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -57.2 -164.63 0.02 OUTLIER 'Trans proline' 0 CA--C 1.518 -0.307 0 C-N-CA 122.611 2.207 . . . . 0.0 111.735 179.637 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 538' ' ' ALA . . . . . 0.482 ' O ' ' HB3' ' A' ' 539' ' ' ALA . . . -74.4 -48.33 28.43 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.432 179.603 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 539' ' ' ALA . . . . . 0.676 ' C ' ' HB1' ' A' ' 530' ' ' ALA . . . 70.62 -51.83 0.67 Allowed 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.391 0.615 . . . . 0.0 111.277 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 540' ' ' GLU . . . . . 0.512 ' HG2' ' HA ' ' A' ' 531' ' ' TRP . 7.2 mt-10 -36.89 -30.68 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.809 -1.087 . . . . 0.0 112.538 -179.169 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 541' ' ' GLY . . . . . . . . . . . . . . . -126.95 -30.15 0.83 Allowed Glycine 0 CA--C 1.518 0.254 0 C-N-CA 120.412 -0.899 . . . . 0.0 112.999 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 542' ' ' ILE . . . . . 0.489 ' CD1' ' HA ' ' A' ' 539' ' ' ALA . 2.6 pp -88.82 -22.03 6.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 -179.532 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 543' ' ' TYR . . . . . 0.466 ' HB2' HD12 ' A' ' 542' ' ' ILE . 10.1 t80 -115.26 -8.43 12.32 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.892 0.377 . . . . 0.0 110.78 179.706 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 544' ' ' ALA . . . . . 0.973 ' HB2' ' HB3' ' A' ' 530' ' ' ALA . . . -103.01 -38.38 7.36 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-O 121.428 0.632 . . . . 0.0 109.572 179.217 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 545' ' ' GLU . . . . . 0.638 ' HG3' ' H ' ' A' ' 548' ' ' MET . 4.7 tp10 -118.95 -32.81 4.36 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.035 -0.984 . . . . 0.0 111.375 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 37.96 46.01 1.7 Allowed Glycine 0 CA--C 1.519 0.298 0 CA-C-N 115.895 -0.593 . . . . 0.0 113.975 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 547' ' ' LEU . . . . . 0.662 HD23 ' H ' ' A' ' 548' ' ' MET . 0.0 OUTLIER 179.03 -60.95 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 117.552 0.676 . . . . 0.0 112.049 179.682 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 548' ' ' MET . . . . . 0.662 ' H ' HD23 ' A' ' 547' ' ' LEU . 0.4 OUTLIER -87.83 11.74 14.8 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 111.765 0.283 . . . . 0.0 111.765 -179.769 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 549' ' ' HIS . . . . . 0.564 ' O ' HG21 ' A' ' 519' ' ' THR . 27.9 t60 -66.69 -11.63 55.01 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.918 0.39 . . . . 0.0 110.233 179.245 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 550' ' ' ASN . . . . . 0.659 ' O ' ' N ' ' A' ' 552' ' ' ASP . 42.1 m-20 -96.24 -56.1 2.74 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.552 -179.751 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 551' ' ' GLN . . . . . 0.555 ' HG3' ' O ' ' A' ' 548' ' ' MET . 0.0 OUTLIER -44.24 76.41 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.583 -179.616 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 552' ' ' ASP . . . . . 0.659 ' N ' ' O ' ' A' ' 550' ' ' ASN . 2.3 p30 -94.45 22.24 6.33 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.247 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . 124.12 -28.39 5.37 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.865 -0.683 . . . . 0.0 111.708 -179.36 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 554' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -58.32 -59.81 4.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.341 0.591 . . . . 0.0 110.162 179.033 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 555' ' ' ILE . . . . . 0.568 HG22 ' O ' ' A' ' 555' ' ' ILE . 5.6 mm -78.4 62.73 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.647 179.721 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 556' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.325 -0.467 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.712 -179.634 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 511' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.528 0.133 0 CA-C-O 121.216 0.532 . . . . 0.0 111.575 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 512' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -136.58 82.18 33.87 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.252 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 513' ' ' PRO . . . . . 0.551 ' HA ' ' O ' ' A' ' 552' ' ' ASP . 58.2 Cg_endo -72.68 9.22 1.33 Allowed 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.839 2.359 . . . . 0.0 113.314 -179.375 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -95.87 -24.81 16.26 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.684 0.278 . . . . 0.0 110.997 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 515' ' ' LEU . . . . . . . . . . . . . 84.6 mt -87.1 74.59 9.6 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.831 0.348 . . . . 0.0 111.062 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 516' ' ' HIS . . . . . 0.435 ' HA ' ' CB ' ' A' ' 552' ' ' ASP . 25.0 p80 -81.14 -7.28 59.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.713 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 517' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -71.49 -46.72 59.06 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.679 0.276 . . . . 0.0 111.541 -179.511 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 518' ' ' TRP . . . . . 0.522 ' O ' ' N ' ' A' ' 520' ' ' THR . 12.3 m-90 -101.8 -3.87 27.31 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -179.314 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 519' ' ' THR . . . . . 0.569 ' HA ' ' HA ' ' A' ' 552' ' ' ASP . 4.1 p 56.41 -78.07 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 120.551 0.215 . . . . 0.0 110.757 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 520' ' ' THR . . . . . 0.522 ' N ' ' O ' ' A' ' 518' ' ' TRP . 1.1 m 176.04 -62.43 0.01 OUTLIER 'General case' 0 CA--C 1.521 -0.171 0 N-CA-C 109.171 -0.678 . . . . 0.0 109.171 179.375 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 521' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -71.64 -12.56 61.4 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 177.887 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 522' ' ' ASP . . . . . 0.418 ' HB2' ' O ' ' A' ' 518' ' ' TRP . 1.2 m-20 -93.86 -11.21 31.62 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.667 178.956 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -45.69 -27.88 0.89 Allowed 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.253 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 524' ' ' GLY . . . . . 0.409 ' HA2' ' CG1' ' A' ' 527' ' ' ILE . . . 145.41 43.02 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.243 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -102.56 -58.97 1.78 Allowed 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 -179.467 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -131.61 39.89 3.45 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-O 121.565 0.698 . . . . 0.0 109.986 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 527' ' ' ILE . . . . . 0.809 ' HA ' ' HB1' ' A' ' 544' ' ' ALA . 1.9 pp -95.61 -0.54 10.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 114.764 -1.107 . . . . 0.0 112.693 -178.864 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 528' ' ' GLY . . . . . 0.569 ' N ' HD12 ' A' ' 527' ' ' ILE . . . -60.23 -14.34 32.65 Favored Glycine 0 CA--C 1.52 0.387 0 C-N-CA 120.865 -0.683 . . . . 0.0 113.901 -179.301 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 529' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -98.55 -33.84 10.83 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 117.477 0.638 . . . . 0.0 111.68 -179.408 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 530' ' ' ALA . . . . . 1.041 ' HB3' ' HB2' ' A' ' 544' ' ' ALA . . . -103.81 1.53 31.69 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -179.057 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 531' ' ' TRP . . . . . 0.44 ' HB2' ' O ' ' A' ' 527' ' ' ILE . 73.2 t-105 -56.08 -12.6 1.55 Allowed 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 -179.378 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 532' ' ' ILE . . . . . 0.683 ' O ' HD12 ' A' ' 532' ' ' ILE . 1.5 pp -129.44 75.21 80.26 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 120.978 0.418 . . . . 0.0 110.984 179.699 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 533' ' ' PRO . . . . . 0.525 ' HB3' ' HB3' ' A' ' 539' ' ' ALA . 5.6 Cg_endo -48.91 89.88 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 123.099 2.533 . . . . 0.0 112.85 -179.672 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 534' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -96.3 -13.33 23.41 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.068 179.524 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -76.85 -34.87 57.81 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.282 -179.676 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 536' ' ' GLY . . . . . 0.417 ' N ' ' CD ' ' A' ' 537' ' ' PRO . . . 141.42 -49.54 0.76 Allowed Glycine 0 CA--C 1.52 0.347 0 C-N-CA 120.518 -0.848 . . . . 0.0 112.915 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 537' ' ' PRO . . . . . 0.417 ' CD ' ' N ' ' A' ' 536' ' ' GLY . 5.6 Cg_exo -76.56 -168.0 0.52 Allowed 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 122.714 2.276 . . . . 0.0 111.931 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 538' ' ' ALA . . . . . 0.422 ' O ' ' HB3' ' A' ' 539' ' ' ALA . . . -56.28 -47.63 78.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.461 179.505 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 539' ' ' ALA . . . . . 0.605 ' C ' ' HB1' ' A' ' 530' ' ' ALA . . . 68.14 -59.47 0.43 Allowed 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 121.362 0.601 . . . . 0.0 111.976 179.339 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 540' ' ' GLU . . . . . 0.409 ' OE2' ' CE3' ' A' ' 531' ' ' TRP . 2.7 mt-10 -37.49 -28.77 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 114.871 -1.059 . . . . 0.0 112.293 -179.108 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 541' ' ' GLY . . . . . 0.425 ' O ' ' HB2' ' A' ' 549' ' ' HIS . . . -121.9 -26.71 1.85 Allowed Glycine 0 CA--C 1.521 0.41 0 C-N-CA 120.479 -0.867 . . . . 0.0 113.27 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 542' ' ' ILE . . . . . 0.594 ' CD1' ' HA ' ' A' ' 539' ' ' ALA . 2.6 pp -95.84 -20.59 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -179.345 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 543' ' ' TYR . . . . . 0.528 ' HB2' ' HA ' ' A' ' 539' ' ' ALA . 0.3 OUTLIER -107.84 -10.73 15.5 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.112 0.482 . . . . 0.0 110.113 178.901 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 544' ' ' ALA . . . . . 1.041 ' HB2' ' HB3' ' A' ' 530' ' ' ALA . . . -103.16 -38.45 7.28 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.78 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 545' ' ' GLU . . . . . 0.573 ' HG3' ' H ' ' A' ' 548' ' ' MET . 5.9 tp10 -118.91 -32.96 4.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.151 -0.932 . . . . 0.0 111.487 -179.716 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 37.72 49.37 1.89 Allowed Glycine 0 CA--C 1.52 0.403 0 CA-C-N 115.988 -0.551 . . . . 0.0 113.822 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 547' ' ' LEU . . . . . 0.625 HD21 ' SD ' ' A' ' 548' ' ' MET . 0.0 OUTLIER 178.99 -60.83 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 117.528 0.664 . . . . 0.0 111.976 179.633 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 548' ' ' MET . . . . . 0.625 ' SD ' HD21 ' A' ' 547' ' ' LEU . 0.0 OUTLIER -86.38 11.76 11.65 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.671 0.272 . . . . 0.0 111.566 -179.802 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 549' ' ' HIS . . . . . 0.509 ' O ' ' CG2' ' A' ' 519' ' ' THR . 56.6 t60 -67.96 -10.97 57.77 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.899 0.381 . . . . 0.0 110.412 179.249 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 550' ' ' ASN . . . . . 0.432 ' O ' ' N ' ' A' ' 552' ' ' ASP . 38.9 t30 -92.89 -25.91 17.86 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.126 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 551' ' ' GLN . . . . . 0.53 ' HG2' ' O ' ' A' ' 548' ' ' MET . 2.3 mm-40 -66.91 70.32 0.08 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.249 0.547 . . . . 0.0 110.123 179.719 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 552' ' ' ASP . . . . . 0.569 ' HA ' ' HA ' ' A' ' 519' ' ' THR . 1.7 p30 -89.37 21.6 3.26 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.679 -179.46 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . 123.41 -32.82 4.19 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.885 -0.674 . . . . 0.0 111.592 -179.607 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 554' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -52.14 -58.06 7.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.498 0.665 . . . . 0.0 110.348 179.226 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 555' ' ' ILE . . . . . 0.587 HG22 ' O ' ' A' ' 555' ' ' ILE . 3.7 mm -72.62 60.86 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 CA-C-N 114.808 -1.087 . . . . 0.0 110.942 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 556' ' ' CYS . . . . . . . . . . . . . 5.3 t . . . . . 0 C--N 1.326 -0.449 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.373 -179.955 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 511' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.462 0.142 0 CA-C-O 121.032 0.444 . . . . 0.0 111.776 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 512' ' ' ASN . . . . . 0.541 ' HB3' HD21 ' A' ' 515' ' ' LEU . 0.9 OUTLIER -158.55 77.93 3.25 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.393 179.865 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 513' ' ' PRO . . . . . 0.568 ' HA ' ' O ' ' A' ' 552' ' ' ASP . 73.8 Cg_endo -76.67 19.14 0.66 Allowed 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 123.039 2.493 . . . . 0.0 113.462 -179.494 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 23.6 t30 -96.79 -34.56 11.26 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.642 0.258 . . . . 0.0 111.137 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 515' ' ' LEU . . . . . 0.541 HD21 ' HB3' ' A' ' 512' ' ' ASN . 0.7 OUTLIER -90.71 72.49 6.71 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.897 0.38 . . . . 0.0 111.085 -179.868 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 516' ' ' HIS . . . . . 0.506 ' HA ' ' HB2' ' A' ' 552' ' ' ASP . 2.6 p-80 -80.13 -7.25 58.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.751 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 517' ' ' TYR . . . . . . . . . . . . . 37.9 m-85 -69.55 -29.69 67.32 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 111.67 0.248 . . . . 0.0 111.67 -179.51 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 518' ' ' TRP . . . . . 0.482 ' O ' ' N ' ' A' ' 520' ' ' THR . 4.7 m-90 -118.03 -8.28 10.74 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -179.246 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 519' ' ' THR . . . . . 0.528 ' OG1' ' N ' ' A' ' 520' ' ' THR . 1.3 p 59.82 -76.53 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 120.475 0.179 . . . . 0.0 110.537 -179.725 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 520' ' ' THR . . . . . 0.528 ' N ' ' OG1' ' A' ' 519' ' ' THR . 1.0 OUTLIER 172.24 -62.7 0.01 OUTLIER 'General case' 0 C--O 1.232 0.147 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 179.146 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 521' ' ' GLN . . . . . 0.471 ' N ' HG22 ' A' ' 520' ' ' THR . 6.4 mt-30 -73.42 -12.01 60.66 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 177.874 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 522' ' ' ASP . . . . . 0.404 ' HB2' ' O ' ' A' ' 518' ' ' TRP . 9.6 m-20 -93.47 -11.12 32.81 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.684 178.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -45.51 -27.09 0.67 Allowed 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.539 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 524' ' ' GLY . . . . . 0.441 ' HA2' ' CG1' ' A' ' 527' ' ' ILE . . . 148.6 41.13 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.577 -0.82 . . . . 0.0 112.225 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -99.62 -59.95 1.62 Allowed 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 111.879 0.325 . . . . 0.0 111.879 -179.477 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -132.0 35.97 3.7 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.505 0.669 . . . . 0.0 110.135 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 527' ' ' ILE . . . . . 0.985 ' HA ' ' HB1' ' A' ' 544' ' ' ALA . 2.2 pp -95.85 -0.42 10.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 114.741 -1.118 . . . . 0.0 112.836 -178.836 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 528' ' ' GLY . . . . . 0.495 ' N ' HD12 ' A' ' 527' ' ' ILE . . . -60.23 -8.82 9.55 Favored Glycine 0 CA--C 1.522 0.495 0 C-N-CA 120.907 -0.663 . . . . 0.0 114.146 -179.243 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 529' ' ' LEU . . . . . 0.718 HD11 ' O ' ' A' ' 543' ' ' TYR . 2.0 pp -98.54 -35.0 10.37 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 117.819 0.809 . . . . 0.0 111.624 -179.565 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 530' ' ' ALA . . . . . 1.008 ' HB3' ' HB2' ' A' ' 544' ' ' ALA . . . -103.64 1.63 32.23 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -179.273 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 531' ' ' TRP . . . . . 0.432 ' HA ' ' HG2' ' A' ' 540' ' ' GLU . 0.2 OUTLIER -70.4 30.71 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -178.853 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 532' ' ' ILE . . . . . 0.469 ' H ' ' C ' ' A' ' 530' ' ' ALA . 1.3 pt -156.68 78.92 3.89 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 120.665 0.269 . . . . 0.0 110.735 179.183 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 533' ' ' PRO . . . . . . . . . . . . . 99.9 Cg_exo -39.46 86.16 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 123.327 2.685 . . . . 0.0 113.212 -179.607 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 534' ' ' TYR . . . . . 0.463 ' N ' ' O ' ' A' ' 532' ' ' ILE . 1.7 t80 -96.61 -50.99 4.49 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.282 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -57.78 -34.95 70.12 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.459 -179.41 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 145.79 -63.98 0.45 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.563 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -59.94 -166.99 0.04 OUTLIER 'Trans proline' 0 CA--C 1.516 -0.393 0 C-N-CA 122.605 2.203 . . . . 0.0 111.833 179.685 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 538' ' ' ALA . . . . . 0.444 ' O ' ' HB3' ' A' ' 539' ' ' ALA . . . -61.65 -52.82 62.75 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.114 179.606 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 539' ' ' ALA . . . . . 0.572 ' O ' ' HB1' ' A' ' 530' ' ' ALA . . . 68.13 -47.01 0.53 Allowed 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.99 179.414 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 540' ' ' GLU . . . . . 0.432 ' HG2' ' HA ' ' A' ' 531' ' ' TRP . 0.8 OUTLIER -37.39 -28.15 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.126 -0.943 . . . . 0.0 112.366 -179.139 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 541' ' ' GLY . . . . . . . . . . . . . . . -127.63 -42.06 0.27 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.012 179.308 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 542' ' ' ILE . . . . . 0.57 HG23 ' CD2' ' A' ' 549' ' ' HIS . 0.8 OUTLIER -69.63 -26.31 30.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 -179.79 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 543' ' ' TYR . . . . . 0.718 ' O ' HD11 ' A' ' 529' ' ' LEU . 1.8 m-85 -110.68 -10.19 14.49 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.054 0.454 . . . . 0.0 110.697 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 544' ' ' ALA . . . . . 1.008 ' HB2' ' HB3' ' A' ' 530' ' ' ALA . . . -97.9 -30.54 12.69 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.035 179.751 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 545' ' ' GLU . . . . . 0.525 ' HG3' ' H ' ' A' ' 548' ' ' MET . 6.3 tp10 -118.87 -32.81 4.39 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.475 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 35.56 40.13 0.28 Allowed Glycine 0 CA--C 1.52 0.399 0 CA-C-N 116.025 -0.534 . . . . 0.0 113.808 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 547' ' ' LEU . . . . . 0.568 HD23 ' H ' ' A' ' 548' ' ' MET . 0.0 OUTLIER -173.65 -61.41 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 117.498 0.649 . . . . 0.0 112.1 179.748 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 548' ' ' MET . . . . . 0.631 ' O ' ' HG3' ' A' ' 551' ' ' GLN . 0.0 OUTLIER -94.36 11.92 28.83 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.758 0.314 . . . . 0.0 111.133 179.674 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 549' ' ' HIS . . . . . 0.57 ' CD2' HG23 ' A' ' 542' ' ' ILE . 38.4 t60 -64.41 -10.75 26.94 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 120.846 -0.342 . . . . 0.0 110.82 179.582 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 550' ' ' ASN . . . . . 0.52 ' O ' ' N ' ' A' ' 552' ' ' ASP . 41.9 m-20 -94.82 -34.8 12.34 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.875 0.695 . . . . 0.0 112.875 -178.557 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 551' ' ' GLN . . . . . 0.631 ' HG3' ' O ' ' A' ' 548' ' ' MET . 1.1 pp0? -62.34 68.12 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.112 0.482 . . . . 0.0 111.238 -179.451 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 552' ' ' ASP . . . . . 0.568 ' O ' ' HA ' ' A' ' 513' ' ' PRO . 1.7 p30 -94.83 20.93 8.09 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.284 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . 123.63 -31.04 4.72 Favored Glycine 0 N--CA 1.45 -0.399 0 N-CA-C 111.321 -0.711 . . . . 0.0 111.321 -179.18 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 554' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -55.9 -52.5 63.87 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.475 0.655 . . . . 0.0 110.037 179.066 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 555' ' ' ILE . . . . . 0.641 HG22 ' O ' ' A' ' 555' ' ' ILE . 5.2 mm -82.9 56.32 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 CA-C-N 114.884 -1.053 . . . . 0.0 110.53 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 556' ' ' CYS . . . . . . . . . . . . . 17.6 t . . . . . 0 C--N 1.327 -0.381 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.432 -179.768 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 511' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.462 0.128 0 CA-C-O 120.974 0.416 . . . . 0.0 111.73 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 512' ' ' ASN . . . . . 0.716 ' OD1' HD12 ' A' ' 515' ' ' LEU . 6.0 p30 -140.13 73.75 31.58 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.39 179.324 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 513' ' ' PRO . . . . . 0.543 ' HA ' ' O ' ' A' ' 552' ' ' ASP . 31.3 Cg_exo -60.96 -14.73 34.5 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.899 2.399 . . . . 0.0 112.625 -179.612 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -69.42 -43.36 73.53 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.474 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 515' ' ' LEU . . . . . 0.716 HD12 ' OD1' ' A' ' 512' ' ' ASN . 53.1 mt -66.53 76.33 0.1 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.88 0.371 . . . . 0.0 111.076 -179.81 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 516' ' ' HIS . . . . . 0.56 ' HA ' ' HB3' ' A' ' 552' ' ' ASP . 0.2 OUTLIER -84.55 -7.16 59.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.722 -179.857 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 517' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -79.11 -61.82 1.89 Allowed 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -179.199 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 518' ' ' TRP . . . . . 0.488 ' O ' ' N ' ' A' ' 520' ' ' THR . 4.1 m-90 -87.13 -3.91 59.1 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -178.696 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 519' ' ' THR . . . . . 0.522 ' HA ' ' HA ' ' A' ' 552' ' ' ASP . 3.0 p 59.66 -76.49 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.391 0.139 . . . . 0.0 110.704 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 520' ' ' THR . . . . . 0.517 ' N ' ' OG1' ' A' ' 519' ' ' THR . 1.0 OUTLIER 173.04 -62.59 0.01 OUTLIER 'General case' 0 CA--C 1.521 -0.17 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 179.367 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 521' ' ' GLN . . . . . 0.43 ' N ' HG22 ' A' ' 520' ' ' THR . 2.7 mt-30 -73.32 -12.75 60.95 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.426 178.189 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 522' ' ' ASP . . . . . 0.422 ' HB2' ' O ' ' A' ' 518' ' ' TRP . 2.5 m-20 -93.91 -11.09 31.78 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.832 179.025 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -45.57 -28.01 0.87 Allowed 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.514 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 524' ' ' GLY . . . . . 0.451 ' HA2' ' CG1' ' A' ' 527' ' ' ILE . . . 147.34 42.18 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.471 -0.871 . . . . 0.0 112.354 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -101.39 -58.6 1.85 Allowed 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -179.43 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -132.03 35.08 3.76 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-O 121.566 0.698 . . . . 0.0 110.161 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 527' ' ' ILE . . . . . 0.968 ' HA ' ' HB1' ' A' ' 544' ' ' ALA . 2.2 pp -95.65 -0.45 10.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 114.797 -1.092 . . . . 0.0 112.606 -178.972 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 528' ' ' GLY . . . . . 0.514 ' N ' HD12 ' A' ' 527' ' ' ILE . . . -59.17 -7.65 5.43 Favored Glycine 0 CA--C 1.522 0.511 0 C-N-CA 121.018 -0.61 . . . . 0.0 114.256 -179.244 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 529' ' ' LEU . . . . . 0.472 HD11 ' O ' ' A' ' 543' ' ' TYR . 1.0 OUTLIER -97.77 -35.9 10.39 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 117.772 0.786 . . . . 0.0 111.36 -179.584 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 530' ' ' ALA . . . . . 0.96 ' HB3' ' HB2' ' A' ' 544' ' ' ALA . . . -103.76 1.97 32.34 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -179.392 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 531' ' ' TRP . . . . . 0.472 ' HA ' ' HG2' ' A' ' 540' ' ' GLU . 9.9 t90 -67.41 30.24 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 -178.8 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 532' ' ' ILE . . . . . 0.496 ' H ' ' C ' ' A' ' 530' ' ' ALA . 1.1 pt -159.31 72.77 3.42 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-O 120.843 0.354 . . . . 0.0 110.403 179.012 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 533' ' ' PRO . . . . . 0.414 ' HB3' ' O ' ' A' ' 537' ' ' PRO . 7.5 Cg_endo -49.74 86.38 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 123.129 2.552 . . . . 0.0 112.692 -179.69 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 534' ' ' TYR . . . . . 0.411 ' N ' ' O ' ' A' ' 532' ' ' ILE . 20.8 t80 -96.55 -29.76 13.69 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.156 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -71.14 -34.86 71.4 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.542 -179.388 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 152.51 -66.13 0.34 Allowed Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.579 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 537' ' ' PRO . . . . . 0.414 ' O ' ' HB3' ' A' ' 533' ' ' PRO . 19.5 Cg_endo -58.06 -162.67 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.612 2.208 . . . . 0.0 111.608 179.729 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 538' ' ' ALA . . . . . 0.482 ' O ' ' HB3' ' A' ' 539' ' ' ALA . . . -76.5 -46.21 27.66 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.645 179.673 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 539' ' ' ALA . . . . . 0.556 ' C ' ' HB1' ' A' ' 530' ' ' ALA . . . 70.56 -51.15 0.67 Allowed 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.264 0.554 . . . . 0.0 111.46 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 540' ' ' GLU . . . . . 0.474 ' O ' ' HB3' ' A' ' 544' ' ' ALA . 7.1 mt-10 -37.38 -28.71 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.85 -1.068 . . . . 0.0 112.347 -179.371 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 541' ' ' GLY . . . . . 0.413 ' O ' ' HB3' ' A' ' 545' ' ' GLU . . . -128.19 -38.07 0.4 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.746 179.59 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 542' ' ' ILE . . . . . 0.493 ' H ' HG13 ' A' ' 542' ' ' ILE . 2.5 pp -78.86 -25.57 13.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -179.19 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 543' ' ' TYR . . . . . 0.5 ' HB2' ' HA ' ' A' ' 539' ' ' ALA . 0.4 OUTLIER -114.58 -6.86 12.8 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.896 0.379 . . . . 0.0 110.73 179.568 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 544' ' ' ALA . . . . . 0.968 ' HB1' ' HA ' ' A' ' 527' ' ' ILE . . . -99.9 -29.99 12.27 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.953 179.206 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 545' ' ' GLU . . . . . 0.547 ' HG3' ' H ' ' A' ' 548' ' ' MET . 6.2 tp10 -118.61 -32.92 4.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.474 -179.737 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 35.2 43.14 0.45 Allowed Glycine 0 CA--C 1.519 0.339 0 CA-C-N 115.923 -0.58 . . . . 0.0 114.295 179.443 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 547' ' ' LEU . . . . . 0.626 HD21 ' SD ' ' A' ' 548' ' ' MET . 0.0 OUTLIER -178.7 -61.27 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 117.753 0.776 . . . . 0.0 112.006 179.683 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 548' ' ' MET . . . . . 0.626 ' SD ' HD21 ' A' ' 547' ' ' LEU . 0.0 OUTLIER -89.96 12.12 18.48 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.854 0.359 . . . . 0.0 111.031 179.669 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 549' ' ' HIS . . . . . 0.494 ' O ' ' CG2' ' A' ' 519' ' ' THR . 75.7 t60 -64.81 -11.21 34.52 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.832 0.349 . . . . 0.0 110.75 179.558 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 550' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -94.24 -17.62 22.49 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.43 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 551' ' ' GLN . . . . . 0.566 ' HG2' ' O ' ' A' ' 548' ' ' MET . 0.9 OUTLIER -70.46 65.82 0.3 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.162 0.506 . . . . 0.0 110.364 179.667 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 552' ' ' ASP . . . . . 0.56 ' HB3' ' HA ' ' A' ' 516' ' ' HIS . 4.3 m-20 -91.37 21.75 4.31 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.35 -179.717 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 553' ' ' GLY . . . . . 0.405 ' HA3' ' C ' ' A' ' 512' ' ' ASN . . . 117.33 -35.28 4.19 Favored Glycine 0 N--CA 1.45 -0.413 0 N-CA-C 111.332 -0.707 . . . . 0.0 111.332 -179.336 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 554' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -56.23 -59.23 5.24 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.524 0.678 . . . . 0.0 109.844 178.903 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 555' ' ' ILE . . . . . 0.565 HG22 ' O ' ' A' ' 555' ' ' ILE . 3.9 mm -73.46 62.33 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 CA-C-N 114.705 -1.134 . . . . 0.0 110.657 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 556' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.327 -0.406 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.647 -179.727 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 511' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.119 0 CA-C-O 121.272 0.558 . . . . 0.0 110.986 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 512' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -140.21 83.34 15.76 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.07 179.383 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 513' ' ' PRO . . . . . 0.519 ' HA ' ' O ' ' A' ' 552' ' ' ASP . 74.2 Cg_endo -76.9 21.94 0.57 Allowed 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.932 2.422 . . . . 0.0 113.246 -179.278 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 20.0 t30 -96.83 -46.21 6.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.691 0.281 . . . . 0.0 110.687 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 515' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -72.18 75.57 0.97 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.925 0.393 . . . . 0.0 110.799 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 516' ' ' HIS . . . . . 0.457 ' HA ' ' HB3' ' A' ' 552' ' ' ASP . 0.1 OUTLIER -73.67 -7.41 51.92 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.786 -179.785 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 517' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -88.72 -48.48 7.49 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.716 0.293 . . . . 0.0 111.711 -179.469 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 518' ' ' TRP . . . . . 0.484 ' O ' ' N ' ' A' ' 520' ' ' THR . 3.7 m-90 -84.07 -8.4 59.12 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 -179.32 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 519' ' ' THR . . . . . 0.565 ' HA ' ' HA ' ' A' ' 552' ' ' ASP . 2.7 p 59.34 -78.56 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 120.581 0.229 . . . . 0.0 110.469 -179.763 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 520' ' ' THR . . . . . 0.549 ' N ' ' OG1' ' A' ' 519' ' ' THR . 1.2 m 172.73 -62.78 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 179.083 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 521' ' ' GLN . . . . . 0.413 ' N ' HG22 ' A' ' 520' ' ' THR . 3.1 mt-30 -74.98 -12.03 60.24 Favored 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 177.928 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 522' ' ' ASP . . . . . 0.436 ' HA ' ' CG2' ' A' ' 527' ' ' ILE . 1.9 m-20 -93.99 -10.95 31.94 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.541 178.874 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -45.33 -27.51 0.68 Allowed 'General case' 0 C--O 1.232 0.158 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.552 -179.656 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 524' ' ' GLY . . . . . 0.433 ' HA2' ' CG1' ' A' ' 527' ' ' ILE . . . 146.35 42.29 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.566 -0.826 . . . . 0.0 112.306 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -101.32 -59.27 1.73 Allowed 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 111.917 0.34 . . . . 0.0 111.917 -179.527 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 526' ' ' ALA . . . . . 0.464 ' O ' HD21 ' A' ' 529' ' ' LEU . . . -132.25 35.97 3.65 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-O 121.512 0.673 . . . . 0.0 110.146 179.763 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 527' ' ' ILE . . . . . 0.943 ' HA ' ' HB1' ' A' ' 544' ' ' ALA . 2.2 pp -95.7 -0.64 10.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 114.769 -1.105 . . . . 0.0 112.701 -178.902 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 528' ' ' GLY . . . . . 0.529 ' N ' HD12 ' A' ' 527' ' ' ILE . . . -62.08 -8.11 15.84 Favored Glycine 0 CA--C 1.521 0.414 0 C-N-CA 120.939 -0.648 . . . . 0.0 114.035 -179.229 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 529' ' ' LEU . . . . . 0.464 HD21 ' O ' ' A' ' 526' ' ' ALA . 0.2 OUTLIER -98.32 -35.62 10.26 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 117.587 0.693 . . . . 0.0 111.556 -179.574 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 530' ' ' ALA . . . . . 0.943 ' HB3' ' HB2' ' A' ' 544' ' ' ALA . . . -103.66 -1.08 28.67 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -179.118 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 531' ' ' TRP . . . . . 0.651 ' CE3' HD13 ' A' ' 527' ' ' ILE . 14.5 t-105 -56.09 -12.3 1.44 Allowed 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 112.039 0.385 . . . . 0.0 112.039 -179.187 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 532' ' ' ILE . . . . . 0.695 ' O ' HD12 ' A' ' 532' ' ' ILE . 1.6 pp -130.13 75.65 79.05 Favored Pre-proline 0 N--CA 1.451 -0.421 0 CA-C-O 121.005 0.431 . . . . 0.0 111.132 179.727 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 533' ' ' PRO . . . . . 0.403 ' HB3' ' O ' ' A' ' 538' ' ' ALA . 3.9 Cg_endo -46.95 92.25 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 123.169 2.579 . . . . 0.0 112.672 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 534' ' ' TYR . . . . . . . . . . . . . 46.9 p90 -96.18 -22.82 17.05 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.127 179.631 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -73.98 -34.86 64.39 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.303 -179.685 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 150.25 -64.28 0.39 Allowed Glycine 0 CA--C 1.519 0.332 0 C-N-CA 120.491 -0.862 . . . . 0.0 112.833 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -59.92 -164.17 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.651 2.234 . . . . 0.0 112.097 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 538' ' ' ALA . . . . . 0.486 ' O ' ' HB3' ' A' ' 539' ' ' ALA . . . -70.41 -46.53 63.79 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.678 179.753 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 539' ' ' ALA . . . . . 0.688 ' C ' ' HB1' ' A' ' 530' ' ' ALA . . . 70.68 -52.35 0.67 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.212 0.53 . . . . 0.0 111.709 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 540' ' ' GLU . . . . . 0.52 ' O ' ' HB3' ' A' ' 544' ' ' ALA . 13.0 mt-10 -37.21 -28.07 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.831 -1.077 . . . . 0.0 112.427 -179.231 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 541' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' A' ' 539' ' ' ALA . . . -126.79 -41.65 0.3 Allowed Glycine 0 CA--C 1.52 0.347 0 C-N-CA 120.505 -0.855 . . . . 0.0 112.338 179.206 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 542' ' ' ILE . . . . . 0.5 ' CD1' ' HA ' ' A' ' 539' ' ' ALA . 2.5 pp -75.8 -25.55 17.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -179.377 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 543' ' ' TYR . . . . . 0.585 ' HB2' ' HA ' ' A' ' 539' ' ' ALA . 0.2 OUTLIER -115.65 -5.66 12.16 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.862 0.363 . . . . 0.0 110.948 179.839 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 544' ' ' ALA . . . . . 0.943 ' HB1' ' HA ' ' A' ' 527' ' ' ILE . . . -102.78 -32.66 9.71 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.783 179.216 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 545' ' ' GLU . . . . . 0.549 ' OE2' HD23 ' A' ' 547' ' ' LEU . 50.3 tp10 -118.53 -32.85 4.48 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.301 179.834 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 35.55 39.35 0.23 Allowed Glycine 0 CA--C 1.519 0.337 0 CA-C-N 115.583 -0.735 . . . . 0.0 114.176 179.767 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 547' ' ' LEU . . . . . 0.587 HD23 ' H ' ' A' ' 548' ' ' MET . 0.0 OUTLIER -173.9 -61.8 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 117.756 0.778 . . . . 0.0 112.621 179.517 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 548' ' ' MET . . . . . 0.587 ' H ' HD23 ' A' ' 547' ' ' LEU . 0.0 OUTLIER -96.22 11.48 34.32 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.68 0.276 . . . . 0.0 111.339 179.96 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 549' ' ' HIS . . . . . 0.466 ' O ' ' CG2' ' A' ' 519' ' ' THR . 2.4 p-80 -62.29 -11.32 14.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.824 0.345 . . . . 0.0 110.804 179.221 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 550' ' ' ASN . . . . . 0.441 ' O ' ' N ' ' A' ' 552' ' ' ASP . 26.2 t-20 -95.1 -32.06 13.27 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -179.212 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 551' ' ' GLN . . . . . 0.453 HE22 HG21 ' A' ' 520' ' ' THR . 0.0 OUTLIER -64.99 74.44 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.421 0.629 . . . . 0.0 110.576 -179.896 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 552' ' ' ASP . . . . . 0.565 ' HA ' ' HA ' ' A' ' 519' ' ' THR . 15.6 m-20 -78.61 19.12 0.51 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.583 -0.735 . . . . 0.0 112.023 -179.544 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . 123.61 -31.05 4.72 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.785 -0.721 . . . . 0.0 111.817 -179.804 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 554' ' ' LEU . . . . . 0.422 HD12 ' H ' ' A' ' 554' ' ' LEU . 1.5 mp -53.02 -56.56 15.17 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.485 0.66 . . . . 0.0 110.592 179.301 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 555' ' ' ILE . . . . . 0.595 HG22 ' O ' ' A' ' 555' ' ' ILE . 2.3 mm -69.57 66.27 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 114.785 -1.098 . . . . 0.0 110.614 -179.748 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 556' ' ' CYS . . . . . . . . . . . . . 7.9 t . . . . . 0 C--N 1.323 -0.575 0 CA-C-N 115.461 -0.79 . . . . 0.0 111.649 -179.635 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 511' ' ' CYS . . . . . 0.417 ' HA ' ' HB3' ' A' ' 556' ' ' CYS . 28.9 t . . . . . 0 C--O 1.231 0.129 0 CA-C-O 121.025 0.441 . . . . 0.0 111.688 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 512' ' ' ASN . . . . . 0.545 ' HB3' HD12 ' A' ' 515' ' ' LEU . 87.4 m-20 -111.07 81.22 2.63 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.871 179.113 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 513' ' ' PRO . . . . . 0.581 ' HA ' ' O ' ' A' ' 552' ' ' ASP . 55.5 Cg_endo -71.79 11.9 0.62 Allowed 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 122.839 2.36 . . . . 0.0 113.276 -179.275 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 -96.62 -15.99 21.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.663 0.268 . . . . 0.0 110.969 179.68 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 515' ' ' LEU . . . . . 0.545 HD12 ' HB3' ' A' ' 512' ' ' ASN . 1.4 mp -94.46 73.94 3.82 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.894 0.378 . . . . 0.0 110.943 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 516' ' ' HIS . . . . . 0.456 ' HA ' ' HB3' ' A' ' 552' ' ' ASP . 0.2 OUTLIER -80.59 -7.09 59.14 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.872 -179.774 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 517' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -72.17 -66.08 0.69 Allowed 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -179.088 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 518' ' ' TRP . . . . . 0.48 ' O ' ' N ' ' A' ' 520' ' ' THR . 12.0 m-90 -93.32 0.51 56.97 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.489 0.552 . . . . 0.0 112.489 -178.737 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 519' ' ' THR . . . . . 0.527 HG21 ' HA ' ' A' ' 549' ' ' HIS . 2.8 p 60.56 -75.19 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 110.627 -0.138 . . . . 0.0 110.627 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 520' ' ' THR . . . . . 0.48 ' N ' ' O ' ' A' ' 518' ' ' TRP . 1.0 OUTLIER 172.27 -62.95 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.241 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 179.155 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 521' ' ' GLN . . . . . 0.458 ' N ' HG22 ' A' ' 520' ' ' THR . 3.1 mp0 -68.33 -15.43 63.56 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 178.245 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 522' ' ' ASP . . . . . 0.409 ' HB2' ' O ' ' A' ' 518' ' ' TRP . 2.8 m-20 -94.19 -11.93 29.34 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 115.668 -0.697 . . . . 0.0 111.273 179.563 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -51.98 -31.73 30.55 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-O 121.069 0.462 . . . . 0.0 110.846 179.785 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . 162.89 40.29 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.471 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.02 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -133.02 -32.17 1.23 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.632 0.253 . . . . 0.0 111.592 -179.62 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -137.84 56.52 1.75 Allowed 'General case' 0 CA--C 1.515 -0.373 0 CA-C-O 121.393 0.615 . . . . 0.0 110.306 179.788 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 527' ' ' ILE . . . . . 0.863 HD12 ' N ' ' A' ' 528' ' ' GLY . 1.4 pp -95.31 -18.55 6.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.721 -179.511 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 528' ' ' GLY . . . . . 0.863 ' N ' HD12 ' A' ' 527' ' ' ILE . . . 26.79 -144.92 0.01 OUTLIER Glycine 0 C--N 1.336 0.559 0 N-CA-C 114.716 0.647 . . . . 0.0 114.716 179.171 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 529' ' ' LEU . . . . . 0.504 HD12 ' H ' ' A' ' 530' ' ' ALA . 0.2 OUTLIER -63.55 -17.59 62.96 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.426 -0.387 . . . . 0.0 111.715 -179.624 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 530' ' ' ALA . . . . . 1.044 ' HB3' ' HB2' ' A' ' 544' ' ' ALA . . . -81.58 1.99 31.23 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -179.361 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 531' ' ' TRP . . . . . 0.484 ' HA ' ' HG2' ' A' ' 540' ' ' GLU . 0.1 OUTLIER -72.18 27.38 0.05 Allowed 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -179.15 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 532' ' ' ILE . . . . . 0.463 HG23 ' O ' ' A' ' 531' ' ' TRP . 1.1 pp -159.03 72.16 3.54 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-O 120.793 0.33 . . . . 0.0 110.541 179.074 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 533' ' ' PRO . . . . . 0.41 ' HB3' ' O ' ' A' ' 537' ' ' PRO . 7.5 Cg_endo -49.62 88.34 0.02 OUTLIER 'Trans proline' 0 C--N 1.343 0.243 0 C-N-CA 123.08 2.52 . . . . 0.0 112.625 -179.733 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 534' ' ' TYR . . . . . . . . . . . . . 65.3 t80 -96.46 -28.37 14.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.273 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -72.59 -35.03 67.81 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.503 -179.452 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 151.99 -65.03 0.36 Allowed Glycine 0 N--CA 1.453 -0.208 0 C-N-CA 120.496 -0.859 . . . . 0.0 112.547 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 537' ' ' PRO . . . . . 0.41 ' O ' ' HB3' ' A' ' 533' ' ' PRO . 17.2 Cg_endo -57.38 -163.27 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.636 2.224 . . . . 0.0 111.718 179.696 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 538' ' ' ALA . . . . . 0.494 ' O ' ' HB3' ' A' ' 539' ' ' ALA . . . -76.81 -46.62 24.24 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.512 179.547 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 539' ' ' ALA . . . . . 0.689 ' C ' ' HB1' ' A' ' 530' ' ' ALA . . . 70.79 -52.4 0.67 Allowed 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 121.336 0.589 . . . . 0.0 111.545 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 540' ' ' GLU . . . . . 0.484 ' HG2' ' HA ' ' A' ' 531' ' ' TRP . 10.2 mt-10 -36.8 -30.85 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.797 -1.092 . . . . 0.0 112.43 -179.143 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 541' ' ' GLY . . . . . . . . . . . . . . . -126.79 -22.29 1.63 Allowed Glycine 0 CA--C 1.518 0.274 0 C-N-CA 120.35 -0.928 . . . . 0.0 113.355 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 542' ' ' ILE . . . . . 0.575 ' CD1' ' HA ' ' A' ' 539' ' ' ALA . 2.6 pp -96.4 -18.85 6.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 -179.133 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 543' ' ' TYR . . . . . 0.482 ' HB2' ' HA ' ' A' ' 539' ' ' ALA . 0.4 OUTLIER -114.21 -11.81 12.57 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.808 179.58 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 544' ' ' ALA . . . . . 1.044 ' HB2' ' HB3' ' A' ' 530' ' ' ALA . . . -103.36 -36.23 8.1 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 121.336 0.589 . . . . 0.0 110.635 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 545' ' ' GLU . . . . . 0.642 ' HG2' ' HB2' ' A' ' 548' ' ' MET . 2.9 tp10 -118.51 -32.7 4.52 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.218 -0.901 . . . . 0.0 111.452 -179.243 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 37.99 51.22 2.11 Favored Glycine 0 C--N 1.332 0.308 0 C-N-CA 121.259 -0.496 . . . . 0.0 112.664 -179.647 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 547' ' ' LEU . . . . . 0.561 HD11 ' SD ' ' A' ' 548' ' ' MET . 0.3 OUTLIER -172.78 -46.19 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 120.9 -0.32 . . . . 0.0 111.618 -179.292 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 548' ' ' MET . . . . . 0.642 ' HB2' ' HG2' ' A' ' 545' ' ' GLU . 0.0 OUTLIER -96.58 11.61 34.61 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.811 0.338 . . . . 0.0 111.0 179.285 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 549' ' ' HIS . . . . . 0.527 ' HA ' HG21 ' A' ' 519' ' ' THR . 11.4 p-80 -69.05 -11.21 60.58 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.008 0.432 . . . . 0.0 110.405 179.528 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 550' ' ' ASN . . . . . . . . . . . . . 35.2 t30 -95.93 -17.63 20.9 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.817 -179.391 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 551' ' ' GLN . . . . . 0.499 ' HG2' ' O ' ' A' ' 548' ' ' MET . 7.8 mm-40 -69.23 62.76 0.14 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.964 0.411 . . . . 0.0 110.569 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 552' ' ' ASP . . . . . 0.581 ' O ' ' HA ' ' A' ' 513' ' ' PRO . 2.8 m-20 -94.12 21.74 6.54 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.18 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 553' ' ' GLY . . . . . 0.443 ' HA3' ' C ' ' A' ' 512' ' ' ASN . . . 115.26 -33.98 5.03 Favored Glycine 0 N--CA 1.448 -0.564 0 N-CA-C 111.212 -0.755 . . . . 0.0 111.212 -179.242 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 554' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -53.37 -50.82 64.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.592 0.711 . . . . 0.0 110.177 178.952 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 555' ' ' ILE . . . . . 0.674 HG22 ' O ' ' A' ' 555' ' ' ILE . 4.1 mm -81.1 54.76 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 114.73 -1.123 . . . . 0.0 110.91 -179.743 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 556' ' ' CYS . . . . . 0.417 ' HB3' ' HA ' ' A' ' 511' ' ' CYS . 29.1 p . . . . . 0 C--N 1.326 -0.444 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.03 179.849 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 511' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.53 0.189 0 CA-C-O 121.079 0.466 . . . . 0.0 111.597 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 512' ' ' ASN . . . . . 0.471 ' O ' ' O ' ' A' ' 552' ' ' ASP . 24.7 p30 -127.0 83.37 66.16 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.177 179.466 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 513' ' ' PRO . . . . . 0.467 ' HA ' ' O ' ' A' ' 552' ' ' ASP . 74.2 Cg_endo -76.17 22.1 0.51 Allowed 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 123.023 2.482 . . . . 0.0 113.27 -179.59 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -96.68 -26.02 15.34 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.811 0.339 . . . . 0.0 110.609 179.553 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 515' ' ' LEU . . . . . . . . . . . . . 31.7 mt -95.55 71.91 3.14 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.885 179.827 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 516' ' ' HIS . . . . . 0.469 ' HA ' ' CB ' ' A' ' 552' ' ' ASP . 6.2 p-80 -73.61 -7.35 51.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.721 -179.821 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 517' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -72.54 -59.74 2.57 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 111.903 0.334 . . . . 0.0 111.903 -179.435 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 518' ' ' TRP . . . . . 0.467 ' CD1' ' HA ' ' A' ' 523' ' ' GLU . 0.7 OUTLIER -80.07 -22.39 42.31 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.06 0.392 . . . . 0.0 112.06 -178.837 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 519' ' ' THR . . . . . 0.539 ' OG1' ' N ' ' A' ' 520' ' ' THR . 3.4 p 57.42 -81.29 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.459 0.171 . . . . 0.0 110.741 -179.728 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 520' ' ' THR . . . . . 0.539 ' N ' ' OG1' ' A' ' 519' ' ' THR . 1.1 m 176.19 -62.58 0.01 OUTLIER 'General case' 0 CA--C 1.52 -0.174 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 179.517 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 521' ' ' GLN . . . . . 0.403 ' N ' HG22 ' A' ' 520' ' ' THR . 2.4 mt-30 -72.07 -11.97 61.0 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.346 177.936 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 522' ' ' ASP . . . . . 0.421 ' HB2' ' O ' ' A' ' 518' ' ' TRP . 62.0 m-20 -93.49 -11.09 32.81 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.803 179.093 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 523' ' ' GLU . . . . . 0.467 ' HA ' ' CD1' ' A' ' 518' ' ' TRP . 0.1 OUTLIER -45.59 -27.92 0.86 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.698 -179.738 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 524' ' ' GLY . . . . . 0.45 ' HA2' ' CG1' ' A' ' 527' ' ' ILE . . . 150.52 40.04 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.343 -0.932 . . . . 0.0 112.439 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -97.91 -60.5 1.55 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.72 0.295 . . . . 0.0 111.589 -179.658 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -133.86 36.98 3.27 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-O 121.645 0.736 . . . . 0.0 110.33 179.735 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 527' ' ' ILE . . . . . 0.948 ' HA ' ' HB1' ' A' ' 544' ' ' ALA . 1.6 pp -96.13 -0.72 10.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 114.676 -1.147 . . . . 0.0 112.956 -178.795 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 528' ' ' GLY . . . . . 0.596 ' N ' HD12 ' A' ' 527' ' ' ILE . . . -55.19 -14.75 6.4 Favored Glycine 0 CA--C 1.521 0.455 0 C-N-CA 120.845 -0.693 . . . . 0.0 114.0 -179.342 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 529' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -98.73 -38.38 9.11 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 117.756 0.778 . . . . 0.0 112.303 -179.266 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 530' ' ' ALA . . . . . 0.946 ' HB3' ' HB2' ' A' ' 544' ' ' ALA . . . -103.68 1.71 32.25 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 -178.492 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 531' ' ' TRP . . . . . 0.462 ' O ' HG23 ' A' ' 532' ' ' ILE . 0.2 OUTLIER -71.31 30.46 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 112.405 0.521 . . . . 0.0 112.405 -178.896 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 532' ' ' ILE . . . . . 0.48 ' H ' ' C ' ' A' ' 530' ' ' ALA . 1.1 pt -159.04 73.24 3.52 Favored Pre-proline 0 N--CA 1.454 -0.256 0 CA-C-O 120.734 0.302 . . . . 0.0 110.403 179.031 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 533' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -50.74 84.95 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 123.071 2.514 . . . . 0.0 112.683 -179.496 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 534' ' ' TYR . . . . . 0.42 ' N ' ' O ' ' A' ' 532' ' ' ILE . 0.2 OUTLIER -96.48 -31.58 12.73 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.975 179.788 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -68.06 -34.94 77.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.333 -179.512 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 148.85 -63.9 0.41 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.651 -179.814 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -59.22 -165.98 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.639 2.226 . . . . 0.0 111.984 179.759 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 538' ' ' ALA . . . . . 0.453 ' O ' ' HB3' ' A' ' 539' ' ' ALA . . . -71.54 -49.79 37.44 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.508 179.78 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 539' ' ' ALA . . . . . 0.591 ' C ' ' HB1' ' A' ' 530' ' ' ALA . . . 69.14 -53.05 0.59 Allowed 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 121.206 0.527 . . . . 0.0 111.688 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 540' ' ' GLU . . . . . 0.486 ' O ' ' HB3' ' A' ' 544' ' ' ALA . 0.8 OUTLIER -37.3 -30.2 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.942 -1.026 . . . . 0.0 112.234 -179.286 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 541' ' ' GLY . . . . . . . . . . . . . . . -126.05 -30.27 0.88 Allowed Glycine 0 N--CA 1.453 -0.223 0 C-N-CA 120.479 -0.867 . . . . 0.0 113.216 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 542' ' ' ILE . . . . . 0.536 ' CD1' ' HA ' ' A' ' 539' ' ' ALA . 2.6 pp -87.89 -21.84 6.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 112.0 0.37 . . . . 0.0 112.0 -179.371 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 543' ' ' TYR . . . . . 0.468 ' CD2' ' CD1' ' A' ' 542' ' ' ILE . 6.1 m-85 -113.54 -10.19 13.19 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 120.812 0.339 . . . . 0.0 110.637 179.259 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 544' ' ' ALA . . . . . 0.948 ' HB1' ' HA ' ' A' ' 527' ' ' ILE . . . -103.35 -37.58 7.58 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 121.213 0.53 . . . . 0.0 110.198 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 545' ' ' GLU . . . . . 0.586 ' CD ' HD23 ' A' ' 547' ' ' LEU . 5.5 tp10 -118.73 -32.69 4.46 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.489 -179.088 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 37.72 45.39 1.48 Allowed Glycine 0 CA--C 1.52 0.398 0 CA-C-N 115.999 -0.546 . . . . 0.0 114.038 179.832 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 547' ' ' LEU . . . . . 0.586 HD23 ' CD ' ' A' ' 545' ' ' GLU . 0.0 OUTLIER -178.59 -61.26 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 117.594 0.697 . . . . 0.0 112.03 179.479 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 548' ' ' MET . . . . . 0.583 ' SD ' HD21 ' A' ' 547' ' ' LEU . 0.0 OUTLIER -90.63 12.06 20.11 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.715 0.293 . . . . 0.0 111.345 179.923 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 549' ' ' HIS . . . . . 0.5 ' O ' ' CG2' ' A' ' 519' ' ' THR . 12.7 t60 -65.51 -11.11 40.49 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.744 -0.383 . . . . 0.0 110.462 179.482 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 550' ' ' ASN . . . . . 0.458 ' O ' HD12 ' A' ' 554' ' ' LEU . 22.8 m-80 -93.7 -12.59 28.93 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.965 -0.294 . . . . 0.0 111.456 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 551' ' ' GLN . . . . . 0.566 ' HG2' ' O ' ' A' ' 548' ' ' MET . 4.8 mm-40 -73.47 59.2 0.6 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.913 0.387 . . . . 0.0 110.35 179.536 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 552' ' ' ASP . . . . . 0.471 ' O ' ' O ' ' A' ' 512' ' ' ASN . 2.8 p30 -98.78 22.04 10.62 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.188 -179.591 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . 123.74 -31.86 4.43 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.819 -0.705 . . . . 0.0 111.487 -179.238 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 554' ' ' LEU . . . . . 0.458 HD12 ' O ' ' A' ' 550' ' ' ASN . 1.4 mt -55.01 -56.12 23.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.382 0.61 . . . . 0.0 110.183 179.121 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 555' ' ' ILE . . . . . 0.595 HG22 ' O ' ' A' ' 555' ' ' ILE . 5.5 mm -79.23 60.01 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.997 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 556' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.327 -0.385 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.376 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 511' ' ' CYS . . . . . 0.414 ' HA ' ' CA ' ' A' ' 553' ' ' GLY . 0.8 OUTLIER . . . . . 0 CA--C 1.53 0.175 0 CA-C-O 121.066 0.46 . . . . 0.0 111.508 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 512' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -122.11 83.89 45.26 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.417 179.542 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 513' ' ' PRO . . . . . 0.435 ' HB3' ' HG ' ' A' ' 554' ' ' LEU . 73.5 Cg_endo -75.36 -0.82 10.53 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.844 2.363 . . . . 0.0 113.124 -179.466 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 20.2 t30 -62.93 -40.24 97.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.736 0.303 . . . . 0.0 110.907 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 515' ' ' LEU . . . . . 0.793 HD13 ' CH2' ' A' ' 518' ' ' TRP . 0.9 OUTLIER -95.71 58.99 2.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.017 0.437 . . . . 0.0 111.06 -179.812 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 516' ' ' HIS . . . . . . . . . . . . . 42.4 t-80 -73.01 -6.54 46.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.874 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 517' ' ' TYR . . . . . . . . . . . . . 48.8 m-85 -61.07 -27.88 68.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.718 0.294 . . . . 0.0 111.174 -179.388 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 518' ' ' TRP . . . . . 0.793 ' CH2' HD13 ' A' ' 515' ' ' LEU . 1.5 p90 -117.92 -14.97 10.02 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.87 -179.612 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 519' ' ' THR . . . . . 0.538 ' CG2' ' O ' ' A' ' 549' ' ' HIS . 14.9 p 55.2 -79.43 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.55 0.214 . . . . 0.0 111.084 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 520' ' ' THR . . . . . 0.522 ' N ' ' O ' ' A' ' 518' ' ' TRP . 1.1 m 177.41 -62.59 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 179.479 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 521' ' ' GLN . . . . . 0.425 ' N ' HG22 ' A' ' 520' ' ' THR . 1.8 mp0 -74.65 -12.06 60.34 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.32 177.918 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 522' ' ' ASP . . . . . 0.451 ' HA ' ' CG2' ' A' ' 527' ' ' ILE . 13.4 m-20 -92.56 -10.7 36.62 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.675 179.037 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -45.19 -26.37 0.48 Allowed 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.581 -179.725 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 524' ' ' GLY . . . . . 0.415 ' HA2' ' CG1' ' A' ' 527' ' ' ILE . . . 146.06 40.92 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.441 -0.885 . . . . 0.0 112.604 179.797 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -100.36 -60.2 1.57 Allowed 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 -179.653 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -132.51 37.63 3.49 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.541 0.686 . . . . 0.0 110.068 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 527' ' ' ILE . . . . . 0.956 ' HA ' ' HB1' ' A' ' 544' ' ' ALA . 2.3 pp -95.97 -0.25 10.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 114.708 -1.133 . . . . 0.0 112.912 -178.802 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 528' ' ' GLY . . . . . 0.472 ' N ' HD12 ' A' ' 527' ' ' ILE . . . -56.87 -9.38 3.73 Favored Glycine 0 CA--C 1.523 0.576 0 C-N-CA 121.01 -0.614 . . . . 0.0 114.47 -179.151 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 529' ' ' LEU . . . . . 0.641 ' H ' HD23 ' A' ' 529' ' ' LEU . 1.2 pt? -98.56 -37.46 9.54 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 118.002 0.901 . . . . 0.0 112.021 -179.407 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 530' ' ' ALA . . . . . 0.984 ' HB3' ' HB2' ' A' ' 544' ' ' ALA . . . -103.82 1.94 32.16 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 -178.966 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 531' ' ' TRP . . . . . 0.464 ' HB2' ' O ' ' A' ' 527' ' ' ILE . 10.2 t90 -68.03 30.31 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 -178.639 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 532' ' ' ILE . . . . . 0.6 ' O ' HD12 ' A' ' 532' ' ' ILE . 1.3 pp -158.89 70.84 3.6 Favored Pre-proline 0 C--N 1.332 -0.177 0 CA-C-O 120.707 0.289 . . . . 0.0 111.462 179.309 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 533' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -54.83 102.07 0.08 OUTLIER 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.335 2.024 . . . . 0.0 111.508 179.374 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 534' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -96.15 -54.88 3.14 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -178.91 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -118.32 -34.91 3.93 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 111.87 0.322 . . . . 0.0 111.87 -179.247 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . -86.37 -176.29 49.69 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.539 -0.839 . . . . 0.0 112.783 -179.633 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 537' ' ' PRO . . . . . 0.419 ' HG2' ' CD1' ' A' ' 542' ' ' ILE . 14.0 Cg_endo -56.52 -158.83 0.01 OUTLIER 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.87 2.38 . . . . 0.0 111.818 179.69 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 538' ' ' ALA . . . . . 0.517 ' O ' ' HB3' ' A' ' 539' ' ' ALA . . . -45.06 -49.06 11.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.141 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 539' ' ' ALA . . . . . 0.541 ' C ' ' HB1' ' A' ' 530' ' ' ALA . . . 71.54 -48.79 0.68 Allowed 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.306 0.574 . . . . 0.0 111.459 179.77 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 540' ' ' GLU . . . . . 0.457 ' HG2' ' HA ' ' A' ' 531' ' ' TRP . 4.3 mt-10 -36.94 -29.33 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 114.901 -1.045 . . . . 0.0 112.354 -179.326 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 541' ' ' GLY . . . . . . . . . . . . . . . -127.98 -42.73 0.25 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.369 179.434 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 542' ' ' ILE . . . . . 0.872 HG22 ' CD2' ' A' ' 549' ' ' HIS . 2.6 pp -74.35 -24.88 19.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -179.317 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 543' ' ' TYR . . . . . 0.494 ' HB2' HD12 ' A' ' 542' ' ' ILE . 2.8 t80 -114.4 -7.97 12.86 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.847 0.356 . . . . 0.0 110.814 179.725 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 544' ' ' ALA . . . . . 0.984 ' HB2' ' HB3' ' A' ' 530' ' ' ALA . . . -98.29 -32.36 11.58 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 179.038 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 545' ' ' GLU . . . . . 0.581 ' HG3' ' H ' ' A' ' 548' ' ' MET . 4.4 tp10 -118.67 -32.6 4.51 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.178 -179.84 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 40.22 42.83 2.53 Favored Glycine 0 CA--C 1.52 0.372 0 CA-C-N 115.941 -0.572 . . . . 0.0 113.956 179.81 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 547' ' ' LEU . . . . . 0.578 HD23 ' H ' ' A' ' 548' ' ' MET . 0.0 OUTLIER -175.54 -61.15 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 117.511 0.656 . . . . 0.0 111.972 179.504 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 548' ' ' MET . . . . . 0.581 ' H ' ' HG3' ' A' ' 545' ' ' GLU . 0.1 OUTLIER -89.76 11.5 19.85 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.649 0.262 . . . . 0.0 111.311 -179.983 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 549' ' ' HIS . . . . . 0.872 ' CD2' HG22 ' A' ' 542' ' ' ILE . 35.0 p-80 -65.61 -11.24 42.67 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.139 0.495 . . . . 0.0 110.662 179.328 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 550' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -96.22 -7.57 35.3 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.413 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 551' ' ' GLN . . . . . 0.536 ' HG3' ' HG2' ' A' ' 548' ' ' MET . 8.2 mm-40 -71.81 53.41 0.24 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.706 0.289 . . . . 0.0 111.63 -179.33 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 552' ' ' ASP . . . . . 0.473 ' HB2' ' HA ' ' A' ' 519' ' ' THR . 6.3 t70 -114.15 21.68 14.53 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.738 0.304 . . . . 0.0 110.766 179.392 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 553' ' ' GLY . . . . . 0.414 ' CA ' ' HA ' ' A' ' 511' ' ' CYS . . . 116.96 -31.07 6.03 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.744 -0.741 . . . . 0.0 111.324 -178.979 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 554' ' ' LEU . . . . . 0.435 ' HG ' ' HB3' ' A' ' 513' ' ' PRO . 11.8 mt -57.61 -53.44 58.16 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-O 121.505 0.669 . . . . 0.0 109.631 178.912 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 555' ' ' ILE . . . . . 0.622 HG22 ' O ' ' A' ' 555' ' ' ILE . 9.6 mm -89.05 54.93 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 CA-C-N 114.978 -1.01 . . . . 0.0 109.99 179.44 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 556' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.867 -179.459 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 511' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.132 0 CA-C-O 121.061 0.458 . . . . 0.0 111.486 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 512' ' ' ASN . . . . . 0.403 ' O ' ' O ' ' A' ' 552' ' ' ASP . 9.6 m-20 -110.7 83.59 3.57 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.503 179.557 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 513' ' ' PRO . . . . . 0.459 ' HA ' ' O ' ' A' ' 552' ' ' ASP . 90.1 Cg_endo -79.27 22.91 0.66 Allowed 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.953 2.436 . . . . 0.0 113.185 -179.639 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -96.65 -27.66 14.69 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.778 0.323 . . . . 0.0 110.798 179.803 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 515' ' ' LEU . . . . . . . . . . . . . 1.6 mt -93.06 72.48 4.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.803 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 516' ' ' HIS . . . . . 0.447 ' HA ' ' CB ' ' A' ' 552' ' ' ASP . 2.4 t60 -72.11 -7.53 49.51 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.827 -179.772 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 517' ' ' TYR . . . . . . . . . . . . . 41.6 m-85 -83.96 -66.11 0.93 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.853 0.359 . . . . 0.0 111.448 -179.634 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 518' ' ' TRP . . . . . 0.446 ' CD1' ' HA ' ' A' ' 523' ' ' GLU . 0.1 OUTLIER -69.33 -19.01 63.87 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.625 -179.459 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 519' ' ' THR . . . . . 0.532 ' OG1' ' N ' ' A' ' 520' ' ' THR . 1.5 p 61.45 -78.26 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.65 -0.25 . . . . 0.0 110.39 -179.69 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 520' ' ' THR . . . . . 0.532 ' N ' ' OG1' ' A' ' 519' ' ' THR . 1.0 OUTLIER 173.12 -62.93 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 179.07 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 521' ' ' GLN . . . . . 0.468 ' HB3' ' OE2' ' A' ' 545' ' ' GLU . 6.0 tt0 -74.52 -15.65 60.86 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 177.864 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 522' ' ' ASP . . . . . 0.434 ' O ' HG21 ' A' ' 527' ' ' ILE . 13.5 t70 -94.07 -10.45 33.35 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.786 178.936 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 523' ' ' GLU . . . . . 0.446 ' HA ' ' CD1' ' A' ' 518' ' ' TRP . 0.0 OUTLIER -44.95 -26.88 0.47 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.539 -179.524 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 524' ' ' GLY . . . . . 0.426 ' HA2' ' CG1' ' A' ' 527' ' ' ILE . . . 153.14 40.56 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.288 179.838 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -97.67 -56.3 2.55 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.165 0.431 . . . . 0.0 112.165 -179.342 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -133.2 41.22 3.13 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-O 121.496 0.665 . . . . 0.0 110.185 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 527' ' ' ILE . . . . . 0.885 ' HA ' ' HB1' ' A' ' 544' ' ' ALA . 1.8 pp -95.82 -0.62 10.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 114.783 -1.099 . . . . 0.0 112.918 -178.853 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 528' ' ' GLY . . . . . 0.608 ' N ' HD12 ' A' ' 527' ' ' ILE . . . -60.3 -13.21 28.0 Favored Glycine 0 CA--C 1.521 0.447 0 C-N-CA 120.852 -0.689 . . . . 0.0 114.131 -179.013 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 529' ' ' LEU . . . . . 0.722 ' N ' HD13 ' A' ' 529' ' ' LEU . 0.0 OUTLIER -99.13 -30.44 12.29 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 117.614 0.707 . . . . 0.0 111.817 -179.645 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 530' ' ' ALA . . . . . 1.012 ' HB3' ' HB2' ' A' ' 544' ' ' ALA . . . -103.61 1.69 32.38 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -179.136 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 531' ' ' TRP . . . . . 0.561 ' HA ' ' HG2' ' A' ' 540' ' ' GLU . 0.2 OUTLIER -71.33 30.34 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -178.92 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 532' ' ' ILE . . . . . 0.475 ' H ' ' C ' ' A' ' 530' ' ' ALA . 1.1 pt -158.58 72.98 3.78 Favored Pre-proline 0 N--CA 1.453 -0.311 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.472 179.14 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 533' ' ' PRO . . . . . 0.423 ' HB3' ' O ' ' A' ' 537' ' ' PRO . 1.2 Cg_endo -44.25 85.25 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 123.46 2.773 . . . . 0.0 113.014 -179.625 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 534' ' ' TYR . . . . . 0.446 ' N ' ' O ' ' A' ' 532' ' ' ILE . 7.7 t80 -96.65 -39.47 9.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.329 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 20.6 t80 -57.68 -34.98 69.97 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.549 -179.191 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 146.55 -52.41 0.56 Allowed Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.467 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 537' ' ' PRO . . . . . 0.423 ' O ' ' HB3' ' A' ' 533' ' ' PRO . 2.0 Cg_endo -78.06 -174.53 2.28 Favored 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 122.725 2.283 . . . . 0.0 111.173 179.392 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 538' ' ' ALA . . . . . 0.496 ' O ' ' HB3' ' A' ' 539' ' ' ALA . . . -57.11 -51.23 70.14 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.951 -0.3 . . . . 0.0 110.624 179.554 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 539' ' ' ALA . . . . . 0.496 ' HB3' ' O ' ' A' ' 538' ' ' ALA . . . 71.07 -50.76 0.69 Allowed 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 121.265 0.555 . . . . 0.0 111.402 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 540' ' ' GLU . . . . . 0.561 ' HG2' ' HA ' ' A' ' 531' ' ' TRP . 5.3 mt-10 -37.74 -24.34 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 114.896 -1.047 . . . . 0.0 112.759 -179.445 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 541' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 539' ' ' ALA . . . -111.15 -58.36 0.48 Allowed Glycine 0 CA--C 1.52 0.384 0 C-N-CA 120.488 -0.863 . . . . 0.0 113.227 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 542' ' ' ILE . . . . . 0.524 HD13 ' H ' ' A' ' 542' ' ' ILE . 0.2 OUTLIER -76.94 -22.82 14.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 113.477 0.917 . . . . 0.0 113.477 -178.366 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 543' ' ' TYR . . . . . 0.465 ' C ' ' HB2' ' A' ' 530' ' ' ALA . 10.5 m-85 -101.56 -11.19 19.44 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.27 0.557 . . . . 0.0 110.345 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 544' ' ' ALA . . . . . 1.012 ' HB2' ' HB3' ' A' ' 530' ' ' ALA . . . -100.03 -28.86 12.85 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 115.228 -0.897 . . . . 0.0 110.034 179.689 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 545' ' ' GLU . . . . . 0.561 ' CD ' HD23 ' A' ' 547' ' ' LEU . 3.9 tp10 -118.68 -32.78 4.45 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.384 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 36.39 39.73 0.36 Allowed Glycine 0 CA--C 1.519 0.308 0 CA-C-N 115.759 -0.655 . . . . 0.0 114.371 179.454 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 547' ' ' LEU . . . . . 0.604 HD23 ' H ' ' A' ' 548' ' ' MET . 0.0 OUTLIER -176.71 -61.73 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 117.734 0.767 . . . . 0.0 112.247 179.449 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 548' ' ' MET . . . . . 0.604 ' H ' HD23 ' A' ' 547' ' ' LEU . 0.0 OUTLIER -95.38 11.38 32.94 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.728 0.299 . . . . 0.0 111.053 179.634 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 549' ' ' HIS . . . . . 0.474 ' O ' ' CG2' ' A' ' 519' ' ' THR . 16.5 p80 -62.72 -10.82 14.0 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.024 179.549 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 550' ' ' ASN . . . . . 0.449 ' O ' ' N ' ' A' ' 552' ' ' ASP . 1.8 m120 -95.56 -33.82 12.26 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -178.633 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 551' ' ' GLN . . . . . 0.404 ' NE2' ' HG2' ' A' ' 548' ' ' MET . 1.0 OUTLIER -65.9 71.51 0.06 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.182 0.515 . . . . 0.0 110.466 -179.694 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 552' ' ' ASP . . . . . 0.491 ' HA ' ' O ' ' A' ' 519' ' ' THR . 2.4 p30 -94.71 22.12 6.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.397 -179.48 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . 123.97 -32.65 4.13 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.799 -0.715 . . . . 0.0 111.677 -179.393 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 554' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -58.75 -59.18 5.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.488 0.661 . . . . 0.0 109.96 178.911 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 555' ' ' ILE . . . . . 0.594 HG22 ' O ' ' A' ' 555' ' ' ILE . 3.2 mm -72.27 65.69 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 CA-C-N 114.867 -1.06 . . . . 0.0 110.618 179.781 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 556' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.324 -0.5 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.565 -179.827 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 511' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.232 0.156 0 CA-C-O 120.993 0.425 . . . . 0.0 111.569 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 512' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -124.04 80.4 57.68 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.48 179.724 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 513' ' ' PRO . . . . . 0.47 ' HA ' ' O ' ' A' ' 552' ' ' ASP . 94.2 Cg_endo -80.98 24.85 0.66 Allowed 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 123.021 2.481 . . . . 0.0 113.179 -179.679 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 17.8 t-20 -96.73 -30.31 13.28 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.707 0.289 . . . . 0.0 110.797 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 515' ' ' LEU . . . . . . . . . . . . . 32.9 mt -89.17 72.97 8.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.847 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 516' ' ' HIS . . . . . 0.425 ' HA ' ' CB ' ' A' ' 552' ' ' ASP . 62.2 t-80 -76.69 -15.69 59.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.541 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 517' ' ' TYR . . . . . . . . . . . . . 57.4 m-85 -80.1 -36.72 35.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.736 0.303 . . . . 0.0 111.373 -179.685 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 518' ' ' TRP . . . . . 0.462 ' O ' ' N ' ' A' ' 520' ' ' THR . 3.9 m-90 -94.92 -21.27 18.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.501 -179.532 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 519' ' ' THR . . . . . 0.551 ' OG1' ' N ' ' A' ' 520' ' ' THR . 1.2 p 58.41 -78.64 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.843 -179.797 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 520' ' ' THR . . . . . 0.551 ' N ' ' OG1' ' A' ' 519' ' ' THR . 1.1 m 178.18 -62.97 0.01 OUTLIER 'General case' 0 CA--C 1.521 -0.171 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 179.234 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 521' ' ' GLN . . . . . 0.41 ' N ' HG22 ' A' ' 520' ' ' THR . 1.2 mp0 -74.42 -14.3 60.83 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 177.825 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -94.13 -11.12 31.16 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.961 179.086 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -45.3 -28.29 0.8 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.235 -179.816 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . 148.61 42.03 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.43 179.806 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -104.37 -54.8 2.47 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 111.833 0.309 . . . . 0.0 111.833 -179.681 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -131.74 48.44 2.42 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-O 121.536 0.684 . . . . 0.0 110.014 179.758 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 527' ' ' ILE . . . . . 0.779 ' HA ' ' HB1' ' A' ' 544' ' ' ALA . 1.5 pp -95.45 -6.33 10.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 114.916 -1.038 . . . . 0.0 112.517 -178.906 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 528' ' ' GLY . . . . . 0.702 ' N ' HD12 ' A' ' 527' ' ' ILE . . . -54.86 -13.04 4.12 Favored Glycine 0 CA--C 1.521 0.445 0 C-N-CA 120.971 -0.633 . . . . 0.0 113.817 -179.472 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 529' ' ' LEU . . . . . 0.83 ' O ' HD22 ' A' ' 529' ' ' LEU . 0.3 OUTLIER -97.01 -41.01 8.59 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 117.392 0.596 . . . . 0.0 111.431 -179.296 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 530' ' ' ALA . . . . . 1.01 ' HB3' ' HB2' ' A' ' 544' ' ' ALA . . . -103.76 2.05 32.46 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.789 0.662 . . . . 0.0 112.789 -178.807 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 531' ' ' TRP . . . . . 0.482 ' HB2' ' O ' ' A' ' 527' ' ' ILE . 62.1 t90 -70.89 25.99 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -179.088 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 532' ' ' ILE . . . . . 0.629 ' O ' HD12 ' A' ' 532' ' ' ILE . 1.3 pp -159.25 70.98 3.45 Favored Pre-proline 0 C--N 1.332 -0.191 0 CA-C-O 120.843 0.354 . . . . 0.0 110.885 179.105 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 533' ' ' PRO . . . . . 0.418 ' HB3' ' O ' ' A' ' 537' ' ' PRO . 10.1 Cg_endo -51.36 110.63 0.44 Allowed 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.735 2.29 . . . . 0.0 111.907 179.735 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 534' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -96.33 -55.01 3.08 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -179.143 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -118.47 -35.23 3.81 Favored 'General case' 0 N--CA 1.463 0.179 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -179.121 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . -83.26 -175.11 50.83 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.535 -0.841 . . . . 0.0 112.89 -179.369 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 537' ' ' PRO . . . . . 0.418 ' O ' ' HB3' ' A' ' 533' ' ' PRO . 19.5 Cg_endo -58.12 -156.9 0.01 OUTLIER 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.657 2.238 . . . . 0.0 111.266 179.554 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 538' ' ' ALA . . . . . 0.488 ' O ' ' HB3' ' A' ' 539' ' ' ALA . . . -43.58 -44.01 5.95 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.7 0.286 . . . . 0.0 111.141 179.811 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 539' ' ' ALA . . . . . 0.488 ' HB3' ' O ' ' A' ' 538' ' ' ALA . . . 71.1 -49.54 0.68 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 121.108 0.48 . . . . 0.0 111.665 179.781 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 540' ' ' GLU . . . . . 0.468 ' CG ' ' HA ' ' A' ' 531' ' ' TRP . 3.7 mt-10 -37.66 -25.75 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.142 -0.935 . . . . 0.0 112.656 -179.506 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 541' ' ' GLY . . . . . 0.431 ' N ' ' O ' ' A' ' 539' ' ' ALA . . . -112.73 -55.42 0.45 Allowed Glycine 0 CA--C 1.523 0.549 0 C-N-CA 120.384 -0.912 . . . . 0.0 113.819 -179.559 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 542' ' ' ILE . . . . . 0.546 HD13 ' H ' ' A' ' 542' ' ' ILE . 0.2 OUTLIER -79.18 -22.94 12.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 113.691 0.997 . . . . 0.0 113.691 -178.133 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 543' ' ' TYR . . . . . 0.494 ' C ' ' HB2' ' A' ' 530' ' ' ALA . 9.7 m-85 -99.02 -16.97 18.51 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.248 0.547 . . . . 0.0 110.028 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 544' ' ' ALA . . . . . 1.01 ' HB2' ' HB3' ' A' ' 530' ' ' ALA . . . -91.52 -24.44 19.63 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.201 179.856 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 545' ' ' GLU . . . . . 0.664 ' CD ' HD23 ' A' ' 547' ' ' LEU . 3.7 tp10 -118.78 -32.65 4.46 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.405 -179.805 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 39.41 42.36 1.82 Allowed Glycine 0 CA--C 1.52 0.378 0 CA-C-N 115.883 -0.599 . . . . 0.0 114.366 179.436 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 547' ' ' LEU . . . . . 0.664 HD23 ' CD ' ' A' ' 545' ' ' GLU . 0.0 OUTLIER -178.51 -61.97 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 117.713 0.756 . . . . 0.0 112.094 179.122 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 548' ' ' MET . . . . . 0.555 ' H ' HD23 ' A' ' 547' ' ' LEU . 0.0 OUTLIER -96.08 11.43 34.21 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.751 0.31 . . . . 0.0 110.975 179.504 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 549' ' ' HIS . . . . . 0.527 ' CD2' ' HA ' ' A' ' 542' ' ' ILE . 11.9 p80 -61.19 -11.08 7.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.079 179.631 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 550' ' ' ASN . . . . . 0.43 ' O ' ' N ' ' A' ' 552' ' ' ASP . 28.9 t-20 -95.12 -34.64 12.2 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 -178.788 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 551' ' ' GLN . . . . . 0.404 ' HG3' ' O ' ' A' ' 548' ' ' MET . 0.5 OUTLIER -66.49 72.08 0.08 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.139 0.495 . . . . 0.0 110.419 179.969 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 552' ' ' ASP . . . . . 0.47 ' O ' ' HA ' ' A' ' 513' ' ' PRO . 4.5 p30 -93.87 22.33 5.76 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.514 -179.448 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . 124.2 -28.03 5.44 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.838 -0.696 . . . . 0.0 111.645 -179.27 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 554' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -59.67 -53.32 59.36 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.551 0.691 . . . . 0.0 109.787 178.824 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 555' ' ' ILE . . . . . 0.649 HG22 ' O ' ' A' ' 555' ' ' ILE . 3.2 mm -78.95 62.02 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 114.755 -1.111 . . . . 0.0 110.374 179.808 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 556' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.325 -0.473 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.444 -179.787 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 511' ' ' CYS . . . . . . . . . . . . . 9.6 m . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.935 0.398 . . . . 0.0 111.573 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 512' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -115.76 79.11 7.48 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.512 179.82 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 513' ' ' PRO . . . . . 0.458 ' HA ' ' O ' ' A' ' 552' ' ' ASP . 84.7 Cg_endo -83.48 25.23 0.7 Allowed 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.839 2.359 . . . . 0.0 113.042 -179.657 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 -96.66 -29.69 13.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.814 0.34 . . . . 0.0 111.107 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 515' ' ' LEU . . . . . . . . . . . . . 1.5 mt -88.13 73.08 9.05 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.025 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 516' ' ' HIS . . . . . 0.433 ' HA ' ' CB ' ' A' ' 552' ' ' ASP . 1.7 t60 -79.53 -7.21 58.32 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.601 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 517' ' ' TYR . . . . . . . . . . . . . 40.2 m-85 -80.19 -54.27 5.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.655 0.264 . . . . 0.0 111.686 -179.318 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 518' ' ' TRP . . . . . 0.526 ' O ' ' N ' ' A' ' 520' ' ' THR . 4.1 m-90 -92.37 -3.33 55.49 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 -179.02 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 519' ' ' THR . . . . . 0.579 ' OG1' ' N ' ' A' ' 520' ' ' THR . 1.3 p 55.83 -78.13 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 120.591 0.234 . . . . 0.0 110.978 179.746 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 520' ' ' THR . . . . . 0.579 ' N ' ' OG1' ' A' ' 519' ' ' THR . 1.1 m 177.01 -62.58 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.515 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 521' ' ' GLN . . . . . 0.456 ' NE2' ' SD ' ' A' ' 548' ' ' MET . 0.0 OUTLIER -73.84 -12.07 60.57 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 177.96 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 522' ' ' ASP . . . . . 0.435 ' HA ' ' CG2' ' A' ' 527' ' ' ILE . 3.2 m-20 -93.62 -10.72 33.65 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.781 179.047 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 523' ' ' GLU . . . . . 0.428 ' HA ' ' CD1' ' A' ' 518' ' ' TRP . 0.3 OUTLIER -45.39 -27.62 0.73 Allowed 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.501 -179.936 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 524' ' ' GLY . . . . . 0.43 ' HA2' ' CG1' ' A' ' 527' ' ' ILE . . . 146.05 42.34 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.579 -0.819 . . . . 0.0 112.299 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -101.52 -59.65 1.66 Allowed 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 111.941 0.349 . . . . 0.0 111.941 -179.478 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -131.82 36.58 3.69 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-O 121.503 0.668 . . . . 0.0 110.066 179.805 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 527' ' ' ILE . . . . . 0.964 ' HA ' ' HB1' ' A' ' 544' ' ' ALA . 2.1 pp -95.7 -0.43 10.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 114.787 -1.097 . . . . 0.0 112.735 -178.929 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 528' ' ' GLY . . . . . 0.516 ' N ' HD12 ' A' ' 527' ' ' ILE . . . -56.83 -13.77 8.84 Favored Glycine 0 CA--C 1.52 0.349 0 C-N-CA 120.892 -0.67 . . . . 0.0 114.024 -179.406 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 529' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -98.55 -32.81 11.26 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 117.639 0.719 . . . . 0.0 111.724 -179.379 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 530' ' ' ALA . . . . . 0.895 ' HB3' ' HB2' ' A' ' 544' ' ' ALA . . . -103.69 1.84 32.36 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -178.901 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 531' ' ' TRP . . . . . 0.533 ' O ' HG23 ' A' ' 532' ' ' ILE . 4.5 t90 -68.26 26.68 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -179.02 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 532' ' ' ILE . . . . . 0.626 ' O ' HD12 ' A' ' 532' ' ' ILE . 1.3 pp -160.56 71.04 2.88 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 120.846 0.355 . . . . 0.0 110.386 179.014 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 533' ' ' PRO . . . . . 0.414 ' HB3' ' O ' ' A' ' 537' ' ' PRO . 1.2 Cg_endo -44.71 85.22 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 123.451 2.768 . . . . 0.0 113.118 -179.449 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 534' ' ' TYR . . . . . 0.449 ' N ' ' O ' ' A' ' 532' ' ' ILE . 5.8 t80 -96.78 -34.26 11.38 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.148 179.606 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -60.92 -34.93 75.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.567 -179.369 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 536' ' ' GLY . . . . . 0.41 ' N ' ' CD ' ' A' ' 537' ' ' PRO . . . 145.12 -50.4 0.64 Allowed Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.522 -0.847 . . . . 0.0 112.603 -179.817 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 537' ' ' PRO . . . . . 0.414 ' O ' ' HB3' ' A' ' 533' ' ' PRO . 6.1 Cg_exo -74.64 -164.08 0.21 Allowed 'Trans proline' 0 N--CA 1.461 -0.43 0 C-N-CA 122.601 2.201 . . . . 0.0 111.474 179.594 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 538' ' ' ALA . . . . . 0.481 ' O ' ' HB3' ' A' ' 539' ' ' ALA . . . -68.4 -46.78 69.05 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.83 0.347 . . . . 0.0 110.258 179.328 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 539' ' ' ALA . . . . . 0.692 ' C ' ' HB1' ' A' ' 530' ' ' ALA . . . 70.15 -54.04 0.63 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 121.363 0.601 . . . . 0.0 111.443 179.841 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 540' ' ' GLU . . . . . 0.484 ' HG2' ' HA ' ' A' ' 531' ' ' TRP . 12.8 mt-10 -37.52 -27.23 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 114.781 -1.099 . . . . 0.0 112.248 -179.31 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 541' ' ' GLY . . . . . 0.423 ' N ' ' O ' ' A' ' 539' ' ' ALA . . . -125.26 -46.35 0.23 Allowed Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.051 179.006 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 542' ' ' ILE . . . . . 0.663 HG22 ' CE1' ' A' ' 549' ' ' HIS . 2.6 pp -73.93 -23.88 19.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -179.503 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 543' ' ' TYR . . . . . 0.465 ' HB2' HD12 ' A' ' 542' ' ' ILE . 23.5 t80 -112.54 -8.45 13.84 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.944 0.402 . . . . 0.0 110.843 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 544' ' ' ALA . . . . . 0.964 ' HB1' ' HA ' ' A' ' 527' ' ' ILE . . . -103.18 -35.21 8.56 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.939 179.316 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 545' ' ' GLU . . . . . 0.53 ' HG3' ' H ' ' A' ' 548' ' ' MET . 28.1 tp10 -118.59 -32.61 4.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.331 -0.85 . . . . 0.0 111.05 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 38.9 40.51 1.09 Allowed Glycine 0 CA--C 1.52 0.355 0 CA-C-N 115.856 -0.611 . . . . 0.0 113.896 179.752 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 547' ' ' LEU . . . . . 0.551 ' HG ' ' N ' ' A' ' 548' ' ' MET . 0.0 OUTLIER -172.0 -61.47 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 117.537 0.669 . . . . 0.0 112.204 179.568 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 548' ' ' MET . . . . . 0.581 ' O ' ' HG3' ' A' ' 551' ' ' GLN . 0.0 OUTLIER -96.17 11.78 33.15 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.773 0.321 . . . . 0.0 111.688 179.95 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 549' ' ' HIS . . . . . 0.663 ' CE1' HG22 ' A' ' 542' ' ' ILE . 12.3 p-80 -64.73 -11.0 31.52 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.88 0.372 . . . . 0.0 110.77 179.255 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 550' ' ' ASN . . . . . 0.46 ' O ' ' N ' ' A' ' 552' ' ' ASP . 5.9 m120 -96.18 -37.98 10.34 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -178.98 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 551' ' ' GLN . . . . . 0.581 ' HG3' ' O ' ' A' ' 548' ' ' MET . 0.0 OUTLIER -64.62 72.51 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.073 0.463 . . . . 0.0 110.712 -179.621 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 552' ' ' ASP . . . . . 0.46 ' N ' ' O ' ' A' ' 550' ' ' ASN . 2.3 p30 -92.51 21.9 5.03 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.203 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . 123.94 -27.81 5.55 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.952 -0.642 . . . . 0.0 111.766 -179.307 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 554' ' ' LEU . . . . . 0.459 HD11 ' OD2' ' A' ' 552' ' ' ASP . 0.6 OUTLIER -60.56 -60.67 3.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.404 0.621 . . . . 0.0 110.066 179.007 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 555' ' ' ILE . . . . . 0.493 HG22 ' O ' ' A' ' 555' ' ' ILE . 3.6 mm -72.71 70.87 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 CA-C-N 114.999 -1.0 . . . . 0.0 110.494 179.696 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 556' ' ' CYS . . . . . . . . . . . . . 58.7 m . . . . . 0 C--N 1.323 -0.546 0 CA-C-N 115.333 -0.849 . . . . 0.0 112.039 -179.446 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 511' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.455 -0.209 0 CA-C-O 121.068 0.461 . . . . 0.0 111.522 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 512' ' ' ASN . . . . . 0.807 ' ND2' HD12 ' A' ' 515' ' ' LEU . 18.7 p30 -115.52 77.44 5.95 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.077 179.326 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 513' ' ' PRO . . . . . 0.573 ' HA ' ' O ' ' A' ' 552' ' ' ASP . 28.5 Cg_endo -64.5 -10.62 24.95 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.805 2.337 . . . . 0.0 112.345 -179.789 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -81.11 -22.29 39.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.213 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 515' ' ' LEU . . . . . 0.807 HD12 ' ND2' ' A' ' 512' ' ' ASN . 61.5 mt -88.85 74.62 8.23 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.928 0.394 . . . . 0.0 111.094 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 516' ' ' HIS . . . . . 0.474 ' HA ' ' HB3' ' A' ' 552' ' ' ASP . 98.9 m-70 -80.08 -7.27 58.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.693 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 517' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 -78.54 -37.94 41.66 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 111.648 0.24 . . . . 0.0 111.648 -179.354 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 518' ' ' TRP . . . . . 0.595 ' O ' ' N ' ' A' ' 520' ' ' THR . 14.8 m-90 -111.06 5.11 19.97 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 111.99 0.367 . . . . 0.0 111.99 -179.376 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 519' ' ' THR . . . . . 0.539 ' HA ' ' HA ' ' A' ' 552' ' ' ASP . 2.4 p 50.08 -78.32 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 120.421 0.153 . . . . 0.0 110.999 -179.862 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 520' ' ' THR . . . . . 0.595 ' N ' ' O ' ' A' ' 518' ' ' TRP . 1.2 m 179.45 -62.57 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 179.248 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 521' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -72.38 -12.02 60.94 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.301 178.004 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 522' ' ' ASP . . . . . 0.473 ' HA ' ' CG2' ' A' ' 527' ' ' ILE . 64.9 m-20 -91.71 -10.82 38.77 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.962 179.21 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -45.28 -26.78 0.55 Allowed 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.464 -179.762 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . 145.59 41.99 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.547 -0.835 . . . . 0.0 112.309 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -101.99 -60.57 1.51 Allowed 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 111.784 0.29 . . . . 0.0 111.784 -179.494 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -131.35 37.8 3.67 Favored 'General case' 0 CA--C 1.512 -0.506 0 CA-C-O 121.52 0.676 . . . . 0.0 110.066 179.823 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 527' ' ' ILE . . . . . 0.92 ' HA ' ' HB1' ' A' ' 544' ' ' ALA . 2.1 pp -95.78 -0.49 10.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-N 114.847 -1.07 . . . . 0.0 112.724 -178.889 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 528' ' ' GLY . . . . . 0.529 ' N ' HD12 ' A' ' 527' ' ' ILE . . . -58.94 -13.34 18.78 Favored Glycine 0 CA--C 1.521 0.443 0 C-N-CA 120.877 -0.678 . . . . 0.0 113.896 -179.336 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 529' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -98.63 -33.11 11.09 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 117.56 0.68 . . . . 0.0 111.759 -179.425 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 530' ' ' ALA . . . . . 0.942 ' HB3' ' HB2' ' A' ' 544' ' ' ALA . . . -103.62 -0.97 28.92 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 -178.84 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 531' ' ' TRP . . . . . 0.475 ' HA ' ' HG2' ' A' ' 540' ' ' GLU . 8.9 t90 -56.62 -11.12 1.19 Allowed 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 112.057 0.392 . . . . 0.0 112.057 -179.189 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 532' ' ' ILE . . . . . 0.716 ' O ' HD12 ' A' ' 532' ' ' ILE . 1.6 pp -133.45 73.79 72.64 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.037 0.446 . . . . 0.0 111.218 179.632 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 533' ' ' PRO . . . . . 0.406 ' HB3' ' O ' ' A' ' 538' ' ' ALA . 1.0 OUTLIER -44.18 92.95 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 123.165 2.577 . . . . 0.0 112.798 -179.988 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 534' ' ' TYR . . . . . . . . . . . . . 45.0 t80 -96.4 -25.51 15.68 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.079 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -70.57 -34.9 72.72 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.355 -179.559 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 147.32 -64.63 0.42 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.549 -0.834 . . . . 0.0 112.889 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -59.14 -165.01 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.641 2.227 . . . . 0.0 112.011 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 538' ' ' ALA . . . . . 0.477 ' O ' ' HB3' ' A' ' 539' ' ' ALA . . . -66.59 -48.27 70.09 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.558 179.759 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 539' ' ' ALA . . . . . 0.699 ' C ' ' HB1' ' A' ' 530' ' ' ALA . . . 69.54 -53.56 0.6 Allowed 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.302 0.573 . . . . 0.0 111.546 179.867 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 540' ' ' GLU . . . . . 0.475 ' HG2' ' HA ' ' A' ' 531' ' ' TRP . 14.4 mt-10 -37.32 -27.39 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.889 -1.051 . . . . 0.0 112.266 -179.377 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 541' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 539' ' ' ALA . . . -125.63 -46.71 0.22 Allowed Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.034 179.007 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 542' ' ' ILE . . . . . 0.476 HD12 ' HB2' ' A' ' 543' ' ' TYR . 2.6 pp -73.28 -23.89 20.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -179.515 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 543' ' ' TYR . . . . . 0.476 ' HB2' HD12 ' A' ' 542' ' ' ILE . 21.4 t80 -112.85 -7.62 13.75 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.991 0.424 . . . . 0.0 110.936 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 544' ' ' ALA . . . . . 0.942 ' HB2' ' HB3' ' A' ' 530' ' ' ALA . . . -103.04 -33.41 9.27 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.866 179.328 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 545' ' ' GLU . . . . . 0.645 ' CD ' HD23 ' A' ' 547' ' ' LEU . 3.9 tp10 -118.59 -32.58 4.54 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.43 -0.805 . . . . 0.0 111.0 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 38.01 46.86 1.85 Allowed Glycine 0 CA--C 1.519 0.294 0 CA-C-N 115.804 -0.635 . . . . 0.0 114.148 179.596 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 547' ' ' LEU . . . . . 0.645 HD23 ' CD ' ' A' ' 545' ' ' GLU . 0.0 OUTLIER -179.07 -61.5 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 117.6 0.7 . . . . 0.0 111.801 179.268 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 548' ' ' MET . . . . . 0.549 ' H ' HD23 ' A' ' 547' ' ' LEU . 0.0 OUTLIER -95.08 11.59 31.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.694 0.283 . . . . 0.0 111.088 179.503 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 549' ' ' HIS . . . . . 0.484 ' O ' HG21 ' A' ' 519' ' ' THR . 16.4 p80 -60.64 -11.52 7.53 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.07 179.586 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 550' ' ' ASN . . . . . 0.544 ' O ' ' N ' ' A' ' 552' ' ' ASP . 8.6 m-20 -94.8 -40.19 9.88 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 -179.332 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 551' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -60.34 73.06 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.189 0.519 . . . . 0.0 110.303 179.829 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 552' ' ' ASP . . . . . 0.573 ' O ' ' HA ' ' A' ' 513' ' ' PRO . 11.8 m-20 -84.62 21.73 1.45 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.933 -179.278 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 553' ' ' GLY . . . . . 0.414 ' HA3' ' N ' ' A' ' 513' ' ' PRO . . . 116.7 12.84 8.35 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.105 -179.653 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 554' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -104.41 -51.59 3.07 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.42 0.629 . . . . 0.0 109.93 179.75 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 555' ' ' ILE . . . . . 0.516 HG22 ' O ' ' A' ' 555' ' ' ILE . 2.2 mm -78.27 -1.69 4.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 114.923 -1.035 . . . . 0.0 111.231 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 556' ' ' CYS . . . . . . . . . . . . . 25.9 p . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.973 178.817 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 511' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.462 0.17 0 CA-C-O 120.878 0.371 . . . . 0.0 111.611 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 512' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -107.72 83.94 1.81 Allowed Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.755 179.736 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 513' ' ' PRO . . . . . 0.455 ' HA ' ' O ' ' A' ' 552' ' ' ASP . 57.2 Cg_endo -71.27 -6.08 18.41 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.76 2.306 . . . . 0.0 112.86 -179.859 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -71.71 -28.29 63.6 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.189 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 515' ' ' LEU . . . . . . . . . . . . . 83.4 mt -92.06 72.24 5.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.855 0.36 . . . . 0.0 111.08 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 516' ' ' HIS . . . . . 0.442 ' HA ' ' CB ' ' A' ' 552' ' ' ASP . 26.9 p-80 -86.15 -7.18 58.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.669 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 517' ' ' TYR . . . . . . . . . . . . . 46.2 m-85 -84.03 -19.43 34.45 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.711 -0.222 . . . . 0.0 111.576 -179.809 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 518' ' ' TRP . . . . . 0.5 ' O ' ' N ' ' A' ' 520' ' ' THR . 4.4 m-90 -118.08 -13.32 9.97 Favored 'General case' 0 C--N 1.332 -0.164 0 N-CA-C 112.227 0.454 . . . . 0.0 112.227 -179.134 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 519' ' ' THR . . . . . 0.563 ' OG1' ' N ' ' A' ' 520' ' ' THR . 1.2 p 57.5 -78.13 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 110.643 -0.132 . . . . 0.0 110.643 -179.691 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 520' ' ' THR . . . . . 0.563 ' N ' ' OG1' ' A' ' 519' ' ' THR . 1.2 m 178.53 -62.75 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.227 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 521' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -75.54 -11.74 60.09 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.268 178.206 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 522' ' ' ASP . . . . . 0.457 ' HB2' ' O ' ' A' ' 518' ' ' TRP . 45.2 m-20 -94.48 -12.39 27.8 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.013 178.588 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 523' ' ' GLU . . . . . 0.412 ' HG3' ' HA ' ' A' ' 520' ' ' THR . 20.2 mm-40 -50.0 -25.22 3.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.701 178.632 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . 139.48 37.9 0.11 Allowed Glycine 0 N--CA 1.445 -0.708 0 N-CA-C 110.3 -1.12 . . . . 0.0 110.3 -179.075 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -107.94 -42.96 4.55 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.273 -0.464 . . . . 0.0 111.61 -178.543 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 526' ' ' ALA . . . . . 0.53 ' O ' ' HB1' ' A' ' 544' ' ' ALA . . . -136.8 42.74 2.45 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-O 121.441 0.638 . . . . 0.0 110.157 179.678 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 527' ' ' ILE . . . . . 0.74 HD12 ' N ' ' A' ' 528' ' ' GLY . 1.8 pp -95.53 -8.38 9.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 114.994 -1.003 . . . . 0.0 112.39 -179.056 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 528' ' ' GLY . . . . . 0.74 ' N ' HD12 ' A' ' 527' ' ' ILE . . . -55.95 -16.32 12.51 Favored Glycine 0 CA--C 1.52 0.402 0 C-N-CA 120.938 -0.649 . . . . 0.0 114.009 -179.222 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 529' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -98.49 -35.3 10.3 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 117.581 0.69 . . . . 0.0 111.767 -179.314 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 530' ' ' ALA . . . . . 1.009 ' HB3' ' HB2' ' A' ' 544' ' ' ALA . . . -103.6 1.06 31.61 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.694 0.627 . . . . 0.0 112.694 -178.9 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 531' ' ' TRP . . . . . 0.457 ' HB2' ' O ' ' A' ' 527' ' ' ILE . 22.4 t90 -56.08 -12.81 1.63 Allowed 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 111.878 0.325 . . . . 0.0 111.878 -179.439 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 532' ' ' ILE . . . . . 0.698 ' O ' HD12 ' A' ' 532' ' ' ILE . 1.6 pp -129.8 74.74 80.43 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 120.908 0.385 . . . . 0.0 111.06 179.665 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 533' ' ' PRO . . . . . 0.58 ' HB3' ' HB3' ' A' ' 539' ' ' ALA . 9.5 Cg_endo -51.89 94.91 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.891 2.394 . . . . 0.0 112.688 -179.68 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 534' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -96.26 -17.13 20.97 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.09 179.558 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -75.89 -35.01 60.0 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.369 -179.595 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 143.88 -64.15 0.48 Allowed Glycine 0 CA--C 1.519 0.297 0 C-N-CA 120.484 -0.865 . . . . 0.0 112.788 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -58.95 -165.79 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.689 2.259 . . . . 0.0 112.177 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 538' ' ' ALA . . . . . 0.436 ' O ' ' HB3' ' A' ' 539' ' ' ALA . . . -63.02 -49.76 73.37 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.474 179.825 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 539' ' ' ALA . . . . . 0.599 ' C ' ' HB1' ' A' ' 530' ' ' ALA . . . 68.01 -57.63 0.46 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 121.389 0.614 . . . . 0.0 111.804 179.578 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -37.48 -29.94 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.942 -1.026 . . . . 0.0 112.338 -179.173 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 541' ' ' GLY . . . . . 0.401 ' O ' ' HB3' ' A' ' 549' ' ' HIS . . . -122.89 -26.23 1.76 Allowed Glycine 0 CA--C 1.52 0.379 0 C-N-CA 120.281 -0.961 . . . . 0.0 113.503 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 542' ' ' ILE . . . . . 0.54 ' CD1' ' HA ' ' A' ' 539' ' ' ALA . 2.6 pp -96.48 -21.47 5.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 112.392 0.515 . . . . 0.0 112.392 -179.247 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 543' ' ' TYR . . . . . 0.455 ' HB2' ' HA ' ' A' ' 539' ' ' ALA . 3.6 t80 -107.86 -13.75 14.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.084 0.468 . . . . 0.0 110.263 179.536 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 544' ' ' ALA . . . . . 1.009 ' HB2' ' HB3' ' A' ' 530' ' ' ALA . . . -92.16 -21.58 20.32 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.309 179.453 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 545' ' ' GLU . . . . . 0.517 ' OE2' ' HB2' ' A' ' 548' ' ' MET . 4.2 tp10 -118.36 -33.35 4.38 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.363 -179.666 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 35.21 40.71 0.26 Allowed Glycine 0 CA--C 1.519 0.297 0 CA-C-N 115.808 -0.633 . . . . 0.0 114.472 179.278 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 547' ' ' LEU . . . . . 0.617 HD23 ' H ' ' A' ' 548' ' ' MET . 0.0 OUTLIER -179.79 -61.43 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 118.004 0.902 . . . . 0.0 112.46 179.567 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 548' ' ' MET . . . . . 0.617 ' H ' HD23 ' A' ' 547' ' ' LEU . 0.0 OUTLIER -94.6 11.65 30.31 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.818 0.342 . . . . 0.0 111.085 179.794 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 549' ' ' HIS . . . . . 0.491 ' O ' ' CG2' ' A' ' 519' ' ' THR . 18.5 p80 -62.6 -11.12 14.88 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.079 179.568 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 550' ' ' ASN . . . . . 0.429 ' O ' ' N ' ' A' ' 552' ' ' ASP . 47.3 m-20 -96.04 -33.06 12.26 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -178.942 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 551' ' ' GLN . . . . . 0.411 ' HG2' ' CG ' ' A' ' 548' ' ' MET . 1.7 pt20 -66.36 71.53 0.07 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.109 0.48 . . . . 0.0 110.654 -179.79 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 552' ' ' ASP . . . . . 0.455 ' O ' ' HA ' ' A' ' 513' ' ' PRO . 3.3 p30 -95.38 21.96 7.47 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.396 -179.661 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . 123.89 -31.05 4.66 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.902 -0.666 . . . . 0.0 111.683 -179.279 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 554' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -61.48 -58.76 6.88 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.42 0.628 . . . . 0.0 109.87 178.992 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 555' ' ' ILE . . . . . 0.637 HG22 ' O ' ' A' ' 555' ' ' ILE . 3.2 mm -73.28 63.29 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.694 179.765 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 556' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.326 -0.447 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.432 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 507' ' ' ALA . . . . . 0.767 ' HB3' ' HG3' ' A' ' 559' ' ' ARG . . . . . . . . 0 N--CA 1.487 1.406 0 CA-C-O 120.922 0.391 . . . . 0.0 111.105 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 508' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -128.58 77.38 77.46 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.949 179.634 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 509' ' ' PRO . . . . . 0.538 ' HB3' HD11 ' A' ' 558' ' ' LEU . 17.4 Cg_exo -66.74 -65.37 0.04 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.245 0 C-N-CA 122.658 2.239 . . . . 0.0 111.755 179.777 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 510' ' ' LYS . . . . . 0.471 ' HG2' ' N ' ' A' ' 511' ' ' CYS . 0.0 OUTLIER 177.25 -34.76 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.406 179.641 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 511' ' ' CYS . . . . . 0.471 ' N ' ' HG2' ' A' ' 510' ' ' LYS . 0.6 OUTLIER 43.97 64.57 1.24 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.103 -0.953 . . . . 0.0 111.428 179.491 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 512' ' ' ASN . . . . . . . . . . . . . 7.5 m-20 -131.35 82.46 62.28 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.434 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 513' ' ' PRO . . . . . 0.468 ' HA ' ' O ' ' A' ' 552' ' ' ASP . 85.3 Cg_endo -79.07 20.71 0.79 Allowed 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.895 2.396 . . . . 0.0 113.097 -179.642 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 34.8 t30 -96.67 -31.25 12.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.96 0.41 . . . . 0.0 110.786 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 515' ' ' LEU . . . . . . . . . . . . . 18.9 mt -83.52 73.85 10.16 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.886 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 516' ' ' HIS . . . . . 0.413 ' HA ' ' CB ' ' A' ' 552' ' ' ASP . 1.4 t-80 -72.47 -15.28 61.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.59 -179.78 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 517' ' ' TYR . . . . . . . . . . . . . 48.2 m-85 -79.16 -66.03 0.92 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.819 0.342 . . . . 0.0 111.433 -179.601 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 518' ' ' TRP . . . . . 0.494 ' O ' ' N ' ' A' ' 520' ' ' THR . 21.2 m-90 -70.32 -14.38 62.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.884 -179.492 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 519' ' ' THR . . . . . 0.541 ' OG1' ' N ' ' A' ' 520' ' ' THR . 1.7 p 56.98 -78.8 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 116.727 -0.215 . . . . 0.0 110.719 -179.705 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 520' ' ' THR . . . . . 0.541 ' N ' ' OG1' ' A' ' 519' ' ' THR . 1.1 m 176.83 -62.68 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.149 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 521' ' ' GLN . . . . . 0.419 ' N ' HG22 ' A' ' 520' ' ' THR . 1.6 mp0 -72.73 -12.27 60.95 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 177.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 522' ' ' ASP . . . . . 0.444 ' HA ' ' CG2' ' A' ' 527' ' ' ILE . 1.9 m-20 -93.89 -11.03 31.95 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.699 178.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -45.48 -27.92 0.81 Allowed 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.44 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 524' ' ' GLY . . . . . 0.436 ' HA2' ' CG1' ' A' ' 527' ' ' ILE . . . 147.62 41.38 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.489 -0.863 . . . . 0.0 112.477 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -100.44 -60.11 1.58 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.743 0.306 . . . . 0.0 111.737 -179.598 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -132.48 37.57 3.5 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-O 121.488 0.661 . . . . 0.0 110.103 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 527' ' ' ILE . . . . . 0.945 ' HA ' ' HB1' ' A' ' 544' ' ' ALA . 1.8 pp -95.94 -0.96 10.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 114.811 -1.086 . . . . 0.0 112.793 -178.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 528' ' ' GLY . . . . . 0.598 ' N ' HD12 ' A' ' 527' ' ' ILE . . . -57.63 -12.56 9.94 Favored Glycine 0 CA--C 1.521 0.414 0 C-N-CA 120.875 -0.679 . . . . 0.0 113.976 -179.344 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 529' ' ' LEU . . . . . 0.504 HD11 ' O ' ' A' ' 543' ' ' TYR . 1.2 pp -98.75 -39.37 8.68 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 117.757 0.779 . . . . 0.0 112.167 -179.241 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 530' ' ' ALA . . . . . 1.019 ' HB3' ' HB2' ' A' ' 544' ' ' ALA . . . -103.93 1.8 31.72 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 -178.461 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 531' ' ' TRP . . . . . 0.481 ' HB2' ' O ' ' A' ' 527' ' ' ILE . 54.9 t90 -72.04 30.3 0.05 Allowed 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -178.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 532' ' ' ILE . . . . . 0.62 ' O ' HD12 ' A' ' 532' ' ' ILE . 1.3 pp -159.65 70.87 3.27 Favored Pre-proline 0 C--N 1.332 -0.181 0 CA-C-O 120.723 0.297 . . . . 0.0 110.894 179.176 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 533' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -51.26 103.51 0.07 OUTLIER 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.659 2.239 . . . . 0.0 111.742 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 534' ' ' TYR . . . . . 0.4 ' CD1' HD12 ' A' ' 532' ' ' ILE . 0.4 OUTLIER -96.17 -55.06 3.08 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -179.006 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 -118.52 -35.23 3.8 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 -179.1 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . -87.44 -175.06 48.68 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.891 -179.229 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 537' ' ' PRO . . . . . 0.402 ' HG2' ' CD1' ' A' ' 542' ' ' ILE . 14.1 Cg_endo -56.59 -159.34 0.01 OUTLIER 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.884 2.39 . . . . 0.0 111.692 179.691 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 538' ' ' ALA . . . . . 0.508 ' O ' ' HB3' ' A' ' 539' ' ' ALA . . . -43.99 -49.83 8.48 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.067 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 539' ' ' ALA . . . . . 0.522 ' C ' ' HB1' ' A' ' 530' ' ' ALA . . . 71.66 -46.7 0.65 Allowed 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.205 0.526 . . . . 0.0 111.548 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 540' ' ' GLU . . . . . 0.444 ' HG2' ' HA ' ' A' ' 531' ' ' TRP . 2.5 mt-10 -36.95 -29.09 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.057 -0.974 . . . . 0.0 112.304 -179.352 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 541' ' ' GLY . . . . . 0.406 ' N ' ' O ' ' A' ' 539' ' ' ALA . . . -127.79 -48.66 0.17 Allowed Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.028 179.21 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 542' ' ' ILE . . . . . 0.628 HG22 ' CE1' ' A' ' 549' ' ' HIS . 2.6 pp -68.09 -25.14 31.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -179.355 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 543' ' ' TYR . . . . . 0.534 ' HB2' HD12 ' A' ' 542' ' ' ILE . 6.1 t80 -115.3 -8.0 12.32 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.857 0.361 . . . . 0.0 111.145 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 544' ' ' ALA . . . . . 1.019 ' HB2' ' HB3' ' A' ' 530' ' ' ALA . . . -99.31 -33.22 10.81 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.06 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 545' ' ' GLU . . . . . 0.529 ' HG3' ' H ' ' A' ' 548' ' ' MET . 14.3 tp10 -118.67 -32.67 4.49 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.209 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 40.71 42.1 2.66 Favored Glycine 0 CA--C 1.521 0.417 0 CA-C-N 115.917 -0.583 . . . . 0.0 113.747 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 547' ' ' LEU . . . . . 0.666 HD23 ' H ' ' A' ' 548' ' ' MET . 0.0 OUTLIER -173.16 -61.14 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 117.4 0.6 . . . . 0.0 112.14 179.608 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 548' ' ' MET . . . . . 0.666 ' H ' HD23 ' A' ' 547' ' ' LEU . 4.3 mtt -95.31 11.71 31.64 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.709 0.29 . . . . 0.0 111.481 -179.832 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 549' ' ' HIS . . . . . 0.628 ' CE1' HG22 ' A' ' 542' ' ' ILE . 29.9 p80 -65.47 -11.08 39.81 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.861 0.363 . . . . 0.0 110.791 179.423 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 550' ' ' ASN . . . . . 0.505 ' O ' ' N ' ' A' ' 552' ' ' ASP . 15.0 m-20 -95.87 -41.08 8.99 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -179.092 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 551' ' ' GLN . . . . . 0.51 ' HG3' ' O ' ' A' ' 548' ' ' MET . 0.0 OUTLIER -62.36 73.31 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.171 0.51 . . . . 0.0 110.469 -179.882 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 552' ' ' ASP . . . . . 0.505 ' N ' ' O ' ' A' ' 550' ' ' ASN . 1.9 p30 -90.25 22.2 3.44 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.601 -179.581 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . 124.04 -30.52 4.78 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.891 -0.671 . . . . 0.0 111.668 -179.319 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 554' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -55.73 -53.65 54.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.559 0.695 . . . . 0.0 110.138 178.863 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 555' ' ' ILE . . . . . 0.793 ' O ' HD23 ' A' ' 558' ' ' LEU . 4.0 mm -79.52 58.96 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.696 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 556' ' ' CYS . . . . . . . . . . . . . 6.3 t -73.98 -7.49 52.59 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.469 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -67.36 -7.67 47.03 Favored Glycine 0 CA--C 1.52 0.375 0 C-N-CA 120.811 -0.709 . . . . 0.0 113.489 -179.491 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 558' ' ' LEU . . . . . 0.793 HD23 ' O ' ' A' ' 555' ' ' ILE . 0.5 OUTLIER -53.55 -59.38 4.67 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 117.276 0.538 . . . . 0.0 111.249 -179.751 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 559' ' ' ARG . . . . . 0.767 ' HG3' ' HB3' ' A' ' 507' ' ' ALA . 2.2 mpt_? 56.55 164.81 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.225 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 560' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.205 -0.903 . . . . 0.0 110.958 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.384 0 CA-C-O 120.838 0.351 . . . . 0.0 111.116 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 508' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.37 77.63 76.81 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.916 179.63 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 509' ' ' PRO . . . . . 0.467 ' O ' ' CE ' ' A' ' 510' ' ' LYS . 73.9 Cg_endo -75.14 -8.82 20.24 Favored 'Trans proline' 0 C--N 1.343 0.241 0 C-N-CA 122.636 2.224 . . . . 0.0 112.63 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 510' ' ' LYS . . . . . 0.467 ' CE ' ' O ' ' A' ' 509' ' ' PRO . 0.0 OUTLIER 82.44 -31.22 0.09 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 121.029 0.442 . . . . 0.0 111.615 -179.912 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 511' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 45.32 90.15 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.485 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 512' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -131.72 77.23 73.09 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.403 179.659 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 513' ' ' PRO . . . . . 0.462 ' HA ' ' O ' ' A' ' 552' ' ' ASP . 87.7 Cg_endo -79.75 22.52 0.72 Allowed 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.932 2.421 . . . . 0.0 113.177 -179.533 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 25.8 t30 -96.67 -28.97 14.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.691 0.281 . . . . 0.0 110.804 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 515' ' ' LEU . . . . . . . . . . . . . 46.4 mt -90.59 72.87 6.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.926 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 516' ' ' HIS . . . . . 0.434 ' HA ' ' CB ' ' A' ' 552' ' ' ASP . 1.4 t60 -76.7 -7.34 55.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.655 -179.742 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 517' ' ' TYR . . . . . . . . . . . . . 42.9 m-85 -85.26 -49.5 8.14 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.674 0.274 . . . . 0.0 111.524 -179.575 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 518' ' ' TRP . . . . . 0.495 ' O ' ' N ' ' A' ' 520' ' ' THR . 3.0 m-90 -88.56 -11.55 45.3 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 111.886 0.328 . . . . 0.0 111.886 -179.331 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 519' ' ' THR . . . . . 0.572 ' OG1' ' N ' ' A' ' 520' ' ' THR . 1.3 p 56.22 -79.08 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.81 -0.177 . . . . 0.0 110.989 179.799 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 520' ' ' THR . . . . . 0.572 ' N ' ' OG1' ' A' ' 519' ' ' THR . 1.2 m 179.46 -62.74 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 179.435 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 521' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -74.16 -12.07 60.48 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 177.79 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 522' ' ' ASP . . . . . 0.438 ' HB2' ' O ' ' A' ' 518' ' ' TRP . 20.8 m-20 -93.95 -10.57 33.28 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.854 179.296 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 523' ' ' GLU . . . . . 0.466 ' HA ' ' CD1' ' A' ' 518' ' ' TRP . 14.1 pt-20 -45.24 -26.65 0.52 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.515 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . 147.6 41.35 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.289 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -101.23 -60.46 1.52 Allowed 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 111.941 0.349 . . . . 0.0 111.941 -179.466 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -131.44 36.84 3.74 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-O 121.541 0.686 . . . . 0.0 110.129 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 527' ' ' ILE . . . . . 0.935 ' HA ' ' HB1' ' A' ' 544' ' ' ALA . 2.1 pp -95.77 -0.38 10.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 114.762 -1.108 . . . . 0.0 112.709 -178.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 528' ' ' GLY . . . . . 0.515 ' N ' HD12 ' A' ' 527' ' ' ILE . . . -60.41 -10.47 16.85 Favored Glycine 0 CA--C 1.521 0.423 0 C-N-CA 120.82 -0.705 . . . . 0.0 113.948 -179.43 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 529' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -98.47 -33.69 10.92 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 117.569 0.684 . . . . 0.0 111.502 -179.585 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 530' ' ' ALA . . . . . 0.93 ' HB3' ' HB2' ' A' ' 544' ' ' ALA . . . -103.75 1.63 31.96 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -178.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 531' ' ' TRP . . . . . 0.547 ' O ' HG23 ' A' ' 532' ' ' ILE . 0.2 OUTLIER -71.15 30.2 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -179.056 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 532' ' ' ILE . . . . . 0.547 HG23 ' O ' ' A' ' 531' ' ' TRP . 1.1 pt -161.02 75.38 2.57 Favored Pre-proline 0 N--CA 1.456 -0.162 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.471 179.301 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 533' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -36.89 85.98 0.01 OUTLIER 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 123.5 2.8 . . . . 0.0 113.399 -179.532 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 534' ' ' TYR . . . . . 0.455 ' N ' ' O ' ' A' ' 532' ' ' ILE . 0.6 OUTLIER -96.7 -49.51 5.07 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.269 -179.991 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -57.53 -34.85 69.56 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.548 -179.329 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 143.47 -64.57 0.48 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.566 -0.826 . . . . 0.0 112.531 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -58.72 -165.48 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.622 2.215 . . . . 0.0 111.711 179.584 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 538' ' ' ALA . . . . . 0.437 ' O ' ' HB3' ' A' ' 539' ' ' ALA . . . -62.13 -51.1 69.24 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.292 179.64 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 539' ' ' ALA . . . . . 0.644 ' C ' ' HB1' ' A' ' 530' ' ' ALA . . . 68.45 -53.72 0.54 Allowed 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.599 179.725 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 540' ' ' GLU . . . . . 0.414 ' O ' ' HB3' ' A' ' 544' ' ' ALA . 0.6 OUTLIER -37.28 -27.98 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.022 -0.99 . . . . 0.0 112.09 -179.416 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 541' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 539' ' ' ALA . . . -124.57 -47.31 0.23 Allowed Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.14 179.155 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 542' ' ' ILE . . . . . 0.514 HG22 ' CE1' ' A' ' 549' ' ' HIS . 2.6 pp -72.65 -22.92 20.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 -179.634 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 543' ' ' TYR . . . . . 0.423 ' C ' ' HB2' ' A' ' 530' ' ' ALA . 89.8 t80 -111.02 -8.05 14.48 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.067 0.461 . . . . 0.0 110.68 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 544' ' ' ALA . . . . . 0.935 ' HB1' ' HA ' ' A' ' 527' ' ' ILE . . . -103.04 -32.86 9.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.02 179.43 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 545' ' ' GLU . . . . . 0.48 ' OE2' HD23 ' A' ' 547' ' ' LEU . 29.3 tp10 -118.49 -32.74 4.52 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.207 -179.76 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 38.17 37.61 0.48 Allowed Glycine 0 CA--C 1.519 0.326 0 CA-C-N 115.723 -0.672 . . . . 0.0 113.985 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 547' ' ' LEU . . . . . 0.6 HD23 ' H ' ' A' ' 548' ' ' MET . 0.0 OUTLIER -170.58 -61.99 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 117.694 0.747 . . . . 0.0 112.506 179.484 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 548' ' ' MET . . . . . 0.6 ' H ' HD23 ' A' ' 547' ' ' LEU . 0.0 OUTLIER -96.45 11.31 35.38 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.731 0.301 . . . . 0.0 111.124 179.682 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 549' ' ' HIS . . . . . 0.514 ' CE1' HG22 ' A' ' 542' ' ' ILE . 6.0 p-80 -63.43 -10.99 19.76 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.919 179.6 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 550' ' ' ASN . . . . . 0.415 ' O ' ' N ' ' A' ' 552' ' ' ASP . 44.9 m-20 -95.73 -34.25 12.0 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -179.021 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 551' ' ' GLN . . . . . 0.418 ' HG2' ' HG3' ' A' ' 548' ' ' MET . 2.5 pt20 -66.87 71.86 0.09 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.016 0.436 . . . . 0.0 110.55 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 552' ' ' ASP . . . . . 0.462 ' O ' ' HA ' ' A' ' 513' ' ' PRO . 2.6 p30 -93.62 21.95 5.89 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.37 -179.626 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . 123.9 -31.91 4.38 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.885 -0.674 . . . . 0.0 111.752 -179.545 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 554' ' ' LEU . . . . . 0.441 HD11 ' OD2' ' A' ' 552' ' ' ASP . 0.5 OUTLIER -59.42 -57.85 11.17 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.493 0.663 . . . . 0.0 110.194 179.017 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 555' ' ' ILE . . . . . 0.648 HG22 ' O ' ' A' ' 555' ' ' ILE . 2.8 mm -72.36 63.77 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 CA-C-N 114.892 -1.049 . . . . 0.0 110.724 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 556' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -70.21 -12.31 61.5 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.328 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 557' ' ' GLY . . . . . 0.412 ' HA2' ' NH1' ' A' ' 559' ' ' ARG . . . -53.96 -21.28 16.44 Favored Glycine 0 CA--C 1.519 0.313 0 C-N-CA 120.885 -0.674 . . . . 0.0 113.118 -179.644 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 558' ' ' LEU . . . . . 0.831 HD12 ' N ' ' A' ' 559' ' ' ARG . 3.0 pp -49.7 -45.98 49.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.791 0.329 . . . . 0.0 111.447 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 559' ' ' ARG . . . . . 0.831 ' N ' HD12 ' A' ' 558' ' ' LEU . 6.4 mpt_? 50.34 -177.73 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.261 -179.8 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 560' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.192 -0.908 . . . . 0.0 111.094 179.928 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.382 0 CA-C-O 120.914 0.388 . . . . 0.0 111.142 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 508' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -128.7 95.01 33.37 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.091 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 509' ' ' PRO . . . . . 0.546 ' O ' ' CE ' ' A' ' 510' ' ' LYS . 73.0 Cg_endo -76.45 -17.66 16.3 Favored 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 122.532 2.155 . . . . 0.0 112.406 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 510' ' ' LYS . . . . . 0.546 ' CE ' ' O ' ' A' ' 509' ' ' PRO . 0.0 OUTLIER 88.5 -15.02 0.36 Allowed 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 122.974 0.51 . . . . 0.0 111.322 -179.761 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 511' ' ' CYS . . . . . . . . . . . . . 1.5 t 47.0 81.65 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.315 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 512' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -109.76 78.2 1.18 Allowed Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.468 179.727 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 513' ' ' PRO . . . . . 0.472 ' HA ' ' O ' ' A' ' 552' ' ' ASP . 73.6 Cg_endo -75.89 18.42 0.63 Allowed 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.92 2.414 . . . . 0.0 113.106 -179.494 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -96.7 -34.26 11.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.782 0.325 . . . . 0.0 110.773 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 515' ' ' LEU . . . . . . . . . . . . . 52.6 mt -78.9 75.13 5.41 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.943 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 516' ' ' HIS . . . . . . . . . . . . . 1.3 p-80 -79.87 -7.23 58.61 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.677 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 517' ' ' TYR . . . . . 0.442 ' HB2' ' CE3' ' A' ' 518' ' ' TRP . 44.5 m-85 -77.79 -59.9 2.59 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.783 0.325 . . . . 0.0 111.309 -179.787 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 518' ' ' TRP . . . . . 0.55 ' O ' ' N ' ' A' ' 520' ' ' THR . 13.9 m-90 -91.17 4.68 51.62 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.793 -179.618 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 519' ' ' THR . . . . . 0.534 ' OG1' ' N ' ' A' ' 520' ' ' THR . 1.3 p 54.42 -76.6 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 116.851 -0.159 . . . . 0.0 110.986 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 520' ' ' THR . . . . . 0.55 ' N ' ' O ' ' A' ' 518' ' ' TRP . 1.2 m 176.98 -62.47 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.231 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 179.436 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 521' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -69.81 -12.37 61.57 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.418 178.103 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 522' ' ' ASP . . . . . 0.462 ' HA ' ' CG2' ' A' ' 527' ' ' ILE . 1.1 m-20 -93.93 -11.2 31.49 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.939 179.294 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 523' ' ' GLU . . . . . 0.403 ' HA ' ' HB3' ' A' ' 518' ' ' TRP . 16.8 pt-20 -45.52 -27.56 0.76 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.474 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 524' ' ' GLY . . . . . 0.428 ' HA2' ' CG1' ' A' ' 527' ' ' ILE . . . 144.99 42.45 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.508 -0.854 . . . . 0.0 112.229 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -101.32 -60.31 1.55 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.713 0.292 . . . . 0.0 111.706 -179.603 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -131.8 38.43 3.55 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-O 121.521 0.677 . . . . 0.0 110.036 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 527' ' ' ILE . . . . . 0.893 ' HA ' ' HB1' ' A' ' 544' ' ' ALA . 2.1 pp -95.8 -0.5 10.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 114.719 -1.128 . . . . 0.0 112.775 -178.751 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 528' ' ' GLY . . . . . 0.538 ' N ' HD12 ' A' ' 527' ' ' ILE . . . -57.71 -14.31 14.94 Favored Glycine 0 CA--C 1.521 0.452 0 C-N-CA 120.762 -0.733 . . . . 0.0 114.005 -179.362 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 529' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -98.74 -33.66 10.83 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 117.666 0.733 . . . . 0.0 111.909 -179.334 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 530' ' ' ALA . . . . . 0.945 ' HB3' ' HB2' ' A' ' 544' ' ' ALA . . . -103.85 1.96 32.11 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -178.604 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 531' ' ' TRP . . . . . 0.512 ' O ' HG23 ' A' ' 532' ' ' ILE . 57.3 t-105 -68.43 30.09 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.546 0.573 . . . . 0.0 112.546 -178.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 532' ' ' ILE . . . . . 0.512 HG23 ' O ' ' A' ' 531' ' ' TRP . 1.1 pt -160.2 71.9 3.04 Favored Pre-proline 0 C--N 1.331 -0.207 0 CA-C-O 120.827 0.346 . . . . 0.0 110.742 179.037 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 533' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_endo -47.11 88.43 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 123.148 2.565 . . . . 0.0 112.821 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 534' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -96.43 -43.6 7.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.283 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -57.75 -34.78 69.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.552 -179.341 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 149.13 -64.77 0.4 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.529 -0.843 . . . . 0.0 112.579 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_endo -57.3 -164.09 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.576 2.184 . . . . 0.0 111.8 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 538' ' ' ALA . . . . . 0.498 ' O ' ' HB3' ' A' ' 539' ' ' ALA . . . -72.03 -47.2 53.45 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.619 179.655 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 539' ' ' ALA . . . . . 0.665 ' C ' ' HB1' ' A' ' 530' ' ' ALA . . . 70.7 -53.73 0.66 Allowed 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.33 0.586 . . . . 0.0 111.227 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 540' ' ' GLU . . . . . 0.508 ' HG2' ' HA ' ' A' ' 531' ' ' TRP . 15.6 mt-10 -37.26 -28.17 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.543 0 CA-C-N 114.828 -1.078 . . . . 0.0 112.37 -179.442 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 541' ' ' GLY . . . . . 0.447 ' HA3' ' CD2' ' A' ' 549' ' ' HIS . . . -126.24 -40.17 0.38 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.388 179.51 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 542' ' ' ILE . . . . . 0.676 HG23 ' ND1' ' A' ' 549' ' ' HIS . 2.6 pp -79.88 -23.16 11.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 112.122 0.415 . . . . 0.0 112.122 -179.406 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 543' ' ' TYR . . . . . 0.434 ' C ' ' HB2' ' A' ' 530' ' ' ALA . 89.0 t80 -111.48 -7.79 14.31 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.042 0.449 . . . . 0.0 110.613 179.63 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 544' ' ' ALA . . . . . 0.945 ' HB2' ' HB3' ' A' ' 530' ' ' ALA . . . -103.06 -36.91 7.98 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.381 179.181 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 545' ' ' GLU . . . . . 0.495 ' CG ' ' H ' ' A' ' 548' ' ' MET . 20.2 tp10 -118.91 -32.57 4.45 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.099 -0.955 . . . . 0.0 111.1 179.753 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 37.09 47.58 1.38 Allowed Glycine 0 C--N 1.331 0.285 0 CA-C-N 115.992 -0.549 . . . . 0.0 113.387 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 547' ' ' LEU . . . . . 0.689 ' HG ' ' N ' ' A' ' 548' ' ' MET . 0.0 OUTLIER -174.87 -57.55 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 117.276 0.538 . . . . 0.0 111.834 179.949 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 548' ' ' MET . . . . . 0.689 ' N ' ' HG ' ' A' ' 547' ' ' LEU . 0.0 OUTLIER -96.0 11.49 33.85 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.644 0.259 . . . . 0.0 111.344 -179.999 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 549' ' ' HIS . . . . . 0.676 ' ND1' HG23 ' A' ' 542' ' ' ILE . 12.8 t-80 -62.59 -11.82 19.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.817 0.341 . . . . 0.0 110.629 179.431 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 550' ' ' ASN . . . . . 0.477 ' O ' ' N ' ' A' ' 552' ' ' ASP . 32.7 m-20 -96.22 -39.74 9.52 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.629 -179.531 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 551' ' ' GLN . . . . . 0.437 ' HG3' ' O ' ' A' ' 548' ' ' MET . 1.5 pt20 -61.81 73.93 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.228 0.537 . . . . 0.0 110.843 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 552' ' ' ASP . . . . . 0.509 ' HA ' ' O ' ' A' ' 519' ' ' THR . 1.6 p30 -83.78 22.24 1.15 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.541 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . 124.25 -26.75 5.73 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 121.01 -0.614 . . . . 0.0 111.62 -179.131 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 554' ' ' LEU . . . . . 0.404 HD11 ' OD1' ' A' ' 552' ' ' ASP . 0.7 OUTLIER -59.23 -53.32 59.65 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.438 0.637 . . . . 0.0 110.117 178.971 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 555' ' ' ILE . . . . . 0.647 HG22 ' O ' ' A' ' 555' ' ' ILE . 8.1 mm -84.59 54.02 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 CA-C-N 114.945 -1.025 . . . . 0.0 111.111 -179.596 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 556' ' ' CYS . . . . . . . . . . . . . 8.0 p -75.02 -7.32 53.35 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.392 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 557' ' ' GLY . . . . . 0.424 ' O ' ' HD3' ' A' ' 559' ' ' ARG . . . -56.73 -12.95 7.26 Favored Glycine 0 CA--C 1.521 0.414 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.963 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 558' ' ' LEU . . . . . 0.738 HD12 ' N ' ' A' ' 559' ' ' ARG . 1.5 pp -46.5 -52.12 13.93 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.89 0.376 . . . . 0.0 111.701 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 559' ' ' ARG . . . . . 0.738 ' N ' HD12 ' A' ' 558' ' ' LEU . 3.0 mpt_? 51.95 -173.63 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.874 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 560' ' ' GLN . . . . . . . . . . . . . 3.9 mm100 . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.255 -0.879 . . . . 0.0 110.85 179.924 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 507' ' ' ALA . . . . . 0.671 ' HB1' ' H ' ' A' ' 560' ' ' GLN . . . . . . . . 0 N--CA 1.484 1.269 0 CA-C-O 120.875 0.369 . . . . 0.0 111.036 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 508' ' ' GLN . . . . . . . . . . . . . 4.8 mp0 -128.26 82.58 68.23 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.955 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 509' ' ' PRO . . . . . 0.484 ' O ' ' CE ' ' A' ' 510' ' ' LYS . 88.9 Cg_endo -85.0 -11.57 7.55 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 122.696 2.264 . . . . 0.0 112.542 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 510' ' ' LYS . . . . . 0.484 ' CE ' ' O ' ' A' ' 509' ' ' PRO . 0.0 OUTLIER 81.33 -26.48 0.15 Allowed 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 121.08 0.467 . . . . 0.0 111.015 -179.252 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 511' ' ' CYS . . . . . . . . . . . . . 2.5 m 44.18 69.25 0.43 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.611 179.543 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 512' ' ' ASN . . . . . 0.416 ' O ' ' O ' ' A' ' 552' ' ' ASP . 0.5 OUTLIER -118.05 81.73 16.63 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.351 179.653 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 513' ' ' PRO . . . . . 0.525 ' HA ' ' O ' ' A' ' 552' ' ' ASP . 64.4 Cg_endo -75.21 18.78 0.54 Allowed 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 123.0 2.467 . . . . 0.0 113.235 -179.773 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 24.2 t30 -96.71 -34.17 11.46 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.873 0.368 . . . . 0.0 110.859 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 515' ' ' LEU . . . . . . . . . . . . . 2.7 mt -84.68 74.07 10.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.006 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 516' ' ' HIS . . . . . 0.448 ' HA ' ' CB ' ' A' ' 552' ' ' ASP . 14.2 t60 -71.47 -8.4 53.65 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.91 -179.726 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 517' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -82.26 -62.5 1.61 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.712 0.291 . . . . 0.0 111.629 -179.547 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 518' ' ' TRP . . . . . 0.506 ' O ' ' N ' ' A' ' 520' ' ' THR . 14.4 m-90 -71.39 -17.86 62.39 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.661 -179.467 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 519' ' ' THR . . . . . 0.508 ' OG1' ' N ' ' A' ' 520' ' ' THR . 1.8 p 54.04 -80.29 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 116.621 -0.263 . . . . 0.0 110.919 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 520' ' ' THR . . . . . 0.508 ' N ' ' OG1' ' A' ' 519' ' ' THR . 1.2 m 177.71 -62.85 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 179.065 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 521' ' ' GLN . . . . . 0.435 ' HB2' ' HB3' ' A' ' 548' ' ' MET . 0.7 OUTLIER -72.64 -11.69 60.74 Favored 'General case' 0 CA--C 1.513 -0.45 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 177.989 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 522' ' ' ASP . . . . . 0.475 ' HA ' ' CG2' ' A' ' 527' ' ' ILE . 2.4 m-20 -87.47 -11.04 50.17 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.745 179.146 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -45.2 -26.6 0.51 Allowed 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.902 -179.453 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 524' ' ' GLY . . . . . 0.46 ' HA2' ' CG1' ' A' ' 527' ' ' ILE . . . 148.51 40.52 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.458 -0.877 . . . . 0.0 112.386 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -98.21 -59.65 1.71 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.806 0.336 . . . . 0.0 111.892 -179.476 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -133.59 32.44 3.6 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.577 0.703 . . . . 0.0 110.018 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 527' ' ' ILE . . . . . 0.866 ' HA ' ' HB1' ' A' ' 544' ' ' ALA . 2.3 pp -95.86 -0.56 10.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 114.593 -1.185 . . . . 0.0 112.644 -178.801 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 528' ' ' GLY . . . . . 0.473 ' N ' HD12 ' A' ' 527' ' ' ILE . . . -58.88 -4.57 2.3 Favored Glycine 0 CA--C 1.522 0.52 0 N-CA-C 114.696 0.638 . . . . 0.0 114.696 -178.924 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 529' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -98.2 -42.24 7.52 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 118.031 0.915 . . . . 0.0 111.672 -179.59 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 530' ' ' ALA . . . . . 1.082 ' HB3' ' HB2' ' A' ' 544' ' ' ALA . . . -103.85 1.99 32.14 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.354 0.502 . . . . 0.0 112.354 -179.239 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 531' ' ' TRP . . . . . 0.66 ' CD2' HD13 ' A' ' 527' ' ' ILE . 22.5 t-105 -54.83 -9.27 0.33 Allowed 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 112.893 0.701 . . . . 0.0 112.893 -178.134 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 532' ' ' ILE . . . . . 0.72 ' O ' HD12 ' A' ' 532' ' ' ILE . 1.6 pp -135.34 76.23 56.89 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-O 121.039 0.447 . . . . 0.0 111.05 179.313 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 533' ' ' PRO . . . . . 0.532 ' HG3' ' HB3' ' A' ' 539' ' ' ALA . 32.4 Cg_exo -63.29 89.51 0.13 Allowed 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 123.058 2.506 . . . . 0.0 112.591 -179.586 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 534' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -60.52 -54.35 46.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.993 0.425 . . . . 0.0 110.151 179.415 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -118.18 22.99 11.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.702 179.361 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . -122.34 153.1 16.84 Favored Glycine 0 C--N 1.333 0.377 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.736 -179.756 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -71.28 -89.47 0.0 OUTLIER 'Trans proline' 0 CA--C 1.534 0.503 0 C-N-CA 122.714 2.276 . . . . 0.0 112.834 -179.693 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 538' ' ' ALA . . . . . . . . . . . . . . . -99.29 17.11 20.89 Favored 'General case' 0 C--N 1.333 -0.114 0 N-CA-C 111.534 0.198 . . . . 0.0 111.534 -179.669 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 539' ' ' ALA . . . . . 0.565 ' HA ' HD12 ' A' ' 542' ' ' ILE . . . -34.12 -43.8 0.16 Allowed 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 -179.395 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 540' ' ' GLU . . . . . 0.468 ' CB ' ' HA ' ' A' ' 531' ' ' TRP . 0.0 OUTLIER -60.1 -6.84 1.53 Allowed 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -178.579 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 541' ' ' GLY . . . . . . . . . . . . . . . -125.62 -40.6 0.38 Allowed Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 121.026 -0.607 . . . . 0.0 111.919 178.811 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 542' ' ' ILE . . . . . 0.565 HD12 ' HA ' ' A' ' 539' ' ' ALA . 2.1 pp -97.26 -19.36 6.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -179.833 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 543' ' ' TYR . . . . . 0.445 ' HB3' ' HB1' ' A' ' 539' ' ' ALA . 29.4 t80 -108.85 -16.3 14.19 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.048 0.452 . . . . 0.0 110.65 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 544' ' ' ALA . . . . . 1.082 ' HB2' ' HB3' ' A' ' 530' ' ' ALA . . . -91.2 -16.81 27.08 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.604 179.73 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 545' ' ' GLU . . . . . 0.522 ' OE2' HD23 ' A' ' 547' ' ' LEU . 5.4 tp10 -118.44 -32.82 4.51 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.343 -179.758 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 35.84 41.35 0.42 Allowed Glycine 0 CA--C 1.521 0.412 0 CA-C-N 115.841 -0.618 . . . . 0.0 114.133 179.647 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 547' ' ' LEU . . . . . 0.621 HD23 ' H ' ' A' ' 548' ' ' MET . 0.0 OUTLIER -172.45 -62.11 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 117.615 0.708 . . . . 0.0 112.084 179.401 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 548' ' ' MET . . . . . 0.621 ' H ' HD23 ' A' ' 547' ' ' LEU . 0.0 OUTLIER -96.32 11.6 34.11 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.06 0.457 . . . . 0.0 110.378 179.02 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 549' ' ' HIS . . . . . 0.49 ' CB ' ' HA ' ' A' ' 542' ' ' ILE . 0.3 OUTLIER -59.53 -11.3 4.43 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.323 179.744 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 550' ' ' ASN . . . . . 0.503 ' O ' ' N ' ' A' ' 552' ' ' ASP . 45.5 t30 -94.54 -34.22 12.75 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -178.461 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 551' ' ' GLN . . . . . 0.459 ' HB2' HD23 ' A' ' 558' ' ' LEU . 0.9 OUTLIER -64.25 70.95 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.131 0.491 . . . . 0.0 110.4 -179.907 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 552' ' ' ASP . . . . . 0.525 ' O ' ' HA ' ' A' ' 513' ' ' PRO . 2.9 p30 -101.69 21.91 13.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.513 -179.319 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . 123.69 -31.73 4.48 Favored Glycine 0 N--CA 1.449 -0.461 0 N-CA-C 111.47 -0.652 . . . . 0.0 111.47 -179.25 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 554' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -62.58 -49.1 76.58 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.493 0.663 . . . . 0.0 109.648 178.846 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 555' ' ' ILE . . . . . 0.639 HG22 ' O ' ' A' ' 555' ' ' ILE . 6.0 mm -88.63 60.62 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 CA-C-N 114.789 -1.096 . . . . 0.0 110.659 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 556' ' ' CYS . . . . . . . . . . . . . 20.1 m -55.37 -20.46 11.97 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.38 -179.781 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -48.15 -24.55 3.49 Favored Glycine 0 C--N 1.333 0.401 0 C-N-CA 120.934 -0.651 . . . . 0.0 113.01 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 558' ' ' LEU . . . . . 0.781 HD12 ' N ' ' A' ' 559' ' ' ARG . 3.9 pp -52.61 -44.94 66.33 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.913 0.387 . . . . 0.0 111.346 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 559' ' ' ARG . . . . . 0.781 ' N ' HD12 ' A' ' 558' ' ' LEU . 0.9 OUTLIER 59.53 169.22 0.07 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.783 -179.909 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 560' ' ' GLN . . . . . 0.671 ' H ' ' HB1' ' A' ' 507' ' ' ALA . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.207 -0.901 . . . . 0.0 110.844 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.325 0 CA-C-O 120.82 0.343 . . . . 0.0 111.175 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 508' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -128.38 77.5 77.0 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.561 179.211 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 509' ' ' PRO . . . . . 0.569 ' C ' ' HG3' ' A' ' 510' ' ' LYS . 70.9 Cg_endo -86.7 62.93 4.56 Favored 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 122.89 2.393 . . . . 0.0 112.85 -179.44 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 510' ' ' LYS . . . . . 0.569 ' HG3' ' C ' ' A' ' 509' ' ' PRO . 0.0 OUTLIER 32.48 -90.49 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 120.966 0.413 . . . . 0.0 111.947 179.365 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 511' ' ' CYS . . . . . 0.464 ' N ' ' O ' ' A' ' 509' ' ' PRO . 0.0 OUTLIER 74.98 75.96 0.1 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.222 179.405 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 512' ' ' ASN . . . . . 0.556 ' HB3' HD23 ' A' ' 515' ' ' LEU . 34.3 m-20 -156.15 79.6 4.03 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.056 179.61 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 513' ' ' PRO . . . . . 0.434 ' HA ' ' O ' ' A' ' 552' ' ' ASP . 26.0 Cg_exo -61.5 -15.83 43.74 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 123.056 2.504 . . . . 0.0 112.479 -179.567 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 22.6 t30 -57.47 -43.52 84.09 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.29 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 515' ' ' LEU . . . . . 0.556 HD23 ' HB3' ' A' ' 512' ' ' ASN . 0.8 OUTLIER -81.18 73.82 8.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.822 0.344 . . . . 0.0 111.065 -179.905 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 516' ' ' HIS . . . . . 0.44 ' HA ' ' HB2' ' A' ' 552' ' ' ASP . 32.3 p-80 -89.25 -7.25 55.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.622 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 517' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -74.93 -30.85 61.36 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 111.702 0.26 . . . . 0.0 111.702 -179.525 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 518' ' ' TRP . . . . . 0.582 ' O ' ' N ' ' A' ' 520' ' ' THR . 8.5 m-90 -117.92 -0.03 11.79 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 -179.504 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 519' ' ' THR . . . . . 0.561 ' OG1' ' N ' ' A' ' 520' ' ' THR . 1.2 p 49.38 -78.37 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 120.485 0.183 . . . . 0.0 111.405 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 520' ' ' THR . . . . . 0.582 ' N ' ' O ' ' A' ' 518' ' ' TRP . 1.3 m -179.15 -62.45 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 179.519 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 521' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -72.78 -11.87 60.78 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.32 177.819 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 522' ' ' ASP . . . . . 0.446 ' HB2' ' O ' ' A' ' 518' ' ' TRP . 68.8 m-20 -91.63 -10.71 39.41 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.81 179.128 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 523' ' ' GLU . . . . . 0.4 ' HA ' ' CD1' ' A' ' 518' ' ' TRP . 0.0 OUTLIER -45.26 -26.71 0.54 Allowed 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.48 -179.72 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . 146.53 41.47 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.356 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -100.66 -60.95 1.43 Allowed 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 111.785 0.291 . . . . 0.0 111.785 -179.629 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -131.96 38.17 3.55 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-O 121.549 0.69 . . . . 0.0 110.132 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 527' ' ' ILE . . . . . 0.894 ' HA ' ' HB1' ' A' ' 544' ' ' ALA . 2.1 pp -95.79 -2.51 10.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 114.746 -1.116 . . . . 0.0 112.844 -178.882 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 528' ' ' GLY . . . . . 0.579 ' N ' HD12 ' A' ' 527' ' ' ILE . . . -56.47 -16.59 16.1 Favored Glycine 0 CA--C 1.52 0.403 0 C-N-CA 120.791 -0.719 . . . . 0.0 114.028 -179.1 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 529' ' ' LEU . . . . . 0.489 ' H ' ' HG ' ' A' ' 529' ' ' LEU . 0.7 OUTLIER -99.21 -32.82 11.02 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 117.809 0.805 . . . . 0.0 112.292 -179.394 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 530' ' ' ALA . . . . . 0.976 ' HB3' ' HB2' ' A' ' 544' ' ' ALA . . . -103.82 1.52 31.66 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -179.022 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 531' ' ' TRP . . . . . 0.467 ' O ' HG23 ' A' ' 532' ' ' ILE . 55.5 t90 -73.48 30.33 0.07 Allowed 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -179.299 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 532' ' ' ILE . . . . . 0.467 HG23 ' O ' ' A' ' 531' ' ' TRP . 1.1 pt -158.26 77.41 3.44 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-O 120.739 0.304 . . . . 0.0 110.888 179.425 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 533' ' ' PRO . . . . . 0.4 ' HG3' ' O ' ' A' ' 538' ' ' ALA . 79.6 Cg_exo -41.74 88.14 0.01 OUTLIER 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 123.045 2.497 . . . . 0.0 112.956 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 534' ' ' TYR . . . . . 0.437 ' N ' ' O ' ' A' ' 532' ' ' ILE . 12.5 t80 -96.51 -51.98 4.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.483 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -57.73 -34.84 69.93 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.635 -179.261 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 144.89 -64.18 0.46 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.506 -0.854 . . . . 0.0 112.597 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -55.29 -168.88 0.02 OUTLIER 'Trans proline' 0 CA--C 1.515 -0.457 0 C-N-CA 122.606 2.204 . . . . 0.0 111.906 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 538' ' ' ALA . . . . . 0.425 ' O ' ' HB3' ' A' ' 539' ' ' ALA . . . -63.93 -53.47 49.9 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.199 179.605 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 539' ' ' ALA . . . . . 0.6 ' O ' ' HB1' ' A' ' 530' ' ' ALA . . . 67.81 -49.93 0.52 Allowed 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.995 179.5 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 540' ' ' GLU . . . . . 0.433 ' O ' ' HB3' ' A' ' 544' ' ' ALA . 0.2 OUTLIER -37.6 -27.0 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.927 -1.033 . . . . 0.0 112.414 -179.275 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 541' ' ' GLY . . . . . 0.411 ' N ' ' O ' ' A' ' 539' ' ' ALA . . . -125.94 -43.6 0.27 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.755 -0.736 . . . . 0.0 111.889 179.129 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 542' ' ' ILE . . . . . 0.444 ' CD1' ' HA ' ' A' ' 539' ' ' ALA . 1.0 OUTLIER -69.93 -25.91 29.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 112.363 0.505 . . . . 0.0 112.363 -179.713 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 543' ' ' TYR . . . . . 0.451 ' C ' ' HB2' ' A' ' 530' ' ' ALA . 0.1 OUTLIER -111.69 -9.27 14.14 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.903 0.382 . . . . 0.0 110.784 179.988 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 544' ' ' ALA . . . . . 0.976 ' HB2' ' HB3' ' A' ' 530' ' ' ALA . . . -100.52 -33.67 10.24 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.84 179.689 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 545' ' ' GLU . . . . . 0.504 ' HG3' ' H ' ' A' ' 548' ' ' MET . 37.6 tp10 -118.86 -32.77 4.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.316 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 39.3 39.82 1.16 Allowed Glycine 0 CA--C 1.519 0.304 0 CA-C-N 115.732 -0.667 . . . . 0.0 113.976 179.815 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 547' ' ' LEU . . . . . 0.616 HD23 ' H ' ' A' ' 548' ' ' MET . 0.0 OUTLIER -173.24 -61.76 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 117.702 0.751 . . . . 0.0 112.303 179.43 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 548' ' ' MET . . . . . 0.616 ' H ' HD23 ' A' ' 547' ' ' LEU . 0.0 OUTLIER -96.32 11.51 34.4 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.7 0.286 . . . . 0.0 111.084 179.559 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 549' ' ' HIS . . . . . 0.496 ' O ' HG21 ' A' ' 519' ' ' THR . 47.8 p-80 -61.12 -11.56 9.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.85 0.357 . . . . 0.0 111.013 179.462 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 550' ' ' ASN . . . . . . . . . . . . . 48.5 m-20 -96.09 -30.79 13.35 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -179.083 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 551' ' ' GLN . . . . . 0.403 ' HG2' ' HG3' ' A' ' 548' ' ' MET . 0.8 OUTLIER -68.08 70.95 0.16 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.038 0.447 . . . . 0.0 110.696 -179.776 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 552' ' ' ASP . . . . . 0.44 ' HB2' ' HA ' ' A' ' 516' ' ' HIS . 1.9 p30 -94.95 21.82 7.21 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.244 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . 123.83 -27.91 5.56 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.856 -0.688 . . . . 0.0 111.629 -179.259 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 554' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -61.93 -55.32 30.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.567 0.698 . . . . 0.0 110.034 179.067 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 555' ' ' ILE . . . . . 0.627 HG22 ' O ' ' A' ' 555' ' ' ILE . 1.8 mm -71.66 66.94 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 114.78 -1.1 . . . . 0.0 110.421 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 556' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -72.79 -7.29 49.96 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.742 -179.588 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 557' ' ' GLY . . . . . 0.428 ' C ' ' HD3' ' A' ' 559' ' ' ARG . . . -62.31 -2.58 4.28 Favored Glycine 0 CA--C 1.524 0.602 0 C-N-CA 121.02 -0.609 . . . . 0.0 113.897 -179.425 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 558' ' ' LEU . . . . . 0.517 HD12 ' C ' ' A' ' 558' ' ' LEU . 3.9 pp -72.33 -9.79 58.95 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -179.457 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 559' ' ' ARG . . . . . 0.477 ' N ' HD12 ' A' ' 558' ' ' LEU . 0.0 OUTLIER -44.97 167.0 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 120.891 0.377 . . . . 0.0 111.49 -179.525 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 560' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 . . . . . 0 C--O 1.25 1.088 0 CA-C-O 118.236 -0.888 . . . . 0.0 110.907 -179.974 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 507' ' ' ALA . . . . . 0.479 ' CB ' ' HB3' ' A' ' 559' ' ' ARG . . . . . . . . 0 N--CA 1.486 1.36 0 CA-C-O 120.898 0.38 . . . . 0.0 111.215 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 508' ' ' GLN . . . . . . . . . . . . . 3.0 mm100 -128.94 77.27 78.13 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.893 179.028 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 509' ' ' PRO . . . . . 0.641 ' HB3' HD11 ' A' ' 558' ' ' LEU . 11.7 Cg_exo -70.49 -65.11 0.04 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 122.714 2.276 . . . . 0.0 111.695 179.765 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 510' ' ' LYS . . . . . 0.478 ' HG2' ' N ' ' A' ' 511' ' ' CYS . 0.0 OUTLIER 173.52 -32.48 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.005 179.69 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 511' ' ' CYS . . . . . 0.478 ' N ' ' HG2' ' A' ' 510' ' ' LYS . 0.0 OUTLIER 43.43 67.14 0.69 Allowed 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.44 179.883 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 512' ' ' ASN . . . . . . . . . . . . . 35.1 m-20 -120.53 79.99 30.16 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.652 179.761 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 513' ' ' PRO . . . . . 0.461 ' HA ' ' O ' ' A' ' 552' ' ' ASP . 42.7 Cg_endo -68.18 -10.23 28.28 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.651 2.234 . . . . 0.0 112.56 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 39.7 t30 -74.62 -29.98 61.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.08 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 515' ' ' LEU . . . . . . . . . . . . . 65.5 mt -84.94 74.6 10.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.886 0.374 . . . . 0.0 110.93 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 516' ' ' HIS . . . . . 0.436 ' HA ' ' HB3' ' A' ' 552' ' ' ASP . 1.9 p-80 -89.09 -7.13 56.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.582 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 517' ' ' TYR . . . . . . . . . . . . . 31.2 m-85 -70.65 -50.79 33.05 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.69 0.281 . . . . 0.0 111.638 -179.507 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 518' ' ' TRP . . . . . 0.494 ' O ' ' N ' ' A' ' 520' ' ' THR . 24.1 m-90 -112.56 10.04 19.52 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 111.914 0.338 . . . . 0.0 111.914 -179.644 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 519' ' ' THR . . . . . 0.56 HG21 ' O ' ' A' ' 549' ' ' HIS . 1.1 p 60.88 -70.13 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 116.65 -0.25 . . . . 0.0 110.915 179.627 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 520' ' ' THR . . . . . 0.494 ' N ' ' O ' ' A' ' 518' ' ' TRP . 1.0 OUTLIER 174.95 -62.82 0.01 OUTLIER 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.152 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 521' ' ' GLN . . . . . 0.507 ' HB3' ' OE1' ' A' ' 545' ' ' GLU . 2.3 mp0 -73.36 -11.95 60.66 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 178.188 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 522' ' ' ASP . . . . . 0.427 ' HB3' ' O ' ' A' ' 518' ' ' TRP . 0.6 OUTLIER -91.93 -10.97 37.57 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.912 179.1 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -45.07 -27.5 0.58 Allowed 'General case' 0 CA--C 1.528 0.107 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.304 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . 151.41 41.24 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.852 -0.69 . . . . 0.0 112.144 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -122.2 -20.33 6.24 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 526' ' ' ALA . . . . . 0.657 ' O ' ' HB1' ' A' ' 544' ' ' ALA . . . -143.79 30.25 1.34 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.254 0.55 . . . . 0.0 110.903 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 527' ' ' ILE . . . . . 0.827 HD12 ' N ' ' A' ' 528' ' ' GLY . 2.3 pp -95.64 -24.72 4.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.934 -179.562 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 528' ' ' GLY . . . . . 0.827 ' N ' HD12 ' A' ' 527' ' ' ILE . . . -49.47 -13.23 0.43 Allowed Glycine 0 CA--C 1.523 0.575 0 C-N-CA 121.154 -0.545 . . . . 0.0 114.369 -179.605 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 529' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -98.03 -47.83 5.36 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 117.864 0.832 . . . . 0.0 111.863 -179.168 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 530' ' ' ALA . . . . . 1.059 ' HB3' ' HB2' ' A' ' 544' ' ' ALA . . . -103.69 1.93 32.49 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 -178.437 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 531' ' ' TRP . . . . . 0.56 ' HB2' ' O ' ' A' ' 527' ' ' ILE . 58.8 t90 -68.85 30.53 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -179.074 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 532' ' ' ILE . . . . . 0.605 ' O ' HD12 ' A' ' 532' ' ' ILE . 1.3 pp -156.76 69.48 4.63 Favored Pre-proline 0 CA--C 1.53 0.182 0 CA-C-O 120.8 0.334 . . . . 0.0 110.91 179.357 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 533' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -52.8 105.15 0.11 Allowed 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.673 2.249 . . . . 0.0 111.875 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 534' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -96.08 -55.31 3.01 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 111.984 0.364 . . . . 0.0 111.984 -179.258 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -118.77 -35.02 3.79 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -179.338 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . -85.08 -175.24 50.57 Favored Glycine 0 CA--C 1.518 0.233 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.979 -179.224 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_endo -56.81 -159.09 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.884 2.389 . . . . 0.0 111.874 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 538' ' ' ALA . . . . . 0.517 ' O ' ' HB3' ' A' ' 539' ' ' ALA . . . -43.87 -48.76 8.42 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.55 -0.296 . . . . 0.0 111.349 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 539' ' ' ALA . . . . . 0.543 ' HA ' ' CD1' ' A' ' 542' ' ' ILE . . . 72.13 -49.3 0.69 Allowed 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.256 0.551 . . . . 0.0 111.482 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 540' ' ' GLU . . . . . 0.437 ' HG2' ' HA ' ' A' ' 531' ' ' TRP . 3.1 mt-10 -36.84 -31.45 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.863 -1.062 . . . . 0.0 112.494 -179.192 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 541' ' ' GLY . . . . . 0.433 ' O ' ' HB3' ' A' ' 549' ' ' HIS . . . -130.89 -18.95 1.32 Allowed Glycine 0 CA--C 1.52 0.369 0 C-N-CA 120.198 -1.001 . . . . 0.0 113.617 -179.738 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 542' ' ' ILE . . . . . 0.543 ' CD1' ' HA ' ' A' ' 539' ' ' ALA . 2.6 pp -96.25 -22.45 5.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 117.148 0.474 . . . . 0.0 112.251 -179.514 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 543' ' ' TYR . . . . . 0.516 ' HB2' ' HA ' ' A' ' 539' ' ' ALA . 0.2 OUTLIER -115.32 -12.08 11.83 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.966 0.412 . . . . 0.0 110.847 179.444 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 544' ' ' ALA . . . . . 1.059 ' HB2' ' HB3' ' A' ' 530' ' ' ALA . . . -92.02 -26.32 18.41 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.216 179.532 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 545' ' ' GLU . . . . . 0.7 ' OE2' HD23 ' A' ' 547' ' ' LEU . 19.7 tp10 -113.09 -33.41 6.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.773 -179.162 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 35.02 34.12 0.04 OUTLIER Glycine 0 CA--C 1.519 0.307 0 CA-C-N 115.776 -0.647 . . . . 0.0 114.259 179.379 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 547' ' ' LEU . . . . . 0.7 HD23 ' OE2' ' A' ' 545' ' ' GLU . 0.0 OUTLIER -176.41 -61.41 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 118.008 0.904 . . . . 0.0 112.695 -179.993 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 548' ' ' MET . . . . . 0.608 ' H ' HD23 ' A' ' 547' ' ' LEU . 0.4 OUTLIER -89.62 11.7 18.97 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.754 0.312 . . . . 0.0 110.935 179.733 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 549' ' ' HIS . . . . . 0.56 ' O ' HG21 ' A' ' 519' ' ' THR . 0.3 OUTLIER -64.88 -12.08 44.87 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.972 0.415 . . . . 0.0 110.62 179.588 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 550' ' ' ASN . . . . . 0.419 ' O ' ' N ' ' A' ' 552' ' ' ASP . 4.2 m120 -96.92 -35.48 10.87 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -179.022 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 551' ' ' GLN . . . . . 0.625 ' NE2' HD22 ' A' ' 558' ' ' LEU . 0.0 OUTLIER -66.37 72.59 0.08 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.044 0.449 . . . . 0.0 110.639 -179.515 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 552' ' ' ASP . . . . . 0.51 ' HA ' ' HA ' ' A' ' 519' ' ' THR . 3.0 m-20 -87.27 21.63 2.36 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.149 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . 114.26 -29.1 7.86 Favored Glycine 0 N--CA 1.451 -0.339 0 N-CA-C 111.315 -0.714 . . . . 0.0 111.315 -179.207 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 554' ' ' LEU . . . . . 0.404 HD11 ' HB2' ' A' ' 552' ' ' ASP . 0.4 OUTLIER -63.16 -57.49 10.37 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.635 0.731 . . . . 0.0 110.054 179.182 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 555' ' ' ILE . . . . . 0.633 HG22 ' O ' ' A' ' 555' ' ' ILE . 2.8 mm -71.54 65.0 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 CA-C-N 114.695 -1.139 . . . . 0.0 110.815 -179.762 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 556' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -73.47 -7.42 51.68 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.56 -0.746 . . . . 0.0 111.232 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 557' ' ' GLY . . . . . 0.409 ' C ' ' HD3' ' A' ' 559' ' ' ARG . . . -63.31 -2.4 5.41 Favored Glycine 0 CA--C 1.522 0.505 0 C-N-CA 121.096 -0.573 . . . . 0.0 113.351 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 558' ' ' LEU . . . . . 0.641 HD11 ' HB3' ' A' ' 509' ' ' PRO . 2.4 pp -63.34 -46.73 85.24 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 117.048 0.424 . . . . 0.0 111.842 -179.643 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 559' ' ' ARG . . . . . 0.526 ' N ' HD12 ' A' ' 558' ' ' LEU . 0.0 OUTLIER 47.34 -171.85 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 120.909 0.385 . . . . 0.0 111.082 -179.582 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 560' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.21 -0.9 . . . . 0.0 111.044 179.676 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 507' ' ' ALA . . . . . 0.438 ' HB3' ' HA ' ' A' ' 559' ' ' ARG . . . . . . . . 0 N--CA 1.487 1.39 0 CA-C-O 120.823 0.344 . . . . 0.0 111.007 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 508' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -128.31 85.19 61.09 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.837 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 509' ' ' PRO . . . . . 0.907 ' HB3' HD11 ' A' ' 558' ' ' LEU . 0.9 OUTLIER -84.51 -16.61 5.65 Favored 'Trans proline' 0 N--CA 1.458 -0.568 0 C-N-CA 123.177 2.585 . . . . 0.0 112.214 -179.816 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 510' ' ' LYS . . . . . 0.533 ' CE ' ' O ' ' A' ' 509' ' ' PRO . 0.0 OUTLIER 83.19 -16.25 0.59 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.113 -179.342 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 511' ' ' CYS . . . . . . . . . . . . . 6.7 m 45.44 66.44 0.91 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.53 179.768 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 512' ' ' ASN . . . . . 0.415 ' HB2' ' HG3' ' A' ' 510' ' ' LYS . 24.3 t30 -113.36 81.73 5.37 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.451 179.536 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 513' ' ' PRO . . . . . 0.515 ' HA ' ' O ' ' A' ' 552' ' ' ASP . 73.0 Cg_endo -76.01 18.95 0.61 Allowed 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.989 2.459 . . . . 0.0 113.293 -179.584 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -96.72 -28.96 14.06 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.705 0.288 . . . . 0.0 111.024 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 515' ' ' LEU . . . . . . . . . . . . . 70.0 mt -84.22 74.54 10.29 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.899 0.38 . . . . 0.0 110.946 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 516' ' ' HIS . . . . . 0.435 ' HA ' ' CB ' ' A' ' 552' ' ' ASP . 68.0 m-70 -70.14 -23.75 63.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.507 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 517' ' ' TYR . . . . . . . . . . . . . 50.3 m-85 -73.62 -64.18 1.05 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.711 0.291 . . . . 0.0 111.637 -179.514 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 518' ' ' TRP . . . . . 0.476 ' O ' ' N ' ' A' ' 520' ' ' THR . 27.3 m-90 -69.82 -17.65 63.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.844 -179.422 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 519' ' ' THR . . . . . 0.548 ' OG1' ' N ' ' A' ' 520' ' ' THR . 2.1 p 57.83 -79.78 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 120.518 0.199 . . . . 0.0 110.519 -179.707 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 520' ' ' THR . . . . . 0.548 ' N ' ' OG1' ' A' ' 519' ' ' THR . 1.2 m 177.67 -62.61 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 179.195 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 521' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -71.68 -13.87 61.87 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 177.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 522' ' ' ASP . . . . . 0.458 ' HA ' ' CG2' ' A' ' 527' ' ' ILE . 2.8 m-20 -94.04 -11.11 31.43 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.88 179.044 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -45.51 -27.48 0.75 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.456 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 524' ' ' GLY . . . . . 0.418 ' HA2' ' CG1' ' A' ' 527' ' ' ILE . . . 146.21 42.11 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.55 -0.833 . . . . 0.0 112.313 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -101.51 -60.16 1.58 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.736 0.303 . . . . 0.0 111.775 -179.505 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -132.15 38.65 3.48 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-O 121.503 0.668 . . . . 0.0 110.049 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 527' ' ' ILE . . . . . 0.954 ' HA ' ' HB1' ' A' ' 544' ' ' ALA . 2.1 pp -95.83 -0.25 10.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 114.663 -1.153 . . . . 0.0 112.71 -178.925 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 528' ' ' GLY . . . . . 0.51 ' N ' HD12 ' A' ' 527' ' ' ILE . . . -53.26 -14.8 3.36 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 114.535 0.574 . . . . 0.0 114.535 -178.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 529' ' ' LEU . . . . . 0.788 ' N ' HD13 ' A' ' 529' ' ' LEU . 0.0 OUTLIER -98.66 -33.98 10.74 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 118.055 0.927 . . . . 0.0 111.609 -179.57 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 530' ' ' ALA . . . . . 0.918 ' HB3' ' HB2' ' A' ' 544' ' ' ALA . . . -103.71 1.17 31.47 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -179.308 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 531' ' ' TRP . . . . . 0.47 ' HA ' ' HG2' ' A' ' 540' ' ' GLU . 9.9 t90 -56.28 -12.33 1.56 Allowed 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -179.14 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 532' ' ' ILE . . . . . 0.731 ' O ' HD12 ' A' ' 532' ' ' ILE . 1.7 pp -133.14 73.95 73.91 Favored Pre-proline 0 N--CA 1.452 -0.373 0 CA-C-O 121.06 0.457 . . . . 0.0 111.327 179.703 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 533' ' ' PRO . . . . . 0.435 ' HB3' ' O ' ' A' ' 538' ' ' ALA . 1.7 Cg_endo -45.73 92.29 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 123.037 2.492 . . . . 0.0 112.671 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 534' ' ' TYR . . . . . . . . . . . . . 47.4 p90 -96.31 -25.4 15.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.116 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -69.75 -34.78 74.28 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.399 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 147.87 -64.09 0.42 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.822 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -59.36 -164.72 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.605 2.203 . . . . 0.0 112.033 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 538' ' ' ALA . . . . . 0.46 ' O ' ' HB3' ' A' ' 539' ' ' ALA . . . -69.3 -47.45 64.48 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.726 179.743 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 539' ' ' ALA . . . . . 0.715 ' C ' ' HB1' ' A' ' 530' ' ' ALA . . . 69.17 -53.94 0.58 Allowed 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.306 0.574 . . . . 0.0 111.45 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 540' ' ' GLU . . . . . 0.522 ' O ' ' HB3' ' A' ' 544' ' ' ALA . 10.6 mt-10 -37.57 -27.59 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.895 -1.048 . . . . 0.0 112.121 -179.541 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 541' ' ' GLY . . . . . 0.433 ' O ' ' HB3' ' A' ' 549' ' ' HIS . . . -124.76 -46.85 0.24 Allowed Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.136 179.069 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 542' ' ' ILE . . . . . 0.604 HG22 ' CE1' ' A' ' 549' ' ' HIS . 2.6 pp -73.47 -24.59 20.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 -179.367 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 543' ' ' TYR . . . . . 0.524 ' HB2' HD12 ' A' ' 542' ' ' ILE . 6.5 t80 -114.11 -7.72 13.04 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.878 0.37 . . . . 0.0 110.963 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 544' ' ' ALA . . . . . 0.954 ' HB1' ' HA ' ' A' ' 527' ' ' ILE . . . -103.14 -33.89 9.06 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 121.22 0.534 . . . . 0.0 109.948 179.362 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 545' ' ' GLU . . . . . 0.515 ' HG3' ' H ' ' A' ' 548' ' ' MET . 23.1 tp10 -118.56 -32.66 4.52 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.272 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 37.68 43.42 1.18 Allowed Glycine 0 CA--C 1.52 0.376 0 CA-C-N 115.931 -0.577 . . . . 0.0 113.771 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 547' ' ' LEU . . . . . 0.568 ' HG ' ' N ' ' A' ' 548' ' ' MET . 0.0 OUTLIER -172.94 -61.23 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 117.362 0.581 . . . . 0.0 111.874 179.628 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 548' ' ' MET . . . . . 0.568 ' N ' ' HG ' ' A' ' 547' ' ' LEU . 0.0 OUTLIER -96.03 11.59 33.54 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.672 0.272 . . . . 0.0 111.209 179.68 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 549' ' ' HIS . . . . . 0.604 ' CE1' HG22 ' A' ' 542' ' ' ILE . 10.0 p80 -61.49 -11.35 10.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.695 0.283 . . . . 0.0 110.904 179.372 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 550' ' ' ASN . . . . . 0.442 ' O ' ' N ' ' A' ' 552' ' ' ASP . 8.3 m120 -95.98 -34.23 11.86 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -179.204 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 551' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.39 72.79 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.133 0.492 . . . . 0.0 110.325 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 552' ' ' ASP . . . . . 0.515 ' O ' ' HA ' ' A' ' 513' ' ' PRO . 1.6 p30 -90.6 22.33 3.54 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.602 -0.727 . . . . 0.0 111.724 -179.447 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . 124.27 -27.52 5.54 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.863 -0.684 . . . . 0.0 111.739 -179.387 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 554' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -61.67 -57.13 13.17 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.49 0.662 . . . . 0.0 109.937 178.886 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 555' ' ' ILE . . . . . 0.511 HG22 ' O ' ' A' ' 555' ' ' ILE . 4.2 mm -76.93 70.42 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 CA-C-N 114.821 -1.081 . . . . 0.0 110.862 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 556' ' ' CYS . . . . . 0.408 ' O ' ' HD2' ' A' ' 559' ' ' ARG . 34.7 m -68.41 -7.68 33.81 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.748 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 557' ' ' GLY . . . . . 0.416 ' O ' ' HD3' ' A' ' 559' ' ' ARG . . . -65.77 -2.42 11.85 Favored Glycine 0 CA--C 1.521 0.461 0 C-N-CA 120.984 -0.627 . . . . 0.0 113.639 -179.734 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 558' ' ' LEU . . . . . 0.907 HD11 ' HB3' ' A' ' 509' ' ' PRO . 4.1 pp -61.33 -15.61 37.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 117.079 0.439 . . . . 0.0 111.847 -179.699 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 559' ' ' ARG . . . . . 0.567 ' N ' HD12 ' A' ' 558' ' ' LEU . 0.0 OUTLIER -51.72 -177.18 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.94 0.4 . . . . 0.0 111.51 -179.474 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 560' ' ' GLN . . . . . . . . . . . . . 16.9 mt-30 . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.214 -0.898 . . . . 0.0 110.92 179.834 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 507' ' ' ALA . . . . . 0.64 ' HB2' ' H ' ' A' ' 560' ' ' GLN . . . . . . . . 0 N--CA 1.486 1.347 0 CA-C-O 120.881 0.372 . . . . 0.0 111.06 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 508' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.36 78.0 76.26 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.012 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 509' ' ' PRO . . . . . 0.507 ' O ' ' CE ' ' A' ' 510' ' ' LYS . 95.3 Cg_endo -80.62 -15.01 11.18 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.538 2.159 . . . . 0.0 112.527 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 510' ' ' LYS . . . . . 0.507 ' CE ' ' O ' ' A' ' 509' ' ' PRO . 0.0 OUTLIER 82.09 -22.26 0.26 Allowed 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.561 -179.885 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 511' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 45.3 81.35 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.426 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 512' ' ' ASN . . . . . . . . . . . . . 18.5 m-20 -131.25 77.68 73.87 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.663 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 513' ' ' PRO . . . . . 0.402 ' HA ' ' O ' ' A' ' 552' ' ' ASP . 41.8 Cg_endo -68.0 -12.28 34.75 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.608 2.206 . . . . 0.0 112.41 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -65.32 -29.03 69.74 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.887 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 515' ' ' LEU . . . . . . . . . . . . . 74.4 mt -95.54 71.18 3.11 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.881 179.81 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 516' ' ' HIS . . . . . 0.465 ' HA ' ' CB ' ' A' ' 552' ' ' ASP . 8.0 p-80 -74.53 -7.34 52.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.676 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 517' ' ' TYR . . . . . . . . . . . . . 65.0 m-85 -79.9 -59.4 2.74 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.781 0.324 . . . . 0.0 111.592 -179.529 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 518' ' ' TRP . . . . . 0.429 ' CD1' ' HA ' ' A' ' 523' ' ' GLU . 0.1 OUTLIER -74.17 -21.61 59.77 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.925 -179.036 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 519' ' ' THR . . . . . 0.564 HG21 ' O ' ' A' ' 549' ' ' HIS . 2.3 p 63.38 -77.27 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 110.321 -0.252 . . . . 0.0 110.321 -179.505 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 520' ' ' THR . . . . . 0.53 ' N ' ' OG1' ' A' ' 519' ' ' THR . 1.0 OUTLIER 171.25 -62.4 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 179.227 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 521' ' ' GLN . . . . . 0.477 ' N ' HG22 ' A' ' 520' ' ' THR . 1.0 OUTLIER -72.72 -11.08 60.48 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.364 178.048 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 522' ' ' ASP . . . . . 0.412 ' HA ' ' CG2' ' A' ' 527' ' ' ILE . 0.8 OUTLIER -91.15 -21.19 21.29 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.631 178.758 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 523' ' ' GLU . . . . . 0.468 ' HG3' ' HA ' ' A' ' 520' ' ' THR . 8.9 mm-40 -45.84 -29.75 1.46 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.435 178.417 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 524' ' ' GLY . . . . . 0.422 ' HA2' ' CG1' ' A' ' 527' ' ' ILE . . . 144.51 39.16 0.06 OUTLIER Glycine 0 N--CA 1.443 -0.838 0 CA-C-N 114.816 -1.083 . . . . 0.0 110.405 -179.28 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -97.89 -59.49 1.75 Allowed 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 -178.31 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 526' ' ' ALA . . . . . 0.524 ' O ' ' HB1' ' A' ' 544' ' ' ALA . . . -130.81 40.37 3.49 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-O 121.549 0.69 . . . . 0.0 110.087 179.774 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 527' ' ' ILE . . . . . 0.8 HD12 ' N ' ' A' ' 528' ' ' GLY . 1.9 pp -95.67 -12.91 8.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 114.903 -1.044 . . . . 0.0 112.483 -179.03 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 528' ' ' GLY . . . . . 0.8 ' N ' HD12 ' A' ' 527' ' ' ILE . . . -48.45 -19.81 1.35 Allowed Glycine 0 CA--C 1.522 0.477 0 N-CA-C 114.624 0.61 . . . . 0.0 114.624 -179.131 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 529' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -98.57 -39.98 8.45 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 117.873 0.837 . . . . 0.0 112.415 -179.01 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 530' ' ' ALA . . . . . 0.973 ' HB3' ' HB2' ' A' ' 544' ' ' ALA . . . -103.88 2.06 32.14 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 -178.467 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 531' ' ' TRP . . . . . 0.519 ' O ' HG23 ' A' ' 532' ' ' ILE . 73.3 t-105 -67.45 30.22 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -178.773 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 532' ' ' ILE . . . . . 0.613 ' O ' HD12 ' A' ' 532' ' ' ILE . 1.3 pp -160.31 71.51 2.99 Favored Pre-proline 0 N--CA 1.454 -0.259 0 CA-C-O 120.837 0.351 . . . . 0.0 110.555 178.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 533' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -48.82 86.86 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 123.22 2.613 . . . . 0.0 112.829 -179.696 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 534' ' ' TYR . . . . . 0.4 ' N ' ' O ' ' A' ' 532' ' ' ILE . 0.2 OUTLIER -96.51 -38.3 10.06 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.049 179.804 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -62.58 -34.87 77.86 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.456 -179.412 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 151.09 -66.88 0.34 Allowed Glycine 0 CA--C 1.519 0.315 0 C-N-CA 120.47 -0.871 . . . . 0.0 112.62 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -57.2 -164.63 0.02 OUTLIER 'Trans proline' 0 CA--C 1.518 -0.307 0 C-N-CA 122.611 2.207 . . . . 0.0 111.735 179.637 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 538' ' ' ALA . . . . . 0.482 ' O ' ' HB3' ' A' ' 539' ' ' ALA . . . -74.4 -48.33 28.43 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.432 179.603 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 539' ' ' ALA . . . . . 0.676 ' C ' ' HB1' ' A' ' 530' ' ' ALA . . . 70.62 -51.83 0.67 Allowed 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.391 0.615 . . . . 0.0 111.277 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 540' ' ' GLU . . . . . 0.512 ' HG2' ' HA ' ' A' ' 531' ' ' TRP . 7.2 mt-10 -36.89 -30.68 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.809 -1.087 . . . . 0.0 112.538 -179.169 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 541' ' ' GLY . . . . . . . . . . . . . . . -126.95 -30.15 0.83 Allowed Glycine 0 CA--C 1.518 0.254 0 C-N-CA 120.412 -0.899 . . . . 0.0 112.999 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 542' ' ' ILE . . . . . 0.489 ' CD1' ' HA ' ' A' ' 539' ' ' ALA . 2.6 pp -88.82 -22.03 6.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 -179.532 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 543' ' ' TYR . . . . . 0.466 ' HB2' HD12 ' A' ' 542' ' ' ILE . 10.1 t80 -115.26 -8.43 12.32 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.892 0.377 . . . . 0.0 110.78 179.706 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 544' ' ' ALA . . . . . 0.973 ' HB2' ' HB3' ' A' ' 530' ' ' ALA . . . -103.01 -38.38 7.36 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-O 121.428 0.632 . . . . 0.0 109.572 179.217 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 545' ' ' GLU . . . . . 0.638 ' HG3' ' H ' ' A' ' 548' ' ' MET . 4.7 tp10 -118.95 -32.81 4.36 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.035 -0.984 . . . . 0.0 111.375 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 37.96 46.01 1.7 Allowed Glycine 0 CA--C 1.519 0.298 0 CA-C-N 115.895 -0.593 . . . . 0.0 113.975 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 547' ' ' LEU . . . . . 0.662 HD23 ' H ' ' A' ' 548' ' ' MET . 0.0 OUTLIER 179.03 -60.95 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 117.552 0.676 . . . . 0.0 112.049 179.682 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 548' ' ' MET . . . . . 0.662 ' H ' HD23 ' A' ' 547' ' ' LEU . 0.4 OUTLIER -87.83 11.74 14.8 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 111.765 0.283 . . . . 0.0 111.765 -179.769 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 549' ' ' HIS . . . . . 0.564 ' O ' HG21 ' A' ' 519' ' ' THR . 27.9 t60 -66.69 -11.63 55.01 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.918 0.39 . . . . 0.0 110.233 179.245 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 550' ' ' ASN . . . . . 0.659 ' O ' ' N ' ' A' ' 552' ' ' ASP . 42.1 m-20 -96.24 -56.1 2.74 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.552 -179.751 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 551' ' ' GLN . . . . . 0.555 ' HG3' ' O ' ' A' ' 548' ' ' MET . 1.4 pp0? -44.24 76.41 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.583 -179.616 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 552' ' ' ASP . . . . . 0.659 ' N ' ' O ' ' A' ' 550' ' ' ASN . 2.3 p30 -94.45 22.24 6.33 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.247 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . 124.12 -28.39 5.37 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.865 -0.683 . . . . 0.0 111.708 -179.36 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 554' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -58.32 -59.81 4.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.341 0.591 . . . . 0.0 110.162 179.033 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 555' ' ' ILE . . . . . 0.568 HG22 ' O ' ' A' ' 555' ' ' ILE . 5.6 mm -78.4 62.73 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.647 179.721 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 556' ' ' CYS . . . . . 0.449 ' O ' ' HD3' ' A' ' 559' ' ' ARG . 0.2 OUTLIER -68.38 -7.51 32.08 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.712 -179.634 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -66.65 -2.38 15.78 Favored Glycine 0 CA--C 1.522 0.517 0 C-N-CA 120.997 -0.621 . . . . 0.0 113.578 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 558' ' ' LEU . . . . . 0.611 HD12 ' N ' ' A' ' 559' ' ' ARG . 2.4 pp -62.78 -48.32 79.66 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 117.072 0.436 . . . . 0.0 111.855 -179.612 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 559' ' ' ARG . . . . . 0.611 ' N ' HD12 ' A' ' 558' ' ' LEU . 0.0 OUTLIER 45.45 -166.54 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.841 -179.227 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 560' ' ' GLN . . . . . 0.64 ' H ' ' HB2' ' A' ' 507' ' ' ALA . 3.4 mp0 . . . . . 0 C--O 1.247 0.972 0 CA-C-O 118.26 -0.876 . . . . 0.0 111.133 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 507' ' ' ALA . . . . . 0.505 ' HB3' HH11 ' A' ' 559' ' ' ARG . . . . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 120.931 0.396 . . . . 0.0 111.205 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 508' ' ' GLN . . . . . . . . . . . . . 8.0 mp0 -128.65 77.12 77.95 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.813 179.342 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 509' ' ' PRO . . . . . 0.615 ' HB3' HD11 ' A' ' 558' ' ' LEU . 21.1 Cg_exo -65.78 -65.21 0.05 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.235 0 C-N-CA 122.645 2.23 . . . . 0.0 111.837 179.766 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 510' ' ' LYS . . . . . 0.572 ' NZ ' HD21 ' A' ' 558' ' ' LEU . 0.0 OUTLIER 179.79 -35.87 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.507 179.723 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 511' ' ' CYS . . . . . 0.446 ' N ' ' HG2' ' A' ' 510' ' ' LYS . 0.5 OUTLIER 43.79 63.32 1.62 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.072 -0.967 . . . . 0.0 111.575 179.53 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 512' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -136.58 82.18 33.87 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.252 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 513' ' ' PRO . . . . . 0.551 ' HA ' ' O ' ' A' ' 552' ' ' ASP . 58.2 Cg_endo -72.68 9.22 1.33 Allowed 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.839 2.359 . . . . 0.0 113.314 -179.375 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -95.87 -24.81 16.26 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.684 0.278 . . . . 0.0 110.997 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 515' ' ' LEU . . . . . . . . . . . . . 84.6 mt -87.1 74.59 9.6 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.831 0.348 . . . . 0.0 111.062 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 516' ' ' HIS . . . . . 0.435 ' HA ' ' CB ' ' A' ' 552' ' ' ASP . 25.0 p80 -81.14 -7.28 59.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.713 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 517' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -71.49 -46.72 59.06 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.679 0.276 . . . . 0.0 111.541 -179.511 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 518' ' ' TRP . . . . . 0.522 ' O ' ' N ' ' A' ' 520' ' ' THR . 12.3 m-90 -101.8 -3.87 27.31 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -179.314 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 519' ' ' THR . . . . . 0.569 ' HA ' ' HA ' ' A' ' 552' ' ' ASP . 4.1 p 56.41 -78.07 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 120.551 0.215 . . . . 0.0 110.757 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 520' ' ' THR . . . . . 0.522 ' N ' ' O ' ' A' ' 518' ' ' TRP . 1.1 m 176.04 -62.43 0.01 OUTLIER 'General case' 0 CA--C 1.521 -0.171 0 N-CA-C 109.171 -0.678 . . . . 0.0 109.171 179.375 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 521' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -71.64 -12.56 61.4 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 177.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 522' ' ' ASP . . . . . 0.418 ' HB2' ' O ' ' A' ' 518' ' ' TRP . 1.2 m-20 -93.86 -11.21 31.62 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.667 178.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -45.69 -27.88 0.89 Allowed 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.253 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 524' ' ' GLY . . . . . 0.409 ' HA2' ' CG1' ' A' ' 527' ' ' ILE . . . 145.41 43.02 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.243 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -102.56 -58.97 1.78 Allowed 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 -179.467 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -131.61 39.89 3.45 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-O 121.565 0.698 . . . . 0.0 109.986 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 527' ' ' ILE . . . . . 0.809 ' HA ' ' HB1' ' A' ' 544' ' ' ALA . 1.9 pp -95.61 -0.54 10.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 114.764 -1.107 . . . . 0.0 112.693 -178.864 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 528' ' ' GLY . . . . . 0.569 ' N ' HD12 ' A' ' 527' ' ' ILE . . . -60.23 -14.34 32.65 Favored Glycine 0 CA--C 1.52 0.387 0 C-N-CA 120.865 -0.683 . . . . 0.0 113.901 -179.301 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 529' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -98.55 -33.84 10.83 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 117.477 0.638 . . . . 0.0 111.68 -179.408 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 530' ' ' ALA . . . . . 1.041 ' HB3' ' HB2' ' A' ' 544' ' ' ALA . . . -103.81 1.53 31.69 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -179.057 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 531' ' ' TRP . . . . . 0.44 ' HB2' ' O ' ' A' ' 527' ' ' ILE . 73.2 t-105 -56.08 -12.6 1.55 Allowed 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 -179.378 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 532' ' ' ILE . . . . . 0.683 ' O ' HD12 ' A' ' 532' ' ' ILE . 1.5 pp -129.44 75.21 80.26 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 120.978 0.418 . . . . 0.0 110.984 179.699 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 533' ' ' PRO . . . . . 0.525 ' HB3' ' HB3' ' A' ' 539' ' ' ALA . 5.6 Cg_endo -48.91 89.88 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 123.099 2.533 . . . . 0.0 112.85 -179.672 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 534' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -96.3 -13.33 23.41 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.068 179.524 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -76.85 -34.87 57.81 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.282 -179.676 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 536' ' ' GLY . . . . . 0.417 ' N ' ' CD ' ' A' ' 537' ' ' PRO . . . 141.42 -49.54 0.76 Allowed Glycine 0 CA--C 1.52 0.347 0 C-N-CA 120.518 -0.848 . . . . 0.0 112.915 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 537' ' ' PRO . . . . . 0.417 ' CD ' ' N ' ' A' ' 536' ' ' GLY . 5.6 Cg_exo -76.56 -168.0 0.52 Allowed 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 122.714 2.276 . . . . 0.0 111.931 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 538' ' ' ALA . . . . . 0.422 ' O ' ' HB3' ' A' ' 539' ' ' ALA . . . -56.28 -47.63 78.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.461 179.505 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 539' ' ' ALA . . . . . 0.605 ' C ' ' HB1' ' A' ' 530' ' ' ALA . . . 68.14 -59.47 0.43 Allowed 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 121.362 0.601 . . . . 0.0 111.976 179.339 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 540' ' ' GLU . . . . . 0.409 ' OE2' ' CE3' ' A' ' 531' ' ' TRP . 2.7 mt-10 -37.49 -28.77 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 114.871 -1.059 . . . . 0.0 112.293 -179.108 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 541' ' ' GLY . . . . . 0.425 ' O ' ' HB2' ' A' ' 549' ' ' HIS . . . -121.9 -26.71 1.85 Allowed Glycine 0 CA--C 1.521 0.41 0 C-N-CA 120.479 -0.867 . . . . 0.0 113.27 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 542' ' ' ILE . . . . . 0.594 ' CD1' ' HA ' ' A' ' 539' ' ' ALA . 2.6 pp -95.84 -20.59 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -179.345 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 543' ' ' TYR . . . . . 0.528 ' HB2' ' HA ' ' A' ' 539' ' ' ALA . 0.3 OUTLIER -107.84 -10.73 15.5 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.112 0.482 . . . . 0.0 110.113 178.901 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 544' ' ' ALA . . . . . 1.041 ' HB2' ' HB3' ' A' ' 530' ' ' ALA . . . -103.16 -38.45 7.28 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.78 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 545' ' ' GLU . . . . . 0.573 ' HG3' ' H ' ' A' ' 548' ' ' MET . 5.9 tp10 -118.91 -32.96 4.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.151 -0.932 . . . . 0.0 111.487 -179.716 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 37.72 49.37 1.89 Allowed Glycine 0 CA--C 1.52 0.403 0 CA-C-N 115.988 -0.551 . . . . 0.0 113.822 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 547' ' ' LEU . . . . . 0.625 HD21 ' SD ' ' A' ' 548' ' ' MET . 0.0 OUTLIER 178.99 -60.83 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 117.528 0.664 . . . . 0.0 111.976 179.633 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 548' ' ' MET . . . . . 0.625 ' SD ' HD21 ' A' ' 547' ' ' LEU . 0.0 OUTLIER -86.38 11.76 11.65 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.671 0.272 . . . . 0.0 111.566 -179.802 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 549' ' ' HIS . . . . . 0.509 ' O ' ' CG2' ' A' ' 519' ' ' THR . 56.6 t60 -67.96 -10.97 57.77 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.899 0.381 . . . . 0.0 110.412 179.249 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 550' ' ' ASN . . . . . 0.432 ' O ' ' N ' ' A' ' 552' ' ' ASP . 38.9 t30 -92.89 -25.91 17.86 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.126 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 551' ' ' GLN . . . . . 0.53 ' HG2' ' O ' ' A' ' 548' ' ' MET . 2.3 mm-40 -66.91 70.32 0.08 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.249 0.547 . . . . 0.0 110.123 179.719 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 552' ' ' ASP . . . . . 0.569 ' HA ' ' HA ' ' A' ' 519' ' ' THR . 1.7 p30 -89.37 21.6 3.26 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.679 -179.46 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . 123.41 -32.82 4.19 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.885 -0.674 . . . . 0.0 111.592 -179.607 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 554' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -52.14 -58.06 7.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.498 0.665 . . . . 0.0 110.348 179.226 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 555' ' ' ILE . . . . . 0.708 ' O ' HD23 ' A' ' 558' ' ' LEU . 3.7 mm -72.62 60.86 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 CA-C-N 114.808 -1.087 . . . . 0.0 110.942 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 556' ' ' CYS . . . . . . . . . . . . . 5.3 t -76.53 -7.78 55.86 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.373 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -74.0 -5.17 69.61 Favored Glycine 0 C--N 1.332 0.308 0 C-N-CA 120.641 -0.79 . . . . 0.0 113.013 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 558' ' ' LEU . . . . . 0.708 HD23 ' O ' ' A' ' 555' ' ' ILE . 2.3 pp -58.72 -47.13 85.65 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.879 0.371 . . . . 0.0 111.133 -179.845 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 559' ' ' ARG . . . . . 0.631 ' N ' HD12 ' A' ' 558' ' ' LEU . 2.8 mmt85 63.87 171.25 0.17 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.232 179.832 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 560' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.116 0 CA-C-O 118.247 -0.882 . . . . 0.0 111.325 179.529 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 507' ' ' ALA . . . . . 0.451 ' HB3' ' HA ' ' A' ' 559' ' ' ARG . . . . . . . . 0 N--CA 1.485 1.295 0 CA-C-O 121.083 0.468 . . . . 0.0 111.196 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 508' ' ' GLN . . . . . . . . . . . . . 7.3 mt-30 -129.02 77.39 77.99 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.507 179.544 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 509' ' ' PRO . . . . . 0.663 ' HB3' HD11 ' A' ' 558' ' ' LEU . 13.2 Cg_exo -69.79 -64.49 0.04 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.298 0 C-N-CA 122.734 2.289 . . . . 0.0 112.016 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 510' ' ' LYS . . . . . 0.44 ' HG3' ' N ' ' A' ' 511' ' ' CYS . 0.0 OUTLIER 178.65 -35.35 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.861 -179.914 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 511' ' ' CYS . . . . . 0.44 ' N ' ' HG3' ' A' ' 510' ' ' LYS . 0.1 OUTLIER 39.71 87.47 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.223 -0.899 . . . . 0.0 111.776 179.537 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 512' ' ' ASN . . . . . 0.541 ' HB3' HD21 ' A' ' 515' ' ' LEU . 0.9 OUTLIER -158.55 77.93 3.25 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.393 179.865 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 513' ' ' PRO . . . . . 0.568 ' HA ' ' O ' ' A' ' 552' ' ' ASP . 73.8 Cg_endo -76.67 19.14 0.66 Allowed 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 123.039 2.493 . . . . 0.0 113.462 -179.494 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 23.6 t30 -96.79 -34.56 11.26 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.642 0.258 . . . . 0.0 111.137 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 515' ' ' LEU . . . . . 0.541 HD21 ' HB3' ' A' ' 512' ' ' ASN . 0.7 OUTLIER -90.71 72.49 6.71 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.897 0.38 . . . . 0.0 111.085 -179.868 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 516' ' ' HIS . . . . . 0.506 ' HA ' ' HB2' ' A' ' 552' ' ' ASP . 2.6 p-80 -80.13 -7.25 58.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.751 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 517' ' ' TYR . . . . . . . . . . . . . 37.9 m-85 -69.55 -29.69 67.32 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 111.67 0.248 . . . . 0.0 111.67 -179.51 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 518' ' ' TRP . . . . . 0.482 ' O ' ' N ' ' A' ' 520' ' ' THR . 4.7 m-90 -118.03 -8.28 10.74 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -179.246 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 519' ' ' THR . . . . . 0.528 ' OG1' ' N ' ' A' ' 520' ' ' THR . 1.3 p 59.82 -76.53 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 120.475 0.179 . . . . 0.0 110.537 -179.725 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 520' ' ' THR . . . . . 0.528 ' N ' ' OG1' ' A' ' 519' ' ' THR . 1.0 OUTLIER 172.24 -62.7 0.01 OUTLIER 'General case' 0 C--O 1.232 0.147 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 179.146 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 521' ' ' GLN . . . . . 0.471 ' N ' HG22 ' A' ' 520' ' ' THR . 6.4 mt-30 -73.42 -12.01 60.66 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 177.874 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 522' ' ' ASP . . . . . 0.404 ' HB2' ' O ' ' A' ' 518' ' ' TRP . 9.6 m-20 -93.47 -11.12 32.81 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.684 178.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -45.51 -27.09 0.67 Allowed 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.539 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 524' ' ' GLY . . . . . 0.441 ' HA2' ' CG1' ' A' ' 527' ' ' ILE . . . 148.6 41.13 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.577 -0.82 . . . . 0.0 112.225 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -99.62 -59.95 1.62 Allowed 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 111.879 0.325 . . . . 0.0 111.879 -179.477 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -132.0 35.97 3.7 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.505 0.669 . . . . 0.0 110.135 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 527' ' ' ILE . . . . . 0.985 ' HA ' ' HB1' ' A' ' 544' ' ' ALA . 2.2 pp -95.85 -0.42 10.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 114.741 -1.118 . . . . 0.0 112.836 -178.836 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 528' ' ' GLY . . . . . 0.495 ' N ' HD12 ' A' ' 527' ' ' ILE . . . -60.23 -8.82 9.55 Favored Glycine 0 CA--C 1.522 0.495 0 C-N-CA 120.907 -0.663 . . . . 0.0 114.146 -179.243 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 529' ' ' LEU . . . . . 0.718 HD11 ' O ' ' A' ' 543' ' ' TYR . 2.0 pp -98.54 -35.0 10.37 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 117.819 0.809 . . . . 0.0 111.624 -179.565 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 530' ' ' ALA . . . . . 1.008 ' HB3' ' HB2' ' A' ' 544' ' ' ALA . . . -103.64 1.63 32.23 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -179.273 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 531' ' ' TRP . . . . . 0.432 ' HA ' ' HG2' ' A' ' 540' ' ' GLU . 0.2 OUTLIER -70.4 30.71 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -178.853 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 532' ' ' ILE . . . . . 0.469 ' H ' ' C ' ' A' ' 530' ' ' ALA . 1.3 pt -156.68 78.92 3.89 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 120.665 0.269 . . . . 0.0 110.735 179.183 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 533' ' ' PRO . . . . . . . . . . . . . 99.9 Cg_exo -39.46 86.16 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 123.327 2.685 . . . . 0.0 113.212 -179.607 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 534' ' ' TYR . . . . . 0.463 ' N ' ' O ' ' A' ' 532' ' ' ILE . 1.7 t80 -96.61 -50.99 4.49 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.282 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -57.78 -34.95 70.12 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.459 -179.41 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 145.79 -63.98 0.45 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.563 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -59.94 -166.99 0.04 OUTLIER 'Trans proline' 0 CA--C 1.516 -0.393 0 C-N-CA 122.605 2.203 . . . . 0.0 111.833 179.685 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 538' ' ' ALA . . . . . 0.444 ' O ' ' HB3' ' A' ' 539' ' ' ALA . . . -61.65 -52.82 62.75 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.114 179.606 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 539' ' ' ALA . . . . . 0.572 ' O ' ' HB1' ' A' ' 530' ' ' ALA . . . 68.13 -47.01 0.53 Allowed 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.99 179.414 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 540' ' ' GLU . . . . . 0.432 ' HG2' ' HA ' ' A' ' 531' ' ' TRP . 0.8 OUTLIER -37.39 -28.15 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.126 -0.943 . . . . 0.0 112.366 -179.139 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 541' ' ' GLY . . . . . . . . . . . . . . . -127.63 -42.06 0.27 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.012 179.308 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 542' ' ' ILE . . . . . 0.57 HG23 ' CD2' ' A' ' 549' ' ' HIS . 0.8 OUTLIER -69.63 -26.31 30.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 -179.79 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 543' ' ' TYR . . . . . 0.718 ' O ' HD11 ' A' ' 529' ' ' LEU . 1.8 m-85 -110.68 -10.19 14.49 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.054 0.454 . . . . 0.0 110.697 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 544' ' ' ALA . . . . . 1.008 ' HB2' ' HB3' ' A' ' 530' ' ' ALA . . . -97.9 -30.54 12.69 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.035 179.751 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 545' ' ' GLU . . . . . 0.525 ' HG3' ' H ' ' A' ' 548' ' ' MET . 6.3 tp10 -118.87 -32.81 4.39 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.475 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 35.56 40.13 0.28 Allowed Glycine 0 CA--C 1.52 0.399 0 CA-C-N 116.025 -0.534 . . . . 0.0 113.808 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 547' ' ' LEU . . . . . 0.568 HD23 ' H ' ' A' ' 548' ' ' MET . 0.0 OUTLIER -173.65 -61.41 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 117.498 0.649 . . . . 0.0 112.1 179.748 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 548' ' ' MET . . . . . 0.631 ' O ' ' HG3' ' A' ' 551' ' ' GLN . 0.0 OUTLIER -94.36 11.92 28.83 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.758 0.314 . . . . 0.0 111.133 179.674 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 549' ' ' HIS . . . . . 0.57 ' CD2' HG23 ' A' ' 542' ' ' ILE . 38.4 t60 -64.41 -10.75 26.94 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 120.846 -0.342 . . . . 0.0 110.82 179.582 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 550' ' ' ASN . . . . . 0.52 ' O ' ' N ' ' A' ' 552' ' ' ASP . 41.9 m-20 -94.82 -34.8 12.34 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.875 0.695 . . . . 0.0 112.875 -178.557 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 551' ' ' GLN . . . . . 0.631 ' HG3' ' O ' ' A' ' 548' ' ' MET . 1.1 pp0? -62.34 68.12 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.112 0.482 . . . . 0.0 111.238 -179.451 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 552' ' ' ASP . . . . . 0.568 ' O ' ' HA ' ' A' ' 513' ' ' PRO . 1.7 p30 -94.83 20.93 8.09 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.284 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . 123.63 -31.04 4.72 Favored Glycine 0 N--CA 1.45 -0.399 0 N-CA-C 111.321 -0.711 . . . . 0.0 111.321 -179.18 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 554' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -55.9 -52.5 63.87 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.475 0.655 . . . . 0.0 110.037 179.066 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 555' ' ' ILE . . . . . 0.641 HG22 ' O ' ' A' ' 555' ' ' ILE . 5.2 mm -82.9 56.32 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 CA-C-N 114.884 -1.053 . . . . 0.0 110.53 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 556' ' ' CYS . . . . . 0.527 ' O ' ' HD2' ' A' ' 559' ' ' ARG . 17.6 t -77.93 -7.24 56.5 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.432 -179.768 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 557' ' ' GLY . . . . . 0.43 ' C ' ' H ' ' A' ' 559' ' ' ARG . . . -67.16 -2.36 18.37 Favored Glycine 0 CA--C 1.522 0.494 0 C-N-CA 121.208 -0.52 . . . . 0.0 113.814 -179.458 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 558' ' ' LEU . . . . . 0.663 HD11 ' HB3' ' A' ' 509' ' ' PRO . 3.8 pp -71.93 27.71 0.05 OUTLIER 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -179.664 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 559' ' ' ARG . . . . . 0.527 ' HD2' ' O ' ' A' ' 556' ' ' CYS . 1.8 mpt_? -61.15 -164.16 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.594 0.235 . . . . 0.0 110.482 179.718 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 560' ' ' GLN . . . . . 0.43 ' H ' ' HB2' ' A' ' 507' ' ' ALA . 5.3 mt-30 . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.227 -0.892 . . . . 0.0 111.052 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 507' ' ' ALA . . . . . 0.525 ' HB3' ' HG3' ' A' ' 559' ' ' ARG . . . . . . . . 0 N--CA 1.486 1.354 0 CA-C-O 120.791 0.329 . . . . 0.0 111.129 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 508' ' ' GLN . . . . . . . . . . . . . 4.0 tm0? -128.45 77.7 76.81 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.962 179.587 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 509' ' ' PRO . . . . . 0.458 ' O ' ' CG ' ' A' ' 510' ' ' LYS . 90.2 Cg_endo -78.77 -19.99 10.78 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.548 2.165 . . . . 0.0 112.509 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 510' ' ' LYS . . . . . 0.458 ' CG ' ' O ' ' A' ' 509' ' ' PRO . 0.0 OUTLIER 91.5 -29.11 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 123.182 0.593 . . . . 0.0 111.077 -179.797 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 511' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 52.03 103.81 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.73 179.166 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 512' ' ' ASN . . . . . 0.716 ' OD1' HD12 ' A' ' 515' ' ' LEU . 6.0 p30 -140.13 73.75 31.58 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.39 179.324 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 513' ' ' PRO . . . . . 0.543 ' HA ' ' O ' ' A' ' 552' ' ' ASP . 31.3 Cg_exo -60.96 -14.73 34.5 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.899 2.399 . . . . 0.0 112.625 -179.612 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -69.42 -43.36 73.53 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.474 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 515' ' ' LEU . . . . . 0.716 HD12 ' OD1' ' A' ' 512' ' ' ASN . 53.1 mt -66.53 76.33 0.1 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.88 0.371 . . . . 0.0 111.076 -179.81 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 516' ' ' HIS . . . . . 0.56 ' HA ' ' HB3' ' A' ' 552' ' ' ASP . 0.2 OUTLIER -84.55 -7.16 59.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.722 -179.857 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 517' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -79.11 -61.82 1.89 Allowed 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -179.199 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 518' ' ' TRP . . . . . 0.488 ' O ' ' N ' ' A' ' 520' ' ' THR . 4.1 m-90 -87.13 -3.91 59.1 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -178.696 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 519' ' ' THR . . . . . 0.522 ' HA ' ' HA ' ' A' ' 552' ' ' ASP . 3.0 p 59.66 -76.49 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.391 0.139 . . . . 0.0 110.704 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 520' ' ' THR . . . . . 0.517 ' N ' ' OG1' ' A' ' 519' ' ' THR . 1.0 OUTLIER 173.04 -62.59 0.01 OUTLIER 'General case' 0 CA--C 1.521 -0.17 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 179.367 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 521' ' ' GLN . . . . . 0.43 ' N ' HG22 ' A' ' 520' ' ' THR . 2.7 mt-30 -73.32 -12.75 60.95 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.426 178.189 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 522' ' ' ASP . . . . . 0.422 ' HB2' ' O ' ' A' ' 518' ' ' TRP . 2.5 m-20 -93.91 -11.09 31.78 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.832 179.025 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -45.57 -28.01 0.87 Allowed 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.514 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 524' ' ' GLY . . . . . 0.451 ' HA2' ' CG1' ' A' ' 527' ' ' ILE . . . 147.34 42.18 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.471 -0.871 . . . . 0.0 112.354 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -101.39 -58.6 1.85 Allowed 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -179.43 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -132.03 35.08 3.76 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-O 121.566 0.698 . . . . 0.0 110.161 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 527' ' ' ILE . . . . . 0.968 ' HA ' ' HB1' ' A' ' 544' ' ' ALA . 2.2 pp -95.65 -0.45 10.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 114.797 -1.092 . . . . 0.0 112.606 -178.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 528' ' ' GLY . . . . . 0.514 ' N ' HD12 ' A' ' 527' ' ' ILE . . . -59.17 -7.65 5.43 Favored Glycine 0 CA--C 1.522 0.511 0 C-N-CA 121.018 -0.61 . . . . 0.0 114.256 -179.244 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 529' ' ' LEU . . . . . 0.472 HD11 ' O ' ' A' ' 543' ' ' TYR . 1.0 OUTLIER -97.77 -35.9 10.39 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 117.772 0.786 . . . . 0.0 111.36 -179.584 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 530' ' ' ALA . . . . . 0.96 ' HB3' ' HB2' ' A' ' 544' ' ' ALA . . . -103.76 1.97 32.34 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -179.392 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 531' ' ' TRP . . . . . 0.472 ' HA ' ' HG2' ' A' ' 540' ' ' GLU . 9.9 t90 -67.41 30.24 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 -178.8 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 532' ' ' ILE . . . . . 0.496 ' H ' ' C ' ' A' ' 530' ' ' ALA . 1.1 pt -159.31 72.77 3.42 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-O 120.843 0.354 . . . . 0.0 110.403 179.012 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 533' ' ' PRO . . . . . 0.414 ' HB3' ' O ' ' A' ' 537' ' ' PRO . 7.5 Cg_endo -49.74 86.38 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 123.129 2.552 . . . . 0.0 112.692 -179.69 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 534' ' ' TYR . . . . . 0.411 ' N ' ' O ' ' A' ' 532' ' ' ILE . 20.8 t80 -96.55 -29.76 13.69 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.156 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -71.14 -34.86 71.4 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.542 -179.388 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 152.51 -66.13 0.34 Allowed Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.579 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 537' ' ' PRO . . . . . 0.414 ' O ' ' HB3' ' A' ' 533' ' ' PRO . 19.5 Cg_endo -58.06 -162.67 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.612 2.208 . . . . 0.0 111.608 179.729 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 538' ' ' ALA . . . . . 0.482 ' O ' ' HB3' ' A' ' 539' ' ' ALA . . . -76.5 -46.21 27.66 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.645 179.673 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 539' ' ' ALA . . . . . 0.556 ' C ' ' HB1' ' A' ' 530' ' ' ALA . . . 70.56 -51.15 0.67 Allowed 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.264 0.554 . . . . 0.0 111.46 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 540' ' ' GLU . . . . . 0.474 ' O ' ' HB3' ' A' ' 544' ' ' ALA . 7.1 mt-10 -37.38 -28.71 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.85 -1.068 . . . . 0.0 112.347 -179.371 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 541' ' ' GLY . . . . . 0.413 ' O ' ' HB3' ' A' ' 545' ' ' GLU . . . -128.19 -38.07 0.4 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.746 179.59 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 542' ' ' ILE . . . . . 0.493 ' H ' HG13 ' A' ' 542' ' ' ILE . 2.5 pp -78.86 -25.57 13.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -179.19 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 543' ' ' TYR . . . . . 0.5 ' HB2' ' HA ' ' A' ' 539' ' ' ALA . 0.4 OUTLIER -114.58 -6.86 12.8 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.896 0.379 . . . . 0.0 110.73 179.568 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 544' ' ' ALA . . . . . 0.968 ' HB1' ' HA ' ' A' ' 527' ' ' ILE . . . -99.9 -29.99 12.27 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.953 179.206 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 545' ' ' GLU . . . . . 0.547 ' HG3' ' H ' ' A' ' 548' ' ' MET . 6.2 tp10 -118.61 -32.92 4.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.474 -179.737 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 35.2 43.14 0.45 Allowed Glycine 0 CA--C 1.519 0.339 0 CA-C-N 115.923 -0.58 . . . . 0.0 114.295 179.443 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 547' ' ' LEU . . . . . 0.626 HD21 ' SD ' ' A' ' 548' ' ' MET . 0.0 OUTLIER -178.7 -61.27 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 117.753 0.776 . . . . 0.0 112.006 179.683 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 548' ' ' MET . . . . . 0.626 ' SD ' HD21 ' A' ' 547' ' ' LEU . 0.0 OUTLIER -89.96 12.12 18.48 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.854 0.359 . . . . 0.0 111.031 179.669 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 549' ' ' HIS . . . . . 0.494 ' O ' ' CG2' ' A' ' 519' ' ' THR . 75.7 t60 -64.81 -11.21 34.52 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.832 0.349 . . . . 0.0 110.75 179.558 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 550' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -94.24 -17.62 22.49 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.43 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 551' ' ' GLN . . . . . 0.566 ' HG2' ' O ' ' A' ' 548' ' ' MET . 0.9 OUTLIER -70.46 65.82 0.3 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.162 0.506 . . . . 0.0 110.364 179.667 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 552' ' ' ASP . . . . . 0.56 ' HB3' ' HA ' ' A' ' 516' ' ' HIS . 4.3 m-20 -91.37 21.75 4.31 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.35 -179.717 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 553' ' ' GLY . . . . . 0.405 ' HA3' ' C ' ' A' ' 512' ' ' ASN . . . 117.33 -35.28 4.19 Favored Glycine 0 N--CA 1.45 -0.413 0 N-CA-C 111.332 -0.707 . . . . 0.0 111.332 -179.336 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 554' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -56.23 -59.23 5.24 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.524 0.678 . . . . 0.0 109.844 178.903 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 555' ' ' ILE . . . . . 0.633 ' O ' HD23 ' A' ' 558' ' ' LEU . 3.9 mm -73.46 62.33 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 CA-C-N 114.705 -1.134 . . . . 0.0 110.657 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 556' ' ' CYS . . . . . 0.413 ' O ' ' HD2' ' A' ' 559' ' ' ARG . 0.1 OUTLIER -68.2 -9.74 49.27 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.647 -179.727 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -57.55 -18.1 29.08 Favored Glycine 0 C--N 1.332 0.348 0 C-N-CA 120.623 -0.799 . . . . 0.0 113.005 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 558' ' ' LEU . . . . . 0.633 HD23 ' O ' ' A' ' 555' ' ' ILE . 0.7 OUTLIER -50.62 -56.56 11.24 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.825 0.345 . . . . 0.0 111.8 -179.743 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 559' ' ' ARG . . . . . 0.589 ' N ' HD12 ' A' ' 558' ' ' LEU . 4.2 mpt_? 56.86 -168.47 0.11 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.922 -179.568 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 560' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.094 0 CA-C-O 118.253 -0.88 . . . . 0.0 111.169 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.323 0 CA-C-O 120.79 0.328 . . . . 0.0 111.211 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 508' ' ' GLN . . . . . . . . . . . . . 22.1 mt-30 -128.41 77.4 77.19 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.672 179.324 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 509' ' ' PRO . . . . . 0.449 ' O ' ' N ' ' A' ' 511' ' ' CYS . 98.5 Cg_endo -85.51 63.26 5.72 Favored 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 122.746 2.297 . . . . 0.0 112.75 -179.734 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 510' ' ' LYS . . . . . 0.854 ' CE ' HD21 ' A' ' 558' ' ' LEU . 0.0 OUTLIER 24.03 -88.36 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 115.947 -0.57 . . . . 0.0 112.366 179.367 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 511' ' ' CYS . . . . . 0.449 ' N ' ' O ' ' A' ' 509' ' ' PRO . 0.0 OUTLIER 75.3 62.11 0.06 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.986 179.61 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 512' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -140.21 83.34 15.76 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.07 179.383 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 513' ' ' PRO . . . . . 0.519 ' HA ' ' O ' ' A' ' 552' ' ' ASP . 74.2 Cg_endo -76.9 21.94 0.57 Allowed 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.932 2.422 . . . . 0.0 113.246 -179.278 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 20.0 t30 -96.83 -46.21 6.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.691 0.281 . . . . 0.0 110.687 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 515' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -72.18 75.57 0.97 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.925 0.393 . . . . 0.0 110.799 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 516' ' ' HIS . . . . . 0.457 ' HA ' ' HB3' ' A' ' 552' ' ' ASP . 0.1 OUTLIER -73.67 -7.41 51.92 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.786 -179.785 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 517' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -88.72 -48.48 7.49 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.716 0.293 . . . . 0.0 111.711 -179.469 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 518' ' ' TRP . . . . . 0.484 ' O ' ' N ' ' A' ' 520' ' ' THR . 3.7 m-90 -84.07 -8.4 59.12 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 -179.32 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 519' ' ' THR . . . . . 0.565 ' HA ' ' HA ' ' A' ' 552' ' ' ASP . 2.7 p 59.34 -78.56 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 120.581 0.229 . . . . 0.0 110.469 -179.763 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 520' ' ' THR . . . . . 0.549 ' N ' ' OG1' ' A' ' 519' ' ' THR . 1.2 m 172.73 -62.78 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 179.083 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 521' ' ' GLN . . . . . 0.413 ' N ' HG22 ' A' ' 520' ' ' THR . 3.1 mt-30 -74.98 -12.03 60.24 Favored 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 177.928 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 522' ' ' ASP . . . . . 0.436 ' HA ' ' CG2' ' A' ' 527' ' ' ILE . 1.9 m-20 -93.99 -10.95 31.94 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.541 178.874 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -45.33 -27.51 0.68 Allowed 'General case' 0 C--O 1.232 0.158 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.552 -179.656 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 524' ' ' GLY . . . . . 0.433 ' HA2' ' CG1' ' A' ' 527' ' ' ILE . . . 146.35 42.29 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.566 -0.826 . . . . 0.0 112.306 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -101.32 -59.27 1.73 Allowed 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 111.917 0.34 . . . . 0.0 111.917 -179.527 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 526' ' ' ALA . . . . . 0.464 ' O ' HD21 ' A' ' 529' ' ' LEU . . . -132.25 35.97 3.65 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-O 121.512 0.673 . . . . 0.0 110.146 179.763 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 527' ' ' ILE . . . . . 0.943 ' HA ' ' HB1' ' A' ' 544' ' ' ALA . 2.2 pp -95.7 -0.64 10.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 114.769 -1.105 . . . . 0.0 112.701 -178.902 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 528' ' ' GLY . . . . . 0.529 ' N ' HD12 ' A' ' 527' ' ' ILE . . . -62.08 -8.11 15.84 Favored Glycine 0 CA--C 1.521 0.414 0 C-N-CA 120.939 -0.648 . . . . 0.0 114.035 -179.229 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 529' ' ' LEU . . . . . 0.464 HD21 ' O ' ' A' ' 526' ' ' ALA . 0.2 OUTLIER -98.32 -35.62 10.26 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 117.587 0.693 . . . . 0.0 111.556 -179.574 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 530' ' ' ALA . . . . . 0.943 ' HB3' ' HB2' ' A' ' 544' ' ' ALA . . . -103.66 -1.08 28.67 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -179.118 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 531' ' ' TRP . . . . . 0.651 ' CE3' HD13 ' A' ' 527' ' ' ILE . 14.5 t-105 -56.09 -12.3 1.44 Allowed 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 112.039 0.385 . . . . 0.0 112.039 -179.187 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 532' ' ' ILE . . . . . 0.695 ' O ' HD12 ' A' ' 532' ' ' ILE . 1.6 pp -130.13 75.65 79.05 Favored Pre-proline 0 N--CA 1.451 -0.421 0 CA-C-O 121.005 0.431 . . . . 0.0 111.132 179.727 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 533' ' ' PRO . . . . . 0.403 ' HB3' ' O ' ' A' ' 538' ' ' ALA . 3.9 Cg_endo -46.95 92.25 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 123.169 2.579 . . . . 0.0 112.672 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 534' ' ' TYR . . . . . . . . . . . . . 46.9 p90 -96.18 -22.82 17.05 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.127 179.631 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -73.98 -34.86 64.39 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.303 -179.685 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 150.25 -64.28 0.39 Allowed Glycine 0 CA--C 1.519 0.332 0 C-N-CA 120.491 -0.862 . . . . 0.0 112.833 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -59.92 -164.17 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.651 2.234 . . . . 0.0 112.097 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 538' ' ' ALA . . . . . 0.486 ' O ' ' HB3' ' A' ' 539' ' ' ALA . . . -70.41 -46.53 63.79 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.678 179.753 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 539' ' ' ALA . . . . . 0.688 ' C ' ' HB1' ' A' ' 530' ' ' ALA . . . 70.68 -52.35 0.67 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.212 0.53 . . . . 0.0 111.709 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 540' ' ' GLU . . . . . 0.52 ' O ' ' HB3' ' A' ' 544' ' ' ALA . 13.0 mt-10 -37.21 -28.07 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.831 -1.077 . . . . 0.0 112.427 -179.231 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 541' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' A' ' 539' ' ' ALA . . . -126.79 -41.65 0.3 Allowed Glycine 0 CA--C 1.52 0.347 0 C-N-CA 120.505 -0.855 . . . . 0.0 112.338 179.206 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 542' ' ' ILE . . . . . 0.5 ' CD1' ' HA ' ' A' ' 539' ' ' ALA . 2.5 pp -75.8 -25.55 17.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -179.377 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 543' ' ' TYR . . . . . 0.585 ' HB2' ' HA ' ' A' ' 539' ' ' ALA . 0.2 OUTLIER -115.65 -5.66 12.16 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.862 0.363 . . . . 0.0 110.948 179.839 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 544' ' ' ALA . . . . . 0.943 ' HB1' ' HA ' ' A' ' 527' ' ' ILE . . . -102.78 -32.66 9.71 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.783 179.216 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 545' ' ' GLU . . . . . 0.549 ' OE2' HD23 ' A' ' 547' ' ' LEU . 50.3 tp10 -118.53 -32.85 4.48 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.301 179.834 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 35.55 39.35 0.23 Allowed Glycine 0 CA--C 1.519 0.337 0 CA-C-N 115.583 -0.735 . . . . 0.0 114.176 179.767 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 547' ' ' LEU . . . . . 0.587 HD23 ' H ' ' A' ' 548' ' ' MET . 0.0 OUTLIER -173.9 -61.8 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 117.756 0.778 . . . . 0.0 112.621 179.517 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 548' ' ' MET . . . . . 0.587 ' H ' HD23 ' A' ' 547' ' ' LEU . 0.0 OUTLIER -96.22 11.48 34.32 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.68 0.276 . . . . 0.0 111.339 179.96 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 549' ' ' HIS . . . . . 0.466 ' O ' ' CG2' ' A' ' 519' ' ' THR . 2.4 p-80 -62.29 -11.32 14.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.824 0.345 . . . . 0.0 110.804 179.221 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 550' ' ' ASN . . . . . 0.441 ' O ' ' N ' ' A' ' 552' ' ' ASP . 26.2 t-20 -95.1 -32.06 13.27 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -179.212 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 551' ' ' GLN . . . . . 0.449 ' HG2' ' CG ' ' A' ' 548' ' ' MET . 1.6 pt20 -64.99 74.44 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.421 0.629 . . . . 0.0 110.576 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 552' ' ' ASP . . . . . 0.565 ' HA ' ' HA ' ' A' ' 519' ' ' THR . 15.6 m-20 -78.61 19.12 0.51 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.583 -0.735 . . . . 0.0 112.023 -179.544 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . 123.61 -31.05 4.72 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.785 -0.721 . . . . 0.0 111.817 -179.804 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 554' ' ' LEU . . . . . 0.422 HD12 ' H ' ' A' ' 554' ' ' LEU . 1.5 mp -53.02 -56.56 15.17 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.485 0.66 . . . . 0.0 110.592 179.301 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 555' ' ' ILE . . . . . 0.595 HG22 ' O ' ' A' ' 555' ' ' ILE . 2.3 mm -69.57 66.27 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 114.785 -1.098 . . . . 0.0 110.614 -179.748 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 556' ' ' CYS . . . . . 0.414 ' O ' ' HD3' ' A' ' 559' ' ' ARG . 7.9 t -73.84 -7.3 51.69 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.461 -0.79 . . . . 0.0 111.649 -179.635 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -62.51 -2.17 4.11 Favored Glycine 0 CA--C 1.524 0.612 0 C-N-CA 121.221 -0.514 . . . . 0.0 113.87 -179.8 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 558' ' ' LEU . . . . . 0.854 HD21 ' CE ' ' A' ' 510' ' ' LYS . 4.1 pp -76.37 27.97 0.12 Allowed 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 -179.158 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 559' ' ' ARG . . . . . 0.44 ' HB3' ' HB3' ' A' ' 509' ' ' PRO . 0.0 OUTLIER -79.79 169.97 17.18 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.83 0.348 . . . . 0.0 110.82 179.682 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 560' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.215 -0.898 . . . . 0.0 110.88 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 507' ' ' ALA . . . . . 0.474 ' O ' ' HA ' ' A' ' 559' ' ' ARG . . . . . . . . 0 N--CA 1.482 1.173 0 CA-C-O 121.368 0.604 . . . . 0.0 111.408 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 508' ' ' GLN . . . . . . . . . . . . . 3.7 mp0 -128.42 80.13 72.97 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.291 179.537 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 509' ' ' PRO . . . . . 0.679 ' HG3' HD11 ' A' ' 558' ' ' LEU . 11.0 Cg_endo -55.42 -66.9 0.08 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.223 0 C-N-CA 122.622 2.215 . . . . 0.0 112.137 -179.802 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 510' ' ' LYS . . . . . 0.489 ' HB3' ' O ' ' A' ' 509' ' ' PRO . 0.0 OUTLIER 171.52 -31.39 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.461 -0.791 . . . . 0.0 110.338 -179.857 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 511' ' ' CYS . . . . . 0.464 ' N ' ' HG2' ' A' ' 510' ' ' LYS . 28.9 t 51.16 68.62 0.76 Allowed 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.688 179.381 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 512' ' ' ASN . . . . . 0.545 ' HB3' HD12 ' A' ' 515' ' ' LEU . 87.4 m-20 -111.07 81.22 2.63 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.871 179.113 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 513' ' ' PRO . . . . . 0.581 ' HA ' ' O ' ' A' ' 552' ' ' ASP . 55.5 Cg_endo -71.79 11.9 0.62 Allowed 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 122.839 2.36 . . . . 0.0 113.276 -179.275 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 -96.62 -15.99 21.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.663 0.268 . . . . 0.0 110.969 179.68 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 515' ' ' LEU . . . . . 0.545 HD12 ' HB3' ' A' ' 512' ' ' ASN . 1.4 mp -94.46 73.94 3.82 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.894 0.378 . . . . 0.0 110.943 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 516' ' ' HIS . . . . . 0.456 ' HA ' ' HB3' ' A' ' 552' ' ' ASP . 0.2 OUTLIER -80.59 -7.09 59.14 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.872 -179.774 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 517' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -72.17 -66.08 0.69 Allowed 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -179.088 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 518' ' ' TRP . . . . . 0.48 ' O ' ' N ' ' A' ' 520' ' ' THR . 12.0 m-90 -93.32 0.51 56.97 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.489 0.552 . . . . 0.0 112.489 -178.737 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 519' ' ' THR . . . . . 0.527 HG21 ' HA ' ' A' ' 549' ' ' HIS . 2.8 p 60.56 -75.19 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 110.627 -0.138 . . . . 0.0 110.627 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 520' ' ' THR . . . . . 0.48 ' N ' ' O ' ' A' ' 518' ' ' TRP . 1.0 OUTLIER 172.27 -62.95 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.241 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 179.155 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 521' ' ' GLN . . . . . 0.458 ' N ' HG22 ' A' ' 520' ' ' THR . 3.1 mp0 -68.33 -15.43 63.56 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 178.245 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 522' ' ' ASP . . . . . 0.409 ' HB2' ' O ' ' A' ' 518' ' ' TRP . 2.8 m-20 -94.19 -11.93 29.34 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 115.668 -0.697 . . . . 0.0 111.273 179.563 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -51.98 -31.73 30.55 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-O 121.069 0.462 . . . . 0.0 110.846 179.785 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . 162.89 40.29 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.471 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.02 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -133.02 -32.17 1.23 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.632 0.253 . . . . 0.0 111.592 -179.62 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -137.84 56.52 1.75 Allowed 'General case' 0 CA--C 1.515 -0.373 0 CA-C-O 121.393 0.615 . . . . 0.0 110.306 179.788 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 527' ' ' ILE . . . . . 0.863 HD12 ' N ' ' A' ' 528' ' ' GLY . 1.4 pp -95.31 -18.55 6.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.721 -179.511 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 528' ' ' GLY . . . . . 0.863 ' N ' HD12 ' A' ' 527' ' ' ILE . . . 26.79 -144.92 0.01 OUTLIER Glycine 0 C--N 1.336 0.559 0 N-CA-C 114.716 0.647 . . . . 0.0 114.716 179.171 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 529' ' ' LEU . . . . . 0.504 HD12 ' H ' ' A' ' 530' ' ' ALA . 0.2 OUTLIER -63.55 -17.59 62.96 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.426 -0.387 . . . . 0.0 111.715 -179.624 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 530' ' ' ALA . . . . . 1.044 ' HB3' ' HB2' ' A' ' 544' ' ' ALA . . . -81.58 1.99 31.23 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -179.361 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 531' ' ' TRP . . . . . 0.484 ' HA ' ' HG2' ' A' ' 540' ' ' GLU . 0.1 OUTLIER -72.18 27.38 0.05 Allowed 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -179.15 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 532' ' ' ILE . . . . . 0.463 HG23 ' O ' ' A' ' 531' ' ' TRP . 1.1 pp -159.03 72.16 3.54 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-O 120.793 0.33 . . . . 0.0 110.541 179.074 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 533' ' ' PRO . . . . . 0.41 ' HB3' ' O ' ' A' ' 537' ' ' PRO . 7.5 Cg_endo -49.62 88.34 0.02 OUTLIER 'Trans proline' 0 C--N 1.343 0.243 0 C-N-CA 123.08 2.52 . . . . 0.0 112.625 -179.733 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 534' ' ' TYR . . . . . . . . . . . . . 65.3 t80 -96.46 -28.37 14.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.273 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -72.59 -35.03 67.81 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.503 -179.452 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 151.99 -65.03 0.36 Allowed Glycine 0 N--CA 1.453 -0.208 0 C-N-CA 120.496 -0.859 . . . . 0.0 112.547 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 537' ' ' PRO . . . . . 0.41 ' O ' ' HB3' ' A' ' 533' ' ' PRO . 17.2 Cg_endo -57.38 -163.27 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.636 2.224 . . . . 0.0 111.718 179.696 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 538' ' ' ALA . . . . . 0.494 ' O ' ' HB3' ' A' ' 539' ' ' ALA . . . -76.81 -46.62 24.24 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.512 179.547 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 539' ' ' ALA . . . . . 0.689 ' C ' ' HB1' ' A' ' 530' ' ' ALA . . . 70.79 -52.4 0.67 Allowed 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 121.336 0.589 . . . . 0.0 111.545 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 540' ' ' GLU . . . . . 0.484 ' HG2' ' HA ' ' A' ' 531' ' ' TRP . 10.2 mt-10 -36.8 -30.85 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.797 -1.092 . . . . 0.0 112.43 -179.143 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 541' ' ' GLY . . . . . . . . . . . . . . . -126.79 -22.29 1.63 Allowed Glycine 0 CA--C 1.518 0.274 0 C-N-CA 120.35 -0.928 . . . . 0.0 113.355 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 542' ' ' ILE . . . . . 0.575 ' CD1' ' HA ' ' A' ' 539' ' ' ALA . 2.6 pp -96.4 -18.85 6.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 -179.133 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 543' ' ' TYR . . . . . 0.482 ' HB2' ' HA ' ' A' ' 539' ' ' ALA . 0.4 OUTLIER -114.21 -11.81 12.57 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.808 179.58 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 544' ' ' ALA . . . . . 1.044 ' HB2' ' HB3' ' A' ' 530' ' ' ALA . . . -103.36 -36.23 8.1 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 121.336 0.589 . . . . 0.0 110.635 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 545' ' ' GLU . . . . . 0.642 ' HG2' ' HB2' ' A' ' 548' ' ' MET . 2.9 tp10 -118.51 -32.7 4.52 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.218 -0.901 . . . . 0.0 111.452 -179.243 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 37.99 51.22 2.11 Favored Glycine 0 C--N 1.332 0.308 0 C-N-CA 121.259 -0.496 . . . . 0.0 112.664 -179.647 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 547' ' ' LEU . . . . . 0.561 HD11 ' SD ' ' A' ' 548' ' ' MET . 0.3 OUTLIER -172.78 -46.19 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 120.9 -0.32 . . . . 0.0 111.618 -179.292 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 548' ' ' MET . . . . . 0.642 ' HB2' ' HG2' ' A' ' 545' ' ' GLU . 0.0 OUTLIER -96.58 11.61 34.61 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.811 0.338 . . . . 0.0 111.0 179.285 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 549' ' ' HIS . . . . . 0.527 ' HA ' HG21 ' A' ' 519' ' ' THR . 11.4 p-80 -69.05 -11.21 60.58 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.008 0.432 . . . . 0.0 110.405 179.528 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 550' ' ' ASN . . . . . . . . . . . . . 35.2 t30 -95.93 -17.63 20.9 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.817 -179.391 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 551' ' ' GLN . . . . . 0.499 ' HG2' ' O ' ' A' ' 548' ' ' MET . 7.8 mm-40 -69.23 62.76 0.14 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.964 0.411 . . . . 0.0 110.569 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 552' ' ' ASP . . . . . 0.581 ' O ' ' HA ' ' A' ' 513' ' ' PRO . 2.8 m-20 -94.12 21.74 6.54 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.18 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 553' ' ' GLY . . . . . 0.443 ' HA3' ' C ' ' A' ' 512' ' ' ASN . . . 115.26 -33.98 5.03 Favored Glycine 0 N--CA 1.448 -0.564 0 N-CA-C 111.212 -0.755 . . . . 0.0 111.212 -179.242 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 554' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -53.37 -50.82 64.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.592 0.711 . . . . 0.0 110.177 178.952 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 555' ' ' ILE . . . . . 0.674 HG22 ' O ' ' A' ' 555' ' ' ILE . 4.1 mm -81.1 54.76 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 114.73 -1.123 . . . . 0.0 110.91 -179.743 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 556' ' ' CYS . . . . . 0.522 ' O ' ' HD2' ' A' ' 559' ' ' ARG . 29.1 p -97.11 -7.24 33.12 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.03 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 557' ' ' GLY . . . . . 0.43 ' C ' ' H ' ' A' ' 559' ' ' ARG . . . -58.09 -2.16 0.86 Allowed Glycine 0 CA--C 1.522 0.528 0 C-N-CA 121.228 -0.511 . . . . 0.0 114.164 -179.315 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 558' ' ' LEU . . . . . 0.679 HD11 ' HG3' ' A' ' 509' ' ' PRO . 3.6 pp -68.82 27.71 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -179.394 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 559' ' ' ARG . . . . . 0.522 ' HD2' ' O ' ' A' ' 556' ' ' CYS . 0.0 OUTLIER -76.36 -167.47 0.79 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.82 0.343 . . . . 0.0 110.394 179.431 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 560' ' ' GLN . . . . . . . . . . . . . 7.7 mt-30 . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.318 -0.848 . . . . 0.0 110.936 179.938 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.365 0 CA-C-O 120.854 0.359 . . . . 0.0 111.236 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 508' ' ' GLN . . . . . . . . . . . . . 63.9 mm-40 -128.55 76.76 78.21 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.702 178.842 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 509' ' ' PRO . . . . . 0.474 ' HG3' ' HA ' ' A' ' 559' ' ' ARG . 13.5 Cg_exo -69.91 -65.39 0.04 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.246 0 C-N-CA 122.816 2.344 . . . . 0.0 111.732 179.662 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 510' ' ' LYS . . . . . 0.469 ' HG2' ' N ' ' A' ' 511' ' ' CYS . 0.0 OUTLIER 177.95 -34.72 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.432 179.785 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 511' ' ' CYS . . . . . 0.469 ' N ' ' HG2' ' A' ' 510' ' ' LYS . 0.5 OUTLIER 43.47 59.2 3.12 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.131 -0.941 . . . . 0.0 111.597 179.535 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 512' ' ' ASN . . . . . 0.471 ' O ' ' O ' ' A' ' 552' ' ' ASP . 24.7 p30 -127.0 83.37 66.16 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.177 179.466 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 513' ' ' PRO . . . . . 0.467 ' HA ' ' O ' ' A' ' 552' ' ' ASP . 74.2 Cg_endo -76.17 22.1 0.51 Allowed 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 123.023 2.482 . . . . 0.0 113.27 -179.59 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -96.68 -26.02 15.34 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.811 0.339 . . . . 0.0 110.609 179.553 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 515' ' ' LEU . . . . . . . . . . . . . 31.7 mt -95.55 71.91 3.14 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.885 179.827 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 516' ' ' HIS . . . . . 0.469 ' HA ' ' CB ' ' A' ' 552' ' ' ASP . 6.2 p-80 -73.61 -7.35 51.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.721 -179.821 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 517' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -72.54 -59.74 2.57 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 111.903 0.334 . . . . 0.0 111.903 -179.435 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 518' ' ' TRP . . . . . 0.467 ' CD1' ' HA ' ' A' ' 523' ' ' GLU . 0.7 OUTLIER -80.07 -22.39 42.31 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.06 0.392 . . . . 0.0 112.06 -178.837 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 519' ' ' THR . . . . . 0.539 ' OG1' ' N ' ' A' ' 520' ' ' THR . 3.4 p 57.42 -81.29 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.459 0.171 . . . . 0.0 110.741 -179.728 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 520' ' ' THR . . . . . 0.539 ' N ' ' OG1' ' A' ' 519' ' ' THR . 1.1 m 176.19 -62.58 0.01 OUTLIER 'General case' 0 CA--C 1.52 -0.174 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 179.517 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 521' ' ' GLN . . . . . 0.403 ' N ' HG22 ' A' ' 520' ' ' THR . 2.4 mt-30 -72.07 -11.97 61.0 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.346 177.936 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 522' ' ' ASP . . . . . 0.421 ' HB2' ' O ' ' A' ' 518' ' ' TRP . 62.0 m-20 -93.49 -11.09 32.81 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.803 179.093 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 523' ' ' GLU . . . . . 0.467 ' HA ' ' CD1' ' A' ' 518' ' ' TRP . 0.1 OUTLIER -45.59 -27.92 0.86 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.698 -179.738 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 524' ' ' GLY . . . . . 0.45 ' HA2' ' CG1' ' A' ' 527' ' ' ILE . . . 150.52 40.04 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.343 -0.932 . . . . 0.0 112.439 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -97.91 -60.5 1.55 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.72 0.295 . . . . 0.0 111.589 -179.658 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -133.86 36.98 3.27 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-O 121.645 0.736 . . . . 0.0 110.33 179.735 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 527' ' ' ILE . . . . . 0.948 ' HA ' ' HB1' ' A' ' 544' ' ' ALA . 1.6 pp -96.13 -0.72 10.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 114.676 -1.147 . . . . 0.0 112.956 -178.795 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 528' ' ' GLY . . . . . 0.596 ' N ' HD12 ' A' ' 527' ' ' ILE . . . -55.19 -14.75 6.4 Favored Glycine 0 CA--C 1.521 0.455 0 C-N-CA 120.845 -0.693 . . . . 0.0 114.0 -179.342 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 529' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -98.73 -38.38 9.11 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 117.756 0.778 . . . . 0.0 112.303 -179.266 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 530' ' ' ALA . . . . . 0.946 ' HB3' ' HB2' ' A' ' 544' ' ' ALA . . . -103.68 1.71 32.25 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 -178.492 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 531' ' ' TRP . . . . . 0.462 ' O ' HG23 ' A' ' 532' ' ' ILE . 0.2 OUTLIER -71.31 30.46 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 112.405 0.521 . . . . 0.0 112.405 -178.896 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 532' ' ' ILE . . . . . 0.48 ' H ' ' C ' ' A' ' 530' ' ' ALA . 1.1 pt -159.04 73.24 3.52 Favored Pre-proline 0 N--CA 1.454 -0.256 0 CA-C-O 120.734 0.302 . . . . 0.0 110.403 179.031 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 533' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -50.74 84.95 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 123.071 2.514 . . . . 0.0 112.683 -179.496 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 534' ' ' TYR . . . . . 0.42 ' N ' ' O ' ' A' ' 532' ' ' ILE . 0.2 OUTLIER -96.48 -31.58 12.73 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.975 179.788 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -68.06 -34.94 77.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.333 -179.512 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 148.85 -63.9 0.41 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.651 -179.814 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -59.22 -165.98 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.639 2.226 . . . . 0.0 111.984 179.759 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 538' ' ' ALA . . . . . 0.453 ' O ' ' HB3' ' A' ' 539' ' ' ALA . . . -71.54 -49.79 37.44 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.508 179.78 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 539' ' ' ALA . . . . . 0.591 ' C ' ' HB1' ' A' ' 530' ' ' ALA . . . 69.14 -53.05 0.59 Allowed 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 121.206 0.527 . . . . 0.0 111.688 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 540' ' ' GLU . . . . . 0.486 ' O ' ' HB3' ' A' ' 544' ' ' ALA . 0.8 OUTLIER -37.3 -30.2 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.942 -1.026 . . . . 0.0 112.234 -179.286 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 541' ' ' GLY . . . . . . . . . . . . . . . -126.05 -30.27 0.88 Allowed Glycine 0 N--CA 1.453 -0.223 0 C-N-CA 120.479 -0.867 . . . . 0.0 113.216 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 542' ' ' ILE . . . . . 0.536 ' CD1' ' HA ' ' A' ' 539' ' ' ALA . 2.6 pp -87.89 -21.84 6.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 112.0 0.37 . . . . 0.0 112.0 -179.371 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 543' ' ' TYR . . . . . 0.468 ' CD2' ' CD1' ' A' ' 542' ' ' ILE . 6.1 m-85 -113.54 -10.19 13.19 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 120.812 0.339 . . . . 0.0 110.637 179.259 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 544' ' ' ALA . . . . . 0.948 ' HB1' ' HA ' ' A' ' 527' ' ' ILE . . . -103.35 -37.58 7.58 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 121.213 0.53 . . . . 0.0 110.198 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 545' ' ' GLU . . . . . 0.586 ' CD ' HD23 ' A' ' 547' ' ' LEU . 5.5 tp10 -118.73 -32.69 4.46 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.489 -179.088 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 37.72 45.39 1.48 Allowed Glycine 0 CA--C 1.52 0.398 0 CA-C-N 115.999 -0.546 . . . . 0.0 114.038 179.832 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 547' ' ' LEU . . . . . 0.586 HD23 ' CD ' ' A' ' 545' ' ' GLU . 0.0 OUTLIER -178.59 -61.26 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 117.594 0.697 . . . . 0.0 112.03 179.479 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 548' ' ' MET . . . . . 0.583 ' SD ' HD21 ' A' ' 547' ' ' LEU . 0.0 OUTLIER -90.63 12.06 20.11 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.715 0.293 . . . . 0.0 111.345 179.923 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 549' ' ' HIS . . . . . 0.5 ' O ' ' CG2' ' A' ' 519' ' ' THR . 12.7 t60 -65.51 -11.11 40.49 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.744 -0.383 . . . . 0.0 110.462 179.482 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 550' ' ' ASN . . . . . 0.458 ' O ' HD12 ' A' ' 554' ' ' LEU . 22.8 m-80 -93.7 -12.59 28.93 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.965 -0.294 . . . . 0.0 111.456 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 551' ' ' GLN . . . . . 0.566 ' HG2' ' O ' ' A' ' 548' ' ' MET . 4.8 mm-40 -73.47 59.2 0.6 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.913 0.387 . . . . 0.0 110.35 179.536 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 552' ' ' ASP . . . . . 0.471 ' O ' ' O ' ' A' ' 512' ' ' ASN . 2.8 p30 -98.78 22.04 10.62 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.188 -179.591 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . 123.74 -31.86 4.43 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.819 -0.705 . . . . 0.0 111.487 -179.238 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 554' ' ' LEU . . . . . 0.458 HD12 ' O ' ' A' ' 550' ' ' ASN . 1.4 mt -55.01 -56.12 23.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.382 0.61 . . . . 0.0 110.183 179.121 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 555' ' ' ILE . . . . . 0.595 HG22 ' O ' ' A' ' 555' ' ' ILE . 5.5 mm -79.23 60.01 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.997 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 556' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -63.98 -13.69 48.21 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.376 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 557' ' ' GLY . . . . . 0.414 ' O ' ' HG2' ' A' ' 559' ' ' ARG . . . -59.47 -15.11 30.68 Favored Glycine 0 C--N 1.331 0.282 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.973 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 558' ' ' LEU . . . . . 0.676 HD12 ' N ' ' A' ' 559' ' ' ARG . 3.0 pp -59.16 -39.31 82.08 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.793 0.297 . . . . 0.0 111.414 -179.802 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 559' ' ' ARG . . . . . 0.676 ' N ' HD12 ' A' ' 558' ' ' LEU . 9.7 mmt180 69.21 -164.16 0.18 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.002 0.43 . . . . 0.0 111.214 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 560' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.25 1.092 0 CA-C-O 118.258 -0.877 . . . . 0.0 110.921 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 507' ' ' ALA . . . . . 0.812 ' HB3' ' HA ' ' A' ' 559' ' ' ARG . . . . . . . . 0 N--CA 1.485 1.295 0 CA-C-O 121.128 0.49 . . . . 0.0 111.296 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 508' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.04 77.46 77.84 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.511 179.423 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 509' ' ' PRO . . . . . 0.538 ' O ' ' HB3' ' A' ' 510' ' ' LYS . 25.1 Cg_exo -63.59 -65.76 0.05 OUTLIER 'Trans proline' 0 N--CA 1.465 -0.179 0 C-N-CA 122.485 2.123 . . . . 0.0 112.022 -179.793 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 510' ' ' LYS . . . . . 0.538 ' HB3' ' O ' ' A' ' 509' ' ' PRO . 0.0 OUTLIER 170.73 -32.33 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.883 179.812 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 511' ' ' CYS . . . . . 0.439 ' N ' ' HG2' ' A' ' 510' ' ' LYS . 0.8 OUTLIER 44.02 47.53 7.27 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.508 179.88 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 512' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -122.11 83.89 45.26 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.417 179.542 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 513' ' ' PRO . . . . . 0.435 ' HB3' ' HG ' ' A' ' 554' ' ' LEU . 73.5 Cg_endo -75.36 -0.82 10.53 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.844 2.363 . . . . 0.0 113.124 -179.466 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 20.2 t30 -62.93 -40.24 97.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.736 0.303 . . . . 0.0 110.907 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 515' ' ' LEU . . . . . 0.793 HD13 ' CH2' ' A' ' 518' ' ' TRP . 0.9 OUTLIER -95.71 58.99 2.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.017 0.437 . . . . 0.0 111.06 -179.812 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 516' ' ' HIS . . . . . . . . . . . . . 42.4 t-80 -73.01 -6.54 46.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.874 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 517' ' ' TYR . . . . . . . . . . . . . 48.8 m-85 -61.07 -27.88 68.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.718 0.294 . . . . 0.0 111.174 -179.388 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 518' ' ' TRP . . . . . 0.793 ' CH2' HD13 ' A' ' 515' ' ' LEU . 1.5 p90 -117.92 -14.97 10.02 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.87 -179.612 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 519' ' ' THR . . . . . 0.538 ' CG2' ' O ' ' A' ' 549' ' ' HIS . 14.9 p 55.2 -79.43 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.55 0.214 . . . . 0.0 111.084 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 520' ' ' THR . . . . . 0.522 ' N ' ' O ' ' A' ' 518' ' ' TRP . 1.1 m 177.41 -62.59 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 179.479 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 521' ' ' GLN . . . . . 0.425 ' N ' HG22 ' A' ' 520' ' ' THR . 1.8 mp0 -74.65 -12.06 60.34 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.32 177.918 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 522' ' ' ASP . . . . . 0.451 ' HA ' ' CG2' ' A' ' 527' ' ' ILE . 13.4 m-20 -92.56 -10.7 36.62 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.675 179.037 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -45.19 -26.37 0.48 Allowed 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.581 -179.725 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 524' ' ' GLY . . . . . 0.415 ' HA2' ' CG1' ' A' ' 527' ' ' ILE . . . 146.06 40.92 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.441 -0.885 . . . . 0.0 112.604 179.797 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -100.36 -60.2 1.57 Allowed 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 -179.653 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -132.51 37.63 3.49 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.541 0.686 . . . . 0.0 110.068 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 527' ' ' ILE . . . . . 0.956 ' HA ' ' HB1' ' A' ' 544' ' ' ALA . 2.3 pp -95.97 -0.25 10.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 114.708 -1.133 . . . . 0.0 112.912 -178.802 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 528' ' ' GLY . . . . . 0.472 ' N ' HD12 ' A' ' 527' ' ' ILE . . . -56.87 -9.38 3.73 Favored Glycine 0 CA--C 1.523 0.576 0 C-N-CA 121.01 -0.614 . . . . 0.0 114.47 -179.151 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 529' ' ' LEU . . . . . 0.641 ' H ' HD23 ' A' ' 529' ' ' LEU . 1.2 pt? -98.56 -37.46 9.54 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 118.002 0.901 . . . . 0.0 112.021 -179.407 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 530' ' ' ALA . . . . . 0.984 ' HB3' ' HB2' ' A' ' 544' ' ' ALA . . . -103.82 1.94 32.16 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 -178.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 531' ' ' TRP . . . . . 0.464 ' HB2' ' O ' ' A' ' 527' ' ' ILE . 10.2 t90 -68.03 30.31 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 -178.639 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 532' ' ' ILE . . . . . 0.6 ' O ' HD12 ' A' ' 532' ' ' ILE . 1.3 pp -158.89 70.84 3.6 Favored Pre-proline 0 C--N 1.332 -0.177 0 CA-C-O 120.707 0.289 . . . . 0.0 111.462 179.309 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 533' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -54.83 102.07 0.08 OUTLIER 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.335 2.024 . . . . 0.0 111.508 179.374 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 534' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -96.15 -54.88 3.14 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -178.91 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -118.32 -34.91 3.93 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 111.87 0.322 . . . . 0.0 111.87 -179.247 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . -86.37 -176.29 49.69 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.539 -0.839 . . . . 0.0 112.783 -179.633 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 537' ' ' PRO . . . . . 0.419 ' HG2' ' CD1' ' A' ' 542' ' ' ILE . 14.0 Cg_endo -56.52 -158.83 0.01 OUTLIER 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.87 2.38 . . . . 0.0 111.818 179.69 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 538' ' ' ALA . . . . . 0.517 ' O ' ' HB3' ' A' ' 539' ' ' ALA . . . -45.06 -49.06 11.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.141 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 539' ' ' ALA . . . . . 0.541 ' C ' ' HB1' ' A' ' 530' ' ' ALA . . . 71.54 -48.79 0.68 Allowed 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.306 0.574 . . . . 0.0 111.459 179.77 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 540' ' ' GLU . . . . . 0.457 ' HG2' ' HA ' ' A' ' 531' ' ' TRP . 4.3 mt-10 -36.94 -29.33 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 114.901 -1.045 . . . . 0.0 112.354 -179.326 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 541' ' ' GLY . . . . . . . . . . . . . . . -127.98 -42.73 0.25 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.369 179.434 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 542' ' ' ILE . . . . . 0.872 HG22 ' CD2' ' A' ' 549' ' ' HIS . 2.6 pp -74.35 -24.88 19.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -179.317 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 543' ' ' TYR . . . . . 0.494 ' HB2' HD12 ' A' ' 542' ' ' ILE . 2.8 t80 -114.4 -7.97 12.86 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.847 0.356 . . . . 0.0 110.814 179.725 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 544' ' ' ALA . . . . . 0.984 ' HB2' ' HB3' ' A' ' 530' ' ' ALA . . . -98.29 -32.36 11.58 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 179.038 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 545' ' ' GLU . . . . . 0.581 ' HG3' ' H ' ' A' ' 548' ' ' MET . 4.4 tp10 -118.67 -32.6 4.51 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.178 -179.84 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 40.22 42.83 2.53 Favored Glycine 0 CA--C 1.52 0.372 0 CA-C-N 115.941 -0.572 . . . . 0.0 113.956 179.81 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 547' ' ' LEU . . . . . 0.578 HD23 ' H ' ' A' ' 548' ' ' MET . 0.0 OUTLIER -175.54 -61.15 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 117.511 0.656 . . . . 0.0 111.972 179.504 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 548' ' ' MET . . . . . 0.581 ' H ' ' HG3' ' A' ' 545' ' ' GLU . 0.1 OUTLIER -89.76 11.5 19.85 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.649 0.262 . . . . 0.0 111.311 -179.983 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 549' ' ' HIS . . . . . 0.872 ' CD2' HG22 ' A' ' 542' ' ' ILE . 35.0 p-80 -65.61 -11.24 42.67 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.139 0.495 . . . . 0.0 110.662 179.328 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 550' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -96.22 -7.57 35.3 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.413 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 551' ' ' GLN . . . . . 0.536 ' HG3' ' HG2' ' A' ' 548' ' ' MET . 8.2 mm-40 -71.81 53.41 0.24 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.706 0.289 . . . . 0.0 111.63 -179.33 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 552' ' ' ASP . . . . . 0.473 ' HB2' ' HA ' ' A' ' 519' ' ' THR . 6.3 t70 -114.15 21.68 14.53 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.738 0.304 . . . . 0.0 110.766 179.392 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 553' ' ' GLY . . . . . 0.414 ' CA ' ' HA ' ' A' ' 511' ' ' CYS . . . 116.96 -31.07 6.03 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.744 -0.741 . . . . 0.0 111.324 -178.979 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 554' ' ' LEU . . . . . 0.435 ' HG ' ' HB3' ' A' ' 513' ' ' PRO . 11.8 mt -57.61 -53.44 58.16 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-O 121.505 0.669 . . . . 0.0 109.631 178.912 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 555' ' ' ILE . . . . . 0.622 HG22 ' O ' ' A' ' 555' ' ' ILE . 9.6 mm -89.05 54.93 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 CA-C-N 114.978 -1.01 . . . . 0.0 109.99 179.44 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 556' ' ' CYS . . . . . 0.489 ' O ' ' HD3' ' A' ' 559' ' ' ARG . 0.8 OUTLIER -64.7 -9.43 19.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.867 -179.459 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 557' ' ' GLY . . . . . 0.421 ' HA2' ' NH1' ' A' ' 559' ' ' ARG . . . -57.31 -2.52 0.67 Allowed Glycine 0 CA--C 1.523 0.569 0 C-N-CA 121.182 -0.532 . . . . 0.0 114.137 -179.589 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 558' ' ' LEU . . . . . 0.56 HD12 ' C ' ' A' ' 558' ' ' LEU . 3.8 pp -78.99 27.38 0.23 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 117.113 0.457 . . . . 0.0 112.084 -179.797 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 559' ' ' ARG . . . . . 0.812 ' HA ' ' HB3' ' A' ' 507' ' ' ALA . 0.0 OUTLIER -62.21 -160.27 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 110.545 -0.168 . . . . 0.0 110.545 -179.937 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 560' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.179 -0.915 . . . . 0.0 110.927 -179.964 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 507' ' ' ALA . . . . . 0.475 ' CB ' ' HB3' ' A' ' 559' ' ' ARG . . . . . . . . 0 N--CA 1.486 1.336 0 CA-C-O 120.978 0.418 . . . . 0.0 111.345 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 508' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 -128.91 76.96 78.56 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.874 179.007 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 509' ' ' PRO . . . . . 0.678 ' HB3' HD11 ' A' ' 558' ' ' LEU . 15.3 Cg_exo -68.97 -65.04 0.04 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.21 0 C-N-CA 122.649 2.232 . . . . 0.0 111.803 179.787 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 510' ' ' LYS . . . . . 0.43 ' HB3' ' O ' ' A' ' 509' ' ' PRO . 0.0 OUTLIER 176.16 -31.71 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.778 179.87 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 511' ' ' CYS . . . . . 0.428 ' N ' ' HG2' ' A' ' 510' ' ' LYS . 0.0 OUTLIER 43.72 52.15 6.41 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.486 179.73 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 512' ' ' ASN . . . . . 0.403 ' O ' ' O ' ' A' ' 552' ' ' ASP . 9.6 m-20 -110.7 83.59 3.57 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.503 179.557 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 513' ' ' PRO . . . . . 0.459 ' HA ' ' O ' ' A' ' 552' ' ' ASP . 90.1 Cg_endo -79.27 22.91 0.66 Allowed 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.953 2.436 . . . . 0.0 113.185 -179.639 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -96.65 -27.66 14.69 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.778 0.323 . . . . 0.0 110.798 179.803 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 515' ' ' LEU . . . . . . . . . . . . . 1.6 mt -93.06 72.48 4.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.803 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 516' ' ' HIS . . . . . 0.447 ' HA ' ' CB ' ' A' ' 552' ' ' ASP . 2.4 t60 -72.11 -7.53 49.51 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.827 -179.772 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 517' ' ' TYR . . . . . . . . . . . . . 41.6 m-85 -83.96 -66.11 0.93 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.853 0.359 . . . . 0.0 111.448 -179.634 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 518' ' ' TRP . . . . . 0.446 ' CD1' ' HA ' ' A' ' 523' ' ' GLU . 0.1 OUTLIER -69.33 -19.01 63.87 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.625 -179.459 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 519' ' ' THR . . . . . 0.532 ' OG1' ' N ' ' A' ' 520' ' ' THR . 1.5 p 61.45 -78.26 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.65 -0.25 . . . . 0.0 110.39 -179.69 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 520' ' ' THR . . . . . 0.532 ' N ' ' OG1' ' A' ' 519' ' ' THR . 1.0 OUTLIER 173.12 -62.93 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 179.07 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 521' ' ' GLN . . . . . 0.468 ' HB3' ' OE2' ' A' ' 545' ' ' GLU . 6.0 tt0 -74.52 -15.65 60.86 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 177.864 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 522' ' ' ASP . . . . . 0.434 ' O ' HG21 ' A' ' 527' ' ' ILE . 13.5 t70 -94.07 -10.45 33.35 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.786 178.936 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 523' ' ' GLU . . . . . 0.446 ' HA ' ' CD1' ' A' ' 518' ' ' TRP . 0.0 OUTLIER -44.95 -26.88 0.47 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.539 -179.524 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 524' ' ' GLY . . . . . 0.426 ' HA2' ' CG1' ' A' ' 527' ' ' ILE . . . 153.14 40.56 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.288 179.838 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -97.67 -56.3 2.55 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.165 0.431 . . . . 0.0 112.165 -179.342 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -133.2 41.22 3.13 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-O 121.496 0.665 . . . . 0.0 110.185 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 527' ' ' ILE . . . . . 0.885 ' HA ' ' HB1' ' A' ' 544' ' ' ALA . 1.8 pp -95.82 -0.62 10.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 114.783 -1.099 . . . . 0.0 112.918 -178.853 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 528' ' ' GLY . . . . . 0.608 ' N ' HD12 ' A' ' 527' ' ' ILE . . . -60.3 -13.21 28.0 Favored Glycine 0 CA--C 1.521 0.447 0 C-N-CA 120.852 -0.689 . . . . 0.0 114.131 -179.013 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 529' ' ' LEU . . . . . 0.722 ' N ' HD13 ' A' ' 529' ' ' LEU . 0.0 OUTLIER -99.13 -30.44 12.29 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 117.614 0.707 . . . . 0.0 111.817 -179.645 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 530' ' ' ALA . . . . . 1.012 ' HB3' ' HB2' ' A' ' 544' ' ' ALA . . . -103.61 1.69 32.38 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -179.136 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 531' ' ' TRP . . . . . 0.561 ' HA ' ' HG2' ' A' ' 540' ' ' GLU . 0.2 OUTLIER -71.33 30.34 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -178.92 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 532' ' ' ILE . . . . . 0.475 ' H ' ' C ' ' A' ' 530' ' ' ALA . 1.1 pt -158.58 72.98 3.78 Favored Pre-proline 0 N--CA 1.453 -0.311 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.472 179.14 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 533' ' ' PRO . . . . . 0.423 ' HB3' ' O ' ' A' ' 537' ' ' PRO . 1.2 Cg_endo -44.25 85.25 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 123.46 2.773 . . . . 0.0 113.014 -179.625 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 534' ' ' TYR . . . . . 0.446 ' N ' ' O ' ' A' ' 532' ' ' ILE . 7.7 t80 -96.65 -39.47 9.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.329 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 20.6 t80 -57.68 -34.98 69.97 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.549 -179.191 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 146.55 -52.41 0.56 Allowed Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.467 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 537' ' ' PRO . . . . . 0.423 ' O ' ' HB3' ' A' ' 533' ' ' PRO . 2.0 Cg_endo -78.06 -174.53 2.28 Favored 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 122.725 2.283 . . . . 0.0 111.173 179.392 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 538' ' ' ALA . . . . . 0.496 ' O ' ' HB3' ' A' ' 539' ' ' ALA . . . -57.11 -51.23 70.14 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.951 -0.3 . . . . 0.0 110.624 179.554 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 539' ' ' ALA . . . . . 0.496 ' HB3' ' O ' ' A' ' 538' ' ' ALA . . . 71.07 -50.76 0.69 Allowed 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 121.265 0.555 . . . . 0.0 111.402 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 540' ' ' GLU . . . . . 0.561 ' HG2' ' HA ' ' A' ' 531' ' ' TRP . 5.3 mt-10 -37.74 -24.34 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 114.896 -1.047 . . . . 0.0 112.759 -179.445 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 541' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 539' ' ' ALA . . . -111.15 -58.36 0.48 Allowed Glycine 0 CA--C 1.52 0.384 0 C-N-CA 120.488 -0.863 . . . . 0.0 113.227 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 542' ' ' ILE . . . . . 0.524 HD13 ' H ' ' A' ' 542' ' ' ILE . 0.2 OUTLIER -76.94 -22.82 14.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 113.477 0.917 . . . . 0.0 113.477 -178.366 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 543' ' ' TYR . . . . . 0.465 ' C ' ' HB2' ' A' ' 530' ' ' ALA . 10.5 m-85 -101.56 -11.19 19.44 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.27 0.557 . . . . 0.0 110.345 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 544' ' ' ALA . . . . . 1.012 ' HB2' ' HB3' ' A' ' 530' ' ' ALA . . . -100.03 -28.86 12.85 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 115.228 -0.897 . . . . 0.0 110.034 179.689 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 545' ' ' GLU . . . . . 0.561 ' CD ' HD23 ' A' ' 547' ' ' LEU . 3.9 tp10 -118.68 -32.78 4.45 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.384 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 36.39 39.73 0.36 Allowed Glycine 0 CA--C 1.519 0.308 0 CA-C-N 115.759 -0.655 . . . . 0.0 114.371 179.454 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 547' ' ' LEU . . . . . 0.604 HD23 ' H ' ' A' ' 548' ' ' MET . 0.0 OUTLIER -176.71 -61.73 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 117.734 0.767 . . . . 0.0 112.247 179.449 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 548' ' ' MET . . . . . 0.604 ' H ' HD23 ' A' ' 547' ' ' LEU . 0.0 OUTLIER -95.38 11.38 32.94 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.728 0.299 . . . . 0.0 111.053 179.634 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 549' ' ' HIS . . . . . 0.474 ' O ' ' CG2' ' A' ' 519' ' ' THR . 16.5 p80 -62.72 -10.82 14.0 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.024 179.549 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 550' ' ' ASN . . . . . 0.449 ' O ' ' N ' ' A' ' 552' ' ' ASP . 1.8 m120 -95.56 -33.82 12.26 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -178.633 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 551' ' ' GLN . . . . . 0.404 ' NE2' ' HG2' ' A' ' 548' ' ' MET . 1.0 OUTLIER -65.9 71.51 0.06 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.182 0.515 . . . . 0.0 110.466 -179.694 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 552' ' ' ASP . . . . . 0.491 ' HA ' ' O ' ' A' ' 519' ' ' THR . 2.4 p30 -94.71 22.12 6.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.397 -179.48 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . 123.97 -32.65 4.13 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.799 -0.715 . . . . 0.0 111.677 -179.393 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 554' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -58.75 -59.18 5.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.488 0.661 . . . . 0.0 109.96 178.911 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 555' ' ' ILE . . . . . 0.594 HG22 ' O ' ' A' ' 555' ' ' ILE . 3.2 mm -72.27 65.69 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 CA-C-N 114.867 -1.06 . . . . 0.0 110.618 179.781 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 556' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -68.95 -7.47 35.44 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.565 -179.827 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -65.76 -2.73 12.75 Favored Glycine 0 CA--C 1.52 0.367 0 C-N-CA 120.913 -0.661 . . . . 0.0 113.391 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 558' ' ' LEU . . . . . 0.715 HD12 ' N ' ' A' ' 559' ' ' ARG . 4.2 pp -64.84 -32.01 73.51 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 117.115 0.458 . . . . 0.0 111.037 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 559' ' ' ARG . . . . . 0.715 ' N ' HD12 ' A' ' 558' ' ' LEU . 1.2 mmm-85 47.96 -172.51 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 120.859 0.362 . . . . 0.0 111.116 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 560' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.254 -0.879 . . . . 0.0 110.95 179.671 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 507' ' ' ALA . . . . . 0.589 ' HB3' ' CG ' ' A' ' 559' ' ' ARG . . . . . . . . 0 N--CA 1.485 1.323 0 CA-C-O 120.883 0.373 . . . . 0.0 111.143 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 508' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -128.28 86.28 58.33 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.689 179.663 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 509' ' ' PRO . . . . . 0.514 ' O ' ' CE ' ' A' ' 510' ' ' LYS . 4.6 Cg_exo -75.74 -23.72 12.36 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.777 2.318 . . . . 0.0 112.149 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 510' ' ' LYS . . . . . 0.514 ' CE ' ' O ' ' A' ' 509' ' ' PRO . 0.0 OUTLIER 84.03 -22.53 0.22 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.506 -179.831 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 511' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 43.46 76.31 0.08 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.569 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 512' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -124.04 80.4 57.68 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.48 179.724 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 513' ' ' PRO . . . . . 0.47 ' HA ' ' O ' ' A' ' 552' ' ' ASP . 94.2 Cg_endo -80.98 24.85 0.66 Allowed 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 123.021 2.481 . . . . 0.0 113.179 -179.679 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 17.8 t-20 -96.73 -30.31 13.28 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.707 0.289 . . . . 0.0 110.797 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 515' ' ' LEU . . . . . . . . . . . . . 32.9 mt -89.17 72.97 8.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.847 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 516' ' ' HIS . . . . . 0.425 ' HA ' ' CB ' ' A' ' 552' ' ' ASP . 62.2 t-80 -76.69 -15.69 59.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.541 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 517' ' ' TYR . . . . . . . . . . . . . 57.4 m-85 -80.1 -36.72 35.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.736 0.303 . . . . 0.0 111.373 -179.685 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 518' ' ' TRP . . . . . 0.462 ' O ' ' N ' ' A' ' 520' ' ' THR . 3.9 m-90 -94.92 -21.27 18.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.501 -179.532 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 519' ' ' THR . . . . . 0.551 ' OG1' ' N ' ' A' ' 520' ' ' THR . 1.2 p 58.41 -78.64 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.843 -179.797 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 520' ' ' THR . . . . . 0.551 ' N ' ' OG1' ' A' ' 519' ' ' THR . 1.1 m 178.18 -62.97 0.01 OUTLIER 'General case' 0 CA--C 1.521 -0.171 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 179.234 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 521' ' ' GLN . . . . . 0.41 ' N ' HG22 ' A' ' 520' ' ' THR . 1.2 mp0 -74.42 -14.3 60.83 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 177.825 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -94.13 -11.12 31.16 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.961 179.086 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -45.3 -28.29 0.8 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.235 -179.816 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . 148.61 42.03 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.43 179.806 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -104.37 -54.8 2.47 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 111.833 0.309 . . . . 0.0 111.833 -179.681 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -131.74 48.44 2.42 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-O 121.536 0.684 . . . . 0.0 110.014 179.758 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 527' ' ' ILE . . . . . 0.779 ' HA ' ' HB1' ' A' ' 544' ' ' ALA . 1.5 pp -95.45 -6.33 10.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 114.916 -1.038 . . . . 0.0 112.517 -178.906 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 528' ' ' GLY . . . . . 0.702 ' N ' HD12 ' A' ' 527' ' ' ILE . . . -54.86 -13.04 4.12 Favored Glycine 0 CA--C 1.521 0.445 0 C-N-CA 120.971 -0.633 . . . . 0.0 113.817 -179.472 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 529' ' ' LEU . . . . . 0.83 ' O ' HD22 ' A' ' 529' ' ' LEU . 0.3 OUTLIER -97.01 -41.01 8.59 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 117.392 0.596 . . . . 0.0 111.431 -179.296 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 530' ' ' ALA . . . . . 1.01 ' HB3' ' HB2' ' A' ' 544' ' ' ALA . . . -103.76 2.05 32.46 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.789 0.662 . . . . 0.0 112.789 -178.807 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 531' ' ' TRP . . . . . 0.482 ' HB2' ' O ' ' A' ' 527' ' ' ILE . 62.1 t90 -70.89 25.99 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -179.088 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 532' ' ' ILE . . . . . 0.629 ' O ' HD12 ' A' ' 532' ' ' ILE . 1.3 pp -159.25 70.98 3.45 Favored Pre-proline 0 C--N 1.332 -0.191 0 CA-C-O 120.843 0.354 . . . . 0.0 110.885 179.105 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 533' ' ' PRO . . . . . 0.418 ' HB3' ' O ' ' A' ' 537' ' ' PRO . 10.1 Cg_endo -51.36 110.63 0.44 Allowed 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.735 2.29 . . . . 0.0 111.907 179.735 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 534' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -96.33 -55.01 3.08 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -179.143 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -118.47 -35.23 3.81 Favored 'General case' 0 N--CA 1.463 0.179 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -179.121 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . -83.26 -175.11 50.83 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.535 -0.841 . . . . 0.0 112.89 -179.369 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 537' ' ' PRO . . . . . 0.418 ' O ' ' HB3' ' A' ' 533' ' ' PRO . 19.5 Cg_endo -58.12 -156.9 0.01 OUTLIER 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.657 2.238 . . . . 0.0 111.266 179.554 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 538' ' ' ALA . . . . . 0.488 ' O ' ' HB3' ' A' ' 539' ' ' ALA . . . -43.58 -44.01 5.95 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.7 0.286 . . . . 0.0 111.141 179.811 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 539' ' ' ALA . . . . . 0.488 ' HB3' ' O ' ' A' ' 538' ' ' ALA . . . 71.1 -49.54 0.68 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 121.108 0.48 . . . . 0.0 111.665 179.781 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 540' ' ' GLU . . . . . 0.468 ' CG ' ' HA ' ' A' ' 531' ' ' TRP . 3.7 mt-10 -37.66 -25.75 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.142 -0.935 . . . . 0.0 112.656 -179.506 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 541' ' ' GLY . . . . . 0.431 ' N ' ' O ' ' A' ' 539' ' ' ALA . . . -112.73 -55.42 0.45 Allowed Glycine 0 CA--C 1.523 0.549 0 C-N-CA 120.384 -0.912 . . . . 0.0 113.819 -179.559 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 542' ' ' ILE . . . . . 0.546 HD13 ' H ' ' A' ' 542' ' ' ILE . 0.2 OUTLIER -79.18 -22.94 12.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 113.691 0.997 . . . . 0.0 113.691 -178.133 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 543' ' ' TYR . . . . . 0.494 ' C ' ' HB2' ' A' ' 530' ' ' ALA . 9.7 m-85 -99.02 -16.97 18.51 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.248 0.547 . . . . 0.0 110.028 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 544' ' ' ALA . . . . . 1.01 ' HB2' ' HB3' ' A' ' 530' ' ' ALA . . . -91.52 -24.44 19.63 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.201 179.856 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 545' ' ' GLU . . . . . 0.664 ' CD ' HD23 ' A' ' 547' ' ' LEU . 3.7 tp10 -118.78 -32.65 4.46 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.405 -179.805 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 39.41 42.36 1.82 Allowed Glycine 0 CA--C 1.52 0.378 0 CA-C-N 115.883 -0.599 . . . . 0.0 114.366 179.436 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 547' ' ' LEU . . . . . 0.664 HD23 ' CD ' ' A' ' 545' ' ' GLU . 0.0 OUTLIER -178.51 -61.97 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 117.713 0.756 . . . . 0.0 112.094 179.122 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 548' ' ' MET . . . . . 0.555 ' H ' HD23 ' A' ' 547' ' ' LEU . 0.0 OUTLIER -96.08 11.43 34.21 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.751 0.31 . . . . 0.0 110.975 179.504 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 549' ' ' HIS . . . . . 0.527 ' CD2' ' HA ' ' A' ' 542' ' ' ILE . 11.9 p80 -61.19 -11.08 7.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.079 179.631 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 550' ' ' ASN . . . . . 0.43 ' O ' ' N ' ' A' ' 552' ' ' ASP . 28.9 t-20 -95.12 -34.64 12.2 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 -178.788 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 551' ' ' GLN . . . . . 0.404 ' HG3' ' O ' ' A' ' 548' ' ' MET . 0.5 OUTLIER -66.49 72.08 0.08 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.139 0.495 . . . . 0.0 110.419 179.969 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 552' ' ' ASP . . . . . 0.47 ' O ' ' HA ' ' A' ' 513' ' ' PRO . 4.5 p30 -93.87 22.33 5.76 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.514 -179.448 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . 124.2 -28.03 5.44 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.838 -0.696 . . . . 0.0 111.645 -179.27 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 554' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -59.67 -53.32 59.36 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.551 0.691 . . . . 0.0 109.787 178.824 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 555' ' ' ILE . . . . . 0.649 HG22 ' O ' ' A' ' 555' ' ' ILE . 3.2 mm -78.95 62.02 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 114.755 -1.111 . . . . 0.0 110.374 179.808 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 556' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -53.44 -22.45 7.85 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.444 -179.787 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 557' ' ' GLY . . . . . 0.422 ' HA2' ' NH1' ' A' ' 559' ' ' ARG . . . -51.91 -22.48 9.22 Favored Glycine 0 C--N 1.332 0.335 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.993 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 558' ' ' LEU . . . . . 0.822 HD12 ' N ' ' A' ' 559' ' ' ARG . 3.8 pp -53.73 -43.58 69.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.924 0.393 . . . . 0.0 111.415 -179.822 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 559' ' ' ARG . . . . . 0.822 ' N ' HD12 ' A' ' 558' ' ' LEU . 3.3 mpt_? 55.76 -178.14 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.934 -179.65 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 560' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.298 -0.858 . . . . 0.0 110.902 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 507' ' ' ALA . . . . . 0.757 ' HB1' ' HB2' ' A' ' 559' ' ' ARG . . . . . . . . 0 N--CA 1.486 1.349 0 CA-C-O 120.765 0.317 . . . . 0.0 111.173 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 508' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -128.62 78.2 76.28 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.889 179.594 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 509' ' ' PRO . . . . . 0.47 ' O ' ' CE ' ' A' ' 510' ' ' LYS . 90.5 Cg_endo -90.25 -13.42 2.44 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 122.877 2.385 . . . . 0.0 112.652 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 510' ' ' LYS . . . . . 0.47 ' CE ' ' O ' ' A' ' 509' ' ' PRO . 0.0 OUTLIER 81.22 -28.07 0.13 Allowed 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.076 0.465 . . . . 0.0 111.261 -179.449 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 511' ' ' CYS . . . . . . . . . . . . . 9.6 m 44.21 77.0 0.08 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.573 179.728 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 512' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -115.76 79.11 7.48 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.512 179.82 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 513' ' ' PRO . . . . . 0.458 ' HA ' ' O ' ' A' ' 552' ' ' ASP . 84.7 Cg_endo -83.48 25.23 0.7 Allowed 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.839 2.359 . . . . 0.0 113.042 -179.657 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 -96.66 -29.69 13.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.814 0.34 . . . . 0.0 111.107 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 515' ' ' LEU . . . . . . . . . . . . . 1.5 mt -88.13 73.08 9.05 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.025 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 516' ' ' HIS . . . . . 0.433 ' HA ' ' CB ' ' A' ' 552' ' ' ASP . 1.7 t60 -79.53 -7.21 58.32 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.601 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 517' ' ' TYR . . . . . . . . . . . . . 40.2 m-85 -80.19 -54.27 5.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.655 0.264 . . . . 0.0 111.686 -179.318 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 518' ' ' TRP . . . . . 0.526 ' O ' ' N ' ' A' ' 520' ' ' THR . 4.1 m-90 -92.37 -3.33 55.49 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 -179.02 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 519' ' ' THR . . . . . 0.579 ' OG1' ' N ' ' A' ' 520' ' ' THR . 1.3 p 55.83 -78.13 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 120.591 0.234 . . . . 0.0 110.978 179.746 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 520' ' ' THR . . . . . 0.579 ' N ' ' OG1' ' A' ' 519' ' ' THR . 1.1 m 177.01 -62.58 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.515 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 521' ' ' GLN . . . . . 0.456 ' NE2' ' SD ' ' A' ' 548' ' ' MET . 0.0 OUTLIER -73.84 -12.07 60.57 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 177.96 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 522' ' ' ASP . . . . . 0.435 ' HA ' ' CG2' ' A' ' 527' ' ' ILE . 3.2 m-20 -93.62 -10.72 33.65 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.781 179.047 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 523' ' ' GLU . . . . . 0.428 ' HA ' ' CD1' ' A' ' 518' ' ' TRP . 0.3 OUTLIER -45.39 -27.62 0.73 Allowed 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.501 -179.936 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 524' ' ' GLY . . . . . 0.43 ' HA2' ' CG1' ' A' ' 527' ' ' ILE . . . 146.05 42.34 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.579 -0.819 . . . . 0.0 112.299 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -101.52 -59.65 1.66 Allowed 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 111.941 0.349 . . . . 0.0 111.941 -179.478 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -131.82 36.58 3.69 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-O 121.503 0.668 . . . . 0.0 110.066 179.805 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 527' ' ' ILE . . . . . 0.964 ' HA ' ' HB1' ' A' ' 544' ' ' ALA . 2.1 pp -95.7 -0.43 10.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 114.787 -1.097 . . . . 0.0 112.735 -178.929 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 528' ' ' GLY . . . . . 0.516 ' N ' HD12 ' A' ' 527' ' ' ILE . . . -56.83 -13.77 8.84 Favored Glycine 0 CA--C 1.52 0.349 0 C-N-CA 120.892 -0.67 . . . . 0.0 114.024 -179.406 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 529' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -98.55 -32.81 11.26 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 117.639 0.719 . . . . 0.0 111.724 -179.379 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 530' ' ' ALA . . . . . 0.895 ' HB3' ' HB2' ' A' ' 544' ' ' ALA . . . -103.69 1.84 32.36 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -178.901 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 531' ' ' TRP . . . . . 0.533 ' O ' HG23 ' A' ' 532' ' ' ILE . 4.5 t90 -68.26 26.68 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -179.02 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 532' ' ' ILE . . . . . 0.626 ' O ' HD12 ' A' ' 532' ' ' ILE . 1.3 pp -160.56 71.04 2.88 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 120.846 0.355 . . . . 0.0 110.386 179.014 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 533' ' ' PRO . . . . . 0.414 ' HB3' ' O ' ' A' ' 537' ' ' PRO . 1.2 Cg_endo -44.71 85.22 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 123.451 2.768 . . . . 0.0 113.118 -179.449 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 534' ' ' TYR . . . . . 0.449 ' N ' ' O ' ' A' ' 532' ' ' ILE . 5.8 t80 -96.78 -34.26 11.38 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.148 179.606 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -60.92 -34.93 75.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.567 -179.369 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 536' ' ' GLY . . . . . 0.41 ' N ' ' CD ' ' A' ' 537' ' ' PRO . . . 145.12 -50.4 0.64 Allowed Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.522 -0.847 . . . . 0.0 112.603 -179.817 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 537' ' ' PRO . . . . . 0.414 ' O ' ' HB3' ' A' ' 533' ' ' PRO . 6.1 Cg_exo -74.64 -164.08 0.21 Allowed 'Trans proline' 0 N--CA 1.461 -0.43 0 C-N-CA 122.601 2.201 . . . . 0.0 111.474 179.594 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 538' ' ' ALA . . . . . 0.481 ' O ' ' HB3' ' A' ' 539' ' ' ALA . . . -68.4 -46.78 69.05 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.83 0.347 . . . . 0.0 110.258 179.328 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 539' ' ' ALA . . . . . 0.692 ' C ' ' HB1' ' A' ' 530' ' ' ALA . . . 70.15 -54.04 0.63 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 121.363 0.601 . . . . 0.0 111.443 179.841 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 540' ' ' GLU . . . . . 0.484 ' HG2' ' HA ' ' A' ' 531' ' ' TRP . 12.8 mt-10 -37.52 -27.23 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 114.781 -1.099 . . . . 0.0 112.248 -179.31 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 541' ' ' GLY . . . . . 0.423 ' N ' ' O ' ' A' ' 539' ' ' ALA . . . -125.26 -46.35 0.23 Allowed Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.051 179.006 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 542' ' ' ILE . . . . . 0.663 HG22 ' CE1' ' A' ' 549' ' ' HIS . 2.6 pp -73.93 -23.88 19.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -179.503 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 543' ' ' TYR . . . . . 0.465 ' HB2' HD12 ' A' ' 542' ' ' ILE . 23.5 t80 -112.54 -8.45 13.84 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.944 0.402 . . . . 0.0 110.843 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 544' ' ' ALA . . . . . 0.964 ' HB1' ' HA ' ' A' ' 527' ' ' ILE . . . -103.18 -35.21 8.56 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.939 179.316 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 545' ' ' GLU . . . . . 0.53 ' HG3' ' H ' ' A' ' 548' ' ' MET . 28.1 tp10 -118.59 -32.61 4.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.331 -0.85 . . . . 0.0 111.05 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 38.9 40.51 1.09 Allowed Glycine 0 CA--C 1.52 0.355 0 CA-C-N 115.856 -0.611 . . . . 0.0 113.896 179.752 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 547' ' ' LEU . . . . . 0.551 ' HG ' ' N ' ' A' ' 548' ' ' MET . 0.0 OUTLIER -172.0 -61.47 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 117.537 0.669 . . . . 0.0 112.204 179.568 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 548' ' ' MET . . . . . 0.581 ' O ' ' HG3' ' A' ' 551' ' ' GLN . 0.0 OUTLIER -96.17 11.78 33.15 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.773 0.321 . . . . 0.0 111.688 179.95 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 549' ' ' HIS . . . . . 0.663 ' CE1' HG22 ' A' ' 542' ' ' ILE . 12.3 p-80 -64.73 -11.0 31.52 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.88 0.372 . . . . 0.0 110.77 179.255 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 550' ' ' ASN . . . . . 0.46 ' O ' ' N ' ' A' ' 552' ' ' ASP . 5.9 m120 -96.18 -37.98 10.34 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -178.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 551' ' ' GLN . . . . . 0.581 ' HG3' ' O ' ' A' ' 548' ' ' MET . 0.0 OUTLIER -64.62 72.51 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.073 0.463 . . . . 0.0 110.712 -179.621 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 552' ' ' ASP . . . . . 0.46 ' N ' ' O ' ' A' ' 550' ' ' ASN . 2.3 p30 -92.51 21.9 5.03 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.203 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . 123.94 -27.81 5.55 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.952 -0.642 . . . . 0.0 111.766 -179.307 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 554' ' ' LEU . . . . . 0.459 HD11 ' OD2' ' A' ' 552' ' ' ASP . 0.6 OUTLIER -60.56 -60.67 3.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.404 0.621 . . . . 0.0 110.066 179.007 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 555' ' ' ILE . . . . . 0.493 HG22 ' O ' ' A' ' 555' ' ' ILE . 3.6 mm -72.71 70.87 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 CA-C-N 114.999 -1.0 . . . . 0.0 110.494 179.696 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 556' ' ' CYS . . . . . 0.536 ' O ' ' HD2' ' A' ' 559' ' ' ARG . 58.7 m -65.09 -8.73 17.8 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.333 -0.849 . . . . 0.0 112.039 -179.446 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 557' ' ' GLY . . . . . 0.45 ' C ' ' H ' ' A' ' 559' ' ' ARG . . . -52.82 -10.34 1.0 Allowed Glycine 0 CA--C 1.522 0.515 0 C-N-CA 121.047 -0.597 . . . . 0.0 113.949 -179.759 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 558' ' ' LEU . . . . . 0.52 HD12 ' C ' ' A' ' 558' ' ' LEU . 4.1 pp -68.8 27.95 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 -179.695 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 559' ' ' ARG . . . . . 0.757 ' HB2' ' HB1' ' A' ' 507' ' ' ALA . 0.0 OUTLIER -100.83 -173.11 2.31 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.816 0.341 . . . . 0.0 111.111 -179.834 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 560' ' ' GLN . . . . . . . . . . . . . 13.9 mt-30 . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.26 -0.876 . . . . 0.0 110.967 179.979 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 507' ' ' ALA . . . . . 0.6 ' O ' ' HA ' ' A' ' 559' ' ' ARG . . . . . . . . 0 N--CA 1.483 1.217 0 CA-C-O 121.445 0.64 . . . . 0.0 111.452 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 508' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.18 77.32 77.0 Favored Pre-proline 0 C--N 1.321 -0.648 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.902 179.142 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 509' ' ' PRO . . . . . 0.515 ' O ' ' HB3' ' A' ' 510' ' ' LYS . 32.3 Cg_exo -62.91 -65.86 0.05 OUTLIER 'Trans proline' 0 C--O 1.231 0.142 0 C-N-CA 122.91 2.407 . . . . 0.0 112.362 -179.558 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 510' ' ' LYS . . . . . 0.515 ' HB3' ' O ' ' A' ' 509' ' ' PRO . 0.0 OUTLIER 168.66 -30.97 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.364 -0.834 . . . . 0.0 109.879 -179.674 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 511' ' ' CYS . . . . . 0.445 ' N ' ' HG2' ' A' ' 510' ' ' LYS . 1.0 OUTLIER 55.86 84.28 0.08 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.006 -0.997 . . . . 0.0 111.522 179.249 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 512' ' ' ASN . . . . . 0.807 ' ND2' HD12 ' A' ' 515' ' ' LEU . 18.7 p30 -115.52 77.44 5.95 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.077 179.326 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 513' ' ' PRO . . . . . 0.573 ' HA ' ' O ' ' A' ' 552' ' ' ASP . 28.5 Cg_endo -64.5 -10.62 24.95 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.805 2.337 . . . . 0.0 112.345 -179.789 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -81.11 -22.29 39.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.213 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 515' ' ' LEU . . . . . 0.807 HD12 ' ND2' ' A' ' 512' ' ' ASN . 61.5 mt -88.85 74.62 8.23 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.928 0.394 . . . . 0.0 111.094 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 516' ' ' HIS . . . . . 0.474 ' HA ' ' HB3' ' A' ' 552' ' ' ASP . 98.9 m-70 -80.08 -7.27 58.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.693 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 517' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 -78.54 -37.94 41.66 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 111.648 0.24 . . . . 0.0 111.648 -179.354 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 518' ' ' TRP . . . . . 0.595 ' O ' ' N ' ' A' ' 520' ' ' THR . 14.8 m-90 -111.06 5.11 19.97 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 111.99 0.367 . . . . 0.0 111.99 -179.376 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 519' ' ' THR . . . . . 0.539 ' HA ' ' HA ' ' A' ' 552' ' ' ASP . 2.4 p 50.08 -78.32 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 120.421 0.153 . . . . 0.0 110.999 -179.862 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 520' ' ' THR . . . . . 0.595 ' N ' ' O ' ' A' ' 518' ' ' TRP . 1.2 m 179.45 -62.57 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 179.248 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 521' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -72.38 -12.02 60.94 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.301 178.004 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 522' ' ' ASP . . . . . 0.473 ' HA ' ' CG2' ' A' ' 527' ' ' ILE . 64.9 m-20 -91.71 -10.82 38.77 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.962 179.21 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -45.28 -26.78 0.55 Allowed 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.464 -179.762 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . 145.59 41.99 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.547 -0.835 . . . . 0.0 112.309 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -101.99 -60.57 1.51 Allowed 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 111.784 0.29 . . . . 0.0 111.784 -179.494 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -131.35 37.8 3.67 Favored 'General case' 0 CA--C 1.512 -0.506 0 CA-C-O 121.52 0.676 . . . . 0.0 110.066 179.823 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 527' ' ' ILE . . . . . 0.92 ' HA ' ' HB1' ' A' ' 544' ' ' ALA . 2.1 pp -95.78 -0.49 10.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-N 114.847 -1.07 . . . . 0.0 112.724 -178.889 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 528' ' ' GLY . . . . . 0.529 ' N ' HD12 ' A' ' 527' ' ' ILE . . . -58.94 -13.34 18.78 Favored Glycine 0 CA--C 1.521 0.443 0 C-N-CA 120.877 -0.678 . . . . 0.0 113.896 -179.336 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 529' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -98.63 -33.11 11.09 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 117.56 0.68 . . . . 0.0 111.759 -179.425 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 530' ' ' ALA . . . . . 0.942 ' HB3' ' HB2' ' A' ' 544' ' ' ALA . . . -103.62 -0.97 28.92 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 -178.84 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 531' ' ' TRP . . . . . 0.475 ' HA ' ' HG2' ' A' ' 540' ' ' GLU . 8.9 t90 -56.62 -11.12 1.19 Allowed 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 112.057 0.392 . . . . 0.0 112.057 -179.189 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 532' ' ' ILE . . . . . 0.716 ' O ' HD12 ' A' ' 532' ' ' ILE . 1.6 pp -133.45 73.79 72.64 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.037 0.446 . . . . 0.0 111.218 179.632 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 533' ' ' PRO . . . . . 0.406 ' HB3' ' O ' ' A' ' 538' ' ' ALA . 1.0 OUTLIER -44.18 92.95 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 123.165 2.577 . . . . 0.0 112.798 -179.988 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 534' ' ' TYR . . . . . . . . . . . . . 45.0 t80 -96.4 -25.51 15.68 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.079 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -70.57 -34.9 72.72 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.355 -179.559 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 147.32 -64.63 0.42 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.549 -0.834 . . . . 0.0 112.889 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -59.14 -165.01 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.641 2.227 . . . . 0.0 112.011 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 538' ' ' ALA . . . . . 0.477 ' O ' ' HB3' ' A' ' 539' ' ' ALA . . . -66.59 -48.27 70.09 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.558 179.759 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 539' ' ' ALA . . . . . 0.699 ' C ' ' HB1' ' A' ' 530' ' ' ALA . . . 69.54 -53.56 0.6 Allowed 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.302 0.573 . . . . 0.0 111.546 179.867 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 540' ' ' GLU . . . . . 0.475 ' HG2' ' HA ' ' A' ' 531' ' ' TRP . 14.4 mt-10 -37.32 -27.39 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.889 -1.051 . . . . 0.0 112.266 -179.377 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 541' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 539' ' ' ALA . . . -125.63 -46.71 0.22 Allowed Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.034 179.007 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 542' ' ' ILE . . . . . 0.476 HD12 ' HB2' ' A' ' 543' ' ' TYR . 2.6 pp -73.28 -23.89 20.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -179.515 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 543' ' ' TYR . . . . . 0.476 ' HB2' HD12 ' A' ' 542' ' ' ILE . 21.4 t80 -112.85 -7.62 13.75 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.991 0.424 . . . . 0.0 110.936 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 544' ' ' ALA . . . . . 0.942 ' HB2' ' HB3' ' A' ' 530' ' ' ALA . . . -103.04 -33.41 9.27 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.866 179.328 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 545' ' ' GLU . . . . . 0.645 ' CD ' HD23 ' A' ' 547' ' ' LEU . 3.9 tp10 -118.59 -32.58 4.54 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.43 -0.805 . . . . 0.0 111.0 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 38.01 46.86 1.85 Allowed Glycine 0 CA--C 1.519 0.294 0 CA-C-N 115.804 -0.635 . . . . 0.0 114.148 179.596 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 547' ' ' LEU . . . . . 0.645 HD23 ' CD ' ' A' ' 545' ' ' GLU . 0.0 OUTLIER -179.07 -61.5 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 117.6 0.7 . . . . 0.0 111.801 179.268 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 548' ' ' MET . . . . . 0.549 ' H ' HD23 ' A' ' 547' ' ' LEU . 0.0 OUTLIER -95.08 11.59 31.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.694 0.283 . . . . 0.0 111.088 179.503 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 549' ' ' HIS . . . . . 0.484 ' O ' HG21 ' A' ' 519' ' ' THR . 16.4 p80 -60.64 -11.52 7.53 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.07 179.586 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 550' ' ' ASN . . . . . 0.544 ' O ' ' N ' ' A' ' 552' ' ' ASP . 8.6 m-20 -94.8 -40.19 9.88 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 -179.332 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 551' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -60.34 73.06 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.189 0.519 . . . . 0.0 110.303 179.829 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 552' ' ' ASP . . . . . 0.573 ' O ' ' HA ' ' A' ' 513' ' ' PRO . 11.8 m-20 -84.62 21.73 1.45 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.933 -179.278 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 553' ' ' GLY . . . . . 0.414 ' HA3' ' N ' ' A' ' 513' ' ' PRO . . . 116.7 12.84 8.35 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.105 -179.653 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 554' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -104.41 -51.59 3.07 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.42 0.629 . . . . 0.0 109.93 179.75 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 555' ' ' ILE . . . . . 0.528 ' O ' HD23 ' A' ' 558' ' ' LEU . 2.2 mm -78.27 -1.69 4.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 114.923 -1.035 . . . . 0.0 111.231 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 556' ' ' CYS . . . . . 0.452 ' O ' ' HD2' ' A' ' 559' ' ' ARG . 25.9 p -68.45 -7.0 28.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.973 178.817 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -56.27 -7.91 2.19 Favored Glycine 0 C--N 1.336 0.557 0 C-N-CA 120.975 -0.631 . . . . 0.0 113.959 -179.364 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 558' ' ' LEU . . . . . 0.528 HD23 ' O ' ' A' ' 555' ' ' ILE . 0.2 OUTLIER -45.36 -72.64 0.05 Allowed 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 117.31 0.555 . . . . 0.0 111.974 -179.699 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 559' ' ' ARG . . . . . 0.6 ' HA ' ' O ' ' A' ' 507' ' ' ALA . 0.3 OUTLIER 47.49 -173.11 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.052 -179.686 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 560' ' ' GLN . . . . . 0.427 ' HG2' ' O ' ' A' ' 559' ' ' ARG . 3.0 pt20 . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.271 -0.871 . . . . 0.0 112.033 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 507' ' ' ALA . . . . . 0.453 ' HB3' ' HA ' ' A' ' 559' ' ' ARG . . . . . . . . 0 N--CA 1.485 1.3 0 CA-C-O 121.15 0.5 . . . . 0.0 111.181 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 508' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.38 77.62 77.12 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.231 179.812 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 509' ' ' PRO . . . . . 0.492 ' O ' ' HB3' ' A' ' 510' ' ' LYS . 11.1 Cg_exo -71.04 -65.44 0.03 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.304 0 C-N-CA 122.563 2.175 . . . . 0.0 111.651 179.631 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 510' ' ' LYS . . . . . 0.492 ' HB3' ' O ' ' A' ' 509' ' ' PRO . 0.0 OUTLIER 173.74 -32.62 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.619 -0.718 . . . . 0.0 110.861 179.706 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 511' ' ' CYS . . . . . 0.448 ' N ' ' HG2' ' A' ' 510' ' ' LYS . 0.1 OUTLIER 42.63 41.11 2.25 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.611 179.78 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 512' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -107.72 83.94 1.81 Allowed Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.755 179.736 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 513' ' ' PRO . . . . . 0.455 ' HA ' ' O ' ' A' ' 552' ' ' ASP . 57.2 Cg_endo -71.27 -6.08 18.41 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.76 2.306 . . . . 0.0 112.86 -179.859 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -71.71 -28.29 63.6 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.189 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 515' ' ' LEU . . . . . . . . . . . . . 83.4 mt -92.06 72.24 5.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.855 0.36 . . . . 0.0 111.08 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 516' ' ' HIS . . . . . 0.442 ' HA ' ' CB ' ' A' ' 552' ' ' ASP . 26.9 p-80 -86.15 -7.18 58.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.669 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 517' ' ' TYR . . . . . . . . . . . . . 46.2 m-85 -84.03 -19.43 34.45 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.711 -0.222 . . . . 0.0 111.576 -179.809 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 518' ' ' TRP . . . . . 0.5 ' O ' ' N ' ' A' ' 520' ' ' THR . 4.4 m-90 -118.08 -13.32 9.97 Favored 'General case' 0 C--N 1.332 -0.164 0 N-CA-C 112.227 0.454 . . . . 0.0 112.227 -179.134 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 519' ' ' THR . . . . . 0.563 ' OG1' ' N ' ' A' ' 520' ' ' THR . 1.2 p 57.5 -78.13 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 110.643 -0.132 . . . . 0.0 110.643 -179.691 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 520' ' ' THR . . . . . 0.563 ' N ' ' OG1' ' A' ' 519' ' ' THR . 1.2 m 178.53 -62.75 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.227 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 521' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -75.54 -11.74 60.09 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.268 178.206 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 522' ' ' ASP . . . . . 0.457 ' HB2' ' O ' ' A' ' 518' ' ' TRP . 45.2 m-20 -94.48 -12.39 27.8 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.013 178.588 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 523' ' ' GLU . . . . . 0.412 ' HG3' ' HA ' ' A' ' 520' ' ' THR . 20.2 mm-40 -50.0 -25.22 3.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.701 178.632 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . 139.48 37.9 0.11 Allowed Glycine 0 N--CA 1.445 -0.708 0 N-CA-C 110.3 -1.12 . . . . 0.0 110.3 -179.075 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -107.94 -42.96 4.55 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.273 -0.464 . . . . 0.0 111.61 -178.543 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 526' ' ' ALA . . . . . 0.53 ' O ' ' HB1' ' A' ' 544' ' ' ALA . . . -136.8 42.74 2.45 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-O 121.441 0.638 . . . . 0.0 110.157 179.678 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 527' ' ' ILE . . . . . 0.74 HD12 ' N ' ' A' ' 528' ' ' GLY . 1.8 pp -95.53 -8.38 9.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 114.994 -1.003 . . . . 0.0 112.39 -179.056 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 528' ' ' GLY . . . . . 0.74 ' N ' HD12 ' A' ' 527' ' ' ILE . . . -55.95 -16.32 12.51 Favored Glycine 0 CA--C 1.52 0.402 0 C-N-CA 120.938 -0.649 . . . . 0.0 114.009 -179.222 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 529' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -98.49 -35.3 10.3 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 117.581 0.69 . . . . 0.0 111.767 -179.314 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 530' ' ' ALA . . . . . 1.009 ' HB3' ' HB2' ' A' ' 544' ' ' ALA . . . -103.6 1.06 31.61 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.694 0.627 . . . . 0.0 112.694 -178.9 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 531' ' ' TRP . . . . . 0.457 ' HB2' ' O ' ' A' ' 527' ' ' ILE . 22.4 t90 -56.08 -12.81 1.63 Allowed 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 111.878 0.325 . . . . 0.0 111.878 -179.439 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 532' ' ' ILE . . . . . 0.698 ' O ' HD12 ' A' ' 532' ' ' ILE . 1.6 pp -129.8 74.74 80.43 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 120.908 0.385 . . . . 0.0 111.06 179.665 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 533' ' ' PRO . . . . . 0.58 ' HB3' ' HB3' ' A' ' 539' ' ' ALA . 9.5 Cg_endo -51.89 94.91 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.891 2.394 . . . . 0.0 112.688 -179.68 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 534' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -96.26 -17.13 20.97 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.09 179.558 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -75.89 -35.01 60.0 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.369 -179.595 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 143.88 -64.15 0.48 Allowed Glycine 0 CA--C 1.519 0.297 0 C-N-CA 120.484 -0.865 . . . . 0.0 112.788 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -58.95 -165.79 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.689 2.259 . . . . 0.0 112.177 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 538' ' ' ALA . . . . . 0.436 ' O ' ' HB3' ' A' ' 539' ' ' ALA . . . -63.02 -49.76 73.37 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.474 179.825 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 539' ' ' ALA . . . . . 0.599 ' C ' ' HB1' ' A' ' 530' ' ' ALA . . . 68.01 -57.63 0.46 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 121.389 0.614 . . . . 0.0 111.804 179.578 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -37.48 -29.94 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.942 -1.026 . . . . 0.0 112.338 -179.173 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 541' ' ' GLY . . . . . 0.401 ' O ' ' HB3' ' A' ' 549' ' ' HIS . . . -122.89 -26.23 1.76 Allowed Glycine 0 CA--C 1.52 0.379 0 C-N-CA 120.281 -0.961 . . . . 0.0 113.503 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 542' ' ' ILE . . . . . 0.54 ' CD1' ' HA ' ' A' ' 539' ' ' ALA . 2.6 pp -96.48 -21.47 5.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 112.392 0.515 . . . . 0.0 112.392 -179.247 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 543' ' ' TYR . . . . . 0.455 ' HB2' ' HA ' ' A' ' 539' ' ' ALA . 3.6 t80 -107.86 -13.75 14.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.084 0.468 . . . . 0.0 110.263 179.536 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 544' ' ' ALA . . . . . 1.009 ' HB2' ' HB3' ' A' ' 530' ' ' ALA . . . -92.16 -21.58 20.32 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.309 179.453 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 545' ' ' GLU . . . . . 0.517 ' OE2' ' HB2' ' A' ' 548' ' ' MET . 4.2 tp10 -118.36 -33.35 4.38 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.363 -179.666 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 35.21 40.71 0.26 Allowed Glycine 0 CA--C 1.519 0.297 0 CA-C-N 115.808 -0.633 . . . . 0.0 114.472 179.278 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 547' ' ' LEU . . . . . 0.617 HD23 ' H ' ' A' ' 548' ' ' MET . 0.0 OUTLIER -179.79 -61.43 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 118.004 0.902 . . . . 0.0 112.46 179.567 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 548' ' ' MET . . . . . 0.617 ' H ' HD23 ' A' ' 547' ' ' LEU . 0.0 OUTLIER -94.6 11.65 30.31 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.818 0.342 . . . . 0.0 111.085 179.794 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 549' ' ' HIS . . . . . 0.491 ' O ' ' CG2' ' A' ' 519' ' ' THR . 18.5 p80 -62.6 -11.12 14.88 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.079 179.568 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 550' ' ' ASN . . . . . 0.429 ' O ' ' N ' ' A' ' 552' ' ' ASP . 47.3 m-20 -96.04 -33.06 12.26 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -178.942 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 551' ' ' GLN . . . . . 0.411 ' HG2' ' CG ' ' A' ' 548' ' ' MET . 1.7 pt20 -66.36 71.53 0.07 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.109 0.48 . . . . 0.0 110.654 -179.79 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 552' ' ' ASP . . . . . 0.455 ' O ' ' HA ' ' A' ' 513' ' ' PRO . 3.3 p30 -95.38 21.96 7.47 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.396 -179.661 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . 123.89 -31.05 4.66 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.902 -0.666 . . . . 0.0 111.683 -179.279 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 554' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -61.48 -58.76 6.88 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.42 0.628 . . . . 0.0 109.87 178.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 555' ' ' ILE . . . . . 0.637 HG22 ' O ' ' A' ' 555' ' ' ILE . 3.2 mm -73.28 63.29 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.694 179.765 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 556' ' ' CYS . . . . . 0.408 ' O ' ' CD ' ' A' ' 559' ' ' ARG . 0.1 OUTLIER -74.09 -8.0 54.55 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.432 -179.763 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 557' ' ' GLY . . . . . 0.462 ' C ' ' HD3' ' A' ' 559' ' ' ARG . . . -48.7 -23.08 3.12 Favored Glycine 0 C--N 1.333 0.413 0 C-N-CA 120.993 -0.622 . . . . 0.0 113.006 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 558' ' ' LEU . . . . . 0.456 HD11 ' CB ' ' A' ' 509' ' ' PRO . 1.2 pp -55.03 -20.95 10.61 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 559' ' ' ARG . . . . . 0.462 ' HD3' ' C ' ' A' ' 557' ' ' GLY . 0.0 OUTLIER -53.38 -166.82 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 121.152 0.501 . . . . 0.0 111.237 -179.98 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 560' ' ' GLN . . . . . 0.414 ' HG3' ' HG2' ' A' ' 559' ' ' ARG . 29.0 mt-30 . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.229 -0.891 . . . . 0.0 111.181 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 511' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.232 0.158 0 CA-C-O 121.108 0.48 . . . . 0.0 111.428 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 512' ' ' ASN . . . . . . . . . . . . . 7.5 m-20 -131.35 82.46 62.28 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.434 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 513' ' ' PRO . . . . . 0.468 ' HA ' ' O ' ' A' ' 552' ' ' ASP . 85.3 Cg_endo -79.07 20.71 0.79 Allowed 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.895 2.396 . . . . 0.0 113.097 -179.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 34.8 t30 -96.67 -31.25 12.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.96 0.41 . . . . 0.0 110.786 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 515' ' ' LEU . . . . . . . . . . . . . 18.9 mt -83.52 73.85 10.16 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.886 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 516' ' ' HIS . . . . . 0.413 ' HA ' ' CB ' ' A' ' 552' ' ' ASP . 1.4 t-80 -72.47 -15.28 61.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.59 -179.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 517' ' ' TYR . . . . . . . . . . . . . 48.2 m-85 -79.16 -66.03 0.92 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.819 0.342 . . . . 0.0 111.433 -179.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 518' ' ' TRP . . . . . 0.494 ' O ' ' N ' ' A' ' 520' ' ' THR . 21.2 m-90 -70.32 -14.38 62.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.884 -179.492 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 519' ' ' THR . . . . . 0.541 ' OG1' ' N ' ' A' ' 520' ' ' THR . 1.7 p 56.98 -78.8 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 116.727 -0.215 . . . . 0.0 110.719 -179.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 520' ' ' THR . . . . . 0.541 ' N ' ' OG1' ' A' ' 519' ' ' THR . 1.1 m 176.83 -62.68 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.149 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 521' ' ' GLN . . . . . 0.419 ' N ' HG22 ' A' ' 520' ' ' THR . 0.5 OUTLIER -72.73 -12.27 60.95 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 177.969 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 522' ' ' ASP . . . . . 0.444 ' HA ' ' CG2' ' A' ' 527' ' ' ILE . 1.9 m-20 -93.89 -11.03 31.95 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.699 178.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -45.48 -27.92 0.81 Allowed 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.44 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 524' ' ' GLY . . . . . 0.436 ' HA2' ' CG1' ' A' ' 527' ' ' ILE . . . 147.62 41.38 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.489 -0.863 . . . . 0.0 112.477 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -100.44 -60.11 1.58 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.743 0.306 . . . . 0.0 111.737 -179.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -132.48 37.57 3.5 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-O 121.488 0.661 . . . . 0.0 110.103 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 527' ' ' ILE . . . . . 0.945 ' HA ' ' HB1' ' A' ' 544' ' ' ALA . 1.8 pp -95.94 -0.96 10.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 114.811 -1.086 . . . . 0.0 112.793 -178.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 528' ' ' GLY . . . . . 0.598 ' N ' HD12 ' A' ' 527' ' ' ILE . . . -57.63 -12.56 9.94 Favored Glycine 0 CA--C 1.521 0.414 0 C-N-CA 120.875 -0.679 . . . . 0.0 113.976 -179.344 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 529' ' ' LEU . . . . . 0.504 HD11 ' O ' ' A' ' 543' ' ' TYR . 1.2 pp -98.75 -39.37 8.68 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 117.757 0.779 . . . . 0.0 112.167 -179.241 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 530' ' ' ALA . . . . . 1.019 ' HB3' ' HB2' ' A' ' 544' ' ' ALA . . . -103.93 1.8 31.72 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 -178.461 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 531' ' ' TRP . . . . . 0.481 ' HB2' ' O ' ' A' ' 527' ' ' ILE . 54.9 t90 -72.04 30.3 0.05 Allowed 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -178.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 532' ' ' ILE . . . . . 0.62 ' O ' HD12 ' A' ' 532' ' ' ILE . 1.3 pp -159.65 70.87 3.27 Favored Pre-proline 0 C--N 1.332 -0.181 0 CA-C-O 120.723 0.297 . . . . 0.0 110.894 179.176 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 533' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -51.26 103.51 0.07 OUTLIER 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.659 2.239 . . . . 0.0 111.742 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 534' ' ' TYR . . . . . 0.4 ' CD1' HD12 ' A' ' 532' ' ' ILE . 0.4 OUTLIER -96.17 -55.06 3.08 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -179.006 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 -118.52 -35.23 3.8 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 -179.1 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . -87.44 -175.06 48.68 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.891 -179.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 537' ' ' PRO . . . . . 0.402 ' HG2' ' CD1' ' A' ' 542' ' ' ILE . 14.1 Cg_endo -56.59 -159.34 0.01 OUTLIER 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.884 2.39 . . . . 0.0 111.692 179.691 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 538' ' ' ALA . . . . . 0.508 ' O ' ' HB3' ' A' ' 539' ' ' ALA . . . -43.99 -49.83 8.48 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.067 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 539' ' ' ALA . . . . . 0.522 ' C ' ' HB1' ' A' ' 530' ' ' ALA . . . 71.66 -46.7 0.65 Allowed 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.205 0.526 . . . . 0.0 111.548 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 540' ' ' GLU . . . . . 0.444 ' HG2' ' HA ' ' A' ' 531' ' ' TRP . 2.5 mt-10 -36.95 -29.09 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.057 -0.974 . . . . 0.0 112.304 -179.352 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 541' ' ' GLY . . . . . 0.406 ' N ' ' O ' ' A' ' 539' ' ' ALA . . . -127.79 -48.66 0.17 Allowed Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.028 179.21 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 542' ' ' ILE . . . . . 0.534 HD12 ' HB2' ' A' ' 543' ' ' TYR . 2.6 pp -68.09 -25.14 31.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -179.355 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 543' ' ' TYR . . . . . 0.534 ' HB2' HD12 ' A' ' 542' ' ' ILE . 6.1 t80 -115.3 -8.0 12.32 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.857 0.361 . . . . 0.0 111.145 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 544' ' ' ALA . . . . . 1.019 ' HB2' ' HB3' ' A' ' 530' ' ' ALA . . . -99.31 -33.22 10.81 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.06 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 545' ' ' GLU . . . . . 0.529 ' HG3' ' H ' ' A' ' 548' ' ' MET . 14.3 tp10 -118.67 -32.67 4.49 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.209 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 40.71 42.1 2.66 Favored Glycine 0 CA--C 1.521 0.417 0 CA-C-N 115.917 -0.583 . . . . 0.0 113.747 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 547' ' ' LEU . . . . . 0.666 HD23 ' H ' ' A' ' 548' ' ' MET . 0.0 OUTLIER -173.16 -61.14 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 117.4 0.6 . . . . 0.0 112.14 179.608 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 548' ' ' MET . . . . . 0.666 ' H ' HD23 ' A' ' 547' ' ' LEU . 4.3 mtt -95.31 11.71 31.64 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.709 0.29 . . . . 0.0 111.481 -179.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 549' ' ' HIS . . . . . 0.523 ' O ' HG21 ' A' ' 519' ' ' THR . 14.7 p-80 -65.47 -11.08 39.81 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.861 0.363 . . . . 0.0 110.791 179.423 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 550' ' ' ASN . . . . . 0.505 ' O ' ' N ' ' A' ' 552' ' ' ASP . 15.0 m-20 -95.87 -41.08 8.99 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -179.092 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 551' ' ' GLN . . . . . 0.51 ' HG3' ' O ' ' A' ' 548' ' ' MET . 0.0 OUTLIER -62.36 73.31 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.171 0.51 . . . . 0.0 110.469 -179.882 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 552' ' ' ASP . . . . . 0.505 ' N ' ' O ' ' A' ' 550' ' ' ASN . 1.9 p30 -90.25 22.2 3.44 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.601 -179.581 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . 124.04 -30.52 4.78 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.891 -0.671 . . . . 0.0 111.668 -179.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 554' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -55.73 -53.65 54.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.559 0.695 . . . . 0.0 110.138 178.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 555' ' ' ILE . . . . . 0.636 HG22 ' O ' ' A' ' 555' ' ' ILE . 4.0 mm -79.52 58.96 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.696 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 556' ' ' CYS . . . . . . . . . . . . . 6.3 t . . . . . 0 C--N 1.326 -0.436 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.469 -179.796 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 511' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.983 0.42 . . . . 0.0 111.485 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 512' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -131.72 77.23 73.09 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.403 179.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 513' ' ' PRO . . . . . 0.462 ' HA ' ' O ' ' A' ' 552' ' ' ASP . 87.7 Cg_endo -79.75 22.52 0.72 Allowed 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.932 2.421 . . . . 0.0 113.177 -179.533 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 25.8 t30 -96.67 -28.97 14.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.691 0.281 . . . . 0.0 110.804 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 515' ' ' LEU . . . . . . . . . . . . . 46.4 mt -90.59 72.87 6.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.926 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 516' ' ' HIS . . . . . 0.434 ' HA ' ' CB ' ' A' ' 552' ' ' ASP . 1.4 t60 -76.7 -7.34 55.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.655 -179.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 517' ' ' TYR . . . . . . . . . . . . . 42.9 m-85 -85.26 -49.5 8.14 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.674 0.274 . . . . 0.0 111.524 -179.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 518' ' ' TRP . . . . . 0.495 ' O ' ' N ' ' A' ' 520' ' ' THR . 3.0 m-90 -88.56 -11.55 45.3 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 111.886 0.328 . . . . 0.0 111.886 -179.331 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 519' ' ' THR . . . . . 0.572 ' OG1' ' N ' ' A' ' 520' ' ' THR . 1.3 p 56.22 -79.08 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.81 -0.177 . . . . 0.0 110.989 179.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 520' ' ' THR . . . . . 0.572 ' N ' ' OG1' ' A' ' 519' ' ' THR . 1.2 m 179.46 -62.74 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 179.435 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 521' ' ' GLN . . . . . . . . . . . . . 6.8 mt-30 -74.16 -12.07 60.48 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 177.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 522' ' ' ASP . . . . . 0.438 ' HB2' ' O ' ' A' ' 518' ' ' TRP . 20.8 m-20 -93.95 -10.57 33.28 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.854 179.296 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 523' ' ' GLU . . . . . 0.466 ' HA ' ' CD1' ' A' ' 518' ' ' TRP . 14.1 pt-20 -45.24 -26.65 0.52 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.515 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . 147.6 41.35 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.289 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -101.23 -60.46 1.52 Allowed 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 111.941 0.349 . . . . 0.0 111.941 -179.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -131.44 36.84 3.74 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-O 121.541 0.686 . . . . 0.0 110.129 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 527' ' ' ILE . . . . . 0.935 ' HA ' ' HB1' ' A' ' 544' ' ' ALA . 2.1 pp -95.77 -0.38 10.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 114.762 -1.108 . . . . 0.0 112.709 -178.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 528' ' ' GLY . . . . . 0.515 ' N ' HD12 ' A' ' 527' ' ' ILE . . . -60.41 -10.47 16.85 Favored Glycine 0 CA--C 1.521 0.423 0 C-N-CA 120.82 -0.705 . . . . 0.0 113.948 -179.43 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 529' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -98.47 -33.69 10.92 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 117.569 0.684 . . . . 0.0 111.502 -179.585 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 530' ' ' ALA . . . . . 0.93 ' HB3' ' HB2' ' A' ' 544' ' ' ALA . . . -103.75 1.63 31.96 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -178.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 531' ' ' TRP . . . . . 0.547 ' O ' HG23 ' A' ' 532' ' ' ILE . 0.2 OUTLIER -71.15 30.2 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -179.056 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 532' ' ' ILE . . . . . 0.547 HG23 ' O ' ' A' ' 531' ' ' TRP . 1.1 pt -161.02 75.38 2.57 Favored Pre-proline 0 N--CA 1.456 -0.162 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.471 179.301 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 533' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -36.89 85.98 0.01 OUTLIER 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 123.5 2.8 . . . . 0.0 113.399 -179.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 534' ' ' TYR . . . . . 0.455 ' N ' ' O ' ' A' ' 532' ' ' ILE . 0.6 OUTLIER -96.7 -49.51 5.07 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.269 -179.991 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -57.53 -34.85 69.56 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.548 -179.329 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 143.47 -64.57 0.48 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.566 -0.826 . . . . 0.0 112.531 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -58.72 -165.48 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.622 2.215 . . . . 0.0 111.711 179.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 538' ' ' ALA . . . . . 0.437 ' O ' ' HB3' ' A' ' 539' ' ' ALA . . . -62.13 -51.1 69.24 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.292 179.64 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 539' ' ' ALA . . . . . 0.644 ' C ' ' HB1' ' A' ' 530' ' ' ALA . . . 68.45 -53.72 0.54 Allowed 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.599 179.725 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 540' ' ' GLU . . . . . 0.414 ' O ' ' HB3' ' A' ' 544' ' ' ALA . 0.6 OUTLIER -37.28 -27.98 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.022 -0.99 . . . . 0.0 112.09 -179.416 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 541' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 539' ' ' ALA . . . -124.57 -47.31 0.23 Allowed Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.14 179.155 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 542' ' ' ILE . . . . . 0.514 HG22 ' CE1' ' A' ' 549' ' ' HIS . 2.6 pp -72.65 -22.92 20.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 -179.634 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 543' ' ' TYR . . . . . 0.423 ' C ' ' HB2' ' A' ' 530' ' ' ALA . 89.8 t80 -111.02 -8.05 14.48 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.067 0.461 . . . . 0.0 110.68 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 544' ' ' ALA . . . . . 0.935 ' HB1' ' HA ' ' A' ' 527' ' ' ILE . . . -103.04 -32.86 9.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.02 179.43 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 545' ' ' GLU . . . . . 0.48 ' OE2' HD23 ' A' ' 547' ' ' LEU . 29.3 tp10 -118.49 -32.74 4.52 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.207 -179.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 38.17 37.61 0.48 Allowed Glycine 0 CA--C 1.519 0.326 0 CA-C-N 115.723 -0.672 . . . . 0.0 113.985 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 547' ' ' LEU . . . . . 0.6 HD23 ' H ' ' A' ' 548' ' ' MET . 0.0 OUTLIER -170.58 -61.99 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 117.694 0.747 . . . . 0.0 112.506 179.484 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 548' ' ' MET . . . . . 0.6 ' H ' HD23 ' A' ' 547' ' ' LEU . 0.0 OUTLIER -96.45 11.31 35.38 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.731 0.301 . . . . 0.0 111.124 179.682 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 549' ' ' HIS . . . . . 0.514 ' CE1' HG22 ' A' ' 542' ' ' ILE . 6.0 p-80 -63.43 -10.99 19.76 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.919 179.6 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 550' ' ' ASN . . . . . 0.415 ' O ' ' N ' ' A' ' 552' ' ' ASP . 44.9 m-20 -95.73 -34.25 12.0 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -179.021 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 551' ' ' GLN . . . . . 0.418 ' HG2' ' HG3' ' A' ' 548' ' ' MET . 2.5 pt20 -66.87 71.86 0.09 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.016 0.436 . . . . 0.0 110.55 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 552' ' ' ASP . . . . . 0.462 ' O ' ' HA ' ' A' ' 513' ' ' PRO . 2.6 p30 -93.62 21.95 5.89 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.37 -179.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . 123.9 -31.91 4.38 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.885 -0.674 . . . . 0.0 111.752 -179.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 554' ' ' LEU . . . . . 0.441 HD11 ' OD2' ' A' ' 552' ' ' ASP . 0.5 OUTLIER -59.42 -57.85 11.17 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.493 0.663 . . . . 0.0 110.194 179.017 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 555' ' ' ILE . . . . . 0.648 HG22 ' O ' ' A' ' 555' ' ' ILE . 2.8 mm -72.36 63.77 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 CA-C-N 114.892 -1.049 . . . . 0.0 110.724 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 556' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.475 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.328 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 511' ' ' CYS . . . . . . . . . . . . . 1.5 t . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.947 0.403 . . . . 0.0 111.315 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 512' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -109.76 78.2 1.18 Allowed Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.468 179.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 513' ' ' PRO . . . . . 0.472 ' HA ' ' O ' ' A' ' 552' ' ' ASP . 73.6 Cg_endo -75.89 18.42 0.63 Allowed 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.92 2.414 . . . . 0.0 113.106 -179.494 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -96.7 -34.26 11.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.782 0.325 . . . . 0.0 110.773 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 515' ' ' LEU . . . . . . . . . . . . . 52.6 mt -78.9 75.13 5.41 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.943 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 516' ' ' HIS . . . . . . . . . . . . . 1.3 p-80 -79.87 -7.23 58.61 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.677 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 517' ' ' TYR . . . . . 0.442 ' HB2' ' CE3' ' A' ' 518' ' ' TRP . 44.5 m-85 -77.79 -59.9 2.59 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.783 0.325 . . . . 0.0 111.309 -179.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 518' ' ' TRP . . . . . 0.55 ' O ' ' N ' ' A' ' 520' ' ' THR . 13.9 m-90 -91.17 4.68 51.62 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.793 -179.618 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 519' ' ' THR . . . . . 0.534 ' OG1' ' N ' ' A' ' 520' ' ' THR . 1.3 p 54.42 -76.6 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 116.851 -0.159 . . . . 0.0 110.986 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 520' ' ' THR . . . . . 0.55 ' N ' ' O ' ' A' ' 518' ' ' TRP . 1.2 m 176.98 -62.47 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.231 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 179.436 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 521' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.81 -12.37 61.57 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.418 178.103 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 522' ' ' ASP . . . . . 0.462 ' HA ' ' CG2' ' A' ' 527' ' ' ILE . 1.1 m-20 -93.93 -11.2 31.49 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.939 179.294 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 523' ' ' GLU . . . . . 0.403 ' HA ' ' HB3' ' A' ' 518' ' ' TRP . 16.8 pt-20 -45.52 -27.56 0.76 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.474 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 524' ' ' GLY . . . . . 0.428 ' HA2' ' CG1' ' A' ' 527' ' ' ILE . . . 144.99 42.45 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.508 -0.854 . . . . 0.0 112.229 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -101.32 -60.31 1.55 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.713 0.292 . . . . 0.0 111.706 -179.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -131.8 38.43 3.55 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-O 121.521 0.677 . . . . 0.0 110.036 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 527' ' ' ILE . . . . . 0.893 ' HA ' ' HB1' ' A' ' 544' ' ' ALA . 2.1 pp -95.8 -0.5 10.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 114.719 -1.128 . . . . 0.0 112.775 -178.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 528' ' ' GLY . . . . . 0.538 ' N ' HD12 ' A' ' 527' ' ' ILE . . . -57.71 -14.31 14.94 Favored Glycine 0 CA--C 1.521 0.452 0 C-N-CA 120.762 -0.733 . . . . 0.0 114.005 -179.362 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 529' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -98.74 -33.66 10.83 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 117.666 0.733 . . . . 0.0 111.909 -179.334 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 530' ' ' ALA . . . . . 0.945 ' HB3' ' HB2' ' A' ' 544' ' ' ALA . . . -103.85 1.96 32.11 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -178.604 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 531' ' ' TRP . . . . . 0.512 ' O ' HG23 ' A' ' 532' ' ' ILE . 57.3 t-105 -68.43 30.09 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.546 0.573 . . . . 0.0 112.546 -178.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 532' ' ' ILE . . . . . 0.512 HG23 ' O ' ' A' ' 531' ' ' TRP . 1.1 pt -160.2 71.9 3.04 Favored Pre-proline 0 C--N 1.331 -0.207 0 CA-C-O 120.827 0.346 . . . . 0.0 110.742 179.037 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 533' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_endo -47.11 88.43 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 123.148 2.565 . . . . 0.0 112.821 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 534' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -96.43 -43.6 7.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.283 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -57.75 -34.78 69.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.552 -179.341 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 149.13 -64.77 0.4 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.529 -0.843 . . . . 0.0 112.579 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_endo -57.3 -164.09 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.576 2.184 . . . . 0.0 111.8 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 538' ' ' ALA . . . . . 0.498 ' O ' ' HB3' ' A' ' 539' ' ' ALA . . . -72.03 -47.2 53.45 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.619 179.655 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 539' ' ' ALA . . . . . 0.665 ' C ' ' HB1' ' A' ' 530' ' ' ALA . . . 70.7 -53.73 0.66 Allowed 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.33 0.586 . . . . 0.0 111.227 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 540' ' ' GLU . . . . . 0.508 ' HG2' ' HA ' ' A' ' 531' ' ' TRP . 15.6 mt-10 -37.26 -28.17 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.543 0 CA-C-N 114.828 -1.078 . . . . 0.0 112.37 -179.442 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 541' ' ' GLY . . . . . 0.447 ' HA3' ' CD2' ' A' ' 549' ' ' HIS . . . -126.24 -40.17 0.38 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.388 179.51 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 542' ' ' ILE . . . . . 0.676 HG23 ' ND1' ' A' ' 549' ' ' HIS . 2.6 pp -79.88 -23.16 11.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 112.122 0.415 . . . . 0.0 112.122 -179.406 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 543' ' ' TYR . . . . . 0.434 ' C ' ' HB2' ' A' ' 530' ' ' ALA . 89.0 t80 -111.48 -7.79 14.31 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.042 0.449 . . . . 0.0 110.613 179.63 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 544' ' ' ALA . . . . . 0.945 ' HB2' ' HB3' ' A' ' 530' ' ' ALA . . . -103.06 -36.91 7.98 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.381 179.181 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 545' ' ' GLU . . . . . 0.495 ' CG ' ' H ' ' A' ' 548' ' ' MET . 20.2 tp10 -118.91 -32.57 4.45 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.099 -0.955 . . . . 0.0 111.1 179.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 37.09 47.58 1.38 Allowed Glycine 0 C--N 1.331 0.285 0 CA-C-N 115.992 -0.549 . . . . 0.0 113.387 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 547' ' ' LEU . . . . . 0.689 ' HG ' ' N ' ' A' ' 548' ' ' MET . 0.0 OUTLIER -174.87 -57.55 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 117.276 0.538 . . . . 0.0 111.834 179.949 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 548' ' ' MET . . . . . 0.689 ' N ' ' HG ' ' A' ' 547' ' ' LEU . 0.0 OUTLIER -96.0 11.49 33.85 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.644 0.259 . . . . 0.0 111.344 -179.999 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 549' ' ' HIS . . . . . 0.676 ' ND1' HG23 ' A' ' 542' ' ' ILE . 12.8 t-80 -62.59 -11.82 19.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.817 0.341 . . . . 0.0 110.629 179.431 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 550' ' ' ASN . . . . . 0.477 ' O ' ' N ' ' A' ' 552' ' ' ASP . 32.7 m-20 -96.22 -39.74 9.52 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.629 -179.531 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 551' ' ' GLN . . . . . 0.437 ' HG3' ' O ' ' A' ' 548' ' ' MET . 1.5 pt20 -61.81 73.93 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.228 0.537 . . . . 0.0 110.843 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 552' ' ' ASP . . . . . 0.509 ' HA ' ' O ' ' A' ' 519' ' ' THR . 1.6 p30 -83.78 22.24 1.15 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.541 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . 124.25 -26.75 5.73 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 121.01 -0.614 . . . . 0.0 111.62 -179.131 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 554' ' ' LEU . . . . . 0.404 HD11 ' OD1' ' A' ' 552' ' ' ASP . 0.7 OUTLIER -59.23 -53.32 59.65 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.438 0.637 . . . . 0.0 110.117 178.971 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 555' ' ' ILE . . . . . 0.647 HG22 ' O ' ' A' ' 555' ' ' ILE . 8.1 mm -84.59 54.02 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 CA-C-N 114.945 -1.025 . . . . 0.0 111.111 -179.596 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 556' ' ' CYS . . . . . . . . . . . . . 8.0 p . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.392 179.953 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 511' ' ' CYS . . . . . . . . . . . . . 2.5 m . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.938 0.399 . . . . 0.0 111.611 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 512' ' ' ASN . . . . . 0.416 ' O ' ' O ' ' A' ' 552' ' ' ASP . 0.5 OUTLIER -118.05 81.73 16.63 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.351 179.653 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 513' ' ' PRO . . . . . 0.525 ' HA ' ' O ' ' A' ' 552' ' ' ASP . 64.4 Cg_endo -75.21 18.78 0.54 Allowed 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 123.0 2.467 . . . . 0.0 113.235 -179.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 24.2 t30 -96.71 -34.17 11.46 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.873 0.368 . . . . 0.0 110.859 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 515' ' ' LEU . . . . . . . . . . . . . 2.7 mt -84.68 74.07 10.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.006 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 516' ' ' HIS . . . . . 0.448 ' HA ' ' CB ' ' A' ' 552' ' ' ASP . 14.2 t60 -71.47 -8.4 53.65 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.91 -179.726 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 517' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -82.26 -62.5 1.61 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.712 0.291 . . . . 0.0 111.629 -179.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 518' ' ' TRP . . . . . 0.506 ' O ' ' N ' ' A' ' 520' ' ' THR . 14.4 m-90 -71.39 -17.86 62.39 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.661 -179.467 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 519' ' ' THR . . . . . 0.508 ' OG1' ' N ' ' A' ' 520' ' ' THR . 1.8 p 54.04 -80.29 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 116.621 -0.263 . . . . 0.0 110.919 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 520' ' ' THR . . . . . 0.508 ' N ' ' OG1' ' A' ' 519' ' ' THR . 1.2 m 177.71 -62.85 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 179.065 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 521' ' ' GLN . . . . . 0.435 ' HB2' ' HB3' ' A' ' 548' ' ' MET . 0.7 OUTLIER -72.64 -11.69 60.74 Favored 'General case' 0 CA--C 1.513 -0.45 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 177.989 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 522' ' ' ASP . . . . . 0.475 ' HA ' ' CG2' ' A' ' 527' ' ' ILE . 2.4 m-20 -87.47 -11.04 50.17 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.745 179.146 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -45.2 -26.6 0.51 Allowed 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.902 -179.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 524' ' ' GLY . . . . . 0.46 ' HA2' ' CG1' ' A' ' 527' ' ' ILE . . . 148.51 40.52 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.458 -0.877 . . . . 0.0 112.386 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -98.21 -59.65 1.71 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.806 0.336 . . . . 0.0 111.892 -179.476 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -133.59 32.44 3.6 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.577 0.703 . . . . 0.0 110.018 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 527' ' ' ILE . . . . . 0.866 ' HA ' ' HB1' ' A' ' 544' ' ' ALA . 2.3 pp -95.86 -0.56 10.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 114.593 -1.185 . . . . 0.0 112.644 -178.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 528' ' ' GLY . . . . . 0.473 ' N ' HD12 ' A' ' 527' ' ' ILE . . . -58.88 -4.57 2.3 Favored Glycine 0 CA--C 1.522 0.52 0 N-CA-C 114.696 0.638 . . . . 0.0 114.696 -178.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 529' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -98.2 -42.24 7.52 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 118.031 0.915 . . . . 0.0 111.672 -179.59 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 530' ' ' ALA . . . . . 1.082 ' HB3' ' HB2' ' A' ' 544' ' ' ALA . . . -103.85 1.99 32.14 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.354 0.502 . . . . 0.0 112.354 -179.239 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 531' ' ' TRP . . . . . 0.66 ' CD2' HD13 ' A' ' 527' ' ' ILE . 22.5 t-105 -54.83 -9.27 0.33 Allowed 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 112.893 0.701 . . . . 0.0 112.893 -178.134 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 532' ' ' ILE . . . . . 0.72 ' O ' HD12 ' A' ' 532' ' ' ILE . 1.6 pp -135.34 76.23 56.89 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-O 121.039 0.447 . . . . 0.0 111.05 179.313 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 533' ' ' PRO . . . . . 0.532 ' HG3' ' HB3' ' A' ' 539' ' ' ALA . 32.4 Cg_exo -63.29 89.51 0.13 Allowed 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 123.058 2.506 . . . . 0.0 112.591 -179.586 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 534' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -60.52 -54.35 46.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.993 0.425 . . . . 0.0 110.151 179.415 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -118.18 22.99 11.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.702 179.361 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . -122.34 153.1 16.84 Favored Glycine 0 C--N 1.333 0.377 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.736 -179.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -71.28 -89.47 0.0 OUTLIER 'Trans proline' 0 CA--C 1.534 0.503 0 C-N-CA 122.714 2.276 . . . . 0.0 112.834 -179.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 538' ' ' ALA . . . . . . . . . . . . . . . -99.29 17.11 20.89 Favored 'General case' 0 C--N 1.333 -0.114 0 N-CA-C 111.534 0.198 . . . . 0.0 111.534 -179.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 539' ' ' ALA . . . . . 0.565 ' HA ' HD12 ' A' ' 542' ' ' ILE . . . -34.12 -43.8 0.16 Allowed 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 -179.395 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 540' ' ' GLU . . . . . 0.468 ' CB ' ' HA ' ' A' ' 531' ' ' TRP . 0.0 OUTLIER -60.1 -6.84 1.53 Allowed 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -178.579 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 541' ' ' GLY . . . . . . . . . . . . . . . -125.62 -40.6 0.38 Allowed Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 121.026 -0.607 . . . . 0.0 111.919 178.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 542' ' ' ILE . . . . . 0.565 HD12 ' HA ' ' A' ' 539' ' ' ALA . 2.1 pp -97.26 -19.36 6.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -179.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 543' ' ' TYR . . . . . 0.445 ' HB3' ' HB1' ' A' ' 539' ' ' ALA . 29.4 t80 -108.85 -16.3 14.19 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.048 0.452 . . . . 0.0 110.65 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 544' ' ' ALA . . . . . 1.082 ' HB2' ' HB3' ' A' ' 530' ' ' ALA . . . -91.2 -16.81 27.08 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.604 179.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 545' ' ' GLU . . . . . 0.522 ' OE2' HD23 ' A' ' 547' ' ' LEU . 5.4 tp10 -118.44 -32.82 4.51 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.343 -179.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 35.84 41.35 0.42 Allowed Glycine 0 CA--C 1.521 0.412 0 CA-C-N 115.841 -0.618 . . . . 0.0 114.133 179.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 547' ' ' LEU . . . . . 0.621 HD23 ' H ' ' A' ' 548' ' ' MET . 0.0 OUTLIER -172.45 -62.11 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 117.615 0.708 . . . . 0.0 112.084 179.401 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 548' ' ' MET . . . . . 0.621 ' H ' HD23 ' A' ' 547' ' ' LEU . 0.0 OUTLIER -96.32 11.6 34.11 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.06 0.457 . . . . 0.0 110.378 179.02 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 549' ' ' HIS . . . . . 0.49 ' CB ' ' HA ' ' A' ' 542' ' ' ILE . 0.3 OUTLIER -59.53 -11.3 4.43 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.323 179.744 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 550' ' ' ASN . . . . . 0.503 ' O ' ' N ' ' A' ' 552' ' ' ASP . 45.5 t30 -94.54 -34.22 12.75 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -178.461 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 551' ' ' GLN . . . . . 0.411 ' HG3' ' O ' ' A' ' 548' ' ' MET . 0.9 OUTLIER -64.25 70.95 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.131 0.491 . . . . 0.0 110.4 -179.907 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 552' ' ' ASP . . . . . 0.525 ' O ' ' HA ' ' A' ' 513' ' ' PRO . 2.9 p30 -101.69 21.91 13.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.513 -179.319 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . 123.69 -31.73 4.48 Favored Glycine 0 N--CA 1.449 -0.461 0 N-CA-C 111.47 -0.652 . . . . 0.0 111.47 -179.25 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 554' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -62.58 -49.1 76.58 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.493 0.663 . . . . 0.0 109.648 178.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 555' ' ' ILE . . . . . 0.639 HG22 ' O ' ' A' ' 555' ' ' ILE . 6.0 mm -88.63 60.62 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 CA-C-N 114.789 -1.096 . . . . 0.0 110.659 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 556' ' ' CYS . . . . . . . . . . . . . 20.1 m . . . . . 0 C--N 1.326 -0.443 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.38 -179.781 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 511' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.11 0 CA-C-O 121.152 0.501 . . . . 0.0 111.222 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 512' ' ' ASN . . . . . 0.556 ' HB3' HD23 ' A' ' 515' ' ' LEU . 34.3 m-20 -156.15 79.6 4.03 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.056 179.61 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 513' ' ' PRO . . . . . 0.434 ' HA ' ' O ' ' A' ' 552' ' ' ASP . 26.0 Cg_exo -61.5 -15.83 43.74 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 123.056 2.504 . . . . 0.0 112.479 -179.567 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 22.6 t30 -57.47 -43.52 84.09 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.29 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 515' ' ' LEU . . . . . 0.556 HD23 ' HB3' ' A' ' 512' ' ' ASN . 0.8 OUTLIER -81.18 73.82 8.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.822 0.344 . . . . 0.0 111.065 -179.905 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 516' ' ' HIS . . . . . 0.491 ' CE1' ' CE1' ' A' ' 517' ' ' TYR . 19.1 p80 -89.25 -7.25 55.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.622 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 517' ' ' TYR . . . . . 0.491 ' CE1' ' CE1' ' A' ' 516' ' ' HIS . 43.1 m-85 -74.93 -30.85 61.36 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 111.702 0.26 . . . . 0.0 111.702 -179.525 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 518' ' ' TRP . . . . . 0.582 ' O ' ' N ' ' A' ' 520' ' ' THR . 8.5 m-90 -117.92 -0.03 11.79 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 -179.504 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 519' ' ' THR . . . . . 0.561 ' OG1' ' N ' ' A' ' 520' ' ' THR . 1.2 p 49.38 -78.37 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 120.485 0.183 . . . . 0.0 111.405 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 520' ' ' THR . . . . . 0.582 ' N ' ' O ' ' A' ' 518' ' ' TRP . 1.3 m -179.15 -62.45 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 179.519 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 521' ' ' GLN . . . . . . . . . . . . . 8.2 mt-30 -72.78 -11.87 60.78 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.32 177.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 522' ' ' ASP . . . . . 0.446 ' HB2' ' O ' ' A' ' 518' ' ' TRP . 68.8 m-20 -91.63 -10.71 39.41 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.81 179.128 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 523' ' ' GLU . . . . . 0.4 ' HA ' ' CD1' ' A' ' 518' ' ' TRP . 0.0 OUTLIER -45.26 -26.71 0.54 Allowed 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.48 -179.72 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . 146.53 41.47 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.356 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -100.66 -60.95 1.43 Allowed 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 111.785 0.291 . . . . 0.0 111.785 -179.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -131.96 38.17 3.55 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-O 121.549 0.69 . . . . 0.0 110.132 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 527' ' ' ILE . . . . . 0.894 ' HA ' ' HB1' ' A' ' 544' ' ' ALA . 2.1 pp -95.79 -2.51 10.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 114.746 -1.116 . . . . 0.0 112.844 -178.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 528' ' ' GLY . . . . . 0.579 ' N ' HD12 ' A' ' 527' ' ' ILE . . . -56.47 -16.59 16.1 Favored Glycine 0 CA--C 1.52 0.403 0 C-N-CA 120.791 -0.719 . . . . 0.0 114.028 -179.1 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 529' ' ' LEU . . . . . 0.489 ' H ' ' HG ' ' A' ' 529' ' ' LEU . 0.7 OUTLIER -99.21 -32.82 11.02 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 117.809 0.805 . . . . 0.0 112.292 -179.394 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 530' ' ' ALA . . . . . 0.976 ' HB3' ' HB2' ' A' ' 544' ' ' ALA . . . -103.82 1.52 31.66 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -179.022 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 531' ' ' TRP . . . . . 0.467 ' O ' HG23 ' A' ' 532' ' ' ILE . 55.5 t90 -73.48 30.33 0.07 Allowed 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -179.299 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 532' ' ' ILE . . . . . 0.467 HG23 ' O ' ' A' ' 531' ' ' TRP . 1.1 pt -158.26 77.41 3.44 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-O 120.739 0.304 . . . . 0.0 110.888 179.425 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 533' ' ' PRO . . . . . 0.4 ' HG3' ' O ' ' A' ' 538' ' ' ALA . 79.6 Cg_exo -41.74 88.14 0.01 OUTLIER 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 123.045 2.497 . . . . 0.0 112.956 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 534' ' ' TYR . . . . . 0.437 ' N ' ' O ' ' A' ' 532' ' ' ILE . 12.5 t80 -96.51 -51.98 4.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.483 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -57.73 -34.84 69.93 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.635 -179.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 144.89 -64.18 0.46 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.506 -0.854 . . . . 0.0 112.597 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -55.29 -168.88 0.02 OUTLIER 'Trans proline' 0 CA--C 1.515 -0.457 0 C-N-CA 122.606 2.204 . . . . 0.0 111.906 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 538' ' ' ALA . . . . . 0.425 ' O ' ' HB3' ' A' ' 539' ' ' ALA . . . -63.93 -53.47 49.9 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.199 179.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 539' ' ' ALA . . . . . 0.6 ' O ' ' HB1' ' A' ' 530' ' ' ALA . . . 67.81 -49.93 0.52 Allowed 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.995 179.5 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 540' ' ' GLU . . . . . 0.433 ' O ' ' HB3' ' A' ' 544' ' ' ALA . 0.2 OUTLIER -37.6 -27.0 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.927 -1.033 . . . . 0.0 112.414 -179.275 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 541' ' ' GLY . . . . . 0.411 ' N ' ' O ' ' A' ' 539' ' ' ALA . . . -125.94 -43.6 0.27 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.755 -0.736 . . . . 0.0 111.889 179.129 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 542' ' ' ILE . . . . . 0.615 HG22 ' CE1' ' A' ' 549' ' ' HIS . 1.0 OUTLIER -69.93 -25.91 29.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 112.363 0.505 . . . . 0.0 112.363 -179.713 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 543' ' ' TYR . . . . . 0.451 ' C ' ' HB2' ' A' ' 530' ' ' ALA . 0.1 OUTLIER -111.69 -9.27 14.14 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.903 0.382 . . . . 0.0 110.784 179.988 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 544' ' ' ALA . . . . . 0.976 ' HB2' ' HB3' ' A' ' 530' ' ' ALA . . . -100.52 -33.67 10.24 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.84 179.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 545' ' ' GLU . . . . . 0.504 ' HG3' ' H ' ' A' ' 548' ' ' MET . 37.6 tp10 -118.86 -32.77 4.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.316 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 39.3 39.82 1.16 Allowed Glycine 0 CA--C 1.519 0.304 0 CA-C-N 115.732 -0.667 . . . . 0.0 113.976 179.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 547' ' ' LEU . . . . . 0.616 HD23 ' H ' ' A' ' 548' ' ' MET . 0.0 OUTLIER -173.24 -61.76 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 117.702 0.751 . . . . 0.0 112.303 179.43 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 548' ' ' MET . . . . . 0.616 ' H ' HD23 ' A' ' 547' ' ' LEU . 0.0 OUTLIER -96.32 11.51 34.4 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.7 0.286 . . . . 0.0 111.084 179.559 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 549' ' ' HIS . . . . . 0.615 ' CE1' HG22 ' A' ' 542' ' ' ILE . 9.8 p80 -61.12 -11.56 9.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.85 0.357 . . . . 0.0 111.013 179.462 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 550' ' ' ASN . . . . . . . . . . . . . 48.5 m-20 -96.09 -30.79 13.35 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -179.083 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 551' ' ' GLN . . . . . 0.403 ' HG2' ' HG3' ' A' ' 548' ' ' MET . 2.7 pt20 -68.08 70.95 0.16 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.038 0.447 . . . . 0.0 110.696 -179.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 552' ' ' ASP . . . . . 0.44 ' HB2' ' HA ' ' A' ' 516' ' ' HIS . 1.9 p30 -94.95 21.82 7.21 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.244 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . 123.83 -27.91 5.56 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.856 -0.688 . . . . 0.0 111.629 -179.259 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 554' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -61.93 -55.32 30.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.567 0.698 . . . . 0.0 110.034 179.067 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 555' ' ' ILE . . . . . 0.627 HG22 ' O ' ' A' ' 555' ' ' ILE . 1.8 mm -71.66 66.94 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 114.78 -1.1 . . . . 0.0 110.421 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 556' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.323 -0.571 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.742 -179.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 511' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.53 0.192 0 CA-C-O 120.912 0.387 . . . . 0.0 111.44 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 512' ' ' ASN . . . . . . . . . . . . . 35.1 m-20 -120.53 79.99 30.16 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.652 179.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 513' ' ' PRO . . . . . 0.461 ' HA ' ' O ' ' A' ' 552' ' ' ASP . 42.7 Cg_endo -68.18 -10.23 28.28 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.651 2.234 . . . . 0.0 112.56 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 39.7 t30 -74.62 -29.98 61.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.08 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 515' ' ' LEU . . . . . . . . . . . . . 65.5 mt -84.94 74.6 10.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.886 0.374 . . . . 0.0 110.93 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 516' ' ' HIS . . . . . 0.436 ' HA ' ' HB3' ' A' ' 552' ' ' ASP . 1.9 p-80 -89.09 -7.13 56.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.582 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 517' ' ' TYR . . . . . . . . . . . . . 31.2 m-85 -70.65 -50.79 33.05 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.69 0.281 . . . . 0.0 111.638 -179.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 518' ' ' TRP . . . . . 0.494 ' O ' ' N ' ' A' ' 520' ' ' THR . 24.1 m-90 -112.56 10.04 19.52 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 111.914 0.338 . . . . 0.0 111.914 -179.644 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 519' ' ' THR . . . . . 0.56 HG21 ' O ' ' A' ' 549' ' ' HIS . 1.1 p 60.88 -70.13 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 116.65 -0.25 . . . . 0.0 110.915 179.627 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 520' ' ' THR . . . . . 0.494 ' N ' ' O ' ' A' ' 518' ' ' TRP . 1.0 OUTLIER 174.95 -62.82 0.01 OUTLIER 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.152 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 521' ' ' GLN . . . . . 0.507 ' HB3' ' OE1' ' A' ' 545' ' ' GLU . 0.7 OUTLIER -73.36 -11.95 60.66 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 178.188 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 522' ' ' ASP . . . . . 0.427 ' HB3' ' O ' ' A' ' 518' ' ' TRP . 0.6 OUTLIER -91.93 -10.97 37.57 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.912 179.1 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -45.07 -27.5 0.58 Allowed 'General case' 0 CA--C 1.528 0.107 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.304 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . 151.41 41.24 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.852 -0.69 . . . . 0.0 112.144 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -122.2 -20.33 6.24 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 526' ' ' ALA . . . . . 0.657 ' O ' ' HB1' ' A' ' 544' ' ' ALA . . . -143.79 30.25 1.34 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.254 0.55 . . . . 0.0 110.903 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 527' ' ' ILE . . . . . 0.827 HD12 ' N ' ' A' ' 528' ' ' GLY . 2.3 pp -95.64 -24.72 4.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.934 -179.562 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 528' ' ' GLY . . . . . 0.827 ' N ' HD12 ' A' ' 527' ' ' ILE . . . -49.47 -13.23 0.43 Allowed Glycine 0 CA--C 1.523 0.575 0 C-N-CA 121.154 -0.545 . . . . 0.0 114.369 -179.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 529' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -98.03 -47.83 5.36 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 117.864 0.832 . . . . 0.0 111.863 -179.168 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 530' ' ' ALA . . . . . 1.059 ' HB3' ' HB2' ' A' ' 544' ' ' ALA . . . -103.69 1.93 32.49 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 -178.437 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 531' ' ' TRP . . . . . 0.56 ' HB2' ' O ' ' A' ' 527' ' ' ILE . 58.8 t90 -68.85 30.53 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -179.074 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 532' ' ' ILE . . . . . 0.605 ' O ' HD12 ' A' ' 532' ' ' ILE . 1.3 pp -156.76 69.48 4.63 Favored Pre-proline 0 CA--C 1.53 0.182 0 CA-C-O 120.8 0.334 . . . . 0.0 110.91 179.357 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 533' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -52.8 105.15 0.11 Allowed 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.673 2.249 . . . . 0.0 111.875 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 534' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -96.08 -55.31 3.01 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 111.984 0.364 . . . . 0.0 111.984 -179.258 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -118.77 -35.02 3.79 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -179.338 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . -85.08 -175.24 50.57 Favored Glycine 0 CA--C 1.518 0.233 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.979 -179.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_endo -56.81 -159.09 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.884 2.389 . . . . 0.0 111.874 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 538' ' ' ALA . . . . . 0.517 ' O ' ' HB3' ' A' ' 539' ' ' ALA . . . -43.87 -48.76 8.42 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.55 -0.296 . . . . 0.0 111.349 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 539' ' ' ALA . . . . . 0.543 ' HA ' ' CD1' ' A' ' 542' ' ' ILE . . . 72.13 -49.3 0.69 Allowed 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.256 0.551 . . . . 0.0 111.482 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 540' ' ' GLU . . . . . 0.437 ' HG2' ' HA ' ' A' ' 531' ' ' TRP . 3.1 mt-10 -36.84 -31.45 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.863 -1.062 . . . . 0.0 112.494 -179.192 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 541' ' ' GLY . . . . . 0.433 ' O ' ' HB3' ' A' ' 549' ' ' HIS . . . -130.89 -18.95 1.32 Allowed Glycine 0 CA--C 1.52 0.369 0 C-N-CA 120.198 -1.001 . . . . 0.0 113.617 -179.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 542' ' ' ILE . . . . . 0.597 HG22 ' HD2' ' A' ' 549' ' ' HIS . 2.6 pp -96.25 -22.45 5.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 117.148 0.474 . . . . 0.0 112.251 -179.514 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 543' ' ' TYR . . . . . 0.516 ' HB2' ' HA ' ' A' ' 539' ' ' ALA . 0.2 OUTLIER -115.32 -12.08 11.83 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.966 0.412 . . . . 0.0 110.847 179.444 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 544' ' ' ALA . . . . . 1.059 ' HB2' ' HB3' ' A' ' 530' ' ' ALA . . . -92.02 -26.32 18.41 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.216 179.532 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 545' ' ' GLU . . . . . 0.7 ' OE2' HD23 ' A' ' 547' ' ' LEU . 19.7 tp10 -113.09 -33.41 6.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.773 -179.162 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 35.02 34.12 0.04 OUTLIER Glycine 0 CA--C 1.519 0.307 0 CA-C-N 115.776 -0.647 . . . . 0.0 114.259 179.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 547' ' ' LEU . . . . . 0.7 HD23 ' OE2' ' A' ' 545' ' ' GLU . 0.0 OUTLIER -176.41 -61.41 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 118.008 0.904 . . . . 0.0 112.695 -179.993 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 548' ' ' MET . . . . . 0.608 ' H ' HD23 ' A' ' 547' ' ' LEU . 0.4 OUTLIER -89.62 11.7 18.97 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.754 0.312 . . . . 0.0 110.935 179.733 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 549' ' ' HIS . . . . . 0.597 ' HD2' HG22 ' A' ' 542' ' ' ILE . 0.2 OUTLIER -64.88 -12.08 44.87 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.972 0.415 . . . . 0.0 110.62 179.588 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 550' ' ' ASN . . . . . 0.419 ' O ' ' N ' ' A' ' 552' ' ' ASP . 4.2 m120 -96.92 -35.48 10.87 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -179.022 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 551' ' ' GLN . . . . . 0.578 ' HG3' ' O ' ' A' ' 548' ' ' MET . 0.0 OUTLIER -66.37 72.59 0.08 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.044 0.449 . . . . 0.0 110.639 -179.515 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 552' ' ' ASP . . . . . 0.51 ' HA ' ' HA ' ' A' ' 519' ' ' THR . 3.0 m-20 -87.27 21.63 2.36 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.149 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . 114.26 -29.1 7.86 Favored Glycine 0 N--CA 1.451 -0.339 0 N-CA-C 111.315 -0.714 . . . . 0.0 111.315 -179.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 554' ' ' LEU . . . . . 0.404 HD11 ' HB2' ' A' ' 552' ' ' ASP . 0.4 OUTLIER -63.16 -57.49 10.37 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.635 0.731 . . . . 0.0 110.054 179.182 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 555' ' ' ILE . . . . . 0.633 HG22 ' O ' ' A' ' 555' ' ' ILE . 2.8 mm -71.54 65.0 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 CA-C-N 114.695 -1.139 . . . . 0.0 110.815 -179.762 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 556' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.325 -0.5 0 CA-C-N 115.56 -0.746 . . . . 0.0 111.232 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 511' ' ' CYS . . . . . . . . . . . . . 6.7 m . . . . . 0 CA--C 1.527 0.08 0 CA-C-O 120.92 0.39 . . . . 0.0 111.53 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 512' ' ' ASN . . . . . . . . . . . . . 24.3 t30 -113.36 81.73 5.37 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.451 179.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 513' ' ' PRO . . . . . 0.515 ' HA ' ' O ' ' A' ' 552' ' ' ASP . 73.0 Cg_endo -76.01 18.95 0.61 Allowed 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.989 2.459 . . . . 0.0 113.293 -179.584 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -96.72 -28.96 14.06 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.705 0.288 . . . . 0.0 111.024 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 515' ' ' LEU . . . . . . . . . . . . . 70.0 mt -84.22 74.54 10.29 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.899 0.38 . . . . 0.0 110.946 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 516' ' ' HIS . . . . . 0.435 ' HA ' ' CB ' ' A' ' 552' ' ' ASP . 68.0 m-70 -70.14 -23.75 63.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.507 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 517' ' ' TYR . . . . . . . . . . . . . 50.3 m-85 -73.62 -64.18 1.05 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.711 0.291 . . . . 0.0 111.637 -179.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 518' ' ' TRP . . . . . 0.476 ' O ' ' N ' ' A' ' 520' ' ' THR . 27.3 m-90 -69.82 -17.65 63.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.844 -179.422 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 519' ' ' THR . . . . . 0.548 ' OG1' ' N ' ' A' ' 520' ' ' THR . 2.1 p 57.83 -79.78 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 120.518 0.199 . . . . 0.0 110.519 -179.707 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 520' ' ' THR . . . . . 0.548 ' N ' ' OG1' ' A' ' 519' ' ' THR . 1.2 m 177.67 -62.61 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 179.195 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 521' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -71.68 -13.87 61.87 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 177.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 522' ' ' ASP . . . . . 0.458 ' HA ' ' CG2' ' A' ' 527' ' ' ILE . 2.8 m-20 -94.04 -11.11 31.43 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.88 179.044 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -45.51 -27.48 0.75 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.456 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 524' ' ' GLY . . . . . 0.418 ' HA2' ' CG1' ' A' ' 527' ' ' ILE . . . 146.21 42.11 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.55 -0.833 . . . . 0.0 112.313 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -101.51 -60.16 1.58 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.736 0.303 . . . . 0.0 111.775 -179.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -132.15 38.65 3.48 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-O 121.503 0.668 . . . . 0.0 110.049 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 527' ' ' ILE . . . . . 0.954 ' HA ' ' HB1' ' A' ' 544' ' ' ALA . 2.1 pp -95.83 -0.25 10.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 114.663 -1.153 . . . . 0.0 112.71 -178.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 528' ' ' GLY . . . . . 0.51 ' N ' HD12 ' A' ' 527' ' ' ILE . . . -53.26 -14.8 3.36 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 114.535 0.574 . . . . 0.0 114.535 -178.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 529' ' ' LEU . . . . . 0.788 HD13 ' N ' ' A' ' 529' ' ' LEU . 0.0 OUTLIER -98.66 -33.98 10.74 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 118.055 0.927 . . . . 0.0 111.609 -179.57 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 530' ' ' ALA . . . . . 0.918 ' HB3' ' HB2' ' A' ' 544' ' ' ALA . . . -103.71 1.17 31.47 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -179.308 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 531' ' ' TRP . . . . . 0.47 ' HA ' ' HG2' ' A' ' 540' ' ' GLU . 9.9 t90 -56.28 -12.33 1.56 Allowed 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -179.14 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 532' ' ' ILE . . . . . 0.731 ' O ' HD12 ' A' ' 532' ' ' ILE . 1.7 pp -133.14 73.95 73.91 Favored Pre-proline 0 N--CA 1.452 -0.373 0 CA-C-O 121.06 0.457 . . . . 0.0 111.327 179.703 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 533' ' ' PRO . . . . . 0.435 ' HB3' ' O ' ' A' ' 538' ' ' ALA . 1.7 Cg_endo -45.73 92.29 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 123.037 2.492 . . . . 0.0 112.671 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 534' ' ' TYR . . . . . . . . . . . . . 47.4 p90 -96.31 -25.4 15.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.116 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -69.75 -34.78 74.28 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.399 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 147.87 -64.09 0.42 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.822 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -59.36 -164.72 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.605 2.203 . . . . 0.0 112.033 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 538' ' ' ALA . . . . . 0.46 ' O ' ' HB3' ' A' ' 539' ' ' ALA . . . -69.3 -47.45 64.48 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.726 179.743 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 539' ' ' ALA . . . . . 0.715 ' C ' ' HB1' ' A' ' 530' ' ' ALA . . . 69.17 -53.94 0.58 Allowed 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.306 0.574 . . . . 0.0 111.45 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 540' ' ' GLU . . . . . 0.522 ' O ' ' HB3' ' A' ' 544' ' ' ALA . 10.6 mt-10 -37.57 -27.59 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.895 -1.048 . . . . 0.0 112.121 -179.541 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 541' ' ' GLY . . . . . 0.433 ' O ' ' HB3' ' A' ' 549' ' ' HIS . . . -124.76 -46.85 0.24 Allowed Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.136 179.069 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 542' ' ' ILE . . . . . 0.604 HG22 ' CE1' ' A' ' 549' ' ' HIS . 2.6 pp -73.47 -24.59 20.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 -179.367 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 543' ' ' TYR . . . . . 0.524 ' HB2' HD12 ' A' ' 542' ' ' ILE . 6.5 t80 -114.11 -7.72 13.04 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.878 0.37 . . . . 0.0 110.963 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 544' ' ' ALA . . . . . 0.954 ' HB1' ' HA ' ' A' ' 527' ' ' ILE . . . -103.14 -33.89 9.06 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 121.22 0.534 . . . . 0.0 109.948 179.362 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 545' ' ' GLU . . . . . 0.515 ' HG3' ' H ' ' A' ' 548' ' ' MET . 23.1 tp10 -118.56 -32.66 4.52 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.272 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 37.68 43.42 1.18 Allowed Glycine 0 CA--C 1.52 0.376 0 CA-C-N 115.931 -0.577 . . . . 0.0 113.771 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 547' ' ' LEU . . . . . 0.568 ' HG ' ' N ' ' A' ' 548' ' ' MET . 0.0 OUTLIER -172.94 -61.23 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 117.362 0.581 . . . . 0.0 111.874 179.628 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 548' ' ' MET . . . . . 0.568 ' N ' ' HG ' ' A' ' 547' ' ' LEU . 0.0 OUTLIER -96.03 11.59 33.54 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.672 0.272 . . . . 0.0 111.209 179.68 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 549' ' ' HIS . . . . . 0.604 ' CE1' HG22 ' A' ' 542' ' ' ILE . 10.0 p80 -61.49 -11.35 10.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.695 0.283 . . . . 0.0 110.904 179.372 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 550' ' ' ASN . . . . . 0.442 ' O ' ' N ' ' A' ' 552' ' ' ASP . 8.3 m120 -95.98 -34.23 11.86 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -179.204 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 551' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.39 72.79 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.133 0.492 . . . . 0.0 110.325 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 552' ' ' ASP . . . . . 0.515 ' HA ' ' O ' ' A' ' 519' ' ' THR . 1.6 p30 -90.6 22.33 3.54 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.602 -0.727 . . . . 0.0 111.724 -179.447 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . 124.27 -27.52 5.54 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.863 -0.684 . . . . 0.0 111.739 -179.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 554' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -61.67 -57.13 13.17 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.49 0.662 . . . . 0.0 109.937 178.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 555' ' ' ILE . . . . . 0.511 HG22 ' O ' ' A' ' 555' ' ' ILE . 4.2 mm -76.93 70.42 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 CA-C-N 114.821 -1.081 . . . . 0.0 110.862 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 556' ' ' CYS . . . . . . . . . . . . . 34.7 m . . . . . 0 C--N 1.323 -0.557 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.748 -179.781 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 511' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.528 0.107 0 CA-C-O 120.961 0.41 . . . . 0.0 111.426 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 512' ' ' ASN . . . . . . . . . . . . . 18.5 m-20 -131.25 77.68 73.87 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.663 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 513' ' ' PRO . . . . . 0.402 ' HA ' ' O ' ' A' ' 552' ' ' ASP . 41.8 Cg_endo -68.0 -12.28 34.75 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.608 2.206 . . . . 0.0 112.41 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -65.32 -29.03 69.74 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.887 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 515' ' ' LEU . . . . . . . . . . . . . 74.4 mt -95.54 71.18 3.11 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.881 179.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 516' ' ' HIS . . . . . 0.465 ' HA ' ' CB ' ' A' ' 552' ' ' ASP . 15.4 p80 -74.53 -7.34 52.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.676 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 517' ' ' TYR . . . . . . . . . . . . . 65.0 m-85 -79.9 -59.4 2.74 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.781 0.324 . . . . 0.0 111.592 -179.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 518' ' ' TRP . . . . . 0.429 ' CD1' ' HA ' ' A' ' 523' ' ' GLU . 0.1 OUTLIER -74.17 -21.61 59.77 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.925 -179.036 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 519' ' ' THR . . . . . 0.564 HG21 ' O ' ' A' ' 549' ' ' HIS . 2.3 p 63.38 -77.27 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 110.321 -0.252 . . . . 0.0 110.321 -179.505 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 520' ' ' THR . . . . . 0.53 ' N ' ' OG1' ' A' ' 519' ' ' THR . 1.0 OUTLIER 171.25 -62.4 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 179.227 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 521' ' ' GLN . . . . . 0.477 ' N ' HG22 ' A' ' 520' ' ' THR . 0.0 OUTLIER -72.72 -11.08 60.48 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.364 178.048 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 522' ' ' ASP . . . . . 0.412 ' HA ' ' CG2' ' A' ' 527' ' ' ILE . 0.8 OUTLIER -91.15 -21.19 21.29 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.631 178.758 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 523' ' ' GLU . . . . . 0.468 ' HG3' ' HA ' ' A' ' 520' ' ' THR . 8.9 mm-40 -45.84 -29.75 1.46 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.435 178.417 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 524' ' ' GLY . . . . . 0.422 ' HA2' ' CG1' ' A' ' 527' ' ' ILE . . . 144.51 39.16 0.06 OUTLIER Glycine 0 N--CA 1.443 -0.838 0 CA-C-N 114.816 -1.083 . . . . 0.0 110.405 -179.28 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -97.89 -59.49 1.75 Allowed 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 -178.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 526' ' ' ALA . . . . . 0.524 ' O ' ' HB1' ' A' ' 544' ' ' ALA . . . -130.81 40.37 3.49 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-O 121.549 0.69 . . . . 0.0 110.087 179.774 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 527' ' ' ILE . . . . . 0.8 HD12 ' N ' ' A' ' 528' ' ' GLY . 1.9 pp -95.67 -12.91 8.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 114.903 -1.044 . . . . 0.0 112.483 -179.03 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 528' ' ' GLY . . . . . 0.8 ' N ' HD12 ' A' ' 527' ' ' ILE . . . -48.45 -19.81 1.35 Allowed Glycine 0 CA--C 1.522 0.477 0 N-CA-C 114.624 0.61 . . . . 0.0 114.624 -179.131 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 529' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -98.57 -39.98 8.45 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 117.873 0.837 . . . . 0.0 112.415 -179.01 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 530' ' ' ALA . . . . . 0.973 ' HB3' ' HB2' ' A' ' 544' ' ' ALA . . . -103.88 2.06 32.14 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 -178.467 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 531' ' ' TRP . . . . . 0.519 ' O ' HG23 ' A' ' 532' ' ' ILE . 73.3 t-105 -67.45 30.22 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -178.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 532' ' ' ILE . . . . . 0.613 ' O ' HD12 ' A' ' 532' ' ' ILE . 1.3 pp -160.31 71.51 2.99 Favored Pre-proline 0 N--CA 1.454 -0.259 0 CA-C-O 120.837 0.351 . . . . 0.0 110.555 178.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 533' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -48.82 86.86 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 123.22 2.613 . . . . 0.0 112.829 -179.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 534' ' ' TYR . . . . . 0.4 ' N ' ' O ' ' A' ' 532' ' ' ILE . 0.2 OUTLIER -96.51 -38.3 10.06 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.049 179.804 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -62.58 -34.87 77.86 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.456 -179.412 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 151.09 -66.88 0.34 Allowed Glycine 0 CA--C 1.519 0.315 0 C-N-CA 120.47 -0.871 . . . . 0.0 112.62 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -57.2 -164.63 0.02 OUTLIER 'Trans proline' 0 CA--C 1.518 -0.307 0 C-N-CA 122.611 2.207 . . . . 0.0 111.735 179.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 538' ' ' ALA . . . . . 0.482 ' O ' ' HB3' ' A' ' 539' ' ' ALA . . . -74.4 -48.33 28.43 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.432 179.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 539' ' ' ALA . . . . . 0.676 ' C ' ' HB1' ' A' ' 530' ' ' ALA . . . 70.62 -51.83 0.67 Allowed 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.391 0.615 . . . . 0.0 111.277 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 540' ' ' GLU . . . . . 0.512 ' HG2' ' HA ' ' A' ' 531' ' ' TRP . 7.2 mt-10 -36.89 -30.68 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.809 -1.087 . . . . 0.0 112.538 -179.169 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 541' ' ' GLY . . . . . 0.459 ' HA3' ' CD2' ' A' ' 549' ' ' HIS . . . -126.95 -30.15 0.83 Allowed Glycine 0 CA--C 1.518 0.254 0 C-N-CA 120.412 -0.899 . . . . 0.0 112.999 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 542' ' ' ILE . . . . . 0.489 ' CD1' ' HA ' ' A' ' 539' ' ' ALA . 2.6 pp -88.82 -22.03 6.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 -179.532 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 543' ' ' TYR . . . . . 0.466 ' HB2' HD12 ' A' ' 542' ' ' ILE . 10.1 t80 -115.26 -8.43 12.32 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.892 0.377 . . . . 0.0 110.78 179.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 544' ' ' ALA . . . . . 0.973 ' HB2' ' HB3' ' A' ' 530' ' ' ALA . . . -103.01 -38.38 7.36 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-O 121.428 0.632 . . . . 0.0 109.572 179.217 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 545' ' ' GLU . . . . . 0.638 ' HG3' ' H ' ' A' ' 548' ' ' MET . 4.7 tp10 -118.95 -32.81 4.36 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.035 -0.984 . . . . 0.0 111.375 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 37.96 46.01 1.7 Allowed Glycine 0 CA--C 1.519 0.298 0 CA-C-N 115.895 -0.593 . . . . 0.0 113.975 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 547' ' ' LEU . . . . . 0.662 HD23 ' H ' ' A' ' 548' ' ' MET . 0.0 OUTLIER 179.03 -60.95 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 117.552 0.676 . . . . 0.0 112.049 179.682 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 548' ' ' MET . . . . . 0.662 ' H ' HD23 ' A' ' 547' ' ' LEU . 0.4 OUTLIER -87.83 11.74 14.8 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 111.765 0.283 . . . . 0.0 111.765 -179.769 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 549' ' ' HIS . . . . . 0.564 ' O ' HG21 ' A' ' 519' ' ' THR . 10.1 t-80 -66.69 -11.63 55.01 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.918 0.39 . . . . 0.0 110.233 179.245 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 550' ' ' ASN . . . . . 0.659 ' O ' ' N ' ' A' ' 552' ' ' ASP . 42.1 m-20 -96.24 -56.1 2.74 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.552 -179.751 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 551' ' ' GLN . . . . . 0.555 ' HG3' ' O ' ' A' ' 548' ' ' MET . 1.4 pp0? -44.24 76.41 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.583 -179.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 552' ' ' ASP . . . . . 0.659 ' N ' ' O ' ' A' ' 550' ' ' ASN . 2.3 p30 -94.45 22.24 6.33 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.247 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . 124.12 -28.39 5.37 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.865 -0.683 . . . . 0.0 111.708 -179.36 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 554' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -58.32 -59.81 4.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.341 0.591 . . . . 0.0 110.162 179.033 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 555' ' ' ILE . . . . . 0.568 HG22 ' O ' ' A' ' 555' ' ' ILE . 5.6 mm -78.4 62.73 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.647 179.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 556' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.325 -0.467 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.712 -179.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 511' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.528 0.133 0 CA-C-O 121.216 0.532 . . . . 0.0 111.575 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 512' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -136.58 82.18 33.87 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.252 179.642 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 513' ' ' PRO . . . . . 0.551 ' HA ' ' O ' ' A' ' 552' ' ' ASP . 58.2 Cg_endo -72.68 9.22 1.33 Allowed 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.839 2.359 . . . . 0.0 113.314 -179.375 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -95.87 -24.81 16.26 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.684 0.278 . . . . 0.0 110.997 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 515' ' ' LEU . . . . . . . . . . . . . 84.6 mt -87.1 74.59 9.6 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.831 0.348 . . . . 0.0 111.062 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 516' ' ' HIS . . . . . 0.435 ' HA ' ' CB ' ' A' ' 552' ' ' ASP . 25.0 p80 -81.14 -7.28 59.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.713 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 517' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -71.49 -46.72 59.06 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.679 0.276 . . . . 0.0 111.541 -179.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 518' ' ' TRP . . . . . 0.522 ' O ' ' N ' ' A' ' 520' ' ' THR . 12.3 m-90 -101.8 -3.87 27.31 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -179.314 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 519' ' ' THR . . . . . 0.569 ' HA ' ' HA ' ' A' ' 552' ' ' ASP . 4.1 p 56.41 -78.07 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 120.551 0.215 . . . . 0.0 110.757 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 520' ' ' THR . . . . . 0.522 ' N ' ' O ' ' A' ' 518' ' ' TRP . 1.1 m 176.04 -62.43 0.01 OUTLIER 'General case' 0 CA--C 1.521 -0.171 0 N-CA-C 109.171 -0.678 . . . . 0.0 109.171 179.375 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 521' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -71.64 -12.56 61.4 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 177.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 522' ' ' ASP . . . . . 0.418 ' HB2' ' O ' ' A' ' 518' ' ' TRP . 1.2 m-20 -93.86 -11.21 31.62 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.667 178.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -45.69 -27.88 0.89 Allowed 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.253 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 524' ' ' GLY . . . . . 0.409 ' HA2' ' CG1' ' A' ' 527' ' ' ILE . . . 145.41 43.02 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.243 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -102.56 -58.97 1.78 Allowed 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 -179.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -131.61 39.89 3.45 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-O 121.565 0.698 . . . . 0.0 109.986 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 527' ' ' ILE . . . . . 0.809 ' HA ' ' HB1' ' A' ' 544' ' ' ALA . 1.9 pp -95.61 -0.54 10.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 114.764 -1.107 . . . . 0.0 112.693 -178.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 528' ' ' GLY . . . . . 0.569 ' N ' HD12 ' A' ' 527' ' ' ILE . . . -60.23 -14.34 32.65 Favored Glycine 0 CA--C 1.52 0.387 0 C-N-CA 120.865 -0.683 . . . . 0.0 113.901 -179.301 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 529' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -98.55 -33.84 10.83 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 117.477 0.638 . . . . 0.0 111.68 -179.408 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 530' ' ' ALA . . . . . 1.041 ' HB3' ' HB2' ' A' ' 544' ' ' ALA . . . -103.81 1.53 31.69 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -179.057 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 531' ' ' TRP . . . . . 0.44 ' HB2' ' O ' ' A' ' 527' ' ' ILE . 73.2 t-105 -56.08 -12.6 1.55 Allowed 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 -179.378 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 532' ' ' ILE . . . . . 0.683 ' O ' HD12 ' A' ' 532' ' ' ILE . 1.5 pp -129.44 75.21 80.26 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 120.978 0.418 . . . . 0.0 110.984 179.699 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 533' ' ' PRO . . . . . 0.525 ' HB3' ' HB3' ' A' ' 539' ' ' ALA . 5.6 Cg_endo -48.91 89.88 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 123.099 2.533 . . . . 0.0 112.85 -179.672 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 534' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -96.3 -13.33 23.41 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.068 179.524 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -76.85 -34.87 57.81 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.282 -179.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 536' ' ' GLY . . . . . 0.417 ' N ' ' CD ' ' A' ' 537' ' ' PRO . . . 141.42 -49.54 0.76 Allowed Glycine 0 CA--C 1.52 0.347 0 C-N-CA 120.518 -0.848 . . . . 0.0 112.915 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 537' ' ' PRO . . . . . 0.417 ' CD ' ' N ' ' A' ' 536' ' ' GLY . 5.6 Cg_exo -76.56 -168.0 0.52 Allowed 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 122.714 2.276 . . . . 0.0 111.931 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 538' ' ' ALA . . . . . 0.422 ' O ' ' HB3' ' A' ' 539' ' ' ALA . . . -56.28 -47.63 78.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.461 179.505 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 539' ' ' ALA . . . . . 0.605 ' C ' ' HB1' ' A' ' 530' ' ' ALA . . . 68.14 -59.47 0.43 Allowed 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 121.362 0.601 . . . . 0.0 111.976 179.339 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 540' ' ' GLU . . . . . 0.409 ' OE2' ' CE3' ' A' ' 531' ' ' TRP . 2.7 mt-10 -37.49 -28.77 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 114.871 -1.059 . . . . 0.0 112.293 -179.108 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 541' ' ' GLY . . . . . 0.425 ' O ' ' HB2' ' A' ' 549' ' ' HIS . . . -121.9 -26.71 1.85 Allowed Glycine 0 CA--C 1.521 0.41 0 C-N-CA 120.479 -0.867 . . . . 0.0 113.27 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 542' ' ' ILE . . . . . 0.594 ' CD1' ' HA ' ' A' ' 539' ' ' ALA . 2.6 pp -95.84 -20.59 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -179.345 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 543' ' ' TYR . . . . . 0.528 ' HB2' ' HA ' ' A' ' 539' ' ' ALA . 0.3 OUTLIER -107.84 -10.73 15.5 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.112 0.482 . . . . 0.0 110.113 178.901 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 544' ' ' ALA . . . . . 1.041 ' HB2' ' HB3' ' A' ' 530' ' ' ALA . . . -103.16 -38.45 7.28 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.78 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 545' ' ' GLU . . . . . 0.573 ' HG3' ' H ' ' A' ' 548' ' ' MET . 5.9 tp10 -118.91 -32.96 4.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.151 -0.932 . . . . 0.0 111.487 -179.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 37.72 49.37 1.89 Allowed Glycine 0 CA--C 1.52 0.403 0 CA-C-N 115.988 -0.551 . . . . 0.0 113.822 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 547' ' ' LEU . . . . . 0.625 HD21 ' SD ' ' A' ' 548' ' ' MET . 0.0 OUTLIER 178.99 -60.83 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 117.528 0.664 . . . . 0.0 111.976 179.633 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 548' ' ' MET . . . . . 0.625 ' SD ' HD21 ' A' ' 547' ' ' LEU . 0.0 OUTLIER -86.38 11.76 11.65 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.671 0.272 . . . . 0.0 111.566 -179.802 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 549' ' ' HIS . . . . . 0.509 ' O ' ' CG2' ' A' ' 519' ' ' THR . 56.6 t60 -67.96 -10.97 57.77 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.899 0.381 . . . . 0.0 110.412 179.249 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 550' ' ' ASN . . . . . 0.432 ' O ' ' N ' ' A' ' 552' ' ' ASP . 38.9 t30 -92.89 -25.91 17.86 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.126 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 551' ' ' GLN . . . . . 0.53 ' HG2' ' O ' ' A' ' 548' ' ' MET . 2.3 mm-40 -66.91 70.32 0.08 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.249 0.547 . . . . 0.0 110.123 179.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 552' ' ' ASP . . . . . 0.569 ' HA ' ' HA ' ' A' ' 519' ' ' THR . 1.7 p30 -89.37 21.6 3.26 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.679 -179.46 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . 123.41 -32.82 4.19 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.885 -0.674 . . . . 0.0 111.592 -179.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 554' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -52.14 -58.06 7.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.498 0.665 . . . . 0.0 110.348 179.226 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 555' ' ' ILE . . . . . 0.587 HG22 ' O ' ' A' ' 555' ' ' ILE . 3.7 mm -72.62 60.86 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 CA-C-N 114.808 -1.087 . . . . 0.0 110.942 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 556' ' ' CYS . . . . . . . . . . . . . 5.3 t . . . . . 0 C--N 1.326 -0.449 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.373 -179.955 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 511' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.462 0.142 0 CA-C-O 121.032 0.444 . . . . 0.0 111.776 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 512' ' ' ASN . . . . . 0.541 ' HB3' HD21 ' A' ' 515' ' ' LEU . 0.9 OUTLIER -158.55 77.93 3.25 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.393 179.865 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 513' ' ' PRO . . . . . 0.568 ' HA ' ' O ' ' A' ' 552' ' ' ASP . 73.8 Cg_endo -76.67 19.14 0.66 Allowed 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 123.039 2.493 . . . . 0.0 113.462 -179.494 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 23.6 t30 -96.79 -34.56 11.26 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.642 0.258 . . . . 0.0 111.137 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 515' ' ' LEU . . . . . 0.541 HD21 ' HB3' ' A' ' 512' ' ' ASN . 0.7 OUTLIER -90.71 72.49 6.71 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.897 0.38 . . . . 0.0 111.085 -179.868 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 516' ' ' HIS . . . . . 0.506 ' HA ' ' HB2' ' A' ' 552' ' ' ASP . 7.7 p80 -80.13 -7.25 58.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.751 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 517' ' ' TYR . . . . . . . . . . . . . 37.9 m-85 -69.55 -29.69 67.32 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 111.67 0.248 . . . . 0.0 111.67 -179.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 518' ' ' TRP . . . . . 0.482 ' O ' ' N ' ' A' ' 520' ' ' THR . 4.7 m-90 -118.03 -8.28 10.74 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -179.246 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 519' ' ' THR . . . . . 0.528 ' OG1' ' N ' ' A' ' 520' ' ' THR . 1.3 p 59.82 -76.53 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 120.475 0.179 . . . . 0.0 110.537 -179.725 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 520' ' ' THR . . . . . 0.528 ' N ' ' OG1' ' A' ' 519' ' ' THR . 1.0 OUTLIER 172.24 -62.7 0.01 OUTLIER 'General case' 0 C--O 1.232 0.147 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 179.146 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 521' ' ' GLN . . . . . 0.471 ' N ' HG22 ' A' ' 520' ' ' THR . 5.8 mt-30 -73.42 -12.01 60.66 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 177.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 522' ' ' ASP . . . . . 0.404 ' HB2' ' O ' ' A' ' 518' ' ' TRP . 9.6 m-20 -93.47 -11.12 32.81 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.684 178.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -45.51 -27.09 0.67 Allowed 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.539 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 524' ' ' GLY . . . . . 0.441 ' HA2' ' CG1' ' A' ' 527' ' ' ILE . . . 148.6 41.13 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.577 -0.82 . . . . 0.0 112.225 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -99.62 -59.95 1.62 Allowed 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 111.879 0.325 . . . . 0.0 111.879 -179.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -132.0 35.97 3.7 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.505 0.669 . . . . 0.0 110.135 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 527' ' ' ILE . . . . . 0.985 ' HA ' ' HB1' ' A' ' 544' ' ' ALA . 2.2 pp -95.85 -0.42 10.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 114.741 -1.118 . . . . 0.0 112.836 -178.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 528' ' ' GLY . . . . . 0.495 ' N ' HD12 ' A' ' 527' ' ' ILE . . . -60.23 -8.82 9.55 Favored Glycine 0 CA--C 1.522 0.495 0 C-N-CA 120.907 -0.663 . . . . 0.0 114.146 -179.243 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 529' ' ' LEU . . . . . 0.718 HD11 ' O ' ' A' ' 543' ' ' TYR . 2.0 pp -98.54 -35.0 10.37 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 117.819 0.809 . . . . 0.0 111.624 -179.565 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 530' ' ' ALA . . . . . 1.008 ' HB3' ' HB2' ' A' ' 544' ' ' ALA . . . -103.64 1.63 32.23 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -179.273 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 531' ' ' TRP . . . . . 0.432 ' HA ' ' HG2' ' A' ' 540' ' ' GLU . 0.2 OUTLIER -70.4 30.71 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -178.853 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 532' ' ' ILE . . . . . 0.469 ' H ' ' C ' ' A' ' 530' ' ' ALA . 1.3 pt -156.68 78.92 3.89 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 120.665 0.269 . . . . 0.0 110.735 179.183 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 533' ' ' PRO . . . . . . . . . . . . . 99.9 Cg_exo -39.46 86.16 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 123.327 2.685 . . . . 0.0 113.212 -179.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 534' ' ' TYR . . . . . 0.463 ' N ' ' O ' ' A' ' 532' ' ' ILE . 1.7 t80 -96.61 -50.99 4.49 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.282 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -57.78 -34.95 70.12 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.459 -179.41 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 145.79 -63.98 0.45 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.563 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -59.94 -166.99 0.04 OUTLIER 'Trans proline' 0 CA--C 1.516 -0.393 0 C-N-CA 122.605 2.203 . . . . 0.0 111.833 179.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 538' ' ' ALA . . . . . 0.444 ' O ' ' HB3' ' A' ' 539' ' ' ALA . . . -61.65 -52.82 62.75 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.114 179.606 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 539' ' ' ALA . . . . . 0.572 ' O ' ' HB1' ' A' ' 530' ' ' ALA . . . 68.13 -47.01 0.53 Allowed 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.99 179.414 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 540' ' ' GLU . . . . . 0.432 ' HG2' ' HA ' ' A' ' 531' ' ' TRP . 0.8 OUTLIER -37.39 -28.15 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.126 -0.943 . . . . 0.0 112.366 -179.139 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 541' ' ' GLY . . . . . 0.456 ' HA3' ' CD2' ' A' ' 549' ' ' HIS . . . -127.63 -42.06 0.27 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.012 179.308 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 542' ' ' ILE . . . . . 0.631 HG23 ' CE1' ' A' ' 549' ' ' HIS . 0.8 OUTLIER -69.63 -26.31 30.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 -179.79 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 543' ' ' TYR . . . . . 0.718 ' O ' HD11 ' A' ' 529' ' ' LEU . 1.8 m-85 -110.68 -10.19 14.49 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.054 0.454 . . . . 0.0 110.697 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 544' ' ' ALA . . . . . 1.008 ' HB2' ' HB3' ' A' ' 530' ' ' ALA . . . -97.9 -30.54 12.69 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.035 179.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 545' ' ' GLU . . . . . 0.525 ' HG3' ' H ' ' A' ' 548' ' ' MET . 6.3 tp10 -118.87 -32.81 4.39 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.475 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 35.56 40.13 0.28 Allowed Glycine 0 CA--C 1.52 0.399 0 CA-C-N 116.025 -0.534 . . . . 0.0 113.808 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 547' ' ' LEU . . . . . 0.568 HD23 ' H ' ' A' ' 548' ' ' MET . 0.0 OUTLIER -173.65 -61.41 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 117.498 0.649 . . . . 0.0 112.1 179.748 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 548' ' ' MET . . . . . 0.631 ' O ' ' HG3' ' A' ' 551' ' ' GLN . 0.0 OUTLIER -94.36 11.92 28.83 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.758 0.314 . . . . 0.0 111.133 179.674 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 549' ' ' HIS . . . . . 0.631 ' CE1' HG23 ' A' ' 542' ' ' ILE . 12.1 t-80 -64.41 -10.75 26.94 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 120.846 -0.342 . . . . 0.0 110.82 179.582 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 550' ' ' ASN . . . . . 0.52 ' O ' ' N ' ' A' ' 552' ' ' ASP . 41.9 m-20 -94.82 -34.8 12.34 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.875 0.695 . . . . 0.0 112.875 -178.557 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 551' ' ' GLN . . . . . 0.631 ' HG3' ' O ' ' A' ' 548' ' ' MET . 1.1 pp0? -62.34 68.12 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.112 0.482 . . . . 0.0 111.238 -179.451 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 552' ' ' ASP . . . . . 0.568 ' O ' ' HA ' ' A' ' 513' ' ' PRO . 1.7 p30 -94.83 20.93 8.09 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.284 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . 123.63 -31.04 4.72 Favored Glycine 0 N--CA 1.45 -0.399 0 N-CA-C 111.321 -0.711 . . . . 0.0 111.321 -179.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 554' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -55.9 -52.5 63.87 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.475 0.655 . . . . 0.0 110.037 179.066 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 555' ' ' ILE . . . . . 0.641 HG22 ' O ' ' A' ' 555' ' ' ILE . 5.2 mm -82.9 56.32 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 CA-C-N 114.884 -1.053 . . . . 0.0 110.53 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 556' ' ' CYS . . . . . . . . . . . . . 17.6 t . . . . . 0 C--N 1.327 -0.381 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.432 -179.768 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 511' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.462 0.128 0 CA-C-O 120.974 0.416 . . . . 0.0 111.73 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 512' ' ' ASN . . . . . 0.716 ' OD1' HD12 ' A' ' 515' ' ' LEU . 6.0 p30 -140.13 73.75 31.58 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.39 179.324 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 513' ' ' PRO . . . . . 0.543 ' HA ' ' O ' ' A' ' 552' ' ' ASP . 31.3 Cg_exo -60.96 -14.73 34.5 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.899 2.399 . . . . 0.0 112.625 -179.612 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -69.42 -43.36 73.53 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.474 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 515' ' ' LEU . . . . . 0.716 HD12 ' OD1' ' A' ' 512' ' ' ASN . 53.1 mt -66.53 76.33 0.1 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.88 0.371 . . . . 0.0 111.076 -179.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 516' ' ' HIS . . . . . 0.56 ' HA ' ' HB3' ' A' ' 552' ' ' ASP . 0.2 OUTLIER -84.55 -7.16 59.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.722 -179.857 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 517' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -79.11 -61.82 1.89 Allowed 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -179.199 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 518' ' ' TRP . . . . . 0.488 ' O ' ' N ' ' A' ' 520' ' ' THR . 4.1 m-90 -87.13 -3.91 59.1 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -178.696 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 519' ' ' THR . . . . . 0.522 ' HA ' ' HA ' ' A' ' 552' ' ' ASP . 3.0 p 59.66 -76.49 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.391 0.139 . . . . 0.0 110.704 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 520' ' ' THR . . . . . 0.517 ' N ' ' OG1' ' A' ' 519' ' ' THR . 1.0 OUTLIER 173.04 -62.59 0.01 OUTLIER 'General case' 0 CA--C 1.521 -0.17 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 179.367 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 521' ' ' GLN . . . . . 0.43 ' N ' HG22 ' A' ' 520' ' ' THR . 2.7 mt-30 -73.32 -12.75 60.95 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.426 178.189 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 522' ' ' ASP . . . . . 0.422 ' HB2' ' O ' ' A' ' 518' ' ' TRP . 2.5 m-20 -93.91 -11.09 31.78 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.832 179.025 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -45.57 -28.01 0.87 Allowed 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.514 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 524' ' ' GLY . . . . . 0.451 ' HA2' ' CG1' ' A' ' 527' ' ' ILE . . . 147.34 42.18 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.471 -0.871 . . . . 0.0 112.354 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -101.39 -58.6 1.85 Allowed 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -179.43 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -132.03 35.08 3.76 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-O 121.566 0.698 . . . . 0.0 110.161 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 527' ' ' ILE . . . . . 0.968 ' HA ' ' HB1' ' A' ' 544' ' ' ALA . 2.2 pp -95.65 -0.45 10.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 114.797 -1.092 . . . . 0.0 112.606 -178.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 528' ' ' GLY . . . . . 0.514 ' N ' HD12 ' A' ' 527' ' ' ILE . . . -59.17 -7.65 5.43 Favored Glycine 0 CA--C 1.522 0.511 0 C-N-CA 121.018 -0.61 . . . . 0.0 114.256 -179.244 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 529' ' ' LEU . . . . . 0.472 HD11 ' O ' ' A' ' 543' ' ' TYR . 1.0 OUTLIER -97.77 -35.9 10.39 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 117.772 0.786 . . . . 0.0 111.36 -179.584 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 530' ' ' ALA . . . . . 0.96 ' HB3' ' HB2' ' A' ' 544' ' ' ALA . . . -103.76 1.97 32.34 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -179.392 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 531' ' ' TRP . . . . . 0.472 ' HA ' ' HG2' ' A' ' 540' ' ' GLU . 9.9 t90 -67.41 30.24 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 -178.8 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 532' ' ' ILE . . . . . 0.496 ' H ' ' C ' ' A' ' 530' ' ' ALA . 1.1 pt -159.31 72.77 3.42 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-O 120.843 0.354 . . . . 0.0 110.403 179.012 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 533' ' ' PRO . . . . . 0.414 ' HB3' ' O ' ' A' ' 537' ' ' PRO . 7.5 Cg_endo -49.74 86.38 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 123.129 2.552 . . . . 0.0 112.692 -179.69 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 534' ' ' TYR . . . . . 0.411 ' N ' ' O ' ' A' ' 532' ' ' ILE . 20.8 t80 -96.55 -29.76 13.69 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.156 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -71.14 -34.86 71.4 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.542 -179.388 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 152.51 -66.13 0.34 Allowed Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.579 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 537' ' ' PRO . . . . . 0.414 ' O ' ' HB3' ' A' ' 533' ' ' PRO . 19.5 Cg_endo -58.06 -162.67 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.612 2.208 . . . . 0.0 111.608 179.729 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 538' ' ' ALA . . . . . 0.482 ' O ' ' HB3' ' A' ' 539' ' ' ALA . . . -76.5 -46.21 27.66 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.645 179.673 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 539' ' ' ALA . . . . . 0.556 ' C ' ' HB1' ' A' ' 530' ' ' ALA . . . 70.56 -51.15 0.67 Allowed 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.264 0.554 . . . . 0.0 111.46 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 540' ' ' GLU . . . . . 0.474 ' O ' ' HB3' ' A' ' 544' ' ' ALA . 7.1 mt-10 -37.38 -28.71 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.85 -1.068 . . . . 0.0 112.347 -179.371 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 541' ' ' GLY . . . . . 0.413 ' O ' ' HB3' ' A' ' 545' ' ' GLU . . . -128.19 -38.07 0.4 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.746 179.59 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 542' ' ' ILE . . . . . 0.493 ' H ' HG13 ' A' ' 542' ' ' ILE . 2.5 pp -78.86 -25.57 13.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -179.19 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 543' ' ' TYR . . . . . 0.5 ' HB2' ' HA ' ' A' ' 539' ' ' ALA . 0.4 OUTLIER -114.58 -6.86 12.8 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.896 0.379 . . . . 0.0 110.73 179.568 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 544' ' ' ALA . . . . . 0.968 ' HB1' ' HA ' ' A' ' 527' ' ' ILE . . . -99.9 -29.99 12.27 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.953 179.206 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 545' ' ' GLU . . . . . 0.547 ' HG3' ' H ' ' A' ' 548' ' ' MET . 6.2 tp10 -118.61 -32.92 4.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.474 -179.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 35.2 43.14 0.45 Allowed Glycine 0 CA--C 1.519 0.339 0 CA-C-N 115.923 -0.58 . . . . 0.0 114.295 179.443 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 547' ' ' LEU . . . . . 0.626 HD21 ' SD ' ' A' ' 548' ' ' MET . 0.0 OUTLIER -178.7 -61.27 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 117.753 0.776 . . . . 0.0 112.006 179.683 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 548' ' ' MET . . . . . 0.626 ' SD ' HD21 ' A' ' 547' ' ' LEU . 0.0 OUTLIER -89.96 12.12 18.48 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.854 0.359 . . . . 0.0 111.031 179.669 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 549' ' ' HIS . . . . . 0.494 ' O ' ' CG2' ' A' ' 519' ' ' THR . 75.7 t60 -64.81 -11.21 34.52 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.832 0.349 . . . . 0.0 110.75 179.558 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 550' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -94.24 -17.62 22.49 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.43 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 551' ' ' GLN . . . . . 0.566 ' HG2' ' O ' ' A' ' 548' ' ' MET . 0.9 OUTLIER -70.46 65.82 0.3 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.162 0.506 . . . . 0.0 110.364 179.667 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 552' ' ' ASP . . . . . 0.56 ' HB3' ' HA ' ' A' ' 516' ' ' HIS . 4.3 m-20 -91.37 21.75 4.31 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.35 -179.717 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 553' ' ' GLY . . . . . 0.405 ' HA3' ' C ' ' A' ' 512' ' ' ASN . . . 117.33 -35.28 4.19 Favored Glycine 0 N--CA 1.45 -0.413 0 N-CA-C 111.332 -0.707 . . . . 0.0 111.332 -179.336 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 554' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -56.23 -59.23 5.24 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.524 0.678 . . . . 0.0 109.844 178.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 555' ' ' ILE . . . . . 0.565 HG22 ' O ' ' A' ' 555' ' ' ILE . 3.9 mm -73.46 62.33 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 CA-C-N 114.705 -1.134 . . . . 0.0 110.657 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 556' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.327 -0.406 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.647 -179.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 511' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.119 0 CA-C-O 121.272 0.558 . . . . 0.0 110.986 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 512' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -140.21 83.34 15.76 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.07 179.383 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 513' ' ' PRO . . . . . 0.519 ' HA ' ' O ' ' A' ' 552' ' ' ASP . 74.2 Cg_endo -76.9 21.94 0.57 Allowed 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.932 2.422 . . . . 0.0 113.246 -179.278 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 20.0 t30 -96.83 -46.21 6.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.691 0.281 . . . . 0.0 110.687 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 515' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -72.18 75.57 0.97 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.925 0.393 . . . . 0.0 110.799 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 516' ' ' HIS . . . . . 0.457 ' HA ' ' HB3' ' A' ' 552' ' ' ASP . 0.1 OUTLIER -73.67 -7.41 51.92 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.786 -179.785 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 517' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -88.72 -48.48 7.49 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.716 0.293 . . . . 0.0 111.711 -179.469 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 518' ' ' TRP . . . . . 0.484 ' O ' ' N ' ' A' ' 520' ' ' THR . 3.7 m-90 -84.07 -8.4 59.12 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 -179.32 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 519' ' ' THR . . . . . 0.565 ' HA ' ' HA ' ' A' ' 552' ' ' ASP . 2.7 p 59.34 -78.56 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 120.581 0.229 . . . . 0.0 110.469 -179.763 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 520' ' ' THR . . . . . 0.549 ' N ' ' OG1' ' A' ' 519' ' ' THR . 1.2 m 172.73 -62.78 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 179.083 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 521' ' ' GLN . . . . . 0.413 ' N ' HG22 ' A' ' 520' ' ' THR . 5.3 mt-30 -74.98 -12.03 60.24 Favored 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 177.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 522' ' ' ASP . . . . . 0.436 ' HA ' ' CG2' ' A' ' 527' ' ' ILE . 1.9 m-20 -93.99 -10.95 31.94 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.541 178.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -45.33 -27.51 0.68 Allowed 'General case' 0 C--O 1.232 0.158 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.552 -179.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 524' ' ' GLY . . . . . 0.433 ' HA2' ' CG1' ' A' ' 527' ' ' ILE . . . 146.35 42.29 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.566 -0.826 . . . . 0.0 112.306 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -101.32 -59.27 1.73 Allowed 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 111.917 0.34 . . . . 0.0 111.917 -179.527 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 526' ' ' ALA . . . . . 0.464 ' O ' HD21 ' A' ' 529' ' ' LEU . . . -132.25 35.97 3.65 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-O 121.512 0.673 . . . . 0.0 110.146 179.763 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 527' ' ' ILE . . . . . 0.943 ' HA ' ' HB1' ' A' ' 544' ' ' ALA . 2.2 pp -95.7 -0.64 10.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 114.769 -1.105 . . . . 0.0 112.701 -178.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 528' ' ' GLY . . . . . 0.529 ' N ' HD12 ' A' ' 527' ' ' ILE . . . -62.08 -8.11 15.84 Favored Glycine 0 CA--C 1.521 0.414 0 C-N-CA 120.939 -0.648 . . . . 0.0 114.035 -179.229 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 529' ' ' LEU . . . . . 0.464 HD21 ' O ' ' A' ' 526' ' ' ALA . 0.2 OUTLIER -98.32 -35.62 10.26 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 117.587 0.693 . . . . 0.0 111.556 -179.574 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 530' ' ' ALA . . . . . 0.943 ' HB3' ' HB2' ' A' ' 544' ' ' ALA . . . -103.66 -1.08 28.67 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -179.118 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 531' ' ' TRP . . . . . 0.651 ' CE3' HD13 ' A' ' 527' ' ' ILE . 14.5 t-105 -56.09 -12.3 1.44 Allowed 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 112.039 0.385 . . . . 0.0 112.039 -179.187 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 532' ' ' ILE . . . . . 0.695 ' O ' HD12 ' A' ' 532' ' ' ILE . 1.6 pp -130.13 75.65 79.05 Favored Pre-proline 0 N--CA 1.451 -0.421 0 CA-C-O 121.005 0.431 . . . . 0.0 111.132 179.727 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 533' ' ' PRO . . . . . 0.403 ' HB3' ' O ' ' A' ' 538' ' ' ALA . 3.9 Cg_endo -46.95 92.25 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 123.169 2.579 . . . . 0.0 112.672 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 534' ' ' TYR . . . . . . . . . . . . . 46.9 p90 -96.18 -22.82 17.05 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.127 179.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -73.98 -34.86 64.39 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.303 -179.685 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 150.25 -64.28 0.39 Allowed Glycine 0 CA--C 1.519 0.332 0 C-N-CA 120.491 -0.862 . . . . 0.0 112.833 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -59.92 -164.17 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.651 2.234 . . . . 0.0 112.097 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 538' ' ' ALA . . . . . 0.486 ' O ' ' HB3' ' A' ' 539' ' ' ALA . . . -70.41 -46.53 63.79 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.678 179.753 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 539' ' ' ALA . . . . . 0.688 ' C ' ' HB1' ' A' ' 530' ' ' ALA . . . 70.68 -52.35 0.67 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.212 0.53 . . . . 0.0 111.709 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 540' ' ' GLU . . . . . 0.52 ' O ' ' HB3' ' A' ' 544' ' ' ALA . 13.0 mt-10 -37.21 -28.07 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.831 -1.077 . . . . 0.0 112.427 -179.231 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 541' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' A' ' 539' ' ' ALA . . . -126.79 -41.65 0.3 Allowed Glycine 0 CA--C 1.52 0.347 0 C-N-CA 120.505 -0.855 . . . . 0.0 112.338 179.206 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 542' ' ' ILE . . . . . 0.5 ' CD1' ' HA ' ' A' ' 539' ' ' ALA . 2.5 pp -75.8 -25.55 17.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -179.377 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 543' ' ' TYR . . . . . 0.585 ' HB2' ' HA ' ' A' ' 539' ' ' ALA . 0.2 OUTLIER -115.65 -5.66 12.16 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.862 0.363 . . . . 0.0 110.948 179.839 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 544' ' ' ALA . . . . . 0.943 ' HB1' ' HA ' ' A' ' 527' ' ' ILE . . . -102.78 -32.66 9.71 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.783 179.216 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 545' ' ' GLU . . . . . 0.549 ' OE2' HD23 ' A' ' 547' ' ' LEU . 50.3 tp10 -118.53 -32.85 4.48 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.301 179.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 35.55 39.35 0.23 Allowed Glycine 0 CA--C 1.519 0.337 0 CA-C-N 115.583 -0.735 . . . . 0.0 114.176 179.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 547' ' ' LEU . . . . . 0.587 HD23 ' H ' ' A' ' 548' ' ' MET . 0.0 OUTLIER -173.9 -61.8 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 117.756 0.778 . . . . 0.0 112.621 179.517 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 548' ' ' MET . . . . . 0.587 ' H ' HD23 ' A' ' 547' ' ' LEU . 0.0 OUTLIER -96.22 11.48 34.32 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.68 0.276 . . . . 0.0 111.339 179.96 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 549' ' ' HIS . . . . . 0.466 ' O ' ' CG2' ' A' ' 519' ' ' THR . 2.4 p-80 -62.29 -11.32 14.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.824 0.345 . . . . 0.0 110.804 179.221 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 550' ' ' ASN . . . . . 0.441 ' O ' ' N ' ' A' ' 552' ' ' ASP . 26.2 t-20 -95.1 -32.06 13.27 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -179.212 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 551' ' ' GLN . . . . . 0.449 ' HG2' ' CG ' ' A' ' 548' ' ' MET . 1.6 pt20 -64.99 74.44 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.421 0.629 . . . . 0.0 110.576 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 552' ' ' ASP . . . . . 0.565 ' HA ' ' HA ' ' A' ' 519' ' ' THR . 15.6 m-20 -78.61 19.12 0.51 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.583 -0.735 . . . . 0.0 112.023 -179.544 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . 123.61 -31.05 4.72 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.785 -0.721 . . . . 0.0 111.817 -179.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 554' ' ' LEU . . . . . 0.422 ' H ' HD12 ' A' ' 554' ' ' LEU . 1.5 mp -53.02 -56.56 15.17 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.485 0.66 . . . . 0.0 110.592 179.301 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 555' ' ' ILE . . . . . 0.595 HG22 ' O ' ' A' ' 555' ' ' ILE . 2.3 mm -69.57 66.27 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 114.785 -1.098 . . . . 0.0 110.614 -179.748 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 556' ' ' CYS . . . . . . . . . . . . . 7.9 t . . . . . 0 C--N 1.323 -0.575 0 CA-C-N 115.461 -0.79 . . . . 0.0 111.649 -179.635 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 511' ' ' CYS . . . . . 0.417 ' HA ' ' HB3' ' A' ' 556' ' ' CYS . 28.9 t . . . . . 0 C--O 1.231 0.129 0 CA-C-O 121.025 0.441 . . . . 0.0 111.688 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 512' ' ' ASN . . . . . 0.545 ' HB3' HD12 ' A' ' 515' ' ' LEU . 87.4 m-20 -111.07 81.22 2.63 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.871 179.113 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 513' ' ' PRO . . . . . 0.581 ' HA ' ' O ' ' A' ' 552' ' ' ASP . 55.5 Cg_endo -71.79 11.9 0.62 Allowed 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 122.839 2.36 . . . . 0.0 113.276 -179.275 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 -96.62 -15.99 21.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.663 0.268 . . . . 0.0 110.969 179.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 515' ' ' LEU . . . . . 0.545 HD12 ' HB3' ' A' ' 512' ' ' ASN . 1.4 mp -94.46 73.94 3.82 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.894 0.378 . . . . 0.0 110.943 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 516' ' ' HIS . . . . . 0.456 ' HA ' ' HB3' ' A' ' 552' ' ' ASP . 0.2 OUTLIER -80.59 -7.09 59.14 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.872 -179.774 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 517' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -72.17 -66.08 0.69 Allowed 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -179.088 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 518' ' ' TRP . . . . . 0.48 ' O ' ' N ' ' A' ' 520' ' ' THR . 12.0 m-90 -93.32 0.51 56.97 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.489 0.552 . . . . 0.0 112.489 -178.737 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 519' ' ' THR . . . . . 0.527 HG21 ' HA ' ' A' ' 549' ' ' HIS . 2.8 p 60.56 -75.19 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 110.627 -0.138 . . . . 0.0 110.627 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 520' ' ' THR . . . . . 0.48 ' N ' ' O ' ' A' ' 518' ' ' TRP . 1.0 OUTLIER 172.27 -62.95 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.241 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 179.155 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 521' ' ' GLN . . . . . 0.458 ' N ' HG22 ' A' ' 520' ' ' THR . 0.7 OUTLIER -68.33 -15.43 63.56 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 178.245 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 522' ' ' ASP . . . . . 0.409 ' HB2' ' O ' ' A' ' 518' ' ' TRP . 2.8 m-20 -94.19 -11.93 29.34 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 115.668 -0.697 . . . . 0.0 111.273 179.563 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -51.98 -31.73 30.55 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-O 121.069 0.462 . . . . 0.0 110.846 179.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . 162.89 40.29 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.471 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.02 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -133.02 -32.17 1.23 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.632 0.253 . . . . 0.0 111.592 -179.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -137.84 56.52 1.75 Allowed 'General case' 0 CA--C 1.515 -0.373 0 CA-C-O 121.393 0.615 . . . . 0.0 110.306 179.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 527' ' ' ILE . . . . . 0.863 HD12 ' N ' ' A' ' 528' ' ' GLY . 1.4 pp -95.31 -18.55 6.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.721 -179.511 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 528' ' ' GLY . . . . . 0.863 ' N ' HD12 ' A' ' 527' ' ' ILE . . . 26.79 -144.92 0.01 OUTLIER Glycine 0 C--N 1.336 0.559 0 N-CA-C 114.716 0.647 . . . . 0.0 114.716 179.171 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 529' ' ' LEU . . . . . 0.504 HD12 ' H ' ' A' ' 530' ' ' ALA . 0.2 OUTLIER -63.55 -17.59 62.96 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.426 -0.387 . . . . 0.0 111.715 -179.624 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 530' ' ' ALA . . . . . 1.044 ' HB3' ' HB2' ' A' ' 544' ' ' ALA . . . -81.58 1.99 31.23 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -179.361 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 531' ' ' TRP . . . . . 0.484 ' HA ' ' HG2' ' A' ' 540' ' ' GLU . 0.1 OUTLIER -72.18 27.38 0.05 Allowed 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -179.15 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 532' ' ' ILE . . . . . 0.463 HG23 ' O ' ' A' ' 531' ' ' TRP . 1.1 pp -159.03 72.16 3.54 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-O 120.793 0.33 . . . . 0.0 110.541 179.074 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 533' ' ' PRO . . . . . 0.41 ' HB3' ' O ' ' A' ' 537' ' ' PRO . 7.5 Cg_endo -49.62 88.34 0.02 OUTLIER 'Trans proline' 0 C--N 1.343 0.243 0 C-N-CA 123.08 2.52 . . . . 0.0 112.625 -179.733 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 534' ' ' TYR . . . . . . . . . . . . . 65.3 t80 -96.46 -28.37 14.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.273 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -72.59 -35.03 67.81 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.503 -179.452 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 151.99 -65.03 0.36 Allowed Glycine 0 N--CA 1.453 -0.208 0 C-N-CA 120.496 -0.859 . . . . 0.0 112.547 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 537' ' ' PRO . . . . . 0.41 ' O ' ' HB3' ' A' ' 533' ' ' PRO . 17.2 Cg_endo -57.38 -163.27 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.636 2.224 . . . . 0.0 111.718 179.696 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 538' ' ' ALA . . . . . 0.494 ' O ' ' HB3' ' A' ' 539' ' ' ALA . . . -76.81 -46.62 24.24 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.512 179.547 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 539' ' ' ALA . . . . . 0.689 ' C ' ' HB1' ' A' ' 530' ' ' ALA . . . 70.79 -52.4 0.67 Allowed 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 121.336 0.589 . . . . 0.0 111.545 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 540' ' ' GLU . . . . . 0.484 ' HG2' ' HA ' ' A' ' 531' ' ' TRP . 10.2 mt-10 -36.8 -30.85 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.797 -1.092 . . . . 0.0 112.43 -179.143 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 541' ' ' GLY . . . . . . . . . . . . . . . -126.79 -22.29 1.63 Allowed Glycine 0 CA--C 1.518 0.274 0 C-N-CA 120.35 -0.928 . . . . 0.0 113.355 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 542' ' ' ILE . . . . . 0.575 ' CD1' ' HA ' ' A' ' 539' ' ' ALA . 2.6 pp -96.4 -18.85 6.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 -179.133 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 543' ' ' TYR . . . . . 0.482 ' HB2' ' HA ' ' A' ' 539' ' ' ALA . 0.4 OUTLIER -114.21 -11.81 12.57 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.808 179.58 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 544' ' ' ALA . . . . . 1.044 ' HB2' ' HB3' ' A' ' 530' ' ' ALA . . . -103.36 -36.23 8.1 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 121.336 0.589 . . . . 0.0 110.635 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 545' ' ' GLU . . . . . 0.642 ' HG2' ' HB2' ' A' ' 548' ' ' MET . 2.9 tp10 -118.51 -32.7 4.52 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.218 -0.901 . . . . 0.0 111.452 -179.243 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 37.99 51.22 2.11 Favored Glycine 0 C--N 1.332 0.308 0 C-N-CA 121.259 -0.496 . . . . 0.0 112.664 -179.647 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 547' ' ' LEU . . . . . 0.561 HD11 ' SD ' ' A' ' 548' ' ' MET . 0.3 OUTLIER -172.78 -46.19 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 120.9 -0.32 . . . . 0.0 111.618 -179.292 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 548' ' ' MET . . . . . 0.642 ' HB2' ' HG2' ' A' ' 545' ' ' GLU . 0.0 OUTLIER -96.58 11.61 34.61 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.811 0.338 . . . . 0.0 111.0 179.285 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 549' ' ' HIS . . . . . 0.527 ' HA ' HG21 ' A' ' 519' ' ' THR . 11.4 p-80 -69.05 -11.21 60.58 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.008 0.432 . . . . 0.0 110.405 179.528 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 550' ' ' ASN . . . . . . . . . . . . . 35.2 t30 -95.93 -17.63 20.9 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.817 -179.391 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 551' ' ' GLN . . . . . 0.499 ' HG2' ' O ' ' A' ' 548' ' ' MET . 7.8 mm-40 -69.23 62.76 0.14 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.964 0.411 . . . . 0.0 110.569 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 552' ' ' ASP . . . . . 0.581 ' O ' ' HA ' ' A' ' 513' ' ' PRO . 2.8 m-20 -94.12 21.74 6.54 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.18 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 553' ' ' GLY . . . . . 0.443 ' HA3' ' C ' ' A' ' 512' ' ' ASN . . . 115.26 -33.98 5.03 Favored Glycine 0 N--CA 1.448 -0.564 0 N-CA-C 111.212 -0.755 . . . . 0.0 111.212 -179.242 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 554' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -53.37 -50.82 64.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.592 0.711 . . . . 0.0 110.177 178.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 555' ' ' ILE . . . . . 0.674 HG22 ' O ' ' A' ' 555' ' ' ILE . 4.1 mm -81.1 54.76 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 114.73 -1.123 . . . . 0.0 110.91 -179.743 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 556' ' ' CYS . . . . . 0.417 ' HB3' ' HA ' ' A' ' 511' ' ' CYS . 29.1 p . . . . . 0 C--N 1.326 -0.444 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.03 179.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 511' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.53 0.189 0 CA-C-O 121.079 0.466 . . . . 0.0 111.597 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 512' ' ' ASN . . . . . 0.471 ' O ' ' O ' ' A' ' 552' ' ' ASP . 24.7 p30 -127.0 83.37 66.16 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.177 179.466 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 513' ' ' PRO . . . . . 0.467 ' HA ' ' O ' ' A' ' 552' ' ' ASP . 74.2 Cg_endo -76.17 22.1 0.51 Allowed 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 123.023 2.482 . . . . 0.0 113.27 -179.59 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -96.68 -26.02 15.34 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.811 0.339 . . . . 0.0 110.609 179.553 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 515' ' ' LEU . . . . . . . . . . . . . 31.7 mt -95.55 71.91 3.14 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.885 179.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 516' ' ' HIS . . . . . 0.469 ' HA ' ' CB ' ' A' ' 552' ' ' ASP . 6.2 p-80 -73.61 -7.35 51.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.721 -179.821 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 517' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -72.54 -59.74 2.57 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 111.903 0.334 . . . . 0.0 111.903 -179.435 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 518' ' ' TRP . . . . . 0.467 ' CD1' ' HA ' ' A' ' 523' ' ' GLU . 0.7 OUTLIER -80.07 -22.39 42.31 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.06 0.392 . . . . 0.0 112.06 -178.837 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 519' ' ' THR . . . . . 0.539 ' OG1' ' N ' ' A' ' 520' ' ' THR . 3.4 p 57.42 -81.29 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.459 0.171 . . . . 0.0 110.741 -179.728 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 520' ' ' THR . . . . . 0.539 ' N ' ' OG1' ' A' ' 519' ' ' THR . 1.1 m 176.19 -62.58 0.01 OUTLIER 'General case' 0 CA--C 1.52 -0.174 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 179.517 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 521' ' ' GLN . . . . . 0.403 ' N ' HG22 ' A' ' 520' ' ' THR . 2.0 mt-30 -72.07 -11.97 61.0 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.346 177.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 522' ' ' ASP . . . . . 0.421 ' HB2' ' O ' ' A' ' 518' ' ' TRP . 62.0 m-20 -93.49 -11.09 32.81 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.803 179.093 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 523' ' ' GLU . . . . . 0.467 ' HA ' ' CD1' ' A' ' 518' ' ' TRP . 0.1 OUTLIER -45.59 -27.92 0.86 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.698 -179.738 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 524' ' ' GLY . . . . . 0.45 ' HA2' ' CG1' ' A' ' 527' ' ' ILE . . . 150.52 40.04 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.343 -0.932 . . . . 0.0 112.439 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -97.91 -60.5 1.55 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.72 0.295 . . . . 0.0 111.589 -179.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -133.86 36.98 3.27 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-O 121.645 0.736 . . . . 0.0 110.33 179.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 527' ' ' ILE . . . . . 0.948 ' HA ' ' HB1' ' A' ' 544' ' ' ALA . 1.6 pp -96.13 -0.72 10.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 114.676 -1.147 . . . . 0.0 112.956 -178.795 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 528' ' ' GLY . . . . . 0.596 ' N ' HD12 ' A' ' 527' ' ' ILE . . . -55.19 -14.75 6.4 Favored Glycine 0 CA--C 1.521 0.455 0 C-N-CA 120.845 -0.693 . . . . 0.0 114.0 -179.342 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 529' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -98.73 -38.38 9.11 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 117.756 0.778 . . . . 0.0 112.303 -179.266 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 530' ' ' ALA . . . . . 0.946 ' HB3' ' HB2' ' A' ' 544' ' ' ALA . . . -103.68 1.71 32.25 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 -178.492 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 531' ' ' TRP . . . . . 0.462 ' O ' HG23 ' A' ' 532' ' ' ILE . 0.2 OUTLIER -71.31 30.46 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 112.405 0.521 . . . . 0.0 112.405 -178.896 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 532' ' ' ILE . . . . . 0.48 ' H ' ' C ' ' A' ' 530' ' ' ALA . 1.1 pt -159.04 73.24 3.52 Favored Pre-proline 0 N--CA 1.454 -0.256 0 CA-C-O 120.734 0.302 . . . . 0.0 110.403 179.031 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 533' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -50.74 84.95 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 123.071 2.514 . . . . 0.0 112.683 -179.496 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 534' ' ' TYR . . . . . 0.42 ' N ' ' O ' ' A' ' 532' ' ' ILE . 0.2 OUTLIER -96.48 -31.58 12.73 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.975 179.788 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -68.06 -34.94 77.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.333 -179.512 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 148.85 -63.9 0.41 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.651 -179.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -59.22 -165.98 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.639 2.226 . . . . 0.0 111.984 179.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 538' ' ' ALA . . . . . 0.453 ' O ' ' HB3' ' A' ' 539' ' ' ALA . . . -71.54 -49.79 37.44 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.508 179.78 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 539' ' ' ALA . . . . . 0.591 ' C ' ' HB1' ' A' ' 530' ' ' ALA . . . 69.14 -53.05 0.59 Allowed 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 121.206 0.527 . . . . 0.0 111.688 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 540' ' ' GLU . . . . . 0.486 ' O ' ' HB3' ' A' ' 544' ' ' ALA . 0.8 OUTLIER -37.3 -30.2 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.942 -1.026 . . . . 0.0 112.234 -179.286 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 541' ' ' GLY . . . . . . . . . . . . . . . -126.05 -30.27 0.88 Allowed Glycine 0 N--CA 1.453 -0.223 0 C-N-CA 120.479 -0.867 . . . . 0.0 113.216 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 542' ' ' ILE . . . . . 0.536 ' CD1' ' HA ' ' A' ' 539' ' ' ALA . 2.6 pp -87.89 -21.84 6.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 112.0 0.37 . . . . 0.0 112.0 -179.371 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 543' ' ' TYR . . . . . 0.468 ' CD2' ' CD1' ' A' ' 542' ' ' ILE . 6.1 m-85 -113.54 -10.19 13.19 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 120.812 0.339 . . . . 0.0 110.637 179.259 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 544' ' ' ALA . . . . . 0.948 ' HB1' ' HA ' ' A' ' 527' ' ' ILE . . . -103.35 -37.58 7.58 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 121.213 0.53 . . . . 0.0 110.198 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 545' ' ' GLU . . . . . 0.586 ' CD ' HD23 ' A' ' 547' ' ' LEU . 5.5 tp10 -118.73 -32.69 4.46 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.489 -179.088 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 37.72 45.39 1.48 Allowed Glycine 0 CA--C 1.52 0.398 0 CA-C-N 115.999 -0.546 . . . . 0.0 114.038 179.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 547' ' ' LEU . . . . . 0.586 HD23 ' CD ' ' A' ' 545' ' ' GLU . 0.0 OUTLIER -178.59 -61.26 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 117.594 0.697 . . . . 0.0 112.03 179.479 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 548' ' ' MET . . . . . 0.583 ' SD ' HD21 ' A' ' 547' ' ' LEU . 0.0 OUTLIER -90.63 12.06 20.11 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.715 0.293 . . . . 0.0 111.345 179.923 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 549' ' ' HIS . . . . . 0.5 ' O ' ' CG2' ' A' ' 519' ' ' THR . 12.7 t60 -65.51 -11.11 40.49 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.744 -0.383 . . . . 0.0 110.462 179.482 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 550' ' ' ASN . . . . . 0.458 ' O ' HD12 ' A' ' 554' ' ' LEU . 22.8 m-80 -93.7 -12.59 28.93 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.965 -0.294 . . . . 0.0 111.456 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 551' ' ' GLN . . . . . 0.662 HE22 HG21 ' A' ' 555' ' ' ILE . 2.9 mm100 -73.47 59.2 0.6 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.913 0.387 . . . . 0.0 110.35 179.536 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 552' ' ' ASP . . . . . 0.471 ' O ' ' O ' ' A' ' 512' ' ' ASN . 2.8 p30 -98.78 22.04 10.62 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.188 -179.591 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . 123.74 -31.86 4.43 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.819 -0.705 . . . . 0.0 111.487 -179.238 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 554' ' ' LEU . . . . . 0.458 HD12 ' O ' ' A' ' 550' ' ' ASN . 1.4 mt -55.01 -56.12 23.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.382 0.61 . . . . 0.0 110.183 179.121 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 555' ' ' ILE . . . . . 0.662 HG21 HE22 ' A' ' 551' ' ' GLN . 5.5 mm -79.23 60.01 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.997 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 556' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.327 -0.385 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.376 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 511' ' ' CYS . . . . . 0.414 ' HA ' ' CA ' ' A' ' 553' ' ' GLY . 0.8 OUTLIER . . . . . 0 CA--C 1.53 0.175 0 CA-C-O 121.066 0.46 . . . . 0.0 111.508 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 512' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -122.11 83.89 45.26 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.417 179.542 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 513' ' ' PRO . . . . . 0.435 ' HB3' ' HG ' ' A' ' 554' ' ' LEU . 73.5 Cg_endo -75.36 -0.82 10.53 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.844 2.363 . . . . 0.0 113.124 -179.466 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 20.2 t30 -62.93 -40.24 97.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.736 0.303 . . . . 0.0 110.907 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 515' ' ' LEU . . . . . 0.793 HD13 ' CH2' ' A' ' 518' ' ' TRP . 0.9 OUTLIER -95.71 58.99 2.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.017 0.437 . . . . 0.0 111.06 -179.812 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 516' ' ' HIS . . . . . . . . . . . . . 42.4 t-80 -73.01 -6.54 46.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.874 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 517' ' ' TYR . . . . . . . . . . . . . 48.8 m-85 -61.07 -27.88 68.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.718 0.294 . . . . 0.0 111.174 -179.388 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 518' ' ' TRP . . . . . 0.793 ' CH2' HD13 ' A' ' 515' ' ' LEU . 1.5 p90 -117.92 -14.97 10.02 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.87 -179.612 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 519' ' ' THR . . . . . 0.538 ' CG2' ' O ' ' A' ' 549' ' ' HIS . 14.9 p 55.2 -79.43 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.55 0.214 . . . . 0.0 111.084 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 520' ' ' THR . . . . . 0.522 ' N ' ' O ' ' A' ' 518' ' ' TRP . 1.1 m 177.41 -62.59 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 179.479 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 521' ' ' GLN . . . . . 0.425 ' N ' HG22 ' A' ' 520' ' ' THR . 0.6 OUTLIER -74.65 -12.06 60.34 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.32 177.918 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 522' ' ' ASP . . . . . 0.451 ' HA ' ' CG2' ' A' ' 527' ' ' ILE . 13.4 m-20 -92.56 -10.7 36.62 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.675 179.037 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -45.19 -26.37 0.48 Allowed 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.581 -179.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 524' ' ' GLY . . . . . 0.415 ' HA2' ' CG1' ' A' ' 527' ' ' ILE . . . 146.06 40.92 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.441 -0.885 . . . . 0.0 112.604 179.797 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -100.36 -60.2 1.57 Allowed 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 -179.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -132.51 37.63 3.49 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.541 0.686 . . . . 0.0 110.068 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 527' ' ' ILE . . . . . 0.956 ' HA ' ' HB1' ' A' ' 544' ' ' ALA . 2.3 pp -95.97 -0.25 10.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 114.708 -1.133 . . . . 0.0 112.912 -178.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 528' ' ' GLY . . . . . 0.472 ' N ' HD12 ' A' ' 527' ' ' ILE . . . -56.87 -9.38 3.73 Favored Glycine 0 CA--C 1.523 0.576 0 C-N-CA 121.01 -0.614 . . . . 0.0 114.47 -179.151 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 529' ' ' LEU . . . . . 0.641 HD23 ' H ' ' A' ' 529' ' ' LEU . 1.2 pt? -98.56 -37.46 9.54 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 118.002 0.901 . . . . 0.0 112.021 -179.407 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 530' ' ' ALA . . . . . 0.984 ' HB3' ' HB2' ' A' ' 544' ' ' ALA . . . -103.82 1.94 32.16 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 -178.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 531' ' ' TRP . . . . . 0.464 ' HB2' ' O ' ' A' ' 527' ' ' ILE . 10.2 t90 -68.03 30.31 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 -178.639 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 532' ' ' ILE . . . . . 0.6 ' O ' HD12 ' A' ' 532' ' ' ILE . 1.3 pp -158.89 70.84 3.6 Favored Pre-proline 0 C--N 1.332 -0.177 0 CA-C-O 120.707 0.289 . . . . 0.0 111.462 179.309 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 533' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -54.83 102.07 0.08 OUTLIER 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.335 2.024 . . . . 0.0 111.508 179.374 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 534' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -96.15 -54.88 3.14 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -178.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -118.32 -34.91 3.93 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 111.87 0.322 . . . . 0.0 111.87 -179.247 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . -86.37 -176.29 49.69 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.539 -0.839 . . . . 0.0 112.783 -179.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 537' ' ' PRO . . . . . 0.419 ' HG2' ' CD1' ' A' ' 542' ' ' ILE . 14.0 Cg_endo -56.52 -158.83 0.01 OUTLIER 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.87 2.38 . . . . 0.0 111.818 179.69 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 538' ' ' ALA . . . . . 0.517 ' O ' ' HB3' ' A' ' 539' ' ' ALA . . . -45.06 -49.06 11.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.141 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 539' ' ' ALA . . . . . 0.541 ' C ' ' HB1' ' A' ' 530' ' ' ALA . . . 71.54 -48.79 0.68 Allowed 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.306 0.574 . . . . 0.0 111.459 179.77 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 540' ' ' GLU . . . . . 0.457 ' HG2' ' HA ' ' A' ' 531' ' ' TRP . 4.3 mt-10 -36.94 -29.33 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 114.901 -1.045 . . . . 0.0 112.354 -179.326 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 541' ' ' GLY . . . . . . . . . . . . . . . -127.98 -42.73 0.25 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.369 179.434 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 542' ' ' ILE . . . . . 0.672 HG22 ' ND1' ' A' ' 549' ' ' HIS . 2.6 pp -74.35 -24.88 19.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -179.317 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 543' ' ' TYR . . . . . 0.494 ' HB2' HD12 ' A' ' 542' ' ' ILE . 2.8 t80 -114.4 -7.97 12.86 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.847 0.356 . . . . 0.0 110.814 179.725 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 544' ' ' ALA . . . . . 0.984 ' HB2' ' HB3' ' A' ' 530' ' ' ALA . . . -98.29 -32.36 11.58 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 179.038 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 545' ' ' GLU . . . . . 0.581 ' HG3' ' H ' ' A' ' 548' ' ' MET . 4.4 tp10 -118.67 -32.6 4.51 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.178 -179.84 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 40.22 42.83 2.53 Favored Glycine 0 CA--C 1.52 0.372 0 CA-C-N 115.941 -0.572 . . . . 0.0 113.956 179.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 547' ' ' LEU . . . . . 0.578 HD23 ' H ' ' A' ' 548' ' ' MET . 0.0 OUTLIER -175.54 -61.15 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 117.511 0.656 . . . . 0.0 111.972 179.504 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 548' ' ' MET . . . . . 0.581 ' H ' ' HG3' ' A' ' 545' ' ' GLU . 0.1 OUTLIER -89.76 11.5 19.85 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.649 0.262 . . . . 0.0 111.311 -179.983 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 549' ' ' HIS . . . . . 0.672 ' ND1' HG22 ' A' ' 542' ' ' ILE . 7.2 p80 -65.61 -11.24 42.67 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.139 0.495 . . . . 0.0 110.662 179.328 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 550' ' ' ASN . . . . . 0.445 ' ND2' ' CE1' ' A' ' 549' ' ' HIS . 1.1 m-80 -96.22 -7.57 35.3 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.413 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 551' ' ' GLN . . . . . 0.536 ' HG3' ' HG2' ' A' ' 548' ' ' MET . 8.2 mm-40 -71.81 53.41 0.24 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.706 0.289 . . . . 0.0 111.63 -179.33 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 552' ' ' ASP . . . . . 0.473 ' HB2' ' HA ' ' A' ' 519' ' ' THR . 6.3 t70 -114.15 21.68 14.53 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.738 0.304 . . . . 0.0 110.766 179.392 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 553' ' ' GLY . . . . . 0.414 ' CA ' ' HA ' ' A' ' 511' ' ' CYS . . . 116.96 -31.07 6.03 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.744 -0.741 . . . . 0.0 111.324 -178.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 554' ' ' LEU . . . . . 0.435 ' HG ' ' HB3' ' A' ' 513' ' ' PRO . 11.8 mt -57.61 -53.44 58.16 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-O 121.505 0.669 . . . . 0.0 109.631 178.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 555' ' ' ILE . . . . . 0.622 HG22 ' O ' ' A' ' 555' ' ' ILE . 9.6 mm -89.05 54.93 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 CA-C-N 114.978 -1.01 . . . . 0.0 109.99 179.44 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 556' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.867 -179.459 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 511' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.132 0 CA-C-O 121.061 0.458 . . . . 0.0 111.486 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 512' ' ' ASN . . . . . 0.403 ' O ' ' O ' ' A' ' 552' ' ' ASP . 9.6 m-20 -110.7 83.59 3.57 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.503 179.557 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 513' ' ' PRO . . . . . 0.459 ' HA ' ' O ' ' A' ' 552' ' ' ASP . 90.1 Cg_endo -79.27 22.91 0.66 Allowed 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.953 2.436 . . . . 0.0 113.185 -179.639 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -96.65 -27.66 14.69 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.778 0.323 . . . . 0.0 110.798 179.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 515' ' ' LEU . . . . . . . . . . . . . 1.6 mt -93.06 72.48 4.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.803 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 516' ' ' HIS . . . . . 0.447 ' HA ' ' CB ' ' A' ' 552' ' ' ASP . 2.4 t60 -72.11 -7.53 49.51 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.827 -179.772 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 517' ' ' TYR . . . . . . . . . . . . . 41.6 m-85 -83.96 -66.11 0.93 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.853 0.359 . . . . 0.0 111.448 -179.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 518' ' ' TRP . . . . . 0.446 ' CD1' ' HA ' ' A' ' 523' ' ' GLU . 0.1 OUTLIER -69.33 -19.01 63.87 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.625 -179.459 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 519' ' ' THR . . . . . 0.532 ' OG1' ' N ' ' A' ' 520' ' ' THR . 1.5 p 61.45 -78.26 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.65 -0.25 . . . . 0.0 110.39 -179.69 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 520' ' ' THR . . . . . 0.532 ' N ' ' OG1' ' A' ' 519' ' ' THR . 1.0 OUTLIER 173.12 -62.93 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 179.07 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 521' ' ' GLN . . . . . 0.468 ' HB3' ' OE2' ' A' ' 545' ' ' GLU . 6.0 tt0 -74.52 -15.65 60.86 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 177.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 522' ' ' ASP . . . . . 0.434 ' O ' HG21 ' A' ' 527' ' ' ILE . 13.5 t70 -94.07 -10.45 33.35 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.786 178.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 523' ' ' GLU . . . . . 0.446 ' HA ' ' CD1' ' A' ' 518' ' ' TRP . 0.0 OUTLIER -44.95 -26.88 0.47 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.539 -179.524 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 524' ' ' GLY . . . . . 0.426 ' HA2' ' CG1' ' A' ' 527' ' ' ILE . . . 153.14 40.56 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.288 179.838 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -97.67 -56.3 2.55 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.165 0.431 . . . . 0.0 112.165 -179.342 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -133.2 41.22 3.13 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-O 121.496 0.665 . . . . 0.0 110.185 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 527' ' ' ILE . . . . . 0.885 ' HA ' ' HB1' ' A' ' 544' ' ' ALA . 1.8 pp -95.82 -0.62 10.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 114.783 -1.099 . . . . 0.0 112.918 -178.853 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 528' ' ' GLY . . . . . 0.608 ' N ' HD12 ' A' ' 527' ' ' ILE . . . -60.3 -13.21 28.0 Favored Glycine 0 CA--C 1.521 0.447 0 C-N-CA 120.852 -0.689 . . . . 0.0 114.131 -179.013 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 529' ' ' LEU . . . . . 0.722 HD13 ' N ' ' A' ' 529' ' ' LEU . 0.0 OUTLIER -99.13 -30.44 12.29 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 117.614 0.707 . . . . 0.0 111.817 -179.645 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 530' ' ' ALA . . . . . 1.012 ' HB3' ' HB2' ' A' ' 544' ' ' ALA . . . -103.61 1.69 32.38 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -179.136 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 531' ' ' TRP . . . . . 0.561 ' HA ' ' HG2' ' A' ' 540' ' ' GLU . 0.2 OUTLIER -71.33 30.34 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -178.92 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 532' ' ' ILE . . . . . 0.475 ' H ' ' C ' ' A' ' 530' ' ' ALA . 1.1 pt -158.58 72.98 3.78 Favored Pre-proline 0 N--CA 1.453 -0.311 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.472 179.14 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 533' ' ' PRO . . . . . 0.423 ' HB3' ' O ' ' A' ' 537' ' ' PRO . 1.2 Cg_endo -44.25 85.25 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 123.46 2.773 . . . . 0.0 113.014 -179.625 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 534' ' ' TYR . . . . . 0.446 ' N ' ' O ' ' A' ' 532' ' ' ILE . 7.7 t80 -96.65 -39.47 9.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.329 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 20.6 t80 -57.68 -34.98 69.97 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.549 -179.191 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 146.55 -52.41 0.56 Allowed Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.467 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 537' ' ' PRO . . . . . 0.423 ' O ' ' HB3' ' A' ' 533' ' ' PRO . 2.0 Cg_endo -78.06 -174.53 2.28 Favored 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 122.725 2.283 . . . . 0.0 111.173 179.392 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 538' ' ' ALA . . . . . 0.496 ' O ' ' HB3' ' A' ' 539' ' ' ALA . . . -57.11 -51.23 70.14 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.951 -0.3 . . . . 0.0 110.624 179.554 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 539' ' ' ALA . . . . . 0.496 ' HB3' ' O ' ' A' ' 538' ' ' ALA . . . 71.07 -50.76 0.69 Allowed 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 121.265 0.555 . . . . 0.0 111.402 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 540' ' ' GLU . . . . . 0.561 ' HG2' ' HA ' ' A' ' 531' ' ' TRP . 5.3 mt-10 -37.74 -24.34 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 114.896 -1.047 . . . . 0.0 112.759 -179.445 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 541' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 539' ' ' ALA . . . -111.15 -58.36 0.48 Allowed Glycine 0 CA--C 1.52 0.384 0 C-N-CA 120.488 -0.863 . . . . 0.0 113.227 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 542' ' ' ILE . . . . . 0.524 HD13 ' H ' ' A' ' 542' ' ' ILE . 0.2 OUTLIER -76.94 -22.82 14.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 113.477 0.917 . . . . 0.0 113.477 -178.366 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 543' ' ' TYR . . . . . 0.465 ' C ' ' HB2' ' A' ' 530' ' ' ALA . 10.5 m-85 -101.56 -11.19 19.44 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.27 0.557 . . . . 0.0 110.345 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 544' ' ' ALA . . . . . 1.012 ' HB2' ' HB3' ' A' ' 530' ' ' ALA . . . -100.03 -28.86 12.85 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 115.228 -0.897 . . . . 0.0 110.034 179.689 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 545' ' ' GLU . . . . . 0.561 ' CD ' HD23 ' A' ' 547' ' ' LEU . 3.9 tp10 -118.68 -32.78 4.45 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.384 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 36.39 39.73 0.36 Allowed Glycine 0 CA--C 1.519 0.308 0 CA-C-N 115.759 -0.655 . . . . 0.0 114.371 179.454 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 547' ' ' LEU . . . . . 0.604 HD23 ' H ' ' A' ' 548' ' ' MET . 0.0 OUTLIER -176.71 -61.73 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 117.734 0.767 . . . . 0.0 112.247 179.449 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 548' ' ' MET . . . . . 0.604 ' H ' HD23 ' A' ' 547' ' ' LEU . 0.0 OUTLIER -95.38 11.38 32.94 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.728 0.299 . . . . 0.0 111.053 179.634 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 549' ' ' HIS . . . . . 0.474 ' O ' ' CG2' ' A' ' 519' ' ' THR . 16.5 p80 -62.72 -10.82 14.0 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.024 179.549 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 550' ' ' ASN . . . . . 0.449 ' O ' ' N ' ' A' ' 552' ' ' ASP . 1.8 m120 -95.56 -33.82 12.26 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -178.633 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 551' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -65.9 71.51 0.06 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.182 0.515 . . . . 0.0 110.466 -179.694 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 552' ' ' ASP . . . . . 0.491 ' HA ' ' O ' ' A' ' 519' ' ' THR . 2.4 p30 -94.71 22.12 6.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.397 -179.48 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . 123.97 -32.65 4.13 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.799 -0.715 . . . . 0.0 111.677 -179.393 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 554' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -58.75 -59.18 5.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.488 0.661 . . . . 0.0 109.96 178.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 555' ' ' ILE . . . . . 0.594 HG22 ' O ' ' A' ' 555' ' ' ILE . 3.2 mm -72.27 65.69 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 CA-C-N 114.867 -1.06 . . . . 0.0 110.618 179.781 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 556' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.324 -0.5 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.565 -179.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 511' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.232 0.156 0 CA-C-O 120.993 0.425 . . . . 0.0 111.569 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 512' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -124.04 80.4 57.68 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.48 179.724 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 513' ' ' PRO . . . . . 0.47 ' HA ' ' O ' ' A' ' 552' ' ' ASP . 94.2 Cg_endo -80.98 24.85 0.66 Allowed 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 123.021 2.481 . . . . 0.0 113.179 -179.679 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 17.8 t-20 -96.73 -30.31 13.28 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.707 0.289 . . . . 0.0 110.797 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 515' ' ' LEU . . . . . . . . . . . . . 32.9 mt -89.17 72.97 8.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.847 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 516' ' ' HIS . . . . . 0.425 ' HA ' ' CB ' ' A' ' 552' ' ' ASP . 62.2 t-80 -76.69 -15.69 59.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.541 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 517' ' ' TYR . . . . . . . . . . . . . 57.4 m-85 -80.1 -36.72 35.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.736 0.303 . . . . 0.0 111.373 -179.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 518' ' ' TRP . . . . . 0.462 ' O ' ' N ' ' A' ' 520' ' ' THR . 3.9 m-90 -94.92 -21.27 18.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.501 -179.532 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 519' ' ' THR . . . . . 0.551 ' OG1' ' N ' ' A' ' 520' ' ' THR . 1.2 p 58.41 -78.64 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.843 -179.797 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 520' ' ' THR . . . . . 0.551 ' N ' ' OG1' ' A' ' 519' ' ' THR . 1.1 m 178.18 -62.97 0.01 OUTLIER 'General case' 0 CA--C 1.521 -0.171 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 179.234 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 521' ' ' GLN . . . . . 0.41 ' N ' HG22 ' A' ' 520' ' ' THR . 0.3 OUTLIER -74.42 -14.3 60.83 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 177.825 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -94.13 -11.12 31.16 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.961 179.086 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -45.3 -28.29 0.8 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.235 -179.816 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . 148.61 42.03 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.43 179.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -104.37 -54.8 2.47 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 111.833 0.309 . . . . 0.0 111.833 -179.681 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -131.74 48.44 2.42 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-O 121.536 0.684 . . . . 0.0 110.014 179.758 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 527' ' ' ILE . . . . . 0.779 ' HA ' ' HB1' ' A' ' 544' ' ' ALA . 1.5 pp -95.45 -6.33 10.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 114.916 -1.038 . . . . 0.0 112.517 -178.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 528' ' ' GLY . . . . . 0.702 ' N ' HD12 ' A' ' 527' ' ' ILE . . . -54.86 -13.04 4.12 Favored Glycine 0 CA--C 1.521 0.445 0 C-N-CA 120.971 -0.633 . . . . 0.0 113.817 -179.472 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 529' ' ' LEU . . . . . 0.83 HD22 ' O ' ' A' ' 529' ' ' LEU . 0.3 OUTLIER -97.01 -41.01 8.59 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 117.392 0.596 . . . . 0.0 111.431 -179.296 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 530' ' ' ALA . . . . . 1.01 ' HB3' ' HB2' ' A' ' 544' ' ' ALA . . . -103.76 2.05 32.46 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.789 0.662 . . . . 0.0 112.789 -178.807 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 531' ' ' TRP . . . . . 0.482 ' HB2' ' O ' ' A' ' 527' ' ' ILE . 62.1 t90 -70.89 25.99 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -179.088 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 532' ' ' ILE . . . . . 0.629 ' O ' HD12 ' A' ' 532' ' ' ILE . 1.3 pp -159.25 70.98 3.45 Favored Pre-proline 0 C--N 1.332 -0.191 0 CA-C-O 120.843 0.354 . . . . 0.0 110.885 179.105 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 533' ' ' PRO . . . . . 0.418 ' HB3' ' O ' ' A' ' 537' ' ' PRO . 10.1 Cg_endo -51.36 110.63 0.44 Allowed 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.735 2.29 . . . . 0.0 111.907 179.735 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 534' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -96.33 -55.01 3.08 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -179.143 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -118.47 -35.23 3.81 Favored 'General case' 0 N--CA 1.463 0.179 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -179.121 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . -83.26 -175.11 50.83 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.535 -0.841 . . . . 0.0 112.89 -179.369 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 537' ' ' PRO . . . . . 0.418 ' O ' ' HB3' ' A' ' 533' ' ' PRO . 19.5 Cg_endo -58.12 -156.9 0.01 OUTLIER 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.657 2.238 . . . . 0.0 111.266 179.554 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 538' ' ' ALA . . . . . 0.488 ' O ' ' HB3' ' A' ' 539' ' ' ALA . . . -43.58 -44.01 5.95 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.7 0.286 . . . . 0.0 111.141 179.811 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 539' ' ' ALA . . . . . 0.488 ' HB3' ' O ' ' A' ' 538' ' ' ALA . . . 71.1 -49.54 0.68 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 121.108 0.48 . . . . 0.0 111.665 179.781 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 540' ' ' GLU . . . . . 0.468 ' CG ' ' HA ' ' A' ' 531' ' ' TRP . 3.7 mt-10 -37.66 -25.75 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.142 -0.935 . . . . 0.0 112.656 -179.506 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 541' ' ' GLY . . . . . 0.431 ' N ' ' O ' ' A' ' 539' ' ' ALA . . . -112.73 -55.42 0.45 Allowed Glycine 0 CA--C 1.523 0.549 0 C-N-CA 120.384 -0.912 . . . . 0.0 113.819 -179.559 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 542' ' ' ILE . . . . . 0.59 HG22 ' CD2' ' A' ' 549' ' ' HIS . 0.2 OUTLIER -79.18 -22.94 12.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 113.691 0.997 . . . . 0.0 113.691 -178.133 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 543' ' ' TYR . . . . . 0.494 ' C ' ' HB2' ' A' ' 530' ' ' ALA . 9.7 m-85 -99.02 -16.97 18.51 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.248 0.547 . . . . 0.0 110.028 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 544' ' ' ALA . . . . . 1.01 ' HB2' ' HB3' ' A' ' 530' ' ' ALA . . . -91.52 -24.44 19.63 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.201 179.856 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 545' ' ' GLU . . . . . 0.664 ' CD ' HD23 ' A' ' 547' ' ' LEU . 3.7 tp10 -118.78 -32.65 4.46 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.405 -179.805 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 39.41 42.36 1.82 Allowed Glycine 0 CA--C 1.52 0.378 0 CA-C-N 115.883 -0.599 . . . . 0.0 114.366 179.436 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 547' ' ' LEU . . . . . 0.664 HD23 ' CD ' ' A' ' 545' ' ' GLU . 0.0 OUTLIER -178.51 -61.97 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 117.713 0.756 . . . . 0.0 112.094 179.122 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 548' ' ' MET . . . . . 0.555 ' H ' HD23 ' A' ' 547' ' ' LEU . 0.0 OUTLIER -96.08 11.43 34.21 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.751 0.31 . . . . 0.0 110.975 179.504 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 549' ' ' HIS . . . . . 0.59 ' CD2' HG22 ' A' ' 542' ' ' ILE . 5.1 p-80 -61.19 -11.08 7.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.079 179.631 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 550' ' ' ASN . . . . . 0.43 ' O ' ' N ' ' A' ' 552' ' ' ASP . 28.9 t-20 -95.12 -34.64 12.2 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 -178.788 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 551' ' ' GLN . . . . . 0.404 ' HG3' ' O ' ' A' ' 548' ' ' MET . 2.0 pt20 -66.49 72.08 0.08 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.139 0.495 . . . . 0.0 110.419 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 552' ' ' ASP . . . . . 0.47 ' O ' ' HA ' ' A' ' 513' ' ' PRO . 4.5 p30 -93.87 22.33 5.76 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.514 -179.448 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . 124.2 -28.03 5.44 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.838 -0.696 . . . . 0.0 111.645 -179.27 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 554' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -59.67 -53.32 59.36 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.551 0.691 . . . . 0.0 109.787 178.824 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 555' ' ' ILE . . . . . 0.649 HG22 ' O ' ' A' ' 555' ' ' ILE . 3.2 mm -78.95 62.02 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 114.755 -1.111 . . . . 0.0 110.374 179.808 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 556' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.325 -0.473 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.444 -179.787 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 511' ' ' CYS . . . . . . . . . . . . . 9.6 m . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.935 0.398 . . . . 0.0 111.573 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 512' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -115.76 79.11 7.48 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.512 179.82 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 513' ' ' PRO . . . . . 0.458 ' HA ' ' O ' ' A' ' 552' ' ' ASP . 84.7 Cg_endo -83.48 25.23 0.7 Allowed 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.839 2.359 . . . . 0.0 113.042 -179.657 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -96.66 -29.69 13.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.814 0.34 . . . . 0.0 111.107 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 515' ' ' LEU . . . . . . . . . . . . . 1.5 mt -88.13 73.08 9.05 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.025 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 516' ' ' HIS . . . . . 0.433 ' HA ' ' CB ' ' A' ' 552' ' ' ASP . 1.7 t60 -79.53 -7.21 58.32 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.601 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 517' ' ' TYR . . . . . . . . . . . . . 40.2 m-85 -80.19 -54.27 5.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.655 0.264 . . . . 0.0 111.686 -179.318 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 518' ' ' TRP . . . . . 0.526 ' O ' ' N ' ' A' ' 520' ' ' THR . 4.1 m-90 -92.37 -3.33 55.49 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 -179.02 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 519' ' ' THR . . . . . 0.579 ' OG1' ' N ' ' A' ' 520' ' ' THR . 1.3 p 55.83 -78.13 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 120.591 0.234 . . . . 0.0 110.978 179.746 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 520' ' ' THR . . . . . 0.579 ' N ' ' OG1' ' A' ' 519' ' ' THR . 1.1 m 177.01 -62.58 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.515 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 521' ' ' GLN . . . . . 0.424 ' N ' HG22 ' A' ' 520' ' ' THR . 0.0 OUTLIER -73.84 -12.07 60.57 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 177.96 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 522' ' ' ASP . . . . . 0.435 ' HA ' ' CG2' ' A' ' 527' ' ' ILE . 3.2 m-20 -93.62 -10.72 33.65 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.781 179.047 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 523' ' ' GLU . . . . . 0.428 ' HA ' ' CD1' ' A' ' 518' ' ' TRP . 0.3 OUTLIER -45.39 -27.62 0.73 Allowed 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.501 -179.936 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 524' ' ' GLY . . . . . 0.43 ' HA2' ' CG1' ' A' ' 527' ' ' ILE . . . 146.05 42.34 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.579 -0.819 . . . . 0.0 112.299 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -101.52 -59.65 1.66 Allowed 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 111.941 0.349 . . . . 0.0 111.941 -179.478 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -131.82 36.58 3.69 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-O 121.503 0.668 . . . . 0.0 110.066 179.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 527' ' ' ILE . . . . . 0.964 ' HA ' ' HB1' ' A' ' 544' ' ' ALA . 2.1 pp -95.7 -0.43 10.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 114.787 -1.097 . . . . 0.0 112.735 -178.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 528' ' ' GLY . . . . . 0.516 ' N ' HD12 ' A' ' 527' ' ' ILE . . . -56.83 -13.77 8.84 Favored Glycine 0 CA--C 1.52 0.349 0 C-N-CA 120.892 -0.67 . . . . 0.0 114.024 -179.406 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 529' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -98.55 -32.81 11.26 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 117.639 0.719 . . . . 0.0 111.724 -179.379 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 530' ' ' ALA . . . . . 0.895 ' HB3' ' HB2' ' A' ' 544' ' ' ALA . . . -103.69 1.84 32.36 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -178.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 531' ' ' TRP . . . . . 0.533 ' O ' HG23 ' A' ' 532' ' ' ILE . 4.5 t90 -68.26 26.68 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -179.02 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 532' ' ' ILE . . . . . 0.626 ' O ' HD12 ' A' ' 532' ' ' ILE . 1.3 pp -160.56 71.04 2.88 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 120.846 0.355 . . . . 0.0 110.386 179.014 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 533' ' ' PRO . . . . . 0.414 ' HB3' ' O ' ' A' ' 537' ' ' PRO . 1.2 Cg_endo -44.71 85.22 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 123.451 2.768 . . . . 0.0 113.118 -179.449 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 534' ' ' TYR . . . . . 0.449 ' N ' ' O ' ' A' ' 532' ' ' ILE . 5.8 t80 -96.78 -34.26 11.38 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.148 179.606 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -60.92 -34.93 75.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.567 -179.369 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 536' ' ' GLY . . . . . 0.41 ' N ' ' CD ' ' A' ' 537' ' ' PRO . . . 145.12 -50.4 0.64 Allowed Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.522 -0.847 . . . . 0.0 112.603 -179.817 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 537' ' ' PRO . . . . . 0.414 ' O ' ' HB3' ' A' ' 533' ' ' PRO . 6.1 Cg_exo -74.64 -164.08 0.21 Allowed 'Trans proline' 0 N--CA 1.461 -0.43 0 C-N-CA 122.601 2.201 . . . . 0.0 111.474 179.594 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 538' ' ' ALA . . . . . 0.481 ' O ' ' HB3' ' A' ' 539' ' ' ALA . . . -68.4 -46.78 69.05 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.83 0.347 . . . . 0.0 110.258 179.328 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 539' ' ' ALA . . . . . 0.692 ' C ' ' HB1' ' A' ' 530' ' ' ALA . . . 70.15 -54.04 0.63 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 121.363 0.601 . . . . 0.0 111.443 179.841 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 540' ' ' GLU . . . . . 0.484 ' HG2' ' HA ' ' A' ' 531' ' ' TRP . 12.8 mt-10 -37.52 -27.23 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 114.781 -1.099 . . . . 0.0 112.248 -179.31 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 541' ' ' GLY . . . . . 0.423 ' N ' ' O ' ' A' ' 539' ' ' ALA . . . -125.26 -46.35 0.23 Allowed Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.051 179.006 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 542' ' ' ILE . . . . . 0.466 ' CD1' ' HA ' ' A' ' 539' ' ' ALA . 2.6 pp -73.93 -23.88 19.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -179.503 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 543' ' ' TYR . . . . . 0.465 ' HB2' HD12 ' A' ' 542' ' ' ILE . 23.5 t80 -112.54 -8.45 13.84 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.944 0.402 . . . . 0.0 110.843 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 544' ' ' ALA . . . . . 0.964 ' HB1' ' HA ' ' A' ' 527' ' ' ILE . . . -103.18 -35.21 8.56 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.939 179.316 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 545' ' ' GLU . . . . . 0.53 ' HG3' ' H ' ' A' ' 548' ' ' MET . 28.1 tp10 -118.59 -32.61 4.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.331 -0.85 . . . . 0.0 111.05 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 38.9 40.51 1.09 Allowed Glycine 0 CA--C 1.52 0.355 0 CA-C-N 115.856 -0.611 . . . . 0.0 113.896 179.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 547' ' ' LEU . . . . . 0.551 ' HG ' ' N ' ' A' ' 548' ' ' MET . 0.0 OUTLIER -172.0 -61.47 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 117.537 0.669 . . . . 0.0 112.204 179.568 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 548' ' ' MET . . . . . 0.581 ' O ' ' HG3' ' A' ' 551' ' ' GLN . 0.0 OUTLIER -96.17 11.78 33.15 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.773 0.321 . . . . 0.0 111.688 179.95 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 549' ' ' HIS . . . . . 0.502 ' O ' ' CG2' ' A' ' 519' ' ' THR . 28.5 p80 -64.73 -11.0 31.52 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.88 0.372 . . . . 0.0 110.77 179.255 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 550' ' ' ASN . . . . . 0.46 ' O ' ' N ' ' A' ' 552' ' ' ASP . 5.9 m120 -96.18 -37.98 10.34 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -178.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 551' ' ' GLN . . . . . 0.581 ' HG3' ' O ' ' A' ' 548' ' ' MET . 0.0 OUTLIER -64.62 72.51 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.073 0.463 . . . . 0.0 110.712 -179.621 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 552' ' ' ASP . . . . . 0.46 ' N ' ' O ' ' A' ' 550' ' ' ASN . 2.3 p30 -92.51 21.9 5.03 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.203 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . 123.94 -27.81 5.55 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.952 -0.642 . . . . 0.0 111.766 -179.307 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 554' ' ' LEU . . . . . 0.459 HD11 ' OD2' ' A' ' 552' ' ' ASP . 0.6 OUTLIER -60.56 -60.67 3.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.404 0.621 . . . . 0.0 110.066 179.007 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 555' ' ' ILE . . . . . 0.493 HG22 ' O ' ' A' ' 555' ' ' ILE . 3.6 mm -72.71 70.87 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 CA-C-N 114.999 -1.0 . . . . 0.0 110.494 179.696 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 556' ' ' CYS . . . . . . . . . . . . . 58.7 m . . . . . 0 C--N 1.323 -0.546 0 CA-C-N 115.333 -0.849 . . . . 0.0 112.039 -179.446 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 511' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.455 -0.209 0 CA-C-O 121.068 0.461 . . . . 0.0 111.522 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 512' ' ' ASN . . . . . 0.807 ' ND2' HD12 ' A' ' 515' ' ' LEU . 18.7 p30 -115.52 77.44 5.95 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.077 179.326 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 513' ' ' PRO . . . . . 0.573 ' HA ' ' O ' ' A' ' 552' ' ' ASP . 28.5 Cg_endo -64.5 -10.62 24.95 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.805 2.337 . . . . 0.0 112.345 -179.789 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -81.11 -22.29 39.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.213 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 515' ' ' LEU . . . . . 0.807 HD12 ' ND2' ' A' ' 512' ' ' ASN . 61.5 mt -88.85 74.62 8.23 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.928 0.394 . . . . 0.0 111.094 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 516' ' ' HIS . . . . . 0.474 ' HA ' ' HB3' ' A' ' 552' ' ' ASP . 98.9 m-70 -80.08 -7.27 58.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.693 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 517' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 -78.54 -37.94 41.66 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 111.648 0.24 . . . . 0.0 111.648 -179.354 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 518' ' ' TRP . . . . . 0.595 ' O ' ' N ' ' A' ' 520' ' ' THR . 14.8 m-90 -111.06 5.11 19.97 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 111.99 0.367 . . . . 0.0 111.99 -179.376 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 519' ' ' THR . . . . . 0.539 ' HA ' ' HA ' ' A' ' 552' ' ' ASP . 2.4 p 50.08 -78.32 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 120.421 0.153 . . . . 0.0 110.999 -179.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 520' ' ' THR . . . . . 0.595 ' N ' ' O ' ' A' ' 518' ' ' TRP . 1.2 m 179.45 -62.57 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 179.248 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 521' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -72.38 -12.02 60.94 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.301 178.004 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 522' ' ' ASP . . . . . 0.473 ' HA ' ' CG2' ' A' ' 527' ' ' ILE . 64.9 m-20 -91.71 -10.82 38.77 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.962 179.21 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -45.28 -26.78 0.55 Allowed 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.464 -179.762 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . 145.59 41.99 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.547 -0.835 . . . . 0.0 112.309 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -101.99 -60.57 1.51 Allowed 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 111.784 0.29 . . . . 0.0 111.784 -179.494 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -131.35 37.8 3.67 Favored 'General case' 0 CA--C 1.512 -0.506 0 CA-C-O 121.52 0.676 . . . . 0.0 110.066 179.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 527' ' ' ILE . . . . . 0.92 ' HA ' ' HB1' ' A' ' 544' ' ' ALA . 2.1 pp -95.78 -0.49 10.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-N 114.847 -1.07 . . . . 0.0 112.724 -178.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 528' ' ' GLY . . . . . 0.529 ' N ' HD12 ' A' ' 527' ' ' ILE . . . -58.94 -13.34 18.78 Favored Glycine 0 CA--C 1.521 0.443 0 C-N-CA 120.877 -0.678 . . . . 0.0 113.896 -179.336 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 529' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -98.63 -33.11 11.09 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 117.56 0.68 . . . . 0.0 111.759 -179.425 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 530' ' ' ALA . . . . . 0.942 ' HB3' ' HB2' ' A' ' 544' ' ' ALA . . . -103.62 -0.97 28.92 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 -178.84 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 531' ' ' TRP . . . . . 0.475 ' HA ' ' HG2' ' A' ' 540' ' ' GLU . 8.9 t90 -56.62 -11.12 1.19 Allowed 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 112.057 0.392 . . . . 0.0 112.057 -179.189 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 532' ' ' ILE . . . . . 0.716 ' O ' HD12 ' A' ' 532' ' ' ILE . 1.6 pp -133.45 73.79 72.64 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.037 0.446 . . . . 0.0 111.218 179.632 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 533' ' ' PRO . . . . . 0.406 ' HB3' ' O ' ' A' ' 538' ' ' ALA . 1.0 OUTLIER -44.18 92.95 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 123.165 2.577 . . . . 0.0 112.798 -179.988 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 534' ' ' TYR . . . . . . . . . . . . . 45.0 t80 -96.4 -25.51 15.68 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.079 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -70.57 -34.9 72.72 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.355 -179.559 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 147.32 -64.63 0.42 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.549 -0.834 . . . . 0.0 112.889 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -59.14 -165.01 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.641 2.227 . . . . 0.0 112.011 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 538' ' ' ALA . . . . . 0.477 ' O ' ' HB3' ' A' ' 539' ' ' ALA . . . -66.59 -48.27 70.09 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.558 179.759 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 539' ' ' ALA . . . . . 0.699 ' C ' ' HB1' ' A' ' 530' ' ' ALA . . . 69.54 -53.56 0.6 Allowed 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.302 0.573 . . . . 0.0 111.546 179.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 540' ' ' GLU . . . . . 0.475 ' HG2' ' HA ' ' A' ' 531' ' ' TRP . 14.4 mt-10 -37.32 -27.39 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.889 -1.051 . . . . 0.0 112.266 -179.377 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 541' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 539' ' ' ALA . . . -125.63 -46.71 0.22 Allowed Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.034 179.007 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 542' ' ' ILE . . . . . 0.476 HD12 ' HB2' ' A' ' 543' ' ' TYR . 2.6 pp -73.28 -23.89 20.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -179.515 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 543' ' ' TYR . . . . . 0.476 ' HB2' HD12 ' A' ' 542' ' ' ILE . 21.4 t80 -112.85 -7.62 13.75 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.991 0.424 . . . . 0.0 110.936 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 544' ' ' ALA . . . . . 0.942 ' HB2' ' HB3' ' A' ' 530' ' ' ALA . . . -103.04 -33.41 9.27 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.866 179.328 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 545' ' ' GLU . . . . . 0.645 ' CD ' HD23 ' A' ' 547' ' ' LEU . 3.9 tp10 -118.59 -32.58 4.54 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.43 -0.805 . . . . 0.0 111.0 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 38.01 46.86 1.85 Allowed Glycine 0 CA--C 1.519 0.294 0 CA-C-N 115.804 -0.635 . . . . 0.0 114.148 179.596 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 547' ' ' LEU . . . . . 0.645 HD23 ' CD ' ' A' ' 545' ' ' GLU . 0.0 OUTLIER -179.07 -61.5 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 117.6 0.7 . . . . 0.0 111.801 179.268 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 548' ' ' MET . . . . . 0.549 ' H ' HD23 ' A' ' 547' ' ' LEU . 0.0 OUTLIER -95.08 11.59 31.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.694 0.283 . . . . 0.0 111.088 179.503 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 549' ' ' HIS . . . . . 0.484 ' O ' HG21 ' A' ' 519' ' ' THR . 16.4 p80 -60.64 -11.52 7.53 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.07 179.586 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 550' ' ' ASN . . . . . 0.544 ' O ' ' N ' ' A' ' 552' ' ' ASP . 8.6 m-20 -94.8 -40.19 9.88 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 -179.332 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 551' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -60.34 73.06 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.189 0.519 . . . . 0.0 110.303 179.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 552' ' ' ASP . . . . . 0.573 ' O ' ' HA ' ' A' ' 513' ' ' PRO . 11.8 m-20 -84.62 21.73 1.45 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.933 -179.278 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 553' ' ' GLY . . . . . 0.414 ' HA3' ' N ' ' A' ' 513' ' ' PRO . . . 116.7 12.84 8.35 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.105 -179.653 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 554' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -104.41 -51.59 3.07 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.42 0.629 . . . . 0.0 109.93 179.75 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 555' ' ' ILE . . . . . 0.516 HG22 ' O ' ' A' ' 555' ' ' ILE . 2.2 mm -78.27 -1.69 4.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 114.923 -1.035 . . . . 0.0 111.231 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 556' ' ' CYS . . . . . . . . . . . . . 25.9 p . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.973 178.817 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 511' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.462 0.17 0 CA-C-O 120.878 0.371 . . . . 0.0 111.611 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 512' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -107.72 83.94 1.81 Allowed Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.755 179.736 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 513' ' ' PRO . . . . . 0.455 ' HA ' ' O ' ' A' ' 552' ' ' ASP . 57.2 Cg_endo -71.27 -6.08 18.41 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.76 2.306 . . . . 0.0 112.86 -179.859 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -71.71 -28.29 63.6 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.189 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 515' ' ' LEU . . . . . . . . . . . . . 83.4 mt -92.06 72.24 5.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.855 0.36 . . . . 0.0 111.08 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 516' ' ' HIS . . . . . 0.511 ' CE1' ' CZ ' ' A' ' 517' ' ' TYR . 10.7 p80 -86.15 -7.18 58.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.669 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 517' ' ' TYR . . . . . 0.511 ' CZ ' ' CE1' ' A' ' 516' ' ' HIS . 46.2 m-85 -84.03 -19.43 34.45 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.711 -0.222 . . . . 0.0 111.576 -179.809 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 518' ' ' TRP . . . . . 0.5 ' O ' ' N ' ' A' ' 520' ' ' THR . 4.4 m-90 -118.08 -13.32 9.97 Favored 'General case' 0 C--N 1.332 -0.164 0 N-CA-C 112.227 0.454 . . . . 0.0 112.227 -179.134 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 519' ' ' THR . . . . . 0.563 ' OG1' ' N ' ' A' ' 520' ' ' THR . 1.2 p 57.5 -78.13 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 110.643 -0.132 . . . . 0.0 110.643 -179.691 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 520' ' ' THR . . . . . 0.563 ' N ' ' OG1' ' A' ' 519' ' ' THR . 1.2 m 178.53 -62.75 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.227 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 521' ' ' GLN . . . . . . . . . . . . . 10.7 mt-30 -75.54 -11.74 60.09 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.268 178.206 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 522' ' ' ASP . . . . . 0.457 ' HB2' ' O ' ' A' ' 518' ' ' TRP . 45.2 m-20 -94.48 -12.39 27.8 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.013 178.588 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 523' ' ' GLU . . . . . 0.412 ' HG3' ' HA ' ' A' ' 520' ' ' THR . 20.2 mm-40 -50.0 -25.22 3.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.701 178.632 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . 139.48 37.9 0.11 Allowed Glycine 0 N--CA 1.445 -0.708 0 N-CA-C 110.3 -1.12 . . . . 0.0 110.3 -179.075 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -107.94 -42.96 4.55 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.273 -0.464 . . . . 0.0 111.61 -178.543 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 526' ' ' ALA . . . . . 0.53 ' O ' ' HB1' ' A' ' 544' ' ' ALA . . . -136.8 42.74 2.45 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-O 121.441 0.638 . . . . 0.0 110.157 179.678 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 527' ' ' ILE . . . . . 0.74 HD12 ' N ' ' A' ' 528' ' ' GLY . 1.8 pp -95.53 -8.38 9.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 114.994 -1.003 . . . . 0.0 112.39 -179.056 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 528' ' ' GLY . . . . . 0.74 ' N ' HD12 ' A' ' 527' ' ' ILE . . . -55.95 -16.32 12.51 Favored Glycine 0 CA--C 1.52 0.402 0 C-N-CA 120.938 -0.649 . . . . 0.0 114.009 -179.222 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 529' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -98.49 -35.3 10.3 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 117.581 0.69 . . . . 0.0 111.767 -179.314 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 530' ' ' ALA . . . . . 1.009 ' HB3' ' HB2' ' A' ' 544' ' ' ALA . . . -103.6 1.06 31.61 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.694 0.627 . . . . 0.0 112.694 -178.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 531' ' ' TRP . . . . . 0.457 ' HB2' ' O ' ' A' ' 527' ' ' ILE . 22.4 t90 -56.08 -12.81 1.63 Allowed 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 111.878 0.325 . . . . 0.0 111.878 -179.439 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 532' ' ' ILE . . . . . 0.698 ' O ' HD12 ' A' ' 532' ' ' ILE . 1.6 pp -129.8 74.74 80.43 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 120.908 0.385 . . . . 0.0 111.06 179.665 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 533' ' ' PRO . . . . . 0.58 ' HB3' ' HB3' ' A' ' 539' ' ' ALA . 9.5 Cg_endo -51.89 94.91 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.891 2.394 . . . . 0.0 112.688 -179.68 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 534' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -96.26 -17.13 20.97 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.09 179.558 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -75.89 -35.01 60.0 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.369 -179.595 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 143.88 -64.15 0.48 Allowed Glycine 0 CA--C 1.519 0.297 0 C-N-CA 120.484 -0.865 . . . . 0.0 112.788 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -58.95 -165.79 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.689 2.259 . . . . 0.0 112.177 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 538' ' ' ALA . . . . . 0.436 ' O ' ' HB3' ' A' ' 539' ' ' ALA . . . -63.02 -49.76 73.37 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.474 179.825 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 539' ' ' ALA . . . . . 0.599 ' C ' ' HB1' ' A' ' 530' ' ' ALA . . . 68.01 -57.63 0.46 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 121.389 0.614 . . . . 0.0 111.804 179.578 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -37.48 -29.94 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.942 -1.026 . . . . 0.0 112.338 -179.173 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 541' ' ' GLY . . . . . 0.401 ' O ' ' HB3' ' A' ' 549' ' ' HIS . . . -122.89 -26.23 1.76 Allowed Glycine 0 CA--C 1.52 0.379 0 C-N-CA 120.281 -0.961 . . . . 0.0 113.503 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 542' ' ' ILE . . . . . 0.54 ' CD1' ' HA ' ' A' ' 539' ' ' ALA . 2.6 pp -96.48 -21.47 5.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 112.392 0.515 . . . . 0.0 112.392 -179.247 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 543' ' ' TYR . . . . . 0.455 ' HB2' ' HA ' ' A' ' 539' ' ' ALA . 3.6 t80 -107.86 -13.75 14.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.084 0.468 . . . . 0.0 110.263 179.536 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 544' ' ' ALA . . . . . 1.009 ' HB2' ' HB3' ' A' ' 530' ' ' ALA . . . -92.16 -21.58 20.32 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.309 179.453 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 545' ' ' GLU . . . . . 0.517 ' OE2' ' HB2' ' A' ' 548' ' ' MET . 4.2 tp10 -118.36 -33.35 4.38 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.363 -179.666 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 35.21 40.71 0.26 Allowed Glycine 0 CA--C 1.519 0.297 0 CA-C-N 115.808 -0.633 . . . . 0.0 114.472 179.278 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 547' ' ' LEU . . . . . 0.617 HD23 ' H ' ' A' ' 548' ' ' MET . 0.0 OUTLIER -179.79 -61.43 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 118.004 0.902 . . . . 0.0 112.46 179.567 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 548' ' ' MET . . . . . 0.617 ' H ' HD23 ' A' ' 547' ' ' LEU . 0.0 OUTLIER -94.6 11.65 30.31 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.818 0.342 . . . . 0.0 111.085 179.794 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 549' ' ' HIS . . . . . 0.491 ' O ' ' CG2' ' A' ' 519' ' ' THR . 6.7 p-80 -62.6 -11.12 14.88 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.079 179.568 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 550' ' ' ASN . . . . . 0.429 ' O ' ' N ' ' A' ' 552' ' ' ASP . 47.3 m-20 -96.04 -33.06 12.26 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -178.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 551' ' ' GLN . . . . . 0.411 ' HG2' ' CG ' ' A' ' 548' ' ' MET . 1.7 pt20 -66.36 71.53 0.07 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.109 0.48 . . . . 0.0 110.654 -179.79 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 552' ' ' ASP . . . . . 0.455 ' O ' ' HA ' ' A' ' 513' ' ' PRO . 3.3 p30 -95.38 21.96 7.47 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.396 -179.661 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . 123.89 -31.05 4.66 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.902 -0.666 . . . . 0.0 111.683 -179.279 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 554' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -61.48 -58.76 6.88 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.42 0.628 . . . . 0.0 109.87 178.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 555' ' ' ILE . . . . . 0.637 HG22 ' O ' ' A' ' 555' ' ' ILE . 3.2 mm -73.28 63.29 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.694 179.765 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 556' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.326 -0.447 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.432 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 507' ' ' ALA . . . . . 0.767 ' HB3' ' HG3' ' A' ' 559' ' ' ARG . . . . . . . . 0 N--CA 1.487 1.406 0 CA-C-O 120.922 0.391 . . . . 0.0 111.105 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 508' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -128.58 77.38 77.46 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.949 179.634 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 509' ' ' PRO . . . . . 0.538 ' HB3' HD11 ' A' ' 558' ' ' LEU . 17.4 Cg_exo -66.74 -65.37 0.04 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.245 0 C-N-CA 122.658 2.239 . . . . 0.0 111.755 179.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 510' ' ' LYS . . . . . 0.471 ' HG2' ' N ' ' A' ' 511' ' ' CYS . 0.0 OUTLIER 177.25 -34.76 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.406 179.641 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 511' ' ' CYS . . . . . 0.471 ' N ' ' HG2' ' A' ' 510' ' ' LYS . 0.6 OUTLIER 43.97 64.57 1.24 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.103 -0.953 . . . . 0.0 111.428 179.491 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 512' ' ' ASN . . . . . . . . . . . . . 7.5 m-20 -131.35 82.46 62.28 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.434 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 513' ' ' PRO . . . . . 0.468 ' HA ' ' O ' ' A' ' 552' ' ' ASP . 85.3 Cg_endo -79.07 20.71 0.79 Allowed 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.895 2.396 . . . . 0.0 113.097 -179.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 34.8 t30 -96.67 -31.25 12.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.96 0.41 . . . . 0.0 110.786 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 515' ' ' LEU . . . . . . . . . . . . . 18.9 mt -83.52 73.85 10.16 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.886 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 516' ' ' HIS . . . . . 0.413 ' HA ' ' CB ' ' A' ' 552' ' ' ASP . 1.4 t-80 -72.47 -15.28 61.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.59 -179.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 517' ' ' TYR . . . . . . . . . . . . . 48.2 m-85 -79.16 -66.03 0.92 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.819 0.342 . . . . 0.0 111.433 -179.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 518' ' ' TRP . . . . . 0.494 ' O ' ' N ' ' A' ' 520' ' ' THR . 21.2 m-90 -70.32 -14.38 62.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.884 -179.492 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 519' ' ' THR . . . . . 0.541 ' OG1' ' N ' ' A' ' 520' ' ' THR . 1.7 p 56.98 -78.8 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.344 0 CA-C-N 116.727 -0.215 . . . . 0.0 110.719 -179.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 520' ' ' THR . . . . . 0.541 ' N ' ' OG1' ' A' ' 519' ' ' THR . 1.1 m 176.83 -62.68 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.149 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 521' ' ' GLN . . . . . 0.419 ' N ' HG22 ' A' ' 520' ' ' THR . 0.5 OUTLIER -72.73 -12.27 60.95 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 177.969 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 522' ' ' ASP . . . . . 0.444 ' HA ' ' CG2' ' A' ' 527' ' ' ILE . 1.9 m-20 -93.89 -11.03 31.95 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.699 178.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -45.48 -27.92 0.81 Allowed 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.44 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 524' ' ' GLY . . . . . 0.436 ' HA2' ' CG1' ' A' ' 527' ' ' ILE . . . 147.62 41.38 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.489 -0.863 . . . . 0.0 112.477 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -100.44 -60.11 1.58 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.743 0.306 . . . . 0.0 111.737 -179.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -132.48 37.57 3.5 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-O 121.488 0.661 . . . . 0.0 110.103 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 527' ' ' ILE . . . . . 0.945 ' HA ' ' HB1' ' A' ' 544' ' ' ALA . 1.8 pp -95.94 -0.96 10.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 114.811 -1.086 . . . . 0.0 112.793 -178.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 528' ' ' GLY . . . . . 0.598 ' N ' HD12 ' A' ' 527' ' ' ILE . . . -57.63 -12.56 9.94 Favored Glycine 0 CA--C 1.521 0.414 0 C-N-CA 120.875 -0.679 . . . . 0.0 113.976 -179.344 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 529' ' ' LEU . . . . . 0.504 HD11 ' O ' ' A' ' 543' ' ' TYR . 1.2 pp -98.75 -39.37 8.68 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 117.757 0.779 . . . . 0.0 112.167 -179.241 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 530' ' ' ALA . . . . . 1.019 ' HB3' ' HB2' ' A' ' 544' ' ' ALA . . . -103.93 1.8 31.72 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 -178.461 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 531' ' ' TRP . . . . . 0.481 ' HB2' ' O ' ' A' ' 527' ' ' ILE . 54.9 t90 -72.04 30.3 0.05 Allowed 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -178.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 532' ' ' ILE . . . . . 0.62 ' O ' HD12 ' A' ' 532' ' ' ILE . 1.3 pp -159.65 70.87 3.27 Favored Pre-proline 0 C--N 1.332 -0.181 0 CA-C-O 120.723 0.297 . . . . 0.0 110.894 179.176 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 533' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -51.26 103.51 0.07 OUTLIER 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.659 2.239 . . . . 0.0 111.742 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 534' ' ' TYR . . . . . 0.4 ' CD1' HD12 ' A' ' 532' ' ' ILE . 0.4 OUTLIER -96.17 -55.06 3.08 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -179.006 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 -118.52 -35.23 3.8 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 -179.1 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . -87.44 -175.06 48.68 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.891 -179.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 537' ' ' PRO . . . . . 0.402 ' HG2' ' CD1' ' A' ' 542' ' ' ILE . 14.1 Cg_endo -56.59 -159.34 0.01 OUTLIER 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.884 2.39 . . . . 0.0 111.692 179.691 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 538' ' ' ALA . . . . . 0.508 ' O ' ' HB3' ' A' ' 539' ' ' ALA . . . -43.99 -49.83 8.48 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.067 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 539' ' ' ALA . . . . . 0.522 ' C ' ' HB1' ' A' ' 530' ' ' ALA . . . 71.66 -46.7 0.65 Allowed 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.205 0.526 . . . . 0.0 111.548 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 540' ' ' GLU . . . . . 0.444 ' HG2' ' HA ' ' A' ' 531' ' ' TRP . 2.5 mt-10 -36.95 -29.09 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.057 -0.974 . . . . 0.0 112.304 -179.352 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 541' ' ' GLY . . . . . 0.406 ' N ' ' O ' ' A' ' 539' ' ' ALA . . . -127.79 -48.66 0.17 Allowed Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.028 179.21 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 542' ' ' ILE . . . . . 0.534 HD12 ' HB2' ' A' ' 543' ' ' TYR . 2.6 pp -68.09 -25.14 31.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -179.355 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 543' ' ' TYR . . . . . 0.534 ' HB2' HD12 ' A' ' 542' ' ' ILE . 6.1 t80 -115.3 -8.0 12.32 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.857 0.361 . . . . 0.0 111.145 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 544' ' ' ALA . . . . . 1.019 ' HB2' ' HB3' ' A' ' 530' ' ' ALA . . . -99.31 -33.22 10.81 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.06 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 545' ' ' GLU . . . . . 0.529 ' HG3' ' H ' ' A' ' 548' ' ' MET . 14.3 tp10 -118.67 -32.67 4.49 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.209 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 40.71 42.1 2.66 Favored Glycine 0 CA--C 1.521 0.417 0 CA-C-N 115.917 -0.583 . . . . 0.0 113.747 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 547' ' ' LEU . . . . . 0.666 HD23 ' H ' ' A' ' 548' ' ' MET . 0.0 OUTLIER -173.16 -61.14 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 117.4 0.6 . . . . 0.0 112.14 179.608 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 548' ' ' MET . . . . . 0.666 ' H ' HD23 ' A' ' 547' ' ' LEU . 4.3 mtt -95.31 11.71 31.64 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.709 0.29 . . . . 0.0 111.481 -179.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 549' ' ' HIS . . . . . 0.523 ' O ' HG21 ' A' ' 519' ' ' THR . 14.7 p-80 -65.47 -11.08 39.81 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.861 0.363 . . . . 0.0 110.791 179.423 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 550' ' ' ASN . . . . . 0.505 ' O ' ' N ' ' A' ' 552' ' ' ASP . 15.0 m-20 -95.87 -41.08 8.99 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -179.092 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 551' ' ' GLN . . . . . 0.51 ' HG3' ' O ' ' A' ' 548' ' ' MET . 0.0 OUTLIER -62.36 73.31 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.171 0.51 . . . . 0.0 110.469 -179.882 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 552' ' ' ASP . . . . . 0.505 ' N ' ' O ' ' A' ' 550' ' ' ASN . 1.9 p30 -90.25 22.2 3.44 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.601 -179.581 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . 124.04 -30.52 4.78 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.891 -0.671 . . . . 0.0 111.668 -179.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 554' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -55.73 -53.65 54.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.559 0.695 . . . . 0.0 110.138 178.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 555' ' ' ILE . . . . . 0.793 ' O ' HD23 ' A' ' 558' ' ' LEU . 4.0 mm -79.52 58.96 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.696 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 556' ' ' CYS . . . . . . . . . . . . . 6.3 t -73.98 -7.49 52.59 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.469 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -67.36 -7.67 47.03 Favored Glycine 0 CA--C 1.52 0.375 0 C-N-CA 120.811 -0.709 . . . . 0.0 113.489 -179.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 558' ' ' LEU . . . . . 0.793 HD23 ' O ' ' A' ' 555' ' ' ILE . 0.5 OUTLIER -53.55 -59.38 4.67 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 117.276 0.538 . . . . 0.0 111.249 -179.751 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 559' ' ' ARG . . . . . 0.767 ' HG3' ' HB3' ' A' ' 507' ' ' ALA . 2.2 mpt_? 56.55 164.81 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.225 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 560' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.205 -0.903 . . . . 0.0 110.958 -179.976 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.384 0 CA-C-O 120.838 0.351 . . . . 0.0 111.116 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 508' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.37 77.63 76.81 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.916 179.63 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 509' ' ' PRO . . . . . 0.467 ' O ' ' CE ' ' A' ' 510' ' ' LYS . 73.9 Cg_endo -75.14 -8.82 20.24 Favored 'Trans proline' 0 C--N 1.343 0.241 0 C-N-CA 122.636 2.224 . . . . 0.0 112.63 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 510' ' ' LYS . . . . . 0.467 ' CE ' ' O ' ' A' ' 509' ' ' PRO . 0.0 OUTLIER 82.44 -31.22 0.09 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 121.029 0.442 . . . . 0.0 111.615 -179.912 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 511' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 45.32 90.15 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.485 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 512' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -131.72 77.23 73.09 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.403 179.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 513' ' ' PRO . . . . . 0.462 ' HA ' ' O ' ' A' ' 552' ' ' ASP . 87.7 Cg_endo -79.75 22.52 0.72 Allowed 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.932 2.421 . . . . 0.0 113.177 -179.533 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 25.8 t30 -96.67 -28.97 14.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.691 0.281 . . . . 0.0 110.804 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 515' ' ' LEU . . . . . . . . . . . . . 46.4 mt -90.59 72.87 6.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.926 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 516' ' ' HIS . . . . . 0.434 ' HA ' ' CB ' ' A' ' 552' ' ' ASP . 1.4 t60 -76.7 -7.34 55.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.655 -179.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 517' ' ' TYR . . . . . . . . . . . . . 42.9 m-85 -85.26 -49.5 8.14 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.674 0.274 . . . . 0.0 111.524 -179.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 518' ' ' TRP . . . . . 0.495 ' O ' ' N ' ' A' ' 520' ' ' THR . 3.0 m-90 -88.56 -11.55 45.3 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 111.886 0.328 . . . . 0.0 111.886 -179.331 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 519' ' ' THR . . . . . 0.572 ' OG1' ' N ' ' A' ' 520' ' ' THR . 1.3 p 56.22 -79.08 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.81 -0.177 . . . . 0.0 110.989 179.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 520' ' ' THR . . . . . 0.572 ' N ' ' OG1' ' A' ' 519' ' ' THR . 1.2 m 179.46 -62.74 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 179.435 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 521' ' ' GLN . . . . . . . . . . . . . 6.8 mt-30 -74.16 -12.07 60.48 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 177.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 522' ' ' ASP . . . . . 0.438 ' HB2' ' O ' ' A' ' 518' ' ' TRP . 20.8 m-20 -93.95 -10.57 33.28 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.854 179.296 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 523' ' ' GLU . . . . . 0.466 ' HA ' ' CD1' ' A' ' 518' ' ' TRP . 14.1 pt-20 -45.24 -26.65 0.52 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.515 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . 147.6 41.35 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.289 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -101.23 -60.46 1.52 Allowed 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 111.941 0.349 . . . . 0.0 111.941 -179.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -131.44 36.84 3.74 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-O 121.541 0.686 . . . . 0.0 110.129 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 527' ' ' ILE . . . . . 0.935 ' HA ' ' HB1' ' A' ' 544' ' ' ALA . 2.1 pp -95.77 -0.38 10.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 114.762 -1.108 . . . . 0.0 112.709 -178.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 528' ' ' GLY . . . . . 0.515 ' N ' HD12 ' A' ' 527' ' ' ILE . . . -60.41 -10.47 16.85 Favored Glycine 0 CA--C 1.521 0.423 0 C-N-CA 120.82 -0.705 . . . . 0.0 113.948 -179.43 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 529' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -98.47 -33.69 10.92 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 117.569 0.684 . . . . 0.0 111.502 -179.585 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 530' ' ' ALA . . . . . 0.93 ' HB3' ' HB2' ' A' ' 544' ' ' ALA . . . -103.75 1.63 31.96 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -178.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 531' ' ' TRP . . . . . 0.547 ' O ' HG23 ' A' ' 532' ' ' ILE . 0.2 OUTLIER -71.15 30.2 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -179.056 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 532' ' ' ILE . . . . . 0.547 HG23 ' O ' ' A' ' 531' ' ' TRP . 1.1 pt -161.02 75.38 2.57 Favored Pre-proline 0 N--CA 1.456 -0.162 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.471 179.301 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 533' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -36.89 85.98 0.01 OUTLIER 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 123.5 2.8 . . . . 0.0 113.399 -179.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 534' ' ' TYR . . . . . 0.455 ' N ' ' O ' ' A' ' 532' ' ' ILE . 0.6 OUTLIER -96.7 -49.51 5.07 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.269 -179.991 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -57.53 -34.85 69.56 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.548 -179.329 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 143.47 -64.57 0.48 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.566 -0.826 . . . . 0.0 112.531 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -58.72 -165.48 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.622 2.215 . . . . 0.0 111.711 179.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 538' ' ' ALA . . . . . 0.437 ' O ' ' HB3' ' A' ' 539' ' ' ALA . . . -62.13 -51.1 69.24 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.292 179.64 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 539' ' ' ALA . . . . . 0.644 ' C ' ' HB1' ' A' ' 530' ' ' ALA . . . 68.45 -53.72 0.54 Allowed 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.599 179.725 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 540' ' ' GLU . . . . . 0.414 ' O ' ' HB3' ' A' ' 544' ' ' ALA . 0.6 OUTLIER -37.28 -27.98 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.022 -0.99 . . . . 0.0 112.09 -179.416 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 541' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 539' ' ' ALA . . . -124.57 -47.31 0.23 Allowed Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.14 179.155 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 542' ' ' ILE . . . . . 0.514 HG22 ' CE1' ' A' ' 549' ' ' HIS . 2.6 pp -72.65 -22.92 20.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 -179.634 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 543' ' ' TYR . . . . . 0.423 ' C ' ' HB2' ' A' ' 530' ' ' ALA . 89.8 t80 -111.02 -8.05 14.48 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.067 0.461 . . . . 0.0 110.68 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 544' ' ' ALA . . . . . 0.935 ' HB1' ' HA ' ' A' ' 527' ' ' ILE . . . -103.04 -32.86 9.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.02 179.43 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 545' ' ' GLU . . . . . 0.48 ' OE2' HD23 ' A' ' 547' ' ' LEU . 29.3 tp10 -118.49 -32.74 4.52 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.207 -179.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 38.17 37.61 0.48 Allowed Glycine 0 CA--C 1.519 0.326 0 CA-C-N 115.723 -0.672 . . . . 0.0 113.985 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 547' ' ' LEU . . . . . 0.6 HD23 ' H ' ' A' ' 548' ' ' MET . 0.0 OUTLIER -170.58 -61.99 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 117.694 0.747 . . . . 0.0 112.506 179.484 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 548' ' ' MET . . . . . 0.6 ' H ' HD23 ' A' ' 547' ' ' LEU . 0.0 OUTLIER -96.45 11.31 35.38 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.731 0.301 . . . . 0.0 111.124 179.682 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 549' ' ' HIS . . . . . 0.514 ' CE1' HG22 ' A' ' 542' ' ' ILE . 6.0 p-80 -63.43 -10.99 19.76 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.919 179.6 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 550' ' ' ASN . . . . . 0.415 ' O ' ' N ' ' A' ' 552' ' ' ASP . 44.9 m-20 -95.73 -34.25 12.0 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -179.021 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 551' ' ' GLN . . . . . 0.418 ' HG2' ' HG3' ' A' ' 548' ' ' MET . 2.5 pt20 -66.87 71.86 0.09 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.016 0.436 . . . . 0.0 110.55 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 552' ' ' ASP . . . . . 0.462 ' O ' ' HA ' ' A' ' 513' ' ' PRO . 2.6 p30 -93.62 21.95 5.89 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.37 -179.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . 123.9 -31.91 4.38 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.885 -0.674 . . . . 0.0 111.752 -179.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 554' ' ' LEU . . . . . 0.441 HD11 ' OD2' ' A' ' 552' ' ' ASP . 0.5 OUTLIER -59.42 -57.85 11.17 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.493 0.663 . . . . 0.0 110.194 179.017 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 555' ' ' ILE . . . . . 0.648 HG22 ' O ' ' A' ' 555' ' ' ILE . 2.8 mm -72.36 63.77 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 CA-C-N 114.892 -1.049 . . . . 0.0 110.724 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 556' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -70.21 -12.31 61.5 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.328 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 557' ' ' GLY . . . . . 0.412 ' HA2' ' NH1' ' A' ' 559' ' ' ARG . . . -53.96 -21.28 16.44 Favored Glycine 0 CA--C 1.519 0.313 0 C-N-CA 120.885 -0.674 . . . . 0.0 113.118 -179.644 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 558' ' ' LEU . . . . . 0.831 HD12 ' N ' ' A' ' 559' ' ' ARG . 3.0 pp -49.7 -45.98 49.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.791 0.329 . . . . 0.0 111.447 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 559' ' ' ARG . . . . . 0.831 ' N ' HD12 ' A' ' 558' ' ' LEU . 6.4 mpt_? 50.34 -177.73 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.261 -179.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 560' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.192 -0.908 . . . . 0.0 111.094 179.928 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.382 0 CA-C-O 120.914 0.388 . . . . 0.0 111.142 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 508' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -128.7 95.01 33.37 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.091 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 509' ' ' PRO . . . . . 0.546 ' O ' ' CE ' ' A' ' 510' ' ' LYS . 73.0 Cg_endo -76.45 -17.66 16.3 Favored 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 122.532 2.155 . . . . 0.0 112.406 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 510' ' ' LYS . . . . . 0.546 ' CE ' ' O ' ' A' ' 509' ' ' PRO . 0.0 OUTLIER 88.5 -15.02 0.36 Allowed 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 122.974 0.51 . . . . 0.0 111.322 -179.761 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 511' ' ' CYS . . . . . . . . . . . . . 1.5 t 47.0 81.65 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.315 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 512' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -109.76 78.2 1.18 Allowed Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.468 179.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 513' ' ' PRO . . . . . 0.472 ' HA ' ' O ' ' A' ' 552' ' ' ASP . 73.6 Cg_endo -75.89 18.42 0.63 Allowed 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.92 2.414 . . . . 0.0 113.106 -179.494 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -96.7 -34.26 11.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.782 0.325 . . . . 0.0 110.773 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 515' ' ' LEU . . . . . . . . . . . . . 52.6 mt -78.9 75.13 5.41 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.943 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 516' ' ' HIS . . . . . . . . . . . . . 1.3 p-80 -79.87 -7.23 58.61 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.677 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 517' ' ' TYR . . . . . 0.442 ' HB2' ' CE3' ' A' ' 518' ' ' TRP . 44.5 m-85 -77.79 -59.9 2.59 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.783 0.325 . . . . 0.0 111.309 -179.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 518' ' ' TRP . . . . . 0.55 ' O ' ' N ' ' A' ' 520' ' ' THR . 13.9 m-90 -91.17 4.68 51.62 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.793 -179.618 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 519' ' ' THR . . . . . 0.534 ' OG1' ' N ' ' A' ' 520' ' ' THR . 1.3 p 54.42 -76.6 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 116.851 -0.159 . . . . 0.0 110.986 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 520' ' ' THR . . . . . 0.55 ' N ' ' O ' ' A' ' 518' ' ' TRP . 1.2 m 176.98 -62.47 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.231 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 179.436 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 521' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.81 -12.37 61.57 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.418 178.103 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 522' ' ' ASP . . . . . 0.462 ' HA ' ' CG2' ' A' ' 527' ' ' ILE . 1.1 m-20 -93.93 -11.2 31.49 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.939 179.294 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 523' ' ' GLU . . . . . 0.403 ' HA ' ' HB3' ' A' ' 518' ' ' TRP . 16.8 pt-20 -45.52 -27.56 0.76 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.474 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 524' ' ' GLY . . . . . 0.428 ' HA2' ' CG1' ' A' ' 527' ' ' ILE . . . 144.99 42.45 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.508 -0.854 . . . . 0.0 112.229 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -101.32 -60.31 1.55 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.713 0.292 . . . . 0.0 111.706 -179.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -131.8 38.43 3.55 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-O 121.521 0.677 . . . . 0.0 110.036 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 527' ' ' ILE . . . . . 0.893 ' HA ' ' HB1' ' A' ' 544' ' ' ALA . 2.1 pp -95.8 -0.5 10.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 114.719 -1.128 . . . . 0.0 112.775 -178.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 528' ' ' GLY . . . . . 0.538 ' N ' HD12 ' A' ' 527' ' ' ILE . . . -57.71 -14.31 14.94 Favored Glycine 0 CA--C 1.521 0.452 0 C-N-CA 120.762 -0.733 . . . . 0.0 114.005 -179.362 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 529' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -98.74 -33.66 10.83 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 117.666 0.733 . . . . 0.0 111.909 -179.334 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 530' ' ' ALA . . . . . 0.945 ' HB3' ' HB2' ' A' ' 544' ' ' ALA . . . -103.85 1.96 32.11 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -178.604 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 531' ' ' TRP . . . . . 0.512 ' O ' HG23 ' A' ' 532' ' ' ILE . 57.3 t-105 -68.43 30.09 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.546 0.573 . . . . 0.0 112.546 -178.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 532' ' ' ILE . . . . . 0.512 HG23 ' O ' ' A' ' 531' ' ' TRP . 1.1 pt -160.2 71.9 3.04 Favored Pre-proline 0 C--N 1.331 -0.207 0 CA-C-O 120.827 0.346 . . . . 0.0 110.742 179.037 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 533' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_endo -47.11 88.43 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 123.148 2.565 . . . . 0.0 112.821 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 534' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -96.43 -43.6 7.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.283 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -57.75 -34.78 69.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.552 -179.341 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 149.13 -64.77 0.4 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.529 -0.843 . . . . 0.0 112.579 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_endo -57.3 -164.09 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.576 2.184 . . . . 0.0 111.8 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 538' ' ' ALA . . . . . 0.498 ' O ' ' HB3' ' A' ' 539' ' ' ALA . . . -72.03 -47.2 53.45 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.619 179.655 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 539' ' ' ALA . . . . . 0.665 ' C ' ' HB1' ' A' ' 530' ' ' ALA . . . 70.7 -53.73 0.66 Allowed 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.33 0.586 . . . . 0.0 111.227 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 540' ' ' GLU . . . . . 0.508 ' HG2' ' HA ' ' A' ' 531' ' ' TRP . 15.6 mt-10 -37.26 -28.17 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.543 0 CA-C-N 114.828 -1.078 . . . . 0.0 112.37 -179.442 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 541' ' ' GLY . . . . . 0.447 ' HA3' ' CD2' ' A' ' 549' ' ' HIS . . . -126.24 -40.17 0.38 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.388 179.51 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 542' ' ' ILE . . . . . 0.676 HG23 ' ND1' ' A' ' 549' ' ' HIS . 2.6 pp -79.88 -23.16 11.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 112.122 0.415 . . . . 0.0 112.122 -179.406 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 543' ' ' TYR . . . . . 0.434 ' C ' ' HB2' ' A' ' 530' ' ' ALA . 89.0 t80 -111.48 -7.79 14.31 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.042 0.449 . . . . 0.0 110.613 179.63 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 544' ' ' ALA . . . . . 0.945 ' HB2' ' HB3' ' A' ' 530' ' ' ALA . . . -103.06 -36.91 7.98 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.381 179.181 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 545' ' ' GLU . . . . . 0.495 ' CG ' ' H ' ' A' ' 548' ' ' MET . 20.2 tp10 -118.91 -32.57 4.45 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.099 -0.955 . . . . 0.0 111.1 179.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 37.09 47.58 1.38 Allowed Glycine 0 C--N 1.331 0.285 0 CA-C-N 115.992 -0.549 . . . . 0.0 113.387 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 547' ' ' LEU . . . . . 0.689 ' HG ' ' N ' ' A' ' 548' ' ' MET . 0.0 OUTLIER -174.87 -57.55 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 117.276 0.538 . . . . 0.0 111.834 179.949 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 548' ' ' MET . . . . . 0.689 ' N ' ' HG ' ' A' ' 547' ' ' LEU . 0.0 OUTLIER -96.0 11.49 33.85 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.644 0.259 . . . . 0.0 111.344 -179.999 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 549' ' ' HIS . . . . . 0.676 ' ND1' HG23 ' A' ' 542' ' ' ILE . 12.8 t-80 -62.59 -11.82 19.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.817 0.341 . . . . 0.0 110.629 179.431 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 550' ' ' ASN . . . . . 0.477 ' O ' ' N ' ' A' ' 552' ' ' ASP . 32.7 m-20 -96.22 -39.74 9.52 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.629 -179.531 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 551' ' ' GLN . . . . . 0.437 ' HG3' ' O ' ' A' ' 548' ' ' MET . 1.5 pt20 -61.81 73.93 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.228 0.537 . . . . 0.0 110.843 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 552' ' ' ASP . . . . . 0.509 ' HA ' ' O ' ' A' ' 519' ' ' THR . 1.6 p30 -83.78 22.24 1.15 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.541 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . 124.25 -26.75 5.73 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 121.01 -0.614 . . . . 0.0 111.62 -179.131 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 554' ' ' LEU . . . . . 0.404 HD11 ' OD1' ' A' ' 552' ' ' ASP . 0.7 OUTLIER -59.23 -53.32 59.65 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.438 0.637 . . . . 0.0 110.117 178.971 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 555' ' ' ILE . . . . . 0.647 HG22 ' O ' ' A' ' 555' ' ' ILE . 8.1 mm -84.59 54.02 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 CA-C-N 114.945 -1.025 . . . . 0.0 111.111 -179.596 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 556' ' ' CYS . . . . . . . . . . . . . 8.0 p -75.02 -7.32 53.35 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.392 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 557' ' ' GLY . . . . . 0.424 ' O ' ' HD3' ' A' ' 559' ' ' ARG . . . -56.73 -12.95 7.26 Favored Glycine 0 CA--C 1.521 0.414 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.963 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 558' ' ' LEU . . . . . 0.738 HD12 ' N ' ' A' ' 559' ' ' ARG . 1.5 pp -46.5 -52.12 13.93 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.89 0.376 . . . . 0.0 111.701 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 559' ' ' ARG . . . . . 0.738 ' N ' HD12 ' A' ' 558' ' ' LEU . 3.0 mpt_? 51.95 -173.63 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.874 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 560' ' ' GLN . . . . . 0.401 ' NE2' ' HB3' ' A' ' 559' ' ' ARG . 14.4 mm-40 . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.255 -0.879 . . . . 0.0 110.85 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 507' ' ' ALA . . . . . 0.671 ' HB1' ' H ' ' A' ' 560' ' ' GLN . . . . . . . . 0 N--CA 1.484 1.269 0 CA-C-O 120.875 0.369 . . . . 0.0 111.036 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 508' ' ' GLN . . . . . . . . . . . . . 4.8 mp0 -128.26 82.58 68.23 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.955 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 509' ' ' PRO . . . . . 0.484 ' O ' ' CE ' ' A' ' 510' ' ' LYS . 88.9 Cg_endo -85.0 -11.57 7.55 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 122.696 2.264 . . . . 0.0 112.542 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 510' ' ' LYS . . . . . 0.484 ' CE ' ' O ' ' A' ' 509' ' ' PRO . 0.0 OUTLIER 81.33 -26.48 0.15 Allowed 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 121.08 0.467 . . . . 0.0 111.015 -179.252 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 511' ' ' CYS . . . . . . . . . . . . . 2.5 m 44.18 69.25 0.43 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.611 179.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 512' ' ' ASN . . . . . 0.416 ' O ' ' O ' ' A' ' 552' ' ' ASP . 0.5 OUTLIER -118.05 81.73 16.63 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.351 179.653 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 513' ' ' PRO . . . . . 0.525 ' HA ' ' O ' ' A' ' 552' ' ' ASP . 64.4 Cg_endo -75.21 18.78 0.54 Allowed 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 123.0 2.467 . . . . 0.0 113.235 -179.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 24.2 t30 -96.71 -34.17 11.46 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.873 0.368 . . . . 0.0 110.859 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 515' ' ' LEU . . . . . . . . . . . . . 2.7 mt -84.68 74.07 10.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.006 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 516' ' ' HIS . . . . . 0.448 ' HA ' ' CB ' ' A' ' 552' ' ' ASP . 14.2 t60 -71.47 -8.4 53.65 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.91 -179.726 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 517' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -82.26 -62.5 1.61 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.712 0.291 . . . . 0.0 111.629 -179.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 518' ' ' TRP . . . . . 0.506 ' O ' ' N ' ' A' ' 520' ' ' THR . 14.4 m-90 -71.39 -17.86 62.39 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.661 -179.467 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 519' ' ' THR . . . . . 0.508 ' OG1' ' N ' ' A' ' 520' ' ' THR . 1.8 p 54.04 -80.29 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 116.621 -0.263 . . . . 0.0 110.919 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 520' ' ' THR . . . . . 0.508 ' N ' ' OG1' ' A' ' 519' ' ' THR . 1.2 m 177.71 -62.85 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 179.065 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 521' ' ' GLN . . . . . 0.435 ' HB2' ' HB3' ' A' ' 548' ' ' MET . 0.7 OUTLIER -72.64 -11.69 60.74 Favored 'General case' 0 CA--C 1.513 -0.45 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 177.989 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 522' ' ' ASP . . . . . 0.475 ' HA ' ' CG2' ' A' ' 527' ' ' ILE . 2.4 m-20 -87.47 -11.04 50.17 Favored 'General case' 0 N--CA 1.441 -0.896 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.745 179.146 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -45.2 -26.6 0.51 Allowed 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.902 -179.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 524' ' ' GLY . . . . . 0.46 ' HA2' ' CG1' ' A' ' 527' ' ' ILE . . . 148.51 40.52 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.458 -0.877 . . . . 0.0 112.386 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -98.21 -59.65 1.71 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.806 0.336 . . . . 0.0 111.892 -179.476 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -133.59 32.44 3.6 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.577 0.703 . . . . 0.0 110.018 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 527' ' ' ILE . . . . . 0.866 ' HA ' ' HB1' ' A' ' 544' ' ' ALA . 2.3 pp -95.86 -0.56 10.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 114.593 -1.185 . . . . 0.0 112.644 -178.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 528' ' ' GLY . . . . . 0.473 ' N ' HD12 ' A' ' 527' ' ' ILE . . . -58.88 -4.57 2.3 Favored Glycine 0 CA--C 1.522 0.52 0 N-CA-C 114.696 0.638 . . . . 0.0 114.696 -178.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 529' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -98.2 -42.24 7.52 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 118.031 0.915 . . . . 0.0 111.672 -179.59 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 530' ' ' ALA . . . . . 1.082 ' HB3' ' HB2' ' A' ' 544' ' ' ALA . . . -103.85 1.99 32.14 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.354 0.502 . . . . 0.0 112.354 -179.239 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 531' ' ' TRP . . . . . 0.66 ' CD2' HD13 ' A' ' 527' ' ' ILE . 22.5 t-105 -54.83 -9.27 0.33 Allowed 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 112.893 0.701 . . . . 0.0 112.893 -178.134 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 532' ' ' ILE . . . . . 0.72 ' O ' HD12 ' A' ' 532' ' ' ILE . 1.6 pp -135.34 76.23 56.89 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-O 121.039 0.447 . . . . 0.0 111.05 179.313 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 533' ' ' PRO . . . . . 0.532 ' HG3' ' HB3' ' A' ' 539' ' ' ALA . 32.4 Cg_exo -63.29 89.51 0.13 Allowed 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 123.058 2.506 . . . . 0.0 112.591 -179.586 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 534' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -60.52 -54.35 46.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.993 0.425 . . . . 0.0 110.151 179.415 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -118.18 22.99 11.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.702 179.361 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . -122.34 153.1 16.84 Favored Glycine 0 C--N 1.333 0.377 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.736 -179.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -71.28 -89.47 0.0 OUTLIER 'Trans proline' 0 CA--C 1.534 0.503 0 C-N-CA 122.714 2.276 . . . . 0.0 112.834 -179.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 538' ' ' ALA . . . . . . . . . . . . . . . -99.29 17.11 20.89 Favored 'General case' 0 C--N 1.333 -0.114 0 N-CA-C 111.534 0.198 . . . . 0.0 111.534 -179.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 539' ' ' ALA . . . . . 0.565 ' HA ' HD12 ' A' ' 542' ' ' ILE . . . -34.12 -43.8 0.16 Allowed 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 -179.395 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 540' ' ' GLU . . . . . 0.468 ' CB ' ' HA ' ' A' ' 531' ' ' TRP . 0.0 OUTLIER -60.1 -6.84 1.53 Allowed 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -178.579 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 541' ' ' GLY . . . . . . . . . . . . . . . -125.62 -40.6 0.38 Allowed Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 121.026 -0.607 . . . . 0.0 111.919 178.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 542' ' ' ILE . . . . . 0.565 HD12 ' HA ' ' A' ' 539' ' ' ALA . 2.1 pp -97.26 -19.36 6.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -179.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 543' ' ' TYR . . . . . 0.445 ' HB3' ' HB1' ' A' ' 539' ' ' ALA . 29.4 t80 -108.85 -16.3 14.19 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.048 0.452 . . . . 0.0 110.65 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 544' ' ' ALA . . . . . 1.082 ' HB2' ' HB3' ' A' ' 530' ' ' ALA . . . -91.2 -16.81 27.08 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.604 179.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 545' ' ' GLU . . . . . 0.522 ' OE2' HD23 ' A' ' 547' ' ' LEU . 5.4 tp10 -118.44 -32.82 4.51 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.343 -179.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 35.84 41.35 0.42 Allowed Glycine 0 CA--C 1.521 0.412 0 CA-C-N 115.841 -0.618 . . . . 0.0 114.133 179.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 547' ' ' LEU . . . . . 0.621 HD23 ' H ' ' A' ' 548' ' ' MET . 0.0 OUTLIER -172.45 -62.11 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 117.615 0.708 . . . . 0.0 112.084 179.401 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 548' ' ' MET . . . . . 0.621 ' H ' HD23 ' A' ' 547' ' ' LEU . 0.0 OUTLIER -96.32 11.6 34.11 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.06 0.457 . . . . 0.0 110.378 179.02 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 549' ' ' HIS . . . . . 0.49 ' CB ' ' HA ' ' A' ' 542' ' ' ILE . 0.3 OUTLIER -59.53 -11.3 4.43 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.323 179.744 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 550' ' ' ASN . . . . . 0.503 ' O ' ' N ' ' A' ' 552' ' ' ASP . 45.5 t30 -94.54 -34.22 12.75 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -178.461 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 551' ' ' GLN . . . . . 0.459 ' HB2' HD23 ' A' ' 558' ' ' LEU . 0.9 OUTLIER -64.25 70.95 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.131 0.491 . . . . 0.0 110.4 -179.907 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 552' ' ' ASP . . . . . 0.525 ' O ' ' HA ' ' A' ' 513' ' ' PRO . 2.9 p30 -101.69 21.91 13.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.513 -179.319 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . 123.69 -31.73 4.48 Favored Glycine 0 N--CA 1.449 -0.461 0 N-CA-C 111.47 -0.652 . . . . 0.0 111.47 -179.25 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 554' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -62.58 -49.1 76.58 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.493 0.663 . . . . 0.0 109.648 178.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 555' ' ' ILE . . . . . 0.639 HG22 ' O ' ' A' ' 555' ' ' ILE . 6.0 mm -88.63 60.62 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 CA-C-N 114.789 -1.096 . . . . 0.0 110.659 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 556' ' ' CYS . . . . . . . . . . . . . 20.1 m -55.37 -20.46 11.97 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.38 -179.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -48.15 -24.55 3.49 Favored Glycine 0 C--N 1.333 0.401 0 C-N-CA 120.934 -0.651 . . . . 0.0 113.01 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 558' ' ' LEU . . . . . 0.781 HD12 ' N ' ' A' ' 559' ' ' ARG . 3.9 pp -52.61 -44.94 66.33 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.913 0.387 . . . . 0.0 111.346 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 559' ' ' ARG . . . . . 0.781 ' N ' HD12 ' A' ' 558' ' ' LEU . 0.9 OUTLIER 59.53 169.22 0.07 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.783 -179.909 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 560' ' ' GLN . . . . . 0.671 ' H ' ' HB1' ' A' ' 507' ' ' ALA . 4.2 mp0 . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.207 -0.901 . . . . 0.0 110.844 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.325 0 CA-C-O 120.82 0.343 . . . . 0.0 111.175 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 508' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -128.38 77.5 77.0 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.561 179.211 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 509' ' ' PRO . . . . . 0.569 ' C ' ' HG3' ' A' ' 510' ' ' LYS . 70.9 Cg_endo -86.7 62.93 4.56 Favored 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 122.89 2.393 . . . . 0.0 112.85 -179.44 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 510' ' ' LYS . . . . . 0.569 ' HG3' ' C ' ' A' ' 509' ' ' PRO . 0.0 OUTLIER 32.48 -90.49 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 120.966 0.413 . . . . 0.0 111.947 179.365 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 511' ' ' CYS . . . . . 0.464 ' N ' ' O ' ' A' ' 509' ' ' PRO . 0.0 OUTLIER 74.98 75.96 0.1 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.222 179.405 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 512' ' ' ASN . . . . . 0.556 ' HB3' HD23 ' A' ' 515' ' ' LEU . 34.3 m-20 -156.15 79.6 4.03 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.056 179.61 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 513' ' ' PRO . . . . . 0.434 ' HA ' ' O ' ' A' ' 552' ' ' ASP . 26.0 Cg_exo -61.5 -15.83 43.74 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 123.056 2.504 . . . . 0.0 112.479 -179.567 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 22.6 t30 -57.47 -43.52 84.09 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.29 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 515' ' ' LEU . . . . . 0.556 HD23 ' HB3' ' A' ' 512' ' ' ASN . 0.8 OUTLIER -81.18 73.82 8.21 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.822 0.344 . . . . 0.0 111.065 -179.905 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 516' ' ' HIS . . . . . 0.491 ' CE1' ' CE1' ' A' ' 517' ' ' TYR . 19.1 p80 -89.25 -7.25 55.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.622 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 517' ' ' TYR . . . . . 0.491 ' CE1' ' CE1' ' A' ' 516' ' ' HIS . 43.1 m-85 -74.93 -30.85 61.36 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 111.702 0.26 . . . . 0.0 111.702 -179.525 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 518' ' ' TRP . . . . . 0.582 ' O ' ' N ' ' A' ' 520' ' ' THR . 8.5 m-90 -117.92 -0.03 11.79 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 -179.504 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 519' ' ' THR . . . . . 0.561 ' OG1' ' N ' ' A' ' 520' ' ' THR . 1.2 p 49.38 -78.37 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 120.485 0.183 . . . . 0.0 111.405 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 520' ' ' THR . . . . . 0.582 ' N ' ' O ' ' A' ' 518' ' ' TRP . 1.3 m -179.15 -62.45 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 179.519 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 521' ' ' GLN . . . . . . . . . . . . . 8.2 mt-30 -72.78 -11.87 60.78 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.32 177.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 522' ' ' ASP . . . . . 0.446 ' HB2' ' O ' ' A' ' 518' ' ' TRP . 68.8 m-20 -91.63 -10.71 39.41 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.81 179.128 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 523' ' ' GLU . . . . . 0.4 ' HA ' ' CD1' ' A' ' 518' ' ' TRP . 0.0 OUTLIER -45.26 -26.71 0.54 Allowed 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.48 -179.72 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . 146.53 41.47 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.356 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -100.66 -60.95 1.43 Allowed 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 111.785 0.291 . . . . 0.0 111.785 -179.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -131.96 38.17 3.55 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-O 121.549 0.69 . . . . 0.0 110.132 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 527' ' ' ILE . . . . . 0.894 ' HA ' ' HB1' ' A' ' 544' ' ' ALA . 2.1 pp -95.79 -2.51 10.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 114.746 -1.116 . . . . 0.0 112.844 -178.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 528' ' ' GLY . . . . . 0.579 ' N ' HD12 ' A' ' 527' ' ' ILE . . . -56.47 -16.59 16.1 Favored Glycine 0 CA--C 1.52 0.403 0 C-N-CA 120.791 -0.719 . . . . 0.0 114.028 -179.1 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 529' ' ' LEU . . . . . 0.489 ' H ' ' HG ' ' A' ' 529' ' ' LEU . 0.7 OUTLIER -99.21 -32.82 11.02 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-N 117.809 0.805 . . . . 0.0 112.292 -179.394 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 530' ' ' ALA . . . . . 0.976 ' HB3' ' HB2' ' A' ' 544' ' ' ALA . . . -103.82 1.52 31.66 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -179.022 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 531' ' ' TRP . . . . . 0.467 ' O ' HG23 ' A' ' 532' ' ' ILE . 55.5 t90 -73.48 30.33 0.07 Allowed 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -179.299 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 532' ' ' ILE . . . . . 0.467 HG23 ' O ' ' A' ' 531' ' ' TRP . 1.1 pt -158.26 77.41 3.44 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-O 120.739 0.304 . . . . 0.0 110.888 179.425 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 533' ' ' PRO . . . . . 0.4 ' HG3' ' O ' ' A' ' 538' ' ' ALA . 79.6 Cg_exo -41.74 88.14 0.01 OUTLIER 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 123.045 2.497 . . . . 0.0 112.956 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 534' ' ' TYR . . . . . 0.437 ' N ' ' O ' ' A' ' 532' ' ' ILE . 12.5 t80 -96.51 -51.98 4.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.483 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -57.73 -34.84 69.93 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.635 -179.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 144.89 -64.18 0.46 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.506 -0.854 . . . . 0.0 112.597 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -55.29 -168.88 0.02 OUTLIER 'Trans proline' 0 CA--C 1.515 -0.457 0 C-N-CA 122.606 2.204 . . . . 0.0 111.906 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 538' ' ' ALA . . . . . 0.425 ' O ' ' HB3' ' A' ' 539' ' ' ALA . . . -63.93 -53.47 49.9 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.199 179.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 539' ' ' ALA . . . . . 0.6 ' O ' ' HB1' ' A' ' 530' ' ' ALA . . . 67.81 -49.93 0.52 Allowed 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.995 179.5 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 540' ' ' GLU . . . . . 0.433 ' O ' ' HB3' ' A' ' 544' ' ' ALA . 0.2 OUTLIER -37.6 -27.0 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.927 -1.033 . . . . 0.0 112.414 -179.275 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 541' ' ' GLY . . . . . 0.411 ' N ' ' O ' ' A' ' 539' ' ' ALA . . . -125.94 -43.6 0.27 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.755 -0.736 . . . . 0.0 111.889 179.129 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 542' ' ' ILE . . . . . 0.615 HG22 ' CE1' ' A' ' 549' ' ' HIS . 1.0 OUTLIER -69.93 -25.91 29.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 112.363 0.505 . . . . 0.0 112.363 -179.713 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 543' ' ' TYR . . . . . 0.451 ' C ' ' HB2' ' A' ' 530' ' ' ALA . 0.1 OUTLIER -111.69 -9.27 14.14 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.903 0.382 . . . . 0.0 110.784 179.988 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 544' ' ' ALA . . . . . 0.976 ' HB2' ' HB3' ' A' ' 530' ' ' ALA . . . -100.52 -33.67 10.24 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.84 179.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 545' ' ' GLU . . . . . 0.504 ' HG3' ' H ' ' A' ' 548' ' ' MET . 37.6 tp10 -118.86 -32.77 4.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.316 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 39.3 39.82 1.16 Allowed Glycine 0 CA--C 1.519 0.304 0 CA-C-N 115.732 -0.667 . . . . 0.0 113.976 179.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 547' ' ' LEU . . . . . 0.616 HD23 ' H ' ' A' ' 548' ' ' MET . 0.0 OUTLIER -173.24 -61.76 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 117.702 0.751 . . . . 0.0 112.303 179.43 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 548' ' ' MET . . . . . 0.616 ' H ' HD23 ' A' ' 547' ' ' LEU . 0.0 OUTLIER -96.32 11.51 34.4 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.7 0.286 . . . . 0.0 111.084 179.559 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 549' ' ' HIS . . . . . 0.615 ' CE1' HG22 ' A' ' 542' ' ' ILE . 9.8 p80 -61.12 -11.56 9.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.85 0.357 . . . . 0.0 111.013 179.462 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 550' ' ' ASN . . . . . . . . . . . . . 48.5 m-20 -96.09 -30.79 13.35 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -179.083 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 551' ' ' GLN . . . . . 0.403 ' HG2' ' HG3' ' A' ' 548' ' ' MET . 2.7 pt20 -68.08 70.95 0.16 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.038 0.447 . . . . 0.0 110.696 -179.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 552' ' ' ASP . . . . . 0.44 ' HB2' ' HA ' ' A' ' 516' ' ' HIS . 1.9 p30 -94.95 21.82 7.21 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.244 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . 123.83 -27.91 5.56 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.856 -0.688 . . . . 0.0 111.629 -179.259 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 554' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -61.93 -55.32 30.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.567 0.698 . . . . 0.0 110.034 179.067 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 555' ' ' ILE . . . . . 0.627 HG22 ' O ' ' A' ' 555' ' ' ILE . 1.8 mm -71.66 66.94 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 114.78 -1.1 . . . . 0.0 110.421 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 556' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -72.79 -7.29 49.96 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.742 -179.588 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 557' ' ' GLY . . . . . 0.428 ' C ' ' HD3' ' A' ' 559' ' ' ARG . . . -62.31 -2.58 4.28 Favored Glycine 0 CA--C 1.524 0.602 0 C-N-CA 121.02 -0.609 . . . . 0.0 113.897 -179.425 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 558' ' ' LEU . . . . . 0.517 ' C ' HD12 ' A' ' 558' ' ' LEU . 3.9 pp -72.33 -9.79 58.95 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -179.457 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 559' ' ' ARG . . . . . 0.477 ' N ' HD12 ' A' ' 558' ' ' LEU . 0.0 OUTLIER -44.97 167.0 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 120.891 0.377 . . . . 0.0 111.49 -179.525 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 560' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 . . . . . 0 C--O 1.25 1.088 0 CA-C-O 118.236 -0.888 . . . . 0.0 110.907 -179.974 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 507' ' ' ALA . . . . . 0.479 ' CB ' ' HB3' ' A' ' 559' ' ' ARG . . . . . . . . 0 N--CA 1.486 1.36 0 CA-C-O 120.898 0.38 . . . . 0.0 111.215 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 508' ' ' GLN . . . . . . . . . . . . . 3.0 mm100 -128.94 77.27 78.13 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.893 179.028 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 509' ' ' PRO . . . . . 0.641 ' HB3' HD11 ' A' ' 558' ' ' LEU . 11.7 Cg_exo -70.49 -65.11 0.04 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 122.714 2.276 . . . . 0.0 111.695 179.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 510' ' ' LYS . . . . . 0.478 ' HG2' ' N ' ' A' ' 511' ' ' CYS . 0.0 OUTLIER 173.52 -32.48 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.005 179.69 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 511' ' ' CYS . . . . . 0.478 ' N ' ' HG2' ' A' ' 510' ' ' LYS . 0.0 OUTLIER 43.43 67.14 0.69 Allowed 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.44 179.883 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 512' ' ' ASN . . . . . . . . . . . . . 35.1 m-20 -120.53 79.99 30.16 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.652 179.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 513' ' ' PRO . . . . . 0.461 ' HA ' ' O ' ' A' ' 552' ' ' ASP . 42.7 Cg_endo -68.18 -10.23 28.28 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.651 2.234 . . . . 0.0 112.56 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 39.7 t30 -74.62 -29.98 61.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.08 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 515' ' ' LEU . . . . . . . . . . . . . 65.5 mt -84.94 74.6 10.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.886 0.374 . . . . 0.0 110.93 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 516' ' ' HIS . . . . . 0.436 ' HA ' ' HB3' ' A' ' 552' ' ' ASP . 1.9 p-80 -89.09 -7.13 56.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.582 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 517' ' ' TYR . . . . . . . . . . . . . 31.2 m-85 -70.65 -50.79 33.05 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.69 0.281 . . . . 0.0 111.638 -179.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 518' ' ' TRP . . . . . 0.494 ' O ' ' N ' ' A' ' 520' ' ' THR . 24.1 m-90 -112.56 10.04 19.52 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 111.914 0.338 . . . . 0.0 111.914 -179.644 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 519' ' ' THR . . . . . 0.56 HG21 ' O ' ' A' ' 549' ' ' HIS . 1.1 p 60.88 -70.13 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 116.65 -0.25 . . . . 0.0 110.915 179.627 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 520' ' ' THR . . . . . 0.494 ' N ' ' O ' ' A' ' 518' ' ' TRP . 1.0 OUTLIER 174.95 -62.82 0.01 OUTLIER 'General case' 0 CA--C 1.52 -0.206 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.152 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 521' ' ' GLN . . . . . 0.507 ' HB3' ' OE1' ' A' ' 545' ' ' GLU . 0.7 OUTLIER -73.36 -11.95 60.66 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 178.188 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 522' ' ' ASP . . . . . 0.427 ' HB3' ' O ' ' A' ' 518' ' ' TRP . 0.6 OUTLIER -91.93 -10.97 37.57 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.912 179.1 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -45.07 -27.5 0.58 Allowed 'General case' 0 CA--C 1.528 0.107 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.304 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . 151.41 41.24 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.852 -0.69 . . . . 0.0 112.144 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -122.2 -20.33 6.24 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 112.223 0.453 . . . . 0.0 112.223 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 526' ' ' ALA . . . . . 0.657 ' O ' ' HB1' ' A' ' 544' ' ' ALA . . . -143.79 30.25 1.34 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.254 0.55 . . . . 0.0 110.903 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 527' ' ' ILE . . . . . 0.827 HD12 ' N ' ' A' ' 528' ' ' GLY . 2.3 pp -95.64 -24.72 4.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.934 -179.562 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 528' ' ' GLY . . . . . 0.827 ' N ' HD12 ' A' ' 527' ' ' ILE . . . -49.47 -13.23 0.43 Allowed Glycine 0 CA--C 1.523 0.575 0 C-N-CA 121.154 -0.545 . . . . 0.0 114.369 -179.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 529' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -98.03 -47.83 5.36 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 117.864 0.832 . . . . 0.0 111.863 -179.168 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 530' ' ' ALA . . . . . 1.059 ' HB3' ' HB2' ' A' ' 544' ' ' ALA . . . -103.69 1.93 32.49 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 -178.437 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 531' ' ' TRP . . . . . 0.56 ' HB2' ' O ' ' A' ' 527' ' ' ILE . 58.8 t90 -68.85 30.53 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -179.074 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 532' ' ' ILE . . . . . 0.605 ' O ' HD12 ' A' ' 532' ' ' ILE . 1.3 pp -156.76 69.48 4.63 Favored Pre-proline 0 CA--C 1.53 0.182 0 CA-C-O 120.8 0.334 . . . . 0.0 110.91 179.357 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 533' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -52.8 105.15 0.11 Allowed 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.673 2.249 . . . . 0.0 111.875 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 534' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -96.08 -55.31 3.01 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 111.984 0.364 . . . . 0.0 111.984 -179.258 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -118.77 -35.02 3.79 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -179.338 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . -85.08 -175.24 50.57 Favored Glycine 0 CA--C 1.518 0.233 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.979 -179.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_endo -56.81 -159.09 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.884 2.389 . . . . 0.0 111.874 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 538' ' ' ALA . . . . . 0.517 ' O ' ' HB3' ' A' ' 539' ' ' ALA . . . -43.87 -48.76 8.42 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.55 -0.296 . . . . 0.0 111.349 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 539' ' ' ALA . . . . . 0.543 ' HA ' ' CD1' ' A' ' 542' ' ' ILE . . . 72.13 -49.3 0.69 Allowed 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.256 0.551 . . . . 0.0 111.482 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 540' ' ' GLU . . . . . 0.437 ' HG2' ' HA ' ' A' ' 531' ' ' TRP . 3.1 mt-10 -36.84 -31.45 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.863 -1.062 . . . . 0.0 112.494 -179.192 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 541' ' ' GLY . . . . . 0.433 ' O ' ' HB3' ' A' ' 549' ' ' HIS . . . -130.89 -18.95 1.32 Allowed Glycine 0 CA--C 1.52 0.369 0 C-N-CA 120.198 -1.001 . . . . 0.0 113.617 -179.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 542' ' ' ILE . . . . . 0.597 HG22 ' HD2' ' A' ' 549' ' ' HIS . 2.6 pp -96.25 -22.45 5.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 117.148 0.474 . . . . 0.0 112.251 -179.514 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 543' ' ' TYR . . . . . 0.516 ' HB2' ' HA ' ' A' ' 539' ' ' ALA . 0.2 OUTLIER -115.32 -12.08 11.83 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.966 0.412 . . . . 0.0 110.847 179.444 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 544' ' ' ALA . . . . . 1.059 ' HB2' ' HB3' ' A' ' 530' ' ' ALA . . . -92.02 -26.32 18.41 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.216 179.532 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 545' ' ' GLU . . . . . 0.7 ' OE2' HD23 ' A' ' 547' ' ' LEU . 19.7 tp10 -113.09 -33.41 6.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.773 -179.162 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 35.02 34.12 0.04 OUTLIER Glycine 0 CA--C 1.519 0.307 0 CA-C-N 115.776 -0.647 . . . . 0.0 114.259 179.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 547' ' ' LEU . . . . . 0.7 HD23 ' OE2' ' A' ' 545' ' ' GLU . 0.0 OUTLIER -176.41 -61.41 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 118.008 0.904 . . . . 0.0 112.695 -179.993 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 548' ' ' MET . . . . . 0.608 ' H ' HD23 ' A' ' 547' ' ' LEU . 0.4 OUTLIER -89.62 11.7 18.97 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.754 0.312 . . . . 0.0 110.935 179.733 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 549' ' ' HIS . . . . . 0.597 ' HD2' HG22 ' A' ' 542' ' ' ILE . 0.2 OUTLIER -64.88 -12.08 44.87 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.972 0.415 . . . . 0.0 110.62 179.588 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 550' ' ' ASN . . . . . 0.419 ' O ' ' N ' ' A' ' 552' ' ' ASP . 4.2 m120 -96.92 -35.48 10.87 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -179.022 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 551' ' ' GLN . . . . . 0.625 ' NE2' HD22 ' A' ' 558' ' ' LEU . 0.0 OUTLIER -66.37 72.59 0.08 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.044 0.449 . . . . 0.0 110.639 -179.515 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 552' ' ' ASP . . . . . 0.51 ' HA ' ' HA ' ' A' ' 519' ' ' THR . 3.0 m-20 -87.27 21.63 2.36 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.149 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . 114.26 -29.1 7.86 Favored Glycine 0 N--CA 1.451 -0.339 0 N-CA-C 111.315 -0.714 . . . . 0.0 111.315 -179.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 554' ' ' LEU . . . . . 0.404 HD11 ' HB2' ' A' ' 552' ' ' ASP . 0.4 OUTLIER -63.16 -57.49 10.37 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.635 0.731 . . . . 0.0 110.054 179.182 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 555' ' ' ILE . . . . . 0.633 HG22 ' O ' ' A' ' 555' ' ' ILE . 2.8 mm -71.54 65.0 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 CA-C-N 114.695 -1.139 . . . . 0.0 110.815 -179.762 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 556' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -73.47 -7.42 51.68 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.56 -0.746 . . . . 0.0 111.232 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 557' ' ' GLY . . . . . 0.409 ' C ' ' HD3' ' A' ' 559' ' ' ARG . . . -63.31 -2.4 5.41 Favored Glycine 0 CA--C 1.522 0.505 0 C-N-CA 121.096 -0.573 . . . . 0.0 113.351 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 558' ' ' LEU . . . . . 0.641 HD11 ' HB3' ' A' ' 509' ' ' PRO . 2.4 pp -63.34 -46.73 85.24 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 117.048 0.424 . . . . 0.0 111.842 -179.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 559' ' ' ARG . . . . . 0.526 ' N ' HD12 ' A' ' 558' ' ' LEU . 0.0 OUTLIER 47.34 -171.85 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 120.909 0.385 . . . . 0.0 111.082 -179.582 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 560' ' ' GLN . . . . . 0.401 ' NE2' ' O ' ' A' ' 558' ' ' LEU . 2.9 mp0 . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.21 -0.9 . . . . 0.0 111.044 179.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 507' ' ' ALA . . . . . 0.438 ' HB3' ' HA ' ' A' ' 559' ' ' ARG . . . . . . . . 0 N--CA 1.487 1.39 0 CA-C-O 120.823 0.344 . . . . 0.0 111.007 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 508' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -128.31 85.19 61.09 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.837 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 509' ' ' PRO . . . . . 0.907 ' HB3' HD11 ' A' ' 558' ' ' LEU . 0.9 OUTLIER -84.51 -16.61 5.65 Favored 'Trans proline' 0 N--CA 1.458 -0.568 0 C-N-CA 123.177 2.585 . . . . 0.0 112.214 -179.816 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 510' ' ' LYS . . . . . 0.533 ' CE ' ' O ' ' A' ' 509' ' ' PRO . 0.0 OUTLIER 83.19 -16.25 0.59 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.113 -179.342 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 511' ' ' CYS . . . . . . . . . . . . . 6.7 m 45.44 66.44 0.91 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.53 179.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 512' ' ' ASN . . . . . 0.415 ' HB2' ' HG3' ' A' ' 510' ' ' LYS . 24.3 t30 -113.36 81.73 5.37 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.451 179.536 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 513' ' ' PRO . . . . . 0.515 ' HA ' ' O ' ' A' ' 552' ' ' ASP . 73.0 Cg_endo -76.01 18.95 0.61 Allowed 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.989 2.459 . . . . 0.0 113.293 -179.584 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -96.72 -28.96 14.06 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.705 0.288 . . . . 0.0 111.024 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 515' ' ' LEU . . . . . . . . . . . . . 70.0 mt -84.22 74.54 10.29 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.899 0.38 . . . . 0.0 110.946 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 516' ' ' HIS . . . . . 0.435 ' HA ' ' CB ' ' A' ' 552' ' ' ASP . 68.0 m-70 -70.14 -23.75 63.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.507 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 517' ' ' TYR . . . . . . . . . . . . . 50.3 m-85 -73.62 -64.18 1.05 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.711 0.291 . . . . 0.0 111.637 -179.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 518' ' ' TRP . . . . . 0.476 ' O ' ' N ' ' A' ' 520' ' ' THR . 27.3 m-90 -69.82 -17.65 63.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.844 -179.422 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 519' ' ' THR . . . . . 0.548 ' OG1' ' N ' ' A' ' 520' ' ' THR . 2.1 p 57.83 -79.78 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.3 0 CA-C-O 120.518 0.199 . . . . 0.0 110.519 -179.707 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 520' ' ' THR . . . . . 0.548 ' N ' ' OG1' ' A' ' 519' ' ' THR . 1.2 m 177.67 -62.61 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 179.195 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 521' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -71.68 -13.87 61.87 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 177.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 522' ' ' ASP . . . . . 0.458 ' HA ' ' CG2' ' A' ' 527' ' ' ILE . 2.8 m-20 -94.04 -11.11 31.43 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.88 179.044 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -45.51 -27.48 0.75 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.456 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 524' ' ' GLY . . . . . 0.418 ' HA2' ' CG1' ' A' ' 527' ' ' ILE . . . 146.21 42.11 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.55 -0.833 . . . . 0.0 112.313 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -101.51 -60.16 1.58 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.736 0.303 . . . . 0.0 111.775 -179.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -132.15 38.65 3.48 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-O 121.503 0.668 . . . . 0.0 110.049 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 527' ' ' ILE . . . . . 0.954 ' HA ' ' HB1' ' A' ' 544' ' ' ALA . 2.1 pp -95.83 -0.25 10.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 114.663 -1.153 . . . . 0.0 112.71 -178.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 528' ' ' GLY . . . . . 0.51 ' N ' HD12 ' A' ' 527' ' ' ILE . . . -53.26 -14.8 3.36 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 114.535 0.574 . . . . 0.0 114.535 -178.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 529' ' ' LEU . . . . . 0.788 HD13 ' N ' ' A' ' 529' ' ' LEU . 0.0 OUTLIER -98.66 -33.98 10.74 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 118.055 0.927 . . . . 0.0 111.609 -179.57 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 530' ' ' ALA . . . . . 0.918 ' HB3' ' HB2' ' A' ' 544' ' ' ALA . . . -103.71 1.17 31.47 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -179.308 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 531' ' ' TRP . . . . . 0.47 ' HA ' ' HG2' ' A' ' 540' ' ' GLU . 9.9 t90 -56.28 -12.33 1.56 Allowed 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -179.14 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 532' ' ' ILE . . . . . 0.731 ' O ' HD12 ' A' ' 532' ' ' ILE . 1.7 pp -133.14 73.95 73.91 Favored Pre-proline 0 N--CA 1.452 -0.373 0 CA-C-O 121.06 0.457 . . . . 0.0 111.327 179.703 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 533' ' ' PRO . . . . . 0.435 ' HB3' ' O ' ' A' ' 538' ' ' ALA . 1.7 Cg_endo -45.73 92.29 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 123.037 2.492 . . . . 0.0 112.671 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 534' ' ' TYR . . . . . . . . . . . . . 47.4 p90 -96.31 -25.4 15.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.116 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -69.75 -34.78 74.28 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.399 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 147.87 -64.09 0.42 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.822 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -59.36 -164.72 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.605 2.203 . . . . 0.0 112.033 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 538' ' ' ALA . . . . . 0.46 ' O ' ' HB3' ' A' ' 539' ' ' ALA . . . -69.3 -47.45 64.48 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.726 179.743 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 539' ' ' ALA . . . . . 0.715 ' C ' ' HB1' ' A' ' 530' ' ' ALA . . . 69.17 -53.94 0.58 Allowed 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.306 0.574 . . . . 0.0 111.45 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 540' ' ' GLU . . . . . 0.522 ' O ' ' HB3' ' A' ' 544' ' ' ALA . 10.6 mt-10 -37.57 -27.59 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.895 -1.048 . . . . 0.0 112.121 -179.541 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 541' ' ' GLY . . . . . 0.433 ' O ' ' HB3' ' A' ' 549' ' ' HIS . . . -124.76 -46.85 0.24 Allowed Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.136 179.069 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 542' ' ' ILE . . . . . 0.604 HG22 ' CE1' ' A' ' 549' ' ' HIS . 2.6 pp -73.47 -24.59 20.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 -179.367 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 543' ' ' TYR . . . . . 0.524 ' HB2' HD12 ' A' ' 542' ' ' ILE . 6.5 t80 -114.11 -7.72 13.04 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.878 0.37 . . . . 0.0 110.963 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 544' ' ' ALA . . . . . 0.954 ' HB1' ' HA ' ' A' ' 527' ' ' ILE . . . -103.14 -33.89 9.06 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 121.22 0.534 . . . . 0.0 109.948 179.362 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 545' ' ' GLU . . . . . 0.515 ' HG3' ' H ' ' A' ' 548' ' ' MET . 23.1 tp10 -118.56 -32.66 4.52 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.272 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 37.68 43.42 1.18 Allowed Glycine 0 CA--C 1.52 0.376 0 CA-C-N 115.931 -0.577 . . . . 0.0 113.771 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 547' ' ' LEU . . . . . 0.568 ' HG ' ' N ' ' A' ' 548' ' ' MET . 0.0 OUTLIER -172.94 -61.23 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 117.362 0.581 . . . . 0.0 111.874 179.628 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 548' ' ' MET . . . . . 0.568 ' N ' ' HG ' ' A' ' 547' ' ' LEU . 0.0 OUTLIER -96.03 11.59 33.54 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.672 0.272 . . . . 0.0 111.209 179.68 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 549' ' ' HIS . . . . . 0.604 ' CE1' HG22 ' A' ' 542' ' ' ILE . 10.0 p80 -61.49 -11.35 10.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.695 0.283 . . . . 0.0 110.904 179.372 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 550' ' ' ASN . . . . . 0.442 ' O ' ' N ' ' A' ' 552' ' ' ASP . 8.3 m120 -95.98 -34.23 11.86 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -179.204 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 551' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.39 72.79 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.133 0.492 . . . . 0.0 110.325 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 552' ' ' ASP . . . . . 0.515 ' HA ' ' O ' ' A' ' 519' ' ' THR . 1.6 p30 -90.6 22.33 3.54 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.602 -0.727 . . . . 0.0 111.724 -179.447 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . 124.27 -27.52 5.54 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.863 -0.684 . . . . 0.0 111.739 -179.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 554' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -61.67 -57.13 13.17 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.49 0.662 . . . . 0.0 109.937 178.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 555' ' ' ILE . . . . . 0.511 HG22 ' O ' ' A' ' 555' ' ' ILE . 4.2 mm -76.93 70.42 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 CA-C-N 114.821 -1.081 . . . . 0.0 110.862 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 556' ' ' CYS . . . . . 0.408 ' O ' ' HD2' ' A' ' 559' ' ' ARG . 34.7 m -68.41 -7.68 33.81 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.748 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 557' ' ' GLY . . . . . 0.416 ' O ' ' HD3' ' A' ' 559' ' ' ARG . . . -65.77 -2.42 11.85 Favored Glycine 0 CA--C 1.521 0.461 0 C-N-CA 120.984 -0.627 . . . . 0.0 113.639 -179.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 558' ' ' LEU . . . . . 0.907 HD11 ' HB3' ' A' ' 509' ' ' PRO . 4.1 pp -61.33 -15.61 37.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 117.079 0.439 . . . . 0.0 111.847 -179.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 559' ' ' ARG . . . . . 0.567 ' N ' HD12 ' A' ' 558' ' ' LEU . 0.0 OUTLIER -51.72 -177.18 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.94 0.4 . . . . 0.0 111.51 -179.474 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 560' ' ' GLN . . . . . . . . . . . . . 16.9 mt-30 . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.214 -0.898 . . . . 0.0 110.92 179.834 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 507' ' ' ALA . . . . . 0.64 ' HB2' ' H ' ' A' ' 560' ' ' GLN . . . . . . . . 0 N--CA 1.486 1.347 0 CA-C-O 120.881 0.372 . . . . 0.0 111.06 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 508' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.36 78.0 76.26 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.012 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 509' ' ' PRO . . . . . 0.507 ' O ' ' CE ' ' A' ' 510' ' ' LYS . 95.3 Cg_endo -80.62 -15.01 11.18 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.538 2.159 . . . . 0.0 112.527 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 510' ' ' LYS . . . . . 0.507 ' CE ' ' O ' ' A' ' 509' ' ' PRO . 0.0 OUTLIER 82.09 -22.26 0.26 Allowed 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.561 -179.885 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 511' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 45.3 81.35 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.426 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 512' ' ' ASN . . . . . . . . . . . . . 18.5 m-20 -131.25 77.68 73.87 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.663 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 513' ' ' PRO . . . . . 0.402 ' HA ' ' O ' ' A' ' 552' ' ' ASP . 41.8 Cg_endo -68.0 -12.28 34.75 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.608 2.206 . . . . 0.0 112.41 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -65.32 -29.03 69.74 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.887 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 515' ' ' LEU . . . . . . . . . . . . . 74.4 mt -95.54 71.18 3.11 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.881 179.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 516' ' ' HIS . . . . . 0.465 ' HA ' ' CB ' ' A' ' 552' ' ' ASP . 15.4 p80 -74.53 -7.34 52.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.676 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 517' ' ' TYR . . . . . . . . . . . . . 65.0 m-85 -79.9 -59.4 2.74 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.781 0.324 . . . . 0.0 111.592 -179.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 518' ' ' TRP . . . . . 0.429 ' CD1' ' HA ' ' A' ' 523' ' ' GLU . 0.1 OUTLIER -74.17 -21.61 59.77 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.925 -179.036 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 519' ' ' THR . . . . . 0.564 HG21 ' O ' ' A' ' 549' ' ' HIS . 2.3 p 63.38 -77.27 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 110.321 -0.252 . . . . 0.0 110.321 -179.505 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 520' ' ' THR . . . . . 0.53 ' N ' ' OG1' ' A' ' 519' ' ' THR . 1.0 OUTLIER 171.25 -62.4 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 179.227 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 521' ' ' GLN . . . . . 0.477 ' N ' HG22 ' A' ' 520' ' ' THR . 0.0 OUTLIER -72.72 -11.08 60.48 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.364 178.048 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 522' ' ' ASP . . . . . 0.412 ' HA ' ' CG2' ' A' ' 527' ' ' ILE . 0.8 OUTLIER -91.15 -21.19 21.29 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.631 178.758 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 523' ' ' GLU . . . . . 0.468 ' HG3' ' HA ' ' A' ' 520' ' ' THR . 8.9 mm-40 -45.84 -29.75 1.46 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.435 178.417 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 524' ' ' GLY . . . . . 0.422 ' HA2' ' CG1' ' A' ' 527' ' ' ILE . . . 144.51 39.16 0.06 OUTLIER Glycine 0 N--CA 1.443 -0.838 0 CA-C-N 114.816 -1.083 . . . . 0.0 110.405 -179.28 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -97.89 -59.49 1.75 Allowed 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 112.243 0.46 . . . . 0.0 112.243 -178.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 526' ' ' ALA . . . . . 0.524 ' O ' ' HB1' ' A' ' 544' ' ' ALA . . . -130.81 40.37 3.49 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-O 121.549 0.69 . . . . 0.0 110.087 179.774 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 527' ' ' ILE . . . . . 0.8 HD12 ' N ' ' A' ' 528' ' ' GLY . 1.9 pp -95.67 -12.91 8.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 114.903 -1.044 . . . . 0.0 112.483 -179.03 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 528' ' ' GLY . . . . . 0.8 ' N ' HD12 ' A' ' 527' ' ' ILE . . . -48.45 -19.81 1.35 Allowed Glycine 0 CA--C 1.522 0.477 0 N-CA-C 114.624 0.61 . . . . 0.0 114.624 -179.131 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 529' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -98.57 -39.98 8.45 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 117.873 0.837 . . . . 0.0 112.415 -179.01 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 530' ' ' ALA . . . . . 0.973 ' HB3' ' HB2' ' A' ' 544' ' ' ALA . . . -103.88 2.06 32.14 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 -178.467 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 531' ' ' TRP . . . . . 0.519 ' O ' HG23 ' A' ' 532' ' ' ILE . 73.3 t-105 -67.45 30.22 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -178.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 532' ' ' ILE . . . . . 0.613 ' O ' HD12 ' A' ' 532' ' ' ILE . 1.3 pp -160.31 71.51 2.99 Favored Pre-proline 0 N--CA 1.454 -0.259 0 CA-C-O 120.837 0.351 . . . . 0.0 110.555 178.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 533' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -48.82 86.86 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 123.22 2.613 . . . . 0.0 112.829 -179.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 534' ' ' TYR . . . . . 0.4 ' N ' ' O ' ' A' ' 532' ' ' ILE . 0.2 OUTLIER -96.51 -38.3 10.06 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.049 179.804 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -62.58 -34.87 77.86 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.456 -179.412 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 151.09 -66.88 0.34 Allowed Glycine 0 CA--C 1.519 0.315 0 C-N-CA 120.47 -0.871 . . . . 0.0 112.62 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -57.2 -164.63 0.02 OUTLIER 'Trans proline' 0 CA--C 1.518 -0.307 0 C-N-CA 122.611 2.207 . . . . 0.0 111.735 179.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 538' ' ' ALA . . . . . 0.482 ' O ' ' HB3' ' A' ' 539' ' ' ALA . . . -74.4 -48.33 28.43 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.432 179.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 539' ' ' ALA . . . . . 0.676 ' C ' ' HB1' ' A' ' 530' ' ' ALA . . . 70.62 -51.83 0.67 Allowed 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.391 0.615 . . . . 0.0 111.277 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 540' ' ' GLU . . . . . 0.512 ' HG2' ' HA ' ' A' ' 531' ' ' TRP . 7.2 mt-10 -36.89 -30.68 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.809 -1.087 . . . . 0.0 112.538 -179.169 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 541' ' ' GLY . . . . . 0.459 ' HA3' ' CD2' ' A' ' 549' ' ' HIS . . . -126.95 -30.15 0.83 Allowed Glycine 0 CA--C 1.518 0.254 0 C-N-CA 120.412 -0.899 . . . . 0.0 112.999 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 542' ' ' ILE . . . . . 0.489 ' CD1' ' HA ' ' A' ' 539' ' ' ALA . 2.6 pp -88.82 -22.03 6.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 -179.532 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 543' ' ' TYR . . . . . 0.466 ' HB2' HD12 ' A' ' 542' ' ' ILE . 10.1 t80 -115.26 -8.43 12.32 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.892 0.377 . . . . 0.0 110.78 179.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 544' ' ' ALA . . . . . 0.973 ' HB2' ' HB3' ' A' ' 530' ' ' ALA . . . -103.01 -38.38 7.36 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-O 121.428 0.632 . . . . 0.0 109.572 179.217 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 545' ' ' GLU . . . . . 0.638 ' HG3' ' H ' ' A' ' 548' ' ' MET . 4.7 tp10 -118.95 -32.81 4.36 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.035 -0.984 . . . . 0.0 111.375 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 37.96 46.01 1.7 Allowed Glycine 0 CA--C 1.519 0.298 0 CA-C-N 115.895 -0.593 . . . . 0.0 113.975 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 547' ' ' LEU . . . . . 0.662 HD23 ' H ' ' A' ' 548' ' ' MET . 0.0 OUTLIER 179.03 -60.95 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 117.552 0.676 . . . . 0.0 112.049 179.682 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 548' ' ' MET . . . . . 0.662 ' H ' HD23 ' A' ' 547' ' ' LEU . 0.4 OUTLIER -87.83 11.74 14.8 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 111.765 0.283 . . . . 0.0 111.765 -179.769 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 549' ' ' HIS . . . . . 0.564 ' O ' HG21 ' A' ' 519' ' ' THR . 10.1 t-80 -66.69 -11.63 55.01 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.918 0.39 . . . . 0.0 110.233 179.245 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 550' ' ' ASN . . . . . 0.659 ' O ' ' N ' ' A' ' 552' ' ' ASP . 42.1 m-20 -96.24 -56.1 2.74 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.552 -179.751 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 551' ' ' GLN . . . . . 0.555 ' HG3' ' O ' ' A' ' 548' ' ' MET . 1.4 pp0? -44.24 76.41 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.583 -179.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 552' ' ' ASP . . . . . 0.659 ' N ' ' O ' ' A' ' 550' ' ' ASN . 2.3 p30 -94.45 22.24 6.33 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.247 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . 124.12 -28.39 5.37 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.865 -0.683 . . . . 0.0 111.708 -179.36 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 554' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -58.32 -59.81 4.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.341 0.591 . . . . 0.0 110.162 179.033 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 555' ' ' ILE . . . . . 0.568 HG22 ' O ' ' A' ' 555' ' ' ILE . 5.6 mm -78.4 62.73 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.647 179.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 556' ' ' CYS . . . . . 0.449 ' O ' ' HD3' ' A' ' 559' ' ' ARG . 0.2 OUTLIER -68.38 -7.51 32.08 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.712 -179.634 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -66.65 -2.38 15.78 Favored Glycine 0 CA--C 1.522 0.517 0 C-N-CA 120.997 -0.621 . . . . 0.0 113.578 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 558' ' ' LEU . . . . . 0.611 HD12 ' N ' ' A' ' 559' ' ' ARG . 2.4 pp -62.78 -48.32 79.66 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 117.072 0.436 . . . . 0.0 111.855 -179.612 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 559' ' ' ARG . . . . . 0.611 ' N ' HD12 ' A' ' 558' ' ' LEU . 0.0 OUTLIER 45.45 -166.54 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.841 -179.227 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 560' ' ' GLN . . . . . 0.64 ' H ' ' HB2' ' A' ' 507' ' ' ALA . 3.4 mp0 . . . . . 0 C--O 1.247 0.972 0 CA-C-O 118.26 -0.876 . . . . 0.0 111.133 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 507' ' ' ALA . . . . . 0.505 ' HB3' HH11 ' A' ' 559' ' ' ARG . . . . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 120.931 0.396 . . . . 0.0 111.205 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 508' ' ' GLN . . . . . . . . . . . . . 8.0 mp0 -128.65 77.12 77.95 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.813 179.342 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 509' ' ' PRO . . . . . 0.615 ' HB3' HD11 ' A' ' 558' ' ' LEU . 21.1 Cg_exo -65.78 -65.21 0.05 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.235 0 C-N-CA 122.645 2.23 . . . . 0.0 111.837 179.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 510' ' ' LYS . . . . . 0.572 ' NZ ' HD21 ' A' ' 558' ' ' LEU . 0.0 OUTLIER 179.79 -35.87 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.507 179.723 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 511' ' ' CYS . . . . . 0.446 ' N ' ' HG2' ' A' ' 510' ' ' LYS . 0.5 OUTLIER 43.79 63.32 1.62 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.072 -0.967 . . . . 0.0 111.575 179.53 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 512' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -136.58 82.18 33.87 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.252 179.642 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 513' ' ' PRO . . . . . 0.551 ' HA ' ' O ' ' A' ' 552' ' ' ASP . 58.2 Cg_endo -72.68 9.22 1.33 Allowed 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.839 2.359 . . . . 0.0 113.314 -179.375 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -95.87 -24.81 16.26 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.684 0.278 . . . . 0.0 110.997 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 515' ' ' LEU . . . . . . . . . . . . . 84.6 mt -87.1 74.59 9.6 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.831 0.348 . . . . 0.0 111.062 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 516' ' ' HIS . . . . . 0.435 ' HA ' ' CB ' ' A' ' 552' ' ' ASP . 25.0 p80 -81.14 -7.28 59.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.713 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 517' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -71.49 -46.72 59.06 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.679 0.276 . . . . 0.0 111.541 -179.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 518' ' ' TRP . . . . . 0.522 ' O ' ' N ' ' A' ' 520' ' ' THR . 12.3 m-90 -101.8 -3.87 27.31 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -179.314 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 519' ' ' THR . . . . . 0.569 ' HA ' ' HA ' ' A' ' 552' ' ' ASP . 4.1 p 56.41 -78.07 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 120.551 0.215 . . . . 0.0 110.757 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 520' ' ' THR . . . . . 0.522 ' N ' ' O ' ' A' ' 518' ' ' TRP . 1.1 m 176.04 -62.43 0.01 OUTLIER 'General case' 0 CA--C 1.521 -0.171 0 N-CA-C 109.171 -0.678 . . . . 0.0 109.171 179.375 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 521' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -71.64 -12.56 61.4 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 177.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 522' ' ' ASP . . . . . 0.418 ' HB2' ' O ' ' A' ' 518' ' ' TRP . 1.2 m-20 -93.86 -11.21 31.62 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.667 178.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -45.69 -27.88 0.89 Allowed 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.253 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 524' ' ' GLY . . . . . 0.409 ' HA2' ' CG1' ' A' ' 527' ' ' ILE . . . 145.41 43.02 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.243 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -102.56 -58.97 1.78 Allowed 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 -179.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -131.61 39.89 3.45 Favored 'General case' 0 CA--C 1.514 -0.426 0 CA-C-O 121.565 0.698 . . . . 0.0 109.986 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 527' ' ' ILE . . . . . 0.809 ' HA ' ' HB1' ' A' ' 544' ' ' ALA . 1.9 pp -95.61 -0.54 10.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 114.764 -1.107 . . . . 0.0 112.693 -178.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 528' ' ' GLY . . . . . 0.569 ' N ' HD12 ' A' ' 527' ' ' ILE . . . -60.23 -14.34 32.65 Favored Glycine 0 CA--C 1.52 0.387 0 C-N-CA 120.865 -0.683 . . . . 0.0 113.901 -179.301 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 529' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -98.55 -33.84 10.83 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 117.477 0.638 . . . . 0.0 111.68 -179.408 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 530' ' ' ALA . . . . . 1.041 ' HB3' ' HB2' ' A' ' 544' ' ' ALA . . . -103.81 1.53 31.69 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -179.057 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 531' ' ' TRP . . . . . 0.44 ' HB2' ' O ' ' A' ' 527' ' ' ILE . 73.2 t-105 -56.08 -12.6 1.55 Allowed 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 -179.378 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 532' ' ' ILE . . . . . 0.683 ' O ' HD12 ' A' ' 532' ' ' ILE . 1.5 pp -129.44 75.21 80.26 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 120.978 0.418 . . . . 0.0 110.984 179.699 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 533' ' ' PRO . . . . . 0.525 ' HB3' ' HB3' ' A' ' 539' ' ' ALA . 5.6 Cg_endo -48.91 89.88 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 123.099 2.533 . . . . 0.0 112.85 -179.672 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 534' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -96.3 -13.33 23.41 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.068 179.524 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -76.85 -34.87 57.81 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.282 -179.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 536' ' ' GLY . . . . . 0.417 ' N ' ' CD ' ' A' ' 537' ' ' PRO . . . 141.42 -49.54 0.76 Allowed Glycine 0 CA--C 1.52 0.347 0 C-N-CA 120.518 -0.848 . . . . 0.0 112.915 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 537' ' ' PRO . . . . . 0.417 ' CD ' ' N ' ' A' ' 536' ' ' GLY . 5.6 Cg_exo -76.56 -168.0 0.52 Allowed 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 122.714 2.276 . . . . 0.0 111.931 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 538' ' ' ALA . . . . . 0.422 ' O ' ' HB3' ' A' ' 539' ' ' ALA . . . -56.28 -47.63 78.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.461 179.505 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 539' ' ' ALA . . . . . 0.605 ' C ' ' HB1' ' A' ' 530' ' ' ALA . . . 68.14 -59.47 0.43 Allowed 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 121.362 0.601 . . . . 0.0 111.976 179.339 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 540' ' ' GLU . . . . . 0.409 ' OE2' ' CE3' ' A' ' 531' ' ' TRP . 2.7 mt-10 -37.49 -28.77 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 114.871 -1.059 . . . . 0.0 112.293 -179.108 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 541' ' ' GLY . . . . . 0.425 ' O ' ' HB2' ' A' ' 549' ' ' HIS . . . -121.9 -26.71 1.85 Allowed Glycine 0 CA--C 1.521 0.41 0 C-N-CA 120.479 -0.867 . . . . 0.0 113.27 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 542' ' ' ILE . . . . . 0.594 ' CD1' ' HA ' ' A' ' 539' ' ' ALA . 2.6 pp -95.84 -20.59 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -179.345 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 543' ' ' TYR . . . . . 0.528 ' HB2' ' HA ' ' A' ' 539' ' ' ALA . 0.3 OUTLIER -107.84 -10.73 15.5 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.112 0.482 . . . . 0.0 110.113 178.901 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 544' ' ' ALA . . . . . 1.041 ' HB2' ' HB3' ' A' ' 530' ' ' ALA . . . -103.16 -38.45 7.28 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.78 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 545' ' ' GLU . . . . . 0.573 ' HG3' ' H ' ' A' ' 548' ' ' MET . 5.9 tp10 -118.91 -32.96 4.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.151 -0.932 . . . . 0.0 111.487 -179.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 37.72 49.37 1.89 Allowed Glycine 0 CA--C 1.52 0.403 0 CA-C-N 115.988 -0.551 . . . . 0.0 113.822 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 547' ' ' LEU . . . . . 0.625 HD21 ' SD ' ' A' ' 548' ' ' MET . 0.0 OUTLIER 178.99 -60.83 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 117.528 0.664 . . . . 0.0 111.976 179.633 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 548' ' ' MET . . . . . 0.625 ' SD ' HD21 ' A' ' 547' ' ' LEU . 0.0 OUTLIER -86.38 11.76 11.65 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.671 0.272 . . . . 0.0 111.566 -179.802 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 549' ' ' HIS . . . . . 0.509 ' O ' ' CG2' ' A' ' 519' ' ' THR . 56.6 t60 -67.96 -10.97 57.77 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.899 0.381 . . . . 0.0 110.412 179.249 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 550' ' ' ASN . . . . . 0.432 ' O ' ' N ' ' A' ' 552' ' ' ASP . 38.9 t30 -92.89 -25.91 17.86 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.126 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 551' ' ' GLN . . . . . 0.53 ' HG2' ' O ' ' A' ' 548' ' ' MET . 2.3 mm-40 -66.91 70.32 0.08 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.249 0.547 . . . . 0.0 110.123 179.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 552' ' ' ASP . . . . . 0.569 ' HA ' ' HA ' ' A' ' 519' ' ' THR . 1.7 p30 -89.37 21.6 3.26 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.679 -179.46 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . 123.41 -32.82 4.19 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.885 -0.674 . . . . 0.0 111.592 -179.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 554' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -52.14 -58.06 7.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.498 0.665 . . . . 0.0 110.348 179.226 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 555' ' ' ILE . . . . . 0.708 ' O ' HD23 ' A' ' 558' ' ' LEU . 3.7 mm -72.62 60.86 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 CA-C-N 114.808 -1.087 . . . . 0.0 110.942 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 556' ' ' CYS . . . . . . . . . . . . . 5.3 t -76.53 -7.78 55.86 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.373 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -74.0 -5.17 69.61 Favored Glycine 0 C--N 1.332 0.308 0 C-N-CA 120.641 -0.79 . . . . 0.0 113.013 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 558' ' ' LEU . . . . . 0.708 HD23 ' O ' ' A' ' 555' ' ' ILE . 2.3 pp -58.72 -47.13 85.65 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.879 0.371 . . . . 0.0 111.133 -179.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 559' ' ' ARG . . . . . 0.631 ' N ' HD12 ' A' ' 558' ' ' LEU . 2.8 mmt85 63.87 171.25 0.17 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.232 179.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 560' ' ' GLN . . . . . 0.477 ' NE2' ' CB ' ' A' ' 559' ' ' ARG . 4.7 mp0 . . . . . 0 C--O 1.25 1.116 0 CA-C-O 118.247 -0.882 . . . . 0.0 111.325 179.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 507' ' ' ALA . . . . . 0.451 ' HB3' ' HA ' ' A' ' 559' ' ' ARG . . . . . . . . 0 N--CA 1.485 1.295 0 CA-C-O 121.083 0.468 . . . . 0.0 111.196 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 508' ' ' GLN . . . . . . . . . . . . . 7.3 mt-30 -129.02 77.39 77.99 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.507 179.544 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 509' ' ' PRO . . . . . 0.663 ' HB3' HD11 ' A' ' 558' ' ' LEU . 13.2 Cg_exo -69.79 -64.49 0.04 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.298 0 C-N-CA 122.734 2.289 . . . . 0.0 112.016 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 510' ' ' LYS . . . . . 0.44 ' HG3' ' N ' ' A' ' 511' ' ' CYS . 0.0 OUTLIER 178.65 -35.35 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.861 -179.914 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 511' ' ' CYS . . . . . 0.44 ' N ' ' HG3' ' A' ' 510' ' ' LYS . 0.1 OUTLIER 39.71 87.47 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.223 -0.899 . . . . 0.0 111.776 179.537 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 512' ' ' ASN . . . . . 0.541 ' HB3' HD21 ' A' ' 515' ' ' LEU . 0.9 OUTLIER -158.55 77.93 3.25 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.393 179.865 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 513' ' ' PRO . . . . . 0.568 ' HA ' ' O ' ' A' ' 552' ' ' ASP . 73.8 Cg_endo -76.67 19.14 0.66 Allowed 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 123.039 2.493 . . . . 0.0 113.462 -179.494 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 23.6 t30 -96.79 -34.56 11.26 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.642 0.258 . . . . 0.0 111.137 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 515' ' ' LEU . . . . . 0.541 HD21 ' HB3' ' A' ' 512' ' ' ASN . 0.7 OUTLIER -90.71 72.49 6.71 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.897 0.38 . . . . 0.0 111.085 -179.868 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 516' ' ' HIS . . . . . 0.506 ' HA ' ' HB2' ' A' ' 552' ' ' ASP . 7.7 p80 -80.13 -7.25 58.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.751 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 517' ' ' TYR . . . . . . . . . . . . . 37.9 m-85 -69.55 -29.69 67.32 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 111.67 0.248 . . . . 0.0 111.67 -179.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 518' ' ' TRP . . . . . 0.482 ' O ' ' N ' ' A' ' 520' ' ' THR . 4.7 m-90 -118.03 -8.28 10.74 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -179.246 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 519' ' ' THR . . . . . 0.528 ' OG1' ' N ' ' A' ' 520' ' ' THR . 1.3 p 59.82 -76.53 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 120.475 0.179 . . . . 0.0 110.537 -179.725 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 520' ' ' THR . . . . . 0.528 ' N ' ' OG1' ' A' ' 519' ' ' THR . 1.0 OUTLIER 172.24 -62.7 0.01 OUTLIER 'General case' 0 C--O 1.232 0.147 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 179.146 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 521' ' ' GLN . . . . . 0.471 ' N ' HG22 ' A' ' 520' ' ' THR . 5.8 mt-30 -73.42 -12.01 60.66 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 177.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 522' ' ' ASP . . . . . 0.404 ' HB2' ' O ' ' A' ' 518' ' ' TRP . 9.6 m-20 -93.47 -11.12 32.81 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.684 178.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -45.51 -27.09 0.67 Allowed 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.539 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 524' ' ' GLY . . . . . 0.441 ' HA2' ' CG1' ' A' ' 527' ' ' ILE . . . 148.6 41.13 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.577 -0.82 . . . . 0.0 112.225 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -99.62 -59.95 1.62 Allowed 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 111.879 0.325 . . . . 0.0 111.879 -179.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -132.0 35.97 3.7 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.505 0.669 . . . . 0.0 110.135 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 527' ' ' ILE . . . . . 0.985 ' HA ' ' HB1' ' A' ' 544' ' ' ALA . 2.2 pp -95.85 -0.42 10.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 114.741 -1.118 . . . . 0.0 112.836 -178.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 528' ' ' GLY . . . . . 0.495 ' N ' HD12 ' A' ' 527' ' ' ILE . . . -60.23 -8.82 9.55 Favored Glycine 0 CA--C 1.522 0.495 0 C-N-CA 120.907 -0.663 . . . . 0.0 114.146 -179.243 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 529' ' ' LEU . . . . . 0.718 HD11 ' O ' ' A' ' 543' ' ' TYR . 2.0 pp -98.54 -35.0 10.37 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 117.819 0.809 . . . . 0.0 111.624 -179.565 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 530' ' ' ALA . . . . . 1.008 ' HB3' ' HB2' ' A' ' 544' ' ' ALA . . . -103.64 1.63 32.23 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -179.273 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 531' ' ' TRP . . . . . 0.432 ' HA ' ' HG2' ' A' ' 540' ' ' GLU . 0.2 OUTLIER -70.4 30.71 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -178.853 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 532' ' ' ILE . . . . . 0.469 ' H ' ' C ' ' A' ' 530' ' ' ALA . 1.3 pt -156.68 78.92 3.89 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 120.665 0.269 . . . . 0.0 110.735 179.183 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 533' ' ' PRO . . . . . . . . . . . . . 99.9 Cg_exo -39.46 86.16 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 123.327 2.685 . . . . 0.0 113.212 -179.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 534' ' ' TYR . . . . . 0.463 ' N ' ' O ' ' A' ' 532' ' ' ILE . 1.7 t80 -96.61 -50.99 4.49 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.282 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -57.78 -34.95 70.12 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.459 -179.41 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 145.79 -63.98 0.45 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.563 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -59.94 -166.99 0.04 OUTLIER 'Trans proline' 0 CA--C 1.516 -0.393 0 C-N-CA 122.605 2.203 . . . . 0.0 111.833 179.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 538' ' ' ALA . . . . . 0.444 ' O ' ' HB3' ' A' ' 539' ' ' ALA . . . -61.65 -52.82 62.75 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.114 179.606 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 539' ' ' ALA . . . . . 0.572 ' O ' ' HB1' ' A' ' 530' ' ' ALA . . . 68.13 -47.01 0.53 Allowed 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.99 179.414 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 540' ' ' GLU . . . . . 0.432 ' HG2' ' HA ' ' A' ' 531' ' ' TRP . 0.8 OUTLIER -37.39 -28.15 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.126 -0.943 . . . . 0.0 112.366 -179.139 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 541' ' ' GLY . . . . . 0.456 ' HA3' ' CD2' ' A' ' 549' ' ' HIS . . . -127.63 -42.06 0.27 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.012 179.308 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 542' ' ' ILE . . . . . 0.631 HG23 ' CE1' ' A' ' 549' ' ' HIS . 0.8 OUTLIER -69.63 -26.31 30.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 -179.79 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 543' ' ' TYR . . . . . 0.718 ' O ' HD11 ' A' ' 529' ' ' LEU . 1.8 m-85 -110.68 -10.19 14.49 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.054 0.454 . . . . 0.0 110.697 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 544' ' ' ALA . . . . . 1.008 ' HB2' ' HB3' ' A' ' 530' ' ' ALA . . . -97.9 -30.54 12.69 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.035 179.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 545' ' ' GLU . . . . . 0.525 ' HG3' ' H ' ' A' ' 548' ' ' MET . 6.3 tp10 -118.87 -32.81 4.39 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.475 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 35.56 40.13 0.28 Allowed Glycine 0 CA--C 1.52 0.399 0 CA-C-N 116.025 -0.534 . . . . 0.0 113.808 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 547' ' ' LEU . . . . . 0.568 HD23 ' H ' ' A' ' 548' ' ' MET . 0.0 OUTLIER -173.65 -61.41 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 117.498 0.649 . . . . 0.0 112.1 179.748 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 548' ' ' MET . . . . . 0.631 ' O ' ' HG3' ' A' ' 551' ' ' GLN . 0.0 OUTLIER -94.36 11.92 28.83 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.758 0.314 . . . . 0.0 111.133 179.674 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 549' ' ' HIS . . . . . 0.631 ' CE1' HG23 ' A' ' 542' ' ' ILE . 12.1 t-80 -64.41 -10.75 26.94 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 120.846 -0.342 . . . . 0.0 110.82 179.582 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 550' ' ' ASN . . . . . 0.52 ' O ' ' N ' ' A' ' 552' ' ' ASP . 41.9 m-20 -94.82 -34.8 12.34 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.875 0.695 . . . . 0.0 112.875 -178.557 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 551' ' ' GLN . . . . . 0.631 ' HG3' ' O ' ' A' ' 548' ' ' MET . 1.1 pp0? -62.34 68.12 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.112 0.482 . . . . 0.0 111.238 -179.451 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 552' ' ' ASP . . . . . 0.568 ' O ' ' HA ' ' A' ' 513' ' ' PRO . 1.7 p30 -94.83 20.93 8.09 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.284 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . 123.63 -31.04 4.72 Favored Glycine 0 N--CA 1.45 -0.399 0 N-CA-C 111.321 -0.711 . . . . 0.0 111.321 -179.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 554' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -55.9 -52.5 63.87 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.475 0.655 . . . . 0.0 110.037 179.066 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 555' ' ' ILE . . . . . 0.641 HG22 ' O ' ' A' ' 555' ' ' ILE . 5.2 mm -82.9 56.32 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 CA-C-N 114.884 -1.053 . . . . 0.0 110.53 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 556' ' ' CYS . . . . . 0.527 ' O ' ' HD2' ' A' ' 559' ' ' ARG . 17.6 t -77.93 -7.24 56.5 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.432 -179.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 557' ' ' GLY . . . . . 0.43 ' C ' ' H ' ' A' ' 559' ' ' ARG . . . -67.16 -2.36 18.37 Favored Glycine 0 CA--C 1.522 0.494 0 C-N-CA 121.208 -0.52 . . . . 0.0 113.814 -179.458 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 558' ' ' LEU . . . . . 0.663 HD11 ' HB3' ' A' ' 509' ' ' PRO . 3.8 pp -71.93 27.71 0.05 OUTLIER 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -179.664 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 559' ' ' ARG . . . . . 0.527 ' HD2' ' O ' ' A' ' 556' ' ' CYS . 1.8 mpt_? -61.15 -164.16 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.594 0.235 . . . . 0.0 110.482 179.718 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 560' ' ' GLN . . . . . 0.43 ' H ' ' HB2' ' A' ' 507' ' ' ALA . 5.3 mt-30 . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.227 -0.892 . . . . 0.0 111.052 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 507' ' ' ALA . . . . . 0.525 ' HB3' ' HG3' ' A' ' 559' ' ' ARG . . . . . . . . 0 N--CA 1.486 1.354 0 CA-C-O 120.791 0.329 . . . . 0.0 111.129 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 508' ' ' GLN . . . . . . . . . . . . . 4.0 tm0? -128.45 77.7 76.81 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.962 179.587 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 509' ' ' PRO . . . . . 0.458 ' O ' ' CG ' ' A' ' 510' ' ' LYS . 90.2 Cg_endo -78.77 -19.99 10.78 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.548 2.165 . . . . 0.0 112.509 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 510' ' ' LYS . . . . . 0.458 ' CG ' ' O ' ' A' ' 509' ' ' PRO . 0.0 OUTLIER 91.5 -29.11 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 123.182 0.593 . . . . 0.0 111.077 -179.797 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 511' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 52.03 103.81 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.73 179.166 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 512' ' ' ASN . . . . . 0.716 ' OD1' HD12 ' A' ' 515' ' ' LEU . 6.0 p30 -140.13 73.75 31.58 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.39 179.324 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 513' ' ' PRO . . . . . 0.543 ' HA ' ' O ' ' A' ' 552' ' ' ASP . 31.3 Cg_exo -60.96 -14.73 34.5 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.899 2.399 . . . . 0.0 112.625 -179.612 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -69.42 -43.36 73.53 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.474 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 515' ' ' LEU . . . . . 0.716 HD12 ' OD1' ' A' ' 512' ' ' ASN . 53.1 mt -66.53 76.33 0.1 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.88 0.371 . . . . 0.0 111.076 -179.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 516' ' ' HIS . . . . . 0.56 ' HA ' ' HB3' ' A' ' 552' ' ' ASP . 0.2 OUTLIER -84.55 -7.16 59.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.722 -179.857 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 517' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -79.11 -61.82 1.89 Allowed 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -179.199 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 518' ' ' TRP . . . . . 0.488 ' O ' ' N ' ' A' ' 520' ' ' THR . 4.1 m-90 -87.13 -3.91 59.1 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -178.696 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 519' ' ' THR . . . . . 0.522 ' HA ' ' HA ' ' A' ' 552' ' ' ASP . 3.0 p 59.66 -76.49 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.391 0.139 . . . . 0.0 110.704 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 520' ' ' THR . . . . . 0.517 ' N ' ' OG1' ' A' ' 519' ' ' THR . 1.0 OUTLIER 173.04 -62.59 0.01 OUTLIER 'General case' 0 CA--C 1.521 -0.17 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 179.367 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 521' ' ' GLN . . . . . 0.43 ' N ' HG22 ' A' ' 520' ' ' THR . 2.7 mt-30 -73.32 -12.75 60.95 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.426 178.189 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 522' ' ' ASP . . . . . 0.422 ' HB2' ' O ' ' A' ' 518' ' ' TRP . 2.5 m-20 -93.91 -11.09 31.78 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.832 179.025 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -45.57 -28.01 0.87 Allowed 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.514 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 524' ' ' GLY . . . . . 0.451 ' HA2' ' CG1' ' A' ' 527' ' ' ILE . . . 147.34 42.18 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.471 -0.871 . . . . 0.0 112.354 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -101.39 -58.6 1.85 Allowed 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -179.43 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -132.03 35.08 3.76 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-O 121.566 0.698 . . . . 0.0 110.161 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 527' ' ' ILE . . . . . 0.968 ' HA ' ' HB1' ' A' ' 544' ' ' ALA . 2.2 pp -95.65 -0.45 10.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 114.797 -1.092 . . . . 0.0 112.606 -178.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 528' ' ' GLY . . . . . 0.514 ' N ' HD12 ' A' ' 527' ' ' ILE . . . -59.17 -7.65 5.43 Favored Glycine 0 CA--C 1.522 0.511 0 C-N-CA 121.018 -0.61 . . . . 0.0 114.256 -179.244 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 529' ' ' LEU . . . . . 0.472 HD11 ' O ' ' A' ' 543' ' ' TYR . 1.0 OUTLIER -97.77 -35.9 10.39 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 117.772 0.786 . . . . 0.0 111.36 -179.584 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 530' ' ' ALA . . . . . 0.96 ' HB3' ' HB2' ' A' ' 544' ' ' ALA . . . -103.76 1.97 32.34 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.449 0.537 . . . . 0.0 112.449 -179.392 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 531' ' ' TRP . . . . . 0.472 ' HA ' ' HG2' ' A' ' 540' ' ' GLU . 9.9 t90 -67.41 30.24 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 -178.8 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 532' ' ' ILE . . . . . 0.496 ' H ' ' C ' ' A' ' 530' ' ' ALA . 1.1 pt -159.31 72.77 3.42 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-O 120.843 0.354 . . . . 0.0 110.403 179.012 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 533' ' ' PRO . . . . . 0.414 ' HB3' ' O ' ' A' ' 537' ' ' PRO . 7.5 Cg_endo -49.74 86.38 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 123.129 2.552 . . . . 0.0 112.692 -179.69 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 534' ' ' TYR . . . . . 0.411 ' N ' ' O ' ' A' ' 532' ' ' ILE . 20.8 t80 -96.55 -29.76 13.69 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.156 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -71.14 -34.86 71.4 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.542 -179.388 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 152.51 -66.13 0.34 Allowed Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.579 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 537' ' ' PRO . . . . . 0.414 ' O ' ' HB3' ' A' ' 533' ' ' PRO . 19.5 Cg_endo -58.06 -162.67 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.612 2.208 . . . . 0.0 111.608 179.729 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 538' ' ' ALA . . . . . 0.482 ' O ' ' HB3' ' A' ' 539' ' ' ALA . . . -76.5 -46.21 27.66 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.645 179.673 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 539' ' ' ALA . . . . . 0.556 ' C ' ' HB1' ' A' ' 530' ' ' ALA . . . 70.56 -51.15 0.67 Allowed 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.264 0.554 . . . . 0.0 111.46 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 540' ' ' GLU . . . . . 0.474 ' O ' ' HB3' ' A' ' 544' ' ' ALA . 7.1 mt-10 -37.38 -28.71 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.85 -1.068 . . . . 0.0 112.347 -179.371 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 541' ' ' GLY . . . . . 0.413 ' O ' ' HB3' ' A' ' 545' ' ' GLU . . . -128.19 -38.07 0.4 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.746 179.59 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 542' ' ' ILE . . . . . 0.493 ' H ' HG13 ' A' ' 542' ' ' ILE . 2.5 pp -78.86 -25.57 13.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -179.19 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 543' ' ' TYR . . . . . 0.5 ' HB2' ' HA ' ' A' ' 539' ' ' ALA . 0.4 OUTLIER -114.58 -6.86 12.8 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.896 0.379 . . . . 0.0 110.73 179.568 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 544' ' ' ALA . . . . . 0.968 ' HB1' ' HA ' ' A' ' 527' ' ' ILE . . . -99.9 -29.99 12.27 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.953 179.206 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 545' ' ' GLU . . . . . 0.547 ' HG3' ' H ' ' A' ' 548' ' ' MET . 6.2 tp10 -118.61 -32.92 4.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.474 -179.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 35.2 43.14 0.45 Allowed Glycine 0 CA--C 1.519 0.339 0 CA-C-N 115.923 -0.58 . . . . 0.0 114.295 179.443 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 547' ' ' LEU . . . . . 0.626 HD21 ' SD ' ' A' ' 548' ' ' MET . 0.0 OUTLIER -178.7 -61.27 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 117.753 0.776 . . . . 0.0 112.006 179.683 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 548' ' ' MET . . . . . 0.626 ' SD ' HD21 ' A' ' 547' ' ' LEU . 0.0 OUTLIER -89.96 12.12 18.48 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.854 0.359 . . . . 0.0 111.031 179.669 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 549' ' ' HIS . . . . . 0.494 ' O ' ' CG2' ' A' ' 519' ' ' THR . 75.7 t60 -64.81 -11.21 34.52 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.832 0.349 . . . . 0.0 110.75 179.558 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 550' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -94.24 -17.62 22.49 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.43 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 551' ' ' GLN . . . . . 0.566 ' HG2' ' O ' ' A' ' 548' ' ' MET . 0.9 OUTLIER -70.46 65.82 0.3 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.162 0.506 . . . . 0.0 110.364 179.667 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 552' ' ' ASP . . . . . 0.56 ' HB3' ' HA ' ' A' ' 516' ' ' HIS . 4.3 m-20 -91.37 21.75 4.31 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.35 -179.717 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 553' ' ' GLY . . . . . 0.405 ' HA3' ' C ' ' A' ' 512' ' ' ASN . . . 117.33 -35.28 4.19 Favored Glycine 0 N--CA 1.45 -0.413 0 N-CA-C 111.332 -0.707 . . . . 0.0 111.332 -179.336 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 554' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -56.23 -59.23 5.24 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.524 0.678 . . . . 0.0 109.844 178.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 555' ' ' ILE . . . . . 0.633 ' O ' HD23 ' A' ' 558' ' ' LEU . 3.9 mm -73.46 62.33 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 CA-C-N 114.705 -1.134 . . . . 0.0 110.657 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 556' ' ' CYS . . . . . 0.413 ' O ' ' HD2' ' A' ' 559' ' ' ARG . 0.1 OUTLIER -68.2 -9.74 49.27 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.647 -179.727 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -57.55 -18.1 29.08 Favored Glycine 0 C--N 1.332 0.348 0 C-N-CA 120.623 -0.799 . . . . 0.0 113.005 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 558' ' ' LEU . . . . . 0.633 HD23 ' O ' ' A' ' 555' ' ' ILE . 0.7 OUTLIER -50.62 -56.56 11.24 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.825 0.345 . . . . 0.0 111.8 -179.743 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 559' ' ' ARG . . . . . 0.589 ' N ' HD12 ' A' ' 558' ' ' LEU . 4.2 mpt_? 56.86 -168.47 0.11 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.922 -179.568 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 560' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.094 0 CA-C-O 118.253 -0.88 . . . . 0.0 111.169 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.323 0 CA-C-O 120.79 0.328 . . . . 0.0 111.211 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 508' ' ' GLN . . . . . . . . . . . . . 22.1 mt-30 -128.41 77.4 77.19 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.672 179.324 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 509' ' ' PRO . . . . . 0.449 ' O ' ' N ' ' A' ' 511' ' ' CYS . 98.5 Cg_endo -85.51 63.26 5.72 Favored 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 122.746 2.297 . . . . 0.0 112.75 -179.734 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 510' ' ' LYS . . . . . 0.854 ' CE ' HD21 ' A' ' 558' ' ' LEU . 0.0 OUTLIER 24.03 -88.36 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 115.947 -0.57 . . . . 0.0 112.366 179.367 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 511' ' ' CYS . . . . . 0.449 ' N ' ' O ' ' A' ' 509' ' ' PRO . 0.0 OUTLIER 75.3 62.11 0.06 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.986 179.61 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 512' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -140.21 83.34 15.76 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.07 179.383 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 513' ' ' PRO . . . . . 0.519 ' HA ' ' O ' ' A' ' 552' ' ' ASP . 74.2 Cg_endo -76.9 21.94 0.57 Allowed 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.932 2.422 . . . . 0.0 113.246 -179.278 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 20.0 t30 -96.83 -46.21 6.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.691 0.281 . . . . 0.0 110.687 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 515' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -72.18 75.57 0.97 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.925 0.393 . . . . 0.0 110.799 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 516' ' ' HIS . . . . . 0.457 ' HA ' ' HB3' ' A' ' 552' ' ' ASP . 0.1 OUTLIER -73.67 -7.41 51.92 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.786 -179.785 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 517' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -88.72 -48.48 7.49 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.716 0.293 . . . . 0.0 111.711 -179.469 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 518' ' ' TRP . . . . . 0.484 ' O ' ' N ' ' A' ' 520' ' ' THR . 3.7 m-90 -84.07 -8.4 59.12 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 -179.32 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 519' ' ' THR . . . . . 0.565 ' HA ' ' HA ' ' A' ' 552' ' ' ASP . 2.7 p 59.34 -78.56 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 120.581 0.229 . . . . 0.0 110.469 -179.763 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 520' ' ' THR . . . . . 0.549 ' N ' ' OG1' ' A' ' 519' ' ' THR . 1.2 m 172.73 -62.78 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 179.083 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 521' ' ' GLN . . . . . 0.413 ' N ' HG22 ' A' ' 520' ' ' THR . 5.3 mt-30 -74.98 -12.03 60.24 Favored 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 177.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 522' ' ' ASP . . . . . 0.436 ' HA ' ' CG2' ' A' ' 527' ' ' ILE . 1.9 m-20 -93.99 -10.95 31.94 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.541 178.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -45.33 -27.51 0.68 Allowed 'General case' 0 C--O 1.232 0.158 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.552 -179.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 524' ' ' GLY . . . . . 0.433 ' HA2' ' CG1' ' A' ' 527' ' ' ILE . . . 146.35 42.29 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.566 -0.826 . . . . 0.0 112.306 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -101.32 -59.27 1.73 Allowed 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 111.917 0.34 . . . . 0.0 111.917 -179.527 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 526' ' ' ALA . . . . . 0.464 ' O ' HD21 ' A' ' 529' ' ' LEU . . . -132.25 35.97 3.65 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-O 121.512 0.673 . . . . 0.0 110.146 179.763 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 527' ' ' ILE . . . . . 0.943 ' HA ' ' HB1' ' A' ' 544' ' ' ALA . 2.2 pp -95.7 -0.64 10.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 114.769 -1.105 . . . . 0.0 112.701 -178.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 528' ' ' GLY . . . . . 0.529 ' N ' HD12 ' A' ' 527' ' ' ILE . . . -62.08 -8.11 15.84 Favored Glycine 0 CA--C 1.521 0.414 0 C-N-CA 120.939 -0.648 . . . . 0.0 114.035 -179.229 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 529' ' ' LEU . . . . . 0.464 HD21 ' O ' ' A' ' 526' ' ' ALA . 0.2 OUTLIER -98.32 -35.62 10.26 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 117.587 0.693 . . . . 0.0 111.556 -179.574 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 530' ' ' ALA . . . . . 0.943 ' HB3' ' HB2' ' A' ' 544' ' ' ALA . . . -103.66 -1.08 28.67 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -179.118 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 531' ' ' TRP . . . . . 0.651 ' CE3' HD13 ' A' ' 527' ' ' ILE . 14.5 t-105 -56.09 -12.3 1.44 Allowed 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 112.039 0.385 . . . . 0.0 112.039 -179.187 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 532' ' ' ILE . . . . . 0.695 ' O ' HD12 ' A' ' 532' ' ' ILE . 1.6 pp -130.13 75.65 79.05 Favored Pre-proline 0 N--CA 1.451 -0.421 0 CA-C-O 121.005 0.431 . . . . 0.0 111.132 179.727 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 533' ' ' PRO . . . . . 0.403 ' HB3' ' O ' ' A' ' 538' ' ' ALA . 3.9 Cg_endo -46.95 92.25 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 123.169 2.579 . . . . 0.0 112.672 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 534' ' ' TYR . . . . . . . . . . . . . 46.9 p90 -96.18 -22.82 17.05 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.127 179.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -73.98 -34.86 64.39 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.303 -179.685 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 150.25 -64.28 0.39 Allowed Glycine 0 CA--C 1.519 0.332 0 C-N-CA 120.491 -0.862 . . . . 0.0 112.833 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -59.92 -164.17 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.651 2.234 . . . . 0.0 112.097 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 538' ' ' ALA . . . . . 0.486 ' O ' ' HB3' ' A' ' 539' ' ' ALA . . . -70.41 -46.53 63.79 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.678 179.753 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 539' ' ' ALA . . . . . 0.688 ' C ' ' HB1' ' A' ' 530' ' ' ALA . . . 70.68 -52.35 0.67 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.212 0.53 . . . . 0.0 111.709 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 540' ' ' GLU . . . . . 0.52 ' O ' ' HB3' ' A' ' 544' ' ' ALA . 13.0 mt-10 -37.21 -28.07 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.831 -1.077 . . . . 0.0 112.427 -179.231 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 541' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' A' ' 539' ' ' ALA . . . -126.79 -41.65 0.3 Allowed Glycine 0 CA--C 1.52 0.347 0 C-N-CA 120.505 -0.855 . . . . 0.0 112.338 179.206 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 542' ' ' ILE . . . . . 0.5 ' CD1' ' HA ' ' A' ' 539' ' ' ALA . 2.5 pp -75.8 -25.55 17.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -179.377 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 543' ' ' TYR . . . . . 0.585 ' HB2' ' HA ' ' A' ' 539' ' ' ALA . 0.2 OUTLIER -115.65 -5.66 12.16 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.862 0.363 . . . . 0.0 110.948 179.839 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 544' ' ' ALA . . . . . 0.943 ' HB1' ' HA ' ' A' ' 527' ' ' ILE . . . -102.78 -32.66 9.71 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.783 179.216 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 545' ' ' GLU . . . . . 0.549 ' OE2' HD23 ' A' ' 547' ' ' LEU . 50.3 tp10 -118.53 -32.85 4.48 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.301 179.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 35.55 39.35 0.23 Allowed Glycine 0 CA--C 1.519 0.337 0 CA-C-N 115.583 -0.735 . . . . 0.0 114.176 179.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 547' ' ' LEU . . . . . 0.587 HD23 ' H ' ' A' ' 548' ' ' MET . 0.0 OUTLIER -173.9 -61.8 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 117.756 0.778 . . . . 0.0 112.621 179.517 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 548' ' ' MET . . . . . 0.587 ' H ' HD23 ' A' ' 547' ' ' LEU . 0.0 OUTLIER -96.22 11.48 34.32 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.68 0.276 . . . . 0.0 111.339 179.96 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 549' ' ' HIS . . . . . 0.466 ' O ' ' CG2' ' A' ' 519' ' ' THR . 2.4 p-80 -62.29 -11.32 14.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.824 0.345 . . . . 0.0 110.804 179.221 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 550' ' ' ASN . . . . . 0.441 ' O ' ' N ' ' A' ' 552' ' ' ASP . 26.2 t-20 -95.1 -32.06 13.27 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -179.212 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 551' ' ' GLN . . . . . 0.449 ' HG2' ' CG ' ' A' ' 548' ' ' MET . 1.6 pt20 -64.99 74.44 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.421 0.629 . . . . 0.0 110.576 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 552' ' ' ASP . . . . . 0.565 ' HA ' ' HA ' ' A' ' 519' ' ' THR . 15.6 m-20 -78.61 19.12 0.51 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.583 -0.735 . . . . 0.0 112.023 -179.544 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . 123.61 -31.05 4.72 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.785 -0.721 . . . . 0.0 111.817 -179.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 554' ' ' LEU . . . . . 0.422 ' H ' HD12 ' A' ' 554' ' ' LEU . 1.5 mp -53.02 -56.56 15.17 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.485 0.66 . . . . 0.0 110.592 179.301 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 555' ' ' ILE . . . . . 0.595 HG22 ' O ' ' A' ' 555' ' ' ILE . 2.3 mm -69.57 66.27 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 114.785 -1.098 . . . . 0.0 110.614 -179.748 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 556' ' ' CYS . . . . . 0.414 ' O ' ' HD3' ' A' ' 559' ' ' ARG . 7.9 t -73.84 -7.3 51.69 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.461 -0.79 . . . . 0.0 111.649 -179.635 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -62.51 -2.17 4.11 Favored Glycine 0 CA--C 1.524 0.612 0 C-N-CA 121.221 -0.514 . . . . 0.0 113.87 -179.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 558' ' ' LEU . . . . . 0.854 HD21 ' CE ' ' A' ' 510' ' ' LYS . 4.1 pp -76.37 27.97 0.12 Allowed 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 -179.158 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 559' ' ' ARG . . . . . 0.44 ' HB3' ' HB3' ' A' ' 509' ' ' PRO . 0.0 OUTLIER -79.79 169.97 17.18 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.83 0.348 . . . . 0.0 110.82 179.682 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 560' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.215 -0.898 . . . . 0.0 110.88 179.973 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 507' ' ' ALA . . . . . 0.474 ' O ' ' HA ' ' A' ' 559' ' ' ARG . . . . . . . . 0 N--CA 1.482 1.173 0 CA-C-O 121.368 0.604 . . . . 0.0 111.408 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 508' ' ' GLN . . . . . . . . . . . . . 3.7 mp0 -128.42 80.13 72.97 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.291 179.537 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 509' ' ' PRO . . . . . 0.679 ' HG3' HD11 ' A' ' 558' ' ' LEU . 11.0 Cg_endo -55.42 -66.9 0.08 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.223 0 C-N-CA 122.622 2.215 . . . . 0.0 112.137 -179.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 510' ' ' LYS . . . . . 0.489 ' HB3' ' O ' ' A' ' 509' ' ' PRO . 0.0 OUTLIER 171.52 -31.39 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.461 -0.791 . . . . 0.0 110.338 -179.857 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 511' ' ' CYS . . . . . 0.464 ' N ' ' HG2' ' A' ' 510' ' ' LYS . 28.9 t 51.16 68.62 0.76 Allowed 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.688 179.381 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 512' ' ' ASN . . . . . 0.545 ' HB3' HD12 ' A' ' 515' ' ' LEU . 87.4 m-20 -111.07 81.22 2.63 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.871 179.113 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 513' ' ' PRO . . . . . 0.581 ' HA ' ' O ' ' A' ' 552' ' ' ASP . 55.5 Cg_endo -71.79 11.9 0.62 Allowed 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 122.839 2.36 . . . . 0.0 113.276 -179.275 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 -96.62 -15.99 21.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.663 0.268 . . . . 0.0 110.969 179.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 515' ' ' LEU . . . . . 0.545 HD12 ' HB3' ' A' ' 512' ' ' ASN . 1.4 mp -94.46 73.94 3.82 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.894 0.378 . . . . 0.0 110.943 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 516' ' ' HIS . . . . . 0.456 ' HA ' ' HB3' ' A' ' 552' ' ' ASP . 0.2 OUTLIER -80.59 -7.09 59.14 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.872 -179.774 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 517' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -72.17 -66.08 0.69 Allowed 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -179.088 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 518' ' ' TRP . . . . . 0.48 ' O ' ' N ' ' A' ' 520' ' ' THR . 12.0 m-90 -93.32 0.51 56.97 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.489 0.552 . . . . 0.0 112.489 -178.737 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 519' ' ' THR . . . . . 0.527 HG21 ' HA ' ' A' ' 549' ' ' HIS . 2.8 p 60.56 -75.19 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 110.627 -0.138 . . . . 0.0 110.627 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 520' ' ' THR . . . . . 0.48 ' N ' ' O ' ' A' ' 518' ' ' TRP . 1.0 OUTLIER 172.27 -62.95 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.241 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 179.155 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 521' ' ' GLN . . . . . 0.458 ' N ' HG22 ' A' ' 520' ' ' THR . 0.7 OUTLIER -68.33 -15.43 63.56 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 178.245 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 522' ' ' ASP . . . . . 0.409 ' HB2' ' O ' ' A' ' 518' ' ' TRP . 2.8 m-20 -94.19 -11.93 29.34 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 115.668 -0.697 . . . . 0.0 111.273 179.563 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -51.98 -31.73 30.55 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-O 121.069 0.462 . . . . 0.0 110.846 179.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . 162.89 40.29 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.471 0 CA-C-N 115.757 -0.656 . . . . 0.0 112.02 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -133.02 -32.17 1.23 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.632 0.253 . . . . 0.0 111.592 -179.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -137.84 56.52 1.75 Allowed 'General case' 0 CA--C 1.515 -0.373 0 CA-C-O 121.393 0.615 . . . . 0.0 110.306 179.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 527' ' ' ILE . . . . . 0.863 HD12 ' N ' ' A' ' 528' ' ' GLY . 1.4 pp -95.31 -18.55 6.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.721 -179.511 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 528' ' ' GLY . . . . . 0.863 ' N ' HD12 ' A' ' 527' ' ' ILE . . . 26.79 -144.92 0.01 OUTLIER Glycine 0 C--N 1.336 0.559 0 N-CA-C 114.716 0.647 . . . . 0.0 114.716 179.171 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 529' ' ' LEU . . . . . 0.504 HD12 ' H ' ' A' ' 530' ' ' ALA . 0.2 OUTLIER -63.55 -17.59 62.96 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.426 -0.387 . . . . 0.0 111.715 -179.624 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 530' ' ' ALA . . . . . 1.044 ' HB3' ' HB2' ' A' ' 544' ' ' ALA . . . -81.58 1.99 31.23 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -179.361 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 531' ' ' TRP . . . . . 0.484 ' HA ' ' HG2' ' A' ' 540' ' ' GLU . 0.1 OUTLIER -72.18 27.38 0.05 Allowed 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -179.15 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 532' ' ' ILE . . . . . 0.463 HG23 ' O ' ' A' ' 531' ' ' TRP . 1.1 pp -159.03 72.16 3.54 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-O 120.793 0.33 . . . . 0.0 110.541 179.074 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 533' ' ' PRO . . . . . 0.41 ' HB3' ' O ' ' A' ' 537' ' ' PRO . 7.5 Cg_endo -49.62 88.34 0.02 OUTLIER 'Trans proline' 0 C--N 1.343 0.243 0 C-N-CA 123.08 2.52 . . . . 0.0 112.625 -179.733 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 534' ' ' TYR . . . . . . . . . . . . . 65.3 t80 -96.46 -28.37 14.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.273 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -72.59 -35.03 67.81 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.503 -179.452 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 151.99 -65.03 0.36 Allowed Glycine 0 N--CA 1.453 -0.208 0 C-N-CA 120.496 -0.859 . . . . 0.0 112.547 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 537' ' ' PRO . . . . . 0.41 ' O ' ' HB3' ' A' ' 533' ' ' PRO . 17.2 Cg_endo -57.38 -163.27 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.636 2.224 . . . . 0.0 111.718 179.696 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 538' ' ' ALA . . . . . 0.494 ' O ' ' HB3' ' A' ' 539' ' ' ALA . . . -76.81 -46.62 24.24 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.512 179.547 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 539' ' ' ALA . . . . . 0.689 ' C ' ' HB1' ' A' ' 530' ' ' ALA . . . 70.79 -52.4 0.67 Allowed 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 121.336 0.589 . . . . 0.0 111.545 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 540' ' ' GLU . . . . . 0.484 ' HG2' ' HA ' ' A' ' 531' ' ' TRP . 10.2 mt-10 -36.8 -30.85 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.797 -1.092 . . . . 0.0 112.43 -179.143 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 541' ' ' GLY . . . . . . . . . . . . . . . -126.79 -22.29 1.63 Allowed Glycine 0 CA--C 1.518 0.274 0 C-N-CA 120.35 -0.928 . . . . 0.0 113.355 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 542' ' ' ILE . . . . . 0.575 ' CD1' ' HA ' ' A' ' 539' ' ' ALA . 2.6 pp -96.4 -18.85 6.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 -179.133 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 543' ' ' TYR . . . . . 0.482 ' HB2' ' HA ' ' A' ' 539' ' ' ALA . 0.4 OUTLIER -114.21 -11.81 12.57 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.808 179.58 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 544' ' ' ALA . . . . . 1.044 ' HB2' ' HB3' ' A' ' 530' ' ' ALA . . . -103.36 -36.23 8.1 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 121.336 0.589 . . . . 0.0 110.635 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 545' ' ' GLU . . . . . 0.642 ' HG2' ' HB2' ' A' ' 548' ' ' MET . 2.9 tp10 -118.51 -32.7 4.52 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.218 -0.901 . . . . 0.0 111.452 -179.243 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 37.99 51.22 2.11 Favored Glycine 0 C--N 1.332 0.308 0 C-N-CA 121.259 -0.496 . . . . 0.0 112.664 -179.647 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 547' ' ' LEU . . . . . 0.561 HD11 ' SD ' ' A' ' 548' ' ' MET . 0.3 OUTLIER -172.78 -46.19 0.02 OUTLIER 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 120.9 -0.32 . . . . 0.0 111.618 -179.292 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 548' ' ' MET . . . . . 0.642 ' HB2' ' HG2' ' A' ' 545' ' ' GLU . 0.0 OUTLIER -96.58 11.61 34.61 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.811 0.338 . . . . 0.0 111.0 179.285 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 549' ' ' HIS . . . . . 0.527 ' HA ' HG21 ' A' ' 519' ' ' THR . 11.4 p-80 -69.05 -11.21 60.58 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.008 0.432 . . . . 0.0 110.405 179.528 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 550' ' ' ASN . . . . . . . . . . . . . 35.2 t30 -95.93 -17.63 20.9 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.817 -179.391 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 551' ' ' GLN . . . . . 0.499 ' HG2' ' O ' ' A' ' 548' ' ' MET . 7.8 mm-40 -69.23 62.76 0.14 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.964 0.411 . . . . 0.0 110.569 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 552' ' ' ASP . . . . . 0.581 ' O ' ' HA ' ' A' ' 513' ' ' PRO . 2.8 m-20 -94.12 21.74 6.54 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.18 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 553' ' ' GLY . . . . . 0.443 ' HA3' ' C ' ' A' ' 512' ' ' ASN . . . 115.26 -33.98 5.03 Favored Glycine 0 N--CA 1.448 -0.564 0 N-CA-C 111.212 -0.755 . . . . 0.0 111.212 -179.242 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 554' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -53.37 -50.82 64.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.592 0.711 . . . . 0.0 110.177 178.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 555' ' ' ILE . . . . . 0.674 HG22 ' O ' ' A' ' 555' ' ' ILE . 4.1 mm -81.1 54.76 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 114.73 -1.123 . . . . 0.0 110.91 -179.743 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 556' ' ' CYS . . . . . 0.522 ' O ' ' HD2' ' A' ' 559' ' ' ARG . 29.1 p -97.11 -7.24 33.12 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.03 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 557' ' ' GLY . . . . . 0.43 ' C ' ' H ' ' A' ' 559' ' ' ARG . . . -58.09 -2.16 0.86 Allowed Glycine 0 CA--C 1.522 0.528 0 C-N-CA 121.228 -0.511 . . . . 0.0 114.164 -179.315 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 558' ' ' LEU . . . . . 0.679 HD11 ' HG3' ' A' ' 509' ' ' PRO . 3.6 pp -68.82 27.71 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -179.394 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 559' ' ' ARG . . . . . 0.522 ' HD2' ' O ' ' A' ' 556' ' ' CYS . 0.0 OUTLIER -76.36 -167.47 0.79 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.82 0.343 . . . . 0.0 110.394 179.431 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 560' ' ' GLN . . . . . . . . . . . . . 7.7 mt-30 . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.318 -0.848 . . . . 0.0 110.936 179.938 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.365 0 CA-C-O 120.854 0.359 . . . . 0.0 111.236 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 508' ' ' GLN . . . . . . . . . . . . . 63.9 mm-40 -128.55 76.76 78.21 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.702 178.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 509' ' ' PRO . . . . . 0.474 ' HG3' ' HA ' ' A' ' 559' ' ' ARG . 13.5 Cg_exo -69.91 -65.39 0.04 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.246 0 C-N-CA 122.816 2.344 . . . . 0.0 111.732 179.662 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 510' ' ' LYS . . . . . 0.469 ' HG2' ' N ' ' A' ' 511' ' ' CYS . 0.0 OUTLIER 177.95 -34.72 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.432 179.785 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 511' ' ' CYS . . . . . 0.469 ' N ' ' HG2' ' A' ' 510' ' ' LYS . 0.5 OUTLIER 43.47 59.2 3.12 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.131 -0.941 . . . . 0.0 111.597 179.535 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 512' ' ' ASN . . . . . 0.471 ' O ' ' O ' ' A' ' 552' ' ' ASP . 24.7 p30 -127.0 83.37 66.16 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.177 179.466 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 513' ' ' PRO . . . . . 0.467 ' HA ' ' O ' ' A' ' 552' ' ' ASP . 74.2 Cg_endo -76.17 22.1 0.51 Allowed 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 123.023 2.482 . . . . 0.0 113.27 -179.59 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -96.68 -26.02 15.34 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.811 0.339 . . . . 0.0 110.609 179.553 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 515' ' ' LEU . . . . . . . . . . . . . 31.7 mt -95.55 71.91 3.14 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.885 179.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 516' ' ' HIS . . . . . 0.469 ' HA ' ' CB ' ' A' ' 552' ' ' ASP . 6.2 p-80 -73.61 -7.35 51.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.721 -179.821 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 517' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -72.54 -59.74 2.57 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 111.903 0.334 . . . . 0.0 111.903 -179.435 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 518' ' ' TRP . . . . . 0.467 ' CD1' ' HA ' ' A' ' 523' ' ' GLU . 0.7 OUTLIER -80.07 -22.39 42.31 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.06 0.392 . . . . 0.0 112.06 -178.837 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 519' ' ' THR . . . . . 0.539 ' OG1' ' N ' ' A' ' 520' ' ' THR . 3.4 p 57.42 -81.29 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.459 0.171 . . . . 0.0 110.741 -179.728 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 520' ' ' THR . . . . . 0.539 ' N ' ' OG1' ' A' ' 519' ' ' THR . 1.1 m 176.19 -62.58 0.01 OUTLIER 'General case' 0 CA--C 1.52 -0.174 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 179.517 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 521' ' ' GLN . . . . . 0.403 ' N ' HG22 ' A' ' 520' ' ' THR . 2.0 mt-30 -72.07 -11.97 61.0 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.346 177.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 522' ' ' ASP . . . . . 0.421 ' HB2' ' O ' ' A' ' 518' ' ' TRP . 62.0 m-20 -93.49 -11.09 32.81 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.803 179.093 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 523' ' ' GLU . . . . . 0.467 ' HA ' ' CD1' ' A' ' 518' ' ' TRP . 0.1 OUTLIER -45.59 -27.92 0.86 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.698 -179.738 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 524' ' ' GLY . . . . . 0.45 ' HA2' ' CG1' ' A' ' 527' ' ' ILE . . . 150.52 40.04 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.343 -0.932 . . . . 0.0 112.439 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -97.91 -60.5 1.55 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.72 0.295 . . . . 0.0 111.589 -179.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -133.86 36.98 3.27 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-O 121.645 0.736 . . . . 0.0 110.33 179.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 527' ' ' ILE . . . . . 0.948 ' HA ' ' HB1' ' A' ' 544' ' ' ALA . 1.6 pp -96.13 -0.72 10.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 114.676 -1.147 . . . . 0.0 112.956 -178.795 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 528' ' ' GLY . . . . . 0.596 ' N ' HD12 ' A' ' 527' ' ' ILE . . . -55.19 -14.75 6.4 Favored Glycine 0 CA--C 1.521 0.455 0 C-N-CA 120.845 -0.693 . . . . 0.0 114.0 -179.342 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 529' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -98.73 -38.38 9.11 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 117.756 0.778 . . . . 0.0 112.303 -179.266 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 530' ' ' ALA . . . . . 0.946 ' HB3' ' HB2' ' A' ' 544' ' ' ALA . . . -103.68 1.71 32.25 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 113.166 0.802 . . . . 0.0 113.166 -178.492 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 531' ' ' TRP . . . . . 0.462 ' O ' HG23 ' A' ' 532' ' ' ILE . 0.2 OUTLIER -71.31 30.46 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 112.405 0.521 . . . . 0.0 112.405 -178.896 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 532' ' ' ILE . . . . . 0.48 ' H ' ' C ' ' A' ' 530' ' ' ALA . 1.1 pt -159.04 73.24 3.52 Favored Pre-proline 0 N--CA 1.454 -0.256 0 CA-C-O 120.734 0.302 . . . . 0.0 110.403 179.031 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 533' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -50.74 84.95 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 123.071 2.514 . . . . 0.0 112.683 -179.496 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 534' ' ' TYR . . . . . 0.42 ' N ' ' O ' ' A' ' 532' ' ' ILE . 0.2 OUTLIER -96.48 -31.58 12.73 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.975 179.788 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -68.06 -34.94 77.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.333 -179.512 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 148.85 -63.9 0.41 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.651 -179.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -59.22 -165.98 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.639 2.226 . . . . 0.0 111.984 179.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 538' ' ' ALA . . . . . 0.453 ' O ' ' HB3' ' A' ' 539' ' ' ALA . . . -71.54 -49.79 37.44 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.508 179.78 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 539' ' ' ALA . . . . . 0.591 ' C ' ' HB1' ' A' ' 530' ' ' ALA . . . 69.14 -53.05 0.59 Allowed 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 121.206 0.527 . . . . 0.0 111.688 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 540' ' ' GLU . . . . . 0.486 ' O ' ' HB3' ' A' ' 544' ' ' ALA . 0.8 OUTLIER -37.3 -30.2 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.942 -1.026 . . . . 0.0 112.234 -179.286 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 541' ' ' GLY . . . . . . . . . . . . . . . -126.05 -30.27 0.88 Allowed Glycine 0 N--CA 1.453 -0.223 0 C-N-CA 120.479 -0.867 . . . . 0.0 113.216 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 542' ' ' ILE . . . . . 0.536 ' CD1' ' HA ' ' A' ' 539' ' ' ALA . 2.6 pp -87.89 -21.84 6.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 112.0 0.37 . . . . 0.0 112.0 -179.371 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 543' ' ' TYR . . . . . 0.468 ' CD2' ' CD1' ' A' ' 542' ' ' ILE . 6.1 m-85 -113.54 -10.19 13.19 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 120.812 0.339 . . . . 0.0 110.637 179.259 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 544' ' ' ALA . . . . . 0.948 ' HB1' ' HA ' ' A' ' 527' ' ' ILE . . . -103.35 -37.58 7.58 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 121.213 0.53 . . . . 0.0 110.198 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 545' ' ' GLU . . . . . 0.586 ' CD ' HD23 ' A' ' 547' ' ' LEU . 5.5 tp10 -118.73 -32.69 4.46 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.489 -179.088 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 37.72 45.39 1.48 Allowed Glycine 0 CA--C 1.52 0.398 0 CA-C-N 115.999 -0.546 . . . . 0.0 114.038 179.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 547' ' ' LEU . . . . . 0.586 HD23 ' CD ' ' A' ' 545' ' ' GLU . 0.0 OUTLIER -178.59 -61.26 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 117.594 0.697 . . . . 0.0 112.03 179.479 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 548' ' ' MET . . . . . 0.583 ' SD ' HD21 ' A' ' 547' ' ' LEU . 0.0 OUTLIER -90.63 12.06 20.11 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.715 0.293 . . . . 0.0 111.345 179.923 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 549' ' ' HIS . . . . . 0.5 ' O ' ' CG2' ' A' ' 519' ' ' THR . 12.7 t60 -65.51 -11.11 40.49 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.744 -0.383 . . . . 0.0 110.462 179.482 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 550' ' ' ASN . . . . . 0.458 ' O ' HD12 ' A' ' 554' ' ' LEU . 22.8 m-80 -93.7 -12.59 28.93 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.965 -0.294 . . . . 0.0 111.456 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 551' ' ' GLN . . . . . 0.662 HE22 HG21 ' A' ' 555' ' ' ILE . 2.9 mm100 -73.47 59.2 0.6 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.913 0.387 . . . . 0.0 110.35 179.536 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 552' ' ' ASP . . . . . 0.471 ' O ' ' O ' ' A' ' 512' ' ' ASN . 2.8 p30 -98.78 22.04 10.62 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.188 -179.591 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . 123.74 -31.86 4.43 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.819 -0.705 . . . . 0.0 111.487 -179.238 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 554' ' ' LEU . . . . . 0.458 HD12 ' O ' ' A' ' 550' ' ' ASN . 1.4 mt -55.01 -56.12 23.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.382 0.61 . . . . 0.0 110.183 179.121 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 555' ' ' ILE . . . . . 0.662 HG21 HE22 ' A' ' 551' ' ' GLN . 5.5 mm -79.23 60.01 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.997 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 556' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -63.98 -13.69 48.21 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.376 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 557' ' ' GLY . . . . . 0.414 ' O ' ' HG2' ' A' ' 559' ' ' ARG . . . -59.47 -15.11 30.68 Favored Glycine 0 C--N 1.331 0.282 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.973 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 558' ' ' LEU . . . . . 0.676 HD12 ' N ' ' A' ' 559' ' ' ARG . 3.0 pp -59.16 -39.31 82.08 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.793 0.297 . . . . 0.0 111.414 -179.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 559' ' ' ARG . . . . . 0.676 ' N ' HD12 ' A' ' 558' ' ' LEU . 9.7 mmt180 69.21 -164.16 0.18 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.002 0.43 . . . . 0.0 111.214 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 560' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.25 1.092 0 CA-C-O 118.258 -0.877 . . . . 0.0 110.921 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 507' ' ' ALA . . . . . 0.812 ' HB3' ' HA ' ' A' ' 559' ' ' ARG . . . . . . . . 0 N--CA 1.485 1.295 0 CA-C-O 121.128 0.49 . . . . 0.0 111.296 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 508' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.04 77.46 77.84 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.511 179.423 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 509' ' ' PRO . . . . . 0.538 ' O ' ' HB3' ' A' ' 510' ' ' LYS . 25.1 Cg_exo -63.59 -65.76 0.05 OUTLIER 'Trans proline' 0 N--CA 1.465 -0.179 0 C-N-CA 122.485 2.123 . . . . 0.0 112.022 -179.793 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 510' ' ' LYS . . . . . 0.538 ' HB3' ' O ' ' A' ' 509' ' ' PRO . 0.0 OUTLIER 170.73 -32.33 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.883 179.812 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 511' ' ' CYS . . . . . 0.439 ' N ' ' HG2' ' A' ' 510' ' ' LYS . 0.8 OUTLIER 44.02 47.53 7.27 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.508 179.88 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 512' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -122.11 83.89 45.26 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.417 179.542 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 513' ' ' PRO . . . . . 0.435 ' HB3' ' HG ' ' A' ' 554' ' ' LEU . 73.5 Cg_endo -75.36 -0.82 10.53 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.844 2.363 . . . . 0.0 113.124 -179.466 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 20.2 t30 -62.93 -40.24 97.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.736 0.303 . . . . 0.0 110.907 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 515' ' ' LEU . . . . . 0.793 HD13 ' CH2' ' A' ' 518' ' ' TRP . 0.9 OUTLIER -95.71 58.99 2.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.017 0.437 . . . . 0.0 111.06 -179.812 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 516' ' ' HIS . . . . . . . . . . . . . 42.4 t-80 -73.01 -6.54 46.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.874 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 517' ' ' TYR . . . . . . . . . . . . . 48.8 m-85 -61.07 -27.88 68.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.718 0.294 . . . . 0.0 111.174 -179.388 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 518' ' ' TRP . . . . . 0.793 ' CH2' HD13 ' A' ' 515' ' ' LEU . 1.5 p90 -117.92 -14.97 10.02 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.87 -179.612 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 519' ' ' THR . . . . . 0.538 ' CG2' ' O ' ' A' ' 549' ' ' HIS . 14.9 p 55.2 -79.43 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.55 0.214 . . . . 0.0 111.084 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 520' ' ' THR . . . . . 0.522 ' N ' ' O ' ' A' ' 518' ' ' TRP . 1.1 m 177.41 -62.59 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 179.479 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 521' ' ' GLN . . . . . 0.425 ' N ' HG22 ' A' ' 520' ' ' THR . 0.6 OUTLIER -74.65 -12.06 60.34 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.32 177.918 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 522' ' ' ASP . . . . . 0.451 ' HA ' ' CG2' ' A' ' 527' ' ' ILE . 13.4 m-20 -92.56 -10.7 36.62 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.675 179.037 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -45.19 -26.37 0.48 Allowed 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.581 -179.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 524' ' ' GLY . . . . . 0.415 ' HA2' ' CG1' ' A' ' 527' ' ' ILE . . . 146.06 40.92 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.441 -0.885 . . . . 0.0 112.604 179.797 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -100.36 -60.2 1.57 Allowed 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 -179.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -132.51 37.63 3.49 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.541 0.686 . . . . 0.0 110.068 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 527' ' ' ILE . . . . . 0.956 ' HA ' ' HB1' ' A' ' 544' ' ' ALA . 2.3 pp -95.97 -0.25 10.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 114.708 -1.133 . . . . 0.0 112.912 -178.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 528' ' ' GLY . . . . . 0.472 ' N ' HD12 ' A' ' 527' ' ' ILE . . . -56.87 -9.38 3.73 Favored Glycine 0 CA--C 1.523 0.576 0 C-N-CA 121.01 -0.614 . . . . 0.0 114.47 -179.151 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 529' ' ' LEU . . . . . 0.641 HD23 ' H ' ' A' ' 529' ' ' LEU . 1.2 pt? -98.56 -37.46 9.54 Favored 'General case' 0 C--N 1.333 -0.118 0 CA-C-N 118.002 0.901 . . . . 0.0 112.021 -179.407 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 530' ' ' ALA . . . . . 0.984 ' HB3' ' HB2' ' A' ' 544' ' ' ALA . . . -103.82 1.94 32.16 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 -178.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 531' ' ' TRP . . . . . 0.464 ' HB2' ' O ' ' A' ' 527' ' ' ILE . 10.2 t90 -68.03 30.31 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 -178.639 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 532' ' ' ILE . . . . . 0.6 ' O ' HD12 ' A' ' 532' ' ' ILE . 1.3 pp -158.89 70.84 3.6 Favored Pre-proline 0 C--N 1.332 -0.177 0 CA-C-O 120.707 0.289 . . . . 0.0 111.462 179.309 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 533' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -54.83 102.07 0.08 OUTLIER 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.335 2.024 . . . . 0.0 111.508 179.374 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 534' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -96.15 -54.88 3.14 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -178.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -118.32 -34.91 3.93 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 111.87 0.322 . . . . 0.0 111.87 -179.247 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . -86.37 -176.29 49.69 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.539 -0.839 . . . . 0.0 112.783 -179.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 537' ' ' PRO . . . . . 0.419 ' HG2' ' CD1' ' A' ' 542' ' ' ILE . 14.0 Cg_endo -56.52 -158.83 0.01 OUTLIER 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.87 2.38 . . . . 0.0 111.818 179.69 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 538' ' ' ALA . . . . . 0.517 ' O ' ' HB3' ' A' ' 539' ' ' ALA . . . -45.06 -49.06 11.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.141 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 539' ' ' ALA . . . . . 0.541 ' C ' ' HB1' ' A' ' 530' ' ' ALA . . . 71.54 -48.79 0.68 Allowed 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.306 0.574 . . . . 0.0 111.459 179.77 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 540' ' ' GLU . . . . . 0.457 ' HG2' ' HA ' ' A' ' 531' ' ' TRP . 4.3 mt-10 -36.94 -29.33 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 114.901 -1.045 . . . . 0.0 112.354 -179.326 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 541' ' ' GLY . . . . . . . . . . . . . . . -127.98 -42.73 0.25 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.369 179.434 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 542' ' ' ILE . . . . . 0.672 HG22 ' ND1' ' A' ' 549' ' ' HIS . 2.6 pp -74.35 -24.88 19.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -179.317 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 543' ' ' TYR . . . . . 0.494 ' HB2' HD12 ' A' ' 542' ' ' ILE . 2.8 t80 -114.4 -7.97 12.86 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.847 0.356 . . . . 0.0 110.814 179.725 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 544' ' ' ALA . . . . . 0.984 ' HB2' ' HB3' ' A' ' 530' ' ' ALA . . . -98.29 -32.36 11.58 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 179.038 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 545' ' ' GLU . . . . . 0.581 ' HG3' ' H ' ' A' ' 548' ' ' MET . 4.4 tp10 -118.67 -32.6 4.51 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.178 -179.84 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 40.22 42.83 2.53 Favored Glycine 0 CA--C 1.52 0.372 0 CA-C-N 115.941 -0.572 . . . . 0.0 113.956 179.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 547' ' ' LEU . . . . . 0.578 HD23 ' H ' ' A' ' 548' ' ' MET . 0.0 OUTLIER -175.54 -61.15 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 117.511 0.656 . . . . 0.0 111.972 179.504 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 548' ' ' MET . . . . . 0.581 ' H ' ' HG3' ' A' ' 545' ' ' GLU . 0.1 OUTLIER -89.76 11.5 19.85 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.649 0.262 . . . . 0.0 111.311 -179.983 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 549' ' ' HIS . . . . . 0.672 ' ND1' HG22 ' A' ' 542' ' ' ILE . 7.2 p80 -65.61 -11.24 42.67 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.139 0.495 . . . . 0.0 110.662 179.328 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 550' ' ' ASN . . . . . 0.445 ' ND2' ' CE1' ' A' ' 549' ' ' HIS . 1.1 m-80 -96.22 -7.57 35.3 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.413 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 551' ' ' GLN . . . . . 0.536 ' HG3' ' HG2' ' A' ' 548' ' ' MET . 8.2 mm-40 -71.81 53.41 0.24 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.706 0.289 . . . . 0.0 111.63 -179.33 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 552' ' ' ASP . . . . . 0.473 ' HB2' ' HA ' ' A' ' 519' ' ' THR . 6.3 t70 -114.15 21.68 14.53 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.738 0.304 . . . . 0.0 110.766 179.392 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 553' ' ' GLY . . . . . 0.414 ' CA ' ' HA ' ' A' ' 511' ' ' CYS . . . 116.96 -31.07 6.03 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.744 -0.741 . . . . 0.0 111.324 -178.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 554' ' ' LEU . . . . . 0.435 ' HG ' ' HB3' ' A' ' 513' ' ' PRO . 11.8 mt -57.61 -53.44 58.16 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-O 121.505 0.669 . . . . 0.0 109.631 178.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 555' ' ' ILE . . . . . 0.622 HG22 ' O ' ' A' ' 555' ' ' ILE . 9.6 mm -89.05 54.93 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 CA-C-N 114.978 -1.01 . . . . 0.0 109.99 179.44 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 556' ' ' CYS . . . . . 0.489 ' O ' ' HD3' ' A' ' 559' ' ' ARG . 0.8 OUTLIER -64.7 -9.43 19.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.867 -179.459 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 557' ' ' GLY . . . . . 0.421 ' HA2' ' NH1' ' A' ' 559' ' ' ARG . . . -57.31 -2.52 0.67 Allowed Glycine 0 CA--C 1.523 0.569 0 C-N-CA 121.182 -0.532 . . . . 0.0 114.137 -179.589 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 558' ' ' LEU . . . . . 0.56 ' C ' HD12 ' A' ' 558' ' ' LEU . 3.8 pp -78.99 27.38 0.23 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 117.113 0.457 . . . . 0.0 112.084 -179.797 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 559' ' ' ARG . . . . . 0.812 ' HA ' ' HB3' ' A' ' 507' ' ' ALA . 0.0 OUTLIER -62.21 -160.27 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 110.545 -0.168 . . . . 0.0 110.545 -179.937 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 560' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.179 -0.915 . . . . 0.0 110.927 -179.964 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 507' ' ' ALA . . . . . 0.475 ' CB ' ' HB3' ' A' ' 559' ' ' ARG . . . . . . . . 0 N--CA 1.486 1.336 0 CA-C-O 120.978 0.418 . . . . 0.0 111.345 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 508' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 -128.91 76.96 78.56 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.874 179.007 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 509' ' ' PRO . . . . . 0.678 ' HB3' HD11 ' A' ' 558' ' ' LEU . 15.3 Cg_exo -68.97 -65.04 0.04 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.21 0 C-N-CA 122.649 2.232 . . . . 0.0 111.803 179.787 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 510' ' ' LYS . . . . . 0.43 ' HB3' ' O ' ' A' ' 509' ' ' PRO . 0.0 OUTLIER 176.16 -31.71 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.778 179.87 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 511' ' ' CYS . . . . . 0.428 ' N ' ' HG2' ' A' ' 510' ' ' LYS . 0.0 OUTLIER 43.72 52.15 6.41 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.486 179.73 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 512' ' ' ASN . . . . . 0.403 ' O ' ' O ' ' A' ' 552' ' ' ASP . 9.6 m-20 -110.7 83.59 3.57 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.503 179.557 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 513' ' ' PRO . . . . . 0.459 ' HA ' ' O ' ' A' ' 552' ' ' ASP . 90.1 Cg_endo -79.27 22.91 0.66 Allowed 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.953 2.436 . . . . 0.0 113.185 -179.639 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -96.65 -27.66 14.69 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.778 0.323 . . . . 0.0 110.798 179.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 515' ' ' LEU . . . . . . . . . . . . . 1.6 mt -93.06 72.48 4.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.803 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 516' ' ' HIS . . . . . 0.447 ' HA ' ' CB ' ' A' ' 552' ' ' ASP . 2.4 t60 -72.11 -7.53 49.51 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.827 -179.772 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 517' ' ' TYR . . . . . . . . . . . . . 41.6 m-85 -83.96 -66.11 0.93 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.853 0.359 . . . . 0.0 111.448 -179.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 518' ' ' TRP . . . . . 0.446 ' CD1' ' HA ' ' A' ' 523' ' ' GLU . 0.1 OUTLIER -69.33 -19.01 63.87 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.625 -179.459 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 519' ' ' THR . . . . . 0.532 ' OG1' ' N ' ' A' ' 520' ' ' THR . 1.5 p 61.45 -78.26 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.65 -0.25 . . . . 0.0 110.39 -179.69 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 520' ' ' THR . . . . . 0.532 ' N ' ' OG1' ' A' ' 519' ' ' THR . 1.0 OUTLIER 173.12 -62.93 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 179.07 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 521' ' ' GLN . . . . . 0.468 ' HB3' ' OE2' ' A' ' 545' ' ' GLU . 6.0 tt0 -74.52 -15.65 60.86 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 177.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 522' ' ' ASP . . . . . 0.434 ' O ' HG21 ' A' ' 527' ' ' ILE . 13.5 t70 -94.07 -10.45 33.35 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.786 178.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 523' ' ' GLU . . . . . 0.446 ' HA ' ' CD1' ' A' ' 518' ' ' TRP . 0.0 OUTLIER -44.95 -26.88 0.47 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.539 -179.524 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 524' ' ' GLY . . . . . 0.426 ' HA2' ' CG1' ' A' ' 527' ' ' ILE . . . 153.14 40.56 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.288 179.838 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -97.67 -56.3 2.55 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.165 0.431 . . . . 0.0 112.165 -179.342 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -133.2 41.22 3.13 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-O 121.496 0.665 . . . . 0.0 110.185 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 527' ' ' ILE . . . . . 0.885 ' HA ' ' HB1' ' A' ' 544' ' ' ALA . 1.8 pp -95.82 -0.62 10.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 114.783 -1.099 . . . . 0.0 112.918 -178.853 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 528' ' ' GLY . . . . . 0.608 ' N ' HD12 ' A' ' 527' ' ' ILE . . . -60.3 -13.21 28.0 Favored Glycine 0 CA--C 1.521 0.447 0 C-N-CA 120.852 -0.689 . . . . 0.0 114.131 -179.013 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 529' ' ' LEU . . . . . 0.722 HD13 ' N ' ' A' ' 529' ' ' LEU . 0.0 OUTLIER -99.13 -30.44 12.29 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 117.614 0.707 . . . . 0.0 111.817 -179.645 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 530' ' ' ALA . . . . . 1.012 ' HB3' ' HB2' ' A' ' 544' ' ' ALA . . . -103.61 1.69 32.38 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -179.136 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 531' ' ' TRP . . . . . 0.561 ' HA ' ' HG2' ' A' ' 540' ' ' GLU . 0.2 OUTLIER -71.33 30.34 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -178.92 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 532' ' ' ILE . . . . . 0.475 ' H ' ' C ' ' A' ' 530' ' ' ALA . 1.1 pt -158.58 72.98 3.78 Favored Pre-proline 0 N--CA 1.453 -0.311 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.472 179.14 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 533' ' ' PRO . . . . . 0.423 ' HB3' ' O ' ' A' ' 537' ' ' PRO . 1.2 Cg_endo -44.25 85.25 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 123.46 2.773 . . . . 0.0 113.014 -179.625 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 534' ' ' TYR . . . . . 0.446 ' N ' ' O ' ' A' ' 532' ' ' ILE . 7.7 t80 -96.65 -39.47 9.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.329 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 20.6 t80 -57.68 -34.98 69.97 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.549 -179.191 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 146.55 -52.41 0.56 Allowed Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.467 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 537' ' ' PRO . . . . . 0.423 ' O ' ' HB3' ' A' ' 533' ' ' PRO . 2.0 Cg_endo -78.06 -174.53 2.28 Favored 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 122.725 2.283 . . . . 0.0 111.173 179.392 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 538' ' ' ALA . . . . . 0.496 ' O ' ' HB3' ' A' ' 539' ' ' ALA . . . -57.11 -51.23 70.14 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.951 -0.3 . . . . 0.0 110.624 179.554 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 539' ' ' ALA . . . . . 0.496 ' HB3' ' O ' ' A' ' 538' ' ' ALA . . . 71.07 -50.76 0.69 Allowed 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 121.265 0.555 . . . . 0.0 111.402 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 540' ' ' GLU . . . . . 0.561 ' HG2' ' HA ' ' A' ' 531' ' ' TRP . 5.3 mt-10 -37.74 -24.34 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 114.896 -1.047 . . . . 0.0 112.759 -179.445 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 541' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 539' ' ' ALA . . . -111.15 -58.36 0.48 Allowed Glycine 0 CA--C 1.52 0.384 0 C-N-CA 120.488 -0.863 . . . . 0.0 113.227 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 542' ' ' ILE . . . . . 0.524 HD13 ' H ' ' A' ' 542' ' ' ILE . 0.2 OUTLIER -76.94 -22.82 14.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 113.477 0.917 . . . . 0.0 113.477 -178.366 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 543' ' ' TYR . . . . . 0.465 ' C ' ' HB2' ' A' ' 530' ' ' ALA . 10.5 m-85 -101.56 -11.19 19.44 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.27 0.557 . . . . 0.0 110.345 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 544' ' ' ALA . . . . . 1.012 ' HB2' ' HB3' ' A' ' 530' ' ' ALA . . . -100.03 -28.86 12.85 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 115.228 -0.897 . . . . 0.0 110.034 179.689 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 545' ' ' GLU . . . . . 0.561 ' CD ' HD23 ' A' ' 547' ' ' LEU . 3.9 tp10 -118.68 -32.78 4.45 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.384 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 36.39 39.73 0.36 Allowed Glycine 0 CA--C 1.519 0.308 0 CA-C-N 115.759 -0.655 . . . . 0.0 114.371 179.454 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 547' ' ' LEU . . . . . 0.604 HD23 ' H ' ' A' ' 548' ' ' MET . 0.0 OUTLIER -176.71 -61.73 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 117.734 0.767 . . . . 0.0 112.247 179.449 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 548' ' ' MET . . . . . 0.604 ' H ' HD23 ' A' ' 547' ' ' LEU . 0.0 OUTLIER -95.38 11.38 32.94 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.728 0.299 . . . . 0.0 111.053 179.634 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 549' ' ' HIS . . . . . 0.474 ' O ' ' CG2' ' A' ' 519' ' ' THR . 16.5 p80 -62.72 -10.82 14.0 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.024 179.549 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 550' ' ' ASN . . . . . 0.449 ' O ' ' N ' ' A' ' 552' ' ' ASP . 1.8 m120 -95.56 -33.82 12.26 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -178.633 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 551' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -65.9 71.51 0.06 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.182 0.515 . . . . 0.0 110.466 -179.694 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 552' ' ' ASP . . . . . 0.491 ' HA ' ' O ' ' A' ' 519' ' ' THR . 2.4 p30 -94.71 22.12 6.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.397 -179.48 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . 123.97 -32.65 4.13 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.799 -0.715 . . . . 0.0 111.677 -179.393 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 554' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -58.75 -59.18 5.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.488 0.661 . . . . 0.0 109.96 178.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 555' ' ' ILE . . . . . 0.594 HG22 ' O ' ' A' ' 555' ' ' ILE . 3.2 mm -72.27 65.69 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 CA-C-N 114.867 -1.06 . . . . 0.0 110.618 179.781 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 556' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -68.95 -7.47 35.44 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.565 -179.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -65.76 -2.73 12.75 Favored Glycine 0 CA--C 1.52 0.367 0 C-N-CA 120.913 -0.661 . . . . 0.0 113.391 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 558' ' ' LEU . . . . . 0.715 HD12 ' N ' ' A' ' 559' ' ' ARG . 4.2 pp -64.84 -32.01 73.51 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 117.115 0.458 . . . . 0.0 111.037 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 559' ' ' ARG . . . . . 0.715 ' N ' HD12 ' A' ' 558' ' ' LEU . 1.2 mmm-85 47.96 -172.51 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 120.859 0.362 . . . . 0.0 111.116 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 560' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.254 -0.879 . . . . 0.0 110.95 179.671 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 507' ' ' ALA . . . . . 0.589 ' HB3' ' CG ' ' A' ' 559' ' ' ARG . . . . . . . . 0 N--CA 1.485 1.323 0 CA-C-O 120.883 0.373 . . . . 0.0 111.143 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 508' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -128.28 86.28 58.33 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.689 179.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 509' ' ' PRO . . . . . 0.514 ' O ' ' CE ' ' A' ' 510' ' ' LYS . 4.6 Cg_exo -75.74 -23.72 12.36 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.777 2.318 . . . . 0.0 112.149 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 510' ' ' LYS . . . . . 0.514 ' CE ' ' O ' ' A' ' 509' ' ' PRO . 0.0 OUTLIER 84.03 -22.53 0.22 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.506 -179.831 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 511' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 43.46 76.31 0.08 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.569 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 512' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -124.04 80.4 57.68 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.48 179.724 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 513' ' ' PRO . . . . . 0.47 ' HA ' ' O ' ' A' ' 552' ' ' ASP . 94.2 Cg_endo -80.98 24.85 0.66 Allowed 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 123.021 2.481 . . . . 0.0 113.179 -179.679 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 17.8 t-20 -96.73 -30.31 13.28 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.707 0.289 . . . . 0.0 110.797 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 515' ' ' LEU . . . . . . . . . . . . . 32.9 mt -89.17 72.97 8.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.847 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 516' ' ' HIS . . . . . 0.425 ' HA ' ' CB ' ' A' ' 552' ' ' ASP . 62.2 t-80 -76.69 -15.69 59.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.541 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 517' ' ' TYR . . . . . . . . . . . . . 57.4 m-85 -80.1 -36.72 35.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.736 0.303 . . . . 0.0 111.373 -179.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 518' ' ' TRP . . . . . 0.462 ' O ' ' N ' ' A' ' 520' ' ' THR . 3.9 m-90 -94.92 -21.27 18.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.501 -179.532 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 519' ' ' THR . . . . . 0.551 ' OG1' ' N ' ' A' ' 520' ' ' THR . 1.2 p 58.41 -78.64 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.843 -179.797 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 520' ' ' THR . . . . . 0.551 ' N ' ' OG1' ' A' ' 519' ' ' THR . 1.1 m 178.18 -62.97 0.01 OUTLIER 'General case' 0 CA--C 1.521 -0.171 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 179.234 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 521' ' ' GLN . . . . . 0.41 ' N ' HG22 ' A' ' 520' ' ' THR . 0.3 OUTLIER -74.42 -14.3 60.83 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 177.825 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 522' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -94.13 -11.12 31.16 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.961 179.086 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -45.3 -28.29 0.8 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.235 -179.816 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . 148.61 42.03 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.43 179.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -104.37 -54.8 2.47 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 111.833 0.309 . . . . 0.0 111.833 -179.681 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -131.74 48.44 2.42 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-O 121.536 0.684 . . . . 0.0 110.014 179.758 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 527' ' ' ILE . . . . . 0.779 ' HA ' ' HB1' ' A' ' 544' ' ' ALA . 1.5 pp -95.45 -6.33 10.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 114.916 -1.038 . . . . 0.0 112.517 -178.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 528' ' ' GLY . . . . . 0.702 ' N ' HD12 ' A' ' 527' ' ' ILE . . . -54.86 -13.04 4.12 Favored Glycine 0 CA--C 1.521 0.445 0 C-N-CA 120.971 -0.633 . . . . 0.0 113.817 -179.472 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 529' ' ' LEU . . . . . 0.83 HD22 ' O ' ' A' ' 529' ' ' LEU . 0.3 OUTLIER -97.01 -41.01 8.59 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 117.392 0.596 . . . . 0.0 111.431 -179.296 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 530' ' ' ALA . . . . . 1.01 ' HB3' ' HB2' ' A' ' 544' ' ' ALA . . . -103.76 2.05 32.46 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.789 0.662 . . . . 0.0 112.789 -178.807 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 531' ' ' TRP . . . . . 0.482 ' HB2' ' O ' ' A' ' 527' ' ' ILE . 62.1 t90 -70.89 25.99 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -179.088 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 532' ' ' ILE . . . . . 0.629 ' O ' HD12 ' A' ' 532' ' ' ILE . 1.3 pp -159.25 70.98 3.45 Favored Pre-proline 0 C--N 1.332 -0.191 0 CA-C-O 120.843 0.354 . . . . 0.0 110.885 179.105 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 533' ' ' PRO . . . . . 0.418 ' HB3' ' O ' ' A' ' 537' ' ' PRO . 10.1 Cg_endo -51.36 110.63 0.44 Allowed 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.735 2.29 . . . . 0.0 111.907 179.735 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 534' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -96.33 -55.01 3.08 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -179.143 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -118.47 -35.23 3.81 Favored 'General case' 0 N--CA 1.463 0.179 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -179.121 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . -83.26 -175.11 50.83 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.535 -0.841 . . . . 0.0 112.89 -179.369 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 537' ' ' PRO . . . . . 0.418 ' O ' ' HB3' ' A' ' 533' ' ' PRO . 19.5 Cg_endo -58.12 -156.9 0.01 OUTLIER 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.657 2.238 . . . . 0.0 111.266 179.554 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 538' ' ' ALA . . . . . 0.488 ' O ' ' HB3' ' A' ' 539' ' ' ALA . . . -43.58 -44.01 5.95 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.7 0.286 . . . . 0.0 111.141 179.811 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 539' ' ' ALA . . . . . 0.488 ' HB3' ' O ' ' A' ' 538' ' ' ALA . . . 71.1 -49.54 0.68 Allowed 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 121.108 0.48 . . . . 0.0 111.665 179.781 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 540' ' ' GLU . . . . . 0.468 ' CG ' ' HA ' ' A' ' 531' ' ' TRP . 3.7 mt-10 -37.66 -25.75 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.142 -0.935 . . . . 0.0 112.656 -179.506 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 541' ' ' GLY . . . . . 0.431 ' N ' ' O ' ' A' ' 539' ' ' ALA . . . -112.73 -55.42 0.45 Allowed Glycine 0 CA--C 1.523 0.549 0 C-N-CA 120.384 -0.912 . . . . 0.0 113.819 -179.559 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 542' ' ' ILE . . . . . 0.59 HG22 ' CD2' ' A' ' 549' ' ' HIS . 0.2 OUTLIER -79.18 -22.94 12.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 113.691 0.997 . . . . 0.0 113.691 -178.133 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 543' ' ' TYR . . . . . 0.494 ' C ' ' HB2' ' A' ' 530' ' ' ALA . 9.7 m-85 -99.02 -16.97 18.51 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.248 0.547 . . . . 0.0 110.028 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 544' ' ' ALA . . . . . 1.01 ' HB2' ' HB3' ' A' ' 530' ' ' ALA . . . -91.52 -24.44 19.63 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.201 179.856 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 545' ' ' GLU . . . . . 0.664 ' CD ' HD23 ' A' ' 547' ' ' LEU . 3.7 tp10 -118.78 -32.65 4.46 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.405 -179.805 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 39.41 42.36 1.82 Allowed Glycine 0 CA--C 1.52 0.378 0 CA-C-N 115.883 -0.599 . . . . 0.0 114.366 179.436 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 547' ' ' LEU . . . . . 0.664 HD23 ' CD ' ' A' ' 545' ' ' GLU . 0.0 OUTLIER -178.51 -61.97 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 117.713 0.756 . . . . 0.0 112.094 179.122 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 548' ' ' MET . . . . . 0.555 ' H ' HD23 ' A' ' 547' ' ' LEU . 0.0 OUTLIER -96.08 11.43 34.21 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.751 0.31 . . . . 0.0 110.975 179.504 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 549' ' ' HIS . . . . . 0.59 ' CD2' HG22 ' A' ' 542' ' ' ILE . 5.1 p-80 -61.19 -11.08 7.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.079 179.631 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 550' ' ' ASN . . . . . 0.43 ' O ' ' N ' ' A' ' 552' ' ' ASP . 28.9 t-20 -95.12 -34.64 12.2 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 -178.788 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 551' ' ' GLN . . . . . 0.404 ' HG3' ' O ' ' A' ' 548' ' ' MET . 2.0 pt20 -66.49 72.08 0.08 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.139 0.495 . . . . 0.0 110.419 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 552' ' ' ASP . . . . . 0.47 ' O ' ' HA ' ' A' ' 513' ' ' PRO . 4.5 p30 -93.87 22.33 5.76 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.514 -179.448 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . 124.2 -28.03 5.44 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.838 -0.696 . . . . 0.0 111.645 -179.27 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 554' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -59.67 -53.32 59.36 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.551 0.691 . . . . 0.0 109.787 178.824 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 555' ' ' ILE . . . . . 0.649 HG22 ' O ' ' A' ' 555' ' ' ILE . 3.2 mm -78.95 62.02 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 114.755 -1.111 . . . . 0.0 110.374 179.808 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 556' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -53.44 -22.45 7.85 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.444 -179.787 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 557' ' ' GLY . . . . . 0.422 ' HA2' ' NH1' ' A' ' 559' ' ' ARG . . . -51.91 -22.48 9.22 Favored Glycine 0 C--N 1.332 0.335 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.993 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 558' ' ' LEU . . . . . 0.822 HD12 ' N ' ' A' ' 559' ' ' ARG . 3.8 pp -53.73 -43.58 69.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.924 0.393 . . . . 0.0 111.415 -179.822 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 559' ' ' ARG . . . . . 0.822 ' N ' HD12 ' A' ' 558' ' ' LEU . 3.3 mpt_? 55.76 -178.14 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.934 -179.65 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 560' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.298 -0.858 . . . . 0.0 110.902 179.998 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 507' ' ' ALA . . . . . 0.757 ' HB1' ' HB2' ' A' ' 559' ' ' ARG . . . . . . . . 0 N--CA 1.486 1.349 0 CA-C-O 120.765 0.317 . . . . 0.0 111.173 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 508' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -128.62 78.2 76.28 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.889 179.594 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 509' ' ' PRO . . . . . 0.47 ' O ' ' CE ' ' A' ' 510' ' ' LYS . 90.5 Cg_endo -90.25 -13.42 2.44 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 122.877 2.385 . . . . 0.0 112.652 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 510' ' ' LYS . . . . . 0.47 ' CE ' ' O ' ' A' ' 509' ' ' PRO . 0.0 OUTLIER 81.22 -28.07 0.13 Allowed 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.076 0.465 . . . . 0.0 111.261 -179.449 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 511' ' ' CYS . . . . . . . . . . . . . 9.6 m 44.21 77.0 0.08 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.573 179.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 512' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -115.76 79.11 7.48 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.512 179.82 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 513' ' ' PRO . . . . . 0.458 ' HA ' ' O ' ' A' ' 552' ' ' ASP . 84.7 Cg_endo -83.48 25.23 0.7 Allowed 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.839 2.359 . . . . 0.0 113.042 -179.657 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -96.66 -29.69 13.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.814 0.34 . . . . 0.0 111.107 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 515' ' ' LEU . . . . . . . . . . . . . 1.5 mt -88.13 73.08 9.05 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.025 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 516' ' ' HIS . . . . . 0.433 ' HA ' ' CB ' ' A' ' 552' ' ' ASP . 1.7 t60 -79.53 -7.21 58.32 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.601 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 517' ' ' TYR . . . . . . . . . . . . . 40.2 m-85 -80.19 -54.27 5.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.655 0.264 . . . . 0.0 111.686 -179.318 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 518' ' ' TRP . . . . . 0.526 ' O ' ' N ' ' A' ' 520' ' ' THR . 4.1 m-90 -92.37 -3.33 55.49 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 -179.02 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 519' ' ' THR . . . . . 0.579 ' OG1' ' N ' ' A' ' 520' ' ' THR . 1.3 p 55.83 -78.13 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 120.591 0.234 . . . . 0.0 110.978 179.746 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 520' ' ' THR . . . . . 0.579 ' N ' ' OG1' ' A' ' 519' ' ' THR . 1.1 m 177.01 -62.58 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.515 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 521' ' ' GLN . . . . . 0.424 ' N ' HG22 ' A' ' 520' ' ' THR . 0.0 OUTLIER -73.84 -12.07 60.57 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 177.96 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 522' ' ' ASP . . . . . 0.435 ' HA ' ' CG2' ' A' ' 527' ' ' ILE . 3.2 m-20 -93.62 -10.72 33.65 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.781 179.047 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 523' ' ' GLU . . . . . 0.428 ' HA ' ' CD1' ' A' ' 518' ' ' TRP . 0.3 OUTLIER -45.39 -27.62 0.73 Allowed 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.501 -179.936 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 524' ' ' GLY . . . . . 0.43 ' HA2' ' CG1' ' A' ' 527' ' ' ILE . . . 146.05 42.34 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.579 -0.819 . . . . 0.0 112.299 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -101.52 -59.65 1.66 Allowed 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 111.941 0.349 . . . . 0.0 111.941 -179.478 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -131.82 36.58 3.69 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-O 121.503 0.668 . . . . 0.0 110.066 179.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 527' ' ' ILE . . . . . 0.964 ' HA ' ' HB1' ' A' ' 544' ' ' ALA . 2.1 pp -95.7 -0.43 10.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 114.787 -1.097 . . . . 0.0 112.735 -178.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 528' ' ' GLY . . . . . 0.516 ' N ' HD12 ' A' ' 527' ' ' ILE . . . -56.83 -13.77 8.84 Favored Glycine 0 CA--C 1.52 0.349 0 C-N-CA 120.892 -0.67 . . . . 0.0 114.024 -179.406 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 529' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -98.55 -32.81 11.26 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 117.639 0.719 . . . . 0.0 111.724 -179.379 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 530' ' ' ALA . . . . . 0.895 ' HB3' ' HB2' ' A' ' 544' ' ' ALA . . . -103.69 1.84 32.36 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -178.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 531' ' ' TRP . . . . . 0.533 ' O ' HG23 ' A' ' 532' ' ' ILE . 4.5 t90 -68.26 26.68 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -179.02 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 532' ' ' ILE . . . . . 0.626 ' O ' HD12 ' A' ' 532' ' ' ILE . 1.3 pp -160.56 71.04 2.88 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 120.846 0.355 . . . . 0.0 110.386 179.014 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 533' ' ' PRO . . . . . 0.414 ' HB3' ' O ' ' A' ' 537' ' ' PRO . 1.2 Cg_endo -44.71 85.22 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 123.451 2.768 . . . . 0.0 113.118 -179.449 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 534' ' ' TYR . . . . . 0.449 ' N ' ' O ' ' A' ' 532' ' ' ILE . 5.8 t80 -96.78 -34.26 11.38 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.148 179.606 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -60.92 -34.93 75.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.567 -179.369 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 536' ' ' GLY . . . . . 0.41 ' N ' ' CD ' ' A' ' 537' ' ' PRO . . . 145.12 -50.4 0.64 Allowed Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.522 -0.847 . . . . 0.0 112.603 -179.817 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 537' ' ' PRO . . . . . 0.414 ' O ' ' HB3' ' A' ' 533' ' ' PRO . 6.1 Cg_exo -74.64 -164.08 0.21 Allowed 'Trans proline' 0 N--CA 1.461 -0.43 0 C-N-CA 122.601 2.201 . . . . 0.0 111.474 179.594 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 538' ' ' ALA . . . . . 0.481 ' O ' ' HB3' ' A' ' 539' ' ' ALA . . . -68.4 -46.78 69.05 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.83 0.347 . . . . 0.0 110.258 179.328 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 539' ' ' ALA . . . . . 0.692 ' C ' ' HB1' ' A' ' 530' ' ' ALA . . . 70.15 -54.04 0.63 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 121.363 0.601 . . . . 0.0 111.443 179.841 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 540' ' ' GLU . . . . . 0.484 ' HG2' ' HA ' ' A' ' 531' ' ' TRP . 12.8 mt-10 -37.52 -27.23 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 114.781 -1.099 . . . . 0.0 112.248 -179.31 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 541' ' ' GLY . . . . . 0.423 ' N ' ' O ' ' A' ' 539' ' ' ALA . . . -125.26 -46.35 0.23 Allowed Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.051 179.006 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 542' ' ' ILE . . . . . 0.466 ' CD1' ' HA ' ' A' ' 539' ' ' ALA . 2.6 pp -73.93 -23.88 19.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -179.503 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 543' ' ' TYR . . . . . 0.465 ' HB2' HD12 ' A' ' 542' ' ' ILE . 23.5 t80 -112.54 -8.45 13.84 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.944 0.402 . . . . 0.0 110.843 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 544' ' ' ALA . . . . . 0.964 ' HB1' ' HA ' ' A' ' 527' ' ' ILE . . . -103.18 -35.21 8.56 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.939 179.316 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 545' ' ' GLU . . . . . 0.53 ' HG3' ' H ' ' A' ' 548' ' ' MET . 28.1 tp10 -118.59 -32.61 4.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.331 -0.85 . . . . 0.0 111.05 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 38.9 40.51 1.09 Allowed Glycine 0 CA--C 1.52 0.355 0 CA-C-N 115.856 -0.611 . . . . 0.0 113.896 179.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 547' ' ' LEU . . . . . 0.551 ' HG ' ' N ' ' A' ' 548' ' ' MET . 0.0 OUTLIER -172.0 -61.47 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 117.537 0.669 . . . . 0.0 112.204 179.568 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 548' ' ' MET . . . . . 0.581 ' O ' ' HG3' ' A' ' 551' ' ' GLN . 0.0 OUTLIER -96.17 11.78 33.15 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.773 0.321 . . . . 0.0 111.688 179.95 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 549' ' ' HIS . . . . . 0.502 ' O ' ' CG2' ' A' ' 519' ' ' THR . 28.5 p80 -64.73 -11.0 31.52 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.88 0.372 . . . . 0.0 110.77 179.255 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 550' ' ' ASN . . . . . 0.46 ' O ' ' N ' ' A' ' 552' ' ' ASP . 5.9 m120 -96.18 -37.98 10.34 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.393 0.516 . . . . 0.0 112.393 -178.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 551' ' ' GLN . . . . . 0.581 ' HG3' ' O ' ' A' ' 548' ' ' MET . 0.0 OUTLIER -64.62 72.51 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.073 0.463 . . . . 0.0 110.712 -179.621 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 552' ' ' ASP . . . . . 0.46 ' N ' ' O ' ' A' ' 550' ' ' ASN . 2.3 p30 -92.51 21.9 5.03 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.203 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . 123.94 -27.81 5.55 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.952 -0.642 . . . . 0.0 111.766 -179.307 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 554' ' ' LEU . . . . . 0.459 HD11 ' OD2' ' A' ' 552' ' ' ASP . 0.6 OUTLIER -60.56 -60.67 3.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.404 0.621 . . . . 0.0 110.066 179.007 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 555' ' ' ILE . . . . . 0.493 HG22 ' O ' ' A' ' 555' ' ' ILE . 3.6 mm -72.71 70.87 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 CA-C-N 114.999 -1.0 . . . . 0.0 110.494 179.696 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 556' ' ' CYS . . . . . 0.536 ' O ' ' HD2' ' A' ' 559' ' ' ARG . 58.7 m -65.09 -8.73 17.8 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.333 -0.849 . . . . 0.0 112.039 -179.446 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 557' ' ' GLY . . . . . 0.45 ' C ' ' H ' ' A' ' 559' ' ' ARG . . . -52.82 -10.34 1.0 Allowed Glycine 0 CA--C 1.522 0.515 0 C-N-CA 121.047 -0.597 . . . . 0.0 113.949 -179.759 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 558' ' ' LEU . . . . . 0.52 ' C ' HD12 ' A' ' 558' ' ' LEU . 4.1 pp -68.8 27.95 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 -179.695 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 559' ' ' ARG . . . . . 0.757 ' HB2' ' HB1' ' A' ' 507' ' ' ALA . 0.0 OUTLIER -100.83 -173.11 2.31 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.816 0.341 . . . . 0.0 111.111 -179.834 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 560' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.26 -0.876 . . . . 0.0 110.967 179.979 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 507' ' ' ALA . . . . . 0.6 ' O ' ' HA ' ' A' ' 559' ' ' ARG . . . . . . . . 0 N--CA 1.483 1.217 0 CA-C-O 121.445 0.64 . . . . 0.0 111.452 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 508' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.18 77.32 77.0 Favored Pre-proline 0 C--N 1.321 -0.648 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.902 179.142 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 509' ' ' PRO . . . . . 0.515 ' O ' ' HB3' ' A' ' 510' ' ' LYS . 32.3 Cg_exo -62.91 -65.86 0.05 OUTLIER 'Trans proline' 0 C--O 1.231 0.142 0 C-N-CA 122.91 2.407 . . . . 0.0 112.362 -179.558 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 510' ' ' LYS . . . . . 0.515 ' HB3' ' O ' ' A' ' 509' ' ' PRO . 0.0 OUTLIER 168.66 -30.97 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.364 -0.834 . . . . 0.0 109.879 -179.674 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 511' ' ' CYS . . . . . 0.445 ' N ' ' HG2' ' A' ' 510' ' ' LYS . 1.0 OUTLIER 55.86 84.28 0.08 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.006 -0.997 . . . . 0.0 111.522 179.249 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 512' ' ' ASN . . . . . 0.807 ' ND2' HD12 ' A' ' 515' ' ' LEU . 18.7 p30 -115.52 77.44 5.95 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.077 179.326 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 513' ' ' PRO . . . . . 0.573 ' HA ' ' O ' ' A' ' 552' ' ' ASP . 28.5 Cg_endo -64.5 -10.62 24.95 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.805 2.337 . . . . 0.0 112.345 -179.789 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -81.11 -22.29 39.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.213 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 515' ' ' LEU . . . . . 0.807 HD12 ' ND2' ' A' ' 512' ' ' ASN . 61.5 mt -88.85 74.62 8.23 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.928 0.394 . . . . 0.0 111.094 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 516' ' ' HIS . . . . . 0.474 ' HA ' ' HB3' ' A' ' 552' ' ' ASP . 98.9 m-70 -80.08 -7.27 58.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.693 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 517' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 -78.54 -37.94 41.66 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 111.648 0.24 . . . . 0.0 111.648 -179.354 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 518' ' ' TRP . . . . . 0.595 ' O ' ' N ' ' A' ' 520' ' ' THR . 14.8 m-90 -111.06 5.11 19.97 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 111.99 0.367 . . . . 0.0 111.99 -179.376 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 519' ' ' THR . . . . . 0.539 ' HA ' ' HA ' ' A' ' 552' ' ' ASP . 2.4 p 50.08 -78.32 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 120.421 0.153 . . . . 0.0 110.999 -179.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 520' ' ' THR . . . . . 0.595 ' N ' ' O ' ' A' ' 518' ' ' TRP . 1.2 m 179.45 -62.57 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 179.248 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 521' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -72.38 -12.02 60.94 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.301 178.004 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 522' ' ' ASP . . . . . 0.473 ' HA ' ' CG2' ' A' ' 527' ' ' ILE . 64.9 m-20 -91.71 -10.82 38.77 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.962 179.21 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 523' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -45.28 -26.78 0.55 Allowed 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.464 -179.762 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . 145.59 41.99 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.547 -0.835 . . . . 0.0 112.309 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -101.99 -60.57 1.51 Allowed 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 111.784 0.29 . . . . 0.0 111.784 -179.494 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 526' ' ' ALA . . . . . . . . . . . . . . . -131.35 37.8 3.67 Favored 'General case' 0 CA--C 1.512 -0.506 0 CA-C-O 121.52 0.676 . . . . 0.0 110.066 179.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 527' ' ' ILE . . . . . 0.92 ' HA ' ' HB1' ' A' ' 544' ' ' ALA . 2.1 pp -95.78 -0.49 10.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-N 114.847 -1.07 . . . . 0.0 112.724 -178.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 528' ' ' GLY . . . . . 0.529 ' N ' HD12 ' A' ' 527' ' ' ILE . . . -58.94 -13.34 18.78 Favored Glycine 0 CA--C 1.521 0.443 0 C-N-CA 120.877 -0.678 . . . . 0.0 113.896 -179.336 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 529' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -98.63 -33.11 11.09 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 117.56 0.68 . . . . 0.0 111.759 -179.425 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 530' ' ' ALA . . . . . 0.942 ' HB3' ' HB2' ' A' ' 544' ' ' ALA . . . -103.62 -0.97 28.92 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 -178.84 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 531' ' ' TRP . . . . . 0.475 ' HA ' ' HG2' ' A' ' 540' ' ' GLU . 8.9 t90 -56.62 -11.12 1.19 Allowed 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 112.057 0.392 . . . . 0.0 112.057 -179.189 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 532' ' ' ILE . . . . . 0.716 ' O ' HD12 ' A' ' 532' ' ' ILE . 1.6 pp -133.45 73.79 72.64 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.037 0.446 . . . . 0.0 111.218 179.632 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 533' ' ' PRO . . . . . 0.406 ' HB3' ' O ' ' A' ' 538' ' ' ALA . 1.0 OUTLIER -44.18 92.95 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 123.165 2.577 . . . . 0.0 112.798 -179.988 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 534' ' ' TYR . . . . . . . . . . . . . 45.0 t80 -96.4 -25.51 15.68 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.079 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -70.57 -34.9 72.72 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.355 -179.559 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 147.32 -64.63 0.42 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.549 -0.834 . . . . 0.0 112.889 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -59.14 -165.01 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.641 2.227 . . . . 0.0 112.011 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 538' ' ' ALA . . . . . 0.477 ' O ' ' HB3' ' A' ' 539' ' ' ALA . . . -66.59 -48.27 70.09 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.558 179.759 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 539' ' ' ALA . . . . . 0.699 ' C ' ' HB1' ' A' ' 530' ' ' ALA . . . 69.54 -53.56 0.6 Allowed 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.302 0.573 . . . . 0.0 111.546 179.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 540' ' ' GLU . . . . . 0.475 ' HG2' ' HA ' ' A' ' 531' ' ' TRP . 14.4 mt-10 -37.32 -27.39 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.889 -1.051 . . . . 0.0 112.266 -179.377 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 541' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 539' ' ' ALA . . . -125.63 -46.71 0.22 Allowed Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.034 179.007 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 542' ' ' ILE . . . . . 0.476 HD12 ' HB2' ' A' ' 543' ' ' TYR . 2.6 pp -73.28 -23.89 20.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -179.515 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 543' ' ' TYR . . . . . 0.476 ' HB2' HD12 ' A' ' 542' ' ' ILE . 21.4 t80 -112.85 -7.62 13.75 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.991 0.424 . . . . 0.0 110.936 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 544' ' ' ALA . . . . . 0.942 ' HB2' ' HB3' ' A' ' 530' ' ' ALA . . . -103.04 -33.41 9.27 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.866 179.328 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 545' ' ' GLU . . . . . 0.645 ' CD ' HD23 ' A' ' 547' ' ' LEU . 3.9 tp10 -118.59 -32.58 4.54 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.43 -0.805 . . . . 0.0 111.0 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 38.01 46.86 1.85 Allowed Glycine 0 CA--C 1.519 0.294 0 CA-C-N 115.804 -0.635 . . . . 0.0 114.148 179.596 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 547' ' ' LEU . . . . . 0.645 HD23 ' CD ' ' A' ' 545' ' ' GLU . 0.0 OUTLIER -179.07 -61.5 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 117.6 0.7 . . . . 0.0 111.801 179.268 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 548' ' ' MET . . . . . 0.549 ' H ' HD23 ' A' ' 547' ' ' LEU . 0.0 OUTLIER -95.08 11.59 31.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.694 0.283 . . . . 0.0 111.088 179.503 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 549' ' ' HIS . . . . . 0.484 ' O ' HG21 ' A' ' 519' ' ' THR . 16.4 p80 -60.64 -11.52 7.53 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.07 179.586 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 550' ' ' ASN . . . . . 0.544 ' O ' ' N ' ' A' ' 552' ' ' ASP . 8.6 m-20 -94.8 -40.19 9.88 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 -179.332 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 551' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -60.34 73.06 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.189 0.519 . . . . 0.0 110.303 179.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 552' ' ' ASP . . . . . 0.573 ' O ' ' HA ' ' A' ' 513' ' ' PRO . 11.8 m-20 -84.62 21.73 1.45 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.933 -179.278 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 553' ' ' GLY . . . . . 0.414 ' HA3' ' N ' ' A' ' 513' ' ' PRO . . . 116.7 12.84 8.35 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.105 -179.653 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 554' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -104.41 -51.59 3.07 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.42 0.629 . . . . 0.0 109.93 179.75 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 555' ' ' ILE . . . . . 0.528 ' O ' HD23 ' A' ' 558' ' ' LEU . 2.2 mm -78.27 -1.69 4.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 114.923 -1.035 . . . . 0.0 111.231 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 556' ' ' CYS . . . . . 0.452 ' O ' ' HD2' ' A' ' 559' ' ' ARG . 25.9 p -68.45 -7.0 28.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.973 178.817 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 557' ' ' GLY . . . . . . . . . . . . . . . -56.27 -7.91 2.19 Favored Glycine 0 C--N 1.336 0.557 0 C-N-CA 120.975 -0.631 . . . . 0.0 113.959 -179.364 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 558' ' ' LEU . . . . . 0.528 HD23 ' O ' ' A' ' 555' ' ' ILE . 0.2 OUTLIER -45.36 -72.64 0.05 Allowed 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 117.31 0.555 . . . . 0.0 111.974 -179.699 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 559' ' ' ARG . . . . . 0.6 ' HA ' ' O ' ' A' ' 507' ' ' ALA . 0.3 OUTLIER 47.49 -173.11 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.052 -179.686 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 560' ' ' GLN . . . . . 0.427 ' HG2' ' O ' ' A' ' 559' ' ' ARG . 3.0 pt20 . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.271 -0.871 . . . . 0.0 112.033 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 507' ' ' ALA . . . . . 0.453 ' HB3' ' HA ' ' A' ' 559' ' ' ARG . . . . . . . . 0 N--CA 1.485 1.3 0 CA-C-O 121.15 0.5 . . . . 0.0 111.181 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 508' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.38 77.62 77.12 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.231 179.812 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 509' ' ' PRO . . . . . 0.492 ' O ' ' HB3' ' A' ' 510' ' ' LYS . 11.1 Cg_exo -71.04 -65.44 0.03 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.304 0 C-N-CA 122.563 2.175 . . . . 0.0 111.651 179.631 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 510' ' ' LYS . . . . . 0.492 ' HB3' ' O ' ' A' ' 509' ' ' PRO . 0.0 OUTLIER 173.74 -32.62 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.619 -0.718 . . . . 0.0 110.861 179.706 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 511' ' ' CYS . . . . . 0.448 ' N ' ' HG2' ' A' ' 510' ' ' LYS . 0.1 OUTLIER 42.63 41.11 2.25 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.611 179.78 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 512' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -107.72 83.94 1.81 Allowed Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.755 179.736 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 513' ' ' PRO . . . . . 0.455 ' HA ' ' O ' ' A' ' 552' ' ' ASP . 57.2 Cg_endo -71.27 -6.08 18.41 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.76 2.306 . . . . 0.0 112.86 -179.859 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 514' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -71.71 -28.29 63.6 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.189 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 515' ' ' LEU . . . . . . . . . . . . . 83.4 mt -92.06 72.24 5.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.855 0.36 . . . . 0.0 111.08 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 516' ' ' HIS . . . . . 0.511 ' CE1' ' CZ ' ' A' ' 517' ' ' TYR . 10.7 p80 -86.15 -7.18 58.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.669 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 517' ' ' TYR . . . . . 0.511 ' CZ ' ' CE1' ' A' ' 516' ' ' HIS . 46.2 m-85 -84.03 -19.43 34.45 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.711 -0.222 . . . . 0.0 111.576 -179.809 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 518' ' ' TRP . . . . . 0.5 ' O ' ' N ' ' A' ' 520' ' ' THR . 4.4 m-90 -118.08 -13.32 9.97 Favored 'General case' 0 C--N 1.332 -0.164 0 N-CA-C 112.227 0.454 . . . . 0.0 112.227 -179.134 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 519' ' ' THR . . . . . 0.563 ' OG1' ' N ' ' A' ' 520' ' ' THR . 1.2 p 57.5 -78.13 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 110.643 -0.132 . . . . 0.0 110.643 -179.691 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 520' ' ' THR . . . . . 0.563 ' N ' ' OG1' ' A' ' 519' ' ' THR . 1.2 m 178.53 -62.75 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.227 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 521' ' ' GLN . . . . . . . . . . . . . 10.7 mt-30 -75.54 -11.74 60.09 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.268 178.206 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 522' ' ' ASP . . . . . 0.457 ' HB2' ' O ' ' A' ' 518' ' ' TRP . 45.2 m-20 -94.48 -12.39 27.8 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.013 178.588 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 523' ' ' GLU . . . . . 0.412 ' HG3' ' HA ' ' A' ' 520' ' ' THR . 20.2 mm-40 -50.0 -25.22 3.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.701 178.632 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 524' ' ' GLY . . . . . . . . . . . . . . . 139.48 37.9 0.11 Allowed Glycine 0 N--CA 1.445 -0.708 0 N-CA-C 110.3 -1.12 . . . . 0.0 110.3 -179.075 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 525' ' ' ALA . . . . . . . . . . . . . . . -107.94 -42.96 4.55 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.273 -0.464 . . . . 0.0 111.61 -178.543 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 526' ' ' ALA . . . . . 0.53 ' O ' ' HB1' ' A' ' 544' ' ' ALA . . . -136.8 42.74 2.45 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-O 121.441 0.638 . . . . 0.0 110.157 179.678 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 527' ' ' ILE . . . . . 0.74 HD12 ' N ' ' A' ' 528' ' ' GLY . 1.8 pp -95.53 -8.38 9.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 114.994 -1.003 . . . . 0.0 112.39 -179.056 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 528' ' ' GLY . . . . . 0.74 ' N ' HD12 ' A' ' 527' ' ' ILE . . . -55.95 -16.32 12.51 Favored Glycine 0 CA--C 1.52 0.402 0 C-N-CA 120.938 -0.649 . . . . 0.0 114.009 -179.222 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 529' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -98.49 -35.3 10.3 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 117.581 0.69 . . . . 0.0 111.767 -179.314 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 530' ' ' ALA . . . . . 1.009 ' HB3' ' HB2' ' A' ' 544' ' ' ALA . . . -103.6 1.06 31.61 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.694 0.627 . . . . 0.0 112.694 -178.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 531' ' ' TRP . . . . . 0.457 ' HB2' ' O ' ' A' ' 527' ' ' ILE . 22.4 t90 -56.08 -12.81 1.63 Allowed 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 111.878 0.325 . . . . 0.0 111.878 -179.439 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 532' ' ' ILE . . . . . 0.698 ' O ' HD12 ' A' ' 532' ' ' ILE . 1.6 pp -129.8 74.74 80.43 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 120.908 0.385 . . . . 0.0 111.06 179.665 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 533' ' ' PRO . . . . . 0.58 ' HB3' ' HB3' ' A' ' 539' ' ' ALA . 9.5 Cg_endo -51.89 94.91 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.891 2.394 . . . . 0.0 112.688 -179.68 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 534' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -96.26 -17.13 20.97 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.09 179.558 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 535' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -75.89 -35.01 60.0 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.369 -179.595 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 536' ' ' GLY . . . . . . . . . . . . . . . 143.88 -64.15 0.48 Allowed Glycine 0 CA--C 1.519 0.297 0 C-N-CA 120.484 -0.865 . . . . 0.0 112.788 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 537' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -58.95 -165.79 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.689 2.259 . . . . 0.0 112.177 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 538' ' ' ALA . . . . . 0.436 ' O ' ' HB3' ' A' ' 539' ' ' ALA . . . -63.02 -49.76 73.37 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.474 179.825 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 539' ' ' ALA . . . . . 0.599 ' C ' ' HB1' ' A' ' 530' ' ' ALA . . . 68.01 -57.63 0.46 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 121.389 0.614 . . . . 0.0 111.804 179.578 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 540' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -37.48 -29.94 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.942 -1.026 . . . . 0.0 112.338 -179.173 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 541' ' ' GLY . . . . . 0.401 ' O ' ' HB3' ' A' ' 549' ' ' HIS . . . -122.89 -26.23 1.76 Allowed Glycine 0 CA--C 1.52 0.379 0 C-N-CA 120.281 -0.961 . . . . 0.0 113.503 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 542' ' ' ILE . . . . . 0.54 ' CD1' ' HA ' ' A' ' 539' ' ' ALA . 2.6 pp -96.48 -21.47 5.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 112.392 0.515 . . . . 0.0 112.392 -179.247 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 543' ' ' TYR . . . . . 0.455 ' HB2' ' HA ' ' A' ' 539' ' ' ALA . 3.6 t80 -107.86 -13.75 14.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.084 0.468 . . . . 0.0 110.263 179.536 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 544' ' ' ALA . . . . . 1.009 ' HB2' ' HB3' ' A' ' 530' ' ' ALA . . . -92.16 -21.58 20.32 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.309 179.453 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 545' ' ' GLU . . . . . 0.517 ' OE2' ' HB2' ' A' ' 548' ' ' MET . 4.2 tp10 -118.36 -33.35 4.38 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.363 -179.666 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 546' ' ' GLY . . . . . . . . . . . . . . . 35.21 40.71 0.26 Allowed Glycine 0 CA--C 1.519 0.297 0 CA-C-N 115.808 -0.633 . . . . 0.0 114.472 179.278 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 547' ' ' LEU . . . . . 0.617 HD23 ' H ' ' A' ' 548' ' ' MET . 0.0 OUTLIER -179.79 -61.43 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 118.004 0.902 . . . . 0.0 112.46 179.567 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 548' ' ' MET . . . . . 0.617 ' H ' HD23 ' A' ' 547' ' ' LEU . 0.0 OUTLIER -94.6 11.65 30.31 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.818 0.342 . . . . 0.0 111.085 179.794 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 549' ' ' HIS . . . . . 0.491 ' O ' ' CG2' ' A' ' 519' ' ' THR . 6.7 p-80 -62.6 -11.12 14.88 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.079 179.568 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 550' ' ' ASN . . . . . 0.429 ' O ' ' N ' ' A' ' 552' ' ' ASP . 47.3 m-20 -96.04 -33.06 12.26 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -178.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 551' ' ' GLN . . . . . 0.411 ' HG2' ' CG ' ' A' ' 548' ' ' MET . 1.7 pt20 -66.36 71.53 0.07 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.109 0.48 . . . . 0.0 110.654 -179.79 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 552' ' ' ASP . . . . . 0.455 ' O ' ' HA ' ' A' ' 513' ' ' PRO . 3.3 p30 -95.38 21.96 7.47 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.396 -179.661 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 553' ' ' GLY . . . . . . . . . . . . . . . 123.89 -31.05 4.66 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.902 -0.666 . . . . 0.0 111.683 -179.279 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 554' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -61.48 -58.76 6.88 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.42 0.628 . . . . 0.0 109.87 178.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 555' ' ' ILE . . . . . 0.637 HG22 ' O ' ' A' ' 555' ' ' ILE . 3.2 mm -73.28 63.29 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 114.973 -1.012 . . . . 0.0 110.694 179.765 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 556' ' ' CYS . . . . . 0.408 ' O ' ' CD ' ' A' ' 559' ' ' ARG . 0.1 OUTLIER -74.09 -8.0 54.55 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.432 -179.763 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 557' ' ' GLY . . . . . 0.462 ' C ' ' HD3' ' A' ' 559' ' ' ARG . . . -48.7 -23.08 3.12 Favored Glycine 0 C--N 1.333 0.413 0 C-N-CA 120.993 -0.622 . . . . 0.0 113.006 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 558' ' ' LEU . . . . . 0.456 HD11 ' CB ' ' A' ' 509' ' ' PRO . 1.2 pp -55.03 -20.95 10.61 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 559' ' ' ARG . . . . . 0.462 ' HD3' ' C ' ' A' ' 557' ' ' GLY . 0.0 OUTLIER -53.38 -166.82 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 121.152 0.501 . . . . 0.0 111.237 -179.98 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 560' ' ' GLN . . . . . 0.414 ' HG3' ' HG2' ' A' ' 559' ' ' ARG . 5.4 mt-30 . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.229 -0.891 . . . . 0.0 111.181 179.85 . . . . . . . . 1 1 . 1 stop_ save_